PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Schriner, SE; Linford, NJ; Martin, GM; Treuting, P; Ogburn, CE; Emond, M; Coskun, PE; Ladiges, W; Wolf, N; Van Remmen, H; Wallace, DC; Rabinovitch, PS				Schriner, SE; Linford, NJ; Martin, GM; Treuting, P; Ogburn, CE; Emond, M; Coskun, PE; Ladiges, W; Wolf, N; Van Remmen, H; Wallace, DC; Rabinovitch, PS			Extension of murine life span by overexpression of catalase targeted to mitochondria	SCIENCE			English	Article							SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; IN-VIVO; THIOREDOXIN; EXPRESSION; LONGEVITY; INCREASE	To determine the, role of reactive oxygen species in mammalian longevity, we generated transgenic mice that overexpress human catalase localized to the peroxisome, the nucleus, or mitochondria (MCAT). Median and maximum life spans were maximally increased (averages of 5 months and 5.5 months, respectively) in MCAT animals. Cardiac pathology and cataract development were delayed, oxidative damage was reduced, H2O2 production and H2O2-induced aconitase inactivation were attenuated, and the development of mitochondria) deletions was reduced. These results support the free radical theory of aging and reinforce the importance of mitochondria as a source of these radicals.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92697 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Texas System; University of Texas Health San Antonio	Rabinovitch, PS (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	petersr@u.washington.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519	NIA NIH HHS [AG13280, AG001751] Funding Source: Medline; NIEHS NIH HHS [ES07033] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG001751, P30AG013280] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BURNS TR, 1990, MODERN PATHOL, V3, P336; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Huang TT, 2000, J GERONTOL A-BIOL, V55, pB5; Jiang JJ, 2003, J BIOCHEM, V133, P423, DOI 10.1093/jb/mvg055; Keaney M, 2004, FREE RADICAL BIO MED, V37, P239, DOI 10.1016/j.freeradbiomed.2004.04.005; Keaney M, 2003, FREE RADICAL BIO MED, V34, P277, DOI 10.1016/S0891-5849(02)01290-X; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974; Mitsui A, 2002, ANTIOXID REDOX SIGN, V4, P693, DOI 10.1089/15230860260220201; Mockett RJ, 2003, FREE RADICAL BIO MED, V34, P207, DOI 10.1016/S0891-5849(02)01190-5; Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Sampayo JN, 2003, AGING CELL, V2, P319, DOI 10.1046/j.1474-9728.2003.00063.x; Schriner SE, 2000, FREE RADICAL BIO MED, V29, P664, DOI 10.1016/S0891-5849(00)00352-X; Sun JT, 2002, GENETICS, V161, P661	20	1263	1325	2	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1909	1911		10.1126/science.1106653	http://dx.doi.org/10.1126/science.1106653			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15879174				2022-12-28	WOS:000230120000040
J	Whitmer, RA; Gunderson, EP; Barrett-Connor, E; Quesenberry, CP; Yaffe, K				Whitmer, RA; Gunderson, EP; Barrett-Connor, E; Quesenberry, CP; Yaffe, K			Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; FOLLOW-UP; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; ABDOMINAL OBESITY; AFRICAN-AMERICAN; WEIGHT-LOSS; INFLAMMATION; ASSOCIATION	Objective To evaluate any association between obesity in middle age, measured by body mass index and skinfold thickness, and risk of dementia later in life. Design Analysis of prospective data from a multiethnic population based cohort. Setting Kaiser Permanente Northern California Medical Group, a healthcare delivery organisation. Participants 10 276 men and women who underwent detailed health evaluations from 1964 to 1973 when they were aged 40-45 and who were still members of the health plan in 1994. Main outcome measures Diagnosis of dementia from January 1994 to April 2003. Time to diagnosis was analysed with Cox proportional hazard models adjusted for age, sex, race, education, smoking, alcohol use, marital status, diabetes, hypertension, hyperlipidaemia, stroke, and ischaemic heart disease. Results Dementia was diagnosed in 713 (6.9%) participants. Obese people (body mass index >= 30) had a 74% increased risk of dementia (hazard ratio 1.74, 95% confidence interval 1.34 to 2.26), while overweight people (body mass index 25.0-29.9) had a 35% greater risk of dementia (1.35, 1.14 to 1.60) compared with those of normal weight (body mass index 18.6-24.9). Compared with those in the lowest fifth, men and women in the highest fifth of the distribution of subscapular or tricep skinfold thickness had a 72% and 59% greater risk of dementia, respectively (1.72, 1.36 to 2.18, and 1.59, 1.24 to 2.04). Conclusions Obesity in middle age increases the risk of future dementia independently of comorbid conditions.	Kaiser Permanente, Div Res, Oakland, CA 94612 USA; Univ Calif, Dept Epidemiol, La Jolla, CA USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	Kaiser Permanente; University of California System; University of California San Diego; University of California System; University of California San Francisco	Whitmer, RA (corresponding author), Kaiser Permanente, Div Res, Oakland, CA 94612 USA.	raw@dor.kaiser.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K12AR047659] Funding Source: NIH RePORTER; NIAMS NIH HHS [5 K12AR47659] Funding Source: Medline; NICHD NIH HHS [K12 HD052163] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abbott RD, 2002, NEUROLOGY, V59, P1051, DOI 10.1212/WNL.59.7.1051; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Barrett-Connor E, 1998, J Nutr Health Aging, V2, P113; BAUMGARTNER RN, 1995, OBES RES, V3, P73, DOI 10.1002/j.1550-8528.1995.tb00124.x; Bray GA, 2004, INT J OBESITY, V28, P34, DOI 10.1038/sj.ijo.0802479; Breteler MMB, 2000, ANN NY ACAD SCI, V903, P457, DOI 10.1111/j.1749-6632.2000.tb06399.x; Brookmeyer R, 2000, STAT MED, V19, P1481, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1481::AID-SIM440>3.0.CO;2-U; Bunout D, 2001, NES NUTR WS, V5, P263, DOI 10.1159/000061838; Chaldakov GN, 2003, CURR PHARM DESIGN, V9, P1023, DOI 10.2174/1381612033455152; COLLEN MF, 1969, JOM-J OCCUP MED, V11, P355; CroninStubbs D, 1997, BMJ-BRIT MED J, V314, P178, DOI 10.1136/bmj.314.7075.178; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; *FANBNRC COMM NUTR, 1956, HUM BIOL, V28, P115; Funahashi H, 2003, INT REV CYTOL, V224, P1, DOI 10.1016/S0074-7696(05)24001-9; Gonzalez-Gross M, 2001, BRIT J NUTR, V86, P313, DOI 10.1079/BJN2001388; Gustafson D, 2004, NEUROLOGY, V63, P1876, DOI 10.1212/01.WNL.0000141850.47773.5F; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Gustafson DR, 2004, INT PSYCHOGERIATR, V16, P327, DOI 10.1017/s1041610204000353; Harvey J, 2003, ANN MED, V35, P197, DOI 10.1080/07853890310008251; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2810, DOI 10.1001/jama.283.21.2810; Kalmijn S, 1999, INT J OBESITY, V23, P395, DOI 10.1038/sj.ijo.0800832; Karter AJ, 1996, DIABETES, V45, P1547, DOI 10.2337/diabetes.45.11.1547; Knittweis J, 1998, J AM GERIATR SOC, V46, P540, DOI 10.1111/j.1532-5415.1998.tb02487.x; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; LANDIN K, 1990, METABOLISM, V39, P1044, DOI 10.1016/0026-0495(90)90164-8; Lofgren I, 2004, J NUTR, V134, P1071, DOI 10.1093/jn/134.5.1071; Luchsinger JA, 2001, AM J EPIDEMIOL, V154, P635, DOI 10.1093/aje/154.7.635; Ramos EJB, 2003, SURGERY, V134, P329, DOI 10.1067/msy.2003.267; Schmidt R, 2002, ANN NEUROL, V52, P168, DOI 10.1002/ana.10265; SELBY JV, 1989, AM J EPIDEMIOL, V129, P43, DOI 10.1093/oxfordjournals.aje.a115123; Wang San Y, 2002, J Nutr Health Aging, V6, P201; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yaffe K, 2004, NEUROLOGY, V63, P658, DOI 10.1212/01.WNL.0000134666.64593.BA; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237; YAFFE K, 2004, JAMA-J AM MED ASSOC, V92, P2237; Yarnell JWG, 2001, INT J OBESITY, V25, P1546, DOI 10.1038/sj.ijo.0801676	37	675	700	2	55	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2005	330	7504					1360	1362B		10.1136/bmj.38446.466238.E0	http://dx.doi.org/10.1136/bmj.38446.466238.E0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936FE	15863436	Green Published			2022-12-28	WOS:000229840100018
J	Thompson, AM; Stonebridge, PA				Thompson, AM; Stonebridge, PA			Building a framework for trust: critical event analysis of deaths in surgical care	BRITISH MEDICAL JOURNAL			English	Article							SURGERY; QUALITY; RISK; IMPROVEMENT; MANAGEMENT; AUDIT; ERROR	The British public's confidence in doctors and hospitals has been dented in recent years. Use of an independent review of deaths before, during, or after surgery reflects an attempt to improve care in this area and may also help to restore the public's trust in their health service.	Univ Dundee, Dept Surg & Mol Oncol, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Inst Cardiovasc Res, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Thompson, AM (corresponding author), Univ Dundee, Dept Surg & Mol Oncol, Dundee DD1 9SY, Scotland.	a.m.thompson@dundee.ac.uk						Carter D, 2003, BRIT MED J, V326, P832, DOI 10.1136/bmj.326.7394.832; Cohen MR, 2000, BRIT MED J, V320, P728, DOI 10.1136/bmj.320.7237.728; Donaldson LJ, 1998, J EPIDEMIOL COMMUN H, V52, P73, DOI 10.1136/jech.52.2.73; *GEN MED COUNC, 1998, GOOD MED PRACT; Gillies TE, 1996, BRIT J SURG, V83, P1394, DOI 10.1002/bjs.1800831021; GRAY CJG, 1998, REPORT NATL CONFIDEN; INBASEGARAN K, 1998, MED J MALAYSIA, V53, P321; Keogh B, 2004, BMJ-BRIT MED J, V329, P450, DOI 10.1136/bmj.329.7463.450; Macarthur DC, 1998, BRIT J SURG, V85, P80; McGugan E, 2000, J ROY COLL SURG EDIN, V45, P183; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Russell EM, 2003, BRIT J SURG, V90, P527, DOI 10.1002/bjs.4126; Sarker Sudip K, 2003, BMJ, V327, ps109, DOI 10.1136/bmj.327.7418.s109; Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406; *SCOTT INT GUID NE, 2004, SIGN GUID 77 POST MA; *SCOTT INT GUID NE, 2002, SIGN GUID 62 PROPH V; SMITH J, 2004, BMJ             0821, P329; Smith R, 2003, BRIT MED J, V327, P1239, DOI 10.1136/bmj.327.7426.1239; Stonebridge PA, 1999, J ROY COLL SURG EDIN, V44, P185; Thompson AM, 2004, BRIT J SURG, V91, P146; Thompson AM, 2004, SURG ENDOSC, V18, P1257, DOI 10.1007/s00464-003-9256-9; Vincent C, 2000, BRIT MED J, V320, P777, DOI 10.1136/bmj.320.7237.777; Vincent C, 1998, BRIT MED J, V316, P1154, DOI 10.1136/bmj.316.7138.1154; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x	24	50	51	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 14	2005	330	7500					1139	1142		10.1136/bmj.330.7500.1139	http://dx.doi.org/10.1136/bmj.330.7500.1139			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15891231	Green Published			2022-12-28	WOS:000229166900025
J	Dong, JH; Yang, GY; Mchaourab, HS				Dong, JH; Yang, GY; Mchaourab, HS			Structural basis of energy transduction in the transport cycle of MsbA	SCIENCE			English	Article							RESISTANCE P-GLYCOPROTEIN; BINDING CASSETTE TRANSPORTERS; MULTIDRUG-RESISTANCE; ABC TRANSPORTERS; ATP-BINDING; ESCHERICHIA-COLI; TRANSMEMBRANE DOMAINS; CROSS-LINKING; MECHANISM; CONFORMATION	We used site-directed spin-labeling and electron paramagnetic resonance spectroscopy to characterize the conformational motion that couples energy expenditure to substrate translocation in the multidrug transporter MsbA. In liposomes, ligand-free MsbA samples conformations that depart from the crystal structures, including looser packing and water penetration along the periplasmic side. Adenosine triphosphate (ATP) binding closes the substrate chamber to the cytoplasm while increasing hydration at the periplasmic side, consistent with an alternating access model. Accentuated by ATP hydrolysis, the changes in the chamber dielectric environment and its geometry provide the likely driving force for flipping amphipathic substrates and a potential exit pathway. These results establish the structural dynamic basis of the power stroke in multidrug-resistant ATP-binding cassette (MDR ABC) transporters.	Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Mchaourab, HS (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	hassane.mchaourab@vanderbilt.edu		Dong, Jinhui/0000-0003-4542-7756				Buchaklian AH, 2004, BIOCHEMISTRY-US, V43, P8600, DOI 10.1021/bi0497751; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Dong J.-K., UNPUB; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2001, SCIENCE, V293, P1782, DOI 10.1126/science.1065588; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Higgins CF, 1997, SEMIN CANCER BIOL, V8, P135, DOI 10.1006/scbi.1997.0067; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Loo TW, 2004, BIOCHEMISTRY-US, V43, P12081, DOI 10.1021/bi049045t; Loo TW, 1996, J BIOL CHEM, V271, P27482, DOI 10.1074/jbc.271.44.27482; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; MITCHELL P, 1990, RES MICROBIOL, V141, P286, DOI 10.1016/0923-2508(90)90002-8; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Nikaido H, 1998, METHOD ENZYMOL, V292, P3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poelarends GJ, 2002, J BIOL CHEM, V277, P42891, DOI 10.1074/jbc.M206508200; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Seigneuret M, 2003, J BIOL CHEM, V278, P30115, DOI 10.1074/jbc.M302443200; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stenham DR, 2003, FASEB J, V17, P2287, DOI 10.1096/fj.03-0107fje; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; van Veen HW, 1998, ADV EXP MED BIOL, V456, P145; van Veen HW, 1998, BBA-BIOENERGETICS, V1365, P31, DOI 10.1016/S0005-2728(98)00039-5; van Veen HW, 2001, RES MICROBIOL, V152, P365, DOI 10.1016/S0923-2508(01)01208-6; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	32	128	133	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1023	1028		10.1126/science.1106592	http://dx.doi.org/10.1126/science.1106592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890883				2022-12-28	WOS:000229190700047
J	Jaccard, SL; Haug, GH; Sigman, DM; Pedersen, TF; Thierstein, HR; Rohl, U				Jaccard, SL; Haug, GH; Sigman, DM; Pedersen, TF; Thierstein, HR; Rohl, U			Glacial/interglacial changes in subarctic North Pacific stratification	SCIENCE			English	Article							ATMOSPHERIC CO2; SOUTHERN-OCEAN; EXPORT PRODUCTION; ATLANTIC SECTOR; CLIMATE; PRODUCTIVITY; RECORDS; WATER; OPAL; ICE	Since the first evidence of low algal productivity during ice ages in the Antarctic Zone of the Southern Ocean was discovered, there has been debate as to whether it was associated with increased polar ocean stratification or with sea-ice cover, shortening the productive season. The sediment concentration of biogenic barium at Ocean Drilling Program site 882 indicates low algal productivity during ice ages in the Subarctic North Pacific as well. Site 882 is located southeast of the summer sea-ice extent even during glacial maxima, ruling out sea-ice-driven light limitation and supporting stratification as the explanation, with implications for the glacial cycles of atmospheric carbon dioxide concentration.	ETH Zentrum, Dept Earth Sci, CH-8092 Zurich, Switzerland; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; Univ Bremen, DFG Res Ctr Ocean Margins, Bremen, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Princeton University; University of Victoria; German Research Foundation (DFG); University of Bremen	Jaccard, SL (corresponding author), ETH Zentrum, Dept Earth Sci, Sonneggstr 5, CH-8092 Zurich, Switzerland.	jaccard@erdw.ethz.ch	Sigman, Daniel M/A-2649-2008; Jaccard, Samuel/G-3447-2014; Röhl, Ursula/G-5986-2011	Sigman, Daniel M/0000-0002-7923-1973; Jaccard, Samuel/0000-0002-5793-0896; Röhl, Ursula/0000-0001-9469-7053				Bender ML, 2002, EARTH PLANET SC LETT, V204, P275, DOI 10.1016/S0012-821X(02)00980-9; Bonn WJ, 1998, PALAEOGEOGR PALAEOCL, V139, P195, DOI 10.1016/S0031-0182(97)00144-2; BROECKER WS, 1998, J GEOPHYS RES, V103, P15; Catubig NR, 1998, PALEOCEANOGRAPHY, V13, P298, DOI 10.1029/98PA00609; CLIMAP project members, 1981, GEOL SOC AM MAP CHAR; Dymond J, 1992, PALEOCEANOGRAPHY, V7, P163, DOI 10.1029/92PA00181; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Frank M, 2000, PALEOCEANOGRAPHY, V15, P642, DOI 10.1029/2000PA000497; Haug GH, 1999, NATURE, V401, P779, DOI 10.1038/44550; HAUG GH, 1996, BERICHTE REPORTS GEO, V78, P1; HILLENBRAND CD, 2000, THESIS A WEGNER I BR; Kiefer T, 2005, QUATERNARY SCI REV, V24, P1063, DOI 10.1016/j.quascirev.2004.02.021; Kienast SS, 2004, J OCEANOGR, V60, P189, DOI 10.1023/B:JOCE.0000038326.73943.aa; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; Marchitto TM, 2005, EARTH PLANET SC LETT, V231, P317, DOI 10.1016/j.epsl.2004.12.024; MORTLOCK RA, 1991, NATURE, V351, P220, DOI 10.1038/351220a0; NAKATSUKA T, 1995, PALEOCEANOGRAPHY, V10, P1047, DOI 10.1029/95PA02644; Narita H, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014320; Nurnberg CC, 1997, PALEOCEANOGRAPHY, V12, P594, DOI 10.1029/97PA01130; Nurnberg D, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001023; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Rea D.K., 1993, PROC OCEAN DRILL SCI, V145, P85, DOI [10.2973/odp.proc.ir.145.106.1993, DOI 10.2973/ODP.PROC.IR.145.106.1993]; SARMIENTO JL, 1991, LIMNOL OCEANOGR, V36, P1928, DOI 10.4319/lo.1991.36.8.1928; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; Sarnthein M, 2004, QUATERNARY SCI REV, V23, P2089, DOI 10.1016/j.quascirev.2004.08.008; Sato MM, 2002, J OCEANOGR, V58, P461, DOI 10.1023/A:1021257130879; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; SIEGENTHALER U, 1984, NATURE, V308, P624, DOI 10.1038/308624a0; Sigman DM, 2004, NATURE, V428, P59, DOI 10.1038/nature02357; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000; Werner M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002365	34	136	140	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1003	1006		10.1126/science.1108696	http://dx.doi.org/10.1126/science.1108696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890879				2022-12-28	WOS:000229190700041
J	Cho, PF; Poulin, F; Cho-Park, YA; Cho-Park, IB; Chicoine, JD; Lasko, P; Sonenberg, N				Cho, PF; Poulin, F; Cho-Park, YA; Cho-Park, IB; Chicoine, JD; Lasko, P; Sonenberg, N			A new paradigm for translational control: Inhibition via 5 '-3 ' mRNA tethering by Bicoid and the eIF4E cognate 4EHP	CELL			English	Article							BINDING-PROTEIN; INITIATION-FACTOR; POLY(A)-BINDING PROTEIN; DROSOPHILA CUP; CAP; REPRESSION; RECOGNITION; RECRUITMENT; OSKAR; MOTIF	Translational control is a key genetic regulatory mechanism implicated in regulation of cell and organismal growth and early embryonic development. Initiation at the mRNA 5' cap structure recognition step is frequently targeted by translational control mechanisms. In the Drosophila embryo, cap-dependent translation of the uniformly distributed caudal (cad) mRNA is inhibited in the anterior by Bicoid (Bcd) to create an asymmetric distribution of Cad protein. Here, we show that d4EHP, an eIF4E-related cap binding protein, specifically interacts with Bcd to suppress cad translation. Translational inhibition depends on the Bcd binding region (BBR) present in the cad 3' untranslated region. Thus, simultaneous interactions of d4EHP with the cap structure and of Bcd with BBR renders cad mRNA translationally inactive. This example of cap-dependent translational control that is not mediated by canonical eIF4E defines a new paradigm for translational inhibition involving tethering of the mRNA 5' and 3' ends.	McGill Univ, Dept Biochem, Mcgill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University	Poulin, F (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	fpoulin@berkeley.edu; nahum.sonenberg@mcgill.ca	Lasko, Paul/C-6761-2014	Lasko, Paul/0000-0002-4037-3501				Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Calero G, 2002, NAT STRUCT BIOL, V9, P912, DOI 10.1038/nsb874; Chan SK, 1997, NATURE, V388, P634, DOI 10.1038/41692; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hodel AE, 1997, NAT STRUCT BIOL, V4, P350, DOI 10.1038/nsb0597-350; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Kobayashi S, 1999, ADV MOLEC BIOL, P426; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Lynch J, 2003, CURR BIOL, V13, pR557, DOI 10.1016/S0960-9822(03)00472-X; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Mazza C, 2001, MOL CELL, V8, P383, DOI 10.1016/S1097-2765(01)00299-4; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Niessing D, 1999, EMBO J, V18, P1966, DOI 10.1093/emboj/18.7.1966; Niessing D, 2002, GENE DEV, V16, P2576, DOI 10.1101/gad.240002; Poulin F, 2003, MOL B INT U, P280; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Sachs A, 2000, COLD SPRING HARBOR M, V39, P447; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; STJOHNSTON D, 1992, CELL, V68, P201; Svitkin YV, 2001, RNA, V7, P1743; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; Tee AR, 2004, FEBS LETT, V564, P58, DOI 10.1016/S0014-5793(04)00313-8; Thomson T, 2004, GENESIS, V40, P164, DOI 10.1002/gene.20079; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088	48	177	178	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					411	423		10.1016/j.cell.2005.02.024	http://dx.doi.org/10.1016/j.cell.2005.02.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882623	Green Published, Bronze			2022-12-28	WOS:000229031600011
J	Tsubouchi, T; Roeder, GS				Tsubouchi, T; Roeder, GS			A synaptonemal complex protein promotes homology-independet centromere coupling	SCIENCE			English	Article							MEIOTIC CHROMOSOMES; BUDDING YEAST; PH1 LOCUS; MEIOSIS; RECOMBINATION; INITIATION; SYNAPSIS; LINK	We describe a process in meiotic cells of budding yeast in which chromosomes become joined together in pairs at their centromeres independent of chromosomal homology. These centromeric interactions depend on the synaptonemal complex component Zip1. During meiosis in wild-type diploids, centromere couples are initially nonhomologous and then undergo switching until all couples involve homologs. This transition to homologous coupling depends on Spo11, a protein required for the initiation of meiotic recombination. Regions of synaptonemal complex assembled early in meiosis are often centromere-associated. We propose that centromere coupling facilitates homolog pairing and promotes synapsis initiation.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Roeder, GS (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	shirleen.roeder@yale.edu		Tsubouchi, Tomomi/0000-0001-9960-3888	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Dong HJ, 2000, J CELL BIOL, V148, P417, DOI 10.1083/jcb.148.3.417; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Maestra B, 2002, CHROMOSOME RES, V10, P655, DOI 10.1023/A:1021564327226; Martinez-Perez E, 2001, NATURE, V411, P204, DOI 10.1038/35075597; NAG DK, 1995, GENETICS, V141, P75; Rockmill B, 1998, GENE DEV, V12, P2574, DOI 10.1101/gad.12.16.2574; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; Walker MY, 2000, CHROMOSOMA, V109, P3, DOI 10.1007/s004120050407	18	124	129	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					870	873		10.1126/science.1108283	http://dx.doi.org/10.1126/science.1108283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879219				2022-12-28	WOS:000228986500053
J	Clark, RN; Brown, RH; Jaumann, R; Cruikshank, DP; Nelson, RM; Buratti, BJ; Mccord, TB; Lunine, J; Baines, KH; Bellucci, G; Bibring, JP; Capaccioni, F; Cerroni, P; Coradini, A; Formisano, V; Langevin, Y; Matson, DL; Mennella, V; Nicholson, PD; Sicardy, B; Sotin, C; Hoefen, TM; Curchin, JM; Hansen, G; Hibbits, K; Matz, KD				Clark, RN; Brown, RH; Jaumann, R; Cruikshank, DP; Nelson, RM; Buratti, BJ; Mccord, TB; Lunine, J; Baines, KH; Bellucci, G; Bibring, JP; Capaccioni, F; Cerroni, P; Coradini, A; Formisano, V; Langevin, Y; Matson, DL; Mennella, V; Nicholson, PD; Sicardy, B; Sotin, C; Hoefen, TM; Curchin, JM; Hansen, G; Hibbits, K; Matz, KD			Compositional maps of Saturn's moon Phoebe from imaging spectroscopy	NATURE			English	Article							WATER-ICE; HYPERION	The origin of Phoebe, which is the outermost large satellite of Saturn, is of particular interest because its inclined, retrograde orbit suggests that it was gravitationally captured by Saturn, having accreted outside the region of the solar nebula in which Saturn formed(1). By contrast, Saturn's regular satellites ( with prograde, low-inclination, circular orbits) probably accreted within the sub-nebula in which Saturn itself formed(2). Here we report imaging spectroscopy of Phoebe resulting from the Cassini - Huygens spacecraft encounter on 11 June 2004. We mapped ferrous-iron-bearing minerals, bound water, trapped CO2, probable phyllosilicates, organics, nitriles and cyanide compounds. Detection of these compounds on Phoebe makes it one of the most compositionally diverse objects yet observed in our Solar System. It is likely that Phoebe's surface contains primitive materials from the outer Solar System, indicating a surface of cometary origin.	US Geol Survey, Denver Fed Ctr, Denver, CO 80225 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Arizona, Stewart Observ, Tucson, AZ 85721 USA; German Aerosp Ctr, Inst Space Sensor Technol & Planetary Explorat, D-12489 Berlin, Germany; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Hawaii Manoa, HIGP, SOEST, Honolulu, HI 96822 USA; CNR, Ist Fis Spazio Interplanetario, I-00133 Rome, Italy; Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Observ Paris, F-92195 Meudon, France; Univ Nantes, Lab Planetol & Geodynam, CNRS, UMR 6112, F-44322 Nantes, France; Planetary Sci Inst NW, Corp Ctr Pasadena, Pasadena, CA 91101 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	United States Department of the Interior; United States Geological Survey; University of Arizona; University of Arizona; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Hawaii System; University of Hawaii Manoa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Cornell University; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Nantes Universite; University of Washington; University of Washington Seattle	Clark, RN (corresponding author), US Geol Survey, Denver Fed Ctr, MS964,Box 25046, Denver, CO 80225 USA.	rclark@usgs.gov	Jaumann, Ralf/N-1001-2018; Bellucci, Giancarlo/ABA-9201-2020	Jaumann, Ralf/0000-0002-9759-6597; Bellucci, Giancarlo/0000-0003-0867-8679; Cerroni, Priscilla/0000-0003-0239-2741; Lunine, Jonathan/0000-0003-2279-4131; Mennella, Vito/0000-0001-9525-895X; Capaccioni, Fabrizio/0000-0003-1631-4314				Barucci MA, 2001, ASTRON ASTROPHYS, V371, P1150, DOI 10.1051/0004-6361:20010501; Brown RH, 1999, ASTROPHYS J, V519, pL101, DOI 10.1086/312098; BROWN RH, IN PRESS SPACE SCI R; BROWN RH, IN PRESS ASTROPHYS J; Buratti BJ, 2002, ICARUS, V155, P375, DOI 10.1006/icar.2001.6730; BURATTI BJ, 2004, B AM ASTRON SOC, V36, P1072; BURNS JA, 1986, SATELLITES, P117; Clark RN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001847; CLARK RN, 2003, 03395 USGS; Cruikshank DP, 2002, ICARUS, V156, P434, DOI 10.1006/icar.2001.6810; Cruikshank DP, 2001, ICARUS, V153, P348, DOI 10.1006/icar.2001.6703; GAFFEY MJ, 1993, SCIENCE, V260, P167, DOI 10.1126/science.260.5105.167; HOOK S, 2004, ASTER SPECTRAL LIB; Jarvis KS, 2000, ICARUS, V146, P125, DOI 10.1006/icar.2000.6311; Levison HF, 2003, NATURE, V426, P419, DOI 10.1038/nature02120; Liou JC, 1997, SCIENCE, V275, P375, DOI 10.1126/science.275.5298.375; McCord TB, 1998, J GEOPHYS RES-PLANET, V103, P8603, DOI 10.1029/98JE00788; Owen TC, 1999, ICARUS, V139, P379, DOI 10.1006/icar.1999.6116; POLLACK JB, 1979, ICARUS, V37, P587, DOI 10.1016/0019-1035(79)90016-2; Soderblom LA, 2002, SCIENCE, V296, P1087, DOI 10.1126/science.1069527; STEIN SE, 2004, 35 NIST SPECTR LIB	21	121	122	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					66	69		10.1038/nature03558	http://dx.doi.org/10.1038/nature03558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875014				2022-12-28	WOS:000228864600036
J	King, CH; Dickman, K; Tisch, DJ				King, CH; Dickman, K; Tisch, DJ			Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis	LANCET			English	Article							NECROSIS-FACTOR-ALPHA; PHYSICAL-FITNESS; CANE CUTTERS; ANTHELMINTIC TREATMENT; HAEMATOBIUM INFECTION; IRON SUPPLEMENTATION; WORKER PRODUCTIVITY; ECONOMIC-EVALUATION; NUTRITIONAL-STATUS; MENTAL-ABILITY	Background Schistosomiasis is one of the world's most prevalent infections, yet its effect on the global burden of disease is controversial. Published disability-adjusted life-year (DALY) estimates suggest that the average effect of schistosome infection is quite small, although this is disputed. To develop an evidenced-based reassessment of schistosomiasis-related disability, we did a systematic review of data on disability-associated outcomes for all forms of schistosomiasis. Methods We did structured searches using EMBASE, PUBMED, and Cochrane electronic databases. Published bibliographies were manually searched, and unpublished studies were obtained by contacting research groups. Reports were reviewed and abstracted independently by two trained readers. All randomised and observational studies of schistosomiasis morbidity were eligible for inclusion. We calculated pooled estimates of reported disability-related effects using weighted odds ratios for categorical outcomes and standardised mean differences for continuous data. Findings 482 published or unpublished reports (March, 1921, to July, 2002) were screened. Of 135 selected for inclusion, 51 provided data for performance-related symptoms, whereas 109 reported observed measures of disability-linked morbidities. Schistosomiasis was significantly associated with anaemia, chronic pain, diarrhoea, exercise intolerance, and undernutrition. Interpretation By contrast with WHO estimates of 0.5% disability weight assigned to schistosomiasis, 2-15% disability seems evident in different functional domains of a person with schistosomiasis. This raised estimate, if confirmed in formal patient-preference studies, indicates a need to reassess our priorities for treating this silent pandemic of schistosomiasis.	Case Western Reserve Univ, Sch Med, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA	Case Western Reserve University	King, CH (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Global Hlth & Dis, Wolstein 4126, Cleveland, OH 44106 USA.	chk@cwru.edu	Tisch, Daniel/Q-5044-2019; Dobbs, Katherine/AAE-8178-2022	Dobbs, Katherine/0000-0002-8529-038X; King, Charles/0000-0001-8349-9270	FOGARTY INTERNATIONAL CENTER [R01TW001543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI045473] Funding Source: NIH RePORTER	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABDALLA A., 1964, Journal of the Egyptian Public Health Association, V39, P135; AbouZahr C, 2000, B WORLD HEALTH ORGAN, V78, P655; BARBOSA FS, 1981, AM J EPIDEMIOL, V114, P102, DOI 10.1093/oxfordjournals.aje.a113156; BELL RMS, 1973, T ROY SOC TROP MED H, V67, P694, DOI 10.1016/0035-9203(73)90040-0; BROOKS RM, 1979, E AFR MED J, V56, P413; CASTLE WM, 1974, S AFR MED J, V48, P2035; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COLLINS KJ, 1976, AM J TROP MED HYG, V25, P410, DOI 10.4269/ajtmh.1976.25.410; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; CONNOLLY KJ, 1993, PARASITOLOGY, V107, pS187, DOI 10.1017/S0031182000075612; COOK J A, 1974, American Journal of Tropical Medicine and Hygiene, V23, P625; Deeks J.J., 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; DEOLALIKAR AB, 1988, REV ECON STAT, V70, P406, DOI 10.2307/1926778; DOMINGO EO, 1980, AM J TROP MED HYG, V29, P858, DOI 10.4269/ajtmh.1980.29.858; Egger M., 2001, SYSTEMATIC REV HLTH, P3; FAROOQ M, 1963, ANN TROP MED PARASIT, V57, P323, DOI 10.1080/00034983.1963.11686185; FENWICK A, 1972, B WORLD HEALTH ORGAN, V47, P567; FOSTER R, 1967, J TROP MED HYG, V70, P185; GARDNER GW, 1977, AM J CLIN NUTR, V30, P910, DOI 10.1093/ajcn/30.6.910; GATEFF C., 1971, Annales de la Societe Belge de Medecine Tropicale, V51, P309; Glaspy J, 1997, J CLIN ONCOL, V15, P1218, DOI 10.1200/JCO.1997.15.3.1218; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; GREENHAM R, 1978, T ROY SOC TROP MED H, V72, P72, DOI 10.1016/0035-9203(78)90304-8; GRYSEELS B, 1989, TROP MED PARASITOL, V40, P134; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; Guerrant RL, 2002, TRENDS PARASITOL, V18, P191, DOI 10.1016/S1471-4922(02)02253-5; Guyatt H, 1995, AM J TROP MED HYG, V53, P660, DOI 10.4269/ajtmh.1995.53.660; Guyatt H, 2000, PARASITOL TODAY, V16, P153, DOI 10.1016/S0169-4758(99)01634-8; HIGGINS J, 1999, CI PLOT VERSION 2; Jukes MCH, 2002, TROP MED INT HEALTH, V7, P104, DOI 10.1046/j.1365-3156.2002.00843.x; KENNEDY E, 1994, EUR J CLIN NUTR, V48, pS45; KING CH, 2001, SCHISTOSOMIASIS, P265; KING CH, 2001, SCHISTOSOMIASIS, P115; King CL, 2001, J INFECT DIS, V184, P1176, DOI 10.1086/323802; Kirigia JM, 1998, HEALTH ECON, V7, P551, DOI 10.1002/(SICI)1099-1050(199809)7:6<551::AID-HEC367>3.0.CO;2-7; Kirigia JM, 1997, ACTA TROP, V64, P175, DOI 10.1016/S0001-706X(96)00630-4; KLOOS H, 1986, TROP MED PARASITOL, V37, P171; MICHAUD CM, 2004, GLOBAL BURDEN DIS DU, P1; Moreno F, 1996, AM J KIDNEY DIS, V27, P548, DOI 10.1016/S0272-6386(96)90166-3; Murray C.J, 1996, GLOBAL BURDEN DIS CO; Murray CJ, 1996, GLOBAL BURDEN DIS; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; NDAMBA J, 1993, ANN TROP MED PARASIT, V87, P553, DOI 10.1080/00034983.1993.11812810; Olds GR, 1999, J INFECT DIS, V179, P996, DOI 10.1086/314686; OLVEDA RM, 2001, SCHISTOSOMIASIS, P361; Osoba D, 1998, OX MED PUBL, P19; OUMA JH, 2001, SCHISTOSOMIASIS, P333; PARKER M, 1992, SOC SCI MED, V35, P877, DOI 10.1016/0277-9536(92)90102-V; Parraga IM, 1996, AM J TROP MED HYG, V55, P150, DOI 10.4269/ajtmh.1996.55.150; POLLITT E, 1993, ANNU REV NUTR, V13, P521, DOI 10.1146/annurev.nu.13.070193.002513; PRATA A, 2001, SCHISTOSOMIASIS, P297; PRUAL A, 1992, AM J TROP MED HYG, V47, P291, DOI 10.4269/ajtmh.1992.47.291; Reidpath DD, 2003, HEALTH POLICY PLANN, V18, P351, DOI 10.1093/heapol/czg043; SALIH SY, 1979, ANN TROP MED PARASIT, V73, P439, DOI 10.1080/00034983.1979.11687283; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; SIONGOK TKA, 1976, AM J TROP MED HYG, V25, P273, DOI 10.4269/ajtmh.1976.25.273; SPURR GB, 1977, AM J CLIN NUTR, V30, P316, DOI 10.1093/ajcn/30.3.316; STEPHENSON LS, 1985, AM J TROP MED HYG, V34, P322, DOI 10.4269/ajtmh.1985.34.322; Stoltzfus RJ, 2001, BRIT MED J, V323, P1389, DOI 10.1136/bmj.323.7326.1389; TANNER M, 1989, TROP MED PARASITOL, V40, P143; Taylor M, 2001, T ROY SOC TROP MED H, V95, P211, DOI 10.1016/S0035-9203(01)90171-3; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; VANDERWERF MJ, 2001, MORBIDITY INFECT SCH, P1; WALKER ARP, 1970, AM J TROP MED HYG, V19, P792, DOI 10.4269/ajtmh.1970.19.792; Wamachi AN, 2004, J INFECT DIS, V190, P2020, DOI 10.1086/425579; WARREN KS, 1979, AM J TROP MED HYG, V28, P864, DOI 10.4269/ajtmh.1979.28.864; WARREN KS, 1973, SCHISTOSOMIASIS EVOL; WEISBROD BA, 1977, ECON DEV CULT CHANGE, V25, P505, DOI 10.1086/450967; WEISBROD BA, 1973, DIS EC DEV IMPACT PA; *WHO, 2002, WHO TECH REP SER, V912, P2; WOLGEMUTH JC, 1982, AM J CLIN NUTR, V36, P68, DOI 10.1093/ajcn/36.1.68; Wu XH, 2002, ACTA TROP, V82, P247, DOI 10.1016/S0001-706X(02)00016-5	73	657	678	0	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1561	1569		10.1016/S0140-6736(05)66457-4	http://dx.doi.org/10.1016/S0140-6736(05)66457-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866310				2022-12-28	WOS:000228754800028
J	Korf, BR; Henson, JW; Harris, NL; MacCollin, M; Smith, ER; Stemmer-Rachamimov, A				Korf, BR; Henson, JW; Harris, NL; MacCollin, M; Smith, ER; Stemmer-Rachamimov, A			A 48-year-old man with weakness of the limbs and multiple tumors of spinal nerves - Neurofibromatosis type 1	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NF1 GENE; MUTATIONS; SCHWANNOMATOSIS; MOSAICISM; PHENOTYPE; SPECTRUM; FAMILIES; VARIANT		Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	University of Alabama System; University of Alabama Birmingham; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Korf, BR (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA.							[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; ARNSMEIER SL, 1994, ARCH DERMATOL, V130, P1425, DOI 10.1001/archderm.130.11.1425; Ars E, 1998, AM J HUM GENET, V62, P834, DOI 10.1086/301803; Blakley P, 2001, J MED GENET, V38, P485, DOI 10.1136/jmg.38.7.485; Castle B, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e109; Evans DGR, 1997, J NEUROL NEUROSUR PS, V62, P361, DOI 10.1136/jnnp.62.4.361; Fahsold R, 2000, AM J HUM GENET, V66, P790, DOI 10.1086/302809; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Kaufmann D, 2001, AM J HUM GENET, V69, P1395, DOI 10.1086/324648; Khong PL, 2003, AM J ROENTGENOL, V180, P413, DOI 10.2214/ajr.180.2.1800413; Kluwe L, 2003, J MED GENET, V40, P368, DOI 10.1136/jmg.40.5.368; Korf BR, 1999, AM J MED GENET, V89, P31, DOI 10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W; LAZARO C, 1994, NEW ENGL J MED, V331, P1403, DOI 10.1056/NEJM199411243312102; Leppig KA, 1997, AM J MED GENET, V73, P197, DOI 10.1002/(SICI)1096-8628(1997)73:2<197::AID-AJMG17>3.0.CO;2-P; MacCollin M, 1996, NEUROLOGY, V46, P1072, DOI 10.1212/WNL.46.4.1072; Messiaen L, 2003, J MED GENET, V40, P122, DOI 10.1136/jmg.40.2.122; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; PULST SM, 1991, NEUROLOGY, V41, P1923, DOI 10.1212/WNL.41.12.1923; Ruggieri M, 2001, NEUROLOGY, V56, P1433, DOI 10.1212/WNL.56.11.1433; SUH JS, 1992, RADIOLOGY, V183, P341, DOI 10.1148/radiology.183.2.1561333; TASSABEHJI M, 1993, AM J HUM GENET, V53, P90; Upadhyaya M, 2003, HUM GENET, V112, P12, DOI 10.1007/s00439-002-0840-1	22	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1800	1808		10.1056/NEJMcpc059008	http://dx.doi.org/10.1056/NEJMcpc059008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858190				2022-12-28	WOS:000228689000012
J	Beroukhim, R; Aquino, SL; Shipp, MA; Harris, NL; Hales, CA				Beroukhim, R; Aquino, SL; Shipp, MA; Harris, NL; Hales, CA			Case 12-2005: A 30-year-old woman with a mediastinal mass - Primary mediastinal diffuse large-B-cell lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HODGKINS-LYMPHOMA; TUMOR; REL; 9P; GAINS; 2P		Massachusetts Gen Hosp, Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Beroukhim, R (corresponding author), Massachusetts Gen Hosp, Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02114 USA.							ADDIS BJ, 1986, HISTOPATHOLOGY, V10, P379, DOI 10.1111/j.1365-2559.1986.tb02491.x; Barth TFE, 2003, BLOOD, V101, P3681, DOI 10.1182/blood-2002-08-2577; Barth TFE, 2002, LANCET ONCOL, V3, P229, DOI 10.1016/S1470-2045(02)00714-3; Bentz M, 2001, GENE CHROMOSOME CANC, V30, P393, DOI 10.1002/1098-2264(2001)9999:9999<::AID-GCC1105>3.0.CO;2-I; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; COHEN W, 2004, ANTERIOR MEDIASTINAL; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Copie-Bergman R, 1999, BLOOD, V94, P3567, DOI 10.1182/blood.V94.10.3567.422k06_3567_3575; de Leval L, 2001, AM J SURG PATHOL, V25, P1277, DOI 10.1097/00000478-200110000-00008; Durkop H, 1999, BLOOD, V93, P617, DOI 10.1182/blood.V93.2.617.402k14_617_623; HOFMANN WJ, 1988, VIRCHOWS ARCH A, V412, P431, DOI 10.1007/BF00750577; Joos S, 1996, BLOOD, V87, P1571, DOI 10.1182/blood.V87.4.1571.bloodjournal8741571; Joos S, 2003, INT J CANCER, V103, P489, DOI 10.1002/ijc.10845; Kuppers R, 2002, ANN ONCOL, V13, P11, DOI 10.1093/annonc/13.S1.11; LAMARRE L, 1989, AM J SURG PATHOL, V13, P730, DOI 10.1097/00000478-198909000-00002; Leithauser F, 2001, BLOOD, V98, P2762, DOI 10.1182/blood.V98.9.2762; LEVITT LJ, 1982, CANCER, V50, P2486, DOI 10.1002/1097-0142(19821201)50:11<2486::AID-CNCR2820501138>3.0.CO;2-G; LICHTENSTEIN AK, 1980, AM J MED, V68, P509, DOI 10.1016/0002-9343(80)90294-6; Martin-Subero JI, 2002, BLOOD, V99, P1474, DOI 10.1182/blood.V99.4.1474; MOLLER P, 1987, BLOOD, V69, P1087; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Roy B, 2002, J LEUKOCYTE BIOL, V72, P580; Rudiger T, 1998, ANN ONCOL, V9, P31, DOI 10.1023/A:1008466208072; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; SCARPA A, 1987, VIRCHOWS ARCH A, V412, P17, DOI 10.1007/BF00750725; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Tsang P, 1996, AM J PATHOL, V148, P2017; van Besien K, 2001, J CLIN ONCOL, V19, P1855, DOI 10.1200/JCO.2001.19.6.1855	28	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1697	1704		10.1056/NEJMcpc059006	http://dx.doi.org/10.1056/NEJMcpc059006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843673				2022-12-28	WOS:000228515200013
J	Silverman, E; Mouy, R; Spiegel, L; Jung, LK; Saurenmann, RK; Lahdenne, P; Horneff, G; Calvo, I; Szer, IS; Simpson, K; Stewart, JA; Strand, V				Silverman, E; Mouy, R; Spiegel, L; Jung, LK; Saurenmann, RK; Lahdenne, P; Horneff, G; Calvo, I; Szer, IS; Simpson, K; Stewart, JA; Strand, V		Lefluonomide JRA Investigator Grp	Leflunomide or methotrexate for juvenile rheumatoid arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIALS; DOUBLE-BLIND; CHILDREN; PLACEBO; MULTICENTER; EFFICACY; SAFETY; PHARMACOKINETICS; SULFASALAZINE; ETANERCEPT	BACKGROUND: We compared the safety and efficacy of leflunomide with that of methotrexate in the treatment of polyarticular juvenile rheumatoid arthritis in a multinational, randomized, controlled trial. METHODS: Patients 3 to 17 years of age received leflunomide or methotrexate for 16 weeks in a double-dummy, blinded fashion, followed by a 32-week blinded extension. The rates of American College of Rheumatology Pediatric 30 percent responses (ACR Pedi 30) and the Percent Improvement Index were assessed at baseline and every 4 weeks for 16 weeks and every 8 weeks during the 32-week extension study. RESULTS: Of 94 patients randomized, 86 completed 16 weeks of treatment, 70 of whom entered the extension study. At week 16, more patients in the methotrexate group than in the leflunomide group had an ACR Pedi 30 response (89 percent vs. 68 percent, P=0.02), whereas the values for the Percent Improvement Index did not differ significantly (-52.87 percent vs. -44.41 percent, P=0.18). In both groups, the improvements achieved at week 16 were maintained at week 48. The most common adverse events in both groups included gastrointestinal symptoms, headache, and nasopharyngeal symptoms. Aminotransferase elevations were more frequent with methotrexate than with leflunomide during the initial study and the extension study. CONCLUSIONS: In patients with polyarticular juvenile rheumatoid arthritis, methotrexate and leflunomide both resulted in high rates of clinical improvement, but the rate was slightly greater for methotrexate. At the doses used in this study, methotrexate was more effective than leflunomide.	Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Toronto, Dept Immunol, Toronto, ON, Canada; Hop Necker Enfants Malad, Paris, France; Creighton Univ, Med Ctr, Dept Pediat, Omaha, NE USA; Univ Childrens Hosp, Zurich, Switzerland; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland; Martin Luther Uniklin Halle, Halle An Der Saale, Germany; Hosp Univ Infantil, Valencia, Spain; Childrens Hosp San Diego, Div Pediat Rheumatol, San Diego, CA USA; Sanofi Aventis, Bridgewater, NJ USA; Sanofi Aventis Pharma Canada, Laval, PQ, Canada; Stanford Univ, Div Immunol, Palo Alto, CA 94304 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Creighton University; University Children's Hospital Zurich; University of Helsinki; Sanofi-Aventis; Sanofi-Aventis; Stanford University	Silverman, E (corresponding author), Hosp Sick Children, Div Rheumatol, 555 Univ Ave,Rm 8248, Toronto, ON M5G 1X8, Canada.	esilverman@sickkids.ca						Brewer E J Jr, 1977, Arthritis Rheum, V20, P195; Cohen S, 2001, ARTHRITIS RHEUM-US, V44, P1984, DOI 10.1002/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B; Dempster H, 2001, ARTHRITIS RHEUM, V44, P1768, DOI 10.1002/1529-0131(200108)44:8<1768::AID-ART312>3.0.CO;2-Q; Emery P, 1999, SCAND J RHEUMATOL, V28, P9, DOI 10.1080/030097499750042236; Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202; GIANNINI EH, 1992, NEW ENGL J MED, V326, P1043, DOI 10.1056/NEJM199204163261602; Lovell DJ, 2000, NEW ENGL J MED, V342, P763, DOI 10.1056/NEJM200003163421103; Lovell DJ, 2003, ARTHRITIS RHEUM, V48, P218, DOI 10.1002/art.10710; Manners PJ, 2002, J RHEUMATOL, V29, P1520; Rozman B, 2002, CLIN PHARMACOKINET, V41, P421, DOI 10.2165/00003088-200241060-00003; Ruperto N, 2001, CLIN EXP RHEUMATOL, V19, pS1; Sharp JT, 2000, ARTHRITIS RHEUM, V43, P1345; Sharp JT, 2000, ARTHRITIS RHEUM-US, V43, P495, DOI 10.1002/1529-0131(200003)43:3<495::AID-ANR4>3.0.CO;2-U; Shi J, 2004, CLIN PHARMACOL THER, V75, pP5, DOI 10.1016/j.clpt.2003.11.017; SILVERMAN E, IN PRESS ARTHRITIS R; SINGH G, 1994, ARTHRITIS RHEUM, V37, P1761, DOI 10.1002/art.1780371209; Smolen JS, 2000, RHEUMATOLOGY, V39, P48, DOI 10.1093/oxfordjournals.rheumatology.a031495; Smolen JS, 1999, LANCET, V353, P259, DOI 10.1016/S0140-6736(98)09403-3; Strand V, 1999, ARCH INTERN MED, V159, P2542, DOI 10.1001/archinte.159.21.2542; Strand V, 2003, ARTHRITIS RHEUM-US, V48, P21, DOI 10.1002/art.10683; van Rossum MAJ, 1998, ARTHRITIS RHEUM, V41, P808, DOI 10.1002/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T; Woo P, 2000, ARTHRITIS RHEUM-US, V43, P1849, DOI 10.1002/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F	22	131	151	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1655	1666		10.1056/NEJMoa041810	http://dx.doi.org/10.1056/NEJMoa041810			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843668				2022-12-28	WOS:000228515200007
J	Flegal, KM; Graubard, BI; Williamson, DF; Gail, MH				Flegal, KM; Graubard, BI; Williamson, DF; Gail, MH			Excess deaths associated with underweight, overweight, and obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; FOLLOW-UP; BREAST-CANCER; ALL-CAUSE; MORTALITY; GUIDELINES; FITNESS; PREVALENCE; CHILDREN; SMOKING	Context As the prevalence of obesity increases in the United States, concern over the association of body weight with excess mortality has also increased. Objective To estimate deaths associated with underweight (body mass index [BMI] <18.5), overweight (BMI 25 to <30), and obesity (BMI >= 30) in the United States in 2000. Design, Setting, and Participants We estimated relative risks of mortality associated with different levels of BMI (calculated as weight in kilograms divided by the square of height in meters) from the nationally representative National Health and Nutrition Examination Survey (NHANES) 1 (1971-1975) and NHANES II (1976-1980), with follow-up through 1992, and from NHANES 111 (1988-1994), with follow-up through 2000. These relative risks were applied to the distribution of BMI and other covariates from NHANES 1999-2002 to estimate attributable fractions and number of excess deaths, adjusted for confounding factors and for effect modification by age. Main Outcome Measures Number of excess deaths in 2000 associated with given BMI levels. Results Relative to the normal weight category (BMI 18.5 to <25), obesity (BMI >= 30) was associated with 111 909 excess deaths (95% confidence interval [CI], 53 754170064) and underweight with 33 746 excess deaths (95% Cl, 15726-51766). Overweight was not associated with excess mortality (-86094 deaths; 95% Cl, -161223 to -10966). The relative risks of mortality associated with obesity were lower in NHANES 11 and NHANES III than in NHANES I. Conclusions Underweight and obesity, particularly higher levels of obesity, were associated with increased mortality relative to the normal weight category. The impact of obesity on mortality may have decreased over time, perhaps because of improvements in public health and medical care. These findings are consistent with the increases in life expectancy in the United States and the declining mortality rates from ischemic heart disease.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; Univ Calif Berkeley, Ctr Weight & Hlth, Berkeley, CA 94720 USA; NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA	Flegal, KM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4311, Hyattsville, MD 20782 USA.	kflegal@cdc.gov	Young, Alexander/A-1523-2009; Flegal, Katherine M/A-4608-2013	Young, Alexander/0000-0002-9367-9213; Flegal, Katherine/0000-0002-0838-469X				Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; [Anonymous], 1994, VITAL HLTH STAT, P1; Banegas JR, 2003, EUR J CLIN NUTR, V57, P201, DOI 10.1038/sj.ejcn.1601538; BENICHOU J, 1998, AM J PUBLIC HEALTH, V88, P15; Caraballo RS, 2001, AM J EPIDEMIOL, V153, P807, DOI 10.1093/aje/153.8.807; COHEN JS, 1987, TRADITION, V22, P1; Cox C S, 1997, Vital Health Stat 1, P1; Dorn JM, 1997, AM J EPIDEMIOL, V146, P919, DOI 10.1093/oxfordjournals.aje.a009218; Dyer AR, 2004, ANN EPIDEMIOL, V14, P101, DOI 10.1016/S1047-2797(03)00121-2; Engel A, 1978, Vital Health Stat 1, P1; Farrell SW, 2002, OBES RES, V10, P417, DOI 10.1038/oby.2002.58; Flegal KM, 2004, AM J PUBLIC HEALTH, V94, P1486, DOI 10.2105/AJPH.94.9.1486; Flegal KM, 2004, AM J EPIDEMIOL, V160, P331, DOI 10.1093/aje/kwh222; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Haapanen-Niemi N, 2000, INT J OBESITY, V24, P1465, DOI 10.1038/sj.ijo.0801426; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Heiat A, 2001, ARCH INTERN MED, V161, P1194, DOI 10.1001/archinte.161.9.1194; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P916, DOI 10.1016/S0895-4356(01)00356-0; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Korn EL., 1999, ANAL HLTH SURVEYS; LORIA CM, 1999, VITAL HLTH STAT 1, V38, P1; MACHLIN SR, 1989, STAT MED, V8, P997, DOI 10.1002/sim.4780080810; MCDOWELL A, 1981, VITAL HLTH STAT, V1, P15; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Meyer HE, 2002, MED SCI SPORT EXER, V34, P1065, DOI 10.1097/00005768-200207000-00002; MILLIMAN JD, 1973, BIOL GEOLOGY CORAL R, V1, P1; Minino Arialdi M, 2002, Natl Vital Stat Rep, V50, P1; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; *NAT CTR HLTH STAT, HLTH US 2004 CHARTB; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; SHAH BV, 2004, SURV METHODOL, V30, P31; Strawbridge WJ, 2000, AM J PUBLIC HEALTH, V90, P340, DOI 10.2105/AJPH.90.3.340; STURGEON SR, 1995, J NATL CANCER I, V87, P1846, DOI 10.1093/jnci/87.24.1846; Troiano RP, 1996, INT J OBESITY, V20, P63; Visscher TLS, 2004, ARCH INTERN MED, V164, P1413, DOI 10.1001/archinte.164.13.1413; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; 1994, VITAL HLTH STAT, V1, P32	41	2002	2047	3	358	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1861	1867		10.1001/jama.293.15.1861	http://dx.doi.org/10.1001/jama.293.15.1861			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840860				2022-12-28	WOS:000228401700024
J	Gregg, EW; Cheng, YLJ; Cadwell, BL; Imperatore, G; Williams, DE; Flegal, KM; Narayan, KMV; Williamson, DF				Gregg, EW; Cheng, YLJ; Cadwell, BL; Imperatore, G; Williams, DE; Flegal, KM; Narayan, KMV; Williamson, DF			Secular trends in cardiovascular disease risk factors according to body mass index in US adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; IMPAIRED GLUCOSE-TOLERANCE; FACTOR SURVEILLANCE SYSTEM; CORONARY-HEART-DISEASE; UNITED-STATES; NATIONAL-HEALTH; PREVALENCE; OBESITY; OVERWEIGHT; DISABILITY	Context Prevalence of obesity in the United States has increased dramatically in recent decades, but the magnitude of change in cardiovascular disease (CVD) risk factors among the growing proportion of overweight and obese Americans remains unknown. Objective To examine 40-year trends in CVD risk factors by body mass index (BMI) groups among US adults aged 20 to 74 years. Design, Setting, and Participants Analysis of 5 cross-sectional, nationally representative surveys: National Health Examination Survey (1960-1962); National Health and Nutrition Examination Survey (NHANES) I (1971-1975), II (1976-1980), and III (1988-1994); and NHANES 1999-2000. Main Outcome Measures Prevalence of high cholesterol level (>= 240 mg/dL [>= 6.2 mmol/L] regardless of treatment), high blood pressure (>= 140/90 mm Hg regardless of treatment), current smoking, and total diabetes (diagnosed and undiagnosed combined) according to BMI group (lean, <25; overweight, 25-29; and obese, >= 30). Results The prevalence of all risk factors except diabetes decreased overtime across all BMI groups, with the greatest reductions observed among overweight and obese groups. Compared with obese persons in 1960-1962, obese persons in 1999-2000 had a 21-percentage-point lower prevalence of high cholesterol level (39% in 19601962 vs 18% in 1999-2000), an 18-percentage-point lower prevalence of high blood pressure (from 42% to 24%), and a 12-percentage-point lower smoking prevalence (from 32% to 20%). Survey X BMI group interaction terms indicated that compared with-the first survey, the prevalence of high cholesterol in the fifth survey had fallen more in obese and overweight persons than in lean persons (P < .05). Survey X BMI changes in blood pressure and smoking were not statistically significant. Changes in risk factors were accompanied by increases in lipid-lowering and antihypertensive medication use, particularly among obese persons. Total diabetes prevalence was stable within BMI groups over time, as nonsignificant 1- to 2-percentage-point increases occurred between 1976-1980 and 1999-2000. Conclusions Except for diabetes, CVD risk factors have declined considerably over the past 40 years in all BMI groups. Although obese persons still have higher risk factor levels than lean persons, the levels of these risk factors are much lower than in previous decades.	Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K-10, Atlanta, GA 30341 USA.	edg7@cdc.gov	Cheng, Yiling J/A-6547-2009; Narayan, K.M. Venkat/J-9819-2012; Flegal, Katherine M/A-4608-2013	Cheng, Yiling J/0000-0002-5053-0814; Narayan, K.M. Venkat/0000-0001-8621-5405; Flegal, Katherine/0000-0002-0838-469X; Gregg, Edward/0000-0003-2381-6822				[Anonymous], 1994, VITAL HLTH STAT, P1; [Anonymous], 2003, MMWR-MORBID MORTAL W, V52, P833; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Arnett DK, 2002, AM J EPIDEMIOL, V156, P929, DOI 10.1093/aje/kwf133; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; *CDCP, 1980, CDCP PREV DIAGN DIAB; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P80; Cooper R, 2000, CIRCULATION, V102, P3137; ERNST ND, 1997, AM J CLIN NUTR S, V66, P9725; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; FLEGAL KM, 1991, DIABETES CARE, V14, P628, DOI 10.2337/diacare.14.7.628; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Gross LS, 2004, AM J CLIN NUTR, V79, P774; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Korn EL., 1999, ANAL HLTH SURVEYS; Kumanyika SK, 1998, AM J EPIDEMIOL, V148, P528; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093; Li RW, 2000, AM J PUBLIC HEALTH, V90, P777, DOI 10.2105/AJPH.90.5.777; *LIP RES CLIN PROG, 1982, MAN LAB OP, V1; MAXWELL MH, 1982, LANCET, V2, P33; McDowell A, 1981, Vital Health Stat 1, P1; Miller SI, 2001, AM J ADDICTION, V10, P1, DOI 10.1080/10550490150504083; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; MYERS GL, 1989, CLIN LAB MED, V9, P105, DOI 10.1016/S0272-2712(18)30645-0; *NHANES NAT CTR HL, 1999 2000 DAT FIL DA; Nielsen Samara Joy, 2003, JAMA (Journal of the American Medical Association), V289, P450, DOI 10.1001/jama.289.4.450; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; *RES TRIANGL I, 2003, SUDAAN US MAN; RISSANEN A, 1990, BRIT MED J, V301, P835, DOI 10.1136/bmj.301.6756.835; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; *SAS I INC, 1999, SAS PROC GUID; Siegel D, 2000, AM J MED, V108, P496, DOI 10.1016/S0002-9343(00)00319-3; Simpson ME, 2003, AM J PREV MED, V25, P95, DOI 10.1016/S0749-3797(03)00112-0; Sturm R, 2004, HEALTH AFFAIR, V23, P199, DOI 10.1377/hlthaff.23.2.199; Visscher TLS, 2004, ARCH INTERN MED, V164, P1413, DOI 10.1001/archinte.164.13.1413; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; 1965, VITAL HLTH STAT 1, V4, P1	48	663	684	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1868	1874		10.1001/jama.293.15.1868	http://dx.doi.org/10.1001/jama.293.15.1868			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840861	Bronze			2022-12-28	WOS:000228401700025
J	Tomita, S; Adesnik, H; Sekiguchi, M; Zhang, W; Wada, K; Howe, JR; Nicoll, RA; Bredt, DS				Tomita, S; Adesnik, H; Sekiguchi, M; Zhang, W; Wada, K; Howe, JR; Nicoll, RA; Bredt, DS			Stargazin modulates AMPA receptor gating and trafficking by distinct domains	NATURE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; CEREBELLAR GRANULE CELLS; NON-NMDA RECEPTOR; SYNAPTIC PLASTICITY; SUBUNIT STOICHIOMETRY; EXCITATORY SYNAPSES; MOUSE STARGAZER; GAMMA-SUBUNIT; ION CHANNELS; MUTANT MOUSE	AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors mediate fast excitatory synaptic transmission in the brain. These ion channels rapidly deactivate and desensitize, which determine the time course of synaptic transmission. Here, we find that the AMPA receptor interacting protein, stargazin, not only mediates AMPA receptor trafficking but also shapes synaptic responses by slowing channel deactivation and desensitization. The cytoplasmic tail of stargazin determines receptor trafficking, whereas the ectodomain controls channel properties. Stargazin alters AMPA receptor kinetics by increasing the rate of channel opening. Disrupting the interaction of stargazin ectodomain with hippocampal AMPA receptors alters the amplitude and shape of synaptic responses, establishing a crucial function for stargazin in controlling the efficacy of synaptic transmission in the brain.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo 1878502, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yale University; National Center for Neurology & Psychiatry - Japan	Bredt, DS (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu; bredt@itsa.ucsf.edu	zhang, wei/V-6712-2018	zhang, wei/0000-0001-9825-0371				Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 1999, P NATL ACAD SCI USA, V96, P12132, DOI 10.1073/pnas.96.21.12132; Chen L, 2003, MOL PHARMACOL, V64, P703, DOI 10.1124/mol.64.3.703; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dingledine R, 1999, PHARMACOL REV, V51, P7; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Goff DC, 2001, J CLIN PSYCHOPHARM, V21, P484, DOI 10.1097/00004714-200110000-00005; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; KOH JY, 1990, J NEUROSCI, V10, P693; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Lynch G, 1997, EXP NEUROL, V145, P89, DOI 10.1006/exnr.1997.6447; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; O'Neill MJ, 2004, EUR J PHARMACOL, V486, P163, DOI 10.1016/j.ejphar.2003.12.023; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Robert A, 2003, J NEUROSCI, V23, P847; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sekiguchi M, 2002, BRIT J PHARMACOL, V136, P1033, DOI 10.1038/sj.bjp.0704804; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Smith TC, 2000, J NEUROSCI, V20, P2073; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; Stein V, 2003, J NEUROSCI, V23, P5503; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; WYLLIE DJA, 1993, J PHYSIOL-LONDON, V463, P193, DOI 10.1113/jphysiol.1993.sp019591; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	43	373	385	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1052	1058		10.1038/nature03624	http://dx.doi.org/10.1038/nature03624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15858532				2022-12-28	WOS:000229970400039
J	Hansen, J; Nazarenko, L; Ruedy, R; Sato, M; Willis, J; Del Genio, A; Koch, D; Lacis, A; Lo, K; Menon, S; Novakov, T; Perlwitz, J; Russell, G; Schmidt, GA; Tausnev, N				Hansen, J; Nazarenko, L; Ruedy, R; Sato, M; Willis, J; Del Genio, A; Koch, D; Lacis, A; Lo, K; Menon, S; Novakov, T; Perlwitz, J; Russell, G; Schmidt, GA; Tausnev, N			Earth's energy imbalance: Confirmation and implications	SCIENCE			English	Article							SEA-LEVEL; CLIMATE SENSITIVITY; UNITED-STATES; OCEAN; ATMOSPHERE	Our climate model, driven mainly by increasing human-made greenhouse gases and aerosols, among other forcings, calculates that Earth is now absorbing 0.85 +/- 0.15 watts per square meter more energy from the Sun than it is emitting to space. This imbalance is confirmed by precise measurements of increasing ocean heat content over the past 10 years. Implications include(i) the expectation of additional global warming of about 0.60 degrees C without further change of atmospheric composition; (ii) the confirmation of the climate system's tag in responding to forcings, implying the need for anticipatory actions to avoid any specified level of climate change; and (iii) the likelihood of acceleration of ice sheet disintegration and sea level rise.	NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Columbia Univ, Columbia Earth Inst, New York, NY 10025 USA; SGT Inc, New York, NY 10025 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Columbia Univ, Dept Earth & Environm Sci, New York, NY 10025 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Columbia University; Stinger Ghaffarian Technologies, Inc. (SGT); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Columbia University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hansen, J (corresponding author), NASA, Goddard Inst Space Studies, New York, NY 10025 USA.	jhansen@giss.nasa.gov	Perlwitz, Judith/B-7201-2008; Lacis, Andrew/GVT-2947-2022; Schmidt, Gavin/D-4427-2012; Willis, Josh/AGY-7817-2022; Del Genio, Anthony/D-4663-2012; Lacis, Andrew A/D-4658-2012	Perlwitz, Judith/0000-0003-4061-2442; Schmidt, Gavin/0000-0002-2258-0486; Del Genio, Anthony/0000-0001-7450-1359; Russell, Gary/0000-0001-7174-5825; Ruedy, Reto/0000-0002-1270-1088				Antonov JI, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018851; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; Douglas BC, 2002, PHYS TODAY, V55, P35, DOI 10.1063/1.1472392; Gregory JM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020258; Hansen J, 2004, P NATL ACAD SCI USA, V101, P16109, DOI 10.1073/pnas.0406982101; Hansen J, 2004, SCI AM, V290, P68, DOI 10.1038/scientificamerican0304-68; HANSEN J, 1985, SCIENCE, V229, P857, DOI 10.1126/science.229.4716.857; Hansen J, 2001, J GEOPHYS RES-ATMOS, V106, P23947, DOI 10.1029/2001JD000354; HANSEN J, 1993, NATIONAL GEOGRAPHIC, V9, P143; Hansen J., 1984, GEOPHYS MONOGR SER, P130, DOI [10.1029/gm029p0130, 10.1029/GM029p0130, DOI 10.1029/GM029P0130]; HANSEN J, UNPUB J GEOPHYS RES; Hansen JE, 2005, CLIMATIC CHANGE, V68, P269, DOI 10.1007/s10584-005-4135-0; HOFFERT MI, 1992, NATURE, V360, P573, DOI 10.1038/360573a0; HOFFERT MI, 1980, J GEOPHYS RES-OCEANS, V85, P6667, DOI 10.1029/JC085iC11p06667; Houghton J. T., 2001, CLIMATE CHANGE 2001; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; Kerr RA, 2004, SCIENCE, V305, P932, DOI 10.1126/science.305.5686.932; Leuliette EW, 2004, MAR GEOD, V27, P79, DOI 10.1080/01490410490465193; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Liepert BG, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014910; Lindzen RS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014360; MENON S, UNPUB; Mishchenko MI, 2004, J QUANT SPECTROSC RA, V88, P149, DOI 10.1016/j.jqsrt.2004.03.030; Munk W, 2002, P NATL ACAD SCI USA, V99, P6550, DOI 10.1073/pnas.092704599; Novakov T, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016345; Roderick ML, 2002, SCIENCE, V298, P1410; Sun S, 2003, J CLIMATE, V16, P2807, DOI 10.1175/1520-0442(2003)016<2807:CSFWAC>2.0.CO;2; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; Thomas R, 2004, SCIENCE, V306, P255, DOI 10.1126/science.1099650; Wetherald RT, 2001, GEOPHYS RES LETT, V28, P1535, DOI 10.1029/2000GL011786; WIGLEY TML, 1985, NATURE, V315, P649, DOI 10.1038/315649a0; Willis JK, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002260; Zwally HJ, 2002, J GEODYN, V34, P405, DOI 10.1016/S0264-3707(02)00042-X; [No title captured]	36	582	613	9	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1431	1435		10.1126/science.1110252	http://dx.doi.org/10.1126/science.1110252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15860591	Green Submitted			2022-12-28	WOS:000229619300043
J	Bischoff-Ferrari, HA; Willett, WC; Wong, JB; Giovannucci, E; Dietrich, T; Dawson-Hughes, B				Bischoff-Ferrari, HA; Willett, WC; Wong, JB; Giovannucci, E; Dietrich, T; Dawson-Hughes, B			Fracture prevention with vitamin D supplementation - A meta-analysis of randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SERUM 25-HYDROXYVITAMIN D; HIP FRACTURE; ELDERLY-WOMEN; CALCIUM SUPPLEMENTATION; BONE LOSS; SECONDARY HYPERPARATHYROIDISM; OSTEOPOROTIC FRACTURES; HEART-DISEASE; RISK-FACTORS; FALLS	Context The role and dose of oral vitamin D supplementation in nonvertebral fracture prevention have not been well established. Objective To estimate the effectiveness of vitamin D supplementation in preventing hip and nonvertebral fractures in older persons. Data Sources A systematic review of English and non -English articles using MEDLINE and the Cochrane Controlled Trials Register (1960-2005), and EMBASE (1991-2005). Additional studies were identified by contacting clinical experts and searching bibliographies and abstracts presented at the American Society for Bone and Mineral Research (1995-2004). Search terms included randomized controlled trial (RCT), controlled clinical trial, random allocation, double-blind method, cholecalciferol, ergocalciferol, 25-hydroxyvitamin D, fractures, humans, elderly, falls, and bone density. Study Selection Only double-blind RCTs of oral vitamin D supplementation (cholecalciferol, ergocalciferol) with or without calcium supplementation vs calcium supplementation or placebo in older persons (>= 60 years) that examined hip or nonvertebral fractures were included. Data Extraction Independent extraction of articles by 2 authors using predefined data fields, including study quality indicators. Data Synthesis All pooled analyses were based on random-effects models. Five RCTs for hip fracture (n=9294) and 7 RCTs for nonvertebral fracture risk (n=9820) met our inclusion criteria. All trials used cholecalciferol. Heterogeneity among studies for both hip and nonvertebral fracture prevention was observed, which disappeared after pooling RCTs with low-dose (400 IU/d) and higher-dose vitamin D (700-800 IU/d), separately. A vitamin D dose of 700 to 800 IU/d reduced the relative risk (RR) of hip fracture by 26% (3 RCTs with 5572 persons; pooled RR, 0.74; 95% confidence interval [CI], 0.61-0.88) and any nonvertebral fracture by 23% (5 RCTs with 6098 persons; pooled RR, 0.77; 95% Cl, 0.68-0.87) vs calcium or placebo. No significant benefit was observed for RCTs with 400 IU/d vitamin D (2 RCTs with 3722 persons; pooled RR for hip fracture, 1.15; 95% Cl, 0.88-1.50; and pooled RR for any nonvertebral fracture, 1.03; 95% Cl, 0.86-1.24). Conclusions Oral vitamin D supplementation between 700 to 800 IU/d appears to reduce the risk of hip and any nonvertebral fractures in ambulatory or institutionalized elderly persons. An oral vitamin D dose of 400 IU/d is not sufficient for fracture prevention.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Brigham & Womens Hosp, Robert B Brigham Arthrit & Musculoskeletal Dis Cl, Div Rheumatol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Aging, Boston, MA 02115 USA; Tufts New England Med Ctr, Dept Med, Boston, MA USA; Boston Univ, Goldman Sch Dent Med, Dept Hlth Policy & Hlth Serv Res, Boston, MA 02215 USA; Tufts Univ, Dept Agr, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Tufts Medical Center; Boston University; Tufts University; United States Department of Agriculture (USDA)	Bischoff-Ferrari, HA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 651 Huntington Ave, Boston, MA 02115 USA.	hbischof@hsph.harvard.edu		Dietrich, Thomas/0000-0002-2557-7645; Bischoff-Ferrari, Heike/0000-0002-4554-658X; Wong, John/0000-0003-4203-9010				Armas LAG, 2004, J CLIN ENDOCR METAB, V89, P5387, DOI 10.1210/jc.2004-0360; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; BIRGE SJ, 1994, CLIN GERIATR MED, V10, P589, DOI 10.1016/S0749-0690(18)30318-5; Bischoff HA, 2003, J BONE MINER RES, V18, P343, DOI 10.1359/jbmr.2003.18.2.343; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Bischoff-Ferrari HA, 2004, J BONE MINER RES, V19, P265, DOI 10.1359/jbmr.2004.19.2.265; CHAPUY MC, 1994, BRIT MED J, V308, P1081, DOI 10.1136/bmj.308.6936.1081; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; CHRISCHILLES EA, 1991, ARCH INTERN MED, V151, P2026, DOI 10.1001/archinte.151.10.2026; COOK DJ, 1995, J CLIN EPIDEMIOL, V48, P167, DOI 10.1016/0895-4356(94)00172-M; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P2445, DOI 10.1001/archinte.149.11.2445; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; CUMMINGS SR, 1990, CLIN ORTHOP RELAT R, P163; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2003, Health Technol Assess, V7, P1; FALCH JA, 1987, J CLIN ENDOCR METAB, V64, P836, DOI 10.1210/jcem-64-4-836; Feit F, 2000, CIRCULATION, V101, P2795, DOI 10.1161/01.CIR.101.24.2795; Flicker L, 2004, J BONE MINER RES, V19, pS99; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Gunter EW., 1996, LAB METHODS USED 3 N; Heaney RP, 2004, AM J CLIN NUTR, V80, p1706S, DOI 10.1093/ajcn/80.6.1706S; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; HEIKINHEIMO RJ, 1991, CALCIFIED TISSUE INT, V49, pS87, DOI 10.1007/BF02555102; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Kinyamu HK, 1997, AM J CLIN NUTR, V65, P790, DOI 10.1093/ajcn/65.3.790; Larsen ER, 2004, J BONE MINER RES, V19, P370, DOI 10.1359/JBMR.0301240; Lips P, 1999, OSTEOPOROSIS INT, V9, P394, DOI 10.1007/s001980050162; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; Meyer HE, 2002, J BONE MINER RES, V17, P709, DOI 10.1359/jbmr.2002.17.4.709; OOMS ME, 1995, J CLIN ENDOCR METAB, V80, P1052, DOI 10.1210/jc.80.4.1052; Pfeifer M, 2004, J BONE MINER RES, V19, pS58; Pfeifer M, 2000, J BONE MINER RES, V15, P1113, DOI 10.1359/jbmr.2000.15.6.1113; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SIMPSON RU, 1985, J BIOL CHEM, V260, P8882; SORENSEN OH, 1979, CLIN SCI, V56, P157, DOI 10.1042/cs0560157; Theiler R, 2000, EUR J ENDOCRINOL, V143, P673, DOI 10.1530/eje.0.1430673; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Trang HM, 1998, AM J CLIN NUTR, V68, P854, DOI 10.1093/ajcn/68.4.854; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Vieth R, 2001, AM J CLIN NUTR, V73, P288; Vieth R, 2004, J STEROID BIOCHEM, V89-90, P575, DOI 10.1016/j.jsbmb.2004.03.038; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373	51	983	1037	0	76	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2257	2264		10.1001/jama.293.18.2257	http://dx.doi.org/10.1001/jama.293.18.2257			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886381				2022-12-28	WOS:000228981100027
J	Marcus, GM; Gerber, IL; McKeown, BH; Vessey, JC; Jordan, MV; Huddleston, M; McCulloch, CE; Foster, E; Chatterjee, K; Michaels, AD				Marcus, GM; Gerber, IL; McKeown, BH; Vessey, JC; Jordan, MV; Huddleston, M; McCulloch, CE; Foster, E; Chatterjee, K; Michaels, AD			Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							JUGULAR VENOUS-PRESSURE; INTEROBSERVER AGREEMENT; NATRIURETIC PEPTIDE; GALLOP SOUNDS; FAILURE; AUSCULTATION; DISEASE; FLOW	Context The third (S-3) and fourth (S-4) heart sounds detected by phonocardiography are considered to represent the criterion standards of the gallop sounds, but their test characteristics have not been explored. Objective To determine the diagnostic test characteristics of the S-3 and S-4 for prediction of left ventricular dysfunction using a computerized heart sound detection algorithm. Design, Setting, and Participants Prospective study of 90 adult patients undergoing elective left-sided heart catheterization at a single US teaching hospital between August 2003 and June 2004. The mean age was 62 (SD, 13) years (range, 24-90 years) and 61 (68%) were male. Within a 4-hour period, participants underwent computerized heart sound phonocardiographic analysis, cardiac catheterization, transthoracic echocardiography, and blood sampling for assessment of an S-3/S-4, left ventricular end-diastolic pressure (LVEDP), left ventricular ejection fraction (LVEF), and B-type natriuretic peptide (BNP), respectively. Main Outcome Measures Diagnostic test characteristics of the computerized phonocardiographic S-3 and S-4 using markers of left ventricular function as criterion standards. Results Mean (SD) LVEDP was significantly elevated (18.4 [6.9] mm Hg vs 12.1 [7.3] mm Hg; P<.001), mean (SD) LVEF was reduced (49.4% [20.2%] vs 63.6% (14.8%]; P<.001), and median (interquartile range) BNP was elevated (330 [98-1155] pg/mL vs 86 [41-192] pg/mL; P<.001) in those with an S-3, S-4, or both compared with patients without a diastolic heart sound. The sensitivities of these heart sounds to detect an elevated LVEDP, reduced LVEF, or elevated BNP were 41%, 52%, and 32% for an S-3, and 46%, 43 %, and 40% for an S-4, respectively. For abnormal levels of the same markers of ventricular function, the specificities of the S-3 were 92 %, 87%, and 92 %, while the specificities of the S-4 were 80%, 72%, and 78%, respectively. Conclusions Neither the phonocardiographic S-3 nor the S-4 is a sensitive marker of left ventricular dysfunction. The phonocardiographic S-3 is specific for left ventricular dysfunction and appears to be superior to the moderate specificity of the phonocardiographic S-4.	Univ Calif San Francisco, Med Ctr, Div Cardiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Michaels, AD (corresponding author), Univ Calif San Francisco, Med Ctr, Div Cardiol, 505 Parnassus Ave,Box 0124, San Francisco, CA 94143 USA.	andrewm@medicine.ucsf.edu	Marcus, Gregory/AAN-8584-2021	Marcus, Gregory/0000-0001-5197-7696	NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR018319] Funding Source: NIH RePORTER; NCRR NIH HHS [K23 RR018319-01 A1] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AREVALO F, 1964, AM J PHYSIOL, V207, P319, DOI 10.1152/ajplegacy.1964.207.2.319; BAIM DS, 2000, GROSSMANS CARDIAC CA; Drazner MH, 2001, NEW ENGL J MED, V345, P574, DOI 10.1056/NEJMoa010641; Drazner MH, 2003, AM J MED, V114, P431, DOI 10.1016/S0002-9343(03)00058-5; GLOWER DD, 1992, J AM COLL CARDIOL, V19, P450, DOI 10.1016/0735-1097(92)90504-G; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; HARLAN WR, 1977, ANN INTERN MED, V86, P133, DOI 10.7326/0003-4819-86-2-133; HOMMA S, 1991, CLIN CARDIOL, V14, P671, DOI 10.1002/clc.4960140809; ISHMAIL AA, 1987, CHEST, V91, P870, DOI 10.1378/chest.91.6.870; KONO T, 1993, J AM COLL CARDIOL, V21, P419, DOI 10.1016/0735-1097(93)90684-S; KUPARI M, 1994, CIRCULATION, V89, P1189, DOI 10.1161/01.CIR.89.3.1189; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; MAISEL AS, 1985, J AM COLL CARDIOL, V6, P731, DOI 10.1016/S0735-1097(85)80474-5; Mangione S, 1997, JAMA-J AM MED ASSOC, V278, P717, DOI 10.1001/jama.278.9.717; MANSON AL, 1995, CIRCULATION, V92, P388, DOI 10.1161/01.CIR.92.3.388; Marcus GM, 2004, AM J CARDIOL, V93, P1312, DOI 10.1016/j.amjcard.2004.01.074; OZAWA Y, 1983, CIRCULATION, V67, P399, DOI 10.1161/01.CIR.67.2.399; PATEL R, 1993, WESTERN J MED, V158, P606; Potain P., 1880, GAZ D HOP, V53, P529; RIHAL CS, 1995, AM J CARDIOL, V75, P220, DOI 10.1016/0002-9149(95)80023-L; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SHAH PM, 1968, NEW ENGL J MED, V278, P753, DOI 10.1056/NEJM196804042781402; STEFADOUROS MA, 1980, ARCH INTERN MED, V140, P537, DOI 10.1001/archinte.140.4.537; VANDEWERF F, 1984, J CLIN INVEST, V73, P1400, DOI 10.1172/JCI111344	25	81	99	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2238	2244		10.1001/jama.293.18.2238	http://dx.doi.org/10.1001/jama.293.18.2238			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886379				2022-12-28	WOS:000228981100025
J	Siotia, AK; Chaudhuri, A; Muzulu, SI; Harling, D; Muthusamy, R				Siotia, AK; Chaudhuri, A; Muzulu, SI; Harling, D; Muthusamy, R			Postoperative hypoxia in a woman with Down's syndrome: case outcome	BRITISH MEDICAL JOURNAL			English	Review									No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England; Ninewells Hosp, Dundee DD1 9SY, Scotland; Rotherham Dist Gen Hosp, Rotherham S60 2UD, S Yorkshire, England	Northern General Hospital; University of Dundee	Siotia, AK (corresponding author), No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England.	Anjan.Siotia@sth.nhs.uk							0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 7	2005	330	7499					1068	1068		10.1136/bmj.330.7499.1068	http://dx.doi.org/10.1136/bmj.330.7499.1068			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925YY	15879393	Green Published			2022-12-28	WOS:000229090900022
J	Fearon, ER; Cadigan, KM				Fearon, ER; Cadigan, KM			Wnt signaling grows with RNAi	SCIENCE			English	Editorial Material							DROSOPHILA; COMPONENTS; PATHWAY; SCREEN; APC2		Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fearon, ER (corresponding author), Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA.	fearon@umich.edu		Cadigan, Ken/0000-0003-2431-1703				Ahmed Y, 2002, DEVELOPMENT, V129, P1751; Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Chou TB, 1996, GENETICS, V144, P1673; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427	10	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					801	803		10.1126/science.1112622	http://dx.doi.org/10.1126/science.1112622			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879199				2022-12-28	WOS:000228986500028
J	Murray, SA; Kendall, M; Boyd, K; Sheikh, A				Murray, SA; Kendall, M; Boyd, K; Sheikh, A			Illness trajectories and palliative care	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PROSPECTIVE QUALITATIVE INTERVIEW; LUNG-CANCER; PEOPLE; LIFE; FAILURE; END		Univ Edinburgh, Gen Practice Sect, Div Community Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Murray, SA (corresponding author), Univ Edinburgh, Gen Practice Sect, Div Community Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland.	Scott.Murray@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Boyd, Kirsty/0000-0002-5526-1078				Asbring P, 2004, QUAL HEALTH RES, V14, P226, DOI 10.1177/1049732303260682; BALLAM M, 2001, CUMULATIVE TRIVIA EX; BUCTOW S, 2001, PATIENT EDUC COUNS, V45, P181; Burke S O, 2000, Can J Nurs Res, V32, P19; CASSELL EJ, 1991, NATURE SUFFERING; Ellershaw JE, 2003, CARE DYING PATHWAY E; GLARE PA, 2004, OXFORD TXB PALLIATIV; Hardin SB, 2004, ARCH INTERN MED, V164, P1531, DOI 10.1001/archinte.164.14.1531; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; Higgs R, 1999, J ROY COLL PHYS LOND, V33, P110; KITE S, 2001, PALLIATIVE MED, V15, P413; Lehman R, 2004, BRIT J GEN PRACT, V54, P892; Levenson JW, 2000, J AM GERIATR SOC, V48, pS101, DOI 10.1111/j.1532-5415.2000.tb03119.x; LUNNEY JR, 2003, JAMA-J AM MED ASSOC, V298, P2387; Lynn J, 2000, JAMA-J AM MED ASSOC, V284, P2508, DOI 10.1001/jama.284.19.2508; Lynn J, 2003, LIVING WELL END LIFE; McKinley RK, 2004, BRIT J GEN PRACT, V54, P909; Murray SA, 2004, PALLIATIVE MED, V18, P39, DOI 10.1191/0269216304pm837oa; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murtagh FEM, 2004, CLIN MED, V4, P39, DOI 10.7861/clinmedicine.4-1-39; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Thomas K., 2003, CARING DYING HOME CO; WILLIAMS R, 1992, SOC SCI MED, V34, P763, DOI 10.1016/0277-9536(92)90363-U; World Health Organization, 2004, PALL CAR SOL FACTS	24	830	838	4	54	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2005	330	7498					1007	1011		10.1136/bmj.330.7498.1007	http://dx.doi.org/10.1136/bmj.330.7498.1007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UP	15860828	Green Submitted, Green Published			2022-12-28	WOS:000228935100024
J	Sakalihasan, N; Limet, R; Defawe, OD				Sakalihasan, N; Limet, R; Defawe, OD			Abdominal aortic aneurysm	LANCET			English	Review							CORONARY-ARTERY REVASCULARIZATION; HIGH-ATTENUATING CRESCENT; SPINAL-CORD ISCHEMIA; SMOOTH-MUSCLE-CELLS; RISK-FACTORS; MATRIX METALLOPROTEINASES; ENDOVASCULAR REPAIR; TISSUE INHIBITOR; ATHEROSCLEROTIC PLAQUE; LOCAL OVEREXPRESSION	Abdominal aortic aneurysms cause 1.3% of all deaths among men aged 65-85 years in developed countries. These aneurysms are typically asymptomatic until the catastrophic event of rupture. Repair of large or symptomatic aneurysms by open surgery or endovascular repair is recommended, whereas repair of small abdominal aortic aneurysms does not provide a significant benefit. Abdominal aortic aneurysm is linked to the degradation of the elastic media of the atheromatous aorta. An inflammatory cell infiltrate, neovascularisation, and production and activation of various proteases and cytokines contribute to the development of this disorder, although the underlying mechanisms are unknown. In this Seminar, we aim to provide an updated review of the pathophysiology, current and new diagnostic procedures, assessment, and treatment of abdominal aortic aneurysm to provide family practitioners with a working knowledge of this disorder.	Univ Liege, Dept Cardiovasc & Thorac Surg, B-4000 Liege, Belgium; Univ Liege, Lab Connect Tissues Biol, B-4000 Liege, Belgium	University of Liege; University of Liege	Limet, R (corresponding author), Univ Liege, Dept Cardiovasc & Thorac Surg, B-4000 Liege, Belgium.	rlimet@ulg.ac.be	Powell, Janet/AAW-8669-2021	Powell, Janet/0000-0002-3905-1468				Ailawadi G, 2004, ARTERIOSCL THROM VAS, V24, P2116, DOI 10.1161/01.ATV.0000143386.26399.84; Allaire E, 1998, J CLIN INVEST, V102, P1413, DOI 10.1172/JCI2909; Allaire E, 2004, ANN SURG, V239, P417, DOI 10.1097/01.sla.0000114131.79899.82; Allaire E, 2002, J VASC SURG, V36, P1018, DOI 10.1067/mva.2002.127347; Allaire E, 1998, CIRCULATION, V98, P249, DOI 10.1161/01.CIR.98.3.249; ANIDJAR S, 1990, CIRCULATION, V82, P973, DOI 10.1161/01.CIR.82.3.973; Arita T, 1997, RADIOLOGY, V204, P765, DOI 10.1148/radiology.204.3.9280256; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; BAXTER BT, 1992, J VASC SURG, V16, P192, DOI 10.1016/0741-5214(92)90107-J; Baxter BT, 2002, J VASC SURG, V36, P1, DOI 10.1067/mva.2002.125018; Beard JD, 2002, BRIT J SURG, V89, P520; Bellosta S, 1998, ARTERIOSCL THROM VAS, V18, P1671, DOI 10.1161/01.ATV.18.11.1671; Bengtsson H, 1996, ANN NY ACAD SCI, V800, P1, DOI 10.1111/j.1749-6632.1996.tb33294.x; Berg P, 2001, EUR J VASC ENDOVASC, V22, P342, DOI 10.1053/ejvs.2001.1470; Bigatel DA, 1999, J VASC SURG, V29, P130, DOI 10.1016/S0741-5214(99)70354-X; Blanchard JF, 2000, AM J EPIDEMIOL, V151, P575; Boersma E, 2001, JAMA-J AM MED ASSOC, V285, P1865, DOI 10.1001/jama.285.14.1865; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Brady AR, 2000, BRIT J SURG, V87, P742, DOI 10.1046/j.1365-2168.2000.01410.x; Brady AR, 2002, NEW ENGL J MED, V346, P1445; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Buckley C, 2004, J AM COLL SURGEONS, V199, P896, DOI 10.1016/j.jamcollsurg.2004.08.010; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; Carrell TWG, 2002, CIRCULATION, V105, P477, DOI 10.1161/hc0402.102621; CLIFTON MA, 1977, BRIT J SURG, V64, P765, DOI 10.1002/bjs.1800641102; Coggia M, 2004, J VASC SURG, V40, P448, DOI 10.1016/j.jvs.2004.06.037; Curci JA, 2004, J CLIN INVEST, V114, P168, DOI 10.1172/JCI200422309; Curci JA, 1998, J VASC SURG, V28, P1082, DOI 10.1016/S0741-5214(98)70035-7; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; Davis PM, 1998, AM J SURG, V176, P115, DOI 10.1016/S0002-9610(98)00166-4; Davis V, 1998, ARTERIOSCL THROM VAS, V18, P1625, DOI 10.1161/01.ATV.18.10.1625; DEFAWE O, 2004, CARDIVOAS PATHOL S3, V13; Defawe OD, 2003, CARDIOVASC RES, V60, P205, DOI 10.1016/S0008-6363(03)00513-3; DEFAWE OD, IN PRESS CARDIOVASC; Deng GG, 2003, CIRC RES, V92, P510, DOI 10.1161/01.RES.0000061571.49375.E1; Dobrin P B, 1994, Cardiovasc Surg, V2, P484; Dobrin PB, 1999, ANN VASC SURG, V13, P641, DOI 10.1007/s100169900315; Dueck AD, 2004, J VASC SURG, V39, P1261, DOI 10.1016/j.jvs.2004.02.021; El-Sabrout RA, 2002, ANN VASC SURG, V16, P321, DOI 10.1007/s10016-001-0046-3; Elkouri S, 2004, J VASC SURG, V39, P497, DOI 10.1016/j.jvs.2003.10.018; Elzouki AN, 1999, EUR J VASC ENDOVASC, V17, P149, DOI 10.1053/ejvs.1998.0740; Erentug V, 2003, ANN VASC SURG, V17, P682, DOI 10.1007/s10016-003-0076-0; Eriksson P, 2004, BRIT J SURG, V91, P86, DOI 10.1002/bjs.4364; Fink HA, 2000, ARCH INTERN MED, V160, P833, DOI 10.1001/archinte.160.6.833; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; Frydman G, 2003, EUR J VASC ENDOVASC, V26, P396, DOI 10.1016/S1078-5884(03)00316-2; GADOWSKI GR, 1994, J VASC SURG, V19, P727, DOI 10.1016/S0741-5214(94)70048-6; Ghorpade A, 1996, ANN NY ACAD SCI, V800, P138, DOI 10.1111/j.1749-6632.1996.tb33305.x; GILLUM RF, 1995, J CLIN EPIDEMIOL, V48, P1289, DOI 10.1016/0895-4356(95)00045-3; Glimaker H, 1991, Eur J Vasc Surg, V5, P125, DOI 10.1016/S0950-821X(05)80675-9; GOLDEN MA, 1990, ANN SURG, V212, P415, DOI 10.1097/00000658-199010000-00004; Gomes D, 2001, J VASC SURG, V34, P707, DOI 10.1067/mva.2001.116802; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Hallett JW, 1997, J VASC SURG, V25, P277, DOI 10.1016/S0741-5214(97)70349-5; Hallin A, 2001, EUR J VASC ENDOVASC, V22, P197, DOI 10.1053/ejvs.2001.1422; Hance KA, 2002, J VASC SURG, V35, P254, DOI 10.1067/mva.2002.120382; HERRON GS, 1991, ARTERIOSCLER THROMB, V11, P1667, DOI 10.1161/01.ATV.11.6.1667; HERTZER NR, 1980, ANN SURG, V192, P667; Hertzer NR, 2002, J VASC SURG, V35, P1145, DOI 10.1067/mva.2002.123686; Hirose H, 2001, ANN NY ACAD SCI, V947, P416; HIST AE, 1951, GASTROENTEROLOGY, V17, P504; HOLLIER LH, 1984, J VASC SURG, V1, P290, DOI 10.1067/mva.1984.avs0010290; HOLLIER LH, 1992, J VASC SURG, V15, P1046, DOI 10.1016/0741-5214(92)90462-H; HOLMES DR, 1995, J VASC SURG, V21, P761, DOI 10.1016/S0741-5214(05)80007-2; Holmes DR, 1996, J SURG RES, V63, P305, DOI 10.1006/jsre.1996.0265; Huffman MD, 2000, SURGERY, V128, P429, DOI 10.1067/msy.2000.107379; Irvine CD, 2000, EUR J VASC ENDOVASC, V20, P374, DOI 10.1053/ejvs.2000.1187; JOHNSTON KW, 1989, J VASC SURG, V9, P437, DOI 10.1067/mva.1989.vs0090437; JOHNSTON KW, 1991, J VASC SURG, V13, P452, DOI 10.1067/mva.1991.26737; JOHNSTON KW, 1994, J VASC SURG, V20, P163, DOI 10.1016/0741-5214(94)90002-7; Jones BV, 2001, IN PRACTICE, V23, P421; KANE JM, 1955, ARCH SURG-CHICAGO, V70, P570, DOI 10.1001/archsurg.1955.01270100096017; KATZ DJ, 1994, J VASC SURG, V19, P804, DOI 10.1016/S0741-5214(94)70005-2; Kertai MD, 2004, AM J MED, V116, P96, DOI 10.1016/j.amjmed.2003.08.029; KIEFFER E, 1990, ANEVRYSMES AORTE ABD, P235; Kniemeyer HW, 2000, EUR J VASC ENDOVASC, V19, P190, DOI 10.1053/ejvs.1999.0980; Knox JB, 1997, CIRCULATION, V95, P205, DOI 10.1161/01.CIR.95.1.205; KOCH AE, 1993, AM J PATHOL, V142, P1423; Kuivaniemi H, 2003, J VASC SURG, V37, P340, DOI 10.1067/mva.2003.71; Laheij RJF, 2000, BRIT J SURG, V87, P1666, DOI 10.1046/j.1365-2168.2000.01661.x; Laupacis A, 2002, J VASC SURG, V35, P72, DOI 10.1067/mva.2002.121308; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Lederle FA, 2004, NEW ENGL J MED, V351, P1677, DOI 10.1056/NEJMe048258; Lederle FA, 2003, J VASC SURG, V38, P329, DOI 10.1016/S0741-5214(03)00136-8; Lederle FA, 2001, J VASC SURG, V34, P122, DOI 10.1067/mva.2001.115275; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Lembo G, 2001, STROKE, V32, P735, DOI 10.1161/01.STR.32.3.735; Lemos DW, 2003, J VASC SURG, V37, P686, DOI 10.1067/mva.2003.101; LIDDINGTON MI, 1992, EUR J VASCULAR SURG, V6, P89, DOI 10.1016/S0950-821X(05)80101-X; LIMET R, 1991, J VASC SURG, V14, P540, DOI 10.1016/0741-5214(91)90249-T; Lindholt JS, 2000, EUR J VASC ENDOVASC, V20, P281, DOI 10.1053/ejvs.2000.1151; Lindholt JS, 2000, EUR J VASC ENDOVASC, V20, P369, DOI 10.1053/ejvs.2000.1191; Lindholt JS, 2001, EUR J VASC ENDOVASC, V21, P51, DOI 10.1053/ejvs.2000.1262; Lindholt JS, 2001, J VASC SURG, V34, P611, DOI 10.1067/mva.2001.119040; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; LopezCandales A, 1997, AM J PATHOL, V150, P993; MACSWEENEY STR, 1994, LANCET, V344, P651, DOI 10.1016/S0140-6736(94)92087-7; MAJUMDER PP, 1991, AM J HUM GENET, V48, P164; Mao DL, 1999, BIOCHEM BIOPH RES CO, V261, P904, DOI 10.1006/bbrc.1999.1142; MATSUMURA K, 1991, ANGIOLOGY, V42, P308, DOI 10.1177/000331979104200408; McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905; MCGREGOR JC, 1975, SCOT MED J, V20, P133, DOI 10.1177/003693307502000313; McMillan WD, 1999, J VASC SURG, V29, P122, DOI 10.1016/S0741-5214(99)70363-0; MEHARD WB, 1994, RADIOLOGY, V192, P359, DOI 10.1148/radiology.192.2.8029397; Melrose J, 1998, J VASC SURG, V28, P676, DOI 10.1016/S0741-5214(98)70094-1; MOHR FW, 1995, CIRCULATION, V91, P379, DOI 10.1161/01.CIR.91.2.379; Moore G, 1999, J VASC SURG, V29, P522, DOI 10.1016/S0741-5214(99)70281-8; Morimoto Keisuke, 2004, Ann Thorac Cardiovasc Surg, V10, P29; Nagashima H, 2002, J VASC SURG, V36, P158, DOI 10.1067/mva.2002.123680; NEVITT MP, 1989, NEW ENGL J MED, V321, P1009, DOI 10.1056/NEJM198910123211504; NEWMAN KM, 1994, CIRCULATION, V90, P224; Nollendorfs A, 2001, J VASC SURG, V34, P316, DOI 10.1067/mva.2001.115962; Norman PE, 2001, CARDIOVASC SURG, V9, P219, DOI 10.1016/S0967-2109(00)00126-5; Ouriel K, 2003, J VASC SURG, V37, P1206, DOI 10.1016/S0741-5214(02)75449-9; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Parry DJ, 2001, J VASC SURG, V33, P874, DOI 10.1067/mva.2001.112328; Paty PSK, 2000, J VASC SURG, V31, P253, DOI 10.1016/S0741-5214(00)90156-3; Peppelenbosch N, 2004, J VASC SURG, V39, P288, DOI 10.1016/j.jvs.2003.09.047; PICONE AL, 1986, J VASC SURG, V3, P94; Pierpont GL, 2004, AM J CARDIOL, V94, P1124, DOI 10.1016/j.amjcard.2004.07.077; Powell JT, 2003, BRIT J SURG, V90, P1173, DOI 10.1002/bjs.4339; Powell JT, 1998, LANCET, V352, P1649; POWELL JT, 1990, CAUSE MANAGEMENT ANE; Prance SE, 1999, EUR J VASC ENDOVASC, V17, P129, DOI 10.1053/ejvs.1998.0718; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; QUILL DS, 1989, SURG CLIN N AM, V69, P713; Rao SK, 1996, ANN NY ACAD SCI, V800, P131; REED D, 1992, CIRCULATION, V85, P205, DOI 10.1161/01.CIR.85.1.205; Reilly JM, 1996, ANN NY ACAD SCI, V800, P151, DOI 10.1111/j.1749-6632.1996.tb33306.x; Rinckenbach S, 2004, ANN VASC SURG, V18, P704, DOI 10.1007/s10016-004-0114-6; ROGER VL, 1989, J AM COLL CARDIOL, V14, P1245, DOI 10.1016/0735-1097(89)90423-3; Rossaak JI, 2000, J VASC SURG, V31, P1026, DOI 10.1067/mva.2000.104589; Rouis M, 1999, CIRCULATION, V100, P533, DOI 10.1161/01.CIR.100.5.533; Sakalihasan N, 1996, J VASC SURG, V24, P127, DOI 10.1016/S0741-5214(96)70153-2; Sakalihasan N, 2002, EUR J VASC ENDOVASC, V23, P431, DOI 10.1053/ejvs.2002.1646; SAKALIHASAN N, 1993, EUR J VASCULAR SURG, V7, P633, DOI 10.1016/S0950-821X(05)80708-X; SATTA J, 1995, J VASC SURG, V22, P155, DOI 10.1016/S0741-5214(95)70110-9; SCOTT RAP, 1991, BRIT J SURG, V78, P1122, DOI 10.1002/bjs.1800780929; Shah PK, 1997, CIRCULATION, V96, P2115; Shi GP, 1999, J CLIN INVEST, V104, P1191, DOI 10.1172/JCI7709; Shibamura H, 2004, CIRCULATION, V109, P2103, DOI 10.1161/01.CIR.0000127857.77161.A1; SIEGEL CL, 1994, AM J ROENTGENOL, V163, P1123, DOI 10.2214/ajr.163.5.7976888; Silence J, 2002, CIRC RES, V90, P897, DOI 10.1161/01.RES.0000016501.56641.83; Silence J, 2001, ARTERIOSCL THROM VAS, V21, P1440, DOI 10.1161/hq0901.097004; Singh K, 2001, AM J EPIDEMIOL, V154, P236, DOI 10.1093/aje/154.3.236; SLAIBY JM, 1994, J VASC SURG, V20, P178, DOI 10.1016/0741-5214(94)90004-3; Sprouse LR, 2004, J VASC SURG, V40, P443, DOI 10.1016/j.jvs.2004.06.024; SZILAGYI DE, 1978, SURGERY, V83, P38; Tamarina NA, 1997, SURGERY, V122, P264, DOI 10.1016/S0039-6060(97)90017-9; Thompson MM, 2003, BRIT J SURG, V90, P897, DOI 10.1002/bjs.4280; Thompson RW, 2002, CURR PROB SURG, V39, P98; Thompson RW, 1996, ANN NY ACAD SCI, V800, P157, DOI 10.1111/j.1749-6632.1996.tb33307.x; TILSON MD, 1992, CIRCULATION, V85, P378, DOI 10.1161/01.CIR.85.1.378; Towbin JA, 1999, AM J HUM GENET, V64, P678, DOI 10.1086/302303; Tromp G, 2004, ANN VASC SURG, V18, P414, DOI 10.1007/s10016-004-0050-5; Vallabhaneni SR, 2001, EUR J RADIOL, V39, P34, DOI 10.1016/S0720-048X(01)00340-0; Vardulaki KA, 2000, BRIT J SURG, V87, P195, DOI 10.1046/j.1365-2168.2000.01353.x; VERLOES A, 1995, J VASC SURG, V21, P646, DOI 10.1016/S0741-5214(95)70196-6; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Walton LJ, 1999, CIRCULATION, V100, P48, DOI 10.1161/01.CIR.100.1.48; Wilmink TBM, 1999, J VASC SURG, V30, P203, DOI 10.1016/S0741-5214(99)70129-1; Xu CP, 2001, J VASC SURG, V33, P91, DOI 10.1067/mva.2001.109744; Yamazumi K, 1998, AM J SURG, V175, P297, DOI 10.1016/S0002-9610(98)00014-2	167	789	815	1	108	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1577	1589		10.1016/S0140-6736(05)66459-8	http://dx.doi.org/10.1016/S0140-6736(05)66459-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866312				2022-12-28	WOS:000228754800030
J	Schulz, KF; Grimes, DA				Schulz, KF; Grimes, DA			Epidemiology 4 - Multiplicity in randomised trials I: endpoints and treatments	LANCET			English	Article							CLINICAL-TRIALS; SAMPLE-SIZE; OUTCOMES; DESIGN	Multiplicity problems emerge from investigators looking at many additional endpoints and treatment group comparisons. Thousands of potential comparisons can emanate from one trial. Investigators might only report the significant comparisons, an unscientific practice if unwitting, and fraudulent if intentional. Researchers must report all the endpoints analysed and treatments compared. Some statisticians propose statistical adjustments to account for multiplicity. Simply defined, they test for no effects in all the primary endpoints undertaken versus an effect in one or more of those endpoints. in general, statistical adjustments for multiplicity provide crude answers to an irrelevant question. However, investigators should use adjustments when the clinical decision-making argument rests solely on one or more of the primary endpoints being significant. In these cases, adjustments somewhat rescue scattershot analyses. Readers need to be aware of the potential for under-reporting of analyses.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Schulz, KF (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	KSchulz@fhi.org						Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Altman DG, 2000, STAT MED, V19, P3275, DOI 10.1002/1097-0258(20001215)19:23<3275::AID-SIM626>3.0.CO;2-M; Altman DG, 1991, PRACTICAL STAT MED R; Bauer Peter, 2003, J Biopharm Stat, V13, P691, DOI 10.1081/BIP-120024203; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; FRIEDMAN LM, 1996, FUNDAMENTALS CLIN TR; Hsu J., 1996, MULTIPLE COMP THEORY, DOI DOI 10.1007/978-1-4899-7180-7; Meinert CL., 1986, CLIN TRIALS DESIGN C; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moye LA, 1998, ANN EPIDEMIOL, V8, P351, DOI 10.1016/S1047-2797(98)00003-9; Ottenbacher KJ, 1998, AM J EPIDEMIOL, V147, P615; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Pocock SJ, 1997, CONTROL CLIN TRIALS, V18, P530, DOI 10.1016/S0197-2456(97)00008-1; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sankoh AJ, 2003, STAT MED, V22, P3133, DOI 10.1002/sim.1557; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; SCHULZ KF, IN PRESS LANCET; SENN S, 1997, STAT ISSUES DRUG DE; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; WESTFALL P, 2003, MULTIPLICITY CLIN TR, P666	25	263	265	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1591	1595		10.1016/S0140-6736(05)66461-6	http://dx.doi.org/10.1016/S0140-6736(05)66461-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866314				2022-12-28	WOS:000228754800032
J	Dawes, AMC; Illing, L; Clark, SM; Gauthier, DJ				Dawes, AMC; Illing, L; Clark, SM; Gauthier, DJ			All-optical switching in rubidium vapor	SCIENCE			English	Article							NONLINEAR OPTICS; SINGLE PHOTONS; INSTABILITIES; CAVITY; OSCILLATION; STATES; MEDIA; BEAMS	We report on an all-optical switch that operates at low light levels. It consists of laser beams counterpropagating through a warm rubidium vapor that induce an off-axis optical pattern. A switching laser beam causes this pattern to rotate even when the power in the switching beam is much lower than the power in the pattern. The observed switching energy density is very low, suggesting that the switch might operate at the single-photon level with system optimization. This approach opens the possibility of realizing a single-photon switch for quantum information networks and for improving transparent optical telecommunication networks.	Duke Univ, Dept Phys, Durham, NC 27708 USA	Duke University	Gauthier, DJ (corresponding author), Duke Univ, Dept Phys, Box 90305, Durham, NC 27708 USA.	gauthier@phy.duke.edu	Dawes, Andrew/A-2157-2011; Gauthier, Daniel J/G-1336-2011; Clark, Susan M/B-1037-2009	Dawes, Andrew/0000-0003-0341-7154; Gauthier, Daniel J/0000-0002-4473-217X; Clark, Susan M/0000-0001-9941-3363				Barland S, 2002, NATURE, V419, P699, DOI 10.1038/nature01049; Braje DA, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.041801; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; FIRTH WJ, 1990, J OPT SOC AM B, V7, P1087, DOI 10.1364/JOSAB.7.001087; GAUTHIER DJ, 1990, PHYS REV LETT, V64, P1721, DOI 10.1103/PhysRevLett.64.1721; Gibbs H., 2012, OPTICAL BISTABILITY; Gutlich B, 2003, CHAOS, V13, P239, DOI 10.1063/1.1519510; HARRIS SE, 1966, APPL PHYS LETT, V9, P114, DOI 10.1063/1.1754668; Harris SE, 1998, PHYS REV LETT, V81, P3611, DOI 10.1103/PhysRevLett.81.3611; KEYES RW, 1970, SCIENCE, V168, P796, DOI 10.1126/science.168.3933.796; KHITROVA G, 1988, PHYS REV LETT, V60, P1126, DOI 10.1103/PhysRevLett.60.1126; LUGIATO LA, 1994, CHAOS SOLITON FRACT, V4, P1251, DOI 10.1016/0960-0779(94)90080-9; Lukin MD, 2003, REV MOD PHYS, V75, P457, DOI 10.1103/RevModPhys.75.457; Lukin MD, 2000, PHYS REV LETT, V84, P1419, DOI 10.1103/PhysRevLett.84.1419; MAITRE A, 1995, OPT COMMUN, V116, P153, DOI 10.1016/0030-4018(95)00044-9; Martin R, 1996, PHYS REV LETT, V77, P4007, DOI 10.1103/PhysRevLett.77.4007; McKeever J, 2004, SCIENCE, V303, P1992, DOI 10.1126/science.1095232; Novikova I, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.061802; Prati F, 1997, PHYS REV A, V55, P690, DOI 10.1103/PhysRevA.55.690; RAMASWAMI R, 2002, OPTICAL NETWORK PRAC, pCH12; Resch KJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.037904; Schmidt H, 1996, OPT LETT, V21, P1936, DOI 10.1364/OL.21.001936; SILBERBERG Y, 1984, J OPT SOC AM B, V1, P662, DOI 10.1364/JOSAB.1.000662; SMITH CP, 1993, OPT COMMUN, V102, P505, DOI 10.1016/0030-4018(93)90430-D; Strecker KE, 2002, NATURE, V417, P150, DOI 10.1038/nature747; van der Wal CH, 2003, SCIENCE, V301, P196, DOI 10.1126/science.1085946; Yan M, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.041801; Yariv A, 1977, OPT LETT, V1, P16, DOI 10.1364/OL.1.000016; Zibrov AS, 1999, PHYS REV LETT, V83, P4049, DOI 10.1103/PhysRevLett.83.4049	29	250	253	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					672	674		10.1126/science.1110151	http://dx.doi.org/10.1126/science.1110151			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860622	Green Submitted			2022-12-28	WOS:000228810900043
J	Kurth, R				Kurth, R			Maurice R. Hilleman (1919-2005) - Obituary	NATURE			English	Biographical-Item									Robert Koch Inst, D-13353 Berlin, Germany	Robert Koch Institute	Kurth, R (corresponding author), Robert Koch Inst, Nordufer 20, D-13353 Berlin, Germany.	schwarzk@rki.de						HILLEMAN MR, PUBLICATION LIST	1	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1083	1083		10.1038/4341083a	http://dx.doi.org/10.1038/4341083a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858560	Bronze			2022-12-28	WOS:000228693300027
J	Oransky, I				Oransky, I			Georgeanna Seegar Jones - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1460	1460		10.1016/S0140-6736(05)66407-0	http://dx.doi.org/10.1016/S0140-6736(05)66407-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15868654				2022-12-28	WOS:000228651600015
J	Krot, AN; Yurimoto, H; Hutcheon, ID; MacPherson, GJ				Krot, AN; Yurimoto, H; Hutcheon, ID; MacPherson, GJ			Chronology of the early Solar System from chondrule-bearing calcium-aluminium-rich inclusions	NATURE			English	Article							CONTEMPORANEOUS FORMATION; REFRACTORY INCLUSIONS; ISOTOPE EVIDENCE; EVAPORATION; CHONDRITES	Chondrules and Ca-Al-rich inclusions (CAIs) are high-temperature components of meteorites that formed during transient heating events in the early Solar System. A major unresolved issue is the relative timing of CAI and chondrule formation(1-4). From the presence of chondrule fragments in an igneous CAI, it was concluded that some chondrules formed before CAIs (ref. 5). This conclusion is contrary to the presence of relict CAIs inside chondrules(6-10), as well as to the higher abundance of Al-26 in CAIs(11); both observations indicate that CAIs predate chondrules by 1-3 million years (Myr). Here we report that relict chondrule material in the Allende meteorite, composed of olivine and low-calcium pyroxene, occurs in the outer portions of two CAIs and is O-16-poor (Delta O-17 approximate to -1 parts per thousand to -5 parts per thousand). Spinel and diopside in the CAI cores are O-16-rich (Delta O-17 up to -20 parts per thousand), whereas diopside in their outer zones, as well as melilite and anorthite, are O-16-depleted (Delta O-17 = -8 parts per thousand to 2 parts per thousand). Both chondrule-bearing CAIs are Al-26-poor with initial Al-26/Al-27 ratios of (4.7 +/- 1.4) x 10(-6) and <1.2 x 10(-6). We conclude that these CAIs had chondrule material added to them during a re-melting episode similar to 2 Myr after formation of CAIs with the canonical Al-26/Al-27 ratio of 5 x 10(-5).	Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94451 USA; Lawrence Livermore Natl Lab, GT Seaborg Inst, Livermore, CA 94451 USA; Smithsonian Inst, Dept Mineral Sci, Washington, DC 20560 USA	University of Hawaii System; University of Hawaii Manoa; Tokyo Institute of Technology; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Smithsonian Institution; Smithsonian National Museum of Natural History	Krot, AN (corresponding author), Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA.	sasha@higp.hawaii.edu	Yurimoto, Hisayoshi/S-9938-2018	Yurimoto, Hisayoshi/0000-0003-0702-0533				Alexander CMO, 2001, METEORIT PLANET SCI, V36, P419, DOI 10.1111/j.1945-5100.2001.tb01883.x; Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Bizzarro M, 2004, NATURE, V431, P275, DOI 10.1038/nature02882; Desch SJ, 2002, METEORIT PLANET SCI, V37, P183, DOI 10.1111/j.1945-5100.2002.tb01104.x; Galy A, 2000, SCIENCE, V290, P1751, DOI 10.1126/science.290.5497.1751; Grossman L, 2002, GEOCHIM COSMOCHIM AC, V66, P145, DOI 10.1016/S0016-7037(01)00731-1; Hsu WB, 2000, EARTH PLANET SC LETT, V182, P15, DOI 10.1016/S0012-821X(00)00233-8; Itoh S, 2003, NATURE, V423, P728, DOI 10.1038/nature01699; Krot AN, 2002, METEORIT PLANET SCI, V37, P91, DOI 10.1111/j.1945-5100.2002.tb00797.x; Krot AN, 2002, SCIENCE, V295, P1051, DOI 10.1126/science.1068200; Krot AN, 2002, METEORIT PLANET SCI, V37, P155, DOI 10.1111/j.1945-5100.2002.tb01103.x; Krot AN, 2004, GEOCHIM COSMOCHIM AC, V68, P2167, DOI 10.1016/j.gca.2003.10.025; KROT AN, IN PRESS ASTROPHYS J; KROT AN, IN PRESS GEOCHIM COS; MACDOUGALL JD, 1981, LUNAR PLANET SCI, V12, P643; MACPHERSON GJ, 1993, GEOCHIM COSMOCHIM AC, V57, P231, DOI 10.1016/0016-7037(93)90481-B; MacPherson GJ, 2005, TREATISE GEOCHEM, V1, P201; Maruyama S, 1999, EARTH PLANET SC LETT, V169, P165, DOI 10.1016/S0012-821X(99)00075-8; Maruyama S, 2003, GEOCHIM COSMOCHIM AC, V67, P3943, DOI 10.1016/S0016-7037(03)00172-8; McKeegan KD, 2005, TREATISE GEOCHEM, V1, P431; McKeegan KD, 2001, REV MINERAL GEOCHEM, V43, P279, DOI 10.2138/gsrmg.43.1.279; NAGASHIMA K, 2004, WORKSH CHONDR PROT D, P153; SCOTT ERD, 2003, METEORITES COMETS PL, V1, P143; Wark D. A., 1977, P 8 LUN SCI C, V8, P95; WARK DA, 1987, GEOCHIM COSMOCHIM AC, V51, P221, DOI 10.1016/0016-7037(87)90234-1; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989; Yurimoto H, 1998, SCIENCE, V282, P1874, DOI 10.1126/science.282.5395.1874; YURIMOTO H, 2000, LUNAR PLANET SCI, V31, P1593; [No title captured]	29	67	67	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					998	1001		10.1038/nature03470	http://dx.doi.org/10.1038/nature03470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846340				2022-12-28	WOS:000228524600032
J	Seynaeve, C; Brekelmans, CTM				Seynaeve, C; Brekelmans, CTM			Tailoring breast cancer therapy to genetic status	LANCET			English	Editorial Material							20-YEAR FOLLOW-UP; CONSERVING TREATMENT; GERMLINE MUTATIONS; LUMPECTOMY; MASTECTOMY; BRCA2; WOMEN		Dr Daniel den Hoed Canc Ctr, Erasmus MC, Dept Med Oncol, NL-3075 AE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Seynaeve, C (corresponding author), Dr Daniel den Hoed Canc Ctr, Erasmus MC, Dept Med Oncol, NL-3075 AE Rotterdam, Netherlands.	c.seynaeve@erasmusmc.nl						Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Haffty BG, 2002, LANCET, V359, P1471, DOI 10.1016/S0140-6736(02)08434-9; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Pierce LJ, 2000, J CLIN ONCOL, V18, P3360, DOI 10.1200/JCO.2000.18.19.3360; Robson M, 2005, CANCER, V103, P44, DOI 10.1002/cncr.20728; Seynaeve C, 2004, EUR J CANCER, V40, P1150, DOI 10.1016/j.ejca.2004.01.017; SEYNAEVE C, 2002, P ASCO, V21, pA426; Turner BC, 1999, J CLIN ONCOL, V17, P3017, DOI 10.1200/JCO.1999.17.10.3017; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989	9	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1672	1673		10.1016/S0140-6736(05)66528-2	http://dx.doi.org/10.1016/S0140-6736(05)66528-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894086				2022-12-28	WOS:000229082300008
J	Moore, P				Moore, P			Hot from the vent	NATURE			English	Article																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					235	235		10.1038/435235b	http://dx.doi.org/10.1038/435235b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889099	Bronze			2022-12-28	WOS:000229021100049
J	Poucet, B; Save, E				Poucet, B; Save, E			Attractors in memory	SCIENCE			English	Editorial Material							LONG-TERM STABILITY; DYNAMICS; CELLS		Univ Aix Marseille 1, CNRS, Lab Neurobiol & Cognit, Ctr St Charles, F-13331 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Poucet, B (corresponding author), Univ Aix Marseille 1, CNRS, Lab Neurobiol & Cognit, Ctr St Charles, F-13331 Marseille, France.	bpoucet@up.univ-mrs.fr	Poucet, Bruno/B-4019-2010	Poucet, Bruno/0000-0003-2704-804X				Guzowski JF, 2004, NEURON, V44, P581, DOI 10.1016/j.neuron.2004.11.003; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MULLER RU, 1987, J NEUROSCI, V7, P1951; Paz-Villagran V, 2004, EUR J NEUROSCI, V20, P1379, DOI 10.1111/j.1460-9568.2004.03570.x; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	8	17	18	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					799	800		10.1126/science.1112555	http://dx.doi.org/10.1126/science.1112555			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879197				2022-12-28	WOS:000228986500026
J	Watson, EB; Harrison, TM				Watson, EB; Harrison, TM			Zircon thermometer reveals minimum melting conditions on earliest Earth	SCIENCE			English	Article							TRACE-ELEMENT COMPOSITION; OLD DETRITAL ZIRCONS; JACK HILLS; INCLUSION ANALYSIS; WESTERN-AUSTRALIA; QUARTZ PHENOCRYSTS; GLASS INCLUSIONS; ANCIENT ZIRCONS; TEMPERATURE; MAGMA	Ancient zircons from Western Australia's Jack Hills preserve a record of conditions that prevailed on Earth not long after its formation. Widely considered to have been a uniquely violent period geodynamicalty, the Hadean Eon [4.5 to 4.0 billion years ago (Ga)] has recently been interpreted by some as far more benign-possibly even characterized by oceans like those of the present day. Knowledge of the crystallization temperatures of the Hadean zircons is key to this debate. A thermometer based on titanium content revealed that these zircons cluster strongly at similar to 700 degrees C, which is indistinguishable from temperatures of granitoid zircon growth today and strongly suggests a regulated mechanism producing zircon-bearing rocks during the Hadean. The temperatures substantiate the existence of wet, minimum-melting conditions within 200 million years of solar system formation. They further suggest that Earth had settled into a pattern of crust formation, erosion, and sediment recycling as early as 4.35 Ga.	Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	Rensselaer Polytechnic Institute; Australian National University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Watson, EB (corresponding author), Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA.	watsoe@rpi.edu	Facility, NENIMF/B-8811-2015; Harrison, Timothy M/E-7443-2012					Amelin Y, 1999, NATURE, V399, P252, DOI 10.1038/20426; ARMSTRONG RL, 1981, PHILOS T R SOC A, V301, P443, DOI 10.1098/rsta.1981.0122; Belousova EA, 2002, CONTRIB MINERAL PETR, V143, P602, DOI 10.1007/s00410-002-0364-7; BENZ W, 1986, ICARUS, V66, P515, DOI 10.1016/0019-1035(86)90088-6; Bindeman IN, 2001, J PETROL, V42, P1491, DOI 10.1093/petrology/42.8.1491; Bowring SA, 1999, CONTRIB MINERAL PETR, V134, P3, DOI 10.1007/s004100050465; BROOKS CK, 1969, GEOCHIM COSMOCHIM AC, V33, P357, DOI 10.1016/0016-7037(69)90168-9; CAWOOD PA, 1997, P OCEAN DRILL PROG, V156, P343; COMPSTON W, 1986, NATURE, V321, P766, DOI 10.1038/321766a0; DUNBAR NW, 1993, AM MINERAL, V78, P612; DUNBAR NW, 1992, J GEOPHYS RES-SOL EA, V97, P15129, DOI 10.1029/92JB00764; DUNBAR NW, 1992, J GEOPHYS RES-SOL EA, V97, P15151, DOI 10.1029/92JB01340; FROUDE DO, 1983, NATURE, V304, P616, DOI 10.1038/304616a0; GHENT ED, 1984, CONTRIB MINERAL PETR, V86, P248, DOI 10.1007/BF00373670; Hanson B, 1996, AM MINERAL, V81, P1249; Harford CL, 2003, J PETROL, V44, P1503, DOI 10.1093/petrology/44.8.1503; Holtz F, 2001, CONTRIB MINERAL PETR, V141, P347, DOI 10.1007/s004100100245; Hoskin PWO, 2005, GEOCHIM COSMOCHIM AC, V69, P637, DOI 10.1016/j.gca.2004.07.006; Izbekov PE, 2004, J PETROL, V45, P2325, DOI 10.1093/petrology/egh059; Lee C.-T., 1999, P 7 INT KIMB C, P503; Lowenstern JB, 1997, J PETROL, V38, P1707, DOI 10.1093/petrology/38.12.1707; LUTH WC, 1964, J GEOPHYS RES, V69, P759, DOI 10.1029/JZ069i004p00759; MAAS R, 1992, GEOCHIM COSMOCHIM AC, V56, P1281, DOI 10.1016/0016-7037(92)90062-N; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; Morgan GB, 1998, J PETROL, V39, P601, DOI 10.1093/petrology/39.4.601; Peppard BT, 2001, AM MINERAL, V86, P1034; Righter K, 1999, EARTH PLANET SC LETT, V171, P383, DOI 10.1016/S0012-821X(99)00156-9; RUDNICK RL, 1999, P 7 INT KIMB C CAP T, P728; RYERSON FJ, 1987, EARTH PLANET SC LETT, V86, P225, DOI 10.1016/0012-821X(87)90223-8; SELVERSTONE J, 1991, J METAMORPH GEOL, V9, P419, DOI 10.1111/j.1525-1314.1991.tb00536.x; Sleep NH, 1998, J GEOPHYS RES-PLANET, V103, P28529, DOI 10.1029/98JE01809; SORENSEN SS, 1988, J METAMORPH GEOL, V6, P405, DOI 10.1111/j.1525-1314.1988.tb00431.x; Storm LC, 2005, J METAMORPH GEOL, V23, P107, DOI 10.1111/j.1525-1314.2005.00565.x; Taylor S.R., 1985, CONTINENTAL CRUST IT; Trail D, 2004, GEOCHIM COSMOCHIM AC, V68, pA743; Turner G, 2004, SCIENCE, V306, P89, DOI 10.1126/science.1101014; Tuttle O.F., 1958, ORIGIN GRANITE LIGHT; Wager L. R., 1968, LAYERED IGNEOUS ROCK; WARK DA, 2004, EOS T AGU; Watson E. A., UNPUB; WATSON EB, 1979, CONTRIB MINERAL PETR, V70, P407, DOI 10.1007/BF00371047; WATSON EB, 1983, EARTH PLANET SC LETT, V64, P295, DOI 10.1016/0012-821X(83)90211-X; WEBSTER JD, 1991, AM MINERAL, V76, P1628; WEBSTER JD, 1995, GEOCHIM COSMOCHIM AC, V59, P711, DOI 10.1016/0016-7037(94)00356-Q; WHITNEY JA, 1975, J GEOL, V83, P1, DOI 10.1086/628042; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	47	691	795	8	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					841	844		10.1126/science.1110873	http://dx.doi.org/10.1126/science.1110873			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879213				2022-12-28	WOS:000228986500044
J	Schon, MP; Boehncke, WH				Schon, MP; Boehncke, WH			Medical progress - Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review									Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97078 Wurzburg, Germany; Univ Wurzburg, Dept Dermatol, D-97078 Wurzburg, Germany; Univ Frankfurt, Dept Dermatol, D-6000 Frankfurt, Germany	German Research Foundation (DFG); University of Wurzburg; University of Wurzburg; Goethe University Frankfurt	Schon, MP (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Versbacher Str 0, D-97078 Wurzburg, Germany.	michael.schoen@virchow.uni-wuerzburg.de		Schon, Michael/0000-0002-0698-4130					0	877	957	2	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1899	1912		10.1056/NEJMra041320	http://dx.doi.org/10.1056/NEJMra041320			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872205				2022-12-28	WOS:000228858600010
J	Ship, AN				Ship, AN			A 50-year-old man with hepatitis C and cirrhosis needing liver transplantation, 18 months later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Hanto DW, 2003, JAMA-J AM MED ASSOC, V290, P3238, DOI 10.1001/jama.290.24.3238	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2005	293	16					2027	2027		10.1001/jama.293.16.2027	http://dx.doi.org/10.1001/jama.293.16.2027			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XS	15855437				2022-12-28	WOS:000228651500029
J	Kolaczinski, J; Graham, K; Fahim, A; Brooker, S; Rowland, M				Kolaczinski, J; Graham, K; Fahim, A; Brooker, S; Rowland, M			Malaria control in Afghanistan: progress and challenges	LANCET			English	Article							INSECTICIDE-TREATED NETS; PLASMODIUM-FALCIPARUM MALARIA; PROVIDES PERSONAL PROTECTION; ANOPHELES-CULICIFACIES; SOUTHWEST AFGHANISTAN; CATTLE OWNERSHIP; REFUGEE CAMP; TOP-SHEETS; PAKISTAN; RESISTANCE	From the 1950s until 1979 malaria control in Afghanistan was implemented through a vertical programme managed by the government, but little of the original programme remained functional by the early 1990s. Delivery of basic health care including malaria diagnosis and treatment was done by non-governmental organisations (NGOs) and UN agencies, which organised cross-border operations from Pakistan and Iran and placed much less emphasis on vertical programming. From 1992 the situation in the east of Afghanistan became stable enough to allow the establishment of a network of NGO-supported clinics and to introduce standardised training and monitoring of microscopists and clinical staff, coordinated by a lead agency specialising in malaria. After the collapse of the Taliban in 2001 and the subsequent establishment of an interim government, the first steps in health-system rehabilitation have been taken. The gradual integration of malaria control into routine health-care delivery is planned. This process should be guided by the knowledge and experience gained during the complex emergency and a focus on malaria should be maintained until the disease is brought under control.	Univ London London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, London WC1E 7HT, England; HealthNet Int, Peshawar, Pakistan; Minist Hlth, Dept Hlth Care & Promot, Kabul, Afghanistan	University of London; London School of Hygiene & Tropical Medicine	Kolaczinski, J (corresponding author), Univ London London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, Keppel St, London WC1E 7HT, England.	jan.kolaczinski@lshtm.ac.uk						Banatvala N, 2000, BMJ-BRIT MED J, V321, P101, DOI 10.1136/bmj.321.7253.101; Bhutta ZA, 2002, BMJ-BRIT MED J, V324, P349, DOI 10.1136/bmj.324.7333.349; BOUMA M, 1995, T ROY SOC TROP MED H, V89, P351, DOI 10.1016/0035-9203(95)90004-7; BOUMA MJ, 1995, T ROY SOC TROP MED H, V89, P62, DOI 10.1016/0035-9203(95)90661-4; Brentlinger PE, 2003, LANCET INFECT DIS, V3, P467, DOI 10.1016/s1473-3099(03)00717-5; Buck A.A., 1972, HLTH DIS RURAL AFGHA; DELFINI LF, 1989, T ROY SOC TROP MED H, V83, P316, DOI 10.1016/0035-9203(89)90486-0; Dhir S. L., 1957, Indian Journal of Malariology, V11, P73; DJELANTIK AAM, 1975, EMMAL169; DY F J, 1954, Bull World Health Organ, V11, P725; ESHGHY N, 1978, MOSQ NEWS, V38, P97; ESHGHY N, 1978, MOSQ NEWS, V38, P268; Hewitt S, 1999, TROP MED INT HEALTH, V4, P481, DOI 10.1046/j.1365-3156.1999.00433.x; HEWITT S, 1994, MED VET ENTOMOL, V8, P160, DOI 10.1111/j.1365-2915.1994.tb00156.x; Hewitt SE, 1996, ANN TROP MED PARASIT, V90, P337, DOI 10.1080/00034983.1996.11813059; Howard N, 2003, TROP MED INT HEALTH, V8, P1043, DOI 10.1046/j.1365-3156.2003.01163.x; JOHNSON C, 1998, AFGHANISTAN LAND SHA; Lengeler C, 2004, COCHRANE DB SYST REV, V2; LINDBERG K., 1949, RIV MALARIOL, V28, P1; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; POLEVOY NI, 1973, WHOMAL73795; Rab MA, 2001, ANN TROP MED PARASIT, V95, P41, DOI 10.1080/00034980020035906; RAMACHANDRA T, 1951, Bull World Health Organ, V3, P639; Reyburn H, 2000, T ROY SOC TROP MED H, V94, P361, DOI 10.1016/S0035-9203(00)90104-4; Rowland M, 1999, T ROY SOC TROP MED H, V93, P465, DOI 10.1016/S0035-9203(99)90341-3; Rowland M, 1997, TROP MED INT HEALTH, V2, P1049, DOI 10.1046/j.1365-3156.1997.d01-185.x; Rowland M, 2004, TROP MED INT HEALTH, V9, P343, DOI 10.1046/j.1365-3156.2003.01183.x; Rowland M, 2004, TROP MED INT HEALTH, V9, P335, DOI 10.1111/j.1365-3156.2004.01198.x; Rowland M, 2002, SOC SCI MED, V55, P2061, DOI 10.1016/S0277-9536(01)00341-0; Rowland M, 2002, TROP MED INT HEALTH, V7, P813, DOI 10.1046/j.1365-3156.2002.00940.x; Rowland M, 1996, T ROY SOC TROP MED H, V90, P357, DOI 10.1016/S0035-9203(96)90505-2; Rowland M, 1999, T ROY SOC TROP MED H, V93, P641, DOI 10.1016/S0035-9203(99)90081-0; Rowland M, 2001, LANCET, V357, P1837, DOI 10.1016/S0140-6736(00)04955-2; Rowland M, 2002, T ROY SOC TROP MED H, V96, P620, DOI 10.1016/S0035-9203(02)90331-7; Shah I, 1997, ANN TROP MED PARASIT, V91, P591, DOI 10.1080/00034989760680; Webster J, 2003, TROP MED INT HEALTH, V8, P196, DOI 10.1046/j.1365-3156.2003.01013.x; *WHO, 2003, WHOEMMAL289EG REG OF; *WHO, 2002, COUNTR UPD AFGH	38	42	45	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1506	1512		10.1016/S0140-6736(05)66423-9	http://dx.doi.org/10.1016/S0140-6736(05)66423-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850637				2022-12-28	WOS:000228651600031
J	Benes, CH; Wu, N; Elia, AEH; Dharia, T; Cantley, LC; Soltoff, SP				Benes, CH; Wu, N; Elia, AEH; Dharia, T; Cantley, LC; Soltoff, SP			The C2 domain of PKC delta is a phosphotyrosine binding domain	CELL			English	Article							PROTEIN-KINASE-C; HUMAN COLON-CANCER; TYROSINE PHOSPHORYLATION; CRYSTAL-STRUCTURE; SRC; CELLS; ACTIVATION; SALIVARY; RECEPTOR; REGION	In eukaryotic cells, the SH2 and PTB domains mediate protein-protein interactions by recognizing phosphotyrosine residues on target proteins. Here we make the unexpected finding that the C2 domain of PKC delta directly binds to phosphotyrosine peptides in a sequence-specific manner. We provide evidence that this domain mediates PKC delta interaction with a Src binding glycoprotein, CDCP1. The crystal structure of the PKC delta C2 domain in complex with an optimal phosphopeptide reveals a new mode of phosphotyrosine binding in which the phosphotyrosine moiety forms a ring-stacking interaction with a histidine residue of the C2 domain. This is also the first example of a protein Ser/Thr kinase containing a domain that binds phosphotyrosine.	Beth Israel Deaconess Med Ctr, Dept Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Soltoff, SP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, New Res Bldg,Room1030 J 330 Brookline Ave, Boston, MA 02215 USA.	ssoltoff@bidmc.harvard.edu	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE014721, R01DE010877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE10877, DE14721] Funding Source: Medline; NIDDK NIH HHS [P30DK34854] Funding Source: Medline; NIGMS NIH HHS [GM56203, R01 GM056203] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benes C, 2001, AM J PHYSIOL-CELL PH, V280, pC1498, DOI 10.1152/ajpcell.2001.280.6.C1498; Blake RA, 1999, CELL GROWTH DIFFER, V10, P231; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buhring HJ, 2004, STEM CELLS, V22, P334, DOI 10.1634/stemcells.22-3-334; Dekker LV, 1997, J BIOL CHEM, V272, P12747, DOI 10.1074/jbc.272.19.12747; DeMali KA, 1999, EXP CELL RES, V253, P271, DOI 10.1006/excr.1999.4669; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Irby R, 1997, CELL GROWTH DIFFER, V8, P1287; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Izumi Y, 1997, J BIOL CHEM, V272, P7381, DOI 10.1074/jbc.272.11.7381; Joseloff E, 2002, J BIOL CHEM, V277, P12318, DOI 10.1074/jbc.M111618200; Lopez-Lluch G, 2001, BIOCHEM J, V357, P39, DOI 10.1042/0264-6021:3570039; Malek RL, 2002, ONCOGENE, V21, P7256, DOI 10.1038/sj.onc.1205900; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Otwinowski Z, 1997, PROCESSING XRAY DIFF, V276; Pappa H, 1998, STRUCT FOLD DES, V6, P885, DOI 10.1016/S0969-2126(98)00090-2; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Pepio AM, 2001, J BIOL CHEM, V276, P3846, DOI 10.1074/jbc.M006339200; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Shanmugam M, 1998, ONCOGENE, V16, P1649, DOI 10.1038/sj.onc.1201684; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SOLTOFF SP, 1995, J BIOL CHEM, V270, P13490, DOI 10.1074/jbc.270.22.13490; Soltoff SP, 1998, ANN NY ACAD SCI, V842, P100, DOI 10.1111/j.1749-6632.1998.tb09637.x; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Storz P, 2004, MOL PHARMACOL, V66, P870, DOI 10.1124/mol.104.000687; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zang Q, 1997, J BIOL CHEM, V272, P13275, DOI 10.1074/jbc.272.20.13275; ZHOU SY, 1995, METHOD ENZYMOL, V254, P523	40	213	229	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					271	280		10.1016/j.cell.2005.02.019	http://dx.doi.org/10.1016/j.cell.2005.02.019			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851033	Bronze			2022-12-28	WOS:000228705000014
J	Sondermann, H; Kuriyan, J				Sondermann, H; Kuriyan, J			C2 can do it, too	CELL			English	Editorial Material							BINDING DOMAINS; RECOGNITION; SH2	In this issue of Cell, Benes et al. (2005) report that the C2 domain of the serine/threonine protein kinase C delta is a phosphotyrosine binding domain and present the crystal structure of this C2 domain bound to a peptide containing phosphotyrosine. Prior to this; work, C2 domains were thought to bind only to phospholipids or to unphosphorylated proteins, and the SH2 and PTB domains were the only signaling domains known to recognize phosphotyrosine. This new role for the C2 domain links phosphotyrosine recognition directly to serine/threonine kinase activity and reveals an unexpected mechanism for crosstalk between distinct signaling pathways.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Sondermann, H (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.							Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; RUSSELL RB, 1993, NATURE, V364, P765, DOI 10.1038/364765a0; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0	10	23	25	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 22	2005	121	2					158	160		10.1016/j.cell.2005.04.001	http://dx.doi.org/10.1016/j.cell.2005.04.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851022	Bronze			2022-12-28	WOS:000228705000003
J	Haynes, BF; Fleming, J; St Clair, EW; Katinger, H; Stiegler, G; Kunert, R; Robinson, J; Scearce, RM; Plonk, K; Staats, HF; Ortel, TL; Liao, HX; Alam, SM				Haynes, BF; Fleming, J; St Clair, EW; Katinger, H; Stiegler, G; Kunert, R; Robinson, J; Scearce, RM; Plonk, K; Staats, HF; Ortel, TL; Liao, HX; Alam, SM			Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ANTIPHOSPHOLIPID SYNDROME; PHOSPHOLIPIDS; EPITOPE; ANTICARDIOLIPIN; AUTOANTIBODIES; LA	The design of a human immunodeficiency virus-1 (HIV-1) immunogen that can induce broadly reactive neutralizing antibodies is a major goal of HIV-1 vaccine development. Although rare human monoclonal antibodies (mAbs) exist that broadly neutralize HIV-1, HIV-1 envelope immunogens do not induce these antibody specificities. Here we demonstrate that the two most broadly reactive HIV-1 envelope gp41 human mAbs, 2175 and 4E10, are polyspecific autoantibodies reactive with the phospholipid cardiolipin. Thus, current HIV-1 vaccines may not induce these types of antibodies because of autoantigen mimicry of the conserved membrane-proximal epitopes of the virus. These results may have important implications for generating effective neutralizing, antibody responses by using HIV-1 vaccines.	Duke Univ, Sch Med, Durham, NC 27710 USA; Univ Agr Vienna, Inst Appl Microbiol, Vienna, Austria; Tulane Univ, Sch Med, New Orleans, LA 70112 USA	Duke University; University of Natural Resources & Life Sciences, Vienna; Tulane University	Haynes, BF (corresponding author), Duke Univ, Sch Med, Durham, NC 27710 USA.	hayne002@mc.duke.edu	Alam, S. Munir/AAC-6711-2019; Kunert, Renate E/B-9185-2018	Kunert, Renate E/0000-0002-3397-3621; Staats, Herman/0000-0003-1039-1087	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI052816, P30AI051445] Funding Source: NIH RePORTER; NIAID NIH HHS [AI51445, P0-1 AI52816] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abuaf N, 1997, THROMB HAEMOSTASIS, V77, P856; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; BEVERS EM, 1991, THROMB HAEMOSTASIS, V66, P629; Bouvet JP, 1998, INFECT IMMUN, V66, P1; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; DELGADO AJ, 2002, ARTHRITIS RHEUM, V46, P2686, DOI DOI 10.1371/JOURNAL.PONE.0186513; Douvas A, 1996, AIDS RES HUM RETROV, V12, P1509, DOI 10.1089/aid.1996.12.1509; Fenger M, 2004, CLIN CHEM, V50, P2141, DOI 10.1373/clinchem.2004.038422; Fox RA, 1997, ARTHRITIS RHEUM-US, V40, P1168, DOI 10.1002/art.1780400623; Guerin J, 1998, BRIT J HAEMATOL, V102, P896, DOI 10.1046/j.1365-2141.1998.00876.x; HAYNES BF, UNPUB; Kessler JA, 1997, AIDS RES HUM RETROV, V13, P575, DOI 10.1089/aid.1997.13.575; Kunert RE, 2002, AIDS, V16, P667, DOI 10.1097/00002030-200203080-00020; Loizou S, 2003, ANN RHEUM DIS, V62, P1106, DOI 10.1136/ard.62.11.1106; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; Meffre E, 2001, J CLIN INVEST, V108, P879, DOI 10.1172/JCI13051; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Opalka D, 2004, J IMMUNOL METHODS, V287, P49, DOI 10.1016/j.jim.2004.01.016; Palacios R, 2004, INT J STD AIDS, V15, P277, DOI 10.1258/095646204773557857; Petrovas C, 1999, J AUTOIMMUN, V13, P347, DOI 10.1006/jaut.1999.0324; Radway-Bright EL, 2000, RHEUMATOLOGY, V39, P427, DOI 10.1093/rheumatology/39.4.427; Scanlan CN, 2003, ADV EXP MED BIOL, V535, P205; Shaw Gerald Sinclair, COMMUNICATION; Stiegler G, 2003, J ANTIMICROB CHEMOTH, V51, P757, DOI 10.1093/jac/dkg172; WEISS L, 1995, CLIN IMMUNOL IMMUNOP, V77, P69, DOI 10.1016/0090-1229(95)90138-8; Zhu M, 1999, BRIT J HAEMATOL, V105, P102, DOI 10.1111/j.1365-2141.1999.01292.x	29	609	650	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1906	1908		10.1126/science.1111781	http://dx.doi.org/10.1126/science.1111781			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15860590				2022-12-28	WOS:000230120000039
J	Reyes, CL; Chang, G				Reyes, CL; Chang, G			Structure of the ABC transporter MsbA in complex with ADP-vanadate and lipopolysaccharide	SCIENCE			English	Article							BINDING CASSETTE TRANSPORTER; 2-CYLINDER ENGINE MECHANISM; ESCHERICHIA-COLI MSBA; ATP-BINDING; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; 3-DIMENSIONAL STRUCTURE; CLOSED CONFORMATION; FAMILY TRANSPORTER; INNATE IMMUNITY	Select members of the adenosine triphosphate (ATP)-binding cassette (ABC) transporter family couple ATP binding and hydrolysis to substrate efflux and confer multidrug resistance. We have determined the x-ray structure of MsbA in complex with magnesium, adenosine diphosphate, and inorganic vanadate (Mg-ADP-V-i) and the rough-chemotype lipopolysaccharide, Ra LPS. The structure supports a model involving a rigid-body torque of the two transmembrane domains during ATP hydrolysis and suggests a mechanism by which the nucleotide-binding domain communicates with the transmembrane domain. We propose a lipid "flip-flop" mechanism in which the sugar groups are sequestered in the chamber while the hydrophobic tails are dragged through the lipid bilayer.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92137 USA	Scripps Research Institute	Chang, G (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd CB105, La Jolla, CA 92137 USA.	gchang@scripps.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061905] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61905] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buchaklian AH, 2004, BIOCHEMISTRY-US, V43, P8600, DOI 10.1021/bi0497751; Chami M, 2002, J MOL BIOL, V315, P1075, DOI 10.1006/jmbi.2001.5309; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Ecker GF, 2004, MOL PHARMACOL, V66, P1169, DOI 10.1124/mol.104.001420; Ferreira-Pereira A, 2003, J BIOL CHEM, V278, P11995, DOI 10.1074/jbc.M212198200; Gruen M, 1999, PROTEIN SCI, V8, P2524; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; KAROW M, 1993, MOL MICROBIOL, V7, P69, DOI 10.1111/j.1365-2958.1993.tb01098.x; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; LING V, 1992, CANCER-AM CANCER SOC, V69, P2603, DOI 10.1002/1097-0142(19920515)69:10<2603::AID-CNCR2820691034>3.0.CO;2-E; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Moellering RC, 1998, CLIN INFECT DIS, V27, pS135; Ouellette M, 2001, J MOL MICROB BIOTECH, V3, P201; Polissi A, 1996, MOL MICROBIOL, V20, P1221, DOI 10.1111/j.1365-2958.1996.tb02642.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; REYES CR, UNPUB; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Senior AE, 1997, SEMIN CANCER BIOL, V8, P143, DOI 10.1006/scbi.1997.0065; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; van Veen HW, 2001, RES MICROBIOL, V152, P365, DOI 10.1016/S0923-2508(01)01208-6; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	35	163	168	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1028	1031		10.1126/science.1107733	http://dx.doi.org/10.1126/science.1107733			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890884				2022-12-28	WOS:000229190700048
J	Nilsson, DE; Gislen, L; Coates, MM; Skogh, C; Garm, A				Nilsson, DE; Gislen, L; Coates, MM; Skogh, C; Garm, A			Advanced optics in a jellyfish eye	NATURE			English	Article							PRIMARY VISUAL-CORTEX; TRIPEDALIA-CYSTOPHORA; CRYSTALLINE LENS; PHOTORECEPTORS; CUBOZOA; BRAIN; MODEL	Cubozoans, or box jellyfish, differ from all other cnidarians by an active fish-like behaviour and an elaborate sensory apparatus(1,2). Each of the four sides of the animal carries a conspicuous sensory club ( the rhopalium), which has evolved into a bizarre cluster of different eyes(3). Two of the eyes on each rhopalium have long been known to resemble eyes of higher animals, but the function and performance of these eyes have remained unknown(4). Here we show that box-jellyfish lenses contain a finely tuned refractive index gradient producing nearly aberration-free imaging. This demonstrates that even simple animals have been able to evolve the sophisticated visual optics previously known only from a few advanced bilaterian phyla. However, the position of the retina does not coincide with the sharp image, leading to very wide and complex receptive fields in individual photoreceptors. We argue that this may be useful in eyes serving a single visual task. The findings indicate that tailoring of complex receptive fields might have been one of the original driving forces in the evolution of animal lenses.	Lund Univ, Dept Cell & Organism Biol, S-22362 Lund, Sweden; Lund Univ, Dept Theoret Phys, SE-22362 Lund, Sweden	Lund University; Lund University	Nilsson, DE (corresponding author), Lund Univ, Dept Cell & Organism Biol, Zool Bldg,Helgonavagen 3, S-22362 Lund, Sweden.	dan-e.nilsson@cob.lu.se	Garm, Anders/K-4362-2014	Garm, Anders/0000-0002-2080-735X				Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Bartels A, 1998, P ROY SOC B-BIOL SCI, V265, P2327, DOI 10.1098/rspb.1998.0579; Berger E. W., 1898, J COMP NEUROL, V8, P223; Buskey EJ, 2003, MAR BIOL, V142, P225, DOI 10.1007/s00227-002-0938-y; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; FLETCHER A, 1954, PROC R SOC LON SER-A, V223, P216, DOI 10.1098/rspa.1954.0110; Jagger WS, 1999, VISION RES, V39, P2841, DOI 10.1016/S0042-6989(99)00012-7; KROGER RHH, 1994, VISION RES, V34, P1815, DOI 10.1016/0042-6989(94)90306-9; Land MF, 2002, ANIMAL EYES; LASKA G, 1984, ZOOMORPHOLOGY, V104, P163, DOI 10.1007/BF00312135; Laska G., 1982, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V108, P107; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; NILSSON DE, 1983, J MICROSC-OXFORD, V132, P21, DOI 10.1111/j.1365-2818.1983.tb04705.x; Nilsson DE, 2004, CURR OPIN NEUROBIOL, V14, P407, DOI 10.1016/j.conb.2004.07.004; Piatigorsky J, 2004, INT J DEV BIOL, V48, P719, DOI 10.1387/ijdb.041851jp; Piatigorsky J, 2001, P NATL ACAD SCI USA, V98, P12362, DOI 10.1073/pnas.231310698; PIATIGORSKY J, 1993, J BIOL CHEM, V268, P11894; Schweigart G, 2002, EUR J NEUROSCI, V15, P1585, DOI 10.1046/j.1460-9568.2002.01996.x; STANGE G, 1981, J COMP PHYSIOL, V141, P335, DOI 10.1007/BF00609936; Stewart SE, 1996, MAR FRESHW BEHAV PHY, V27, P175, DOI 10.1080/10236249609378963; Suder K, 2002, EXP BRAIN RES, V144, P430, DOI 10.1007/s00221-002-1061-5; Warrant EJ, 1998, VISION RES, V38, P195, DOI 10.1016/S0042-6989(97)00151-X; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0	24	164	167	4	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					201	205		10.1038/nature03484	http://dx.doi.org/10.1038/nature03484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889091				2022-12-28	WOS:000229021100039
J	Schwaab, T; Nangia, AK				Schwaab, T; Nangia, AK			Scrotal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA	Dartmouth College	Schwaab, T (corresponding author), Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA.								0	0	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					2002	2002		10.1056/NEJMicm040559	http://dx.doi.org/10.1056/NEJMicm040559			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888701				2022-12-28	WOS:000229017100011
J	McMillan, J				McMillan, J			Commentary: Doing what's best and best interests	BRITISH MEDICAL JOURNAL			English	Editorial Material									Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Hull; University of York - UK	McMillan, J (corresponding author), Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England.	john.mcmillan@hyms.ac.uk	McMillan, John/S-9660-2018	McMillan, John/0000-0002-7507-1861				BUCHANAN ALLEN E., 1990, DECIDING OTHERS ETHI, P26; Kevles DJ, 1999, BRIT MED J, V319, P435, DOI 10.1136/bmj.319.7207.435; Siotia AK, 2005, BRIT MED J, V330, P1068, DOI 10.1136/bmj.330.7499.1068	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 7	2005	330	7499					1069	1069		10.1136/bmj.330.7499.1069-a	http://dx.doi.org/10.1136/bmj.330.7499.1069-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925YY	15879394	Green Published			2022-12-28	WOS:000229090900024
J	Hochedlinger, K; Yamada, Y; Beard, C; Jaenisch, R				Hochedlinger, K; Yamada, Y; Beard, C; Jaenisch, R			Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues	CELL			English	Article							EMBRYONIC STEM-CELLS; BREAST-CANCER CELLS; GENE-EXPRESSION; SOMATIC-CELLS; BETA-CATENIN; HAIR FOLLICLE; SELF-RENEWAL; ES CELLS; INTESTINAL EPITHELIUM; TRANSCRIPTION FACTOR	The POU-domain transcription factor Oct-4 is normally expressed in pluripotent cells of the mammalian embryo. In addition, germ-cell tumors and a few somatic tumors show detectable expression of Oct-4. While Oct-4's role during preimplantation development is to maintain embryonic cells in a pluripotent state, little is known about its potential oncogenic properties. Here we investigate the effect of ectopic Oct-4 expression on somatic tissues of adult mice using a doxycycline-dependent expression system. Activation of Oct-4 results in dysplastic growths in epithelial tissues that are dependent on continuous Oct-4 expression. Dysplastic lesions show an expansion of progenitor cells and increased beta-catenin transcriptional activity. In the intestine, Oct-4 expression causes dysplasia by inhibiting cellular differentiation in a manner similar to that in embryonic cells. These data show that certain adult progenitors remain competent to interpret key embryonic signals and support the notion that progenitor cells are a driving force in tumorigenesis.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02141 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu			NATIONAL CANCER INSTITUTE [R37CA084198, R01CA087869] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA 84198, R01 CA 87869] Funding Source: Medline; NICHD NIH HHS [R01 HD 445022] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adamson ED, 2002, J CELL PHYSIOL, V190, P267, DOI 10.1002/jcp.10072; Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Belting HG, 2001, DEVELOPMENT, V128, P4165; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Brickman JM, 2002, NAT GENET, V32, P557, DOI 10.1038/ng1202-557; Burgess S, 2002, DEVELOPMENT, V129, P905; Byrne JA, 2003, CURR BIOL, V13, P1206, DOI 10.1016/S0960-9822(03)00462-7; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cheng L, 2004, CANCER-AM CANCER SOC, V101, P2006, DOI 10.1002/cncr.20566; Cheng L, 2004, AM J SURG PATHOL, V28, P1341, DOI 10.1097/01.pas.0000135528.03942.1f; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CIARDIELLO F, 1991, CANCER RES, V51, P1051; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Felsher DW, 2004, CURR OPIN GENET DEV, V14, P37, DOI 10.1016/j.gde.2003.12.008; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Honecker F, 2004, WORLD J UROL, V22, P15, DOI 10.1007/s00345-004-0399-7; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones TD, 2004, AM J SURG PATHOL, V28, P935, DOI 10.1097/00000478-200407000-00014; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Looijenga LHJ, 2003, APMIS, V111, P161, DOI 10.1034/j.1600-0463.2003.11101201.x; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OGUIN WM, 1992, J INVEST DERMATOL, V98, P24, DOI 10.1111/1523-1747.ep12494172; Okuda T, 2004, MOL BRAIN RES, V132, P18, DOI 10.1016/j.molbrainres.2004.08.021; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Ramos-Mejia V, 2005, DEV DYNAM, V232, P180, DOI 10.1002/dvdy.20211; Reim G, 2002, DEVELOPMENT, V129, P917; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; SHIMAZAKI T, 1993, EMBO J, V12, P4489, DOI 10.1002/j.1460-2075.1993.tb06138.x; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Steingart RA, 2002, LIFE SCI, V71, P2543, DOI 10.1016/S0024-3205(02)02082-9; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013; Wang PX, 2003, BIOCHEM J, V375, P199, DOI 10.1042/BJ20030579; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Yamaguchi S, 2005, GENE CHROMOSOME CANC, V43, P217, DOI 10.1002/gcc.20171; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	83	649	699	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					465	477		10.1016/j.cell.2005.02.018	http://dx.doi.org/10.1016/j.cell.2005.02.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882627	Bronze			2022-12-28	WOS:000229031600015
J	Wild, M; Gilgen, H; Roesch, A; Ohmura, A; Long, CN; Dutton, EG; Forgan, B; Kallis, A; Russak, V; Tsvetkov, A				Wild, M; Gilgen, H; Roesch, A; Ohmura, A; Long, CN; Dutton, EG; Forgan, B; Kallis, A; Russak, V; Tsvetkov, A			From dimming to brightening: Decadal changes in solar radiation at Earth's surface	SCIENCE			English	Article							CLIMATE; TRENDS	Variations in solar radiation incident at Earth's surface profoundly affect the human and terrestrial environment. A decline in solar radiation at land surfaces has become apparent in many observational records up to 1990, a phenomenon known as global dimming. Newly available surface observations from 1990 to the present, primarily from the Northern Hemisphere, show that the dimming did not persist into the 1990s. Instead, a widespread brightening has been observed since the late 1980s. This reversal is reconcilable with changes in cloudiness and atmospheric transmission and may substantially affect surface climate, the hydrological cycle, glaciers, and ecosystems.	Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, CH-8057 Zurich, Switzerland; Pacific NW Natl Lab, Richland, WA 99352 USA; NOAA, Climate Monitoring & Diagnost Lab, Boulder, CO 80305 USA; Bur Meteorol, Melbourne, Vic 3001, Australia; Estonian Meteorol & Hydrol Inst, EE-61602 Toravere, Estonia; Tartu Astrophys Observ, EE-61602 Toravere, Estonia; World Radiat Data Ctr, AI Voeikov Main Geophys Observ, St Petersburg 194021, Russia	Swiss Federal Institutes of Technology Domain; ETH Zurich; United States Department of Energy (DOE); Pacific Northwest National Laboratory; National Oceanic Atmospheric Admin (NOAA) - USA; Bureau of Meteorology - Australia	Wild, M (corresponding author), Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	martin.witd@env.ethz.ch	Wild, Martin/J-8977-2012					ABAKUMOVA GM, 2000, METEOROL GIDROL, V9, P51; Dutton EG, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003568; DUTTON EG, 1991, J CLIMATE, V4, P848, DOI 10.1175/1520-0442(1991)004<0848:RIVISR>2.0.CO;2; Gilgen H, 1999, B AM METEOROL SOC, V80, P831, DOI 10.1175/1520-0477(1999)080<0831:TGEBA>2.0.CO;2; Gilgen H, 1998, J CLIMATE, V11, P2042, DOI 10.1175/1520-0442-11.8.2042; Kruger O, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014081; Liepert BG, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019060; Liepert BG, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014910; Liu BH, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004511; Long CN, 2000, J GEOPHYS RES-ATMOS, V105, P15609, DOI 10.1029/2000JD900077; Ohmura A, 2002, SCIENCE, V298, P1345, DOI 10.1126/science.1078972; Ohmura A, 1998, B AM METEOROL SOC, V79, P2115, DOI 10.1175/1520-0477(1998)079<2115:BSRNBW>2.0.CO;2; Ohmura A, 1989, CURRENT PROBLEMS ATM, P298; Palle E, 2004, SCIENCE, V304, P1299, DOI 10.1126/science.1094070; Pinker RT, 2005, SCIENCE, V308, P850, DOI 10.1126/science.1103159; Ramanathan V, 2001, J GEOPHYS RES-ATMOS, V106, P28371, DOI 10.1029/2001JD900133; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Roderick ML, 2002, SCIENCE, V298, P1410; ROSSOW WB, 2004, B AM METEOROL SOC, V85; RUSSAK V, 2003, HDB ESTONIAN SOLAR R; Sharma S, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004331; Stanhill G, 2001, AGR FOREST METEOROL, V107, P255, DOI 10.1016/S0168-1923(00)00241-0; Wielicki BA, 2005, SCIENCE, V308, P825, DOI 10.1126/science.1106484; Wild M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019188	24	937	1042	9	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					847	850		10.1126/science.1103215	http://dx.doi.org/10.1126/science.1103215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879214				2022-12-28	WOS:000228986500046
J	Fung, E; Wong, WW; Suen, JK; Bulter, T; Lee, SG; Liao, JC				Fung, E; Wong, WW; Suen, JK; Bulter, T; Lee, SG; Liao, JC			A synthetic gene-metabolic oscillator	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; CELL-CELL COMMUNICATION; ESCHERICHIA-COLI; GLYCOLYTIC OSCILLATIONS; TOGGLE SWITCH; NETWORKS; EXPRESSION; REGULATORS; CLOCK; YEAST	Autonomous oscillations found in gene expression and metabolic, cardiac and neuronal systems(1-4) have attracted significant attention both because of their obvious biological roles and their intriguing dynamics. In addition, de novo designed(5-12) oscillators(13,14) have been demonstrated, using components that are not part of the natural oscillators. Such oscillators are useful in testing the design principles and in exploring potential applications not limited by natural cellular behaviour(15). To achieve transcriptional and metabolic integration characteristic of natural oscillators, here we designed and constructed a synthetic circuit in Escherichia coli K12, using glycolytic flux to generate oscillation through the signalling metabolite acetyl phosphate. If two metabolite pools are interconverted by two enzymes that are placed under the transcriptional control of acetyl phosphate, the system oscillates when the glycolytic rate exceeds a critical value. We used bifurcation analysis to identify the boundaries of oscillation, and verified these experimentally. This work demonstrates the possibility of using metabolic flux as a control factor in system-wide oscillation, as well as the predictability of a de novo gene - metabolic circuit designed using nonlinear dynamic analysis.	Univ Calif Los Angeles, Dept Chem Engn, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Biomed Engn Interdepartmental Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem Engn, Los Angeles, CA 90095 USA.	liaoj@ucla.edu		Liao, James/0000-0002-4580-7276; Bulter, Thomas/0000-0002-7968-5844				Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bier M, 2000, BIOPHYS J, V78, P1087, DOI 10.1016/S0006-3495(00)76667-7; Bier M, 1996, BIOPHYS CHEM, V62, P15, DOI 10.1016/S0301-4622(96)02195-3; BROSIUS J, 1984, P NATL ACAD SCI-BIOL, V81, P6929, DOI 10.1073/pnas.81.22.6929; Bulter T, 2004, P NATL ACAD SCI USA, V101, P2299, DOI 10.1073/pnas.0306484101; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; FENG JL, 1992, J BACTERIOL, V174, P6061, DOI 10.1128/JB.174.19.6061-6070.1992; Ferry G, 2000, J BIOL CHEM, V275, P8794, DOI 10.1074/jbc.275.12.8794; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hess B, 2000, NATURWISSENSCHAFTEN, V87, P199, DOI 10.1007/s001140050704; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Joseph D., 1989, ELEMENTARY STABILITY; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Rines DR, 2002, METHOD ENZYMOL, V351, P16; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	29	294	312	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					118	122		10.1038/nature03508	http://dx.doi.org/10.1038/nature03508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875027				2022-12-28	WOS:000228864600050
J	Gardner, CD; Coulston, A; Chatterjee, L; Rigby, A; Spiller, G; Farquhar, JW				Gardner, CD; Coulston, A; Chatterjee, L; Rigby, A; Spiller, G; Farquhar, JW			The effect of a plant-based diet on plasma lipids in hypercholesterolemic adults - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							SERUM-LIPIDS; LIPOPROTEIN CHOLESTEROL; NUTRITION COMMITTEE; MEDITERRANEAN DIET; PHYSICAL-ACTIVITY; FATTY-ACIDS; SOY PROTEIN; RISK; GUIDELINES; STATEMENT	Background: A variety of food combinations can be used to meet national U.S. guidelines for obtaining 30% of energy or less from total fat and 10% of energy or less from saturated fat. Objective: To contrast plasma lipid responses to 2 low-fat diet patterns. Design: Randomized clinical trial. Setting: 4-week outpatient feeding study with weight held constant. Participants: 120 adults 30 to 65 years of age with prestudy low-density lipoprotein (LDL) cholesterol concentrations of 3.3 to 4.8 mmol/L (130 to 190 mg/dL), body mass index less than 31 kg/m(2), estimated dietary saturated fat at least 10% of calories, and otherwise general good health. Measurements: Plasma lipid levels. Intervention: Two diets, the Low-Fat diet and the Low-Fat Plus diet, designed to be identical in total fat, saturated fat, protein, carbohydrate, and cholesterol content, consistent with former American Heart Association Step I guidelines. The Low-Fat diet was relatively typical of a low-fat U.S. diet. The Low-Fat Plus diet incorporated considerably more vegetables, legumes, and whole grains, consistent with the 2000 American Heart Association revised guidelines. Results: Four-week changes in the Low-Fat and Low-Fat Plus groups were -0.24 mmol/L (-9.2 mg/dL) versus -0.46 mmol/L (-17.6 mg/dL) for total cholesterol (P = 0.01) and -0.18 mmol/L (-7.0 mg/dL) versus -0.36 mmol/L (-13.8 mg/dL) for LDL cholesterol (P= 0.02); between-group differences were -0.22 mmol/L (-9 mg/dL) (95% Cl, -0.05 to -0.39 mmol/L [-2 to -15 mg/dL]) and -0.18 mmol/L (-7 mg/dL) (Cl, -0.04 to -0.32 mmol/L [-2 to -12 mg/dL]) for total and LDL cholesterol, respectively. The 2 diet groups did not differ significantly in high-density lipoprotein cholesterol and triglycericle levels. Limitations: 4-week duration. Conclusions: Previous national dietary guidelines primarily emphasized avoiding saturated fat and cholesterol; as a result, the guidelines probably underestimated the potential LDL cholesterol-lowering effect of diet. In this study, emphasis on including nutrient-dense plant-based foods, consistent with recently revised national guidelines, increased the total and LDL cholesterol-lowering effect of a low-fat diet.	Stanford Univ, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Stanford, CA 94305 USA; Hlth Sci Res Studies Ctr, Los Altos, CA USA	Stanford University; Stanford University	Gardner, CD (corresponding author), Hoover Pavil,N229,211 Quarry Rd, Stanford, CA 94305 USA.	cgardner@stanford.edu	Rigby, Alan/AFM-1194-2022	Rigby, Alan/0000-0001-8331-3907	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057386] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00070] Funding Source: Medline; NHLBI NIH HHS [R01 HL57386] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ackermann RT, 2001, ARCH INTERN MED, V161, P813, DOI 10.1001/archinte.161.6.813; ALLAIN CC, 1974, CLIN CHEM, V20, P470; ANDERSON JW, 1995, NEW ENGL J MED, V333, P276, DOI 10.1056/NEJM199508033330502; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Asztalos B, 2000, J LIPID RES, V41, P321; Byers T, 2002, CA-CANCER J CLIN, V52, P92, DOI 10.3322/canjclin.52.2.92; CHAIT A, 1993, CIRCULATION, V88, P3008, DOI 10.1161/01.CIR.88.6.3008; Crouse JR, 1999, ARCH INTERN MED, V159, P2070, DOI 10.1001/archinte.159.17.2070; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GARDNER CD, 1995, ARTERIOSCL THROM VAS, V15, P1917, DOI 10.1161/01.ATV.15.11.1917; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Jenkins DJA, 2003, JAMA-J AM MED ASSOC, V290, P502, DOI 10.1001/jama.290.4.502; Jenkins DJA, 1999, METABOLISM, V48, P809, DOI 10.1016/S0026-0495(99)90184-1; Katan MB, 1997, NEW ENGL J MED, V337, P563; Krauss RM, 1996, CIRCULATION, V94, P1795, DOI 10.1161/01.CIR.94.7.1795; Krauss RM, 2000, CIRCULATION, V102, P2284; KRISETHERTON PM, 1988, J AM DIET ASSOC, V88, P1373; Law M, 2000, BMJ-BRIT MED J, V320, P861, DOI 10.1136/bmj.320.7238.861; LEWIS B, 1981, LANCET, V2, P1310; MENSINK RP, 1992, ARTERIOSCLER THROMB, V12, P911, DOI 10.1161/01.ATV.12.8.911; RAMSAY LE, 1991, BMJ-BRIT MED J, V303, P953, DOI 10.1136/bmj.303.6808.953; RIPSIN CM, 1992, JAMA-J AM MED ASSOC, V267, P3317, DOI 10.1001/jama.267.24.3317; Sabate J, 2003, AM J CLIN NUTR, V77, P1379, DOI 10.1093/ajcn/77.6.1379; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; SAMPSON EJ, 1975, CLIN CHEM, V21, P1983; Schaefer EJ, 1996, AM J CLIN NUTR, V63, P234, DOI 10.1093/ajcn/63.2.234; Schaefer EJ, 1997, AM J CLIN NUTR, V65, P823, DOI 10.1093/ajcn/65.3.823; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; SPRECHER DL, 1993, ANN INTERN MED, V119, P545, DOI 10.7326/0003-4819-119-7_Part_1-199310010-00001; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WOOD PD, 1988, NEW ENGL J MED, V319, P1173, DOI 10.1056/NEJM198811033191801; *WORLD MED ASS DEC, 1997, JAMA-J AM MED ASSOC, V277, P925, DOI DOI 10.1001/JAMA.1997.03540350075038	35	67	69	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					725	733		10.7326/0003-4819-142-9-200505030-00007	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922GW	15867404				2022-12-28	WOS:000228825800001
J	Crawford, ED				Crawford, ED			PSA testing: what is the use?	LANCET			English	Editorial Material							PROSTATE-SPECIFIC ANTIGEN; UNITED-STATES; CANCER; FINASTERIDE; MEN		Univ Colorado, Denver, CO 80262 USA	University of Colorado System; University of Colorado Denver	Crawford, ED (corresponding author), Univ Colorado, Denver, CO 80262 USA.	david.crawford@uchsc.edu						Andriole GL, 2005, JNCI-J NATL CANCER I, V97, P433, DOI 10.1093/jnci/dji065; Chu KC, 2003, CANCER-AM CANCER SOC, V97, P1507, DOI 10.1002/cncr.11212; Crawford ED, 1999, PROSTATE, V38, P296; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Oottamasathien S, 2003, ARCH INTERN MED, V163, P661, DOI 10.1001/archinte.163.6.661; Raaijmakers R, 2004, UROLOGY, V63, P316, DOI 10.1016/j.urology.2003.09.028; Stamey TA, 2004, J UROLOGY, V172, P1297, DOI 10.1097/01.ju.0000139993.51181.5d; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Wilson SS, 2004, UROL CLIN N AM, V31, P219, DOI 10.1016/j.ucl.2004.01.002	11	16	18	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1447	1449		10.1016/S0140-6736(05)66398-2	http://dx.doi.org/10.1016/S0140-6736(05)66398-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850617				2022-12-28	WOS:000228651600008
J	Grimes, DA; Schulz, KF				Grimes, DA; Schulz, KF			Refining clinical diagnosis with likelihood ratios	LANCET			English	Article							DECISION-MAKING; ACCURACY; TESTS; VALIDITY; CANCER	Likelihood ratios can refine clinical diagnosis on the basis of signs and symptoms; however, they are underused for patients' care. A likelihood ratio is the percentage of ill people with a given test result divided by the percentage of well individuals with the same result. Ideally, abnormal test results should be much more typical in ill individuals than in those who are well (high likelihood ratio) and normal test results should be most frequent in well people than in sick people (low likelihood ratio). Likelihood ratios near unity have little effect on decision-making; by contrast, high or low ratios can greatly shift the clinician's estimate of the probability of disease. Likelihood ratios can be calculated not only for dichotomous (positive or negative) tests but also for tests with multiple levels of results, such as creatine kinase or ventilation-perfusion scans. When combined with an accurate clinical diagnosis, likelihood ratios from ancillary tests improve diagnostic accuracy in a synergistic manner.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	dgrimes@fhi.org						Altman DG., 2000, STAT CONFIDENCE CONF; Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Bachur R, 2001, ARCH PEDIAT ADOL MED, V155, P60, DOI 10.1001/archpedi.155.1.60; Chien PFW, 2001, BRIT J OBSTET GYNAEC, V108, P568, DOI 10.1111/j.1471-0528.2001.00128.x; *CHILDR MERC HOSP, LIK RAT SLID RUL; Choi BCK, 1998, AM J EPIDEMIOL, V148, P1127; CHOI BCK, 1993, AM J EPIDEMIOL, V138, P723, DOI 10.1093/oxfordjournals.aje.a116910; *CTR EV BAS MED, NOM LIK RAT; DABEKAUSEN YAJM, 1994, FERTIL STERIL, V61, P833; Davidson M, 2002, AUST J PHYSIOTHER, V48, P227, DOI 10.1016/S0004-9514(14)60228-2; DeAlleaume L, 2003, J FAM PRACTICE, V52, P563; DUJARDIN B, 1994, EUR J EPIDEMIOL, V10, P29, DOI 10.1007/BF01717448; Eapen CE, 1997, NATL MED J INDIA, V10, P270; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; FEINSTEIN AR, 1977, CLIN PHARMACOL THER, V21, P482; Fowler VG, 2003, CIRCULATION, V108, P73, DOI 10.1161/01.CIR.0000079105.65762.DB; GIARD RWM, 1990, ARCH PATHOL LAB MED, V114, P852; GOLDENBERG K, 1989, DIAGNOSTIC TESTING H; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Halkin A, 1998, QJM-INT J MED, V91, P247, DOI 10.1093/qjmed/91.4.247; Hayden SR, 1999, ANN EMERG MED, V33, P575, DOI 10.1016/S0196-0644(99)70346-X; HERBERT R, 2002, CONFIDENCE INTERVAL; Hoffman Richard M, 2002, BMC Fam Pract, V3, P19, DOI 10.1186/1471-2296-3-19; Hubbard TW, 1999, ARCH PEDIAT ADOL MED, V153, P1150, DOI 10.1001/archpedi.153.11.1150; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P39, DOI 10.1001/jama.276.1.39; Khan KS, 1999, AM J OBSTET GYNECOL, V181, P112, DOI 10.1016/S0002-9378(99)70445-X; Kurien M., 2000, SMJ Singapore Medical Journal, V41, P324; Laslett M, 2003, AUST J PHYSIOTHER, V49, P89, DOI 10.1016/S0004-9514(14)60125-2; Lee WC, 1999, INT J EPIDEMIOL, V28, P521, DOI 10.1093/ije/28.3.521; McCormick JP, 2003, J ORTHOP TRAUMA, V17, P257, DOI 10.1097/00005131-200304000-00003; McGee S, 2002, J GEN INTERN MED, V17, P646; Meigs JB, 1996, J GEN INTERN MED, V11, P505, DOI 10.1007/BF02599596; Moore J, 2002, ULTRASOUND OBST GYN, V20, P630, DOI 10.1046/j.1469-0705.2002.00862.x; NAYLOR CD, 1995, LANCET, V345, P840, DOI 10.1016/S0140-6736(95)92969-X; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Reid MC, 1998, AM J MED, V104, P374, DOI 10.1016/S0002-9343(98)00054-0; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Sharma S, 1997, CAN J OPHTHALMOL, V32, P475; Snyder BK, 1999, ANN EMERG MED, V33, P565, DOI 10.1016/S0196-0644(99)70345-8; Sonis J, 1999, Fam Med, V31, P432; Steurer J, 2002, BRIT MED J, V324, P824, DOI 10.1136/bmj.324.7341.824; Tokuda Y, 2003, POSTGRAD MED J, V79, P49, DOI 10.1136/pmj.79.927.49; Weiss Steve J, 2003, Violence Vict, V18, P131, DOI 10.1891/vivi.2003.18.2.131	44	562	574	1	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1500	1505		10.1016/S0140-6736(05)66422-7	http://dx.doi.org/10.1016/S0140-6736(05)66422-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850636				2022-12-28	WOS:000228651600030
J	Heil, M; Rattke, J; Boland, W				Heil, M; Rattke, J; Boland, W			Postsecretory hydrolysis of nectar sucrose and specialization in ant/plant mutualism	SCIENCE			English	Article							IMPORTED FIRE ANT; DIGESTIVE ENZYMES; AMINO-ACIDS; HYMENOPTERA; SUGARS; FORMICIDAE; BEHAVIOR	Obligate Acacia ant plants house mutualistic ants as a defense mechanism and provide them with extrafloral nectar (EFN). Ant/plant mutualisms are widespread, but little is known about the biochemical basis of their species specificity. Despite its importance in these and other plant/animal interactions, little attention has been paid to the control of the chemical composition of nectar. We found high invertase (sucrose-cleaving) activity in Acacia EFN, which thus contained no sucrose. Sucrose, a disaccharide common in other EFNs, usually attracts nonsymbiotic ants. The EFN of the ant acacias was therefore unattractive to such ants. The Pseudomyrmex ants that are specialized to live on Acacia had almost no invertase activity in their digestive tracts and preferred sucrose-free EFN. Our results demonstrate postsecretory regulation of the carbohydrate composition of nectar.	Max Planck Inst Chem Ecol, Dept Bioorgan Chem, D-07745 Jena, Germany	Max Planck Society	Heil, M (corresponding author), Univ Duisburg Essen, FB Biogeoallgemeine Bot Pflanzenokol 9, Univ Str 5, D-45117 Essen, Germany.	Heil_Martin@web.de	Heil, Martin/AAC-2730-2022; Heil, Martin/T-3960-2019; Heil, Martin/I-1797-2012; Boland, Wilhelm/K-7762-2012	Heil, Martin/0000-0001-8036-8697; Boland, Wilhelm/0000-0001-6784-2534				AYRE GL, 1967, CAN ENTOMOL, V99, P408, DOI 10.4039/Ent99408-4; BAKER HG, 1973, NATURE, V241, P543, DOI 10.1038/241543b0; Baker HG., 1982, BIOCH ASPECTS EVOLUT, P131; BENTLEY B, 1983, BIOL NECTARIES; Bluthgen N, 2004, J ANIM ECOL, V73, P155, DOI 10.1111/j.1365-2656.2004.00789.x; Boeve JL, 2003, OECOLOGIA, V136, P508, DOI 10.1007/s00442-003-1249-9; Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Brouat C, 2001, P ROY SOC B-BIOL SCI, V268, P2131, DOI 10.1098/rspb.2001.1763; Carter C, 2004, TRENDS PLANT SCI, V9, P320, DOI 10.1016/j.tplants.2004.05.008; Cornelius ML, 1996, ANZ SCHADLINGSKD PFL, V69, P41, DOI 10.1007/BF01907668; Elias T. S., 1983, The biology of nectaries, P174; Ghazoul J, 2001, ECOL LETT, V4, P295, DOI 10.1046/j.1461-0248.2001.00229.x; Heil M, 2004, J CHEM ECOL, V30, P1289, DOI 10.1023/B:JOEC.0000030299.59863.69; Heil M, 2004, NATURE, V430, P205, DOI 10.1038/nature02703; Heil M, 2004, J TROP ECOL, V20, P201, DOI 10.1017/S026646740300110X; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Hoeksema JD, 2000, OECOLOGIA, V125, P321, DOI 10.1007/s004420000496; JANZEN DH, 1975, SCIENCE, V188, P936, DOI 10.1126/science.188.4191.936; LANZA J, 1991, ECOL ENTOMOL, V16, P203, DOI 10.1111/j.1365-2311.1991.tb00210.x; LETOURNEAU DK, 1990, SCIENCE, V248, P215, DOI 10.1126/science.248.4952.215; Peumans WJ, 1997, PLANTA, V201, P298, DOI 10.1007/s004250050070; Raine NE, 2004, ECOL ENTOMOL, V29, P345, DOI 10.1111/j.0307-6946.2004.00608.x; Raine NE, 2002, ECOLOGY, V83, P3086, DOI 10.1890/0012-9658(2002)083[3086:SSAFAB]2.0.CO;2; RICKS BL, 1972, ENTOMOL EXP APPL, V15, P329, DOI 10.1007/BF00428298; Roshchina VV., 1993, EXCRETORY FUNCTION H, DOI [10.1007/978-3-642-78130-8, DOI 10.1007/978-3-642-78130-8]; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; Stapel JO, 1997, ENVIRON ENTOMOL, V26, P617, DOI 10.1093/ee/26.3.617; SVATOS A, UNPUB; Thornburg RW, 2003, PLANT SYST EVOL, V238, P211, DOI 10.1007/s00606-003-0282-9; VANDERMEER RK, 1995, FLA ENTOMOL, V78, P144, DOI 10.2307/3495679; Wilkinson DM, 2001, OIKOS, V92, P377, DOI 10.1034/j.1600-0706.2001.920222.x	33	122	129	6	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					560	563		10.1126/science.1107536	http://dx.doi.org/10.1126/science.1107536			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845855				2022-12-28	WOS:000228810500055
J	Louie, T				Louie, T			The pastor and the party of the century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												tedlouie@msn.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1835	1836		10.1001/jama.293.15.1835	http://dx.doi.org/10.1001/jama.293.15.1835			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840843				2022-12-28	WOS:000228401700001
J	Gupta, RK; Best, J; MacMahon, E				Gupta, RK; Best, J; MacMahon, E			Mumps and the UK epidemic 2005	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CENTRAL-NERVOUS-SYSTEM; MMR VACCINE; RUBELLA MMR; MEASLES; VIRUS; ANTIBODIES; POPULATION; CHILDREN; DISEASES; FAILURE		Guys & St Thomas NHS Fdn Trust, Dept Infect, London SE1 7EH, England; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	MacMahon, E (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Infect, London SE1 7EH, England.	eithne.macmahon@gstt.sthames.nhs.uk	Gupta, Ravindra K/G-5529-2015	Gupta, Ravindra K/0000-0001-9751-1808				Anderson R M, 1990, Lancet, V335, P641; BEST JM, 1994, BRIT MED J, V309, P876, DOI 10.1136/bmj.309.6958.876; BJORVATN B, 1973, SCAND J INFECT DIS, V5, P253, DOI 10.3109/inf.1973.5.issue-4.04; BRISS PA, 1994, J INFECT DIS, V169, P77, DOI 10.1093/infdis/169.1.77; BROWN JW, 1948, AM J MED SCI, V215, P434, DOI 10.1097/00000441-194804000-00012; CARBONE KM, 2001, FIELDS VIROLOGY, P1381; DAVIDKIN I, 1995, VACCINE, V13, P1617, DOI 10.1016/0264-410X(95)00064-8; DEBOER AW, 1989, EUR J PEDIATR, V148, P618, DOI 10.1007/BF00441513; Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001; *DEP HLTH, 1996, IMM INF DIS, P125; FORSBERG P, 1986, ACTA NEUROL SCAND, V73, P372, DOI 10.1111/j.1600-0404.1986.tb03292.x; GAMBLE DR, 1980, BRIT MED J, V281, P99, DOI 10.1136/bmj.281.6233.99; GAY N, 1997, COMMUNICAB DIS REP, V7, P21; Goon P, 2001, VACCINE, V19, P3816, DOI 10.1016/S0264-410X(01)00122-0; Johnson RT, 1996, CLIN INFECT DIS, V23, P219, DOI 10.1093/clinids/23.2.219; Kidd IM, 2003, LANCET, V362, P832, DOI 10.1016/S0140-6736(03)14256-0; King SM, 1996, BONE MARROW TRANSPL, V17, P633; LEINIKKI P, 2004, PRINCIPLES PRACTICE, P459; LJUNGMAN P, 1989, J INFECT DIS, V159, P610, DOI 10.1093/infdis/159.4.610; Mitchell LA, 1998, CAN J PUBLIC HEALTH, V89, P325, DOI 10.1007/BF03404484; Pebody RG, 2002, VACCINE, V20, P1134, DOI 10.1016/S0264-410X(01)00435-2; PERRY KR, 1993, J MED VIROL, V40, P235, DOI 10.1002/jmv.1890400312; PHILIP RN, 1959, AM J HYG, V69, P91; Poggio GP, 2000, J CLIN MICROBIOL, V38, P274; Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention, 1998, MMWR RECOMMENDATIONS, V47, P1; Richardson M, 2001, PEDIATR INFECT DIS J, V20, P380, DOI 10.1097/00006454-200104000-00004; SCHULZ B, 1987, EXP CLIN ENDOCRINOL, V90, P62, DOI 10.1055/s-0029-1210673; SIEGEL M, 1966, NEW ENGL J MED, V274, P768, DOI 10.1056/NEJM196604072741404; SIEGEL M, 1973, JAMA-J AM MED ASSOC, V226, P1521, DOI 10.1001/jama.226.13.1521; Uchida K, 2005, J MED VIROL, V75, P470, DOI 10.1002/jmv.20291; Vandermeulen C, 2004, VACCINE, V22, P2713, DOI 10.1016/j.vaccine.2004.02.001; *WHO, MUMPS VACC	32	110	114	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2005	330	7500					1132	1135		10.1136/bmj.330.7500.1132	http://dx.doi.org/10.1136/bmj.330.7500.1132			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15891229	Green Published			2022-12-28	WOS:000229166900023
J	Paraje, G; Sadana, R; Karam, G				Paraje, G; Sadana, R; Karam, G			Public health - Increasing international gaps in health-related publications	SCIENCE			English	Editorial Material							COUNTRIES; NATIONS		WHO, CH-1211 Geneva, Switzerland	World Health Organization	Sadana, R (corresponding author), WHO, CH-1211 Geneva, Switzerland.	sadanar@who.int		Paraje, Guillermo/0000-0002-7863-907X				CHEN J, 2005, COMMUNICATION   0117; *EUR COMM, 2001, IND BENCHM NAT RES P; GAILLARD J, 1992, SCIENTOMETRICS, V23, P57, DOI 10.1007/BF02020914; *GFHR, 2004, MON FIN FLOWS HLTH R, V2; GIBBS WW, 1995, SCI AM, V273, P92, DOI 10.1038/scientificamerican0895-92; HILL DL, 2004, 04336 NSF DIV SCI RE; KEISER J, 2004, BRIT MED J, V338, P1229; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Li ZZ, 2004, NAT BIOTECHNOL, V22, pDC13, DOI 10.1038/nbt1204supp-DC13; Maselli D, 2004, IMPROVING IMPACTS RE; May RM, 1997, SCIENCE, V275, P793, DOI 10.1126/science.275.5301.793; PANG T, 2003, B WORLD HEALTH ORGAN, V81, P777; Perez-Iratxeta C, 2002, SCIENCE, V297, P519; Rahman M, 2003, INT J TECHNOL ASSESS, V19, P249, DOI 10.1017/S0266462303000229; Sadana R, 2004, BMJ-BRIT MED J, V328, P826, DOI 10.1136/bmj.328.7443.826; Swinbanks D, 1997, NATURE, V389, P113; Wong J, 2004, NAT BIOTECHNOL, V22, pDC42, DOI 10.1038/nbt1204supp-DC42	17	66	75	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					959	960		10.1126/science.1108705	http://dx.doi.org/10.1126/science.1108705			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890863				2022-12-28	WOS:000229190700023
J	Moore, P				Moore, P			Photocopiers for DNA	NATURE			English	Article																			0	0	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					237	237		10.1038/435237a	http://dx.doi.org/10.1038/435237a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889102	Bronze			2022-12-28	WOS:000229021100051
J	Feenstra, J; de Herder, WW; ten Have, SMTH; van den Beld, AW; Feelders, RA; Janssen, JAMJL; van der Lely, AJ				Feenstra, J; de Herder, WW; ten Have, SMTH; van den Beld, AW; Feelders, RA; Janssen, JAMJL; van der Lely, AJ			Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly	LANCET			English	Article							HORMONE-RECEPTOR ANTAGONIST; OCTREOTIDE	Pegvisomant monotherapy once daily returns concentrations of insulin-like growth factor I (IGF-I) to normal in most patients with acromegaly, but is very costly. In a 42-week dose-finding study, we assessed the efficacy of the combination of long-acting somatostatin analogues once monthly and pegvisomant once weekly in 26 patients with active acromegaly. Dose of pegvisomant was increased until IGF-I concentration became normal or until a weekly dose of 80 mg was reached. IGF-I reached normal concentrations in 18 of 19 (95%) patients who completed 42 weeks of treatment, with a median weekly dose of 60 mg pegvisomant (range 40-80). No signs of pituitary tumour growth were noted, but mild increases in liver enzymes were observed in ten patients (38%). This combined treatment is effective, might increase compliance, and could greatly reduce the costs of medical treatment for acromegaly in some patients.	Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van der Lely, AJ (corresponding author), Erasmus MC, Dept Internal Med, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.vanderlelij@erasmusmc.nl	de+Herder, Wouter/AAN-8429-2021; Janssen, Joseph A.M.J.L./AAU-5133-2021	Janssen, Joseph A.M.J.L./0000-0002-9363-6408				Drake WM, 2003, EUR J ENDOCRINOL, V149, P521, DOI 10.1530/eje.0.1490521; Jehle S, 2005, J CLIN ENDOCR METAB, V90, P1588, DOI 10.1210/jc.2004-1967; Leung KC, 2000, J CLIN ENDOCR METAB, V85, P4712, DOI 10.1210/jc.85.12.4712; Sheppard MC, 2003, CLIN ENDOCRINOL, V58, P387, DOI 10.1046/j.1365-2265.2003.01734.x; Trainer PJ, 2000, NEW ENGL J MED, V342, P1171, DOI 10.1056/NEJM200004203421604; van der Lely AJ, 2001, J CLIN ENDOCR METAB, V86, P478, DOI 10.1210/jc.86.2.478; van der Lely AJ, 2001, LANCET, V358, P1754, DOI 10.1016/S0140-6736(01)06844-1	7	149	158	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1644	1646		10.1016/S0140-6736(05)63011-5	http://dx.doi.org/10.1016/S0140-6736(05)63011-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885297				2022-12-28	WOS:000228933700030
J	Gill, CJ; Sabin, L; Schmid, CH				Gill, CJ; Sabin, L; Schmid, CH			Why clinicians are natural bayesians	BRITISH MEDICAL JOURNAL			English	Article							PATIENT		Boston Univ, Sch Publ Hlth, Dept Int Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA; Tufts Univ, New England Med Ctr, Biostat Res Ctr, Div Clin Care Res,Dept Med, Boston, MA 02111 USA	Boston University; Tufts Medical Center; Tufts University	Gill, CJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Int Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA.	cgill@bu.edu	Schmid, Christopher H./J-2398-2014	Schmid, Christopher H./0000-0002-0855-5313; gill, christopher/0000-0003-3353-0617	NIAID NIH HHS [K23 AI62208 01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI062208] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barton MB, 1999, JAMA-J AM MED ASSOC, V282, P1270, DOI 10.1001/jama.282.13.1270; Berry D.A., 1996, STAT BAYESIAN PERSPE; CATTAU EL, 1982, JAMA-J AM MED ASSOC, V247, P1164, DOI 10.1001/jama.247.8.1164; Ebell MH, 2000, JAMA-J AM MED ASSOC, V284, P2912, DOI 10.1001/jama.284.22.2912; Goodman SN, 1999, ANN INTERN MED, V130, P1005, DOI 10.7326/0003-4819-130-12-199906150-00019; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Lederle FA, 1999, JAMA-J AM MED ASSOC, V281, P77, DOI 10.1001/jama.281.1.77; Myers KA, 2001, JAMA-J AM MED ASSOC, V286, P341, DOI 10.1001/jama.286.3.341; SELKER HP, 1991, MED CARE, V29, P610, DOI 10.1097/00005650-199107000-00002; Stoll C., 2001, Community Genet, V4, P225, DOI 10.1159/000064197; van den Berk GEL, 2003, J CLIN MICROBIOL, V41, P3868, DOI 10.1128/JCM.41.8.3868-3869.2003	11	161	162	1	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 7	2005	330	7499					1080	1083		10.1136/bmj.330.7499.1080	http://dx.doi.org/10.1136/bmj.330.7499.1080			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925YY	15879401	Green Published			2022-12-28	WOS:000229090900030
J	Lampe, FC; Morris, RW; Walker, M; Shaper, AG; Whincup, PH				Lampe, FC; Morris, RW; Walker, M; Shaper, AG; Whincup, PH			Trends in rates of different forms of diagnosed coronary heart disease, 1978 to 2000: prospective, population based study of British men	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MONICA PROJECT POPULATIONS; EVENT RATES; GENERAL-PRACTICE; RISK-FACTORS; FOLLOW-UP; MORTALITY; ANGINA; QUESTIONNAIRE; MANAGEMENT; SURVIVAL	Objective To examine trends over time in rates of different forms of diagnosed coronary heart disease among British men, during a period in which mortality due to coronary heart disease has been declining. Design Prospective cohort study covering the period 1978-80 to 1998-2000. Participants 7735 men, aged 40-59 at entry, randomly selected from one general practice in each of 24 British towns. Main outcome measures Trends in the rates of major coronary events, first diagnosed angina and first diagnosed coronary heart disease (any fatal or non-fatal documented event or diagnosis). Events were ascertained from NHS central registers and reviews of medical records from general practices. Results Over the 20 year period, 1561 major coronary events occurred; 1087 and 1816 men had new diagnoses of angina and coronary heart disease, respectively. The age adjusted annual relative changes were -3.6% (95% confidence interval -4.8% to -2.4%, P < 0.001) for all major coronary events, 2.6% (1.1% to 4.0%, P < 0.001) for first diagnosed angina and -0.8% (-1.8% to 0.3%, P = 0.18) for first diagnosed coronary heart disease. The fall in major coronary events occurred across all categories of event (fatal and non-fatal, first and recurrent). Similarly, first diagnosed angina increased for both uncomplicated angina and angina after myocardial infarction. The age adjusted annual relative change in case fatality at 28 days of first major coronary events was -1.4% (-3.1% to 0.4%, P = 0.12). Conclusions Among British middle aged men, a substantial decline in the rate of major coronary events over the past two decades seems to have been largely offset by an increase in the incidence of diagnosed angina. Overall there was little change in the incidence of first diagnosed coronary heart disease. A continuing need exists for resources and services for coronary heart disease in general, and for new angina in particular.	UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat, London NW3 2PF, England; Univ London St Georges Hosp, Sch Med, Dept Community Hlth Sci, London SW17 ORE, England	University of London; University College London; UCL Medical School; St Georges University London	Lampe, FC (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat, London NW3 2PF, England.	f.lampe@pcps.ucl.ac.uk	Lampe, Fiona/I-5826-2019	Lampe, Fiona/0000-0001-6851-5471; Whincup, Peter/0000-0002-5589-4107; Morris, Richard/0000-0001-7240-4563				Capewell S, 2001, LANCET, V358, P1213, DOI 10.1016/S0140-6736(01)06343-7; Chambless L, 1997, CIRCULATION, V96, P3849; CLARKE KW, 1994, BRIT HEART J, V71, P38; Critchley JA, 2003, J CLIN EPIDEMIOL, V56, P583, DOI 10.1016/S0895-4356(03)00059-3; GANDHI MM, 1995, BRIT J GEN PRACT, V45, P11; Gill D, 1999, J PSYCHOSOM RES, V46, P349, DOI 10.1016/S0022-3999(98)00102-0; Jousilahti P, 2003, EUR HEART J, V24, P685, DOI 10.1016/S0195-668X(03)96131-8; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lampe FC, 1999, J CLIN EPIDEMIOL, V52, P73, DOI 10.1016/S0895-4356(98)00146-2; Lampe FC, 2001, HEART, V86, P499, DOI 10.1136/heart.86.5.499; MURABITO JM, 1993, CIRCULATION, V88, P2548, DOI 10.1161/01.CIR.88.6.2548; Murphy NF, 2004, BMJ-BRIT MED J, V328, P1413, DOI 10.1136/bmj.38111.650741.F7; *OFF NAT STAT, 1995, MORB STAT GEN PRACT; Peterson S, 2004, CORONARY HEART DIS S; Rosser SJ, 2001, BIOREMED SER, V6, P69; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; SHAPER AG, 1984, BRIT HEART J, V51, P606; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Walker M, 2000, J PUBLIC HEALTH MED, V22, P479, DOI 10.1093/pubmed/22.4.479; Walker MK, 1998, AM J EPIDEMIOL, V148, P355; Wood D, 2001, BMJ-BRIT MED J, V323, P586, DOI 10.1136/bmj.323.7313.586; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	24	47	47	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2005	330	7499					1046	1049		10.1136/bmj.330.7499.1046	http://dx.doi.org/10.1136/bmj.330.7499.1046			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925YY	15879388	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000229090900012
J	Wills, TJ; Lever, C; Cacucci, F; Burgess, N; O'Keefe, J				Wills, TJ; Lever, C; Cacucci, F; Burgess, N; O'Keefe, J			Attractor dynamics in the hippocampal representation of the local environment	SCIENCE			English	Article							COMPLEMENTARY-LEARNING-SYSTEMS; PLACE CELLS; NETWORK MODEL; MEMORY; CA3; DISTINCT; INTEGRATION; NEURONS; FIELDS; CODES	Memories are thought to be attractor states of neuronal representations, with the hippocampus a likely substrate for context-dependent episodic memories. However, such states have not been directly observed. For example, the hippocampal place cell representation of location was previously found to respond continuously to changes in environmental shape alone. We report that exposure to novel square and circular environments made of different materials creates attractor representations for both shapes: Place cells abruptly and simultaneously switch between representations as environmental shape changes incrementally. This enables study of attractor dynamics in a cognitive representation and may correspond to the formation of distinct contexts in context-dependent memory.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; UCL, Inst Cognit Neurosci, London WC1E 6BT, England	University of London; University College London; University of London; University College London	O'Keefe, J (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.	j.okeefe@ucl.ac.uk	Burgess, Neil/B-2420-2009; Wills, Tom J/B-3621-2011; Lever, Colin/B-4860-2008	Burgess, Neil/0000-0003-0646-6584; Lever, Colin/0000-0002-8955-2885; Cacucci, Francesca/0000-0002-1968-5156; Wills, Thomas/0000-0002-1331-2869	MRC [G117/433] Funding Source: UKRI; Medical Research Council [G117/433] Funding Source: Medline; Wellcome Trust [071248] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Amit D. J., 1992, MODELLING BRAIN FUNC; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; FYHN M, 2004, SOC NEUR ABSTR; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; LEUTGEB JK, 2004, SOC NEUR ABSTR; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; SQUIRE LR, 1988, TRENDS NEUROSCI, V11, P170, DOI 10.1016/0166-2236(88)90144-0; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004	31	395	400	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					873	876		10.1126/science.1108905	http://dx.doi.org/10.1126/science.1108905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879220	Green Submitted, Green Accepted			2022-12-28	WOS:000228986500054
J	Lane, TW; Saito, MA; George, GN; Pickering, IJ; Prince, RC; Morel, FMM				Lane, TW; Saito, MA; George, GN; Pickering, IJ; Prince, RC; Morel, FMM			A cadmium enzyme from a marine diatom	NATURE			English	Editorial Material									Sandia Natl Labs, Biosyst Res Dept, Livermore, CA 94551 USA; Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA; Univ Saskatchewan, Dept Geol Sci, Saskatoon, SK S7N 5E2, Canada; ExxonMobile Res & Engn Co, Annandale, NJ 08801 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	United States Department of Energy (DOE); Sandia National Laboratories; Woods Hole Oceanographic Institution; University of Saskatchewan; Exxon Mobil Corporation; Princeton University	Lane, TW (corresponding author), Sandia Natl Labs, Biosyst Res Dept, Livermore, CA 94551 USA.	mak@whoi.edu	Morel, Francois M M/A-8107-2008; George, Graham N/E-3290-2013; Saito, Mak/ADT-4986-2022; Pickering, Ingrid J/A-4547-2013	Pickering, Ingrid J/0000-0002-0936-2994; Lane, Todd/0000-0002-5816-2649; Prince, Roger/0000-0002-5174-4216; George, Graham/0000-0002-0420-7493					0	433	451	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					42	42		10.1038/435042a	http://dx.doi.org/10.1038/435042a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875011	Bronze			2022-12-28	WOS:000228864600032
J	Pilcher, CD; Fiscus, SA; Nguyen, TQ; Foust, E; Wolf, L; Williams, D; Ashby, R; O'Dowd, JO; McPherson, JT; Stalzer, B; Hightow, L; Miller, WC; Eron, JJ; Cohen, MS; Leone, PA				Pilcher, CD; Fiscus, SA; Nguyen, TQ; Foust, E; Wolf, L; Williams, D; Ashby, R; O'Dowd, JO; McPherson, JT; Stalzer, B; Hightow, L; Miller, WC; Eron, JJ; Cohen, MS; Leone, PA			Detection of acute infections during HIV testing in North Carolina	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUAL TRANSMISSION; DIAGNOSIS; RISK; CARE; RNA; SEROCONVERSION; SETTINGS; SERA	BACKGROUND: North Carolina has added nucleic acid amplification testing for the human immunodeficiency virus (HIV) to standard HIV antibody tests to detect persons with acute HIV infection who are viremic but antibody-negative. METHODS: To determine the effect of nucleic acid amplification testing on the yield and accuracy of HIV detection in public health practice, we conducted a 12-month observational study of methods for state-funded HIV testing. We compared the diagnostic performance of standard HIV antibody tests (i.e., enzyme immunoassay and Western blot analysis) with an algorithm whereby serum samples that yielded negative results on standard antibody tests were tested again with the use of nucleic acid amplification. A surveillance algorithm with repeated sensitive-less-sensitive enzyme immunoassay tests was also evaluated. HIV infection was defined as a confirmed positive result on a nucleic acid amplification test or as HIV antibody seroconversion. RESULTS: Between November 1, 2002, and October 31, 2003, 109,250 persons at risk for HIV infection who had consented to HIV testing presented at state-funded sites. There were 606 HIV-positive results. Established infection, as identified by standard enzyme immunoassay or Western blot analysis, appeared in 583 participants; of these, 107 were identified, with the use of sensitive-less-sensitive enzyme immunoassay tests, as recent infections. A total of 23 acutely infected persons were identified only with the use of the nucleic acid amplification algorithm. With all detectable infections taken into account, the sensitivity of standard antibody testing was 0.962 (95 percent confidence interval, 0.944 to 0.976). There were two false positive results on nucleic acid amplification tests. The specificity and positive predictive value of the algorithm that included nucleic acid amplification testing were greater than 0.999 (95 percent confidence interval, 0.999 to >0.999) and 0.997 (95 percent confidence interval, 0.988 to >0.999), respectively. Of the 23 acute HIV infections, 16 were detected at sexually transmitted disease clinics. Emergency measures for HIV prevention protected 48 sex partners and one fetus from high-risk exposure to HIV. CONCLUSIONS: The addition of nucleic acid amplification testing to an HIV testing algorithm significantly increases the identification of cases of infection without impairing the performance of diagnostic testing. The detection of highly contagious, acutely infected persons creates new opportunities for HIV surveillance and prevention.	Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; N Carolina Dept Hlth & Human Serv, HIV STD Prevent & Care Branch, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Pilcher, CD (corresponding author), Univ N Carolina, Dept Med, CB 7215,211A W Cameron Ave, Chapel Hill, NC 27599 USA.	cpilcher@med.unc.edu	Miller, William C/H-4800-2014; Abrams, William R/A-5782-2008	Miller, William C/0000-0002-1934-7827; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00046] Funding Source: Medline; NIAID NIH HHS [9-P30-AI50410, P30 AI050410] Funding Source: Medline; PHS HHS [R01 049381, R01 068686, K23 001781] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bollinger RC, 1997, JAMA-J AM MED ASSOC, V278, P2085, DOI 10.1001/jama.278.23.2085; Brambilla DJ, 2004, J CLIN MICROBIOL, V42, P2819, DOI 10.1128/JCM.42.6.2819-2820.2004; CLARK SJ, 1994, J INFECT DIS, V170, P194, DOI 10.1093/infdis/170.1.194; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; Daar ES, 2001, ANN INTERN MED, V134, P25, DOI 10.7326/0003-4819-134-1-200101020-00010; Dybul M, 2002, J INFECT DIS, V185, P1818, DOI 10.1086/340650; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Hightow LB, 2005, JAIDS-J ACQ IMM DEF, V38, P531, DOI 10.1097/01.qai.0000155037.10628.cb; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Janssen RS, 1999, JAMA-J AM MED ASSOC, V281, P1893; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; MCDOUGAL JS, IN PRESS AIDS S; Morandi PA, 1998, J CLIN MICROBIOL, V36, P1534, DOI 10.1128/JCM.36.6.1534-1538.1998; PETERMAN TA, 1988, JAMA-J AM MED ASSOC, V259, P55, DOI 10.1001/jama.259.1.55; PETERMAN TA, 1989, JAMA-J AM MED ASSOC, V262, P502; Pilcher CD, 2001, JAMA-J AM MED ASSOC, V286, P1713, DOI 10.1001/jama.286.14.1713; Pilcher CD, 2004, AIDS, V18, P517, DOI 10.1097/00002030-200402200-00019; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pilcher CD, 2002, JAMA-J AM MED ASSOC, V288, P216, DOI 10.1001/jama.288.2.216; Pincus JM, 2003, CLIN INFECT DIS, V37, P1699, DOI 10.1086/379772; Quinn TC, 2000, AIDS, V14, P2751, DOI 10.1097/00002030-200012010-00015; REED C, 2004, 11 C RETR OPP INF SA; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1999, NEW ENGL J MED, V340, P969, DOI 10.1056/NEJM199903253401217; Schoenbach VJ, 2001, AM J EPIDEMIOL, V153, P935, DOI 10.1093/aje/153.10.935; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Thomas JC, 1996, J INFECT DIS, V174, pS134, DOI 10.1093/infdis/174.Supplement_2.S134; Valdiserri RO, 1999, AIDS, V13, P2317, DOI 10.1097/00002030-199912030-00003; WAWER MJ, IN PRESS J INFECT DI; Weintrob AC, 2003, ARCH INTERN MED, V163, P2097, DOI 10.1001/archinte.163.17.2097	32	280	289	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1873	1883		10.1056/NEJMoa042291	http://dx.doi.org/10.1056/NEJMoa042291			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872202	Green Published			2022-12-28	WOS:000228858600007
J	Sack, AT; Camprodon, JA; Pascual-Leone, A; Goebel, R				Sack, AT; Camprodon, JA; Pascual-Leone, A; Goebel, R			The dynamics of interhemispheric compensatory processes in mental imagery	SCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; COGNITIVE NEUROSCIENCE; FUNCTIONAL-ANATOMY; SPATIAL ATTENTION; MINDS IMAGE; PARIETAL; TRACKING; CLOCKS	The capacity to generate and analyze mental visual images is essential for many cognitive abilities. We combined triple-pulse transcranial magnetic Stimulation (tpTMS) and repetitive TMS (rTMS) to determine which distinct aspect of mental imagery is carried out by the left and right parietal lobe and to reveal interhemispheric compensatory interactions. The left parietal lobe was predominant in generating mental images, whereas the right parietal lobe was specialized in the spatial comparison of the imagined content. Furthermore, in case of an rTMS-induced left parietal lesion, the right parietal cortex could immediately compensate such a left parietal disruption by taking over the specific function of the left hemisphere.	Maastricht Univ, Fac Psychol, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; Beth Israel Deaconess Med Ctr, Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Maastricht University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Sack, AT (corresponding author), Maastricht Univ, Fac Psychol, Dept Cognit Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.	a.sack@psychology.unimaas.nl	Camprodon, Joan Albert/M-9093-2017; Pascual-Leone, Alvaro/G-6566-2011; Pascual-Leone, Alvaro/AAC-5101-2019	Camprodon, Joan Albert/0000-0003-1282-9257; Pascual-Leone, Alvaro/0000-0001-8975-0382; Sack, Alexander/0000-0002-1471-0885; Goebel, Rainer/0000-0003-1780-2467	NCRR NIH HHS [K24 RR018875, NCRR MO1 RR01032] Funding Source: Medline; NIMH NIH HHS [R01MH60734] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875, M01RR001032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060734] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		FARAH MJ, 1989, TRENDS NEUROSCI, V12, P395, DOI 10.1016/0166-2236(89)90079-9; FARAH MJ, 1985, NEUROPSYCHOLOGIA, V23, P115, DOI 10.1016/0028-3932(85)90049-1; Formisano E, 2002, NEURON, V35, P185, DOI 10.1016/S0896-6273(02)00747-X; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; KOSSLYN SM, 1995, NEUROPSYCHOLOGIA, V33, P1335, DOI 10.1016/0028-3932(95)00067-D; KOSSLYN SM, 1980, IMAE MIND; Mellet E, 1996, J NEUROSCI, V16, P6504; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Moliadze V, 2003, J PHYSIOL-LONDON, V553, P665, DOI 10.1113/jphysiol.2003.050153; PAIVIO A, 1978, J EXP PSYCHOL HUMAN, V4, P61, DOI 10.1037/0096-1523.4.1.61; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Sack AT, 2002, NEURON, V35, P195, DOI 10.1016/S0896-6273(02)00745-6; Thut G, 2003, CLIN NEUROPHYSIOL, V114, P2071, DOI 10.1016/S1388-2457(03)00205-0; TROJANO L, 1994, BRAIN COGNITION, V24, P213, DOI 10.1006/brcg.1994.1012; Trojano L, 2000, CEREB CORTEX, V10, P473, DOI 10.1093/cercor/10.5.473; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; WALSH V, 2003, NEUROCHRONOMETRICS M	17	151	155	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2005	308	5722					702	704		10.1126/science.1107784	http://dx.doi.org/10.1126/science.1107784			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	922BO	15860630				2022-12-28	WOS:000228810900052
J	Suma, K; Sumiyoshi, Y; Endo, Y				Suma, K; Sumiyoshi, Y; Endo, Y			The rotational spectrum and structure of the HOOO radical	SCIENCE			English	Article							POTENTIAL-ENERGY SURFACES; MICROWAVE-SPECTRUM; COMPLEX; WATER; HO3	The adduct of the hydroxyl radical with oxygen has been studied theoretically, in connection with atmospheric reactions, but its stability and structure remained an open question. Pure rotational spectra of the HOOO and DOOO radicals have now been observed in a supersonic jet by using a Fourier-transform microwave spectrometer with a pulsed discharge nozzle. The molecular constants extracted from 12 rotational transitions with fine and hyperfine splittings support a trans planar molecular structure, in contrast to the cis planar structure predicted by most ab initio calculations. The bond linking the HO and O-2 moieties is fairly long (1.688 angstroms) and comparable to the F-O bond in the isoelectronic FOO radical.	Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan	University of Tokyo	Endo, Y (corresponding author), Univ Tokyo, Dept Basic Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.	endo@bunshi.c.u-tokyo.ac.jp	Endo, Yasuki/AAA-8611-2022					BOGEY M, 1989, MOL PHYS, V67, P1033, DOI 10.1080/00268978900101611; Brauer CS, 2005, CHEM PHYS LETT, V401, P420, DOI 10.1016/j.cplett.2004.11.090; Cacace F, 1999, SCIENCE, V285, P81, DOI 10.1126/science.285.5424.81; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; KOPUT J, 1986, J MOL SPECTROSC, V115, P438, DOI 10.1016/0022-2852(86)90058-5; LIDA M, 1991, J CHEM PHYS, V94, P6989; MATHISEN KB, 1984, CHEM PHYS, V90, P225, DOI 10.1016/0301-0104(84)85321-5; Nelander B, 2000, CHEM PHYS LETT, V332, P403, DOI 10.1016/S0009-2614(00)01280-X; Ohshima Y, 2005, J AM CHEM SOC, V127, P1108, DOI 10.1021/ja0442973; SAITO S, 1977, J MOL SPECTROSC, V65, P229, DOI 10.1016/0022-2852(77)90190-4; Setokuchi O, 2000, J PHYS CHEM A, V104, P3204, DOI 10.1021/jp993573a; Silveira DM, 2004, J PHYS CHEM A, V108, P8721, DOI 10.1021/jp049575z; Suma K, 2004, J CHEM PHYS, V121, P8351, DOI 10.1063/1.1792591; Varandas AJC, 1997, MOL PHYS, V91, P301, DOI 10.1080/00268979709482720; VINCENT MA, 1995, J PHYS CHEM-US, V99, P3109, DOI 10.1021/j100010a021; YAMADA C, 1984, J CHEM PHYS, V80, P4694, DOI 10.1063/1.446534	16	100	102	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1885	1886		10.1126/science.1112233	http://dx.doi.org/10.1126/science.1112233			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15879172				2022-12-28	WOS:000230120000032
J	Patel, V; Kirkwood, B; Weiss, H; Pednekar, S; Fernandes, J; Pereira, B; Upadhye, M; Mabey, D				Patel, V; Kirkwood, B; Weiss, H; Pednekar, S; Fernandes, J; Pereira, B; Upadhye, M; Mabey, D			Chronic fatigue in developing countries: population based survey of women in India	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; PSYCHIATRIC-DISORDER; SOMATIC SYMPTOMS; DEPRESSION; EPIDEMIOLOGY; COMMUNITY; MORBIDITY; POVERTY; WORLD; GOA	Objectives To describe the prevalence of and risk factors for chronic fatigue in a developing country; in particular, to determine the association of anaemia, mental health, and gender disadvantage factors with chronic fatigue. Design Community survey. Setting Primary health centre catchment area in Goa, India. Participants 3000 randomly sampled women aged 18 to 50 years. Main outcome measures Data on the primary outcome (reporting of fatigue for at least six months) and psychosocial exposures elicited by structured interview; presence of anaemia determined from a blood sample. Results 2494 (83%) women consented to participate; 12.1% (95% confidence interval 10.8 to 13.4%) complained of chronic fatigue. In multivariate analyses, older women (P=0.03) and those experiencing socioeconomic deprivation-less education (P < 0.001), families in debt (P=0.09), hunger in the past three months(P=0.03)-were more likely to report chronic fatigue. After adjustment for these factors, factors indicating gender disadvantage (notably sexual violence by the husband; P < 0.001) and poor mental health (P < 0.001) were strongly associated with chronic fatigue. Although women with a high body mass index had a reduced risk, suggesting an influence of poor nutrition, no association was found between chronic fatigue and haemoglobin concentrations. Conclusions Chronic fatigue was commonly reported by women in this community study from India. The strongest associations with chronic fatigue were for psychosocial factors indicative of poor mental health and gender disadvantage.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Sangath, Porvorim, Goa, India	University of London; London School of Hygiene & Tropical Medicine	Patel, V (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Vikram.patel@lshtm.ac.uk	Pednekar, Sulochana/GVS-0184-2022; weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Pednekar, Sulochana/0000-0002-4538-4795; Mabey, David/0000-0002-0031-8276; Kirkwood, Betty/0000-0001-5274-6072; Patel, Vikram/0000-0003-1066-8584				Araya R, 2001, BRIT J PSYCHIAT, V178, P228, DOI 10.1192/bjp.178.3.228; Astbury J., 2001, MENTAL HLTH CALL ACT, P73; BHATIA JC, 1995, STUD FAMILY PLANN, V26, P203, DOI 10.2307/2137846; Chaturvedi S K, 1987, Indian J Psychiatry, V29, P337; DINESHKUMAR B, 1995, PHARMACOECONOMICS, V7, P332, DOI 10.2165/00019053-199507040-00007; GUREJE O, 1992, ACTA PSYCHIAT SCAND, V86, P223, DOI 10.1111/j.1600-0447.1992.tb03256.x; *INT I POP SCI, 2001, NAT FAM HLTH SURV, V2; ISAAC M, 1995, PSYCHOTHER PSYCHOSOM, V64, P88, DOI 10.1159/000288996; *IUSSP COMM REPR H, 1997, GEND REPR HLTH WEAKN; Krenzischek D A, 1996, Am J Crit Care, V5, P427; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Patel V, 1998, BRIT J PSYCHIAT, V172, P533, DOI 10.1192/bjp.172.6.533; Patel V, 2004, TROP MED INT HEALTH, V9, P539, DOI 10.1111/j.1365-3156.2004.01243.x; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; Patel V, 2001, BRIT MED J, V322, P482, DOI 10.1136/bmj.322.7284.482; Patel V, 1998, PSYCHOL MED, V28, P135, DOI 10.1017/S0033291797005941; SHIVA M, 1992, STATE INDIAS HLTH, P265; Skapinakis P, 2003, INT REV PSYCHIATR, V15, P57, DOI 10.1080/0954026021000045958; Skapinakis P, 2003, BRIT J PSYCHIAT, V182, P205, DOI 10.1192/bjp.182.3.205; Sumathipala A, 2000, PSYCHOL MED, V30, P747, DOI 10.1017/S0033291799002160; USTUN TB, 1995, MENTAL ILLNESS GEN H, P347; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Wessely S, 1996, AM J PSYCHIAT, V153, P1050; WESSELY S, 1995, EPIDEMIOL REV, V17, P139, DOI 10.1093/oxfordjournals.epirev.a036170	24	47	47	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 21	2005	330	7501					1190	1193		10.1136/bmj.38442.636181.E0	http://dx.doi.org/10.1136/bmj.38442.636181.E0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	929CU	15870118	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000229320500022
J	Curet, MJ				Curet, MJ			Laparoscopic-assisted resection of colorectal carcinoma	LANCET			English	Editorial Material							COLON-CANCER; OPEN COLECTOMY; RANDOMIZED-TRIAL; METASTASES; SURGERY		Stanford Univ, Dept Surg, Minimally Invas Surg Program, Stanford, CA 94305 USA	Stanford University	Curet, MJ (corresponding author), Stanford Univ, Dept Surg, Minimally Invas Surg Program, Stanford, CA 94305 USA.	mcuret@stanford.edu						BERENDS FJ, 1994, LANCET, V344, P58, DOI 10.1016/S0140-6736(94)91079-0; Curet MJ, 2004, AM J SURG, V187, P705, DOI 10.1016/j.amjsurg.2003.10.015; Franklin ME, 1996, DIS COLON RECTUM, V39, pS35, DOI 10.1007/BF02053804; Hasegawa H, 2003, SURG ENDOSC, V17, P636, DOI 10.1007/s00464-002-8516-4; Hazebroek EJ, 2002, SURG ENDOSC, V16, P949, DOI 10.1007/s00464-001-8165-z; Kieran JA, 2004, J SURG RES, V117, P79, DOI 10.1016/j.jss.2003.11.025; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Lezoche E, 2002, SURG ENDOSC, V16, P596, DOI 10.1007/s00464-001-9053-2; Milsom JW, 1998, J AM COLL SURGEONS, V187, P46, DOI 10.1016/S1072-7515(98)00132-X; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Skullman S, 2000, DIGEST SURG, V17, P617; Stage JG, 1997, BRIT J SURG, V84, P391, DOI 10.1046/j.1365-2168.1997.02516.x; Weeks JC, 2002, JAMA-J AM MED ASSOC, V287, P321, DOI 10.1001/jama.287.3.321	13	12	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1666	1668		10.1016/S0140-6736(05)66525-7	http://dx.doi.org/10.1016/S0140-6736(05)66525-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894083				2022-12-28	WOS:000229082300005
J	Jouven, X; Empana, JP; Schwartz, PJ; Desnos, M; Courbon, D; Ducimetiere, P				Jouven, X; Empana, JP; Schwartz, PJ; Desnos, M; Courbon, D; Ducimetiere, P			Heart-rate profile during exercise as a predictor of sudden death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; BAROREFLEX SENSITIVITY; VENTRICULAR-TACHYCARDIA; RATE-VARIABILITY; CARDIAC DEATH; NERVOUS-SYSTEM; RATE RECOVERY; MORTALITY; RISK; REFLEXES	BACKGROUND: Changes in heart rate during exercise and recovery from exercise are mediated by the balance between sympathetic and vagal activity. Since alterations in the neural control of cardiac function contribute to the risk of sudden death, we tested the hypothesis that among apparently healthy persons, sudden death is more likely to occur in the presence of abnormal heart-rate profiles during exercise and recovery. METHODS: A total of 5713 asymptomatic working men (between the ages of 42 and 53 years), none of whom had clinically detectable cardiovascular disease, underwent standardized graded exercise testing between 1967 and 1972. We examined data on the subjects' resting heart rates, the increase in rate from the resting level to the peak exercise level, and the decrease in rate from the peak exercise level to the level one minute after the termination of exercise. RESULTS: During a 23-year follow-up period, 81 subjects died suddenly. The risk of sudden death from myocardial infarction was increased in subjects with a resting heart rate that was more than 75 beats per minute (relative risk, 3.92; 95 percent confidence interval, 1.91 to 8.00); in subjects with an increase in heart rate during exercise that was less than 89 beats per minute (relative risk, 6.18; 95 percent confidence interval, 2.37 to 16.11); and in subjects with a decrease in heart rate of less than 25 beats per minute after the termination of exercise (relative risk, 2.20; 95 percent confidence interval, 1.02 to 4.74). After adjustment for potential confounding variables, these three factors remained strongly associated with an increased risk of sudden death, with a moderate but significantly increased risk of death from any cause but not of nonsudden death from myocardial infarction. CONCLUSIONS: The heart-rate profile during exercise and recovery is a predictor of sudden death.	Univ Paris 05, Hop Europeen Georges Pompidou, Fac Rene Descartes, Serv Cardiol, F-75015 Paris, France; Hop Paul Brousse, INSERM, Avenir Unite 258, Villejuif, France; Univ Pavia, Dept Cardiol, I-27100 Pavia, Italy; Policlin San Matteo, Ist Ricovera & Cura Carattere, I-27100 Pavia, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Pavia; IRCCS Fondazione San Matteo	Jouven, X (corresponding author), Univ Paris 05, Hop Europeen Georges Pompidou, Fac Rene Descartes, Serv Cardiol, 20 Rue Leblanc, F-75015 Paris, France.	xavier.jouven@egp.aphp.fr	Empana, Jean-Philippe/AAF-6923-2021; Schwartz, Peter J/J-4267-2016	Empana, Jean-Philippe/0000-0002-1469-7772; Schwartz, Peter J/0000-0003-0367-1048				Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; BILLMAN GE, 1984, CIRCULATION, V69, P1182, DOI 10.1161/01.CIR.69.6.1182; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; DEVREEDESWAGEMAKER, 1997, J AM COLL CARDIOL, V30, P1500; FARB A, 1995, CIRCULATION, V92, P1701, DOI 10.1161/01.CIR.92.7.1701; Ghuran A, 2002, AM J CARDIOL, V89, P184, DOI 10.1016/S0002-9149(01)02198-1; HULL SS, 1994, CIRCULATION, V89, P548, DOI 10.1161/01.CIR.89.2.548; Jouven X, 2000, NEW ENGL J MED, V343, P826, DOI 10.1056/NEJM200009213431201; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Jouven X, 2001, CARDIOVASC RES, V50, P373, DOI 10.1016/S0008-6363(01)00230-9; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.0000027565.12764.E1; La Rovere MT, 2001, CIRCULATION, V103, P2072; La Rovere MT, 1998, LANCET, V351, P478; Landolina M, 1997, J AM COLL CARDIOL, V29, P568, DOI 10.1016/S0735-1097(96)00533-5; Lauer MS, 1996, CIRCULATION, V93, P1520, DOI 10.1161/01.CIR.93.8.1520; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; LOWN B, 1976, NEW ENGL J MED, V294, P1165; MALLIANI A, 1969, AM J PHYSIOL, V217, P703, DOI 10.1152/ajplegacy.1969.217.3.703; SCHWARTZ PJ, 1988, CIRCULATION, V78, P969, DOI 10.1161/01.CIR.78.4.969; Schwartz PJ, 1998, EUR HEART J, V19, pF72; SCHWARTZ PJ, 1992, CIRCULATION, V85, P77; Schwartz PJ, 2001, J CARDIOVASC ELECTR, V12, P500, DOI 10.1046/j.1540-8167.2001.00500.x; Smith ML, 1996, CIRCULATION, V93, P1033, DOI 10.1161/01.CIR.93.5.1033; SMITH ML, 1991, J AM COLL CARDIOL, V18, P1015, DOI 10.1016/0735-1097(91)90761-W; VANOLI E, 1995, J AM COLL CARDIOL, V25, P1609, DOI 10.1016/0735-1097(95)00046-7; Vivekananthan DP, 2003, J AM COLL CARDIOL, V42, P831, DOI 10.1016/S0735-1097(03)00833-7; Weaver WD, 2002, NEW ENGL J MED, V347, P1223, DOI 10.1056/NEJMp020108; *WHO, 1967, INT CLASS DIS MAN IN, V1, P3	29	751	783	2	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1951	1958		10.1056/NEJMoa043012	http://dx.doi.org/10.1056/NEJMoa043012			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888695				2022-12-28	WOS:000229017100005
J	Colditz, GA; Stein, C				Colditz, GA; Stein, C			Smoking cessation, weight gain, and lung function	LANCET			English	Editorial Material							PHYSICAL-ACTIVITY; WOMEN; MORTALITY; COHORT; TRIAL		Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Colditz, GA (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 75 Francis St, Boston, MA 02115 USA.	graham.colditz@channing.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291				COLDITZ GA, 1992, J SMOKING RELATED DI, V3, P145; Danielsson T, 1999, BRIT MED J, V319, P490, DOI 10.1136/bmj.319.7208.490; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; Kawachi I, 1996, AM J PUBLIC HEALTH, V86, P999, DOI 10.2105/AJPH.86.7.999; KLESGES RC, 1988, HEALTH PSYCHOL, V7, P575, DOI 10.1037/0278-6133.7.6.575; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Marcus BH, 1999, ARCH INTERN MED, V159, P1229, DOI 10.1001/archinte.159.11.1229; *TASK FORC COMM PR, 2003, GUID COMM PREV SERV; *WHO, 1998, WHO CONS OB OB PREV; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106	12	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 7	2005	365	9471					1600	1601		10.1016/S0140-6736(05)66486-0	http://dx.doi.org/10.1016/S0140-6736(05)66486-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885280				2022-12-28	WOS:000228933700005
J	Klimanskaya, I; Chung, Y; Meisner, L; Johnson, J; West, MD; Lanza, R				Klimanskaya, I; Chung, Y; Meisner, L; Johnson, J; West, MD; Lanza, R			Human embryonic stem cells derived without feeder cells	LANCET			English	Article							GROWTH; CULTURE; LINES	Background Human embryonic stem cells are likely to play an important role in the future of regenerative medicine. However, exposure of existing human embryonic stem-cell lines to live animal cells and serum risks contamination with pathogens that could lead to human health risks. We aimed to derive an embryonic stem-cell line without exposure to cells or serum. Methods Frozen cleavage-stage embryos were thawed and cultured to the blastocyst stage. Inner cell masses were isolated by immunosurgery and plated onto extraceflular-matrix-coated plates that can be easily sterilised. Six established human embryonic stem-cell lines were also maintained with this serum and feeder free culture system. Findings A new stem-cell line was derived from human embryos under completely cell and serum free conditions. The cells maintained normal karyotype and markers of pluripotency, including octamer binding protein 4 (Oct-4), stage-specific embryonic antigen (SSEA)-3, SSEA-4, tumour-rejection antigen (TRA)-1-60, TRA-1-81, and alkaline phosphatase. After more than 6 months of undifferentiated proliferation, these cells retained the potential to form derivatives of all three embryonic germ layers both in vitro and in teratomas. These properties were also successfully maintained (for more than 30 passages) with the established stem-cell lines. Interpretation This system eliminates exposure of human embryonic stem cells and their progeny to animal and human feeder layers, and thus the risk of contamination with pathogenic agents capable of transmitting diseases to patients..	Adv Cell Technol, Worcester, MA 01605 USA; Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI USA; Wisconsin State Lab Hyg, Cytogenet Lab, Madison, WI USA; Wake Forest Univ, Bowman Gray Sch Med, Inst Regenerat Med, Winston Salem, NC USA	University of Wisconsin System; University of Wisconsin Madison; Wake Forest University; Wake Forest Baptist Medical Center	Lanza, R (corresponding author), Adv Cell Technol, 381 Plantat St, Worcester, MA 01605 USA.	rlanza@advancedcell.com		West, Michael/0000-0002-4842-5468; Lanza, Robert/0000-0002-3047-3074				Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; COOPER DKC, 2000, XENO PROMISE TRANSPL; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; GORDON MY, 1987, NATURE, V326, P403, DOI 10.1038/326403a0; HEDMAN K, 1979, J CELL BIOL, V81, P83, DOI 10.1083/jcb.81.1.83; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Klimanskaya I, 2004, HDB STEM CELLS, V1, P437; Lanzendorf SE, 2001, FERTIL STERIL, V76, P132, DOI 10.1016/S0015-0282(01)01825-8; Lee JB, 2005, BIOL REPROD, V72, P42, DOI 10.1095/biolreprod.104.033480; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; *US DEP HHS FDA CB, 2002, INF REC PHYS INV COC; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744	20	249	341	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1636	1641		10.1016/S0140-6736(05)66473-2	http://dx.doi.org/10.1016/S0140-6736(05)66473-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885296				2022-12-28	WOS:000228933700028
J	Orimo, A; Gupta, PB; Sgroi, DC; Arenzana-Seisdedos, F; Delaunay, T; Naeem, R; Carey, VJ; Richardson, AL; Weinberg, RA				Orimo, A; Gupta, PB; Sgroi, DC; Arenzana-Seisdedos, F; Delaunay, T; Naeem, R; Carey, VJ; Richardson, AL; Weinberg, RA			Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion	CELL			English	Article							ENDOTHELIAL PROGENITOR CELLS; EPITHELIAL-CELLS; CANCER-CELLS; MALIGNANT BREAST; PROGNOSTIC VALUE; TGF-BETA; CXCR4; SDF-1; STEM; RECRUITMENT	Fibroblasts often constitute the majority of the stromal cells within a breast carcinoma, yet the functional contributions of these cells to tumorigenesis are poorly understood. Using a coimplantation tumor xenograft model, we demonstrate that carcinoma-associated fibroblasts (CAFs) extracted from human breast carcinomas promote the growth of admixed breast carcinoma cells significantly more than do normal mammary fibroblasts derived from the same patients. The CAFs, which exhibit the traits of myofibroblasts, play a central role in promoting the growth of tumor cells through their ability to secrete stromal cell-derived factor 1 (SDF-1); CAFs promote angiogenesis by recruiting endothelial progenitor cells (EPCs) into carcinomas, an effect mediated in part by SDF-1. CAF-secreted SDF-1 also stimulates tumor growth directly, acting through the cognate receptor, CXCR4, which is expressed by carcinoma cells. Our findings indicate that fibroblasts within invasive breast carcinomas contribute to tumor promotion in large part through the secretion of SDF-1.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Mol Pathol Res Unit,Massachusetts Gen Hosp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat & Pathol, Houston, TX 77030 USA; Inst Pasteur, Unite Immunol Virale, F-75724 Paris, France; INRA, F-33883 Villenave Dornon, France	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Baylor College of Medicine; Texas Children's Cancer Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Thomson, Axel/A-7893-2013; Arenzana-Seisdedos, Fernando/E-5835-2016; Sgroi, Dennis/AAV-2487-2021	Orimo, Akira/0000-0001-5330-7282	NCI NIH HHS [R21 CA 87081-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA087081] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Anderson J, 2003, AIDS RES HUM RETROV, V19, P699, DOI 10.1089/088922203322280928; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Bertolini F, 2003, CANCER RES, V63, P4342; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bogatkevich GS, 2001, J BIOL CHEM, V276, P45184, DOI 10.1074/jbc.M106441200; Brisken C, 2002, DEV CELL, V3, P877, DOI 10.1016/S1534-5807(02)00365-9; Cardone A, 1997, PANMINERVA MED, V39, P174; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Coulomb-L'Hermine A, 1999, P NATL ACAD SCI USA, V96, P8585, DOI 10.1073/pnas.96.15.8585; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; DOUGLAS MR, 2002, EXPERT REV MOL MED, P1; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Hatzopoulos AK, 1998, DEVELOPMENT, V125, P1457; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Ishii G, 2003, BIOCHEM BIOPH RES CO, V309, P232, DOI 10.1016/S0006-291X(03)01544-4; Jacobs TW, 1999, NEW ENGL J MED, V340, P430, DOI 10.1056/NEJM199902113400604; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; KASID A, 1985, SCIENCE, V228, P725, DOI 10.1126/science.4039465; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lapteva N, 2005, CANCER GENE THER, V12, P84, DOI 10.1038/sj.cgt.7700770; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Maeshima AM, 2002, CANCER, V95, P2546, DOI 10.1002/cncr.11006; Moinfar F, 2000, CANCER RES, V60, P2562; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2001, CLIN CANCER RES, V7, P3097; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Schober A, 2003, CIRCULATION, V108, P2491, DOI 10.1161/01.CIR.0000099508.76665.9A; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; SIEWEKE MH, 1990, SCIENCE, V248, P1656, DOI 10.1126/science.2163544; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; Tlsty TD, 2001, SEMIN CANCER BIOL, V11, P97, DOI 10.1006/scbi.2000.0361; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031	60	2770	2892	6	279	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					335	348		10.1016/j.cell.2005.02.034	http://dx.doi.org/10.1016/j.cell.2005.02.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882617	Bronze			2022-12-28	WOS:000229031600005
J	Su, I; Dobenecker, MW; Dickinson, E; Oser, M; Basavaraj, A; Marqueron, R; Viale, A; Reinberg, D; Wulfing, C; Tarakhovsky, A				Su, I; Dobenecker, MW; Dickinson, E; Oser, M; Basavaraj, A; Marqueron, R; Viale, A; Reinberg, D; Wulfing, C; Tarakhovsky, A			Polycomb group protein Ezh2 controls actin polymerization and cell signaling	CELL			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; T-CELLS; IMMUNOLOGICAL SYNAPSE; LYSINE METHYLATION; GENE-EXPRESSION; RECEPTOR SIGNAL; VAV FAMILY; B-CELLS; TRANSDUCTION; CYTOSKELETON	Polycomb group protein Ezh2, one of the key regulators of development in organisms from flies to mice, exerts its epigenetic function through regulation of histone methylation. Here, we report the existence of the cytosolic Ezh2-containing methyltransferase complex and tie the function of this complex to regulation of actin polymerization in various cell types. Genetic evidence supports the essential role of cytosolic Ezh2 in actin polymerization-dependent processes such as antigen receptor signaling in T cells and PDGF-induced dorsal circular ruffle formation in fibroblasts. Revealed function of Ezh2 points to a broader usage of lysine methylation in regulation of both nuclear and extra-nuclear signaling processes.	Rockefeller Univ, Lab Lymphoocyte Signaling, New York, NY 10021 USA; Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst, Div Nucle Acids Enzymol, Piscataway, NJ 08854 USA; Mem Sloan Kettering Canc Ctr, Dept Mol Biol, Genom Core Lab, New York, NY 10021 USA; Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA	Rockefeller University; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Su, I (corresponding author), Rockefeller Univ, Lab Lymphoocyte Signaling, 1230 York Ave, New York, NY 10021 USA.	sui@mail.rockefeller.edu; tarakho@mail.rockefeller.edu	Su, I-hsin/A-2207-2011; Margueron, Raphael F/B-9996-2015	Su, I-hsin/0000-0002-5894-9580; Margueron, Raphael F/0000-0002-9093-7977; Basavaraj, Ashwin/0000-0002-9904-6230; Reinberg, Danny/0000-0003-4288-2016; Wuelfing, Christoph/0000-0002-6156-9861	NIAID NIH HHS [5R01 AI 053545, 5R01 AI 050867] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053545, R01AI050867] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Cannon JL, 2002, IMMUNOL REV, V186, P90, DOI 10.1034/j.1600-065X.2002.18609.x; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Fuller CL, 2003, IMMUNOL REV, V191, P220, DOI 10.1034/j.1600-065X.2003.00004.x; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hobert O, 1996, MOL CELL BIOL, V16, P3066; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Singer AL, 2002, SCIENCE, V296, P1639, DOI 10.1126/science.1071551; Soga N, 2001, EXP CELL RES, V269, P73, DOI 10.1006/excr.2001.5295; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8	48	287	291	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					425	436		10.1016/j.cell.2005.02.029	http://dx.doi.org/10.1016/j.cell.2005.02.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882624	Bronze			2022-12-28	WOS:000229031600012
J	Zong, H; Espinosa, S; Su, HH; Muzumdar, MD; Luo, LQ				Zong, H; Espinosa, S; Su, HH; Muzumdar, MD; Luo, LQ			Mosaic analysis with double markers in mice	CELL			English	Article							SITE-SPECIFIC RECOMBINATION; PROGENITOR-CELL MAINTENANCE; TAMOXIFEN-INDUCIBLE FORM; RED FLUORESCENT PROTEIN; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; NERVOUS-SYSTEM; LOXP RECOMBINATION; MOUSE CHROMOSOMES; CRE RECOMBINASE	We describe a method termed MADM (mosaic analysis with double markers) in mice that allows simultaneous labeling and gene knockout in clones of somatic cells or isolated single cells in vivo. Two reciprocally chimeric genes, each containing the N terminus of one marker and the C terminus of the other marker interrupted by a loxP-containing intron, are knocked in at identical locations on homologous chromosomes. Functional expression of markers requires Cre-mediated interchromosomal recombination. MADM reveals that interchromosomal recombination can be induced efficiently in vivo in both mitotic and postmitotic cells in all tissues examined. It can be used to create conditional knockouts in small populations of labeled cells, to determine cell lineage, and to trace neuronal connections. To illustrate the utility of MADM, we show that cerebellar granule cell progenitors are fated at an early stage to produce granule cells with axonal projections limited to specific sublayers of the cerebellar cortex.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264; Muzumdar, Mandar/0000-0001-7424-7223				Altman J, 1997, DEV CEREBELLAR SYSTE; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Badea TC, 2003, J NEUROSCI, V23, P2314; BONNEROT C, 1993, CR ACAD SCI III-VIE, V316, P1207; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Cajal S.R., 1911, HISTOLOGY NERVOUS SY; CEPKO CL, 1993, METHOD ENZYMOL, V225, P933; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grueber WB, 2002, DEVELOPMENT, V129, P2867; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; Hashimoto M, 2004, J NEUROSCI, V24, P286, DOI 10.1523/JNEUROSCI.2529-03.2004; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kimmel RA, 2000, GENE DEV, V14, P1377; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koike H, 2002, EMBO REP, V3, P433, DOI 10.1093/embo-reports/kvf097; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; Metz CW, 1916, J EXP ZOOL, V21, P213, DOI 10.1002/jez.1400210204; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; VANDEURSEN J, 1995, P NATL ACAD SCI USA, V92, P7376, DOI 10.1073/pnas.92.16.7376; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; XU T, 1993, DEVELOPMENT, V117, P1223; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199; Zugates CT, 2004, CURR OPIN NEUROBIOL, V14, P647, DOI 10.1016/j.conb.2004.08.005	67	387	395	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					479	492		10.1016/j.cell.2005.02.012	http://dx.doi.org/10.1016/j.cell.2005.02.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882628	Bronze			2022-12-28	WOS:000229031600016
J	Kapitein, LC; Peterman, EJG; Kwok, BH; Kim, JH; Kapoor, TM; Schmidt, CF				Kapitein, LC; Peterman, EJG; Kwok, BH; Kim, JH; Kapoor, TM; Schmidt, CF			The bipolar mitotic kinesin Eg5 moves on both microtubules that it crosslinks	NATURE			English	Article							CELL-DIVISION; SPINDLES; MOTOR; DROSOPHILA; TUBULIN; MITOSIS; FAMILY; FLUX; NCD	During cell division, mitotic spindles are assembled by microtubule-based motor proteins(1,2). The bipolar organization of spindles is essential for proper segregation of chromosomes, and requires plus-end-directed homotetrameric motor proteins of the widely conserved kinesin-5 ( BimC) family(3). Hypotheses for bipolar spindle formation include the 'push-pull mitotic muscle' model, in which kinesin-5 and opposing motor proteins act between overlapping microtubules(2,4,5). However, the precise roles of kinesin-5 during this process are unknown. Here we show that the vertebrate kinesin-5 Eg5 drives the sliding of microtubules depending on their relative orientation. We found in controlled in vitro assays that Eg5 has the remarkable capability of simultaneously moving at similar to 20 nm s(-1) towards the plus-ends of each of the two microtubules it crosslinks. For anti-parallel microtubules, this results in relative sliding at similar to 40 nm s(-1), comparable to spindle pole separation rates in vivo(6). Furthermore, we found that Eg5 can tether microtubule plus-ends, suggesting an additional microtubule-binding mode for Eg5. Our results demonstrate how members of the kinesin-5 family are likely to function in mitosis, pushing apart interpolar microtubules as well as recruiting microtubules into bundles that are subsequently polarized by relative sliding.	Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Ctr Laser, NL-1081 HV Amsterdam, Netherlands; Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Rockefeller University	Peterman, EJG (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	erwinp@nat.vu.nl; kapoor@mail.rockefeller.edu	Schmidt, Christoph F/G-3787-2011; Kapitein, Lukas C/J-4776-2016; Peterman, Erwin/G-5529-2010	Schmidt, Christoph F/0000-0003-2864-6973; Kapitein, Lukas C/0000-0001-9418-6739; Peterman, Erwin/0000-0003-1058-249X				Brust-Mascher I, 2002, MOL BIOL CELL, V13, P3967, DOI 10.1091/mbc.02-05-0069; Chui KK, 2000, J BIOL CHEM, V275, P38005, DOI 10.1074/jbc.M005948200; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Crevel IMTC, 1997, J MOL BIOL, V273, P160, DOI 10.1006/jmbi.1997.1319; Crevel IMTC, 2004, CURR BIOL, V14, pR411, DOI 10.1016/j.cub.2004.05.030; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; GIBBONS IR, 1979, J BIOL CHEM, V254, P187; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HYMAN AA, 1991, J CELL SCI, P125; Kapoor TM, 1999, P NATL ACAD SCI USA, V96, P9106, DOI 10.1073/pnas.96.16.9106; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Kashina AS, 1997, BBA-MOL CELL RES, V1357, P257, DOI 10.1016/S0167-4889(97)00037-2; Kwok BH, 2004, CURR BIOL, V14, P1783, DOI 10.1016/j.cub.2004.09.052; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCINTOSH JR, 1969, NATURE, V224, P659, DOI 10.1038/224659a0; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Stock MF, 2003, J BIOL CHEM, V278, P52315, DOI 10.1074/jbc.M309419200; van Dijk MA, 2004, J PHYS CHEM B, V108, P6479, DOI 10.1021/jp049805+; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376	27	492	499	4	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					114	118		10.1038/nature03503	http://dx.doi.org/10.1038/nature03503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875026				2022-12-28	WOS:000228864600049
J	Singh, BN; Singh, SN; Reda, DJ; Tang, XC; Lopez, B; Harris, CL; Fletcher, RD; Sharma, SC; Atwood, JE; Jacobson, AK; Lewis, HDJ; Raisch, DW; Ezekowitz, MD; Singh, BN; Lopez, B; Singh, SN; Fletcher, R; Platt, M; Paul, P; Crawford, K; Meza, D; Harrington, R; Reda, D; Henderson, WG; Tang, XC; Abdellatif, M; Motyka, D; Mackay, B; Reinhard, M; Anfinsen, L; Alvardado-Garcia, N; Jimenez, J; Semlow, DJ; Sather, MR; Buchanan, SL; Harris, C; Fye, C; Gagne, W; Gifford, L; Guidarelli, L; Lewis, HD; Ezekowitz, M; Falk, R; Antman, E; Lewis, HD; Atwood, JE; Jacobson, A; Singh, BN; Singh, SN; Fletcher, R; Atwood, JE; Jacobson, AK; Sharma, S; Ezekowitz, M; Lewis, HD; Fye, C; Reda, D; Henderson, WG; Podrid, PJ; Torner, JC; Brodsky, MA; Kowey, PR; Feussner, J; Berkowitz, S; Gough, J; Cadman, C; Cataldo, R; Beeman, L; Ahmed, R; Verma, S; Jordan, J; Shettigar, UR; Appunn, G; Norvalis, R; Dove, D; El-Sherif, N; Graham, S; Mohamed, A; Caref, E; Hamdan, M; Willis, C; Mull, S; Nichols, J; Roesle, M; Deedwania, P; Barker, J; Frigon, C; Kanefield, R; Hariman, R; O'Sullivan, M; Martins, JB; Lee, HC; Morse, J; Wolfe, L; Liston, M; Lewis, D; Martin, B; Payne, W; Voshall, B; Keeton, S; Bisett, J; Cotter, B; Jacobson, AK; Simpson, V; Russell, DC; Luick, E; Williams, LE; Ramanathan, KB; Johnson, L; Qualls, Z; Anand, I; Berg, S; Atwood, JE; Danabar, B; Myers, J; Zipp, C; Ferguson, C; Shalaby, A; Thompson, E; Weiss, R; Hickey, K; Zana, K; Jones, K; DiTommaso, M; Raitt, MH; Martin, K; Sharma, S; Marquis, L; Beliard, M; Jesse, R; Gilligan, D; Dan, D; Mohanty, P; Spencer, T; Mark, A; Stratmann, HG; Manns, H; Isenberg, C; Heng, MK; Birner-Burley, G; Rhee, J; Reynolds, S; Church, D; Lyu, C; Zoble, RG; Dejesus, I; Garrett, D; Dellaportas, A; Goldman, S; Pennock, G; Gregorio, B; Ohm, J; Bernheim, C; Quattlander, C; Karasik, P; Vogel, KD; Abbott, B; Cohen, IS; Ezekowitz, M; Sheehan, L; Pace, K; Mody, FV; Ziff, EL; Davidson, T; Orlov, M; Katcher, M; Stambler, BS; Faber, JA; Bogosh, C				Singh, BN; Singh, SN; Reda, DJ; Tang, XC; Lopez, B; Harris, CL; Fletcher, RD; Sharma, SC; Atwood, JE; Jacobson, AK; Lewis, HDJ; Raisch, DW; Ezekowitz, MD; Singh, BN; Lopez, B; Singh, SN; Fletcher, R; Platt, M; Paul, P; Crawford, K; Meza, D; Harrington, R; Reda, D; Henderson, WG; Tang, XC; Abdellatif, M; Motyka, D; Mackay, B; Reinhard, M; Anfinsen, L; Alvardado-Garcia, N; Jimenez, J; Semlow, DJ; Sather, MR; Buchanan, SL; Harris, C; Fye, C; Gagne, W; Gifford, L; Guidarelli, L; Lewis, HD; Ezekowitz, M; Falk, R; Antman, E; Lewis, HD; Atwood, JE; Jacobson, A; Singh, BN; Singh, SN; Fletcher, R; Atwood, JE; Jacobson, AK; Sharma, S; Ezekowitz, M; Lewis, HD; Fye, C; Reda, D; Henderson, WG; Podrid, PJ; Torner, JC; Brodsky, MA; Kowey, PR; Feussner, J; Berkowitz, S; Gough, J; Cadman, C; Cataldo, R; Beeman, L; Ahmed, R; Verma, S; Jordan, J; Shettigar, UR; Appunn, G; Norvalis, R; Dove, D; El-Sherif, N; Graham, S; Mohamed, A; Caref, E; Hamdan, M; Willis, C; Mull, S; Nichols, J; Roesle, M; Deedwania, P; Barker, J; Frigon, C; Kanefield, R; Hariman, R; O'Sullivan, M; Martins, JB; Lee, HC; Morse, J; Wolfe, L; Liston, M; Lewis, D; Martin, B; Payne, W; Voshall, B; Keeton, S; Bisett, J; Cotter, B; Jacobson, AK; Simpson, V; Russell, DC; Luick, E; Williams, LE; Ramanathan, KB; Johnson, L; Qualls, Z; Anand, I; Berg, S; Atwood, JE; Danabar, B; Myers, J; Zipp, C; Ferguson, C; Shalaby, A; Thompson, E; Weiss, R; Hickey, K; Zana, K; Jones, K; DiTommaso, M; Raitt, MH; Martin, K; Sharma, S; Marquis, L; Beliard, M; Jesse, R; Gilligan, D; Dan, D; Mohanty, P; Spencer, T; Mark, A; Stratmann, HG; Manns, H; Isenberg, C; Heng, MK; Birner-Burley, G; Rhee, J; Reynolds, S; Church, D; Lyu, C; Zoble, RG; Dejesus, I; Garrett, D; Dellaportas, A; Goldman, S; Pennock, G; Gregorio, B; Ohm, J; Bernheim, C; Quattlander, C; Karasik, P; Vogel, KD; Abbott, B; Cohen, IS; Ezekowitz, M; Sheehan, L; Pace, K; Mody, FV; Ziff, EL; Davidson, T; Orlov, M; Katcher, M; Stambler, BS; Faber, JA; Bogosh, C		SAFE-T Investigators	Amiodarone versus sotalol for atrial fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; QUALITY-OF-LIFE; LOW-DOSE AMIODARONE; SINUS RHYTHM; ELECTRICAL CARDIOVERSION; ANTIARRHYTHMIC-DRUGS; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; CARDIAC MUSCLE; THERAPY	BACKGROUND: The optimal pharmacologic means to restore and maintain sinus rhythm in patients with atrial fibrillation remains controversial. METHODs: In this double-blind, placebo-controlled trial, we randomly assigned 665 patients who were receiving anticoagulants and had persistent atrial fibrillation to receive amiodarone (267 patients), sotalol (261 patients), or placebo (137 patients) and monitored them for 1 to 4.5 years. The primary end point was the time to recurrence of atrial fibrillation beginning on day 28, determined by means of weekly transtelephonic monitoring. RESULTS: Spontaneous conversion occurred in 27.1 percent of the amiodarone group, 24.2 percent of the sotalol group, and 0.8 percent of the placebo group, and direct-current cardioversion failed in 27.7 percent, 26.5 percent, and 32.1 percent, respectively. The median times to a recurrence of atrial f ibrillation were 487 days in the amiodarone group, 74 days in the sotalol group, and 6 days in the placebo group according to intention to treat and 809, 209, and 13 days, respectively, according to treatment received. Amiodarone was superior to sotalol (P<0.001) and to placebo (P<0.001), and sotalol was superior to placebo (P<0.001). In patients with ischemic heart disease, the median time to a recurrence of atrial fibrillation was 569 days with amiodarone therapy and 428 days with sotalol therapy (P=0.53). Restoration and maintenance of sinus rhythm significantly improved the quality of life and exercise capacity. There were no significant differences in major adverse events among the three groups. CONCLUSIONS: Amiodarone and sotalol are equally efficacious in converting atrial fibrillation to sinus rhythm. Amiodarone is superior for maintaining sinus rhythm, but both drugs have similar efficacy in patients with ischemic heart disease. Sustained sinus rhythm is associated with an improved quality of life and improved exercise performance.	W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA; Dept Vet Affairs Med Ctr, Washington, DC USA; Dept Vet Affairs Hosp, Hines, IL USA; Dept Vet Affairs Med Ctr, Albuquerque, NM USA; Dept Vet Affairs Med Ctr, Providence, RI USA; Walter Reed Army Med Ctr, Washington, DC 20307 USA; Dept Vet Affairs Med Ctr, Loma Linda, CA USA; Dept Vet Affairs Med Ctr, Kansas City, MO USA; Med Coll Penn & Hahnemann Univ, Philadelphia, PA USA; Dept Vet Affairs Med Ctr, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Drexel University; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Singh, BN (corresponding author), W Los Angeles Vet Affairs Med Ctr, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	bsingh@ucla.edu	Adams, Mark/AAO-1415-2020; ABDEL-LATIF, Mohamed E./N-3372-2018; Ezekowitz, Michael/AAJ-2543-2021; Stambler, Bruce/ABC-1982-2021	ABDEL-LATIF, Mohamed E./0000-0003-4306-2933; , Domenic/0000-0003-1831-4270				Benditt DG, 1999, AM J CARDIOL, V84, P270, DOI 10.1016/S0002-9149(99)00275-1; CHUN SH, 1995, AM J CARDIOL, V76, P47, DOI 10.1016/S0002-9149(99)80799-1; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Connolly SJ, 1997, LANCET, V350, P1417; Deedwania PC, 1998, CIRCULATION, V98, P2574, DOI 10.1161/01.CIR.98.23.2574; Dorian P, 2000, J AM COLL CARDIOL, V36, P1303, DOI 10.1016/S0735-1097(00)00886-X; Dorian P, 2002, AM HEART J, V143, P984, DOI 10.1067/mhj.2002.122518; DOVAL HC, 1994, LANCET, V344, P493, DOI 10.1016/S0140-6736(94)91895-3; Frick M, 2001, CLIN CARDIOL, V24, P238, DOI 10.1002/clc.4960240313; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hagens VE, 2004, J AM COLL CARDIOL, V43, P241, DOI 10.1016/j.jacc.2003.08.037; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; JULIAN DG, 1982, LANCET, V1, P1142; Keller Seth, 2003, Cardiol Rev, V11, P73, DOI 10.1097/01.CRD.0000053453.89776.2D; Kochiadakis GE, 1998, AM J CARDIOL, V81, P995, DOI 10.1016/S0002-9149(98)00078-2; Lehto M, 2003, INT J CARDIOL, V92, P145, DOI 10.1016/S0167-5273(03)00099-8; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; McNamara RL, 2003, ANN INTERN MED, V139, P1018, DOI 10.7326/0003-4819-139-12-200312160-00012; Nattel S, 1999, J CARDIOVASC ELECTR, V10, P272, DOI 10.1111/j.1540-8167.1999.tb00673.x; Nattel S, 1999, AM J CARDIOL, V84, p11R; PATTERSON JA, 1972, AM J CARDIOL, V30, P757, DOI 10.1016/0002-9149(72)90151-8; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Shinagawa K, 2003, CIRCULATION, V107, P1440, DOI 10.1161/01.CIR.0000055316.35552.74; Singh, 1999, J Cardiovasc Pharmacol Ther, V4, P49, DOI 10.1177/107424849900400108; Singh BN, 1997, CLIN CARDIOL, V20, P608, DOI 10.1002/clc.4960200706; Singh BN, 1999, J CARDIOVASC ELECTR, V10, P283, DOI 10.1111/j.1540-8167.1999.tb00674.x; SINGH BN, 1970, BRIT J PHARMACOL, V39, P675, DOI 10.1111/j.1476-5381.1970.tb09893.x; SINGH BN, 1970, BRIT J PHARMACOL, V39, P657, DOI 10.1111/j.1476-5381.1970.tb09891.x; Singh Bramah N., 2002, Journal of Cardiovascular Pharmacology and Therapeutics, V7, P131, DOI 10.1177/107424840200700301; Singh Bramah N., 2003, Journal of Cardiovascular Pharmacology and Therapeutics, V8, pS13, DOI 10.1177/107424840300800103; SINGH SN, 1995, NEW ENGL J MED, V333, P77, DOI 10.1056/NEJM199507133330201; Singh SN, 2003, AM J CARDIOL, V92, P468, DOI 10.1016/S0002-9149(03)00671-4; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Tsang TSM, 2002, AM J MED, V113, P432, DOI 10.1016/S0002-9343(02)01245-7; UESHIMA K, 1993, AM HEART J, V126, P1021, DOI 10.1016/0002-8703(93)90732-O; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; VANGELDER IC, 1993, AM J CARDIOL, V72, P560, DOI 10.1016/0002-9149(93)90352-D; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; [No title captured]	40	513	557	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1861	1872		10.1056/NEJMoa041705	http://dx.doi.org/10.1056/NEJMoa041705			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872201				2022-12-28	WOS:000228858600006
J	Valgimigli, M; Percoco, G; Malagutti, P; Campo, G; Ferrari, F; Barbieri, D; Cicchitelli, G; McFadden, EP; Merlini, F; Ansani, L; Guardigli, G; Bettini, A; Parrinello, G; Boersma, E; Ferrari, R				Valgimigli, M; Percoco, G; Malagutti, P; Campo, G; Ferrari, F; Barbieri, D; Cicchitelli, G; McFadden, EP; Merlini, F; Ansani, L; Guardigli, G; Bettini, A; Parrinello, G; Boersma, E; Ferrari, R		STRATEGY Investigators	Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITORS; HIGH-DOSE BOLUS; CORONARY ANGIOPLASTY; IMPLANTATION; PREVENTION; MULTICENTER; RESTENOSIS; STRATEGY; TERM	Context Bare-metal stenting with abciximab pretreatment is currently considered a reasonable reperfusion strategy for acute ST-segment elevation myocardial infarction (STEMI). Sirolimus-eluting stents significantly reduce the need for target-vessel revascularization (TVR) vs bare-metal stents but substantially increase procedural costs. At current European list prices, the use of tirofiban instead of abciximab would absorb the difference in cost between stenting with sirolimus-eluting vs bare-metal stents. Objective To evaluate the clinical and angiographic impact of single high-dose bolus tirofiban plus sirolimus-eluting stenting vs abciximab plus bare-metal stenting in patients with STEMI. Design, Setting, and Patients Prospective, single-blind, randomized controlled study (Single High Dose Bolus Tirofiban and Sirolimus Eluting Stent vs Abciximab and Bare Metal Stent in Myocardial Infarction [STRATEGY]) of 175 patients (median age, 63 [interquartile range, 55-72] years) presenting to a single referral center in Italy with STEMI or presumed new left bundle-branch block and randomized between March 6, 2003, and April 23, 2004. Intervention Single high-dose bolus tirofiban regimen plus sirolimus-eluting stenting (n = 87) vs standard-dose abciximab plus bare-metal stenting (n = 88). Main Outcome Measures The primary end point was a composite of death, nonfatal myocardial infarction, stroke, or binary restenosis at 8 months. Secondary outcomes included freedom, at day 30 and month 8, from major cardiac or cerebrovascular adverse events (composite of death, reinfarction, stroke, and repeat TVR). Results Cumulatively, 14 of 74 patients (19%; 95% confidence interval [CI], 10%-28%) in the tirofiban plus sirolimus-eluting stent group and 37 of 74 patients (50%; 95% Cl, 44%-56%) in the abciximab plus bare-metal stent group reached the primary end point (hazard ratio, 0.33; 95% Cl, 0.18-0.60; P<.001 [P<.001 by Fischer exact test]). The cumulative incidence of death, reinfarction, stroke, or TVR was significantly lower in the tirofiban plus sirolimus-eluting stent group (18%) vs the abciximab plus bare-metal stent group (32%) (hazard ratio, 0.53; 95 % Cl, 0.28-0.92; P=.04), predominantly reflecting a reduction in the need for TVR. Binary restenosis was present in 6 of 67 (9%; 95% Cl, 2%-16%) and 24 of 66 (36%; 95% Cl, 26%-46%) patients in the tirofiban plus sirolimus-eluting stent and abciximab plus bare-metal stent groups, respectively (P=.002). Conclusion Tirofiban-supported sirolimus-eluting stenting of infarcted arteries holds promise for improving outcomes while limiting health care expenditure in patients with myocardial infarction undergoing primary intervention.	Univ Ferrara, Chair Cardiol, I-44100 Ferrara, Italy; IRCCS, Salvatore Maugeri Fdn, Cardiovasc Res Ctr, Gussago, BS, Italy; Univ Brescia, Med Stat Unit, I-25121 Brescia, Italy; Erasmus MC, Thoraxctr, Rotterdam, Netherlands	University of Ferrara; Istituti Clinici Scientifici Maugeri IRCCS; University of Brescia; Erasmus University Rotterdam; Erasmus MC	Valgimigli, M (corresponding author), Univ Ferrara, Arcispedale S Anna, Chair Cardiol, Cardiovasc Inst, Corso Giovecca 203, I-44100 Ferrara, Italy.	vigmrc@unife.it	Ansani, Lucia/K-2991-2016; Valgimigli, Marco/AAE-9103-2019	Ansani, Lucia/0000-0001-5511-0133; Valgimigli, Marco/0000-0002-4353-7110; Ferrari, Roberto/0000-0003-2046-9175; Campo, Gianluca/0000-0002-5150-188X				Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Antoniucci D, 2004, CIRCULATION, V109, P1704, DOI 10.1161/01.CIR.0000126284.40075.98; Antoniucci D, 2003, J AM COLL CARDIOL, V42, P1879, DOI 10.1016/j.jacc.2003.07.017; Ardissino D, 2004, JAMA-J AM MED ASSOC, V292, P2727, DOI 10.1001/jama.292.22.2727; Danzi GB, 2004, AM J CARDIOL, V94, P35, DOI 10.1016/j.amjcard.2004.03.026; Eisenberg MJ, 2004, LANCET, V364, P1466, DOI 10.1016/S0140-6736(04)17287-5; Frossard M, 2004, CIRCULATION, V110, P1392, DOI 10.1161/01.CIR.0000141575.92958.9C; Greenberg D, 2004, J AM COLL CARDIOL, V43, P513, DOI 10.1016/j.jacc.2003.11.020; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Kabbani SS, 2002, AM J CARDIOL, V89, P647, DOI 10.1016/S0002-9149(01)02319-0; Lemos PA, 2004, J AM COLL CARDIOL, V43, P704, DOI 10.1016/j.jacc.2003.12.022; Lemos PA, 2004, CIRCULATION, V109, P190, DOI 10.1161/01.CIR.0000109138.84579.FA; Leon MB, 2003, AM HEART J, V146, DOI 10.1016/j.ahj.2003.09.004; Mack MJ, 2004, NEW ENGL J MED, V350, P413; Marks DS, 2005, J AM COLL CARDIOL, V45, p73A; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Montalescot G, 2004, JAMA-J AM MED ASSOC, V292, P362, DOI 10.1001/jama.292.3.362; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Muni NI, 2004, NEW ENGL J MED, V351, P1593, DOI 10.1056/NEJMp048262; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; Saia F, 2003, CIRCULATION, V108, P1927, DOI 10.1161/01.CIR.0000096053.87580.CD; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Topol EJ, 2003, J AM COLL CARDIOL, V42, P1886, DOI 10.1016/j.jacc.2003.09.010; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; Valgimigli M, 2004, J AM COLL CARDIOL, V44, P14, DOI 10.1016/j.jacc.2004.03.042; Valgimigli M, 2004, CARDIOVASC DRUG THER, V18, P225, DOI 10.1023/B:CARD.0000033644.91126.f7; Varani E, 2001, Ital Heart J Suppl, V2, P647; WAKSMAN R, 2004, CIRCULATION S3, V110, pA2473; Zahn R, 2004, Z KARDIOL, V93, P287, DOI 10.1007/s00392-004-0048-6	30	243	270	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2109	2117		10.1001/jama.293.17.2109	http://dx.doi.org/10.1001/jama.293.17.2109			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870414	Bronze, Green Published			2022-12-28	WOS:000228808200020
J	Amalberti, R; Auroy, Y; Berwick, D; Barach, P				Amalberti, R; Auroy, Y; Berwick, D; Barach, P			Five system barriers to achieving ultrasafe health care	ANNALS OF INTERNAL MEDICINE			English	Article							ADVERSE DRUG EVENTS; PATIENT SAFETY; REPORTING SYSTEMS; MEDICAL ERRORS; RISK; ANESTHESIA; HOSPITALS; CLINICIAN; AVIATION; OUTCOMES	Although debate continues over estimates of the amount of preventable medical harm that occurs in health care, there seems to be a consensus that health care is not as safe and reliable as it might be. It is often assumed that copying and adapting the success stories of nonmedical industries, such as civil aviation and nuclear power, will make medicine as safe as these industries. However, the solution is not that simple. This article explains why a benchmarking approach to safety in high-risk industries is needed to help translate lessons so that they are usable and long lasting in health care. The most important difference among industries lies not so much in the pertinent safety toolkit, which is similar for most industries, but in an industry ' s willingness to abandon historical and cultural precedents and beliefs that are linked to performance and autonomy, in a constant drive toward a culture of safety. Five successive systemic barriers currently prevent health care from becoming an ultrasafe industrial system: the need to limit the discretion of workers, the need to reduce worker autonomy, the need to make the transition from a craftsmanship mindset to that of equivalent actors, the need for system-level (senior leadership) arbitration to optimize safety strategies, and the need for simplification. Finally, health care must overcome 3 unique problems: a wide range of risk among medical specialties, difficulty in defining medical error, and various structural constraints (such as public demand, teaching role, and chronic shortage of staff). Without such a framework to guide development, ongoing efforts to improve safety by adopting the safety strategies of other industries may yield reduced dividends. Rapid progress is possible only if the health care industry is willing to address these structural constraints needed to overcome the 5 barriers to ultrasafe performance.	Univ Miami, Sch Med, Miami Ctr Patient Safety, Miami, FL 33136 USA; Dept Cognit Sci, Bretigny sur Orge, France; Percy Mil Hosp, Paris, France; Inst Healthcare Improvement, Cambridge, MA USA; Univ Miami, Jackson Mem Hosp, Miami, FL 33136 USA	University of Miami; Institute for Healthcare Improvement; University of Miami	Barach, P (corresponding author), Univ Miami, Sch Med, Miami Ctr Patient Safety, North Wing 109,1611 NW 12th Ave, Miami, FL 33136 USA.	pbarach@med.miami.edu	Barach, Paul/AAX-5315-2020; Barach, paul/B-9915-2016	Barach, Paul/0000-0002-7906-698X; Barach, paul/0000-0002-7906-698X				ABBOTT K, 1996, INTERFACES BETWEEN F; Amalberti R, 2001, SAFETY SCI, V37, P109, DOI 10.1016/S0925-7535(00)00045-X; Amalberti R., 2002, SYSTEM SAFETY CHALLE, P265; ANDEREGG K, 2004, TRANSFUSION MED UPDA; [Anonymous], 1994, HOSTAGES EACH OTHER; APOSTOLAKIS G, 2003, PATIENT SAFETY INT T, P205; Arbous MS, 2001, ANAESTHESIA, V56, P1141, DOI 10.1046/j.1365-2044.2001.02051.x; BAKER DP, 2003, MED TEAM WORKS PATIE; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Barach P, 2000, BMJ-BRIT MED J, V320, P759, DOI 10.1136/bmj.320.7237.759; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Battles JB, 2001, ACAD MED, V76, P125, DOI 10.1097/00001888-200102000-00008; Billings CE, 1998, ARCH PATHOL LAB MED, V122, P214; CARROLL D, 1950, AM J MED, V9, P175, DOI 10.1016/0002-9343(50)90020-9; Cook RI, 1996, J CLIN ANESTH, V8, pS29, DOI 10.1016/S0952-8180(96)90009-4; de Leval MR, 2000, J THORAC CARDIOV SUR, V119, P661, DOI 10.1016/S0022-5223(00)70006-7; Edmondson A.C., 2004, J APPL BEHAV SCI, V40, P66, DOI [10.1177/0021886396321001, DOI 10.1177/0021886396321001, 10.1177/0021886304263849]; Gaba DM, 2000, CALIF MANAGE REV, V43, P83, DOI 10.2307/41166067; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; Gaba DM, 2000, BRIT MED J, V320, P785, DOI 10.1136/bmj.320.7237.785; Gander PH, 2000, ANAESTH INTENS CARE, V28, P178, DOI 10.1177/0310057X0002800209; Gremy F, 2000, Sante Publique, V12, P91; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; Hollnagel E, 2004, BARRIERS ACCIDENT PR, V1; Joseph Vilma A, 2004, Int Anesthesiol Clin, V42, P113, DOI 10.1097/00004311-200404220-00009; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Khuri SF, 2001, ANN SURG, V234, P370, DOI 10.1097/00000658-200109000-00011; KOHN LT, 1999, ERR HUMAN BUILDING S; LAMENDOLA B, 2004, DOCTORS LAWYERS FIGH; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Leape LL, 2000, BMJ-BRIT MED J, V320, P725, DOI 10.1136/bmj.320.7237.725; LUCAS DA, 1987, HUMAN RELIABILITY NU; Michel P, 2004, BRIT MED J, V328, P199, DOI 10.1136/bmj.328.7433.199; Murff HJ, 2003, J BIOMED INFORM, V36, P131, DOI 10.1016/j.jbi.2003.08.003; Nebeker JR, 2004, ANN INTERN MED, V140, P795, DOI 10.7326/0003-4819-140-10-200405180-00009; OELZ O, 1999, LAVER INT POST GRADU, P5; OZIER Y, 2003, P S HEM 21 C SFTS; Perrow, 1984, NORMAL ACCIDENTS LIV; Philibert I, 2002, BRIT MED J, V325, P1184, DOI 10.1136/bmj.325.7374.1184; PILLONEL S, 2005, EUROSURVEILLANCE, V10, P5; Rasmussen J., 2000, PROACTIVE RISK MANAG; Reason J.T., 1997, ACTOOLKIT UNPRME ORG, V43, P147; Richter ED, 2004, AM J PUBLIC HEALTH, V94, P568, DOI 10.2105/AJPH.94.4.568; Roberts KH, 1990, ORGAN SCI, V1, P160, DOI 10.1287/orsc.1.2.160; SAUGES O, 2004, 40 PROPOSITIOINS AME; Stagl K. C., 2004, LEADER DEV TRANSFORM; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; Vila H, 2003, ARCH SURG-CHICAGO, V138, P991, DOI 10.1001/archsurg.138.9.991; Vincent C, 1998, BRIT MED J, V316, P1154, DOI 10.1136/bmj.316.7138.1154; VOHRA P, 2004, ANESTH ANALG; WEICK KE, 1993, ADMIN SCI QUART, V38, P357, DOI 10.2307/2393372; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089	53	311	317	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					756	764		10.7326/0003-4819-142-9-200505030-00012	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00012			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	922GW	15867408	Green Published			2022-12-28	WOS:000228825800005
J	Guimera, R; Uzzi, B; Spiro, J; Amaral, LAN				Guimera, R; Uzzi, B; Spiro, J; Amaral, LAN			Team assembly mechanisms determine collaboration network structure and team performance	SCIENCE			English	Article							SMALL-WORLD NETWORKS; COMPLEX NETWORKS; SCIENTIFIC COLLABORATION; DIVERSITY; INFORMATION; EVOLUTION	Agents in creative enterprises are embedded in networks that inspire, support, and evaluate their work. Here, we investigate how the mechanisms by which creative teams self-assemble determine the structure of these collaboration networks. We propose a model for the self-assembly of creative teams that has its basis in three parameters: team size, the fraction of newcomers in new productions, and the tendency of incumbents to repeat previous collaborations. The model suggests that the emergence of a large connected community of practitioners can be described as a phase transition. We find that team assembly mechanisms determine both the structure of the collaboration network and team performance for teams derived from both artistic and scientific fields.	Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA; Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA; Northwestern Univ, Dept Sociol, Evanston, IL 60208 USA; Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA	Northwestern University; Northwestern University; Northwestern University; Stanford University	Amaral, LAN (corresponding author), Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.	amaral@northwestern.edu	Spiro, Jarrett/B-3894-2010; Amaral, LAN/A-4980-2008; Amaral, Luis N./C-5485-2009; Guimera, Roger/M-9808-2019; Guimera, Roger/C-1727-2008	Amaral, LAN/0000-0002-3762-789X; Guimera, Roger/0000-0002-3597-4310; Guimera, Roger/0000-0002-3597-4310	NIGMS NIH HHS [K25 GM069546-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K25GM069546] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Amaral LAN, 2004, EUR PHYS J B, V38, P147, DOI 10.1140/epjb/e2004-00110-5; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barsade SG, 2001, ADMIN SCI QUART, V46, P174; Borner K, 2004, P NATL ACAD SCI USA, V101, P5266, DOI 10.1073/pnas.0307625100; Brown JR, 2000, SCIENCE, V290, P1701, DOI 10.1126/science.290.5497.1701; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; Edmondson A, 1999, ADMIN SCI QUART, V44, P350, DOI 10.2307/2666999; ETZKOWITZ H, 1994, SCIENCE, V266, P51, DOI 10.1126/science.7939644; Gladwell M., 2006, TIPPING POINT LITTLE; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Green S., 1996, BROADWAY MUSICALS SH; Harrison DA, 1998, ACAD MANAGE J, V41, P96, DOI 10.2307/256901; Jehn KA, 1999, ADMIN SCI QUART, V44, P741, DOI 10.2307/2667054; KATZENBACK JR, 1993, WISDOM TEAMS; Larson JR, 1996, J PERS SOC PSYCHOL, V71, P315, DOI 10.1037/0022-3514.71.2.315; Merton R.K., 1979, SOCIOLOGY SCI; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Reagans R, 2001, ORGAN SCI, V12, P502, DOI 10.1287/orsc.12.4.502.10637; Simas R., 1988, MUSICALS NO ONE CAME; STASSER G, 1995, J EXP SOC PSYCHOL, V31, P244, DOI 10.1006/jesp.1995.1012; Stauffer D., 1992, INTRO PERCOLATION TH; UZZI B, IN PRESS AM J SOCIOL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Ziman JM., 1994, PROMETHEUS BOUND, DOI [10.1017/CBO9780511585067, DOI 10.1017/CBO9780511585067]	31	614	630	21	307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					697	702		10.1126/science.1106340	http://dx.doi.org/10.1126/science.1106340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	922BO	15860629	Green Accepted, Green Submitted			2022-12-28	WOS:000228810900051
J	Basu, S; Gerchman, Y; Collins, CH; Arnold, FH; Weiss, R				Basu, S; Gerchman, Y; Collins, CH; Arnold, FH; Weiss, R			A synthetic multicellular system for programmed pattern formation	NATURE			English	Article							GENE-EXPRESSION; VIBRIO-FISCHERI; BACTERIA; LUXR; NETWORKS; LACTONES; GROWTH	Pattern formation is a hallmark of coordinated cell behaviour in both single and multicellular organisms(1-3). It typically involves cell-cell communication and intracellular signal processing. Here we show a synthetic multicellular system in which genetically engineered 'receiver' cells are programmed to formring-like patterns of differentiation based on chemical gradients of an acyl-homoserine lactone (AHL) signal that is synthesized by 'sender' cells. In receiver cells, 'band-detect' gene networks respond to user-defined ranges of AHL concentrations. By fusing different fluorescent proteins as outputs of network variants, an initially undifferentiated 'lawn' of receivers is engineered to form a bullseye pattern around a sender colony. Other patterns, such as ellipses and clovers, are achieved by placing senders in different configurations. Experimental and theoretical analyses reveal which kinetic parameters most significantly affect ring development over time. Construction and study of such synthetic multicellular systems can improve our quantitative understanding of naturally occurring developmental processes and may foster applications in tissue engineering, biomaterial fabrication and biosensing.	Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Princeton University; Princeton University; California Institute of Technology	Weiss, R (corresponding author), Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA.	rweiss@princeton.edu	Gerchman, Yoram/F-5226-2015; Gerchman, Yoram/H-4698-2019	Gerchman, Yoram/0000-0002-8637-9589; Arnold, Frances H./0000-0002-4027-364X; Collins, Cynthia/0000-0003-1647-860X				Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; BENJACOB E, 1995, PHYS REV LETT, V75, P2899, DOI 10.1103/PhysRevLett.75.2899; Choi S. H., 1992, Molecular Marine Biology and Biotechnology, V1, P408; Collins CH, 2005, MOL MICROBIOL, V55, P712, DOI 10.1111/j.1365-2958.2004.04437.x; Egland KA, 1999, MOL MICROBIOL, V31, P1197, DOI 10.1046/j.1365-2958.1999.01261.x; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Golden JW, 1998, CURR OPIN MICROBIOL, V1, P623, DOI 10.1016/S1369-5274(98)80106-9; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; PTASHNE M, 1986, GENETIC SWITCH PHAGE; SCHERRER R, 1986, CAN J MICROBIOL, V32, P607, DOI 10.1139/m86-113; WEISS R, 2002, NSC 1 1 WORKSH NON S; WEISS R, 2001, THESIS MIT; WEISS R, 2000, DNA6 6 INT M DNA BAS, P1; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002	18	746	784	6	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1130	1134		10.1038/nature03461	http://dx.doi.org/10.1038/nature03461			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858574				2022-12-28	WOS:000228693300043
J	Beggs, AD; Al-Rawi, H; Parfitt, A				Beggs, AD; Al-Rawi, H; Parfitt, A			Chest pain and fleeting neurological signs	LANCET			English	Editorial Material									St Thomas Hosp, Emergency Dept, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust	Beggs, AD (corresponding author), St Thomas Hosp, Emergency Dept, Lambeth Palace Rd, London SE1 7EH, England.	andrew.beggs@kcl.ac.uk	Beggs, Andrew/F-5902-2010; Beggs, Andrew D/A-6912-2013	Beggs, Andrew/0000-0003-0784-2967; Beggs, Andrew D/0000-0003-0784-2967				Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; ARCHER AG, 1986, CARDIOVASC INTER RAD, V9, P142, DOI 10.1007/BF02577924; Donovan EM, 2000, ARCH PHYS MED REHAB, V81, P1436, DOI 10.1053/apmr.2000.7158; *NAT I CLIN EXC, 2002, MYOC INF THROMB; Ogun S A, 2004, East Afr Med J, V81, P549	5	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1514	1514		10.1016/S0140-6736(05)66425-2	http://dx.doi.org/10.1016/S0140-6736(05)66425-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850639				2022-12-28	WOS:000228651600033
J	Blackstone, E; Morrison, M; Roth, MB				Blackstone, E; Morrison, M; Roth, MB			H2S induces a suspended animation-like state in mice	SCIENCE			English	Article							HIBERNATION		Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98105 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Roth, MB (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98105 USA.	mroth@fhcrc.org			NIA NIH HHS [T32 AG00057] Funding Source: Medline; NIGMS NIH HHS [GM48435] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; BLACKSTONE E, UNPUB; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Nystul TG, 2004, P NATL ACAD SCI USA, V101, P9133, DOI 10.1073/pnas.0403312101; Padilla PA, 2001, P NATL ACAD SCI USA, V98, P7331, DOI 10.1073/pnas.131213198; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; STOREY KB, 1990, Q REV BIOL, V65, P145, DOI 10.1086/416717	8	618	658	1	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					518	518		10.1126/science.1108581	http://dx.doi.org/10.1126/science.1108581			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845845				2022-12-28	WOS:000228810500043
J	Lecellier, CH; Dunoyer, P; Arar, K; Lehmann-Che, J; Eyquem, S; Himber, C; Saib, A; Voinnet, O				Lecellier, CH; Dunoyer, P; Arar, K; Lehmann-Che, J; Eyquem, S; Himber, C; Saib, A; Voinnet, O			A cellular MicroRNA mediates antiviral defense in human cells	SCIENCE			English	Article							SMALL INTERFERING RNA; VIRAL SUPPRESSOR; GENES; IDENTIFICATION; RECOGNITION; ANTISENSE	In eukaryotes, 21- to 24-nucteotide-long RNAs engage in sequence-specific interactions that inhibit gene expression by RNA silencing. This process has regulatory roles involving microRNAs and, in plants and insects, it also forms the basis of a defense mechanism directed by small interfering RNAs that derive from replicative or integrated viral genomes. We show that a cellular microRNA effectively restricts the accumulation of the retrovirus primate foamy virus type 1 (PFV-1) in human cells. PFV-1 also encodes a protein, Tas, that suppresses microRNA-directed functions in mammalian cells and displays cross-kingdom antisilencing activities. Therefore, through fortuitous recognition of foreign nucleic acids, cellular microRNAs have direct antiviral effects in addition to their regulatory functions.	CNRS, Inst Biol Mol Plantes, UPR 2357, F-67084 Strasbourg, France; Proligo, Paris, France; Hop St Louis, CNRS, UPR9051, Paris, France; Hop St Louis, INSERM, U462, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lecellier, CH (corresponding author), CNRS, Inst Biol Mol Plantes, UPR 2357, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	charles.lecellier@infobiogen.fr; olivier.voinnet@ibmp-ulp.u-strasbg.fr		Voinnet, Olivier/0000-0001-6982-9544; Lehmann-Che, jacqueline/0000-0001-6685-3354				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BAUNACH G, 1993, J VIROL, V67, P5411, DOI 10.1128/JVI.67.9.5411-5418.1993; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Heinkelein M, 2000, EMBO J, V19, P3436, DOI 10.1093/emboj/19.13.3436; Jepsen JS, 2004, OLIGONUCLEOTIDES, V14, P130, DOI 10.1089/1545457041526317; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Llave C, 2004, MOL PLANT PATHOL, V5, P361, DOI 10.1111/j.1364-3703.2004.00227.x; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Schramke V, 2004, CURR OPIN GENET DEV, V14, P174, DOI 10.1016/j.gde.2004.02.006; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213	22	728	852	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					557	560		10.1126/science.1108784	http://dx.doi.org/10.1126/science.1108784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845854				2022-12-28	WOS:000228810500054
J	Wolfe, JM				Wolfe, JM			Watching single cells pay attention	SCIENCE			English	Editorial Material							VISUAL-SEARCH		Brigham & Womens Hosp, Visual Attent Lab, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University	Wolfe, JM (corresponding author), Brigham & Womens Hosp, Visual Attent Lab, Cambridge, MA 02139 USA.	wolfe@search.bwh.harvard.edu	Wolfe, Jeremy M/A-9248-2016; Wolfe, Jeremy M/C-1621-2012	Wolfe, Jeremy M/0000-0002-6475-1984; Wolfe, Jeremy M/0000-0002-6475-1984				Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bricolo E, 2002, J COGNITIVE NEUROSCI, V14, P980, DOI 10.1162/089892902320474454; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; PALMER J, 1995, CURR DIR PSYCHOL SCI, V4, P118, DOI 10.1111/1467-8721.ep10772534; Wolfe JM, 2003, TRENDS COGN SCI, V7, P70, DOI 10.1016/S1364-6613(02)00024-4; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Woodman GF, 2003, J EXP PSYCHOL HUMAN, V29, P121, DOI 10.1037/0096-1523.29.1.121	8	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2005	308	5721					503	504		10.1126/science.1112616	http://dx.doi.org/10.1126/science.1112616			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	922BK	15845839				2022-12-28	WOS:000228810500037
J	Cannon, CP; Braunwald, E; McCabe, CH; Grayston, JT; Muhlestein, B; Giugliano, RP; Cairns, R; Skene, AM				Cannon, CP; Braunwald, E; McCabe, CH; Grayston, JT; Muhlestein, B; Giugliano, RP; Cairns, R; Skene, AM		Prevastatin Atorvastatin Evaluatio	Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEART-DISEASE; RABBIT MODEL; AZITHROMYCIN PREVENTS; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS; INFECTION; ARTERIES; EVENTS; ROXITHROMYCIN	BACKGROUND: Chlamydia pneumoniae has been found within atherosclerotic plaques, and elevated titers of antibody to this organism have been linked to a higher risk of coronary events. Pilot studies have suggested that antibiotic treatment may reduce the risk of cardiovascular events. METHODS: We enrolled 4162 patients who had been hospitalized for an acute coronary syndrome within the preceding 10 days and evaluated the efficacy of long-term treatment with gatifloxacin, a bactericidal antibiotic known to be effective against C. pneumoniae, in a double-blind, randomized, placebo-controlled trial. Subjects received 400 mg of gatifloxacin daily during an initial 2-week course of therapy that began 2 weeks after randomization, followed by a 10-day course every month for the duration of the trial (mean duration, 2 years), or placebo. The primary end point was a composite of death from all causes, myocardial infarction, documented unstable angina requiring rehospitalization, revascularization (performed at least 30 days after randomization), and stroke. RESULTS: A Kaplan-Meier analysis revealed that the rates of primary-end-point events at two years were 23.7 percent in the gatifloxacin group and 25.1 percent in the placebo group (hazard ratio, 0.95; 95 percent confidence interval, 0.84 to 1.08; P=0.41). No benefit was seen in any of the prespecified secondary end points or in any of the prespecified subgroups, including patients with elevated titers to C. pneumoniae or C-reactive protein. CONCLUSIONS: Despite long-term treatment with a bactericidal antibiotic effective against C. pneumoniae, no reduction in the rate of cardiovascular events was observed.	Brigham & Womens Hosp, Dept Med, Div Cardiovasc, TIMI Study Grp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Latter Day St Hosp, Salt Lake City, UT 84143 USA; Nottingham Clin Res Grp, Nottingham, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle	Cannon, CP (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA.	cpcannon@partners.org	Arnold, Malcolm/G-2869-2011; Cannon, Christopher P/AAY-7644-2020; Giugliano, Robert/N-7233-2017	Cannon, Christopher P/0000-0003-4596-2791; Giugliano, Robert/0000-0003-4110-7675				Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cercek B, 2003, LANCET, V361, P809, DOI 10.1016/S0140-6736(03)12706-7; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Danesh J, 2000, BRIT MED J, V321, P208, DOI 10.1136/bmj.321.7255.208; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Fong IW, 1997, J CLIN MICROBIOL, V35, P48, DOI 10.1128/JCM.35.1.48-52.1997; Gajjar DA, 2000, PHARMACOTHERAPY, V20, p76S, DOI 10.1592/phco.20.8.76S.35182; Grayston JT, 2005, NEW ENGL J MED, V352, P1637, DOI 10.1056/NEJMoa043526; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gupta S, 1997, CIRCULATION, V96, P404; Gurfinkel E, 1997, LANCET, V350, P404, DOI 10.1016/S0140-6736(97)07201-2; Jones HU, 2003, J AM COLL CARDIOL, V41, p289A; Juvonen JJ, 1997, J VASC SURG, V25, P499, DOI 10.1016/S0741-5214(97)70260-X; KUO CC, 1993, J INFECT DIS, V167, P841, DOI 10.1093/infdis/167.4.841; KUO CC, 1995, P NATL ACAD SCI USA, V92, P6911, DOI 10.1073/pnas.92.15.6911; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 1997, CIRCULATION, V96, P4095; Moazed TC, 1999, J INFECT DIS, V180, P238, DOI 10.1086/314855; Muhlestein JB, 1998, CIRCULATION, V97, P633, DOI 10.1161/01.CIR.97.7.633; Muhlestein JB, 1996, J AM COLL CARDIOL, V27, P1555, DOI 10.1016/0735-1097(96)00055-1; Neumann FJ, 2001, LANCET, V357, P2085, DOI 10.1016/S0140-6736(00)05181-3; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; WANG SP, 1979, J CLIN MICROBIOL, V10, P259, DOI 10.1128/JCM.10.2.259-261.1979; Zahn R, 2003, CIRCULATION, V107, P1253, DOI 10.1161/01.CIR.0000054613.57105.06	24	217	234	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1646	1654		10.1056/NEJMoa043528	http://dx.doi.org/10.1056/NEJMoa043528			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843667				2022-12-28	WOS:000228515200006
J	Gottfried, K; Salpeter, EE				Gottfried, K; Salpeter, EE			Hans A. Bethe (1906-2005) - Obituary	NATURE			English	Biographical-Item									Cornell Univ, Dept Phys, Ithaca, NY 14853 USA	Cornell University	Gottfried, K (corresponding author), Cornell Univ, Dept Phys, Ithaca, NY 14853 USA.	kg13@cornell.edu						BETHE H, PUBLICATION LIST	1	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					970	971		10.1038/434970a	http://dx.doi.org/10.1038/434970a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846332				2022-12-28	WOS:000228524600025
J	Pocai, A; Lam, TKT; Gutierrez-Juarez, R; Obici, S; Schwartz, GJ; Bryan, J; Aguilar-Bryan, L; Rossetti, L				Pocai, A; Lam, TKT; Gutierrez-Juarez, R; Obici, S; Schwartz, GJ; Bryan, J; Aguilar-Bryan, L; Rossetti, L			Hypothalamic K-ATP channels control hepatic glucose production	NATURE			English	Article							SENSITIVE POTASSIUM CHANNELS; FOOD-INTAKE; BODY-WEIGHT; SULFONYLUREA RECEPTOR; INSULIN-SECRETION; ARCUATE NUCLEUS; MICE; INHIBITION; OBESITY; LEPTIN	Obesity is the driving force behind the worldwide increase in the prevalence of type 2 diabetes mellitus(1,2). Hyperglycaemia is a hallmark of diabetes and is largely due to increased hepatic gluconeogenesis(3). The medial hypothalamus is a major integrator of nutritional and hormonal signals(1,2,4), which play pivotal roles not only in the regulation of energy balance but also in the modulation of liver glucose output(5,6). Bidirectional changes in hypothalamic insulin signalling therefore result in parallel changes in both energy balance(7-10) and glucose metabolism(5). Here we show that activation of ATP-sensitive potassium (K-ATP) channels(11) in the mediobasal hypothalamus is sufficient to lower blood glucose levels through inhibition of hepatic gluconeogenesis. Finally, the infusion of a K-ATP blocker within the mediobasal hypothalamus, or the surgical resection of the hepatic branch of the vagus nerve, negates the effects of central insulin and halves the effects of systemic insulin on hepatic glucose production. Consistent with these results, mice lacking the SUR1 subunit of the K-ATP channel(12) are resistant to the inhibitory action of insulin on gluconeogenesis. These findings suggest that activation of hypothalamic K-ATP channels normally restrains hepatic gluconeogenesis, and that any alteration within this central nervous system/liver circuit can contribute to diabetic hyperglycaemia.	Albert Einstein Coll Med, Dept Med, Diabet Res Ctr, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Neurosci, Diabet Res Ctr, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Mol Pharmacol, Diabet Res Ctr, Bronx, NY 10461 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Baylor College of Medicine	Rossetti, L (corresponding author), Albert Einstein Coll Med, Dept Med, Diabet Res Ctr, Bronx, NY 10461 USA.	rossetti@aecom.yu.edu						Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Chutkow WA, 2001, P NATL ACAD SCI USA, V98, P11760, DOI 10.1073/pnas.201390398; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; la Fleur SE, 2003, DIABETES, V52, P2321, DOI 10.2337/diabetes.52.9.2321; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Massillon D, 1995, AM J PHYSIOL-ENDOC M, V269, pE1037, DOI 10.1152/ajpendo.1995.269.6.E1037; Matsuhisa M, 2000, METABOLISM, V49, P11, DOI 10.1016/S0026-0495(00)90538-9; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; NORGREN R, 1988, J COMP NEUROL, V273, P207, DOI 10.1002/cne.902730206; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Seino S, 2000, DIABETES, V49, P311, DOI 10.2337/diabetes.49.3.311; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0	29	480	495	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1026	1031		10.1038/nature03439	http://dx.doi.org/10.1038/nature03439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846348				2022-12-28	WOS:000228524600040
J	Sackner-Bernstein, JD; Kowalski, M; Fox, M; Aaronson, K				Sackner-Bernstein, JD; Kowalski, M; Fox, M; Aaronson, K			Short-term risk of death after treatment with nesiritide for decompensated heart failure - A pooled analysis of randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							WORSENING RENAL-FUNCTION; NATRIURETIC PEPTIDE; INTRAVENOUS NESIRITIDE; DOUBLE-BLIND; DOBUTAMINE; MORTALITY; VALSARTAN; INFUSION; SURVIVAL; OUTCOMES	Context Nesiritide improves symptoms inpatients with acutely decompensated heart failure compared with placebo and appears to be safer than dobutamine. Its short-term safety relative to standard diuretic and vasodilator therapies is less clear. Objective To investigate the safety of nesiritide relative to noninotrope-based control therapies, primarily consisting of diuretics or vasodilators. Data Sources Primary reports of completed clinical trials as of December 2004 were obtained from the US Food and Drug Administration (FDA), the study sponsor (Scios Inc), a PubMed literature search using the terms nesiritide, clinical trials, and humans, and a manual search of annual meetings of 3 heart associations. Study Selection Of 12 randomized controlled trials evaluating nesiritide, 3 met all inclusion criteria: randomized double-blind study of patients with acutely decompensated heart failure, therapy administered as single infusion (>= 6 hours), inotrope not mandated as control, and reported 30-day mortality. Data Extraction Data were extracted from FDA and sponsor documents and corroborated with published articles when available. Thirty-day survival was assessed by meta-analysis using a fixed-effects model and time-dependent risk by Kaplan-Meier analysis with Cox proportional hazards regression modeling. Where deaths were described within a range of days after treatment, an extreme assumption was made favoring nesiritide over control therapy, an approach relevant to the time-dependent analyses. Data Synthesis In the 3 trials, 485 patients were randomized to nesiritide and 377 to control therapy. Death within 30 days tended to occur more often among patients randomized to nesiritide therapy (35 [7.2%] of 485 vs 15 [4.0%] of 377 patients; risk ratio from meta-analysis, 1.74; 95% confidence interval [CI], 0.97-3.12; P = .059; and hazard ratio after adjusting for study, 1.80; 95% Cl, 0.98-3.31; P = .057). Conclusions Compared with noninotrope-based control therapy, nesiritide may be associated with an increased risk of death after treatment for acutely decompensated heart failure. The possibility of an increased risk of death should be investigated in a large-scale, adequately powered, controlled trial before routine use of nesiritide for acutely decompensated heart failure.	N Shore Univ Hosp, Div Cardiol, Clin Scholars Program, Manhasset, NY 11030 USA; St Lukes Roosevelt Hosp, Dept Med, New York, NY USA; Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA	Northwell Health; North Shore University Hospital; Mount Sinai St. Luke's; Mount Sinai West; University of Michigan System; University of Michigan	Sackner-Bernstein, JD (corresponding author), N Shore Univ Hosp, Div Cardiol, Clin Scholars Program, 1st Floor Cohen,300 Community Dr, Manhasset, NY 11030 USA.	jonathansb@yahoo.com						Abraham W T, 1998, J Card Fail, V4, P37, DOI 10.1016/S1071-9164(98)90506-1; BRESLOW NE, 1994, IARC SCI PUBLICATION, V82; Burger AJ, 2002, AM HEART J, V144, P1102, DOI 10.1067/mhj.2002.125620; Butler J, 2004, AM HEART J, V147, P331, DOI 10.1016/j.ahj.2003.08.012; Califf RM, 1997, AM HEART J, V134, P44, DOI 10.1016/S0002-8703(97)70105-4; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Cohn JN, 1998, NEW ENGL J MED, V339, P1810, DOI 10.1056/NEJM199812173392503; Cohn JN, 2003, EUR J HEART FAIL, V5, P659, DOI 10.1016/S1388-9842(03)00163-6; Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; COWLEY AJ, 1994, BRIT HEART J, V72, P226; DIES F, 1986, CIRCULATION, V74, P38; Gottlieb SS, 2002, J CARD FAIL, V8, P136, DOI 10.1054/jcaf.2002.125289; Hampton JR, 1997, LANCET, V349, P971, DOI 10.1016/S0140-6736(96)10488-8; Heyndrickx G, 1996, HEART, V76, P223, DOI 10.1136/hrt.76.3.223; Horton R, 2004, LANCET, V364, P1995, DOI 10.1016/S0140-6736(04)17523-5; HUNG H, 2001, 20920 NDA; Joshi Ashish V, 2004, Congest Heart Fail, V10, P76, DOI 10.1111/j.1527-5299.2004.02008.x; Krumholz HM, 2000, AM J CARDIOL, V85, P1110, DOI 10.1016/S0002-9149(00)00705-0; Marcus LS, 1996, CIRCULATION, V94, P3184, DOI 10.1161/01.CIR.94.12.3184; Mills RM, 1999, J AM COLL CARDIOL, V34, P155, DOI 10.1016/S0735-1097(99)00184-9; Moe GW, 2000, AM HEART J, V139, P587, DOI 10.1016/S0002-8703(00)90035-8; Packer M, 2002, CIRCULATION, V106, P920, DOI 10.1161/01.CIR.0000029801.86489.50; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Peacock WF, 2003, J AM COLL CARDIOL, V41, p336A; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4; *SCIOS INC, 20920 NDA SCIOS INC; *SCIOS INC, 2001, NATR PROD INS; *SCIOS INC, 1999, 20920 NDA SCIOS INC; *SCIOS INC, 2002, PREL RES PROACT PIL; Silver MA, 2002, J AM COLL CARDIOL, V39, P798, DOI 10.1016/S0735-1097(01)01818-6; Smith GL, 2003, J CARD FAIL, V9, P13, DOI 10.1054/jcaf.2003.3; Temple R, 1999, JAMA-J AM MED ASSOC, V281, P841, DOI 10.1001/jama.281.9.841; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; *US FDA, 2002, CARD REN DRUGS ADV C; Yancy CW, 2004, AM J CARDIOL, V94, P595, DOI 10.1016/j.amjcard.2004.05.022; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531	39	447	482	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1900	1905		10.1001/jama.293.15.1900	http://dx.doi.org/10.1001/jama.293.15.1900			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840865				2022-12-28	WOS:000228401700029
J	Esmail, A				Esmail, A			GMC and the future of revalidation - Failure to act on good intentions	BRITISH MEDICAL JOURNAL			English	Article									Univ Manchester, Rusholme Hlth Ctr, Sch Med, Div Primary Care, Manchester M14 5NP, Lancs, England	University of Manchester	Esmail, A (corresponding author), Univ Manchester, Rusholme Hlth Ctr, Sch Med, Div Primary Care, Manchester M14 5NP, Lancs, England.	aneez.esmail@manchester.ac.uk	Esmail, Aneez/I-6903-2013						0	25	25	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 14	2005	330	7500					1144	+		10.1136/bmj.330.7500.1144	http://dx.doi.org/10.1136/bmj.330.7500.1144			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15891233	Green Published			2022-12-28	WOS:000229166900031
J	Kaur, R				Kaur, R			Breast cancer	LANCET			English	Editorial Material									Int Union Canc UICC, Reach Recovery Int Global Breast Canc Support Net, Geneva, Switzerland		Kaur, R (corresponding author), Int Union Canc UICC, Reach Recovery Int Global Breast Canc Support Net, Geneva, Switzerland.								0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1742	1742		10.1016/S0140-6736(05)66547-6	http://dx.doi.org/10.1016/S0140-6736(05)66547-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894100				2022-12-28	WOS:000229082300025
J	Hovatta, O; Skottman, H				Hovatta, O; Skottman, H			Feeder-free derivation of human embryonic stem-cell lines	LANCET			English	Editorial Material							MOUSE EMBRYOS; CULTURE; GROWTH		Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Clin Sci, SE-14186 Stockholm, Sweden; Univ Tampere, Inst Regenerat Med, REGEA, FIN-33101 Tampere, Finland	Karolinska Institutet; Karolinska University Hospital; Tampere University	Hovatta, O (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Clin Sci, SE-14186 Stockholm, Sweden.	Outi.Hovatta@klinvet.ki.se		Skottman, Heli/0000-0002-4127-8792				Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nichols J, 2001, DEVELOPMENT, V128, P2333; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971	11	11	15	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 7	2005	365	9471					1601	1603		10.1016/S0140-6736(05)66477-X	http://dx.doi.org/10.1016/S0140-6736(05)66477-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885281				2022-12-28	WOS:000228933700006
J	Beral, V; Bull, D; Reeves, G				Beral, V; Bull, D; Reeves, G		Million Women Study Collaborators	Endometrial cancer and hormone-replacement therapy in the Million Women Study	LANCET			English	Article							ESTROGEN REPLACEMENT; RISK; PROGESTIN	Background Postmenopausal women who use hormone-replacement therapy (HRT) containing oestrogen alone are at increased risk of endometrial cancer. To minimise this risk, many HRT users who have not had a hysterectomy use combined oestrogen-progestagen preparations or tibolone. Limited information is available on the incidence of endometrial cancer in users of these therapies. Methods 716 738 postmenopausal women in the UK without previous cancer or previous hysterectomy were recruited into the Million Women Study in 1996-2001, provided information about their use of HRT and other personal details, and were followed up for an average of 3.4 years, during which time 1320 incident endometrial cancers were diagnosed. Findings 320 953 women (45%) reported at recruitment that they had used HRT, among whom 69 577 (22%) last used continuous combined therapy (progestagen added daily to oestrogen), 145 486 (45%) last used cyclic combined therapy (progestagen added to oestrogen, usually for 10-14 days per month), 28 028 (9%) last used tibolone, and 14 204 (4%) last used oestrogen-only HRT. These HRT types had sharply contrasting effects on the overall risk of endometrial cancer (p<0.0001 for heterogeneity). Compared with never users of HRT, risk was: reduced with last use of continuous combined preparations (relative risk 0.71 [95% Cl 0.56-0.90]; p=0.005); increased with last use of tibolone (1.79 [1.43-2.25]; p<0.0001) and oestrogen only (1.45 [1.02-2.06]; p=0.04); and not significantly altered with last use of cyclic combined preparations (1.05 [0.91-1.22]; p=0.5). A woman's body-mass index significantly affected these associations, such that the adverse effects of tibolone and oestrogen-only HRT were greatest in non-obese women, and the beneficial effects of combined HRT were greatest in obese women. Interpretation Oestrogens and tibolone increase the risk of endometrial cancer. Progestagens counteract the adverse effect of oestrogens on the endometrium, the effect being greater the more days every month that they are added to oestrogen and the more obese that women are. However, combined oestrogen-progestagen HRT causes a greater increase in breast cancer than the other therapies do. Thus, when endometrial and breast cancers are added together, there is a greater increase in total cancer incidence with use of combined HRT, both continuous and cyclic, than with use of the other therapies.	Radcliffe Infirm, Mill Women Study Coordinating Ctr, Canc Res UK Epidemiol Unit, Oxford OX2 6HE, England	Cancer Research UK; Radcliffe Infirmary; University of Oxford	Beral, V (corresponding author), Radcliffe Infirm, Mill Women Study Coordinating Ctr, Canc Res UK Epidemiol Unit, Gibson Bldg,Woodstock Rd, Oxford OX2 6HE, England.	secretariat@millionwomenstudy.org						Abbott S, 2002, BJOG-INT J OBSTET GY, V109, P1319; Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; ARMITAGE M, 2004, MENOPAUSE HORMONE RE, P325; BAKKEN K, 2002, INT J CANCER, V112, P130; Banks E, 2001, J Epidemiol Biostat, V6, P357; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 2005, BJOG-INT J OBSTET GY, V112, P692, DOI 10.1111/j.1471-0528.2005.00541.x; Beresford SAA, 1997, LANCET, V349, P458, DOI 10.1016/S0140-6736(96)07365-5; BRINTON LA, 1993, OBSTET GYNECOL, V81, P265; de Vries CS, 2005, DRUG SAFETY, V28, P241, DOI 10.2165/00002018-200528030-00005; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; Hill DA, 2000, AM J OBSTET GYNECOL, V183, P1456, DOI 10.1067/mob.2000.108081; *IARC, 1999, IARC MON EV CARC RIS, V72; JICK SS, 1993, EPIDEMIOLOGY, V4, P20, DOI 10.1097/00001648-199301000-00005; *JOINT FORM COMM, 1999, BRIT NAT FORM; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; Lukanova A, 2004, INT J CANCER, V108, P425, DOI 10.1002/ijc.11529; *NAT STAT, 2003, CANC STAT REG CA MB1, V31; Newcomb PA, 2003, CANCER CAUSE CONTROL, V14, P195, DOI 10.1023/A:1023066304473; PERSSON I, 1989, BRIT MED J, V298, P147, DOI 10.1136/bmj.298.6667.147; Pike MC, 1997, J NATL CANCER I, V89, P1110, DOI 10.1093/jnci/89.15.1110; SIITERI PK, 1987, AM J CLIN NUTR, V45, P277, DOI 10.1093/ajcn/45.1.277; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Townsend PP., 1988, HLTH DEPRIVATION INE; VOIGT LF, 1991, LANCET, V338, P274, DOI 10.1016/0140-6736(91)90417-N; Weiderpass E, 1999, J NATL CANCER I, V91, P1131, DOI 10.1093/jnci/91.13.1131; World Health Organization, 1998, INT CLASS DIS; Yazigi R, 2004, GYNECOL ONCOL, V93, P568, DOI 10.1016/j.ygyno.2004.02.003; Zeleniuch-Jacquotte A, 2001, BRIT J CANCER, V84, P975, DOI 10.1054/bjoc.2001.1704	29	441	465	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1543	1551						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866308				2022-12-28	WOS:000228754800026
J	Savioli, L; Engels, D; Endo, H				Savioli, L; Engels, D; Endo, H			Extending the benefits of deworming for development	LANCET			English	Editorial Material							PUBLIC-HEALTH; SCHISTOSOMIASIS; INFECTIONS		WHO, CH-1211 Geneva, Switzerland	World Health Organization	Savioli, L (corresponding author), WHO, CH-1211 Geneva, Switzerland.	saviolil@who.int						Albonico M, 2004, INT J PARASITOL, V34, P1205, DOI 10.1016/j.ijpara.2004.08.001; Bleakley H, 2003, J EUR ECON ASSOC, V1, P376, DOI 10.1162/154247603322391017; BUNDY DA, IN PRESS DIS CONTROL; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; ENGELS D, 2005, SCHISTOSOMIASIS WORL, V10; GRYSEELS B, 1989, TROP MED PARASITOL, V40, P134; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Molyneux DH, 2004, LANCET, V364, P380, DOI 10.1016/S0140-6736(04)16728-7; Savioli L, 2004, LANCET, V363, P658, DOI 10.1016/S0140-6736(04)15603-1; Savioli L, 2002, T ROY SOC TROP MED H, V96, P577, DOI 10.1016/S0035-9203(02)90316-0; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; *WHO UNICEF, 2004, WHOCDSCPEPVC200411; World Health Organization, 2002, PREV CONTR SCHIST SO; World Health Organization, 2001, SCHIST SOIL TRANSM H; [No title captured]	15	23	23	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 30	2005	365	9470					1520	1521		10.1016/S0140-6736(05)66433-1	http://dx.doi.org/10.1016/S0140-6736(05)66433-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866291	Green Published, Bronze			2022-12-28	WOS:000228754800006
J	Dimmeler, S				Dimmeler, S			Platelet-derived growth factor CC - A clinically useful angiogenic factor at last?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PDGF		Univ Frankfurt, Dept Mol Cardiol, D-6000 Frankfurt, Germany	Goethe University Frankfurt	Dimmeler, S (corresponding author), Univ Frankfurt, Dept Mol Cardiol, D-6000 Frankfurt, Germany.			Dimmeler, Stefanie/0000-0002-1045-2436				Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Li XR, 2005, J CLIN INVEST, V115, P118, DOI 10.1172/JCI200519189; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Vincent L, 2004, CANCER CELL, V6, P307, DOI 10.1016/j.ccr.2004.09.024	5	22	26	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1815	1816		10.1056/NEJMcibr050670	http://dx.doi.org/10.1056/NEJMcibr050670			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858193				2022-12-28	WOS:000228689000015
J	McQueen, A				McQueen, A			"I think she's just crazy"	LANCET			English	Editorial Material									Childrens Hosp Boston, Emergency Dept, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	McQueen, A (corresponding author), Childrens Hosp Boston, Emergency Dept, Boston, MA 02115 USA.	Alisa.mcqueen@childrens.harvard.edu							0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1513	1513		10.1016/S0140-6736(05)66424-0	http://dx.doi.org/10.1016/S0140-6736(05)66424-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850638				2022-12-28	WOS:000228651600032
J	Allen, P				Allen, P			Striking a chord	NATURE			English	Editorial Material									ETH Zentrum, Dept Earth Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Allen, P (corresponding author), ETH Zentrum, Dept Earth Sci, CH-8092 Zurich, Switzerland.							ALLEN PA, 2005, BASIN ANAL PRINCIPLE, P221; Summerfield MA., 2000, GEOMORPHOLOGY GLOBAL	2	35	47	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 21	2005	434	7036					961	961		10.1038/434961a	http://dx.doi.org/10.1038/434961a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846325	Bronze			2022-12-28	WOS:000228524600019
J	Hunter, DG				Hunter, DG			Early detection vs late treatment of amblyopia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VISION; EYE		Childrens Hosp Boston, Dept Ophthalmol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Hunter, DG (corresponding author), Childrens Hosp Boston, Dept Ophthalmol, 300 Longwood Ave, Boston, MA 02115 USA.	david.hunter@childrens.harvard.edu		Hunter, David/0000-0002-4587-4794				Beck Roy W, 2002, Curr Opin Ophthalmol, V13, P337, DOI 10.1097/00055735-200210000-00008; Donahue SP, 2004, J AAPOS, V8, P224, DOI 10.1016/j.jaapos.2004.05.004; Krueger D. E., 1984, REPORT NATL EYE I VI; Rahi JS, 2002, LANCET, V360, P597, DOI 10.1016/S0140-6736(02)09782-9; Scheiman MM, 2005, ARCH OPHTHALMOL-CHIC, V123, P437; Schmidt P, 2004, OPHTHALMOLOGY, V111, P637, DOI 10.1016/j.ophtha.2004.01.022; Simons K, 2005, SURV OPHTHALMOL, V50, P123, DOI 10.1016/j.survophthal.2004.12.005; STEWART J, 1991, AUST NZ J OPHTHALMOL, V19, P283; TOMMILA V, 1981, BRIT J OPHTHALMOL, V65, P575, DOI 10.1136/bjo.65.8.575	9	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1920	1922		10.1001/jama.293.15.1920	http://dx.doi.org/10.1001/jama.293.15.1920			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15844230				2022-12-28	WOS:000228401700033
J	Scherer, K; Bedlack, RS; Simel, DL				Scherer, K; Bedlack, RS; Simel, DL			Does this patient have myashtenia gravis?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OCULAR MYASTHENIA-GRAVIS; RAPID EYE-MOVEMENTS; ICE PACK TEST; ACETYLCHOLINE-RECEPTOR; TENSILON TEST; DIAGNOSIS; EPIDEMIOLOGY; AUTOANTIBODIES; POPULATION; SYMPTOMS	Context Clinicians must be able to diagnose myasthenia gravis, since delays in establishing the diagnosis may put patients at risk for complications from this treatable disease. Objective To determine if items in the history and examination or results of simple tests change the likelihood of myasthenia gravis as a diagnosis. Data Sources MEDLINE search of English-language articles (January 1966-January 2005) using the terms myasthenia gravis, diagnosis, and test, and a search of bibliographies of retrieved articles. Study Selection Studies evaluating a particular symptom or sign in patients both with and without myasthenia gravis. Of 640 articles retrieved, 33 were eligible for review. Of these, 15 met inclusion criteria and form the basis of this review. Data Extraction Two authors independently reviewed each study to determine eligibility, abstracted data using a standardized instrument, and classified study quality using previously published criteria. Data Synthesis A history of "speech becoming unintelligible during prolonged speaking" and the Presence of the peek sign increase the likelihood of myasthenia gravis (likelihood ratio [LR], 4.5; 95% confidence interval [CI], 1.2-17.0 and LR, 30.0; 95% CI, 3.2-278.0, respectively). Their absence does not significantly reduce the likelihood of myasthenia gravis. The identified studies only assessed 1 other historical feature and sign each ("food remaining in the mouth after swallowing" and quiver eye movements, respectively), and neither of these significantly changes the likelihood of myasthenia. The ice test is useful when the response is abnormal (summary positive LR, 24.0; 95% CI, 8.5-67.0) and diminishes the likelihood of myasthenia gravis when the response is normal (summary negative LR, 0.16; 95% CI, 0.09-0.27). A positive response to an anticholinesterase medication (mainly edrophonium test) increases the probability of a diagnosis of myasthenia gravis (summary positive LR, 15.0; 95% CI, 7.5-31.0), and a negative response reduces the diagnostic probability of myasthenia (summary negative LR, 0.11; 95% CI, 0.06-0.21). An abnormal sleep test result is useful in confirming the diagnosis (LR, 53.0; 95% CI, 3.4-832.0). The rest and sleep tests make the probability of myasthenia unlikely when results are normal (LR, 0.52-1 95% CI, 0.29-0.95 and LR, 0.01; 95% CI, 0.00-0.16, respectively). Conclusions Items in the history and physical examination along with results of certain simple tests performed in the office (ice test, sleep test, and edrophonium test) are useful in predicting the likelihood of myasthenia gravis. These results must be interpreted with caution, however, given the high prevalence of disease in the populations reported in clinical studies. This review is limited by the small number of signs and symptoms scientifically studied and reported in the literature. Future studies evaluating the value of common historical features and easy maneuvers commonly known and practiced by experts in the clinical diagnosis of myasthenia are needed.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Durham Vet Affairs Med Ctr, Dept Med, Durham, NC USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Scherer, K (corresponding author), DUMC Box 3403, Durham, NC 27710 USA.	scher012@mc.duke.edu		Bedlack, Richard/0000-0003-4666-7495				Bartley G B, 1986, Ophthalmic Plast Reconstr Surg, V2, P95, DOI 10.1097/00002341-198601050-00007; Batocchi AP, 1997, J NEUROL, V244, P639, DOI 10.1007/s004150050160; Bedlack RS, 2002, MUSCLE NERVE, V25, P117, DOI 10.1002/mus.1221; BEGHI E, 1991, J NEUROL SCI, V106, P213, DOI 10.1016/0022-510X(91)90260-E; Borenstein M., 1999, COMPREHENSIVE META A; BORENSTEIN S, 1975, ARCH NEUROL-CHICAGO, V32, P152, DOI 10.1001/archneur.1975.00490450032003; COGAN DG, 1976, ARCH OPHTHALMOL-CHIC, V94, P1083, DOI 10.1001/archopht.1976.03910040003001; COGAN DG, 1965, ARCH OPHTHALMOL-CHIC, V74, P217, DOI 10.1001/archopht.1965.00970040219016; Czaplinski A, 2003, J NEUROL, V250, P883, DOI 10.1007/s00415-003-1121-1; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Eddy DM, 1992, METAANALYSIS CONFIDE; Ellis FD, 2000, J AAPOS, V4, P271, DOI 10.1067/mpa.2000.106204; ERTAS M, 1994, ACTA NEUROL SCAND, V89, P227; GARLEPP MJ, 1982, J NEUROIMMUNOL, V3, P337, DOI 10.1016/0165-5728(82)90036-4; GIAGHEDDU M, 1989, ACTA NEUROL SCAND, V79, P326, DOI 10.1111/j.1600-0404.1989.tb03793.x; Golnik KC, 1999, OPHTHALMOLOGY, V106, P1282, DOI 10.1016/S0161-6420(99)00709-5; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; HOWARD FM, 1987, ANN NY ACAD SCI, V505, P526; Ing EB, 2000, CAN J OPHTHALMOL, V35, P141, DOI 10.1016/S0008-4182(00)80007-1; Jaeschke RZ, 1997, CRIT CARE MED, V25, P1514, DOI 10.1097/00003246-199709000-00018; Kalb B, 2002, NEUROEPIDEMIOLOGY, V21, P221, DOI 10.1159/000065639; Kubis KC, 2000, OPHTHALMOLOGY, V107, P1995, DOI 10.1016/S0161-6420(00)00458-9; Lertchavanakul Arunee, 2001, Journal of the Medical Association of Thailand, V84, pS131; LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054; Massey JM, 1997, NEUROL CLIN, V15, P577, DOI 10.1016/S0733-8619(05)70335-2; Nicholson G A, 1983, Clin Exp Neurol, V19, P45; ODEL JG, 1991, J CLIN NEURO-OPHTHAL, V11, P288; OH SJ, 1992, MUSCLE NERVE, V15, P720, DOI 10.1002/mus.880150616; OOSTERHUIS HJG, 1964, J NEUROL SCI, V1, P512, DOI 10.1016/0022-510X(64)90171-6; OOSTERHUIS HJGH, 1982, DOC OPHTHALMOL, V52, P363, DOI 10.1007/BF01675867; Oosterhuis HJGH, 1996, CLIN NEUROL NEUROSUR, V98, P1, DOI 10.1016/0303-8467(95)00087-9; OSHER RH, 1979, ARCH OPHTHALMOL-CHIC, V97, P677, DOI 10.1001/archopht.1979.01020010333009; OSSERMAN KE, 1958, ARCH INTERN MED, V102, P72, DOI 10.1001/archinte.1958.00260190074008; OSSERMAN KE, 1952, JAMA-J AM MED ASSOC, V150, P265, DOI 10.1001/jama.1952.03680040007002; Padua L, 2000, CLIN NEUROPHYSIOL, V111, P1203, DOI 10.1016/S1388-2457(00)00307-2; PASCUZZI RM, 1984, ANN NEUROL, V15, P291, DOI 10.1002/ana.410150316; PHILLIPS LH, 1994, NEUROL CLIN, V12, P263, DOI 10.1016/S0733-8619(18)30096-3; PHILLIPS LH, 1992, NEUROLOGY, V42, P1888, DOI 10.1212/WNL.42.10.1888; Phillips LH, 1996, NEUROLOGY, V47, P1233, DOI 10.1212/WNL.47.5.1233; Romi F, 2000, J NEUROL, V247, P369, DOI 10.1007/s004150050604; Sanders Donald B., 1997, Neurology, V48, pS40; SETHI KD, 1987, NEUROLOGY, V37, P1383, DOI 10.1212/WNL.37.8.1383; SEYBOLD ME, 1986, ARCH NEUROL-CHICAGO, V43, P842, DOI 10.1001/archneur.1986.00520080080028; SIMPSON JF, 1966, ACTA NEUROL SCAND, VS 42, P7; SNEDDON J, 1980, BRIT J PSYCHIAT, V136, P92, DOI 10.1192/bjp.136.1.92; SOMNIER FE, 1993, ELECTROEN CLIN NEURO, V89, P73, DOI 10.1016/0168-5597(93)90088-7; VANDYK HJL, 1980, OPHTHALMOLOGY, V87, P210; Weijnen FG, 2000, ACTA NEUROL SCAND, V102, P303, DOI 10.1034/j.1600-0404.2000.102005303.x; Weizer JS, 2001, CAN J OPHTHALMOL, V36, P26, DOI 10.1016/S0008-4182(01)80063-6; YEE RD, 1976, ARCH OPHTHALMOL-CHIC, V94, P1465, DOI 10.1001/archopht.1976.03910040299001	50	52	55	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1906	1914		10.1001/jama.293.15.1906	http://dx.doi.org/10.1001/jama.293.15.1906			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840866				2022-12-28	WOS:000228401700030
J	Chiaverini, J; Britton, J; Leibfried, D; Knill, E; Barrett, MD; Blakestad, RB; Itano, WP; Jost, JD; Langer, C; Ozeri, R; Schaetz, T; Wineland, DJ				Chiaverini, J; Britton, J; Leibfried, D; Knill, E; Barrett, MD; Blakestad, RB; Itano, WP; Jost, JD; Langer, C; Ozeri, R; Schaetz, T; Wineland, DJ			Implementation of the semiclassical quantum Fourier transform in a scalable system	SCIENCE			English	Article							EXPERIMENTAL REALIZATION; FACTORING ALGORITHM; TRAPPED IONS; COMPUTATION; COMPUTER	We report the implementation of the semiclassical quantum Fourier transform in a system of three beryllium ion qubits (two-level quantum systems) confined in a segmented multizone trap. The quantum Fourier transform is the crucial final step in Shor's algorithm, and it acts on a register of qubits to determine the periodicity of the quantum state's amplitudes. Because only probability amplitudes are required for this task, a more efficient semiclassical version can be used, for which only single-qubit operations conditioned on measurement outcomes are required. We apply the transform to several input states of different periodicities; the results enable the location of peaks corresponding to the original periods. This demonstration incorporates the key elements of a scalable ion-trap architecture, suggesting the future capability of applying the quantum Fourier transform to a large number of qubits as required for a useful quantum factoring algorithm.	Natl Inst Stand & Technol, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Chiaverini, J (corresponding author), Natl Inst Stand & Technol, Boulder, CO 80305 USA.	john.chiaverini@boulder.nist.gov	Itano, Wayne/AAV-8781-2020; Barrett, Murray D/G-2732-2012; Jost, John D/F-4701-2010	Barrett, Murray D/0000-0002-1483-8029; Britton, Joe/0000-0001-8103-7347; jost, john/0000-0002-1698-8602				Allen L, 1987, OPTICAL RESONANCE 2; Arfken GB., 1999, MATH METHODS PHYS; Coppersmith D, 1994, RC19642 IBM, Patent No. [RC19642, 19642]; Cory DG, 2000, FORTSCHR PHYS, V48, P875, DOI 10.1002/1521-3978(200009)48:9/11<875::AID-PROP875>3.0.CO;2-V; Ekert A, 1996, REV MOD PHYS, V68, P733, DOI 10.1103/RevModPhys.68.733; Fuchs C A, 1996, THESIS U NEW MEXICO; Griffiths RB, 1996, PHYS REV LETT, V76, P3228, DOI 10.1103/PhysRevLett.76.3228; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; King BE, 1998, PHYS REV LETT, V81, P1525, DOI 10.1103/PhysRevLett.81.1525; Lee JS, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.042316; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; MONROE C, 1995, PHYS REV LETT, V75, P4011, DOI 10.1103/PhysRevLett.75.4011; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Rowe MA, 2002, QUANTUM INF COMPUT, V2, P257; Schaetz T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040505; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700; Vandersypen LMK, 2000, PHYS REV LETT, V85, P5452, DOI 10.1103/PhysRevLett.85.5452; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Weinstein YS, 2004, J CHEM PHYS, V121, P6117, DOI 10.1063/1.1785151; Weinstein YS, 2001, PHYS REV LETT, V86, P1889, DOI 10.1103/PhysRevLett.86.1889; Wineland DJ, 2003, PHILOS T R SOC A, V361, P1349, DOI 10.1098/rsta.2003.1205	24	109	110	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					997	1000		10.1126/science.1110335	http://dx.doi.org/10.1126/science.1110335			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890877				2022-12-28	WOS:000229190700039
J	Kaineg, B; Hudgins, PA				Kaineg, B; Hudgins, PA			Wernicke's encephalopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Emory Univ, Sch Med, Atlanta, GA 30319 USA	Emory University	Kaineg, B (corresponding author), Emory Univ, Sch Med, Atlanta, GA 30319 USA.								0	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					E18	E18		10.1056/NEJMicm040862	http://dx.doi.org/10.1056/NEJMicm040862			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888690				2022-12-28	WOS:000229017100012
J	Vermot, J; Pourquie, O				Vermot, J; Pourquie, O			Retinoic acid coordinates somitogenesis and left-right patterning in vertebrate embryos	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; CHICK-EMBRYO; SEGMENTATION CLOCK; NODAL EXPRESSION; SOMITE FORMATION; MOUSE; INFORMATION; PATHWAYS; GENE; BUD	A striking feature of the body plan of a majority of animals is bilateral symmetry. Almost nothing is known about the mechanisms controlling the symmetrical arrangement of the left and right body sides during development. Here we report that blocking the production of retinoic acid ( RA) in chicken embryos leads to a desynchronization of somite formation between the two embryonic sides, demonstrated by a shortened left segmented region. This defect is linked to a loss of coordination of the segmentation clock oscillations(1). The lateralization of this defect led us to investigate the relation between somitogenesis and the left - right asymmetry machinery(2,3) in RA-deficient embryos. Reversal of the situs in chick(4,5) or mouse(6) embryos lacking RA results in a reversal of the somitogenesis laterality defect. Our data indicate that RA is important in buffering the lateralizing influence of the left - right machinery, thus permitting synchronization of the development of the two embryonic sides.	Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Pourquie, O (corresponding author), Stowers Inst Med Res, 1000E 50th St, Kansas City, MO 64110 USA.	olp@stowers-institute.org	Vermot, Julien/I-6568-2016; Pourquié, Olivier/CAJ-5443-2022	Pourquié, Olivier/0000-0001-5189-1227; , Julien/0000-0002-8924-732X				Adachi H, 1999, GENE DEV, V13, P1589, DOI 10.1101/gad.13.12.1589; BRUECKNER M, 1989, P NATL ACAD SCI USA, V86, P5035, DOI 10.1073/pnas.86.13.5035; Buchberger A, 1998, DEV BIOL, V199, P201, DOI 10.1006/dbio.1998.8919; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 1997, DEV BIOL, V189, P57, DOI 10.1006/dbio.1997.8662; Maden M, 1998, DEVELOPMENT, V125, P4133; Maden M, 2000, INT J DEV BIOL, V44, P151; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Pagan-Westphal SM, 1998, CELL, V93, P25, DOI 10.1016/S0092-8674(00)81143-5; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Raya A, 2004, CURR OPIN GENET DEV, V14, P575, DOI 10.1016/j.gde.2004.07.011; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Schubert M, 2001, DEV BIOL, V240, P262, DOI 10.1006/dbio.2001.0460; Stratford T, 1996, CURR BIOL, V6, P1124, DOI 10.1016/S0960-9822(02)70679-9; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363	29	184	193	3	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					215	220		10.1038/nature03488	http://dx.doi.org/10.1038/nature03488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889094				2022-12-28	WOS:000229021100043
J	Brogly, S; Williams, P; Seage, GR; Oleske, JM; Van Dyke, R; McIntosh, K				Brogly, S; Williams, P; Seage, GR; Oleske, JM; Van Dyke, R; McIntosh, K		PACTG 219C Team	Antiretroviral treatment in pediatric HIV infection in the United States - From clinical trials to clinical practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEASE INHIBITOR INDINAVIR; RANDOMIZED CONTROLLED-TRIAL; COMBINATION THERAPY; TYPE-1 INFECTION; VIRAL LOAD; CHILDREN; ZIDOVUDINE; RITONAVIR; NEVIRAPINE	Context Antiretroviral therapy (ART) for pediatric human immunodeficiency virus (HIV) infection has evolved from simple nucleoside reverse transcriptase inhibitor (NRTI) regimens to complex combination therapies based largely on evidence from clinical trials. However, the integration of novel ART into the clinical care of pediatric HIV infection has not been examined. Objectives To describe changes in the treatment of pediatric HIV infection in the United States from 1987-2003, to assess concordance of initial regimens with US pediatric guidelines, and to identify predictors of the first regimen switch. Design, Setting, and Participants The study population included 766 perinatally HIV-infected children in the Pediatric AIDS Clinical Trials Group 219C cohort born before January 1, 2004, who had not participated in an ART clinical trial at 219C enrollment or during follow-up. Main Outcome Measures Proportion of children receiving specific ART regimens, proportion of children initiating ART according to pediatric guidelines, and time to first regimen switch (risk of switching). Results Single and dual NRTI regimens were used most frequently through 1997. In 1998, 2 years after protease inhibitors were approved for adult HIV infection and at the time pediatric guidelines were issued, regimens of highly active antiretroviral therapy including a protease inhibitor became most frequently used. From 1998-2003, 22% of children initiated ART with a regimen not recommended by pediatric guidelines. in multivariate regression, the risk of switching decreased with age at ART initiation (hazard ratio [HR], 0.96; 95% confidence interval [CI], 0.94-0.99) and increased with year of initiation (HR, 1.28; 95% Cl, 1.23-1.33). The risk of switching was higher in children who started with 1 NRTI (HR, 8.05; 95% Cl, 5.80-11.18), 2 NRTIs (HR, 4.08; 95% Cl, 3.08-5.40), or an unconventional regimen (HR, 6.23; 95% Cl, 3.36-11.54) vs children who started with a protease inhibitor-containing regimen; and in children who initiated ART at CD4 T lymphocyte percentages less than 15 vs 15 or greater (HR, 2.90; 95% Cl, 1.03-8.13). Conclusions There was a short lag between the identification of novel ART and its adoption in the pediatric community. A variety of regimens were used, including some unorthodox therapies. Important predictors of first regimen switch were identified.	Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Med & Dent New Jersey, Dept Pediat, Newark, NJ 07103 USA; Tulane Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70118 USA; Childrens Hosp Boston, Div Infect Dis, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tulane University; Harvard University; Boston Children's Hospital	Brogly, S (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, 651 Huntington Ave,FXB-607, Boston, MA 02115 USA.	sbrogly@sdac.harvard.edu	Oleske, James M/C-1951-2016	Oleske, James M/0000-0003-2305-5605; Brogly, Susan/0000-0002-2339-3287	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI041110] Funding Source: NIH RePORTER; NIAID NIH HHS [5 U01 AI41110] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bernardi S, 2000, EUR J PEDIATR, V159, P170, DOI 10.1007/s004310050045; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P1; Collier AC, 1996, NEW ENGL J MED, V334, P1011, DOI 10.1056/NEJM199604183341602; CONNOR EM, 1993, PEDIATR INFECT DIS J, V12, P513, DOI 10.1097/00006454-199306000-00011; DANNER SA, 1995, NEW ENGL J MED, V333, P1528, DOI 10.1056/NEJM199512073332303; DAquila RT, 1996, ANN INTERN MED, V124, P1019, DOI 10.7326/0003-4819-124-12-199606150-00001; *DEP HLTH HUM SERV, GUID US ANT AG HIV I; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Giaquinto C, 2002, AIDS, V16, P97, DOI 10.1097/00002030-200201040-00012; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Kirstein LM, 2002, J ACQ IMMUN DEF SYND, V29, P495, DOI 10.1097/00126334-200204150-00010; Luzuriaga K, 1997, NEW ENGL J MED, V336, P1343, DOI 10.1056/NEJM199705083361902; MARKOWITZ M, 1995, NEW ENGL J MED, V333, P1534, DOI 10.1056/NEJM199512073332304; MCCONNELL M, 2002, 14 INT AIDS C JUL 7; Melvin AJ, 1997, PEDIATR INFECT DIS J, V16, P968, DOI 10.1097/00006454-199710000-00013; Mocroft A, 2001, AIDS, V15, P185, DOI 10.1097/00002030-200101260-00007; Mueller BU, 1998, PEDIATRICS, V102, P101, DOI 10.1542/peds.102.1.101; Nachman SA, 2000, JAMA-J AM MED ASSOC, V283, P492, DOI 10.1001/jama.283.4.492; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Rutstein RM, 1997, AIDS, V11, pF107, DOI 10.1097/00002030-199712000-00004; SANDE MA, 1993, JAMA-J AM MED ASSOC, V270, P2583, DOI 10.1001/jama.270.21.2583; Starr SE, 1999, NEW ENGL J MED, V341, P1874, DOI 10.1056/NEJM199912163412502; van Roon EN, 1999, J ACQ IMMUN DEF SYND, V20, P290, DOI 10.1097/00042560-199903010-00012; VANDYKE RB, 2002, PEDIATRICS, V109, P109; Wintergerst U, 1998, PEDIATR INFECT DIS J, V17, P495, DOI 10.1097/00006454-199806000-00012; Wiznia A, 2000, AIDS RES HUM RETROV, V16, P1113, DOI 10.1089/088922200414956; *WORK GROUP ANT TH, GUID US ANT AG PED H	30	47	48	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2213	2220		10.1001/jama.293.18.2213	http://dx.doi.org/10.1001/jama.293.18.2213			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886376	Bronze			2022-12-28	WOS:000228981100022
J	Blank, S; Schillinger, JA; Harbatkin, D				Blank, S; Schillinger, JA; Harbatkin, D			Lymphogranuloma venereum in the industrialised world	LANCET			English	Editorial Material									New York City Dept Hlth & Mental Hyg, Bur Sexually Transmitted Dis Control, New York, NY 10013 USA; Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA; Callen Lorde Community Hlth Ctr, New York, NY USA	New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA	Blank, S (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Sexually Transmitted Dis Control, New York, NY 10013 USA.	sblank@health.nyc.gov						*CDC, 2004, MMWR-MORBID MORTAL W, V53, P955; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; GOTZ HM, 2004, EURASURVEILLANC 0122; *HLTH PROT AG, 2005, CDR WKLY        0415; Koo D, 1996, J Public Health Manag Pract, V2, P4; Nieuwenhuis RF, 2004, CLIN INFECT DIS, V39, P996, DOI 10.1086/423966; PERINE PL, 1999, SEXUALLY TRANSMITTED, P423	7	33	33	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 7	2005	365	9471					1607	1608		10.1016/S0140-6736(05)66490-2	http://dx.doi.org/10.1016/S0140-6736(05)66490-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885284				2022-12-28	WOS:000228933700009
J	Smith, GD; Ebrahim, S				Smith, GD; Ebrahim, S			What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; ALCOHOL; RISK; GENE; ASSOCIATIONS; CAUSALITY		Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Smith, GD (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	zetkin@bristol.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314				[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; Austin MA, 2004, AM J EPIDEMIOL, V160, P421, DOI 10.1093/aje/kwh237; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Brennan P, 2004, INT J EPIDEMIOL, V33, P17, DOI 10.1093/ije/dyh033; BURR ML, 1986, BRIT J NUTR, V56, P81, DOI 10.1079/BJN19860087; Cherry N, 2002, LANCET, V359, P763, DOI 10.1016/S0140-6736(02)07847-9; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DYER AR, 1981, CIRCULATION, V64, P20; ENOMOTO N, 1991, ALCOHOL CLIN EXP RES, V15, P141, DOI 10.1111/j.1530-0277.1991.tb00532.x; Frederiksen J, 2004, BLOOD, V104, P3046, DOI 10.1182/blood-2004-03-0897; HASKELL WL, 1984, NEW ENGL J MED, V310, P805, DOI 10.1056/NEJM198403293101301; Katan MB, 2004, INT J EPIDEMIOL, V33, P10, DOI 10.1093/ije/dyh023; Keavney B, 2004, INT J EPIDEMIOL, V33, P11, DOI 10.1093/ije/dyh056; Keavney B, 2002, INT J EPIDEMIOL, V31, P730, DOI 10.1093/ije/31.4.730; Klipstein-Grobusch K, 1999, AM J CLIN NUTR, V69, P261; Lawlor DA, 2004, INT J EPIDEMIOL, V33, P464, DOI 10.1093/ije/dyh124; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Le Fanu J., 1999, RISE FALL MODERN MED; Little J, 2003, LANCET, V362, P930, DOI 10.1016/S0140-6736(03)14396-6; Marks D, 2003, ATHEROSCLEROSIS, V168, P1, DOI 10.1016/S0021-9150(02)00330-1; ROSE G, 1982, BRIT MED J, V284, P1600, DOI 10.1136/bmj.284.6329.1600; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2004, QJM-INT J MED, V97, P163, DOI 10.1093/qjmed/hch025; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; Takagi S, 2002, HYPERTENS RES, V25, P677; Tobin MD, 2004, INT J EPIDEMIOL, V33, P26, DOI 10.1093/ije/dyh016; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; WALLACE RB, 1981, CIRCULATION, V64, P41; WILLETT WC, 1990, NUTR REV, V48, P201, DOI 10.1111/j.1753-4887.1990.tb02936.x; LDL RECEPTOR MUTATIO	34	278	283	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2005	330	7499					1076	1079		10.1136/bmj.330.7499.1076	http://dx.doi.org/10.1136/bmj.330.7499.1076			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925YY	15879400	Green Accepted, Green Published			2022-12-28	WOS:000229090900029
J	McCammon, C				McCammon, C			The paradox of mantle redox	SCIENCE			English	Editorial Material							FERRIC IRON; OXIDATION-STATE; HISTORY; EARTH		Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany	University of Bayreuth	McCammon, C (corresponding author), Univ Bayreuth, Bayer Geoinst, POB 101251, D-95440 Bayreuth, Germany.	cather-ine.mccammon@uni-bayreuth.de	McCammon, Catherine/B-4983-2010	McCammon, Catherine/0000-0001-5680-9106				Canil D, 1997, NATURE, V389, P842, DOI 10.1038/39860; CANIL D, 1994, EARTH PLANET SC LETT, V123, P205, DOI 10.1016/0012-821X(94)90268-2; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; Holland HD., 1984, CHEM EVOLUTION ATMOS; Kasting JF, 2001, SCIENCE, V293, P819, DOI 10.1126/science.1063811; Li ZXA, 2004, EARTH PLANET SC LETT, V228, P483, DOI 10.1016/j.epsl.2004.10.006; McCammon C, 1997, SCIENCE, V278, P434, DOI 10.1126/science.278.5337.434; McCammon C, 1997, NATURE, V387, P694, DOI 10.1038/42685; MCCAMMON C, IN PRESS STRUCTURE C; ONEILL HSC, 1993, AM MINERAL, V78, P456; RINGWOOD AE, 1966, GEOCHIM COSMOCHIM AC, V30, P41, DOI 10.1016/0016-7037(66)90090-1; WOOD BJ, 1990, SCIENCE, V248, P337, DOI 10.1126/science.248.4953.337	14	126	136	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					807	808		10.1126/science.1110532	http://dx.doi.org/10.1126/science.1110532			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879203				2022-12-28	WOS:000228986500032
J	Anderson, B; Cole, WW; Barrett, SCH				Anderson, B; Cole, WW; Barrett, SCH			Specialized bird perch aids cross-pollination	NATURE			English	Editorial Material									Univ KwaZulu Natal, Sch Bot & Zool, ZA-3209 Pietermaritzburg, South Africa; Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada	University of Kwazulu Natal; University of Toronto	Anderson, B (corresponding author), Univ KwaZulu Natal, Sch Bot & Zool, Private Bag X01, ZA-3209 Pietermaritzburg, South Africa.	barrett@botany.utoronto.ca	Barrett, Spencer C.H./S-5782-2019; Barrett, Spencer CH/M-3751-2013; ANDERSON, BRUCE/E-5853-2011	Barrett, Spencer C.H./0000-0002-7762-3455; Anderson, Bruce/0000-0002-7264-4505				Barrett SCH, 1996, TRENDS ECOL EVOL, V11, P73, DOI 10.1016/0169-5347(96)81046-9; BROWN NE, 1932, T ROY SOC S AFR, V20, P261; Goldblatt Peter, 1999, Adansonia (Paris), V21, P25; WESTERKAMP C, 1990, BOT ACTA, V103, P366, DOI 10.1111/j.1438-8677.1990.tb00176.x	4	51	52	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					41	42		10.1038/435041a	http://dx.doi.org/10.1038/435041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875009				2022-12-28	WOS:000228864600031
J	Carragee, EJ				Carragee, EJ			Persistent low back pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED TRIAL; HIGH-INTENSITY ZONE; CLINICAL-TRIAL; LUMBAR SPINE; PROVOCATIVE DISCOGRAPHY; ASYMPTOMATIC SUBJECTS; THERAPY; DISABILITY; INJECTIONS; EXERCISES		Stanford Univ, Sch Med, Dept Orthoped Surg, Stanford, CA 94305 USA	Stanford University	Carragee, EJ (corresponding author), Stanford Univ, Sch Med, Dept Orthoped Surg, R171 Edwards Bldg, Stanford, CA 94305 USA.	carragee@stanford.edu						APRILL C, 1992, BRIT J RADIOL, V65, P361, DOI 10.1259/0007-1285-65-773-361; Assendelft WJJ, 2003, ANN INTERN MED, V138, P871, DOI 10.7326/0003-4819-138-11-200306030-00008; Barendse GAM, 2001, SPINE, V26, P287, DOI 10.1097/00007632-200102010-00014; BIGOS SJ, 1991, SPINE, V16, P1, DOI 10.1097/00007632-199101000-00001; BIGOS SJ, 1991, SPINE, V16, P669, DOI 10.1097/00007632-199106000-00017; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Boos N, 2000, SPINE, V25, P1484, DOI 10.1097/00007632-200006150-00006; Borenstein DG, 2001, J BONE JOINT SURG AM, V83A, P1306, DOI 10.2106/00004623-200109000-00002; Brox JI, 2003, SPINE, V28, P1913; Buchbinder R, 2004, BRIT MED J, V328, P321, DOI 10.1136/bmj.328.7435.321; BURTON AK, 1995, SPINE, V20, P722, DOI 10.1097/00007632-199503150-00014; Cairns MC, 2003, SPINE, V28, P953, DOI 10.1097/00007632-200305010-00021; CARETTE S, 1991, NEW ENGL J MED, V325, P1002, DOI 10.1056/NEJM199110033251405; CARRAGEE E, 2003, P 30 ANN M INT SOC S; CARRAGEE E, IN PRESS SPINE; CARRAGEE E, 2004, P 19 ANN M N AM SPIN, P216; Carragee E J, 2001, Spine J, V1, P198; Carragee EJ, 2000, SPINE, V25, P2987, DOI 10.1097/00007632-200012010-00005; Carragee EJ, 2000, SPINE, V25, P3065, DOI 10.1097/00007632-200012010-00014; Carragee EJ, 1999, SPINE, V24, P2542, DOI 10.1097/00007632-199912010-00017; Carragee EJ, 2000, SPINE, V25, P1373, DOI 10.1097/00007632-200006010-00009; Carragee Eugene J, 2005, Spine J, V5, P24, DOI 10.1016/j.spinee.2004.05.250; Cassidy JD, 1998, SPINE, V23, P1860, DOI 10.1097/00007632-199809010-00012; Cassidy JD, 2003, SPINE, V28, P1002, DOI 10.1097/00007632-200305150-00008; Cherkin DC, 2003, ANN INTERN MED, V138, P898, DOI 10.7326/0003-4819-138-11-200306030-00011; Coats TL, 2004, CLIN THER, V26, P1249, DOI 10.1016/S0149-2918(04)80081-X; Dechow E, 1999, RHEUMATOLOGY, V38, P1255, DOI 10.1093/rheumatology/38.12.1255; DEYO RA, 1986, NEW ENGL J MED, V315, P1064, DOI 10.1056/NEJM198610233151705; Deyo RA, 2004, NEW ENGL J MED, V350, P722, DOI 10.1056/NEJMsb031771; Dreyfuss P, 2000, SPINE, V25, P1270, DOI 10.1097/00007632-200005150-00012; FAIRBANK J, 2004, P 31 ANN M INT SOC S, P38; FREEMAN BJ, 2004, J BONE JOINT SURG BR, V86, P484; Fritzell P, 2001, SPINE, V26, P2521, DOI 10.1097/00007632-200112010-00002; Gilbert FJ, 2004, RADIOLOGY, V231, P343, DOI 10.1148/radiol.2312030886; Goldstein Michael S, 2002, Spine J, V2, P391, DOI 10.1016/S1529-9430(02)00414-X; Guzman J, 2002, COCHRANE DB SYST REV, V1, P1, DOI [10.1002/14651858.CD000963, DOI 10.1002/14651858.CD000963]; Huang RC, 2004, SPINE, V29, P2538, DOI 10.1097/01.brs.0000144829.57885.20; Hurwitz EL, 2002, SPINE, V27, P2193, DOI 10.1097/00007632-200210150-00002; Hurwitz EL, 2003, J CLIN EPIDEMIOL, V56, P463, DOI 10.1016/S0895-4356(03)00010-6; Ito M, 1998, SPINE, V23, P1252, DOI 10.1097/00007632-199806010-00016; Jarvik JJ, 2001, SPINE, V26, P1158, DOI 10.1097/00007632-200105150-00014; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Khot A, 2004, SPINE, V29, P833, DOI 10.1097/00007632-200404150-00002; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; Leclaire R, 2001, SPINE, V26, P1411, DOI 10.1097/00007632-200107010-00003; Madan S, 2002, J SPINAL DISORD TECH, V15, P245, DOI 10.1097/00024720-200206000-00014; Mannion AF, 1999, SPINE, V24, P2435, DOI 10.1097/00007632-199912010-00004; Nelemans PJ, 2001, SPINE, V26, P501, DOI 10.1097/00007632-200103010-00014; Niemisto L, 2003, SPINE, V28, P2185, DOI 10.1097/01.BRS.0000085096.62603.61; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; OSTELO RW, 2005, COCHRANE DB SYST REV, V1; Pauza Kevin J, 2004, Spine J, V4, P27, DOI 10.1016/j.spinee.2003.07.001; Salerno SM, 2002, ARCH INTERN MED, V162, P19, DOI 10.1001/archinte.162.1.19; SCHONSTEIN E, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001822; SKOVRON ML, 1994, SPINE, V19, P129, DOI 10.1097/00007632-199401001-00002; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Staal JB, 2004, ANN INTERN MED, V140, P77, DOI 10.7326/0003-4819-140-2-200401200-00007; Staiger TO, 2003, SPINE, V28, P2540, DOI 10.1097/01.BRS.0000092372.73527.BA; van Kleef M, 2001, Spine (Phila Pa 1976), V26, pE163, DOI 10.1097/00007632-200104010-00036; van Kleef M, 1999, SPINE, V24, P1937, DOI 10.1097/00007632-199909150-00013; van Tulder M W, 2003, Cochrane Database Syst Rev, pCD004252; van Tulder MW, 2001, SPINE, V26, P270, DOI 10.1097/00007632-200102010-00012; van Tulder MW, 2000, SPINE, V25, P2501, DOI 10.1097/00007632-200010010-00013; van Tulder MW, 2000, COCHRANE DB SYST REV, V2; VANKLEEF M, 2000, SPINE, V25, P1270; Weinstein JN, 2000, SPINE, V25, P1; Weishaupt D, 2001, RADIOLOGY, V218, P420, DOI 10.1148/radiology.218.2.r01fe15420; WONG DA, 2000, UNREMITTING LOW BACK, P96; Yelland MJ, 2004, SPINE, V29, P9, DOI 10.1097/01.BRS.0000105529.07222.5B; Zigler JE, 2003, SPINE, V28, pS163, DOI 10.1097/00007632-200310151-00009	70	128	142	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1891	1898		10.1056/NEJMcp042054	http://dx.doi.org/10.1056/NEJMcp042054			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872204				2022-12-28	WOS:000228858600009
J	Hetzel, R; Hampel, A				Hetzel, R; Hampel, A			Slip rate variations on normal faults during glacial-interglacial changes in surface loads	NATURE			English	Article							EASTERN GREAT-BASIN; SAN-ANDREAS FAULT; WASATCH FAULT; LAKE BONNEVILLE; UPPER-MANTLE; UTAH; DEFORMATION; EARTHQUAKES; ZONE; MODEL	Geologic and palaeoseismological data(1,2) document a marked increase in the slip rates of the Wasatch fault and three adjacent normal faults in the Basin and Range Province during the Late Pleistocene/Early Holocene epochs(3). The cause of this synchronous acceleration of fault slip and the subsequent clustering of earthquakes during the Holocene(3) has remained enigmatic, although it has been suggested that the coincidence between the acceleration of slip and the shrinkage of Lake Bonneville after the Last Glacial Maximum may indicate a causal relationship(4). Here we use finite-element models of a discrete normal fault within a rheologically layered lithosphere to evaluate the relative importance of two competing processes that affect fault slip: postglacial unloading ( the removal of mass), which decreases the slip rate, and lithospheric rebound, which promotes faster slip. We show that lithospheric rebound caused by regression of Lake Bonneville(4-6) and deglaciation of adjacent mountain ranges(7,8) provides a feasible mechanism for the high Holocene rates of faulting in the Wasatch region. Our analysis implies that climate-controlled changes in loads applied to Earth's surface may exert a fundamental control on the slip history of individual normal faults.	ETH, Inst Geol, Dept Earth Sci, CH-8092 Zurich, Switzerland; Univ Bern, Inst Geol Sci, CH-3012 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern	Hetzel, R (corresponding author), Univ Munster, Inst Geol Palaontol, Corrensstr 24, D-48149 Munster, Germany.	rahetzel@uni-muenster.de						BILLS BG, 1987, J GEOPHYS RES-SOLID, V92, P11493, DOI 10.1029/JB092iB11p11493; BILLS BG, 1994, J GEOPHYS RES-SOL EA, V99, P22059, DOI 10.1029/94JB01192; Ehlers TA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001723; Ellis S, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002744; Friedrich AM, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000682; GRANT LB, 1994, J GEOPHYS RES-SOL EA, V99, P6819, DOI 10.1029/94JB00125; *HIBB KARLS SOR IN, 2002, ABAQUS STAND US MAN; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; JOHNSTON AC, 1989, NATO ADV SCI I C-MAT, V266, P581; MACHETTE MN, 1991, J STRUCT GEOL, V13, P137, DOI 10.1016/0191-8141(91)90062-N; MADSEN DB, 1979, QUATERNARY RES, V12, P254, DOI 10.1016/0033-5894(79)90061-9; Malservisi R, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017408; Marco S, 1996, J GEOPHYS RES-SOL EA, V101, P6179, DOI 10.1029/95JB01587; Martinez LJ, 1998, GEOPHYS RES LETT, V25, P567, DOI 10.1029/98GL00090; McCalpin JP, 1996, J GEOPHYS RES-SOL EA, V101, P6233, DOI 10.1029/95JB02851; Osborn G, 2001, QUATERNARY SCI REV, V20, P1377, DOI 10.1016/S0277-3791(01)00002-6; OVIATT CG, 1992, PALAEOGEOGR PALAEOCL, V99, P225, DOI 10.1016/0031-0182(92)90017-Y; PARRY WT, 1986, J GEOPHYS RES-SOLID, V91, P730, DOI 10.1029/JB091iB01p00730; REID HF, 1910, PUBL CALIF STATE EAR, V87; SCHWARTZ DP, 1984, J GEOPHYS RES, V89, P5681, DOI 10.1029/JB089iB07p05681; SHIMAZAKI K, 1980, GEOPHYS RES LETT, V7, P279, DOI 10.1029/GL007i004p00279; Smith R. B, 1989, GEOL SOC AM MEM, V172, P205; Stewart IS, 2000, QUATERNARY SCI REV, V19, P1367, DOI 10.1016/S0277-3791(00)00094-9; THATCHER W, 1984, J GEOPHYS RES, V89, P5674, DOI 10.1029/JB089iB07p05674; WALLACE RE, 1987, B SEISMOL SOC AM, V77, P868; Watts A.B., 2001, ISOSTASY FLEXURE LIT; WERNICKE B, 1988, GEOL SOC AM BULL, V100, P1738, DOI 10.1130/0016-7606(1988)100<1738:BARETA>2.3.CO;2; Wernicke B, 1998, INT GEOL REV, V40, P403, DOI 10.1080/00206819809465217; Wu P, 1996, GEOPHYS J INT, V125, P415, DOI 10.1111/j.1365-246X.1996.tb00008.x; Wu P, 1999, GEOPHYS J INT, V139, P657, DOI 10.1046/j.1365-246x.1999.00963.x	30	124	126	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					81	84		10.1038/nature03562	http://dx.doi.org/10.1038/nature03562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875019				2022-12-28	WOS:000228864600041
J	Ravitsky, V; Wendler, D				Ravitsky, V; Wendler, D			Dissolving the dilemma over forced treatment	LANCET			English	Editorial Material							LIMITS		NIH, Dept Clin Bioeth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Wendler, D (corresponding author), NIH, Dept Clin Bioeth, Bldg 10, Bethesda, MD 20892 USA.	dwendler@nih.gov						Appelbaum P, 1998, ASSESSING COMPETENCE; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Barilan YM, 2001, J MED PHILOS, V26, P13; BERG JW, 2001, INFORMED CONSENT LEG; Buchanan AE, 1990, DECIDING OTHERS ETHI; Gross ML, 2005, J MED ETHICS, V31, P29, DOI 10.1136/jme.2002.000877	6	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1525	1526		10.1016/S0140-6736(05)66436-7	http://dx.doi.org/10.1016/S0140-6736(05)66436-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866294				2022-12-28	WOS:000228754800009
J	Benderly, BL				Benderly, BL			Not your father's postdoc	SCIENCE			English	Editorial Material																			0	11	11	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2005	308	5722					717	718		10.1126/science.308.5722.717	http://dx.doi.org/10.1126/science.308.5722.717			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860631				2022-12-28	WOS:000228810900053
J	Brown, SA; Ripperger, J; Kadener, S; Fleury-Olela, F; Vilbois, F; Rosbash, M; Schibler, U				Brown, SA; Ripperger, J; Kadener, S; Fleury-Olela, F; Vilbois, F; Rosbash, M; Schibler, U			PERIOD1-associated proteins modulate the negative limb of the mammalian circadian oscillator	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; COURTSHIP SONG; CLOCK; CELLS	The clock proteins PERIOD1 (PER1) and PERIOD2 (PER2) play essential roles in a negative transcriptional feedback loop that generates circadian rhythms in mammalian cells. We identified two PER1-associated factors, NONO and WDR5, that modulate PER activity. The reduction of NONO expression by RNA interference (RNAi) attenuated circadian rhythms in mammalian cells, and fruit flies carrying a hypomorphic allele were nearly arrhythmic. WDR5, a subunit of histone methyltransferase complexes, augmented PER-mediated transcriptional repression, and its reduction by RNAi diminished circadian histone methylations at the promoter of a clock gene.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; Univ Geneva, Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland; Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA; Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland	University of Geneva; University of Geneva; Brandeis University; Howard Hughes Medical Institute	Brown, SA (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	steven.brown@molbio.unige.ch; Ueli.schibler@molbio.unige.ch	Brown, Steven/E-4955-2013					Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; RENDAHL KG, 1992, J NEUROSCI, V12, P390; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; STANEWSKY R, 1993, GENETICS, V135, P419; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	18	212	231	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					693	696		10.1126/science.1107373	http://dx.doi.org/10.1126/science.1107373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860628				2022-12-28	WOS:000228810900050
J	Schmitt, RW; Ledwell, JR; Montgomery, ET; Polzin, KL; Toole, JM				Schmitt, RW; Ledwell, JR; Montgomery, ET; Polzin, KL; Toole, JM			Enhanced diapycnal mixing by salt fingers in the thermocline of the tropical Atlantic	SCIENCE			English	Article							TRACER-RELEASE EXPERIMENT; THERMOHALINE STAIRCASE; TURBULENT DISSIPATION; ABYSSAL OCEAN; WATER MASSES; PACIFIC; MICROSTRUCTURE; PYCNOCLINE; DIFFUSION	Diapycnal mixing plays a significant role in the ocean's circulation and uptake of heat and carbon dioxide, but has not been quantified in salt finger-driven thermohaline staircases. We recently performed a tracer release experiment in the western tropical Atlantic staircase at similar to 400 m depth. The observed dispersion implies an effective diapycnal diffusivity for tracer and salt of 0.8 to 0.9 x 10(-4) m(2)/s. Temperature microstructure data interpreted in terms of a vertical production-dissipation balance yields a smaller effective diffusivity for heat of 0.45 (+/- 0.2) x 10(-4) m(2)/s, consistent with salt fingers and well above the mixing ascribable to mechanical turbulence.	Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Schmitt, RW (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	rschmitt@whoi.edu	Schmitt, Raymond W/B-7451-2011	Toole, John/0000-0003-2905-0637; Montgomery, Ellyn/0000-0002-9354-4220				BOYD JD, 1987, DEEP-SEA RES, V34, P337, DOI 10.1016/0198-0149(87)90142-7; FERRARI R, IN PRESS J PHYS OCEA; GARGETT AE, 1982, J GEOPHYS RES-OCEANS, V87, P8017, DOI 10.1029/JC087iC10p08017; GARRETT C, 1982, J PHYS OCEANOGR, V12, P952, DOI 10.1175/1520-0485(1982)012<0952:OTPODF>2.0.CO;2; GREGG MC, 1987, DEEP-SEA RES, V34, P1689, DOI 10.1016/0198-0149(87)90017-3; GREGG MC, 1989, J GEOPHYS RES-OCEANS, V94, P9686, DOI 10.1029/JC094iC07p09686; JOYCE TM, 1977, J PHYS OCEANOGR, V7, P626, DOI 10.1175/1520-0485(1977)007<0626:ANOTLM>2.0.CO;2; KUNZE E, 1987, DEEP-SEA RES, V34, P1697, DOI 10.1016/0198-0149(87)90018-5; KUZNE E, 1995, GEOPHYS MONOGR, V94, P313; LAMBERT RB, 1977, DEEP-SEA RES, V24, P211, DOI 10.1016/S0146-6291(77)80001-5; Ledwell JR, 2000, NATURE, V403, P179, DOI 10.1038/35003164; Ledwell JR, 1998, J GEOPHYS RES-OCEANS, V103, P21499, DOI 10.1029/98JC01738; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; LUECK RG, 1987, DEEP-SEA RES, V34, P1677, DOI 10.1016/0198-0149(87)90016-1; MARMORINO GO, 1987, DEEP-SEA RES, V34, P1667, DOI 10.1016/0198-0149(87)90015-X; McDougall T. J., 1988, ELSEVIER OCEANOGR SE, V46, P21; MCDOUGALL TJ, 1991, DEEP-SEA RES, V38, P367; Merryfield WJ, 2000, J PHYS OCEANOGR, V30, P1046, DOI 10.1175/1520-0485(2000)030<1046:OOTS>2.0.CO;2; Osborn T. R., 1972, Geophysical Fluid Dynamics, V3, P321, DOI 10.1080/03091927208236085; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; POLZIN KL, 1995, J PHYS OCEANOGR, V25, P306, DOI 10.1175/1520-0485(1995)025<0306:FPOTD>2.0.CO;2; Polzin KL, 1997, SCIENCE, V276, P93, DOI 10.1126/science.276.5309.93; RUDDICK B, 1992, J PHYS OCEANOGR, V22, P1274, DOI 10.1175/1520-0485(1992)022<1274:IMIAMS>2.0.CO;2; Schmitt R. W., 1988, Journal of Atmospheric and Oceanic Technology, V5, P484, DOI 10.1175/1520-0426(1988)005<0484:TDOAFA>2.0.CO;2; Schmitt R.W., 1988, SMALL SCALE TURBULEN, P435, DOI [10.1016/S0422-9894(08)70563-4, DOI 10.1016/S0422-9894(08)70563-4]; SCHMITT RW, 1979, DEEP-SEA RES, V26, P23, DOI 10.1016/0198-0149(79)90083-9; SCHMITT RW, 1994, ANNU REV FLUID MECH, V26, P255, DOI 10.1146/annurev.fl.26.010194.001351; SCHMITT RW, 1981, J PHYS OCEANOGR, V11, P1015, DOI 10.1175/1520-0485(1981)011<1015:FOTTSR>2.0.CO;2; SCHMITZ WJ, 1993, B MAR SCI, V53, P1048; St Laurent L, 1999, J PHYS OCEANOGR, V29, P1404, DOI 10.1175/1520-0485(1999)029<1404:TCOSFT>2.0.CO;2; STERN ME, 1960, TELLUS, V12, P172, DOI 10.1111/j.2153-3490.1960.tb01295.x; STERN ME, 1967, DEEP-SEA RES, V14, P747, DOI 10.1016/S0011-7471(67)80011-1; Toole J. M., 1981, Progress in Oceanography, V10, P123, DOI 10.1016/0079-6611(81)90003-3; Tsuchiya M, 1998, J GEOPHYS RES-OCEANS, V103, P12899, DOI 10.1029/97JC03415; Wong APS, 2003, J PHYS OCEANOGR, V33, P1493, DOI 10.1175/1520-0485(2003)033<1493:SPESMW>2.0.CO;2	35	124	132	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2005	308	5722					685	688		10.1126/science.1108678	http://dx.doi.org/10.1126/science.1108678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860625				2022-12-28	WOS:000228810900047
J	Gollogly, S				Gollogly, S			Do as I say, not as I do	LANCET			English	Editorial Material																			0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1499	1499		10.1016/S0140-6736(05)66421-5	http://dx.doi.org/10.1016/S0140-6736(05)66421-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850635				2022-12-28	WOS:000228651600029
J	Mutabingwa, TK; Anthony, D; Heller, A; Hallett, R; Ahmed, J; Drakeley, C; Greenwood, BM; Whitty, CJM				Mutabingwa, TK; Anthony, D; Heller, A; Hallett, R; Ahmed, J; Drakeley, C; Greenwood, BM; Whitty, CJM			Amodiaquine alone, amodiaquine plus sulfadoxine-pyrimethamine, amodiaquine plus artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial	LANCET			English	Article							PLASMODIUM-FALCIPARUM MALARIA; EFFICACY; COMBINATION; CHLOROQUINE; ADHERENCE; DAPSONE	Background Many countries in Africa are considering a change to combination treatment for falciparum malaria because of the increase in drug resistance. However, there are few effectiveness data for these combinations. Our aim was to study the effectiveness of three drug combinations that have proven efficacious in east Africa compared with amodiaquine monotherapy. Methods We undertook a randomised trial of antimalarial drug combinations for children (aged 4-59 months) with uncomplicated malaria in Muheza, Tanzania, an area with a high prevalence of resistance to sulfadoxine-pyrimethamine and chloroquine. Children were randomly allocated 3 days of amodiaquine (n=270), amodiaquine +sulfadoxine-pyrimethamine (n=507), or amodiaquine+artesunate (n=515), or a 3-day six-dose regimen of artemether-lumefantrine (n=519). Drugs were taken orally, at home, unobserved by medical staff. The primary endpoint was parasitological failure by day 14 assessed blind to treatment allocation. Secondary endpoints included day 28 follow-up and gametocyte carriage. Analysis was by intention to treat. Findings Of 3158 children screened, 1811 were randomly assigned treatment and 1717 (95%) reached the 14-day follow-up. The amodiaquine group was stopped early by the data and safety monitoring board. By day 14, the parasitological failure rates were 103 of 248 (42%) for amodiaquine, 97 of 476 (20%) for amodiaquine+sulfadoxine-pyrimethamine, 54 of 491 (11%) for amodiaquine+artesunate, and seven of 502 (1%) for artemether-lumefantrine. By day 28, the parasitological failure rates were 182 of 239 (76%), 282 of 476 (61%), 193 of 472 (40%), and 103 of 485 (21%), respectively. The difference between individual treatment groups and the next best treatment combination was significant (p<0.001) in every case. Recrudescence rates by day 28, after correction by genotyping, were 48.4%, 34.5%, 11.2%, and 2.8%, respectively. Interpretation The study shows how few the options are for treating malaria where there is already a high level of resistance to sulfadoxine-pyrimethamine and amodiaquine. The WHO-packaged six-dose regimen of artemetherlumefantrine is effective taken unsupervised, although cost is a major limitation.	London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1B 3DP, England; Natl Inst Med Res, Dar Es Salaam, Tanzania; Muheza Designated Dist Hosp, Teule Hosp, Muheza, Tanga Region, Tanzania; Joint Malaria Programme, Moshi, Tanzania	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Whitty, CJM (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, 50 Bedford Sq, London WC1B 3DP, England.	c.whitty@lshtm.ac.uk	Whitty, Christopher/C-7740-2012	Whitty, Christopher/0000-0002-6076-5027				Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Amin AA, 2004, TROP MED INT HEALTH, V9, P967, DOI 10.1111/j.1365-3156.2004.01291.x; [Anonymous], 2003, ASS MON ANT DRUG EFF; Ansah EK, 2001, TROP MED INT HEALTH, V6, P496, DOI 10.1046/j.1365-3156.2001.00740.x; Arrow KJ, 2004, SAVING LIVES BUYING, P388; Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5; Cattamanchi A, 2003, AM J TROP MED HYG, V68, P133, DOI 10.4269/ajtmh.2003.68.133; Depoortere E, 2005, TROP MED INT HEALTH, V10, P139, DOI 10.1111/j.1365-3156.2004.01363.x; Fogg C, 2004, AM J TROP MED HYG, V71, P525, DOI 10.4269/ajtmh.2004.71.525; Hien TT, 2004, LANCET, V363, P18, DOI 10.1016/S0140-6736(03)15163-X; Mutabingwa T, 2001, LANCET, V358, P1218, DOI 10.1016/S0140-6736(01)06344-9; Mutabingwa TK, 2001, T ROY SOC TROP MED H, V95, P433, DOI 10.1016/S0035-9203(01)90207-X; Omari AA, 2004, TROP MED INT HEALTH, V9, P192, DOI 10.1046/j.1365-3156.2003.01186.x; Rapuoda B, 2003, TROP MED INT HEALTH, V8, P860, DOI 10.1046/j.1360-2276.2003.01114.x; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rwagacondo CE, 2003, AM J TROP MED HYG, V68, P743, DOI 10.4269/ajtmh.2003.68.743; Schellenberg D, 2002, AM J TROP MED HYG, V67, P17, DOI 10.4269/ajtmh.2002.67.17; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Staedke SG, 2004, LANCET, V364, P1950, DOI 10.1016/S0140-6736(04)17478-3; Sutherland CJ, 2003, AM J TROP MED HYG, V69, P19, DOI 10.4269/ajtmh.2003.69.19; SUTHERLAND CJ, IN PRESS PLOS MED; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; Whitty CJM, 2004, B WORLD HEALTH ORGAN, V82, P381; *WHO, T R SOC TROP MED HYG, V94, pS1; *WHO, 2001, ANT DRUG COMB THER R, P33	26	198	200	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1474	1480		10.1016/S0140-6736(05)66417-3	http://dx.doi.org/10.1016/S0140-6736(05)66417-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850631				2022-12-28	WOS:000228651600025
J	Wu, T; Malinverni, J; Ruiz, N; Kim, S; Silhavy, TJ; Kahne, D				Wu, T; Malinverni, J; Ruiz, N; Kim, S; Silhavy, TJ; Kahne, D			Identification of a multicomponent complex required for outer membrane biogenesis in Escherichia coli	CELL			English	Article							CELL-SURFACE; PROTEINS; LIPOPROTEIN; LIPOPOLYSACCHARIDE; EXPORT; GENE; K-12; LOCALIZATION; PATHWAY; SYSTEM	Gram-negative bacteria have an outer membrane (OM) that functions as a barrier to protect the cell from toxic compounds such as antibiotics and detergents. The OM is a highly asymmetric bilayer composed of phospholipids, glycolipids, and proteins. Assembly of this essential organelle occurs outside the cytoplasm in an environment that lacks obvious energy sources such as ATP, and the mechanisms involved are poorly understood. We describe the identification of a multiprotein complex required for the assembly of proteins in the OM of Escherichia coli. We also demonstrate genetic interactions between genes encoding components of this protein assembly complex and imp, which encodes a protein involved in the assembly of lipopolysaccharides (LPS) in the OM. These genetic interactions suggest a role for YfgL, one of the lipoprotein components of the protein assembly complex, in a homeostatic control mechanism that coordinates the overall OM assembly process.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Harvard Univ, Sch Med, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Princeton University; Harvard University; Princeton University; Harvard University; Harvard Medical School	Kahne, D (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	kahne@chemistry.harvard.edu	Wu, Tao/C-7533-2013; Kim, Seokhee/C-2303-2018	Kim, Seokhee/0000-0003-0806-583X; Ruiz, Natividad/0000-0002-6369-2206; Silhavy, Thomas/0000-0001-7672-5153	NIGMS NIH HHS [GM34821, GM66174] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034821, R01GM066174, R37GM034821] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAYER ME, 1968, J VIROL, V2, P346, DOI 10.1128/JVI.2.4.346-356.1968; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; BOUVIER J, 1991, J BACTERIOL, V173, P5523, DOI 10.1128/jb.173.17.5523-5531.1991; Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; FREUDL R, 1985, EMBO J, V4, P3593, DOI 10.1002/j.1460-2075.1985.tb04122.x; Fussenegger M, 1996, MOL MICROBIOL, V19, P1095, DOI 10.1046/j.1365-2958.1996.457984.x; Genevrois S, 2003, EMBO J, V22, P1780, DOI 10.1093/emboj/cdg174; GENNITY JM, 1991, J BIOL CHEM, V266, P16458; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; HALEGOUA S, 1979, J MOL BIOL, V130, P39, DOI 10.1016/0022-2836(79)90551-5; HALL MN, 1981, J MOL BIOL, V146, P23, DOI 10.1016/0022-2836(81)90364-8; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KELLENBERGER E, 1990, MOL MICROBIOL, V4, P697, DOI 10.1111/j.1365-2958.1990.tb00640.x; Kloser A, 1998, MOL MICROBIOL, V27, P1003, DOI 10.1046/j.1365-2958.1998.00746.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; METCALFE M, 1980, FEMS MICROBIOL LETT, V7, P111, DOI 10.1111/j.1574-6941.1980.tb01587.x; MISRA R, 1991, J BIOL CHEM, V266, P13592; MUHLRADT PF, 1973, EUR J BIOCHEM, V35, P471, DOI 10.1111/j.1432-1033.1973.tb02861.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; ONUFRYK C, 2005, J BACTERIOL, V25, P765; PAGES JM, 1990, BIOCHIMIE, V72, P169, DOI 10.1016/0300-9084(90)90142-4; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; RIED G, 1990, J BACTERIOL, V172, P6048, DOI 10.1128/jb.172.10.6048-6053.1990; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; SAMPSON BA, 1989, GENETICS, V122, P491; SCHWEIZER M, 1978, EUR J BIOCHEM, V82, P211, DOI 10.1111/j.1432-1033.1978.tb12013.x; SCIDMORE MA, 1993, MOL BIOL CELL, V4, P1145, DOI 10.1091/mbc.4.11.1145; SILHAVY TJ, 1984, EXPT GENE FUSIONS PL; SMIT J, 1978, J BACTERIOL, V135, P687, DOI 10.1128/JB.135.2.687-702.1978; SNYDER WB, 1995, J BACTERIOL, V177, P4216, DOI 10.1128/jb.177.15.4216-4223.1995; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; Yokota N, 1999, J BIOL CHEM, V274, P30995, DOI 10.1074/jbc.274.43.30995	43	550	561	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					235	245		10.1016/j.cell.2005.02.015	http://dx.doi.org/10.1016/j.cell.2005.02.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851030	Bronze			2022-12-28	WOS:000228705000011
J	Dejean, A; Solano, PJ; Ayroles, J; Corbara, B; Orivel, J				Dejean, A; Solano, PJ; Ayroles, J; Corbara, B; Orivel, J			Insect behaviour: Arboreal ants build traps to capture prey	NATURE			English	Editorial Material									Univ Toulouse 3, Lab Evolut & Divers Biol, CNRS, UMR 5174, F-31062 Toulouse, France; Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; Univ Clermont Ferrand, Lab Psychol Sociale Cognit, CNRS, ESA 6024, F-63037 Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); University of Illinois System; University of Illinois Urbana-Champaign; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Dejean, A (corresponding author), Univ Toulouse 3, Lab Evolut & Divers Biol, CNRS, UMR 5174, F-31062 Toulouse, France.	orivel@cict.fr	Orivel, Jerome/C-4034-2011	Orivel, Jerome/0000-0002-5636-3228; CORBARA, Bruno/0000-0003-4232-8234; Dejean, Alain/0000-0002-3561-2248				Benson WW, 1985, AMAZONIA, P239; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Dejean A, 2003, ARTHROPODS OF TROPICAL FORESTS, P341; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Holldobler B., 1990, pi; MORAIS HC, 1994, INSECT SOC, V41, P339, DOI 10.1007/BF01242307; Offenberg J, 2001, BEHAV ECOL SOCIOBIOL, V49, P304, DOI 10.1007/s002650000303; van Borm S, 2002, P ROY SOC B-BIOL SCI, V269, P2023, DOI 10.1098/rspb.2002.2101	8	88	96	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					973	973		10.1038/434973a	http://dx.doi.org/10.1038/434973a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846335				2022-12-28	WOS:000228524600026
J	Quill, TE				Quill, TE			The million dollar question	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*OR DEP HUM SERV, PHYS ASS SUIC; Tolle SW, 2004, J CLIN ETHIC, V15, P111	2	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1632	1632		10.1056/NEJMp058081	http://dx.doi.org/10.1056/NEJMp058081			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843664				2022-12-28	WOS:000228515200003
J	Wobus, C; Heimsath, A; Whipple, K; Hodges, K				Wobus, C; Heimsath, A; Whipple, K; Hodges, K			Active out-of-sequence thrust faulting in the central Nepalese Himalaya	NATURE			English	Article							MAIN CENTRAL THRUST; COSMOGENIC NUCLIDES; EROSION RATES; EVOLUTION; BE-10; PRECIPITATION; ACCUMULATION; DEFORMATION; EQUILIBRIUM; CONSTRAINTS	Recent convergence between India and Eurasia is commonly assumed to be accommodated mainly along a single fault-the Main Himalayan Thrust (MHT)-which reaches the surface in the Siwalik Hills of southern Nepal(1-3). Although this model is consistent with geodetic(4,5), geomorphic(6) and microseismic data(7), an alternative model incorporating slip on more northerly surface faults has been proposed to be consistent with these data as well(8-10). Here we present in situ cosmogenic Be-10 data indicating a fourfold increase in millennial timescale erosion rates occurring over a distance of less than 2 km in central Nepal, delineating for the first time an active thrust fault nearly 100 km north of the surface expression of the MHT. These data challenge the view that rock uplift gradients in central Nepal reflect only passive transport over a ramp in the MHT. Instead, when combined with previously reported 40Ar-39Ar data(9), our results indicate persistent exhumation above deep-seated, surface-breaking structures at the foot of the high Himalaya. These results suggest that strong dynamic interactions between climate, erosion and tectonics have maintained a locus of active deformation well to the north of the Himalayan deformation front.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA	Massachusetts Institute of Technology (MIT); Dartmouth College	Wobus, C (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	cwobus@mit.edu	Hodges, Kip/A-7992-2009; Heimsath, Arjun M/D-9214-2013	Hodges, Kip/0000-0003-2805-8899; Heimsath, Arjun/0000-0002-6300-6069; Wobus, Cameron/0000-0002-9654-1738				Beaumont C, 2001, NATURE, V414, P738, DOI 10.1038/414738a; Bierman P, 1996, EARTH SURF PROC LAND, V21, P125, DOI 10.1002/(SICI)1096-9837(199602)21:2<125::AID-ESP511>3.0.CO;2-8; Bierman PR, 2004, ANNU REV EARTH PL SC, V32, P215, DOI 10.1146/annurev.earth.32.101802.120539; Bilham R, 1997, NATURE, V386, P61, DOI 10.1038/386061a0; BROWN ET, 1995, EARTH PLANET SC LETT, V129, P193, DOI 10.1016/0012-821X(94)00249-X; Burbank DW, 2003, NATURE, V426, P652, DOI 10.1038/nature02187; Burbank DW, 1996, NATURE, V379, P505, DOI 10.1038/379505a0; Catlos EJ, 2001, J GEOPHYS RES-SOL EA, V106, P16177, DOI 10.1029/2000JB900375; Cattin R, 2000, J GEOPHYS RES-SOL EA, V105, P13389, DOI 10.1029/2000JB900032; COPELAND P, 1991, J GEOPHYS RES-SOLID, V96, P8475, DOI 10.1029/91JB00178; DeCelles PG, 2001, TECTONICS, V20, P487, DOI 10.1029/2000TC001226; Granger DE, 1996, J GEOL, V104, P249, DOI 10.1086/629823; Hodges KV, 2001, TECTONICS, V20, P799, DOI 10.1029/2001TC001281; Hodges KV, 2004, EARTH PLANET SC LETT, V220, P379, DOI 10.1016/S0012-821X(04)00063-9; Hodges KV, 2000, GEOL SOC AM BULL, V112, P324, DOI 10.1130/0016-7606(2000)112<324:TOTHAS>2.0.CO;2; JACKSON M, 1994, J GEOPHYS RES-SOL EA, V99, P13897, DOI 10.1029/94JB00714; Lave J, 2000, J GEOPHYS RES-SOL EA, V105, P5735, DOI 10.1029/1999JB900292; Lave J, 2001, J GEOPHYS RES-SOL EA, V106, P26561, DOI 10.1029/2001JB000359; NIEMI NA, 2004, EOS S, V85; PANDEY MR, 1995, GEOPHYS RES LETT, V22, P751, DOI 10.1029/94GL02971; Pandey MR, 1999, J ASIAN EARTH SCI, V17, P703, DOI 10.1016/S1367-9120(99)00034-6; Putkonen JK, 2004, ARCT ANTARCT ALP RES, V36, P244, DOI 10.1657/1523-0430(2004)036[0244:CSARDA]2.0.CO;2; Riebe CS, 2000, GEOLOGY, V28, P803, DOI 10.1130/0091-7613(2000)028<0803:EEADIT>2.3.CO;2; Roering J. J., 2001, Journal of Geophysical Research, V106, P16499, DOI 10.1029/2001JB000323; Schaller M, 2001, EARTH PLANET SC LETT, V188, P441, DOI 10.1016/S0012-821X(01)00320-X; Vance D, 2003, EARTH PLANET SC LETT, V206, P273, DOI 10.1016/S0012-821X(02)01102-0; Wobus CW, 2003, GEOLOGY, V31, P861, DOI 10.1130/G19730.1	27	249	261	1	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1008	1011		10.1038/nature03499	http://dx.doi.org/10.1038/nature03499			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846343				2022-12-28	WOS:000228524600035
J	Baker, R				Baker, R			Commentary: Can poorly performing doctors blame their assessment tools?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICIANS		Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Baker, R (corresponding author), Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester LE5 4PW, Leics, England.	rb14@le.ac.uk						Archer JC, 2005, BMJ-BRIT MED J, V330, P1251, DOI 10.1136/bmj.38447.610451.8F; Evans R, 2004, BMJ-BRIT MED J, V328, P1240, DOI 10.1136/bmj.328.7450.1240; Sargeant JM, 2003, ACAD MED, V78, pS42, DOI 10.1097/00001888-200310001-00014; Schuwirth LWT, 2002, MED EDUC, V36, P925, DOI 10.1046/j.1365-2923.2002.01313.x; Van der Vleuten CPM, 1996, ADV HEALTH SCI EDUC, V1, P41, DOI 10.1007/BF00596229	5	6	6	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2005	330	7502					1254	1254		10.1136/bmj.38469.406597.0B	http://dx.doi.org/10.1136/bmj.38469.406597.0B			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930WX	15883136	Bronze, Green Published			2022-12-28	WOS:000229448900022
J	Peile, E				Peile, E			Commentary: Quality assuring our learning from others	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Warwick, Warwick Med Sch, Div Med Educ, Coventry CV4 7AL, W Midlands, England	University of Warwick	Peile, E (corresponding author), Univ Warwick, Warwick Med Sch, Div Med Educ, Coventry CV4 7AL, W Midlands, England.	ed.peile@warwick.ac.uk						Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; Siotia AK, 2005, BRIT MED J, V330, P1068, DOI 10.1136/bmj.330.7499.1068	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 7	2005	330	7499					1070	1070		10.1136/bmj.330.7499.1070	http://dx.doi.org/10.1136/bmj.330.7499.1070			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925YY	15879397	Green Published			2022-12-28	WOS:000229090900025
J	Hey, T; Trefethen, AE				Hey, T; Trefethen, AE			Cyberinfrastructure for e-science	SCIENCE			English	Article								Here we describe the requirements of an e-Infrastructure to enable faster, better, and different scientific research capabilities. We use two application exemplars taken from the United Kingdom's e-Science Programme to illustrate these requirements and make the case for a service-oriented infrastructure. We provide a brief overview of the UK "plug-and-play composable services" vision and the role of semantics in such an e-Infrastructure.	Engn & Phys Sci Res Council, Swindon SN2 1ET, Wilts, England	UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC)	Hey, T (corresponding author), Engn & Phys Sci Res Council, Polaris House,N Star Ave, Swindon SN2 1ET, Wilts, England.			Hey, Tony/0000-0001-6782-3691				ATKINS D, REVOLUTIONIZING SCI; Berners-Lee T, 2001, SCI AM, V284, P34, DOI 10.1038/scientificamerican0501-34; Chin J, 2003, CONTEMP PHYS, V44, P417, DOI 10.1080/00107510310001605046; *CLEF, CLEF PROJ; *DAME, DAME PROJ; De Roure D, 2005, P IEEE, V93, P669, DOI 10.1109/JPROC.2004.842781; *E FAM, E FAM PROJ; *EDIAMOND, EDIAMOND PROJ; *EPSRC, EPSRC COMP SCI E SCI; Foster I, 2001, INT J HIGH PERFORM C, V15, P200, DOI 10.1177/109434200101500302; FREY JG, 2003, GRID COMPUTING MAKIN, P945; FREY JG, EUR 2002 C WEB GRID; *GENIE, GENIE PROJ; *GEWITTS, GEWITTS PROJ; Hey AJG, 2003, GRID COMPUTING MAKIN, P809, DOI DOI 10.1002/0470867167.CH36; Hey T, 2002, FUTURE GENER COMP SY, V18, P1017, DOI 10.1016/S0167-739X(02)00082-1; Hughes G, 2004, ORG BIOMOL CHEM, V2, P3284, DOI 10.1039/b410075a; Miles S., 2003, IEE Proceedings-Software, V150, P252, DOI 10.1049/ip-sen:20030812; *MYGRID, MYGRID PROJ; *NERC, NERC DATAGRID PROJ; SCHRAEFEL MC, IN PRESS P C DES INT; SCHRAEFEL MC, 2004, P ACM CHI 2004 C HUM; SEGALLER S, 1998, NERDS BRIEF HIST INT; Shadbolt N.R, 2001, RES AGENDA SEMANTIC; *SMARTTEA, SMARTTEA PROJ; STEVENS R, 2004, P C INT SYST MOL BIO; World Wide Web Consortium (W3C), 2004, WEB SERV ARCH; Wroe C, 2004, IEEE INTELL SYST, V19, P48, DOI 10.1109/MIS.2004.1265885; INTEGRATIVE BIOL PRO; LHC COMPUTING GRID	31	219	232	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					817	821		10.1126/science.1110410	http://dx.doi.org/10.1126/science.1110410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879209				2022-12-28	WOS:000228986500038
J	Kaul, DR; Flanders, SA; Saint, S				Kaul, DR; Flanders, SA; Saint, S			Clear as mud	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEPTOSPIROSIS; PENICILLIN; THERAPY; ASSAY		Methodist Hosp Indiana Inc, Indianapolis, IN USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; Dept Vet Affairs, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA	Indiana University System; University of Michigan System; University of Michigan	Kaul, DR (corresponding author), Univ Michigan, Med Ctr, Div Infect Dis, Ann Arbor, MI 48109 USA.	kauld@umich.edu	Saint, Sanjay/AAF-5126-2019		AHRQ HHS [P20-HS11540] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P20HS011540] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Covic A, 2003, NEPHROL DIAL TRANSPL, V18, P1128, DOI 10.1093/ndt/gfg095; DUNN MM, 1994, ACAD MED, V69, P683, DOI 10.1097/00001888-199408000-00019; EDWARDS CN, 1988, AM J TROP MED HYG, V39, P388, DOI 10.4269/ajtmh.1988.39.388; Effler PV, 2000, J CLIN MICROBIOL, V38, P1081, DOI 10.1128/JCM.38.3.1081-1084.2000; Guidugli F, 2000, COCHRANE DB SYST REV, V2; Guidugli F, 2000, COCHRANE DB SYST REV, V4; Luks AM, 2003, CHEST, V123, P639, DOI 10.1378/chest.123.2.639; MCCLAIN JBL, 1984, ANN INTERN MED, V100, P696, DOI 10.7326/0003-4819-100-5-696; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13; TAPPERO JW, 2000, MANDELL DOUGLAS BENN, P2495; Vinetz JM, 2001, CURR OPIN INFECT DIS, V14, P527, DOI 10.1097/00001432-200110000-00005; WATT G, 1988, LANCET, V1, P433	13	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1914	1918		10.1056/NEJMcps042340	http://dx.doi.org/10.1056/NEJMcps042340			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872207				2022-12-28	WOS:000228858600013
J	Royle, SJ; Bright, NA; Lagnado, L				Royle, SJ; Bright, NA; Lagnado, L			Clathrin is required for the function of the mitotic spindle	NATURE			English	Article							RECEPTOR TRAFFICKING; PROTEINS; KINETOCHORES; IDENTIFICATION; SEGREGATION; DYNAMICS; LINK	Clathrin has an established function in the generation of vesicles that transfer membrane and proteins around the cell(1-4). The formation of clathrin-coated vesicles occurs continuously in nondividing cells(5), but is shut down during mitosis(6), when clathrin concentrates at the spindle apparatus(7,8). Here, we show that clathrin stabilizes fibres of the mitotic spindle to aid congression of chromosomes. Clathrin bound to the spindle directly by the amino-terminal domain of clathrin heavy chain. Depletion of clathrin heavy chain using RNA interference prolonged mitosis; kinetochore fibres were destabilized, leading to defective congression of chromosomes to the metaphase plate and persistent activation of the spindle checkpoint. Normal mitosis was rescued by clathrin triskelia but not the N-terminal domain of clathrin heavy chain, indicating that stabilization of kinetochore fibres was dependent on the unique structure of clathrin. The importance of clathrin for normal mitosis may be relevant to understanding human cancers that involve gene fusions of clathrin heavy chain.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2XY, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Royle, SJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	sjr51@mrc-lmb.cam.ac.uk	Gimenez, Luis E Diaz/D-9291-2011	Royle, Stephen/0000-0001-8927-6967	Medical Research Council [MC_U105178794, U.1051.02.006(78794)] Funding Source: Medline; MRC [MC_U105178794] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Argani P, 2003, ONCOGENE, V22, P5374, DOI 10.1038/sj.onc.1206686; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Bright NA, 1997, J CELL SCI, V110, P2027; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; HEPLER PK, 1970, J CELL BIOL, V45, P438, DOI 10.1083/jcb.45.2.438; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; KIRCHHAUSEN T, 1986, J ULTRA MOL STRUCT R, V94, P199, DOI 10.1016/0889-1605(86)90067-4; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; MARO B, 1985, J EMBRYOL EXP MORPH, V90, P287; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Waters JC, 1996, J CELL SCI, V109, P2823; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518	30	195	199	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1152	1157		10.1038/nature03502	http://dx.doi.org/10.1038/nature03502			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858577	Green Accepted			2022-12-28	WOS:000228693300048
J	Tringe, SG; von Mering, C; Kobayashi, A; Salamov, AA; Chen, K; Chang, HW; Podar, M; Short, JM; Mathur, EJ; Detter, JC; Bork, P; Hugenholtz, P; Rubin, EM				Tringe, SG; von Mering, C; Kobayashi, A; Salamov, AA; Chen, K; Chang, HW; Podar, M; Short, JM; Mathur, EJ; Detter, JC; Bork, P; Hugenholtz, P; Rubin, EM			Comparative metagenomics of microbial communities	SCIENCE			English	Article							SOIL; DIVERSITY; RESOURCE; GENES	The species complexity of microbial communities and challenges in culturing representative isolates make it difficult to obtain assembled genomes. Here we characterize and compare the metabolic capabilities of terrestrial and marine microbial communities using largely unassembled sequence data obtained by shotgun sequencing DNA isolated from the various environments. Quantitative gene content analysis reveals habitat-specific fingerprints that reflect known characteristics of the sampled environments. The identification of environment-specific genes through a gene-centric comparative analysis presents new opportunities for interpreting and diagnosing environments.	US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; Diversa Corp, San Diego, CA 92121 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; European Molecular Biology Laboratory (EMBL); University of California System; University of California Berkeley	Rubin, EM (corresponding author), US DOE, Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov	Short, Jay/GQY-7343-2022; Bork, Peer/F-1813-2013; von Mering, Christian/B-3300-2008; Tringe, Susannah Green/T-9431-2019; Hugenholtz, Philip/AAD-9138-2019; Podar, Mircea/B-7299-2012; WU, TAKLON/A-2827-2010	Bork, Peer/0000-0002-2627-833X; von Mering, Christian/0000-0001-7734-9102; Tringe, Susannah Green/0000-0001-6479-8427; Hugenholtz, Philip/0000-0001-5386-7925; Podar, Mircea/0000-0003-2776-0205; 				Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; COLWELL RK, 1994, COMMUNICATION; Daniel R, 2004, CURR OPIN BIOTECH, V15, P199, DOI 10.1016/j.copbio.2004.04.005; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; Goo YA, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-3; Hugenholtz P, 2002, GENOME BIOL, V3; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Liles MR, 2003, APPL ENVIRON MICROB, V69, P2684, DOI 10.1128/AEM.69.5.2684-2691.2003; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Rhee SK, 2004, APPL ENVIRON MICROB, V70, P4303, DOI 10.1128/AEM.70.7.4303-4317.2004; Robertson DE, 2004, APPL ENVIRON MICROB, V70, P2429, DOI 10.1128/AEM.70.4.2429-2436.2004; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Treusch AH, 2004, ENVIRON MICROBIOL, V6, P970, DOI 10.1111/j.1462-2920.2004.00663.x; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005	21	1109	1183	8	573	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					554	557		10.1126/science.1107851	http://dx.doi.org/10.1126/science.1107851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845853	Green Submitted			2022-12-28	WOS:000228810500053
J	Relaix, F; Rocancourt, D; Mansouri, A; Buckingham, M				Relaix, F; Rocancourt, D; Mansouri, A; Buckingham, M			A Pax3/Pax7-dependent population of skeletal muscle progenitor cells	NATURE			English	Article							PAX-3 EXPRESSION; SATELLITE CELLS; MYF-5; SPECIFICATION; DERMOMYOTOME; MIGRATION	During vertebrate development, successive phases of embryonic and fetal myogenesis lead to the formation and growth of skeletal muscles(1). Although the origin and molecular regulation of the earliest embryonic muscle cells is well understood(2), less is known about later stages of myogenesis. We have identified a new cell population that expresses the transcription factors Pax3 and Pax7 (paired box proteins 3 and 7) but no skeletal-muscle-specific markers. These cells are maintained as a proliferating population in embryonic and fetal muscles of the trunk and limbs throughout development. Using a stable green fluorescent protein (GFP) reporter targeted to Pax3, we demonstrate that they constitute resident muscle progenitor cells that subsequently become myogenic and form skeletal muscle. Late in fetal development, these cells adopt a satellite cell position characteristic of progenitor cells in postnatal muscle. In the absence of both Pax3 and Pax7, further muscle development is arrested and only the early embryonic muscle of the myotome forms. Cells failing to express Pax3 or Pax7 die or assume a non-myogenic fate. We conclude that this resident Pax3/Pax7-dependent progenitor cell population constitutes a source of myogenic cells of prime importance for skeletal muscle formation, a finding also of potential value in the context of cell therapy for muscle disease.	Inst Pasteur, CNRS, URA 2578, Dept Dev Biol, F-75724 Paris, France; Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Max Planck Society	Relaix, F (corresponding author), Inst Pasteur, CNRS, URA 2578, Dept Dev Biol, F-75724 Paris, France.	frelaix@pasteur.fr; margab@pasteur.fr		Relaix, Frederic/0000-0003-1270-1472				ARMAND O, 1983, ARCH ANAT MICROSC MO, V72, P163; Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; BOBER E, 1994, DEVELOPMENT, V120, P603; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; COSSU G, 2001, ADV DEV BIOL BIOCH, P127; GOULDING M, 1994, DEVELOPMENT, V120, P957; GROS J, 2005, NATURE          0420, DOI DOI 10.1038/NATURE03572; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Mansouri A, 1996, DEVELOPMENT, V122, P831; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Schubert FR, 2001, DEV DYNAM, V222, P506, DOI 10.1002/dvdy.1211; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Tajbakhsh S, 2000, CURR TOP DEV BIOL, V48, P225; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tremblay P, 1998, DEV BIOL, V203, P49, DOI 10.1006/dbio.1998.9041; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785	25	772	801	0	53	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					948	953		10.1038/nature03594	http://dx.doi.org/10.1038/nature03594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15843801	Green Published			2022-12-28	WOS:000229799700048
J	Yarovinsky, F; Zhang, DK; Andersen, JF; Bannenberg, GL; Serhan, CN; Hayden, MS; Hieny, S; Sutterwala, FS; Flavell, RA; Ghosh, S; Sher, A				Yarovinsky, F; Zhang, DK; Andersen, JF; Bannenberg, GL; Serhan, CN; Hayden, MS; Hieny, S; Sutterwala, FS; Flavell, RA; Ghosh, S; Sher, A			TLR11 activation of dendritic cells by a protozoan profilin-like protein	SCIENCE			English	Article							TOXOPLASMA-GONDII INFECTION; TOLL-LIKE RECEPTOR-5; CUTTING EDGE; STRANDED-RNA; IL-12; RECOGNITION; RESISTANCE; PARASITE; IMMUNITY; GENE	Mammalian Toll-like receptors (TLRs) play an important role in the innate recognition of pathogens by dendritic cells (DCs). Although TLRs are clearly involved in the detection of bacteria and viruses, relatively little is known about. their function in the innate response to eukaryotic microorganisms. Here we identify a profilin-like molecule from the protozoan parasite Toxoplasma gondii that generates a potent interleukin-12 (IL-12) response in murine DCs that is dependent on myeloid differentiation factor 88. T. gondii profilin activates DCs through TLR11 and is the first chemically defined ligand for this TLR. Moreover, TLR11 is required in vivo for parasite-induced IL-12 production and optimal resistance to infection, thereby establishing a role for the receptor in host recognition of protozoan pathogens.	NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NIAID, Med Entomol Sect, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med,Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Yarovinsky, F (corresponding author), NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	fyarovinsky@niaid.nih.gov; asher@niaid.nih.gov	Cassel, Suzanne/AAI-3947-2021; Hayden, Matthew/C-1263-2008; Bannenberg, Gerard/AAF-6216-2020; Sutterwala, Fayyaz/AAH-5859-2021	Cassel, Suzanne/0000-0003-2492-1923; Bannenberg, Gerard/0000-0001-7763-6224; Yarovinsky, Felix/0000-0001-5825-8002	Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [AI05093, R01-AI59440, 1R01AI045806-01A1] Funding Source: Medline; NIGMS NIH HHS [R01-GM38765] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000579, R01AI045806, Z01AI005093, R01AI059440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; POLLARD TD, 1994, ANNU REV CELL BIOL, V10, P207, DOI 10.1146/annurev.cellbio.10.1.207; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rosenberg B, 2005, INT J CANCER, V114, P756, DOI 10.1002/ijc.20801; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; YAROVINSKY F, UNPUB; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	28	707	774	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1626	1629		10.1126/science.1109893	http://dx.doi.org/10.1126/science.1109893			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15860593				2022-12-28	WOS:000229827000057
J	Bissell, P; Anderson, C				Bissell, P; Anderson, C			Enhanced access to emergency contraception	LANCET			English	Editorial Material							PREGNANCY		Univ Nottingham, Sch Pharm, Ctr Pharm Hlth & Soc, Nottingham NG7 2RD, England	University of Nottingham	Bissell, P (corresponding author), Univ Nottingham, Sch Pharm, Ctr Pharm Hlth & Soc, Nottingham NG7 2RD, England.	Paul.Bissell@nottingham.ac.uk		Anderson, Claire/0000-0002-5406-2296				ANDERSON C, 2001, MANCHESTER SALFORD T; Bissell P, 2003, SOC SCI MED, V57, P2367, DOI 10.1016/S0277-9536(03)00129-1; *IND ADV GROUP SEX, 2004, ANN REP 2003 2004; Litt IF, 2005, JAMA-J AM MED ASSOC, V293, P98, DOI 10.1001/jama.293.1.98; MARSH B, 2003, DAILY MAIL      1018; McLeod A, 2001, BRIT MED J, V323, P199, DOI 10.1136/bmj.323.7306.199; Raine TR, 2005, JAMA-J AM MED ASSOC, V293, P54, DOI 10.1001/jama.293.1.54; Stammers T, 2001, BRIT MED J, V322, P1245, DOI 10.1136/bmj.322.7296.1245; Ziebland S, 2005, SOC SCI MED, V60, P1767, DOI 10.1016/j.socscimed.2004.08.022; Ziebland S, 1999, SOC SCI MED, V49, P1409, DOI 10.1016/S0277-9536(99)00249-X	10	6	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2005	365	9472					1668	1670		10.1016/S0140-6736(05)66526-9	http://dx.doi.org/10.1016/S0140-6736(05)66526-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	925VV	15894084				2022-12-28	WOS:000229082300006
J	Davidson, AL; Chen, J				Davidson, AL; Chen, J			Structural biology - Flipping lipids: Is the third time the charm?	SCIENCE			English	Editorial Material							ATP-BINDING; MALTOSE TRANSPORT; ABC TRANSPORTER; P-GLYCOPROTEIN; DIMER; HYDROLYSIS; NUCLEOTIDE		Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Baylor College of Medicine; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Davidson, AL (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	davidson@bcm.tmc.edu; chenjue@purdue.edu						Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Raetz C. R. H., 1996, ESCHERICHIA COLI SAL, V1, P1035; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tombline G, 2004, J BIOL CHEM, V279, P5363, DOI 10.1074/jbc.M311964200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Verdon G, 2003, J MOL BIOL, V334, P255, DOI 10.1016/j.jmb.2003.08.065	13	8	8	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					963	965		10.1126/science.1113414	http://dx.doi.org/10.1126/science.1113414			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890866				2022-12-28	WOS:000229190700026
J	Eghbali-Fatourechi, GZ; Lamsam, J; Fraser, D; Nagel, D; Riggs, BL; Khosla, S				Eghbali-Fatourechi, GZ; Lamsam, J; Fraser, D; Nagel, D; Riggs, BL; Khosla, S			Circulating osteoblast-lineage cells in humans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE TURNOVER; GROWTH; BLOOD	BACKGROUND: Although current evidence suggests that only a minuscule number of osteoblast-lineage cells are present in peripheral blood, we hypothesized that such cells circulate but that their concentration has been vastly underestimated owing to the use of assays that required adherence to plastic. We further reasoned that the concentration of these cells is elevated during times of increased bone formation, such as during pubertal growth. METHODS: We used flow cytometry with antibodies to bone-specific proteins to identify circulating osteoblast-lineage cells in 11 adolescent males and 11 adult males (mean [+/-SD] age, 14.5+/-0.7 vs. 37.7+/-7.6 years). Gene expression and in vitro and in vivo bone-forming assays were used to establish the osteoblastic lineage of sorted cells. RESULTS: Cells positive for osteocalcin and cells positive for bone-specific alkaline phosphatase were detected in the peripheral blood of adult subjects (1 to 2 percent of mononuclear cells). There were more than five times as many cells positive for osteocalcin in the circulation of adolescent boys (whose markers of bone formation were clearly increased as a result of pubertal growth) as compared with adult subjects (P<0.001). The percentage of cells positive for osteocalcin correlated with markers of bone formation. Sorted osteocalcin-positive cells expressed osteoblastic genes, formed mineralized nodules in vitro, and formed bone in an in vivo transplantation assay. Increased values were also found in three adults with recent fractures. CONCLUSIONS: Osteoblast-lineage cells circulate in physiologically significant numbers, correlate with markers of bone formation, and are markedly higher during pubertal growth; therefore, they may represent a previously unrecognized circulatory component to the process of bone formation.	Mayo Clin, Coll Med, Endocrine Res Unit, Rochester, MN 55905 USA	Mayo Clinic	Khosla, S (corresponding author), Mayo Clin, Coll Med, Endocrine Res Unit, 200 1st St SW,5-194 Joseph, Rochester, MN 55905 USA.	khosla.sundeep@mayo.edu	Khosla, Sundeep/AAE-6170-2020	Khosla, Sundeep/0000-0002-2936-4372	NCRR NIH HHS [M01 RR00585] Funding Source: Medline; NIA NIH HHS [AG-024901, AG-004875] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004875, R21AG024901] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Devine MJ, 2002, J ORTHOP RES, V20, P1232, DOI 10.1016/S0736-0266(02)00051-7; Dominici M, 2004, P NATL ACAD SCI USA, V101, P11761, DOI 10.1073/pnas.0404626101; EASTELL R, 1992, CLIN SCI, V83, P375, DOI 10.1042/cs0830375; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; FRIERSON HF, 1990, DIAGN CYTOPATHOL, V6, P243, DOI 10.1002/dc.2840060404; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; Ingle BM, 1999, OSTEOPOROSIS INT, V10, P399, DOI 10.1007/s001980050246; KASSEM M, 1991, APMIS, V99, P262, DOI 10.1111/j.1699-0463.1991.tb05148.x; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; LONG MW, 1990, J CLIN INVEST, V86, P1387, DOI 10.1172/JCI114852; LONG MW, 1995, J CLIN INVEST, V96, P2541; LONG MW, 1995, J CLIN INVEST, V95, P881, DOI 10.1172/JCI117738; Mankani MH, 2004, RADIOLOGY, V230, P369, DOI 10.1148/radiol.2302011529; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; STEWART CA, 1974, PATHOLOGY, V6, P287, DOI 10.3109/00313027409068999; THIEDE MA, 1994, ENDOCRINOLOGY, V135, P929, DOI 10.1210/en.135.3.929; Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130	21	304	320	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1959	1966		10.1056/NEJMoa044264	http://dx.doi.org/10.1056/NEJMoa044264			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888696				2022-12-28	WOS:000229017100006
J	Knoers, NVAM				Knoers, NVAM			Hyperactive vasopressin receptors and disturbed water homeostasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands	Radboud University Nijmegen	Knoers, NVAM (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands.							Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Verbalis JG, 2003, BEST PRACT RES CL EN, V17, P471, DOI 10.1016/S1521-690X(03)00049-6	3	15	15	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1847	1850		10.1056/NEJMp058006	http://dx.doi.org/10.1056/NEJMp058006			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872199				2022-12-28	WOS:000228858600004
J	Lane, R; Horton, R				Lane, R; Horton, R			Thelancet.com - new horizons	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Lane, R (corresponding author), The Lancet, London NW1 7BY, England.	webeditor@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1528	1528		10.1016/S0140-6736(05)66438-0	http://dx.doi.org/10.1016/S0140-6736(05)66438-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866296				2022-12-28	WOS:000228754800011
J	Smith, JA; Seltzer, GO; Farber, DL; Rodbell, DT; Finkel, RC				Smith, JA; Seltzer, GO; Farber, DL; Rodbell, DT; Finkel, RC			Early local last glacial maximum in the tropical Andes	SCIENCE			English	Article							SOUTH-AMERICA; LAKE TITICACA; CLIMATE; HISTORY; ALTIPLANO; BOLIVIA; PERU	The local last glacial maximum in the tropical Andes was earlier and less extensive than previously thought, based on 106 cosmogenic ages (from beryllium-10 dating) from moraines in Peru and Bolivia. Glaciers reached their greatest extent in the last glacial cycle similar to 34,000 years before the present and were retreating by similar to 21,000 years before the present, implying that tropical controls on ice volumes were asynchronous with those in the Northern Hemisphere. Our estimates of snowline depression reflect about half the temperature change indicated by previous widely cited figures, which helps resolve the discrepancy between estimates of terrestrial and marine temperature depression during the last glacial cycle.	Syracuse Univ, Dept Earth Sci, Heroy Geol Lab 204, Syracuse, NY 13244 USA; Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; Union Coll, Dept Geol, Schenectady, NY 12308 USA; Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA	Syracuse University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Union College; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Smith, JA (corresponding author), Syracuse Univ, Dept Earth Sci, Heroy Geol Lab 204, Syracuse, NY 13244 USA.	jasmit10@syr.edu	Farber, Daniel L/F-9237-2011					Baker PA, 2001, NATURE, V409, P698, DOI 10.1038/35055524; Baker PA, 2001, SCIENCE, V291, P640, DOI 10.1126/science.291.5504.640; CLARK DH, 1994, QUATERNARY RES, V41, P139, DOI 10.1006/qres.1994.1016; Clark PU, 1999, SCIENCE, V286, P1104, DOI 10.1126/science.286.5442.1104; *CLIMAP, 1981, GEOL SOC AM MAP CHAR; Fritz SC, 2004, QUATERNARY RES, V61, P95, DOI 10.1016/j.yqres.2003.08.007; Garreaud R, 2003, PALAEOGEOGR PALAEOCL, V194, P5, DOI 10.1016/S0031-0182(03)00269-4; GILLESPIE A, 1995, REV GEOPHYS, V33, P311, DOI 10.1029/95RG00995; Gosse JC, 2001, QUATERNARY SCI REV, V20, P1475, DOI 10.1016/S0277-3791(00)00171-2; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; Johnson A.M., 1976, CLIMATES CENTRAL S A, V12, P147; Klein AG, 1999, QUATERNARY SCI REV, V18, P63, DOI 10.1016/S0277-3791(98)00095-X; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LOWELL TV, 1995, QUATERNARY SCI REV, V14, P85, DOI 10.1016/0277-3791(94)00113-P; MULLER R, 1985, THESIS U ZURICH; OERLEMANS J, 1989, GLAC QUAT G, V6, P353; OWEN LA, IN PRESS QUAT SCI RE; Paduano GM, 2003, PALAEOGEOGR PALAEOCL, V194, P259, DOI 10.1016/S0031-0182(03)00281-5; Porter SC, 2001, QUATERNARY SCI REV, V20, P1067, DOI 10.1016/S0277-3791(00)00178-5; RIND D, 1985, QUATERNARY RES, V24, P1, DOI 10.1016/0033-5894(85)90080-8; Seltzer G, 2000, GEOLOGY, V28, P35; Seltzer GO, 2002, SCIENCE, V296, P1685, DOI 10.1126/science.1070136; Seltzer GO, 2001, QUATERNARY SCI REV, V20, P1063, DOI 10.1016/S0277-3791(00)00179-7; SELTZER GO, 1994, QUATERNARY RES, V41, P154, DOI 10.1006/qres.1994.1017; SMITH JA, 2002, GEOLOGICAL SOC AM AB, V34, P131; SMITH JA, IN PRESS QUAT INT; STUTE M, 1995, SCIENCE, V269, P379, DOI 10.1126/science.269.5222.379; Tapia PM, 2003, PALAEOGEOGR PALAEOCL, V194, P139, DOI 10.1016/S0031-0182(03)00275-X; Thackray GD, 2001, QUATERNARY RES, V55, P257, DOI 10.1006/qres.2001.2220	29	144	146	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					678	681		10.1126/science.1107075	http://dx.doi.org/10.1126/science.1107075			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860623				2022-12-28	WOS:000228810900045
J	Fang, N; Lee, H; Sun, C; Zhang, X				Fang, N; Lee, H; Sun, C; Zhang, X			Sub-diffraction-limited optical imaging with a silver superlens	SCIENCE			English	Article							INDEX; VERIFICATION; TRANSMISSION; PLASMONS; WAVE	Recent theory has predicted a superlens that is capable of producing subdiffraction-limited images. This superlens would allow the recovery of evanescent waves in an image via the excitation of surface plasmons. Using silver as a natural optical superlens, we demonstrated sub-diffraction-limited imaging with 60-nanometer half-pitch resolution, or one-sixth of the illumination wavelength. By proper design of the working wavelength and the thickness of silver that allows access to a broad spectrum of subwavelength features, we also showed that arbitrary nanostructures can be imaged with good fidelity. The optical superlens promises exciting avenues to nanoscale optical imaging and ultrasmall opto-electronic devices.	Univ Calif Berkeley, Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zhang, X (corresponding author), Univ Calif Berkeley, Nanoscale Sci & Engn Ctr, 5130 Etcheverry Hall, Berkeley, CA 94720 USA.	xiang@berkeley.edu	Fang, Nicholas/A-5856-2008; Zhang, Xiang/F-6905-2011; Sun, Cheng/B-7609-2009; Sun, Cheng/A-8111-2010	Fang, Nicholas/0000-0001-5713-629X; Sun, Cheng/0000-0002-2744-0896; Zhang, Xiang/0000-0002-3272-894X				Blaikie RJ, 2005, J OPT A-PURE APPL OP, V7, pS176, DOI 10.1088/1464-4258/7/2/023; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Fang N, 2003, OPT EXPRESS, V11, P682, DOI 10.1364/OE.11.000682; Fang N, 2003, APPL PHYS LETT, V82, P161, DOI 10.1063/1.1536712; FISCHER UC, 1981, J VAC SCI TECHNOL, V19, P881, DOI 10.1116/1.571227; Goodberlet JG, 2002, APPL PHYS LETT, V81, P1315, DOI 10.1063/1.1495538; Grbic A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.117403; Houck AA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.137401; Iyer AK, 2003, OPT EXPRESS, V11, P696, DOI 10.1364/OE.11.000696; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Lezec HJ, 2002, SCIENCE, V297, P820, DOI 10.1126/science.1071895; Linden S, 2004, SCIENCE, V306, P1351, DOI 10.1126/science.1105371; Liu ZW, 2003, APPL PHYS LETT, V83, P5184, DOI 10.1063/1.1636250; Loewen EG., 1997, DIFFRACTION GRATINGS; Luo XG, 2004, APPL PHYS LETT, V84, P4780, DOI 10.1063/1.1760221; Melville DOS, 2004, J VAC SCI TECHNOL B, V22, P3470, DOI 10.1116/1.1813462; Parazzoli CG, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.107401; Parimi PV, 2003, NATURE, V426, P404, DOI 10.1038/426404a; Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 2004, SCIENCE, V305, P847, DOI 10.1126/science.1098999; Ramakrishna SA, 2002, J MOD OPTIC, V49, P1747, DOI 10.1080/09500340110120950; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2003, APPL PHYS LETT, V82, P1506, DOI 10.1063/1.1554779; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; SMITH HI, 1974, P IEEE, V62, P1361, DOI 10.1109/PROC.1974.9627; Wiltshire MCK, 2003, OPT EXPRESS, V11, P709, DOI 10.1364/OE.11.000709; Wiltshire MCK, 2001, SCIENCE, V291, P849, DOI 10.1126/science.291.5505.849; Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025	29	3239	3360	28	1061	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					534	537		10.1126/science.1108759	http://dx.doi.org/10.1126/science.1108759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845849				2022-12-28	WOS:000228810500047
J	Zou, WQ; Gambetti, P				Zou, WQ; Gambetti, P			From microbes to prions: The final proof of the prion hypothesis	CELL			English	Review							SCRAPIE; PROTEIN	Much like the "microbe hypothesis" put forth over 150 years ago, the "prion hypothesis" can be definitely proven only if a prion disease is engendered in a natural host from an infectious prion produced in vitro. In this issue of Cell, Castilla et al. (2005) come very close to accomplishing this goal by producing a prion disease in a natural host from a prion entirely generated in vitro using a PCR-like amplification system.	Case Western Reserve Univ, Div Neuropathol, Dept Pathol, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA	Case Western Reserve University	Zou, WQ (corresponding author), Case Western Reserve Univ, Div Neuropathol, Dept Pathol, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA.		Zou, Wenquan/GWQ-3489-2022; Zou, Wenquan/ABF-2875-2020					Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Magner LN., 2017, HIST MED, V3rd edition; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392	10	16	18	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 22	2005	121	2					155	157		10.1016/j.cell.2005.04.002	http://dx.doi.org/10.1016/j.cell.2005.04.002			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851020	Bronze			2022-12-28	WOS:000228705000001
J	Calin, GA; Trapasso, F; Shimizu, M; Dumitru, CD; Yendamuri, S; Godwin, AK; Ferracin, M; Bernardi, G; Chatterjee, D; Baldassarre, G; Rattan, S; Alder, H; Mabuchi, H; Shiraishi, T; Hansen, LL; Overgaard, J; Herlea, V; Mauro, FR; Dighiero, G; Movsas, B; Rassenti, L; Kipps, T; Baffa, R; Fusco, A; Mori, M; Russo, G; Liu, CG; Neuberg, D; Bullrich, F; Negrini, M; Croce, CM				Calin, GA; Trapasso, F; Shimizu, M; Dumitru, CD; Yendamuri, S; Godwin, AK; Ferracin, M; Bernardi, G; Chatterjee, D; Baldassarre, G; Rattan, S; Alder, H; Mabuchi, H; Shiraishi, T; Hansen, LL; Overgaard, J; Herlea, V; Mauro, FR; Dighiero, G; Movsas, B; Rassenti, L; Kipps, T; Baffa, R; Fusco, A; Mori, M; Russo, G; Liu, CG; Neuberg, D; Bullrich, F; Negrini, M; Croce, CM			Familial cancer associated with a polymorphism in ARLTS1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-SUPPRESSOR LOCUS; DOWN-REGULATION; 13Q14; GENE; SEQUENCE; REGION; IDENTIFICATION; EXPRESSION; DELETIONS	BACKGROUND: The finding of hemizygous or homozygous deletions at band 14 on chromosome 13 in a variety of neoplasms suggests the presence of a tumor-suppressor locus telomeric to the RB1 gene. METHODS: We studied samples from 216 patients with various types of sporadic tumors or idiopathic pancytopenia, peripheral-blood samples from 109 patients with familial cancer or multiple cancers, and control blood samples from 475 healthy people or patients with diseases other than cancer. We performed functional studies of cell lines lacking ARLTS1 expression with the use of both the full-length ARLTS1 gene and a truncated variant. RESULTS: We found a gene at 13q14, ARLTS1, a member of the ADP-ribosylation factor family, with properties of a tumor-suppressor gene. We analyzed 800 DNA samples from tumors and blood cells from patients with sporadic or familial cancer and controls and found that the frequency of a nonsense polymorphism, G446A (Trp149Stop), was similar in controls and patients with sporadic tumors but was significantly more common among patients with familial cancer than among those in the other two groups (P=0.02; odds ratio, 5.7; 95 percent confidence interval, 1.3 to 24.8). ARLTS1 was down-regulated by promoter methylation in 25 percent of the primary tumors we analyzed. Transfection of wild-type ARLTS1 into A549 lung-cancer cells suppressed tumor formation in immunodeficient mice and induced apoptosis, whereas transfection of truncated ARLTS1 had a limited effect on apoptosis and tumor suppression. Microarray analysis revealed that the wild-type and Trp149Stop-transfected clones had different expression profiles. CONCLUSIONS: A genetic variant of ARLTS1 predisposes patients to familial cancer.	Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Univ Ferrara, I-44100 Ferrara, Italy; Natl Canc Inst, Aviano, Italy; Aarhus Univ, Aarhus, Denmark; Fundeni Clin Hosp, Bucharest, Romania; Univ Roma La Sapienza, Rome, Italy; Inst Pasteur, Paris, France; Univ Calif San Diego, La Jolla, CA 92093 USA; Univ Catanzaro, Catanzaro, Italy; Kyushu Univ, Beppu, Oita, Japan; Ist Ricovero & Cura Carattere Sci, Rome, Italy; Dana Farber Canc Inst, Boston, MA 02115 USA	Jefferson University; Fox Chase Cancer Center; University of Ferrara; Aarhus University; Institutul Clinic Fundeni; Sapienza University Rome; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California San Diego; Magna Graecia University of Catanzaro; Kyushu University; Harvard University; Dana-Farber Cancer Institute	Croce, CM (corresponding author), Ohio State Univ, Ctr Comprehens Canc, 385K Wiseman Hall,400 W 12th Ave, Columbus, OH 43210 USA.	carlo.croce@osumc.edu	Hansen, Lise Lotte/I-3377-2016; Baldassarre, Gustavo/K-1350-2016; Young, Richard A/F-6495-2012; herlea, vlad/AAT-3967-2021; Ferracin, Manuela/K-2097-2016; Negrini, Massimo/J-2377-2016; Russo, Giandomenico/K-9566-2016; Calin, George/E-9390-2011	Hansen, Lise Lotte/0000-0001-7915-2506; Baldassarre, Gustavo/0000-0002-9750-8825; Young, Richard A/0000-0001-8855-8647; Ferracin, Manuela/0000-0002-1595-6887; Negrini, Massimo/0000-0002-0007-1920; Russo, Giandomenico/0000-0002-7718-9687; Fusco, Alfredo/0000-0003-3332-5197; Mauro, Francesca Romana/0000-0003-2425-9474; Calin, George/0000-0001-6704-5615; Yendamuri, Sai/0000-0001-6654-3487	NCI NIH HHS [P01CA81534, P30CA56036, P01CA76259] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA081534, P30CA056036, P01CA076259] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abudugupur A, 2002, CELL DEATH DIFFER, V9, P158, DOI 10.1038/sj.cdd.4400942; BROWN AG, 1993, NAT GENET, V3, P67, DOI 10.1038/ng0193-67; Bullrich F, 1996, BLOOD, V88, P3109, DOI 10.1182/blood.V88.8.3109.bloodjournal8883109; Bullrich F, 2001, CANCER RES, V61, P6640; Bullrich F, 2001, CHRONIC LYMPHOCYTIC, P9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Dahlen A, 2003, INT J CANCER, V103, P616, DOI 10.1002/ijc.10864; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Ghosh K, 1999, BIOCHEM CELL BIOL, V77, P165; Goggins M, 1996, CANCER RES, V56, P5360; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; He H, 2002, GENE EXPRESSION, V10, P231, DOI 10.3727/000000002783992406; Houlston RS, 2003, LEUKEMIA RES, V27, P871, DOI 10.1016/S0145-2126(03)00023-7; KAHN RA, 1992, FASEB J, V6, P2512, DOI 10.1096/fasebj.6.8.1592203; La Starza R, 1998, BLOOD, V91, P231, DOI 10.1182/blood.V91.1.231.231_231_237; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mabuchi H, 2001, CANCER RES, V61, P2870; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; Mertens D, 2002, BLOOD, V99, P4116, DOI 10.1182/blood.V99.11.4116; Migliazza A, 2001, BLOOD, V97, P2098, DOI 10.1182/blood.V97.7.2098; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Ramakrishnan R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e30; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rondeau Gaelle, 2001, Mutation Research, V458, P55, DOI 10.1016/S0027-5107(01)00219-6; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Venter JC, 2001, SCIENCE, V292, P1838; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yin ZN, 1999, ONCOGENE, V18, P7576, DOI 10.1038/sj.onc.1203203	30	104	113	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1667	1676		10.1056/NEJMoa042280	http://dx.doi.org/10.1056/NEJMoa042280			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843669				2022-12-28	WOS:000228515200008
J	Forster, P; Matsumura, S				Forster, P; Matsumura, S			Evolution - Did early humans go north or south?	SCIENCE			English	Editorial Material							MITOCHONDRIAL-DNA; ANDAMAN ISLANDERS; AGES		Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3ER, England	University of Cambridge	Forster, P (corresponding author), Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3ER, England.	pf223@cam.ac.uk	Matsumura, Shuichi/C-7986-2013	Matsumura, Shuichi/0000-0002-0368-006X				Barker G., 2005, ASIAN PERSPECT, V44, P90, DOI [10.1353/asi.2005.0004, DOI 10.1353/ASI.2005.0004]; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cordaux R, 2003, AM J HUM GENET, V72, P1586, DOI 10.1086/375407; Endicott P, 2003, AM J HUM GENET, V72, P178, DOI 10.1086/345487; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Oppenheimer S., 2003, OUT EDEN; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Underhill PA, 2003, COLD SPRING HARB SYM, V68, P487, DOI 10.1101/sqb.2003.68.487; Venkateswar S, 1999, SCI AM, V280, P82, DOI 10.1038/scientificamerican0599-82; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702	12	111	120	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					965	966		10.1126/science.1113261	http://dx.doi.org/10.1126/science.1113261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890867				2022-12-28	WOS:000229190700027
J	Carporzen, L; Gilder, SA; Hart, RJ				Carporzen, L; Gilder, SA; Hart, RJ			Palaeomagnetism of the Vredefort meteorite crater and implications for craters on Mars	NATURE			English	Article							SHOCK METAMORPHISM; SOUTH-AFRICA; MAGNETIC-FIELDS; IMPACT; QUARTZ; ROCKS	Magnetic surveys of the martian surface have revealed significantly lower magnetic field intensities over the gigantic impact craters Hellas and Argyre than over surrounding regions(1). The reduced fields are commonly attributed to pressure demagnetization caused by shock waves generated during meteorite impact(2,3), in the absence of a significant ambient magnetic field. Lower than average magnetic field intensities are also observed above the Vredefort meteorite crater in South Africa, yet here we show that the rocks in this crater possess much higher magnetic intensities than equivalent lithologies found elsewhere on Earth. We find that palaeomagnetic directions of these strongly magnetized rocks are randomly oriented, with vector directions changing over centimetre length scales. Moreover, the magnetite grains contributing to the magnetic remanence crystallized during impact, which directly relates the randomization and intensification to the impact event. The strong and randomly oriented magnetization vectors effectively cancel out when summed over the whole crater. Seen from high altitudes, as for martian craters, the magnetic field appears much lower than that of neighbouring terranes, implying that magnetic anomalies of meteorite craters cannot be used as evidence for the absence of the planet's internally generated magnetic field at the time of impact.	Inst Phys Globe, Lab Paleomagnetisme, F-75252 Paris, France; Univ Witwatersrand, Schonland Res Ctr, ZA-2050 Wits, Johannesburg, South Africa	UDICE-French Research Universities; Universite Paris Cite; University of Witwatersrand	Gilder, SA (corresponding author), Inst Phys Globe, Lab Paleomagnetisme, 4 Pl Jussieu, F-75252 Paris, France.	gilder@ipgp.jussieu.fr	Gilder, Stuart A/B-1871-2016	Gilder, Stuart A/0000-0001-8724-7812				Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Clark D., 1991, EXPLOR GEOPHYS, V22, P547, DOI DOI 10.1071/EG991547; Cloete M, 1999, CONTRIB MINERAL PETR, V137, P232, DOI 10.1007/s004100050548; CRAWFORD DA, 1988, NATURE, V336, P50, DOI 10.1038/336050a0; Crawford DA, 1999, INT J IMPACT ENG, V23, P169, DOI 10.1016/S0734-743X(99)00070-6; Gilder S, 1999, GEOLOGY, V27, P919, DOI 10.1130/0091-7613(1999)027<0919:TEATOT>2.3.CO;2; Gilder SA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019844; Grieve RAF, 1996, METEORIT PLANET SCI, V31, P6, DOI 10.1111/j.1945-5100.1996.tb02049.x; GRIEVE RAF, 1996, AGSO J AU GEO GEOPH, V16, P399; HALLS HC, 1975, NATURE, V255, P692, DOI 10.1038/255692a0; HARGRAVE.RB, 1970, J GEOL, V78, P253, DOI 10.1086/627516; HARGRAVES RB, 1974, CAN J EARTH SCI, V11, P854, DOI 10.1139/e74-085; HART RJ, 1995, GEOLOGY, V23, P277, DOI 10.1130/0091-7613(1995)023<0277:MANTCO>2.3.CO;2; Hart RJ, 2000, S AFR J GEOL, V103, P151, DOI 10.2113/103.2.151; Hood LL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016657; Jackson G.M., 1982, PALEOMAGNETIC STUDY; Mohit PS, 2004, ICARUS, V168, P305, DOI 10.1016/j.icarus.2003.12.005; Moser DE, 1997, GEOLOGY, V25, P7, DOI 10.1130/0091-7613(1997)025<0007:DTSWAT>2.3.CO;2; SAMARA GA, 1969, PHYS REV, V186, P577, DOI 10.1103/PhysRev.186.577; SCHULTZ SR, 1986, J COMPUT ASSIST TOMO, V10, P81, DOI 10.1097/00004728-198601000-00018; STOFFLER D, 1994, METEORITICS, V29, P155, DOI 10.1111/j.1945-5100.1994.tb00670.x; TURCOTT DL, 1982, GEODYNAMICS; Turtle EP, 1998, METEORIT PLANET SCI, V33, P483, DOI 10.1111/j.1945-5100.1998.tb01652.x; Wennerstrom M, 1998, LITHOS, V45, P131, DOI 10.1016/S0024-4937(98)00029-2	24	57	57	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					198	201		10.1038/nature03560	http://dx.doi.org/10.1038/nature03560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889090				2022-12-28	WOS:000229021100038
J	Matsumoto, S; Okitsu, T; Wanaga, Y; Noguchi, H; Nagata, H; Yonekawa, Y; Yamada, Y; Fukuda, K; Tsukiyama, K; Suzuki, H; Kawasaki, Y; Shimodaira, M; Matsuoka, K; Shibata, T; Kasai, Y; Maekawa, T; Shapiro, AMJ; Tanaka, K				Matsumoto, S; Okitsu, T; Wanaga, Y; Noguchi, H; Nagata, H; Yonekawa, Y; Yamada, Y; Fukuda, K; Tsukiyama, K; Suzuki, H; Kawasaki, Y; Shimodaira, M; Matsuoka, K; Shibata, T; Kasai, Y; Maekawa, T; Shapiro, AMJ; Tanaka, K			Insulin independence after living-donor distal pancreatectomy and islet allotransplantation	LANCET			English	Article							TRANSPLANTATION; PRESERVATION; PANCREAS	Rising demand for islet transplantation will lead to severe donor shortage in the near future, especially in countries where cadaveric organ donation is scarce. We undertook a successful transplantation of living-donor islets for unstable diabetes. The recipient was a 27-year-old woman who had had brittle, insulin-dependent diabetes mellitus for 12 years. The donor, who was a healthy 56-year-old woman and mother of the recipient, underwent a distal pancreatectomy. After isolation, 408 114 islet equivalents were transplanted immediately. The transplants functioned immediately and the recipient became insulin-independent 22 days after the operation. The donor had no complications and both women showed healthy glucose tolerance. Transplantation of living-donor islets from the distal pancreas can be sufficient to reverse brittle diabetes.	Kyoto Univ Hosp, Transplantat Unit, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Transplantat & Immunol, Kyoto, Japan; Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto, Japan; Kyoto Univ Hosp, Radiol & Nucl Med Serv, Kyoto 6068507, Japan; Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 6068507, Japan; Univ Alberta, Clin Islet TRansplant Programme, Edmonton, AB, Canada	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; University of Alberta	Matsumoto, S (corresponding author), Kyoto Univ Hosp, Transplantat Unit, Sakyo Ku, Kyoto 6068507, Japan.	shinichi@kuhp.kyoto-u.ac.jp	Yamada, Yuichiro/G-4766-2011	Noguchi, Hirofumi/0000-0002-0880-6805				GRUESSNER RWG, 2002, TRANSPLANT REV, V16, P108; Hathout E, 2003, ARCH DIS CHILD, V88, P591, DOI 10.1136/adc.88.7.591; Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830; Matsumoto S, 2004, TRANSPLANTATION, V78, P839, DOI 10.1097/01.TP.0000130177.03326.D5; Matsumoto S, 2003, AM J TRANSPLANT, V3, P53, DOI 10.1034/j.1600-6143.2003.30110.x; Ryan EA, 2005, DIABETES CARE, V28, P343, DOI 10.2337/diacare.28.2.343; Sawada T, 2003, TRANSPLANTATION, V75, P1965, DOI 10.1097/01.TP.0000068871.09469.E0; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SUTHERLAND D E R, 1980, Diabetes, V29, P31	9	167	178	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1642	1644		10.1016/S0140-6736(05)66383-0	http://dx.doi.org/10.1016/S0140-6736(05)66383-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15889479				2022-12-28	WOS:000228933700029
J	Thompson, SM				Thompson, SM			Matching at the synapse	SCIENCE			English	Editorial Material							PYRAMIDAL NEURONS; RAT NEOCORTEX; CONNECTIONS; TERMINALS; RELEASE		Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Thompson, SM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	sthom003@umaryland.edu	Thompson, Scott M/K-8921-2015					AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x	10	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					800	801		10.1126/science.1112623	http://dx.doi.org/10.1126/science.1112623			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879198				2022-12-28	WOS:000228986500027
J	Eichinger, L; Pachebat, JA; Glockner, G; Rajandream, MA; Sucgang, R; Berriman, M; Song, J; Olsen, R; Szafranski, K; Xu, Q; Tunggal, B; Kummerfeld, S; Madera, M; Konfortov, BA; Rivero, F; Bankier, AT; Lehmann, R; Hamlin, N; Davies, R; Gaudet, P; Fey, P; Pilcher, K; Chen, G; Saunders, D; Sodergren, E; Davis, P; Kerhornou, A; Nie, X; Hall, N; Anjard, C; Hemphill, L; Bason, N; Farbrother, P; Desany, B; Just, E; Morio, T; Rost, R; Churcher, C; Cooper, J; Haydock, S; van Driessche, N; Cronin, A; Goodhead, I; Muzny, D; Mourier, T; Pain, A; Lu, M; Harper, D; Lindsay, R; Hauser, H; James, K; Quiles, M; Babu, MM; Saito, T; Buchrieser, C; Wardroper, A; Felder, M; Thangavelu, M; Johnson, D; Knights, A; Loulseged, H; Mungall, K; Oliver, K; Price, C; Quail, MA; Urushihara, H; Hernandez, J; Rabbinowitsch, E; Steffen, D; Sanders, M; Ma, J; Kohara, Y; Sharp, S; Simmonds, M; Spiegler, S; Tivey, A; Sugano, S; White, B; Walker, D; Woodward, J; Winckler, T; Tanaka, Y; Shaulsky, G; Schleicher, M; Weinstock, G; Rosenthal, A; Cox, EC; Chisholm, RL; Gibbs, R; Loomis, WF; Platzer, M; Kay, RR; Williams, J; Dear, PH; Noegel, AA; Barrell, B; Kuspa, A				Eichinger, L; Pachebat, JA; Glockner, G; Rajandream, MA; Sucgang, R; Berriman, M; Song, J; Olsen, R; Szafranski, K; Xu, Q; Tunggal, B; Kummerfeld, S; Madera, M; Konfortov, BA; Rivero, F; Bankier, AT; Lehmann, R; Hamlin, N; Davies, R; Gaudet, P; Fey, P; Pilcher, K; Chen, G; Saunders, D; Sodergren, E; Davis, P; Kerhornou, A; Nie, X; Hall, N; Anjard, C; Hemphill, L; Bason, N; Farbrother, P; Desany, B; Just, E; Morio, T; Rost, R; Churcher, C; Cooper, J; Haydock, S; van Driessche, N; Cronin, A; Goodhead, I; Muzny, D; Mourier, T; Pain, A; Lu, M; Harper, D; Lindsay, R; Hauser, H; James, K; Quiles, M; Babu, MM; Saito, T; Buchrieser, C; Wardroper, A; Felder, M; Thangavelu, M; Johnson, D; Knights, A; Loulseged, H; Mungall, K; Oliver, K; Price, C; Quail, MA; Urushihara, H; Hernandez, J; Rabbinowitsch, E; Steffen, D; Sanders, M; Ma, J; Kohara, Y; Sharp, S; Simmonds, M; Spiegler, S; Tivey, A; Sugano, S; White, B; Walker, D; Woodward, J; Winckler, T; Tanaka, Y; Shaulsky, G; Schleicher, M; Weinstock, G; Rosenthal, A; Cox, EC; Chisholm, RL; Gibbs, R; Loomis, WF; Platzer, M; Kay, RR; Williams, J; Dear, PH; Noegel, AA; Barrell, B; Kuspa, A			The genome of the social amoeba Dictyostelium discoideum	NATURE			English	Article							HORIZONTAL GENE-TRANSFER; SIGNAL-TRANSDUCTION; ABC TRANSPORTERS; CELL-ADHESION; PROTEIN; DIFFERENTIATION; EVOLUTION; SEQUENCE; EXPRESSION; CELLULOSE	The social amoebae are exceptional in their ability to alternate between unicellular and multicellular forms. Here we describe the genome of the best-studied member of this group, Dictyostelium discoideum. The gene-dense chromosomes of this organism encode approximately 12,500 predicted proteins, a high proportion of which have long, repetitive amino acid tracts. There are many genes for polyketide synthases and ABC transporters, suggesting an extensive secondary metabolism for producing and exporting small molecules. The genome is rich in complex repeats, one class of which is clustered and may serve as centromeres. Partial copies of the extrachromosomal ribosomal DNA ( rDNA) element are found at the ends of each chromosome, suggesting a novel telomere structure and the use of a common mechanism to maintain both the rDNA and chromosomal termini. A proteome-based phylogeny shows that the amoebozoa diverged from the animal - fungal lineage after the plant - animal split, but Dictyostelium seems to have retained more of the diversity of the ancestral genome than have plants, animals or fungi.	MRC Ctr, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Cologne, Ctr Biochem, D-50931 Cologne, Germany; Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; Inst Mol Biotechnol, D-07745 Jena, Germany; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Northwestern Univ, Ctr Med Genet, DictyBase, Chicago, IL 60611 USA; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; Univ Munich, Adolf Butenandt Inst Cell Biol, D-80336 Munich, Germany; Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan; Inst Pasteur, Unite Genom Microorganismes Pathogenes, F-75724 Paris, France; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 2XZ, England; Natl Inst Genet, Ctr Genet Resource Informat, Shizuoka 4118540, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo 1088639, Japan; Goethe Univ Frankfurt, Biozentrum, Inst Pharmazeut Biol, D-60439 Frankfurt, Germany; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	MRC Laboratory Molecular Biology; University of Cologne; University of Cologne; Wellcome Trust Sanger Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Diego; Northwestern University; University of Tsukuba; University of Munich; University of Cambridge; Hokkaido University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of York - UK; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo; Goethe University Frankfurt; Princeton University; University of Dundee	Dear, PH (corresponding author), MRC Ctr, Mol Biol Lab, Cambridge CB2 2QH, England.	phd@mrc-lmb.cam.ac.uk	Driemeier, David/H-3461-2012; Glöckner, Gernot/A-7800-2010; Quail, michael/ABE-6131-2020; Pain, Arnab/L-5766-2015; Mourier, Tobias/C-1164-2015; Eichinger, Ludwig/AAJ-8895-2021; Mohan, Babu P./I-7362-2019; Puigbò, Pere/A-2214-2008; Chisholm, Rex L/B-3418-2009; Weinstock, George M/C-6314-2013; Fey, Petra/O-5977-2015; Lu, Mingyang/F-6865-2013; Goodhead, Ian/ABC-9200-2020; Hall, Neil/A-8717-2013; Dear, Paul H/A-1162-2012; Rivero, Francisco/N-2969-2013; Anjard, Christophe/H-5012-2017	Driemeier, David/0000-0003-3766-0654; Glöckner, Gernot/0000-0002-9061-1061; Pain, Arnab/0000-0002-1755-2819; Mourier, Tobias/0000-0003-2727-1903; Eichinger, Ludwig/0000-0003-1594-6117; Chisholm, Rex L/0000-0002-5638-3990; Weinstock, George M/0000-0002-2997-4592; Fey, Petra/0000-0002-4532-2703; Hall, Neil/0000-0002-7995-3810; Rivero, Francisco/0000-0001-5435-6991; Kerhornou, Arnaud/0000-0002-2890-295X; Pachebat, Justin/0000-0003-3369-3205; Kay, Robert R/0000-0001-9836-7967; Harper, David/0000-0002-8313-3516; Davis, Paul/0000-0001-5545-0824; Rost, Rene/0000-0002-5393-0370; Anjard, Christophe/0000-0002-6905-1493; Kuspa, Adam/0000-0002-9156-149X; Kummerfeld, Sarah/0000-0002-0089-2358; Kerr, Alan/0000-0001-9093-0348; Goodhead, Ian/0000-0002-3110-9442; Shaulsky, Gad/0000-0002-0532-0551; MORIO, Takahiro/0000-0002-4007-881X; Buchrieser, Carmen/0000-0003-3477-9190; Hall, Neil/0000-0003-2808-0009	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035925] Funding Source: NIH RePORTER; Medical Research Council [MC_U105115237] Funding Source: Medline; NICHD NIH HHS [R01 HD035925] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrade AC, 2000, MOL GEN GENET, V263, P966, DOI 10.1007/PL00008697; Anjard C, 2002, EUKARYOT CELL, V1, P643, DOI 10.1128/EC.1.4.643-652.2002; Anjard C, 1998, DEV BIOL, V193, P146, DOI 10.1006/dbio.1997.8804; Appelgren H, 2003, J CELL SCI, V116, P4035, DOI 10.1242/jcs.00707; Baldauf SL, 1997, P NATL ACAD SCI USA, V94, P12007, DOI 10.1073/pnas.94.22.12007; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Blanton RL, 2000, P NATL ACAD SCI USA, V97, P2391, DOI 10.1073/pnas.040565697; Blumberg DD, 2002, J MUSCLE RES CELL M, V23, P817, DOI 10.1023/A:1024440014857; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brown LY, 2004, TRENDS GENET, V20, P51, DOI 10.1016/j.tig.2003.11.002; BURGER G, 1995, J MOL BIOL, V245, P522, DOI 10.1006/jmbi.1994.0043; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; CAPPELLO J, 1984, MOL CELL BIOL, V4, P2207, DOI 10.1128/MCB.4.10.2207; CAPPELLO J, 1985, CELL, V43, P105, DOI 10.1016/0092-8674(85)90016-9; Chibalina Margarita V., 2004, BMC Developmental Biology, V4, P1; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; COX EC, 1990, P NATL ACAD SCI USA, V87, P8247, DOI 10.1073/pnas.87.21.8247; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; DEAR PH, 1993, NUCLEIC ACIDS RES, V21, P13, DOI 10.1093/nar/21.1.13; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; DYNES JL, 1994, GENE DEV, V8, P948, DOI 10.1101/gad.8.8.948; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; FREEZE H, 1978, BIOCHIM BIOPHYS ACTA, V539, P529, DOI 10.1016/0304-4165(78)90086-7; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GINSBURG GT, 1995, J EUKARYOT MICROBIOL, V42, P200, DOI 10.1111/j.1550-7408.1995.tb01565.x; Glockner G, 2002, NATURE, V418, P79, DOI 10.1038/nature00847; Glockner G, 2001, GENOME RES, V11, P585, DOI 10.1101/gr.GR-1622RR; Good JR, 2003, DEVELOPMENT, V130, P2953, DOI 10.1242/dev.00523; Good JR, 2000, DEV BIOL, V220, P53, DOI 10.1006/dbio.2000.9611; Goodwin TJD, 2000, GENOME RES, V10, P174, DOI 10.1101/gr.10.2.174; Grimson MJ, 2000, NATURE, V408, P727, DOI 10.1038/35047099; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; Iranfar N, 2001, MOL BIOL CELL, V12, P2590, DOI 10.1091/mbc.12.9.2590; Iyer LM, 2004, TRENDS GENET, V20, P292, DOI 10.1016/j.tig.2004.05.007; Jain R, 2002, THEOR POPUL BIOL, V61, P489, DOI 10.1006/tpbi.2002.1596; Katoh M, 2004, P NATL ACAD SCI USA, V101, P7005, DOI 10.1073/pnas.0306983101; Kawata T, 1997, CELL, V89, P909, DOI 10.1016/S0092-8674(00)80276-7; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KESSIN RH, 2001, DICTYOSTELIUM EVOLUT, V14, P294; Kibler K, 2003, DEV BIOL, V264, P506, DOI 10.1016/j.ydbio.2003.08.025; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973, DOI 10.1128/MCB.6.11.3973; Konfortov BA, 2000, GENOME RES, V10, P1737, DOI 10.1101/gr.141700; KONIJN TM, 1967, P NATL ACAD SCI USA, V58, P1152, DOI 10.1073/pnas.58.3.1152; KUSPA A, 1992, GENOMICS, V13, P49, DOI 10.1016/0888-7543(92)90201-3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Loomis WF, 1995, EXPERIENTIA, V51, P1110, DOI 10.1007/BF01944728; LOOMIS WF, 1995, GENETICS, V141, P147; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Maeda M, 2003, EUKARYOT CELL, V2, P627, DOI 10.1128/EC.2.3.627-637.2003; McClintock B, 1938, GENETICS, V23, P315; Mendez C, 2001, RES MICROBIOL, V152, P341, DOI 10.1016/S0923-2508(01)01205-0; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; MORRISON A, 1994, DEV BIOL, V163, P457, DOI 10.1006/dbio.1994.1162; MULLER K, 1978, NATURE, V274, P445, DOI 10.1038/274445a0; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; Nara T, 2000, GENE, V257, P209, DOI 10.1016/S0378-1119(00)00411-X; Noegel AA, 2000, J CELL SCI, V113, P759; Ogawa S, 2000, MOL GEN GENET, V263, P514, DOI 10.1007/PL00008685; OLSEN R, IN PRESS J MOL EVOL; Raisley B, 2004, DEV BIOL, V265, P433, DOI 10.1016/j.ydbio.2003.09.035; Raper K. B., 1984, DICTYOSTELIDS; Raper KB, 1935, J AGRIC RES, V50, P0135; RAPER KENNETH B., 1940, JOUR ELISHA MITCHELL SCI SOC, V56, P241; Richards TA, 2003, PROTIST, V154, P17, DOI 10.1078/143446103764928468; Rivero F, 2002, J MUSCLE RES CELL M, V23, P737, DOI 10.1023/A:1024423611223; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schoonbeek HJ, 2002, MOL PLANT MICROBE IN, V15, P1165, DOI 10.1094/MPMI.2002.15.11.1165; SHAULSKY G, 1995, GENE DEV, V9, P1111, DOI 10.1101/gad.9.9.1111; Skriwan C, 2002, INT J MED MICROBIOL, V291, P615, DOI 10.1078/1438-4221-00177; SMITH SS, 1991, BIOCHEM J, V277, P273, DOI 10.1042/bj2770273; Soler-Lopez M, 2004, MOL CELL, V13, P791, DOI 10.1016/S1097-2765(04)00130-3; Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000; Sucgang R, 2003, NUCLEIC ACIDS RES, V31, P2361, DOI 10.1093/nar/gkg348; Su┬ll D., 1995, TRNA STRUCTURE BIOSY; Szafranski K, 2004, MOL GENET GENOMICS, V271, P98, DOI 10.1007/s00438-003-0961-9; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Thomason P, 2000, J CELL SCI, V113, P3141; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; Trusov YA, 1996, NUCLEIC ACIDS RES, V24, P995, DOI 10.1093/nar/24.6.995; Urushihara H, 2004, NUCLEIC ACIDS RES, V32, P1647, DOI 10.1093/nar/gkh262; Van Driessche N, 2002, DEVELOPMENT, V129, P1543; Wang J, 2000, DEV BIOL, V227, P734, DOI 10.1006/dbio.2000.9881; Wang YZ, 2001, EUR J BIOCHEM, V268, P4334, DOI 10.1046/j.1432-1327.2001.02354.x; West CM, 2002, EUKARYOT CELL, V1, P281, DOI 10.1128/EC.1.2.281-292.2002; Xu QK, 2004, EUKARYOT CELL, V3, P1101, DOI 10.1128/EC.3.5.1101-1110.2004; Zhang HY, 2003, BIOINFORMATICS, V19, P1391, DOI 10.1093/bioinformatics/btg168; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zhang P, 2001, DIFFERENTIATION, V67, P72, DOI 10.1046/j.1432-0436.2001.067003072.x; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	98	968	5107	7	251	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					43	57		10.1038/nature03481	http://dx.doi.org/10.1038/nature03481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875012	Green Accepted, Bronze			2022-12-28	WOS:000228864600034
J	Iakovou, I; Schmidt, T; Bonizzoni, E; Ge, L; Sangiorgi, GM; Stankovic, G; Airoldi, F; Chieffo, A; Montorfano, M; Carlino, M; Michev, I; Corvaja, N; Briguori, C; Gerckens, U; Grube, E; Colombo, A				Iakovou, I; Schmidt, T; Bonizzoni, E; Ge, L; Sangiorgi, GM; Stankovic, G; Airoldi, F; Chieffo, A; Montorfano, M; Carlino, M; Michev, I; Corvaja, N; Briguori, C; Gerckens, U; Grube, E; Colombo, A			Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY REVASCULARIZATION; INTRAVASCULAR ULTRASOUND; RESTENOSIS; ARTERY; ANGIOPLASTY; STANDARD; THERAPY; DISEASE; ERA; ANTIPLATELET	Context Traditionally, stent thrombosis has been regarded as a complication of percutaneous coronary interventions during the first 30 postprocedural days. However, delayed endothelialization associated with the implantation of drug-eluting stents may extend the risk of thrombosis beyond 30 days. Data are limited regarding the risks and the impact of this phenomenon outside clinical trials. Objective To evaluate the incidence, predictors, and clinical outcome of stent thrombosis after implantation of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice. Design, Setting, and Patients Prospective observational cohort study conducted at 1 academic hospital and 2 community hospitals in Germany and Italy. A total of 2229 consecutive patients underwent successful implantation of sirolimus-eluting (1062 patients, 1996 lesions, 2272 stents) or paclitaxel-eluting (1167 patients, 1801 lesions, 2223 Stents) stents between April 2002 and January 2004. Interventions implantation of a drug-eluting stent (sirolimus or paclitaxel). All patients were pretreated with ticlopidine or clopidogrel and aspirin. Aspirin was continued indefinitely and clopidogrel or. ticlopidine for at least 3 months after sirolimus-eluting and for at least 6 months after paclitaxel-eluting stent implantation. Main Outcome Measures Subacute thrombosis (from procedure end through 30 days), late thrombosis (>30 days), and cumulative stent thrombosis. Results At 9-month follow-up, 29 patients (1.3%) had stent thrombosis (9 [0.8%] with sirolimus and 20 [1.7%] with paclitaxel; P=.09). Fourteen patients had subacute thrombosis (0.6%) and 15 patients had late thrombosis (0.7%). Among these 29 patients, 13 died (case fatality rate, 45%). Independent predictors of stent thrombosis were premature antiplatelet therapy discontinuation (hazard ratio [HR], 89.78; 95% Cl, 29.90-269.60; P<.001), renal failure (HR, 6.49; 95% Cl, 2.60-16.15; P<.001), bifurcation lesions (HR, 6.42; 95% Cl, 2.93-14.07; P<.001), diabetes (HR, 3.71; 95% Cl, 1.74-7.89; P=.001), and a lower ejection fraction (HR, 1.09; 95% Cl, 1.05-1.36; P<.001 for each 10% decrease). Conclusions The cumulative incidence of stent thrombosis 9 months after successful drug-eluting stent implantation in consecutive "real-world" patients was substantially higher than the rate reported in clinical trials. Premature antiplatelet therapy discontinuation, renal failure, bifurcation lesions, diabetes, and low ejection fraction were identified as predictors of thrombotic events.	Ctr Cuore Columbus, Milan, Italy; Hosp San Raffaele, I-20132 Milan, Italy; Mediolanum Cardio Res, Milan, Italy; Klinikum Siegburg Rhein Sieg GmbH, Dept Cardiol, Siegburg, Germany; Univ Milan, Inst Med Stat & Biometry, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan	Colombo, A (corresponding author), EMO Ctr Cuore Columbus, 48 Via M Buonarroti, I-20145 Milan, Italy.	info@emocolumbus.it	Stankovic, Goran/Q-8507-2019; Airoldi, Flavio/AAY-4492-2021; Sangiorgi, Giuseppe M/H-5141-2019	Stankovic, Goran/0000-0002-9414-0885; Sangiorgi, Giuseppe M/0000-0001-5862-1967; chieffo, alaide/0000-0002-3505-9112				Amann K, 1997, Adv Ren Replace Ther, V4, P212; Ardissino D, 2004, JAMA-J AM MED ASSOC, V292, P2727, DOI 10.1001/jama.292.22.2727; Cheneau E, 2003, CIRCULATION, V108, P43, DOI 10.1161/01.CIR.0000078636.71728.40; Chieffo A, 2004, CIRCULATION, V109, P2732, DOI 10.1161/01.CIR.0000131890.83839.5B; Colombo A, 2003, CIRCULATION, V107, P2178, DOI 10.1161/01.CIR.0000070592.04766.36; Colombo A, 2004, EUR HEART J, V25, P895, DOI 10.1016/j.ehj.2004.04.004; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Cutlip DE, 2001, CIRCULATION, V103, P1967; ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193; Farb A, 2003, CIRCULATION, V108, P1701, DOI 10.1161/01.CIR.0000091115.05480.B0; GLAGOV S, 1988, ARCH PATHOL LAB MED, V112, P1018; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Gruberg L, 2000, J AM COLL CARDIOL, V36, P1542, DOI 10.1016/S0735-1097(00)00917-7; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Herzog CA, 2002, CIRCULATION, V106, P2207, DOI 10.1161/01.CIR.0000035248.71165.EB; Iakovou I, 2004, J AM COLL CARDIOL, V44, P967, DOI 10.1016/j.jacc.2004.05.058; Iakovou L, 2004, AM J CARDIOL, V94, P351, DOI 10.1016/j.amjcarf.2004.04.33; Jeremias A, 2004, CIRCULATION, V109, P1930, DOI 10.1161/01.CIR.0000127105.99982.21; Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165; Lansky AJ, 2002, J AM COLL CARDIOL, V39, P274, DOI 10.1016/S0735-1097(01)01745-4; Lyon CJ, 2003, AM J MED, V115, P62, DOI 10.1016/j.amjmed.2003.08.014; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Moreno PR, 2000, CIRCULATION, V102, P2180; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Moussa I, 1997, J AM COLL CARDIOL, V29, P6, DOI 10.1016/S0735-1097(96)00452-4; Nesto RW, 2004, AM J MED, V116, P11, DOI 10.1016/j.amjmed.2003.10.016; Rubenstein MH, 2000, CIRCULATION, V102, P2966; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Schuhlen H, 1998, CIRCULATION, V98, P104, DOI 10.1161/01.CIR.98.2.104; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441	33	2451	2643	1	104	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2126	2130		10.1001/jama.293.17.2126	http://dx.doi.org/10.1001/jama.293.17.2126			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870416	Bronze			2022-12-28	WOS:000228808200022
J	Linde, K; Streng, A; Jurgens, S; Hoppe, A; Brinkhaus, B; Witt, C; Wagenpfeil, S; Pfaffenrath, V; Hammes, MG; Weidenhammer, W; Willich, SN; Melchart, D				Linde, K; Streng, A; Jurgens, S; Hoppe, A; Brinkhaus, B; Witt, C; Wagenpfeil, S; Pfaffenrath, V; Hammes, MG; Weidenhammer, W; Willich, SN; Melchart, D			Acupuncture for patients with migraine - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC HEADACHE; PLACEBO; PROPHYLAXIS; PREVALENCE	Context Acupuncture is widely used to prevent migraine attacks, but the available evidence of its benefit is scarce. Objective To investigate the effectiveness of acupuncture compared with sham acupuncture and with no acupuncture in patients with migraine. Design, Setting, and Patients Three-group, randomized, controlled trial (April 2002-January 2003) involving 302 patients (88% women), mean (SD) age of 43 (11) years, with migraine headaches, based on International Headache Society criteria. Patients were treated at 18 outpatient centers in Germany. Interventions Acupuncture, sham acupuncture, or waiting list control. Acupuncture and sham acupuncture were administered by specialized physicians and consisted of 12 sessions per patient over 8 weeks. Patients completed headache diaries from 4 weeks before to 12 weeks after randomization and from week 21 to 24 after randomization. Main Outcome Measures Difference in headache days of moderate or severe intensity between the 4 weeks before and weeks 9 to 12 after randomization. Results Between baseline and weeks 9 to 12, the mean (SD) number of days with headache of moderate or severe intensity decreased by 2.2 (2.7) days from a baseline of 5.2 (2.5) days in the acupuncture group compared with a decrease to 2.2 (2.7) days from a baseline of 5.0 (2.4) days in the sham acupuncture group, and by 0.8 (2.0) days from a baseline if 5.4 (3.0) days in the waiting list group. No difference was detected between the Acupuncture and the sham acupuncture groups (0.0 days, 95% confidence interval, -0.7 to 0.7 days; P=.96) while there was a difference between the acupuncture group compared with the waiting list group (1.4 days; 95% confidence interval; 0.8-2.1 days; P<.001). The proportion of responders (reduction in headache days by at least 50%) was 51 % in the acupuncture group, 53% in the sham acupuncture group, and 15% in the waiting list group. Conclusion Acupuncture was no more effective than sham acupuncture in reducing migraine headaches although both interventions were more effective than a waiting list control.	Tech Univ Munich, Dept Internal Med 2, Ctr Complementary Med Res, D-80801 Munich, Germany; Tech Univ Munich, Inst Med Stat & Epidemiol, D-80801 Munich, Germany; Tech Univ Munich, Dept Neurol, D-80801 Munich, Germany; Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; Univ Zurich Hosp, Dept Internal Med, Div Complementary Med, Zurich, Switzerland	Technical University of Munich; Technical University of Munich; Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; University Zurich Hospital	Linde, K (corresponding author), Tech Univ Munich, Dept Internal Med 2, Ctr Complementary Med Res, Kaiserstr 9, D-80801 Munich, Germany.	Klaus.Linde@lrz.tu-muenchen.de	Witt, Claudia M./AAX-2370-2021; Brinkhaus, Benno/AAU-2428-2021; Streng, Andrea/AAR-4986-2020	Witt, Claudia M./0000-0002-5440-7805; Brinkhaus, Benno/0000-0001-6290-744X; Streng, Andrea/0000-0003-2377-7106; Linde, Klaus/0000-0002-2902-970X				Allais G, 2002, HEADACHE, V42, P855, DOI 10.1046/j.1526-4610.2002.02203.x; Brandes JL, 2004, JAMA-J AM MED ASSOC, V291, P965, DOI 10.1001/jama.291.8.965; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Diener HC, 2002, CEPHALALGIA, V22, P209, DOI 10.1046/j.1468-2982.2002.t01-1-00309.x; DIENER HC, 1997, DTSCH ARZTEBL, V94, pC2277; Dillmann U, 1994, Schmerz, V8, P100, DOI 10.1007/BF02530415; Geissner E, 1996, SCHMERZEMPFINDUNGSSK; Gray RN, 1999, DRUG TREATMENTS PREV; HAUYZINGER M, 1993, ALLGEMEINE DEPRESSIO; HESSE J, 1994, J INTERN MED, V235, P451, DOI 10.1111/j.1365-2796.1994.tb01102.x; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Irnich D, 2002, SCHMERZ, V16, P93, DOI 10.1007/s004820100094; JENA S, 2004, FOCUS ALTERNATIVE S, V9, P17; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; MACHIN D, 1997, PINOL APY SAMPLE SIZ; Melchart D, 1999, CEPHALALGIA, V19, P779, DOI 10.1046/j.1468-2982.1999.1909779.x; Melchart D, 2003, FORSCH KOMP KLAS NAT, V10, P179, DOI 10.1159/000073473; Melchart Dieter, 2004, Z Arztl Fortbild Qualitatssich, V98, P471; MOLSBERGER A, 2002, DTSCH ARZTEBL, V99, pA1819; Nagel B, 2002, SCHMERZ, V16, P263, DOI 10.1007/s00482-002-0162-1; Sandkuhler J, 1996, PROG NEUROBIOL, V50, P49; STEWART WF, 1994, NEUROLOGY, V44, P17; Tfelt-Hansen P, 2000, CEPHALALGIA, V20, P765; Vickers AJ, 2004, BRIT MED J, V328, P744, DOI 10.1136/bmj.38029.421863.EB; Vincent C, 1990, COMPLEMENT MED RES, V4, P8; Walach H, 2004, J ALTERN COMPLEM MED, V10, pS103; Welch KMA, 1997, CEPHALALGIA, V17, P1, DOI 10.1046/j.1468-2982.1997.1701001.x; Wonderling D, 2004, BMJ-BRIT MED J, V328, P747, DOI 10.1136/bmj.38033.896505.EB	30	424	490	8	116	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2118	2125		10.1001/jama.293.17.2118	http://dx.doi.org/10.1001/jama.293.17.2118			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870415	Bronze			2022-12-28	WOS:000228808200021
J	Adams, PC; Reboussin, DM; Barton, JC; McLaren, CE; Eckfeldt, JH; McLaren, GD; Dawkins, FW; Acton, RT; Harris, EL; Gordeuk, VR; Leiendecker-Foster, C; Speechley, M; Snively, BM; Holup, JL; Thomson, E; Sholinsky, P; Acton, RT; Barton, JC; Dixon, D; Rivers, CA; Tucker, D; Ware, JC; McLaren, CE; McLaren, GD; Anton-Culver, H; Baca, JA; Bent, TC; Brunner, LC; Dao, MM; Jorgensen, KS; Kuniyoshi, J; Le, HD; Masatsugu, MK; Meyskens, FL; Morohashi, D; Nguyen, HP; Panagon, SN; Phung, C; Raymundo, V; Ton, T; Walker, AP; Wenzel, LB; Ziogas, A; Adams, PC; Bloch, E; Chakrabarti, S; Fleischhauer, A; Harrison, H; Jia, K; Larson, S; Lin, E; Lopez, M; Nguyen, L; Pepper, C; Power, T; Speechley, M; Sun, D; Woelfle, D; Jordan, J; Hogan, B; Moses, G; Harris, EL; Aickin, M; Baker, E; Erwin, M; Holup, J; Lloyd, C; Press, N; Press, RD; Reiss, J; Ritenbaugh, C; Uchida, A; Vogt, T; Yim, D; Gordeuk, VR; Dawkins, FW; Fadojutimi-Akinsiku, M; Castro, O; White-Coleman, D; Gerald, M; Harrison, BW; Lewis-Jack, O; Murray, RF; McDonald-Pinkett, S; Romagoza, J; Williams, R; Eckfeldt, JH; Leiendecker-Foster, C; McGlennen, RC; Rynders, G; Tsai, MY; Reboussin, DM; Snively, BM; Anderson, R; Bostic, E; Craven, BL; Ellis, S; Furberg, C; Griffin, J; Hall, M; Harris, D; Henkin, L; Jackson, S; Jewett, T; King, MD; Lohman, K; Lovato, L; Michaleckyj, J; Palla, S; Parks, T; Passmore, L; Phatak, PD; Rich, S; Ruggiero, A; Vitolins, M; Wolgast, G; Zaccaro, D; Sholinsky, P; Bookman, E; Chang, H; Fabsitz, R; Jaquish, C; Manolio, T; O'Neill, L; Thomson, E				Adams, PC; Reboussin, DM; Barton, JC; McLaren, CE; Eckfeldt, JH; McLaren, GD; Dawkins, FW; Acton, RT; Harris, EL; Gordeuk, VR; Leiendecker-Foster, C; Speechley, M; Snively, BM; Holup, JL; Thomson, E; Sholinsky, P; Acton, RT; Barton, JC; Dixon, D; Rivers, CA; Tucker, D; Ware, JC; McLaren, CE; McLaren, GD; Anton-Culver, H; Baca, JA; Bent, TC; Brunner, LC; Dao, MM; Jorgensen, KS; Kuniyoshi, J; Le, HD; Masatsugu, MK; Meyskens, FL; Morohashi, D; Nguyen, HP; Panagon, SN; Phung, C; Raymundo, V; Ton, T; Walker, AP; Wenzel, LB; Ziogas, A; Adams, PC; Bloch, E; Chakrabarti, S; Fleischhauer, A; Harrison, H; Jia, K; Larson, S; Lin, E; Lopez, M; Nguyen, L; Pepper, C; Power, T; Speechley, M; Sun, D; Woelfle, D; Jordan, J; Hogan, B; Moses, G; Harris, EL; Aickin, M; Baker, E; Erwin, M; Holup, J; Lloyd, C; Press, N; Press, RD; Reiss, J; Ritenbaugh, C; Uchida, A; Vogt, T; Yim, D; Gordeuk, VR; Dawkins, FW; Fadojutimi-Akinsiku, M; Castro, O; White-Coleman, D; Gerald, M; Harrison, BW; Lewis-Jack, O; Murray, RF; McDonald-Pinkett, S; Romagoza, J; Williams, R; Eckfeldt, JH; Leiendecker-Foster, C; McGlennen, RC; Rynders, G; Tsai, MY; Reboussin, DM; Snively, BM; Anderson, R; Bostic, E; Craven, BL; Ellis, S; Furberg, C; Griffin, J; Hall, M; Harris, D; Henkin, L; Jackson, S; Jewett, T; King, MD; Lohman, K; Lovato, L; Michaleckyj, J; Palla, S; Parks, T; Passmore, L; Phatak, PD; Rich, S; Ruggiero, A; Vitolins, M; Wolgast, G; Zaccaro, D; Sholinsky, P; Bookman, E; Chang, H; Fabsitz, R; Jaquish, C; Manolio, T; O'Neill, L; Thomson, E		HEIRS Study Res Investigators	Hemochromatosis and iron-overload screening in a racially diverse population	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEREDITARY HEMOCHROMATOSIS; AFRICAN-AMERICANS; GENE HFE; PREVALENCE; MUTATION; HEPATITIS; FIBROSIS; ORIGIN	BACKGROUND: Iron overload and hemochromatosis are common, treatable conditions. HFE genotypes, levels of serum ferritin, transferrin saturation values, and self-reported medical history were studied in a multiethnic primary care population. METHODS: Participants were recruited from primary care practices and blood-drawing laboratories. Blood samples were tested for transferrin saturation, serum ferritin, and C282Y and H63D mutations of the HFE gene. Before genetic screening, participants were asked whether they had a history of medical conditions related to iron overload. RESULTS: Of the 99,711 participants, 299 were homozygous for the C282Y mutation. The estimated prevalence of C282Y homozygotes was higher in non-Hispanic whites (0.44 percent) than in Native Americans (0.11 percent), Hispanics (0.027 percent), blacks (0.014 percent), Pacific Islanders (0.012 percent), or Asians (0.000039 percent). Among participants who were homozygous for the C282Y mutation but in whom iron overload had not been diagnosed (227 participants), serum ferritin levels were greater than 300 microg per liter in 78 of 89 men (88 percent) and greater than 200 microg per liter in 79 of 138 women (57 percent). Pacific Islanders and Asians had the highest geometric mean levels of serum ferritin and mean transferrin saturation despite having the lowest prevalence of C282Y homozygotes. There were 364 participants in whom iron overload had not been diagnosed (29 C282Y homozygotes) who had a serum ferritin level greater than 1000 microg per liter. Among men, C282Y homozygotes and compound heterozygotes were more likely to report a history of liver disease than were participants without HFE mutations. CONCLUSIONS: The C282Y mutation is most common in whites, and most C282Y homozygotes have elevations in serum ferritin levels and transferrin saturation. The C282Y mutation does not account for high mean serum ferritin levels and transferrin saturation values in nonwhites.	London Hlth Sci Ctr, Dept Med, London, ON N6A 5A5, Canada; Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27103 USA; So Iron Disorders Ctr, Birmingham, AL USA; Univ Calif Irvine, Dept Med, Div Hematol & Oncol, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92717 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN USA; Vet Affairs Long Beach Healthcare Syst, Long Beach, CA USA; Howard Univ, Dept Med, Washington, DC 20059 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA; Kaiser Permanente Ctr Hlth Res, Portland, OR USA; Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; Kaiser Permanente Ctr Hlth Res, Honolulu, HI USA; NHGRI, Bethesda, MD 20892 USA; NHLBI, Epidemiol & Biometry Program, Bethesda, MD 20892 USA	London Health Sciences Centre; Wake Forest University; Wake Forest Baptist Medical Center; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; Howard University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Kaiser Permanente; Western University (University of Western Ontario); Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Adams, PC (corresponding author), London Hlth Sci Ctr, Dept Med, 339 Windermere Rd, London, ON N6A 5A5, Canada.	padams@uwo.ca	Gordeuk, Victor/AAG-6577-2019; Ellis, Shellie/GXG-6869-2022; Adams, Paul/G-2868-2011; Ellis, Shellie/I-4811-2015	Ellis, Shellie/0000-0002-3599-0804; Adams, Paul/0000-0002-9921-2956; Barton, James/0000-0003-2876-8276	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005190, N01HC005192, N01HC005189, N01HC005186, N01HC005191, N01HC005185, N01HC005188] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000032, M01RR000827, M01RR010284] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH1HL003679] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00032, M01-RR10284, M01-RR00827] Funding Source: Medline; NHLBI NIH HHS [N01-HC-05188, N01-HC-05189, N01-HC-05192, UH1-HL03679-05, N01-HC-05186, N01-HC-05190, N01-HC-05185, N01-HC-05191] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams PC, 1996, HEPATOLOGY, V23, P724, DOI 10.1002/hep.510230411; Adams PC, 1997, HEPATOLOGY, V25, P162, DOI 10.1002/hep.510250130; Andersen RV, 2004, BLOOD, V103, P2914, DOI 10.1182/blood-2003-10-3564; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Asberg A, 2001, SCAND J GASTROENTERO, V36, P1108; Bacon BR, 1999, ANN INTERN MED, V130, P953, DOI 10.7326/0003-4819-130-12-199906150-00002; Bacon BR, 2001, GASTROENTEROLOGY, V120, P718, DOI 10.1053/gast.2001.21913; Barton JC, 2003, BLOOD CELL MOL DIS, V31, P310, DOI 10.1016/S1079-9796(03)00166-9; Beaton M, 2002, HEPATOLOGY, V36, P673, DOI 10.1053/jhep.2002.35343; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Cox DR, 1974, THEORETICAL STAT; DIBISCEGLIE AM, 1992, GASTROENTEROLOGY, V102, P2108, DOI 10.1016/0016-5085(92)90339-Z; EASON RJ, 1990, AUST NZ J MED, V20, P226, DOI 10.1111/j.1445-5994.1990.tb01024.x; GORDEUK VR, 1986, LANCET, V1, P1310; Gordeuk VR, 2003, BLOOD CELL MOL DIS, V31, P299, DOI 10.1016/S1079-9796(03)00164-5; Ioannou GN, 2004, GASTROENTEROLOGY, V126, P1293, DOI 10.1053/j.gastro.2004.01.020; Kng C, 2001, J CLIN GASTROENTEROL, V33, P69, DOI 10.1097/00004836-200107000-00017; Lucotte G, 2003, BLOOD CELL MOL DIS, V31, P262, DOI 10.1016/S1079-9796(03)00133-5; McLaren CE, 2003, AM J MED SCI, V325, P53, DOI 10.1097/00000441-200302000-00001; Merryweather-Clarke AT, 2000, GENET TEST, V4, P183, DOI 10.1089/10906570050114902; Morrison ED, 2003, ANN INTERN MED, V139, P235, DOI 10.7326/0003-4819-139-3-200308050-00022; Morrison ED, 2003, ANN INTERN MED, V138, P627, DOI 10.7326/0003-4819-138-8-200304150-00008; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; OLIVER M, 1995, DIGEST DIS SCI, V40, P1589, DOI 10.1007/BF02285215; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Olynyk JK, 2004, MAYO CLIN PROC, V79, P309, DOI 10.4065/79.3.309; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Riggio O, 1997, AM J GASTROENTEROL, V92, P1298; Rochette J, 1999, AM J HUM GENET, V64, P1056, DOI 10.1086/302318; Steinberg KK, 2001, JAMA-J AM MED ASSOC, V285, P2216, DOI 10.1001/jama.285.17.2216; Tung BY, 2003, GASTROENTEROLOGY, V124, P318, DOI 10.1053/gast.2003.50046; Weir B.S., 1996, GENETIC DATA ANAL; Yamashita C, 2003, CLIN GASTROENTEROL H, V1, P388, DOI 10.1053/S1542-3565(03)00187-3	33	518	537	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1769	1778		10.1056/NEJMoa041534	http://dx.doi.org/10.1056/NEJMoa041534			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858186	Green Published			2022-12-28	WOS:000228689000007
J	Chamberlain, P				Chamberlain, P			Death after withdrawal of nutrition and hydration	LANCET			English	Editorial Material							RIGHT-TO-DIE		John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Oxford	Chamberlain, P (corresponding author), John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.	paul.chamberlain@obs-gyn.ox.ac.uk						GOVE M, 2005, TIMES LONDON    0329, P18; *IR MED COUNC, 1995, IR MED COUNC STAT; JENNETT B, 2002, VEGETATIVE STATE MED; MURDOCH A, 1995, BRIT MED J, V311, P405; SHERWELL P, 2005, SUNDAY TELEGRAP 0327, P17; WALL M, 1995, LANCET, V346, P368, DOI 10.1016/S0140-6736(95)92243-1	6	9	9	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1446	1447		10.1016/S0140-6736(05)66397-0	http://dx.doi.org/10.1016/S0140-6736(05)66397-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850616				2022-12-28	WOS:000228651600007
J	Singh, DK; Kumar, D; Siddiqui, Z; Basu, SK; Kumar, V; Rao, KVS				Singh, DK; Kumar, D; Siddiqui, Z; Basu, SK; Kumar, V; Rao, KVS			The strength of receptor signaling is centrally controlled through a cooperative loop between Ca2+ and an oxidant signal	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CELL ANTIGEN RECEPTOR; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; B-LYMPHOCYTES; NADPH OXIDASE; IN-VIVO; ACTIVATION; KINASE; IDENTIFICATION	Activation of cell-surface receptors stimulates generation of intracellular signals that, in turn, direct the cellular response. However, mechanisms that ensure combinatorial control of these signaling events are not well understood. We show here that the Ca2+ and reactive oxygen intermediates generated upon BCR activation rapidly engage in a cooperative interaction that acts in a feedback manner to amplify the early signal generated. This cooperativity acts by regulating the concentration of the oxidant produced. The latter exerts its influence through a pulsed inactivation of receptor-coupled phosphatases, where the amplitude of this pulse is determined by oxidant concentration. The extent of phosphatase inhibition, in turn, dictates what proportion of receptor-proximal kinases are activated and, as a result, the net strength of the initial signal. It is the strength of this initial signal that finally determines the eventual duration of BCR signaling and the rate of its transmission through downstream pathways.	Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Rao, KVS (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	kanury@icgeb.res.in	Singh, Dinesh/S-3636-2019; Kumar, Vikas/D-3406-2009; Singh, Dinesh/A-1045-2009	Singh, Dinesh/0000-0002-3594-2431; Singh, Dinesh/0000-0002-3594-2431				Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; CAMPBELL MA, 1992, MOL CELL BIOL, V12, P2315, DOI 10.1128/MCB.12.5.2315; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fuentes-Panana EM, 2004, IMMUNOL REV, V197, P26, DOI 10.1111/j.0105-2896.2004.0105.x; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hua CT, 1998, J BIOL CHEM, V273, P28332, DOI 10.1074/jbc.273.43.28332; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Kubohara Y, 1999, BIOCHEM BIOPH RES CO, V263, P790, DOI 10.1006/bbrc.1999.1468; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; NAKAMURA Y, 1991, BIOCHEMISTRY-US, V30, P4880, DOI 10.1021/bi00234a007; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 1999, CELL, V97, P675, DOI 10.1016/S0092-8674(00)80779-5; Qin SF, 2000, P NATL ACAD SCI USA, V97, P7118, DOI 10.1073/pnas.130198197; Reth M, 2004, NAT REV IMMUNOL, V4, P269, DOI 10.1038/nri1335; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Saito K, 2003, IMMUNITY, V19, P669, DOI 10.1016/S1074-7613(03)00297-8; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Smith FD, 2002, CURR BIOL, V12, pR32, DOI 10.1016/S0960-9822(01)00646-7; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Yadava N, 1997, MOL BIOCHEM PARASIT, V84, P69, DOI 10.1016/S0166-6851(96)02782-X; Yoshida K, 2001, MOL PHARMACOL, V60, P1431, DOI 10.1124/mol.60.6.1431; Zhang S, 1998, ACM SIGPLAN NOTICES, V33, P11, DOI 10.1145/277633.277635	38	166	171	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					281	293		10.1016/j.cell.2005.02.036	http://dx.doi.org/10.1016/j.cell.2005.02.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851034	Bronze			2022-12-28	WOS:000228705000015
J	Dean, RA; Talbot, NJ; Ebbole, DJ; Farman, ML; Mitchell, TK; Orbach, MJ; Thon, M; Kulkarni, R; Xu, JR; Pan, HQ; Read, ND; Lee, YH; Carbone, I; Brown, D; Oh, YY; Donofrio, N; Jeong, JS; Soanes, DM; Djonovic, S; Kolomiets, E; Rehmeyer, C; Li, WX; Harding, M; Kim, S; Lebrun, MH; Bohnert, H; Coughlan, S; Butler, J; Calvo, S; Ma, LJ; Nicol, R; Purcell, S; Nusbaum, C; Galagan, JE; Birren, BW				Dean, RA; Talbot, NJ; Ebbole, DJ; Farman, ML; Mitchell, TK; Orbach, MJ; Thon, M; Kulkarni, R; Xu, JR; Pan, HQ; Read, ND; Lee, YH; Carbone, I; Brown, D; Oh, YY; Donofrio, N; Jeong, JS; Soanes, DM; Djonovic, S; Kolomiets, E; Rehmeyer, C; Li, WX; Harding, M; Kim, S; Lebrun, MH; Bohnert, H; Coughlan, S; Butler, J; Calvo, S; Ma, LJ; Nicol, R; Purcell, S; Nusbaum, C; Galagan, JE; Birren, BW			The genome sequence of the rice blast fungus Magnaporthe grisea	NATURE			English	Article							INDUCED POINT MUTATION; GENE-EXPRESSION; DRAFT SEQUENCE; PHYSICAL MAP; RESISTANCE; INFECTION; KINASE; ORGANIZATION; SPECIFICITY; CONTAINS	Magnaporthe grisea is the most destructive pathogen of rice worldwide and the principal model organism for elucidating the molecular basis of fungal disease of plants. Here, we report the draft sequence of the M. grisea genome. Analysis of the gene set provides an insight into the adaptations required by a fungus to cause disease. The genome encodes a large and diverse set of secreted proteins, including those defined by unusual carbohydrate-binding domains. This fungus also possesses an expanded family of G-protein-coupled receptors, several new virulence-associated genes and large suites of enzymes involved in secondary metabolism. Consistent with a role in fungal pathogenesis, the expression of several of these genes is upregulated during the early stages of infection-related development. The M. grisea genome has been subject to invasion and proliferation of active transposable elements, reflecting the clonal nature of this fungus imposed by widespread rice cultivation.	N Carolina State Univ, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA; Univ Exeter, Sch Biol & Chem Sci, Washington Singer Labs, Exeter EX4 4QG, Devon, England; Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; Univ Arizona, Dept Plant Pathol, Tucson, AZ 85721 USA; Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland; Seoul Natl Univ, Sch Agr Biotechnol, Seoul 151742, South Korea; Bayer Cropsci, CNRS Bayer, FRE2579, F-69263 Lyon, France; Agilent Technol, Wilmington, DE 19808 USA; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA	University of North Carolina; North Carolina State University; University of Exeter; Texas A&M University System; Texas A&M University College Station; University of Kentucky; University of Arizona; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Edinburgh; Seoul National University (SNU); Bayer AG; Bayer CropScience; Agilent Technologies; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Dean, RA (corresponding author), N Carolina State Univ, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA.	Ralph_Dean@ncsu.edu	Talbot, Nicholas J/I-9584-2014; Ma, Li-Jun/AAG-2359-2020; Thon, Michael/M-9463-2014; Harding, Michael/R-4098-2019; Talbot, Nicholas J/I-5618-2019	Talbot, Nicholas J/0000-0001-6434-7757; Thon, Michael/0000-0002-7225-7003; Harding, Michael/0000-0002-9322-1894; Talbot, Nicholas J/0000-0001-6434-7757; Nicol, Robert/0000-0003-1932-1392; Ma, Li-Jun/0000-0002-2733-3708; Bohnert, Heidi/0000-0002-0887-5026; Rehmeyer Caudill, Cathryn/0000-0001-8267-8795; Read, Nick/0000-0002-2286-2862; Galagan, James/0000-0003-0542-3291; Oh, Yeonyee/0000-0002-5571-3687; Pan, Huaqin/0000-0002-7166-108X; LEBRUN, marc-henri/0000-0003-1562-1902				Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Bolker M, 1998, FUNGAL GENET BIOL, V25, P143, DOI 10.1006/fgbi.1998.1102; BONMAN JM, 1992, EUPHYTICA, V63, P115, DOI 10.1007/BF00023917; CHAO CCT, 1991, CAN J BOT, V69, P2130, DOI 10.1139/b91-267; Dean RA, 1997, ANNU REV PHYTOPATHOL, V35, P211, DOI 10.1146/annurev.phyto.35.1.211; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Ebbole DJ, 2004, MOL PLANT MICROBE IN, V17, P1337, DOI 10.1094/MPMI.2004.17.12.1337; Farman ML, 2002, GENETICS, V160, P137; Farman ML, 2002, MOL PLANT MICROBE IN, V15, P6, DOI 10.1094/MPMI.2002.15.1.6; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; HAMER JE, 1988, SCIENCE, V239, P288, DOI 10.1126/science.239.4837.288; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Idnurm A, 2001, MOL PLANT PATHOL, V2, P241, DOI 10.1046/j.1464-6722.2001.00070.x; Ikeda K, 2002, MOL MICROBIOL, V45, P1355, DOI 10.1046/j.1365-2958.2002.03101.x; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Kang S, 2001, MOL PLANT MICROBE IN, V14, P671, DOI 10.1094/MPMI.2001.14.5.671; Kang SC, 1995, MOL PLANT MICROBE IN, V8, P939, DOI 10.1094/MPMI-8-0939; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; MOSS J, 1993, J BIOL CHEM, V268, P6383; Nakayashiki H, 2001, NUCLEIC ACIDS RES, V29, P4106, DOI 10.1093/nar/29.20.4106; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nitta N, 1997, THEOR APPL GENET, V95, P20, DOI 10.1007/s001220050528; Ptashne M, 2003, SCIENCE, V299, P1025, DOI 10.1126/science.1081519; Schmidt R, 2000, CURR OPIN PLANT BIOL, V3, P97, DOI 10.1016/S1369-5266(99)00048-5; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Steiner-Lange S, 2003, MOL PLANT MICROBE IN, V16, P893, DOI 10.1094/MPMI.2003.16.10.893; SWEIGARD JA, 1992, MOL GEN GENET, V232, P183, DOI 10.1007/BF00279995; SWEIGARD JA, 1993, GENETIC MAPS; Takano Y, 2003, MOL PLANT PATHOL, V4, P337, DOI [10.1046/j.1364-3703.2003.00182.x, 10.1046/J.1364-3703.2003.00182.X]; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; THIERINGER R, 1991, J BIOL CHEM, V266, P13110; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Thon MR, 2004, FUNGAL GENET BIOL, V41, P657, DOI 10.1016/j.fgb.2004.02.003; VALENT B, 1991, ANNU REV PHYTOPATHOL, V29, P443, DOI 10.1146/annurev.py.29.090191.002303; van den Burg HA, 2003, J BIOL CHEM, V278, P27340, DOI 10.1074/jbc.M212196200; Weiland J., 1997, FUNGAL GENET NEWSL, V44, P60, DOI DOI 10.4148/1941-4765.1290; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; ZEIGELR RS, 1994, RICE BLAST DIS; Zhu H, 1999, GENOME RES, V9, P739	50	1118	1649	13	243	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					980	986		10.1038/nature03449	http://dx.doi.org/10.1038/nature03449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846337	hybrid			2022-12-28	WOS:000228524600029
J	Tanaka, K; Mukae, N; Dewar, H; van Breugel, M; James, EK; Prescott, AR; Antony, C; Tanaka, TU				Tanaka, K; Mukae, N; Dewar, H; van Breugel, M; James, EK; Prescott, AR; Antony, C; Tanaka, TU			Molecular mechanisms of kinetochore capture by spindle microtubules	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; NEWT LUNG-CELLS; BUDDING YEAST; MITOTIC-SPINDLE; CHROMOSOME ATTACHMENT; PRECOCIOUS SEPARATION; SISTER CHROMATIDS; BI-ORIENTATION; DASH COMPLEX; DYNAMICS	For high-fidelity chromosome segregation, kinetochores must be properly captured by spindle microtubules, but the mechanisms underlying initial kinetochore capture have remained elusive. Here we visualized individual kinetochore-microtubule interactions in Saccharomyces cerevisiae by regulating the activity of a centromere. Kinetochores are captured by the side of microtubules extending from spindle poles, and are subsequently transported poleward along them. The microtubule extension from spindle poles requires microtubule plus-end-tracking proteins and the Ran GDP/GTP exchange factor. Distinct kinetochore components are used for kinetochore capture by microtubules and for ensuring subsequent sister kinetochore bi-orientation on the spindle. Kar3, a kinesin-14 family member, is one of the regulators that promote transport of captured kinetochores along microtubules. During such transport, kinetochores ensure that they do not slide off their associated microtubules by facilitating the conversion of microtubule dynamics from shrinkage to growth at the plus ends. This conversion is promoted by the transport of Stu2 from the captured kinetochores to the plus ends of microtubules.	Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	University of Dundee; Max Planck Society; European Molecular Biology Laboratory (EMBL)	Tanaka, K (corresponding author), Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland.	t.tanaka@dundee.ac.uk	Prescott, Alan/Y-5956-2018; James, Euan K/K-1135-2012; antony, claude/K-5342-2013; Tanaka, Tomoyuki U/A-4775-2008; Tanaka, Kozo/Y-6566-2018	Prescott, Alan/0000-0002-0747-7317; James, Euan K/0000-0001-7969-6570; Tanaka, Kozo/0000-0001-6086-2858; Tanaka, Tomoyuki/0000-0002-9886-5947				Adams IR, 2000, TRENDS CELL BIOL, V10, P329, DOI 10.1016/S0962-8924(00)01798-0; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; ALEXANDER SP, 1991, J CELL BIOL, V113, P805, DOI 10.1083/jcb.113.4.805; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Corbett AH, 1997, MICROBIOL MOL BIOL R, V61, P193, DOI 10.1128/.61.2.193-211.1997; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Gupta ML, 2002, MOL BIOL CELL, V13, P2919, DOI 10.1091/mbc.E02-01-0003; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; King JM, 2000, J CELL BIOL, V151, P739, DOI 10.1083/jcb.151.4.739; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Lin HJ, 2001, J CELL BIOL, V155, P1173, DOI 10.1083/jcb.200108119; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; MERDES A, 1990, EUR J CELL BIOL, V53, P313; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Muller-Reichert T, 2003, CHROMOSOMA, V111, P417, DOI 10.1007/s00412-002-0220-6; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; PICKETTHEAPS J, 1991, INT REV CYTOL, V128, P63; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; SAUNDERS WS, 1995, J CELL BIOL, V128, P617, DOI 10.1083/jcb.128.4.617; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanaka TU, 2005, PHILOS T R SOC B, V360, P581, DOI 10.1098/rstb.2004.1612; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Winey M, 2001, NAT CELL BIOL, V3, pE23, DOI 10.1038/35050663	50	216	219	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					987	994		10.1038/nature03483	http://dx.doi.org/10.1038/nature03483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846338				2022-12-28	WOS:000228524600030
J	Rich-Edwards, JW; Kleinman, K; Michels, KB; Stampfer, MJ; Manson, JE; Rexrode, KM; Hibert, EN; Willett, WC				Rich-Edwards, JW; Kleinman, K; Michels, KB; Stampfer, MJ; Manson, JE; Rexrode, KM; Hibert, EN; Willett, WC			Longitudinal study of birth weight and adult body mass index in predicting risk of coronary heart disease and stroke in women	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; FETAL ORIGINS; EARLY GROWTH; CHILDHOOD; DEATH; ASSOCIATION; COHORT	Objectives To determine whether birth weight and adult body size interact to predict coronary heart disease in women, as has been observed for men. To determine whether birth weight and adult body size interact to predict risk of stroke. Design Longitudinal cohort study. Setting and participants 66 111 female nurses followed since 1976 who were born of singleton, term pregnancies and reported their birth weight in 1992. Main outcome measures 1504 events of coronary heart disease (myocardial infarction or sudden cardiac death) and 1164 strokes. Results For each kilogram of higher birth weight, age adjusted hazard ratios from prospective analysis were 0.77 (95% confidence interval 0.69 to 0.87) for coronary heart disease and 0.89 (0.78 to 1.01) for total stroke. In combined prospective and retrospective analysis, hazard ratios were 0.84 (0.76 to 0.93) for total stroke, 0.83 (0.71 to 0.96) for ischaemic stroke, and 0.86 (0.66 to 1. 11) for haemorrhagic stroke. Exclusion of macrosomic infants (> 4536 g) yielded stronger estimates. Risk of coronary heart disease was especially high for women who crossed from a low centile of weight at birth to a high centile of body mass index. in adulthood. The association of lower birth weight with increased risk of stroke was apparent across categories of body mass index in adults and was not especially strong among heavier women. Conclusions Higher body mass index in adulthood is an especially strong risk factor for coronary heart disease among women who were small at birth. In this large cohort of women, size at birth and adiposity in adulthood interacted to predict events of coronary heart disease but not stroke events.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA 02215 USA; Harvard Univ, Sch Med, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Rich-Edwards, JW (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave, Boston, MA 02215 USA.	janet_rich-edwards@hphc.org	Rexrode, Kathryn M/I-1177-2018	Kleinman, Ken/0000-0002-5600-5834; Rexrode, Kathryn/0000-0003-3387-8429				Bailey SCC, 2002, J TURBUL, V3; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; COX DR, 1972, J R STAT SOC B, V34, P187; Eriksson JG, 2000, STROKE, V31, P869, DOI 10.1161/01.STR.31.4.869; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; FORSEN T, 1990, BRIT MED J, V314, P1403; Frankel S, 1996, PUBLIC HEALTH, V110, P139, DOI 10.1016/S0033-3506(96)80066-7; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; Gunnarsdottir I, 2002, AM J CLIN NUTR, V76, P1290, DOI 10.1093/ajcn/76.6.1290; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Koupilova I, 1999, J HYPERTENS, V17, P19, DOI 10.1097/00004872-199917010-00004; Lawlor DA, 2004, AM J PUBLIC HEALTH, V94, P1386, DOI 10.2105/AJPH.94.8.1386; LEON D, 2001, BMJ-BRIT MED J, V323, P1033; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; OSMOND C, 1993, BRIT MED J, V307, P1919; Rich-Edwards J., 2004, Fetal nutrition and adult disease: programming of chronic disease through fetal exposure to undernutrition, P87, DOI 10.1079/9780851998213.0087; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Tilling K, 2004, EPIDEMIOLOGY, V15, P557, DOI 10.1097/01.ede.0000135172.67293.60; TROY LM, 1995, INT J OBESITY, V19, P570	26	154	165	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2005	330	7500					1115	1118A		10.1136/bmj.38434.629630.E0	http://dx.doi.org/10.1136/bmj.38434.629630.E0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15857857	Green Submitted, Green Published			2022-12-28	WOS:000229166900017
J	Thangaraj, K; Chaubey, G; Kivisild, T; Reddy, AG; Singh, VK; Rasalkar, AA; Singh, L				Thangaraj, K; Chaubey, G; Kivisild, T; Reddy, AG; Singh, VK; Rasalkar, AA; Singh, L			Reconstructing the origin of Andaman Islanders	SCIENCE			English	Article							MODERN HUMANS		Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; Estonian Bioctr, EE-51010 Tartu, Estonia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Estonian Biocentre	Singh, L (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	lalji@ccmb.res.in	Rasalkar, Avinash Arvind/ABA-6519-2021; Kivisild, Toomas/P-5889-2017; Thangaraj, Kumarasamy/G-5596-2010; Chaubey, Gyaneshwer/H-2753-2012; Chaubey, Gyaneshwer/AAC-6409-2019	Rasalkar, Avinash Arvind/0000-0003-2277-9556; Kivisild, Toomas/0000-0002-6297-7808; Chaubey, Gyaneshwer/0000-0003-2899-3852; Chaubey, Gyaneshwer/0000-0003-2899-3852; Thangaraj, Kumarasamy/0000-0002-0075-0106				Endicott P, 2003, AM J HUM GENET, V72, P1590, DOI 10.1086/375408; Endicott P, 2003, AM J HUM GENET, V72, P178, DOI 10.1086/345487; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; THANGARAJ K, UNPUB; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	9	215	222	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					996	996		10.1126/science.1109987	http://dx.doi.org/10.1126/science.1109987			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890876				2022-12-28	WOS:000229190700038
J	Bradshaw, GA; Finlay, BL				Bradshaw, GA; Finlay, BL			Natural symmetry	NATURE			English	Article									Oregon State Univ, Environm Sci Grad Programme, Corvallis, OR 97331 USA; Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Oregon State University; Cornell University; Cornell University	Bradshaw, GA (corresponding author), Oregon State Univ, Environm Sci Grad Programme, Corvallis, OR 97331 USA.							BERRIDGE KC, 2003, HDB AFFECTIVE SCI, pCH3; Finlay BL, 2001, BEHAV BRAIN SCI, V24, P263, DOI 10.1017/S0140525X01003958; Gee H, 2002, NATURE, V420, P611, DOI 10.1038/420611a; Sapolsky R.M., 2001, PRIMATES MEMOIR NEUR	4	9	9	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					149	149		10.1038/435149a	http://dx.doi.org/10.1038/435149a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889070				2022-12-28	WOS:000229021100020
J	Goldfinger, SE				Goldfinger, SE			On needless words	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Goldfinger, SE (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1947	1947		10.1056/NEJMp048355	http://dx.doi.org/10.1056/NEJMp048355			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888693				2022-12-28	WOS:000229017100003
J	Horvitz, HR				Horvitz, HR			Stanley J. Korsmeyer (1950-2005) - Obituary	NATURE			English	Biographical-Item									MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Horvitz, HR (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	horvitz@mit.edu							0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					161	161		10.1038/435161a	http://dx.doi.org/10.1038/435161a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889078				2022-12-28	WOS:000229021100027
J	Sambrook, P				Sambrook, P			Vitamin D and fractures: quo vadis?	LANCET			English	Editorial Material							D SUPPLEMENTATION; WOMEN; CALCIUM; OLDER; MEN		Royal N Shore Hosp, Inst Bone & Joint Res, Sydney, NSW 2065, Australia	Royal North Shore Hospital; University of Sydney	Sambrook, P (corresponding author), Royal N Shore Hosp, Inst Bone & Joint Res, Sydney, NSW 2065, Australia.	sambrook@med.usyd.edy.au						ANDERSON FH, 2004, J BONE MINER RES  S1, V19, P1220; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; DOYLE AC, 1912, SPECKLED BAND; Latham NK, 2003, J AM GERIATR SOC, V51, P1219, DOI 10.1046/j.1532-5415.2003.51405.x; NEWCOMBE RG, 1988, STAT MED, V7, P1179, DOI 10.1002/sim.4780071111; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469	7	15	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 7	2005	365	9471					1599	1600		10.1016/S0140-6736(05)66385-4	http://dx.doi.org/10.1016/S0140-6736(05)66385-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885279				2022-12-28	WOS:000228933700004
J	Pettifer, RF; Mathon, O; Pascarelli, S; Cooke, MD; Gibbs, MRJ				Pettifer, RF; Mathon, O; Pascarelli, S; Cooke, MD; Gibbs, MRJ			Measurement of femtometre-scale atomic displacements by X-ray absorption spectroscopy	NATURE			English	Article							FINE-STRUCTURE; BEAMLINE; EDGE	The frequencies of extended X-ray absorption fine-structure (EXAFS)(1) measurements, which are oscillations occurring on the high-energy side of an X-ray absorption edge, can be used to identify interatomic distances in materials. We have used a dispersive X-ray spectrometer(2-5), which has no moving components, to make rapid measurements with minimal energy drift of the difference in EXAFS from the Fe K edge in an iron-cobalt thin film undergoing periodic strain through magnetostriction(6,7). We show that magnetostriction can be detected by differential X-ray absorption. The magnitude of the recorded signal relative to the noise shows a sensitivity to mean differential atomic motion of one femtometre: a factor of 100 times more sensitive than that normally available(8,9).	Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; European Synchrotron Radiat Facil, F-38043 Grenoble, France; Univ Sheffield, Dept Mat Engn, Sheffield S1 3JD, S Yorkshire, England	University of Warwick; European Synchrotron Radiation Facility (ESRF); University of Sheffield	Pettifer, RF (corresponding author), Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.	r.pettifer@warwick.ac.uk		pascarelli, sakura/0000-0003-4658-3195				Aksenov VL, 2001, PHYS PART NUCLEI, V32, P675; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; BAYLISS P, 1990, CAN MINERAL, V28, P751; BENFATTO M, 1986, PHYS REV B, V34, P5774, DOI 10.1103/PhysRevB.34.5774; BENFATTO M, 1989, PHYS REV B, V39, P1936, DOI 10.1103/PhysRevB.39.1936; BROUDER C, 1989, PHYS REV B, V39, P1488, DOI 10.1103/PhysRevB.39.1488; Dalba G, 1999, PHYS REV LETT, V82, P4240, DOI 10.1103/PhysRevLett.82.4240; DELACHEISSERIE ED, 1993, MAGNETOSTRICTION THE, P133; Gibbs M., 2001, MODERN TRENDS MAGNET; Hagelstein M, 1997, J PHYS IV, V7, P303, DOI 10.1051/jp4/1997206; HAGELSTEIN M, 1993, JPN J APPL PHYS 1, V32, P240, DOI 10.7567/JJAPS.32S2.240; Hanham ML, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.180101; KOCH A, 1996, IS T SPIE P S EL IM, V2416, P85; LEE PA, 1975, PHYS REV B, V11, P2795, DOI 10.1103/PhysRevB.11.2795; Mathon O, 2004, J SYNCHROTRON RADIAT, V11, P423, DOI 10.1107/S0909049504018862; PASCARELLI S, 2002, J ALLOY COMPD, V362, P33; Rehr JJ, 2000, REV MOD PHYS, V72, P621, DOI 10.1103/RevModPhys.72.621; SAYERS DE, 1971, PHYS REV LETT, V27, P1204, DOI 10.1103/PhysRevLett.27.1204	18	92	92	6	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					78	81		10.1038/nature03516	http://dx.doi.org/10.1038/nature03516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875018				2022-12-28	WOS:000228864600040
J	Merryfield, B				Merryfield, B			Ocean mixing in 10 steps	SCIENCE			English	Editorial Material							SALT-FINGER CONVECTION; ABYSSAL OCEAN		Meteorol Serv Canada, Canadian Ctr Climate Modelling & Anal, Victoria, BC V8W 2Y2, Canada	Environment & Climate Change Canada; Canadian Centre for Climate Modelling & Analysis (CCCma); Meteorological Service of Canada	Merryfield, B (corresponding author), Meteorol Serv Canada, Canadian Ctr Climate Modelling & Anal, Victoria, BC V8W 2Y2, Canada.	bill.merryfield@ec.gc.ca						Garrett C, 2003, SCIENCE, V301, P1858; Griffies SM, 2000, OCEAN MODEL, V2, P123, DOI 10.1016/S1463-5003(00)00014-7; Kunze E., 2004, OCEANOGRAPHY, V17, P55, DOI [10.5670/oceanog.2004.67, DOI 10.5670/OCEANOG.2004.67]; Ledwell JR, 2000, NATURE, V403, P179, DOI 10.1038/35003164; Ledwell JR, 1998, J GEOPHYS RES-OCEANS, V103, P21499, DOI 10.1029/98JC01738; MUNK W., 1966, DEEP SEA RES OCEANOG, V13, P707, DOI [10.1016/0011-7471(66)90602-4, DOI 10.1016/0011-7471(66)90602-4]; Osborn T. R., 1972, Geophysical Fluid Dynamics, V3, P321, DOI 10.1080/03091927208236085; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Polzin KL, 1997, SCIENCE, V276, P93, DOI 10.1126/science.276.5309.93; Schmitt RW, 2005, SCIENCE, V308, P685, DOI 10.1126/science.1108678; Schmitt RW, 2003, PROG OCEANOGR, V56, P419, DOI 10.1016/S0079-6611(03)00033-8; Yoshida J, 2003, PROG OCEANOGR, V56, P435, DOI 10.1016/S0079-6611(03)00032-6	12	4	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2005	308	5722					641	642		10.1126/science.1111417	http://dx.doi.org/10.1126/science.1111417			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860614				2022-12-28	WOS:000228810900033
J	Sapolsky, RM				Sapolsky, RM			The influence of social hierarchy on primate health	SCIENCE			English	Review							CORTISOL-LEVELS; STRESS; RANK; DOMINANCE; BEHAVIOR; PERSONALITY; COMPETITION; POPULATION; STYLES; IMMUNE	Dominance hierarchies occur in numerous social species, and rank within them can greatly influence the quality of life of an animal. In this review, I consider how rank can also influence physiology and health. I first consider whether it is high- or low-ranking animals that are most stressed in a dominance hierarchy; this turns out to vary as a function of the social organization in different species and populations. I then review how the stressful characteristics of social rank have adverse adrenocortical, cardiovascular, reproductive, immunological, and neurobiological consequences. Finally, I consider how these findings apply to the human realm of health, disease, and socioeconomic status.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya	Stanford University; Stanford University	Sapolsky, RM (corresponding author), Stanford Univ, Dept Biol Sci, MC 5020, Stanford, CA 94305 USA.	sapolsky@stanford.edu						Abbott DH, 1998, COMP BIOCHEM PHYS C, V119, P261, DOI 10.1016/S0742-8413(98)00015-2; Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Ader R., 2001, PSYCHONEUROIMMUNOLOG; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; ALTMANN J, 1995, NATURE, V377, P688, DOI 10.1038/377688a0; BARNETT SA, 1955, NATURE, V175, P126, DOI 10.1038/175126b0; BERCOVITCH FB, 1995, PHYSIOL BEHAV, V58, P215, DOI 10.1016/0031-9384(95)00055-N; BRADY JV, 1958, J EXP ANAL BEHAV, V1, P69, DOI 10.1901/jeab.1958.1-69; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Cavigelli SA, 1999, ANIM BEHAV, V57, P935, DOI 10.1006/anbe.1998.1054; Cohen S, 1997, PSYCHOSOM MED, V59, P213, DOI 10.1097/00006842-199705000-00001; Creel S, 1996, NATURE, V379, P212, DOI 10.1038/379212a0; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; DAVIS DE, 1957, P SOC EXP BIOL MED, V94, P728; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; DEWAAL F, 1983, CHIMPANZEE POLITICS; Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059; EBERHART JA, 1983, PHYSIOL BEHAV, V30, P361, DOI 10.1016/0031-9384(83)90139-7; Fehr E, 2004, CURR OPIN NEUROBIOL, V14, P784, DOI 10.1016/j.conb.2004.10.007; FOX MW, 1973, BEHAVIOUR, V46, P128; Goymann W, 2003, HORM BEHAV, V43, P474, DOI 10.1016/S0018-506X(03)00032-1; GUST DA, 1991, BRAIN BEHAV IMMUN, V5, P296, DOI 10.1016/0889-1591(91)90024-5; KAWACHI I, 2002, HLTH NATIONS WHY INE; Kozorovitskiy Y, 2004, J NEUROSCI, V24, P6755, DOI 10.1523/JNEUROSCI.0345-04.2004; Lucassen PJ, 2001, EUR J NEUROSCI, V14, P161, DOI 10.1046/j.0953-816x.2001.01629.x; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Magarinos AM, 1996, J NEUROSCI, V16, P3534; Maggioncalda AN, 2002, AM J PHYS ANTHROPOL, V118, P25, DOI 10.1002/ajpa.10074; MANOGUE K R, 1975, Primates, V16, P457, DOI 10.1007/BF02382742; MANUCK SB, 1995, PSYCHOSOM MED, V57, P275, DOI 10.1097/00006842-199505000-00009; MASATAKA N, 1990, ETHOLOGY, V85, P147; McLeod PJ, 1996, CAN J ZOOL, V74, P209, DOI 10.1139/z96-026; Morgan D, 2000, AM J PRIMATOL, V52, P115, DOI 10.1002/1098-2345(200011)52:3<115::AID-AJP1>3.0.CO;2-Z; PACKER C, 1995, NATURE, V373, P60, DOI 10.1038/373060a0; RAY JC, 1992, AM J PRIMATOL, V28, P231, DOI 10.1002/ajp.1350280402; Sands J, 2004, ANIM BEHAV, V67, P387, DOI 10.1016/j.anbehav.2003.03.019; SAPOLSKY RM, 1991, PSYCHONEUROENDOCRINO, V16, P281, DOI 10.1016/0306-4530(91)90015-L; Sapolsky RM, 2004, PLOS BIOL, V2, P534, DOI 10.1371/journal.pbio.0020106; SAPOLSKY RM, 1994, AM J PRIMATOL, V32, P261, DOI 10.1002/ajp.1350320404; SAPOLSKY RM, 1990, BIOL PSYCHIAT, V28, P862, DOI 10.1016/0006-3223(90)90568-M; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sapolsky RM., 1993, PRIMATE SOCIAL CONFL, P171; Schoech SJ, 1997, PHYSIOL ZOOL, V70, P68, DOI 10.1086/639545; SHIVELY CA, 1994, ARTERIOSCLER THROMB, V14, P721, DOI 10.1161/01.ATV.14.5.721; Siegrist J, 2004, SOC SCI MED, V58, P1463, DOI 10.1016/S0277-9536(03)00349-6; Smuts B. B., 1999, SEX FRIENDSHIP BABOO; Thierry B., 2004, MACAQUE SOC MODEL ST; Virgin CE, 1997, AM J PRIMATOL, V42, P25, DOI 10.1002/(SICI)1098-2345(1997)42:1<25::AID-AJP2>3.3.CO;2-T; WALLNER B, 1996, INTEGRATIVE NEUROBIO, P45; Wilkinson Richard G, 2000, MIND GAP HIERARCHIES; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x	51	1201	1227	34	465	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					648	652		10.1126/science.1106477	http://dx.doi.org/10.1126/science.1106477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	922BO	15860617				2022-12-28	WOS:000228810900036
J	Sachs, JP; Anderson, RF				Sachs, JP; Anderson, RF			Increased productivity in the subantarctic ocean during Heinrich events	NATURE			English	Article							ICE CORE; THERMOHALINE CIRCULATION; CLIMATE-CHANGE; LABRADOR-SEA; TAYLOR DOME; IRON; SEDIMENT; MELTWATER; BIOMASS; RECORD	Massive iceberg discharges from the Northern Hemisphere ice sheets, 'Heinrich events', coincided with the coldest periods of the last ice age(1). There is widespread evidence for Heinrich events and their profound impact on the climate and circulation of the North Atlantic Ocean, but their influence beyond that region remains uncertain(1). Here we use a combination of molecular fingerprints of algal productivity and radioisotope tracers of sedimentation to document eight periods of increased productivity in the subpolar Southern Ocean during the past 70,000 years that occurred within 1,000-2,000 years of a Northern Hemisphere Heinrich event. We discuss possible causes for such a link, including increased supply of iron from upwelling and increased stratification during the growing season, which imply an alteration of the global ocean circulation during Heinrich events. The mechanisms linking North Atlantic iceberg discharges with subantarctic productivity remain unclear at this point. We suggest that understanding how the Southern Ocean was altered during these extreme climate perturbations is critical to understanding the role of the ocean in climate change.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Massachusetts Institute of Technology (MIT); Columbia University	Sachs, JP (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave,Room E34-254, Cambridge, MA 02139 USA.	jsachs@mit.edu		Anderson, Robert/0000-0002-8472-2494				Abbott MR, 2000, DEEP-SEA RES PT II, V47, P3285, DOI 10.1016/S0967-0645(00)00069-2; Arz HW, 1998, QUATERNARY RES, V50, P157, DOI 10.1006/qres.1998.1992; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Boyd P, 1999, J GEOPHYS RES-OCEANS, V104, P13395, DOI 10.1029/1999JC900009; Chase Z, 2001, PALEOCEANOGRAPHY, V16, P468, DOI 10.1029/2000PA000542; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Lefevre N, 1999, GLOBAL BIOGEOCHEM CY, V13, P727, DOI 10.1029/1999GB900034; Little MG, 1997, PALEOCEANOGRAPHY, V12, P568, DOI 10.1029/97PA00823; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; MITCHELL BG, 1991, LIMNOL OCEANOGR, V36, P1662, DOI 10.4319/lo.1991.36.8.1662; Nilsson J, 2003, J PHYS OCEANOGR, V33, P2781, DOI 10.1175/1520-0485(2003)033<2781:TTCAVM>2.0.CO;2; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Piotrowski AM, 2004, EARTH PLANET SC LETT, V225, P205, DOI 10.1016/j.epsl.2004.06.002; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Rashid H, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000913; Rind D, 2001, J GEOPHYS RES-ATMOS, V106, P27355, DOI 10.1029/2001JD000954; Rohling EJ, 2004, NATURE, V430, P1016, DOI 10.1038/nature02859; Sachs JP, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000862; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; SMITH WO, 1985, SCIENCE, V227, P163, DOI 10.1126/science.227.4683.163; Steig EJ, 2000, GEOGR ANN A, V82A, P213, DOI 10.1111/j.0435-3676.2000.00122.x; Stoner JS, 2000, EARTH PLANET SC LETT, V183, P161, DOI 10.1016/S0012-821X(00)00272-7; van Kreveld S, 2000, PALEOCEANOGRAPHY, V15, P425, DOI 10.1029/1999PA000464; Volkman JK, 1998, ORG GEOCHEM, V29, P1163, DOI 10.1016/S0146-6380(98)00062-X; Watson AJ, 1999, TELLUS B, V51, P453, DOI 10.1034/j.1600-0889.1999.00022.x; Weaver PPE, 1998, PALEOCEANOGRAPHY, V13, P70, DOI 10.1029/97PA02982; Webb DJ, 2001, NATURE, V409, P37, DOI 10.1038/35051171	30	83	86	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1118	1121		10.1038/nature03544	http://dx.doi.org/10.1038/nature03544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858571				2022-12-28	WOS:000228693300040
J	Friedrich, MJ				Friedrich, MJ			Nanoscale biosensors show promise	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								Nanoscale devices could lead to a new future in medical diagnostics, detectingproteins, viruses, or DNA in a highly sensitive and selective manner. While such a prediction may sound unrealistic, work on such biological sensors by Charles Lieber, professor of chemistry at Harvard University, and members of his laboratory suggest that these tiny devices could one day help transform diagnostic medicine. Lieber, who holds more than 25 patents for various fundamental aspects of nanotechnology and its applications, is also a scientific founder of a nanotechnology company, Nanosys Inc, in Palo Alto, California.										Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b; Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101	2	5	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2005	293	16					1965	1965		10.1001/jama.293.16.1965	http://dx.doi.org/10.1001/jama.293.16.1965			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XS	15855416				2022-12-28	WOS:000228651500003
J	Fitzpatrick, JW; Lammertink, M; Luneau, MD; Gallagher, TW; Harrison, BR; Sparling, GM; Rosenberg, KV; Rohrbaugh, RW; Swarthout, ECH; Wrege, PH; Swarthout, SB; Dantzker, MS; Charif, RA; Barksdale, TR; Remsen, JV; Simon, SD; Zollner, D				Fitzpatrick, JW; Lammertink, M; Luneau, MD; Gallagher, TW; Harrison, BR; Sparling, GM; Rosenberg, KV; Rohrbaugh, RW; Swarthout, ECH; Wrege, PH; Swarthout, SB; Dantzker, MS; Charif, RA; Barksdale, TR; Remsen, JV; Simon, SD; Zollner, D			Ivory-billed woodpecker (Campephilus principalis) persists in continental North America	SCIENCE			English	Article								The ivory-billed woodpecker (Campephilus principalis), long suspected to be extinct, has been rediscovered in the Big Woods region of eastern Arkansas. Visual encounters during 2004 and 2005, and analysis of a video clip from April 2004, confirm the existence of at least one mate. Acoustic signatures consistent with Campephilus display drums also have been heard from the region. Extensive efforts to find birds away from the primary encounter site remain unsuccessful, but potential habitat for a thinly distributed source population is vast (over 220,000 hectares).	Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA; Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1092 AD Amsterdam, Netherlands; Univ Arkansas, Dept Engn Technol, Little Rock, AR 72204 USA; Univ Arkansas, Dept Informat Technol, Little Rock, AR 72204 USA; Oakwood Coll, Dept Commun, Huntsville, AL 35896 USA; Birdman Prod, Choteau, MT 59422 USA; Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; Nature Conservancy, Little Rock, AR 72205 USA	Cornell University; University of Amsterdam; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Oakwood University; Louisiana State University System; Louisiana State University; Nature Conservancy	Fitzpatrick, JW (corresponding author), Cornell Univ, Cornell Lab Ornithol, 159 Sapsucker Woods Rd, Ithaca, NY 14850 USA.	jwf7@cornell.edu	Charif, Russell/AAA-8506-2021; Zöllner, Dana/AAP-2725-2020	Zöllner, Dana/0000-0002-0413-2700; Charif, Russell/0000-0002-2228-4740				ALLEN ARTHUR A., 1937, AUK, V54, P164; AMERICAN ORNITHOLOGISTS' UNION, 1998, CHECKL N AM BIRDS; BLUME D, 1996, SCHWARZSPECHT GRUSPE; Bull EL, 1995, BIRDS N AM; Christensen Hans, 2002, Dansk Ornitologisk Forenings Tidsskrift, V96, P187; Eckelberry D., 1961, DISCOVERY GREAT MOME, P195; Hoose Phillip M., 2004, RACE SAVE LORD GOD B; Jackson J.A, 2002, BIRDS N AM; Jackson JJ, 2004, SEARCH IVORY BILLED; LAMB GR, 1957, 1 INT COMM BIRD PRES; Lammertink Martjan, 1995, Bird Conservation International, V5, P53; Tanner JT., 1942, 1 NAT AUD SOC; The Nature Conservancy, 2002, CONS PLANN MISS RIV; TJERNBERG M, 1993, ORNIS FENNICA, V70, P155; 1991, BIRDS PREY NATURAL H, P111	15	107	116	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2005	308	5727					1460	1462		10.1126/science.1114103	http://dx.doi.org/10.1126/science.1114103			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15860589				2022-12-28	WOS:000229619300051
J	Rose, R; Weyand, M; Lammers, M; Ishizaki, T; Ahmadian, MR; Wittinghofer, A				Rose, R; Weyand, M; Lammers, M; Ishizaki, T; Ahmadian, MR; Wittinghofer, A			Structural and mechanistic insights into the interaction between Rho and mammalian Dia	NATURE			English	Article							DIAPHANOUS-RELATED FORMIN; SMALL G-PROTEIN; CRYSTAL-STRUCTURE; ACTIN NUCLEATION; EFFECTOR RECOGNITION; SMALL GTPASE; MDIA1; DOMAIN; SWITCH; REORGANIZATION	Formins are involved in a variety of cellular processes that require the remodelling of the cytoskeleton. They contain formin homology domains FH1 and FH2, which initiate actin assembly(1,2). The Diaphanous-related formins form a subgroup that is characterized by an amino-terminal Rho GTPase-binding domain (GBD) and an FH3 domain, which bind somehow to the carboxy-terminal Diaphanous autoregulatory domain ( DAD) to keep the protein in an inactive conformation(3,4). Upon binding of activated Rho proteins, the DAD is released and the ability of the formin to nucleate and elongate unbranched actin filaments is induced. Here we present the crystal structure of RhoC in complex with the regulatory N terminus of mammalian Diaphanous 1 (mDia1) containing the GBD/FH3 region, an all-helical structure with armadillo repeats. Rho uses its 'switch' regions for interacting with two subdomains of GBD/FH3. We show that the FH3 domain of mDia1 forms a stable dimer and we also identify the DAD-binding site. Although binding of Rho and DAD on the N-terminal fragment of mDia1 are mutually exclusive, their binding sites are only partially overlapping. On the basis of our results, we propose a structural model for the regulation of mDia1 by Rho and DAD.	Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Dept Biol Struct, Otto Hahn Str 11, D-44227 Dortmund, Germany.	Alfred.wittinghofer@mpi-dortmund.mpg.de	Lammers, Michael/AAX-1164-2020	Lammers, Michael/0000-0003-4168-4640				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Blumenstein L, 2004, J BIOL CHEM, V279, P53419, DOI 10.1074/jbc.M409551200; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; EHRESMAN.B, 1973, ANAL BIOCHEM, V54, P454, DOI 10.1016/0003-2697(73)90374-6; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Kato T, 2001, J CELL SCI, V114, P775; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Krebs A, 2001, J CELL SCI, V114, P3663; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Rose R, 2005, ACTA CRYSTALLOGR F, V61, P225, DOI 10.1107/S1744309105001065; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	30	197	206	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2005	435	7041					513	518		10.1038/nature03604	http://dx.doi.org/10.1038/nature03604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15864301				2022-12-28	WOS:000229337800058
J	Dale, VH; Crisafulli, CM; Swanson, FJ				Dale, VH; Crisafulli, CM; Swanson, FJ			Ecology - 25 years of ecological change at Mount St. Helens	SCIENCE			English	Editorial Material									Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; US Forest Serv, USDA, Pacific NW Res Stn, Forestry Sci Lab, Olympia, WA 98512 USA; US Forest Serv, USDA, Pacific NW Res Stn, Forestry Sci Lab, Corvallis, OR 97331 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Dale, VH (corresponding author), Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA.	dalevh@ornl.gov	Dale, Virginia H/GSO-3448-2022; Dale, Virginia H/ABI-6672-2020; Dale, Virginia H/B-6023-2009	Dale, Virginia H/0000-0002-4123-7202; 				Dale V, 2005, ECOLOGICAL RESPONSES; Dzurisin D, 2005, EOS T AGU, V86, P25, DOI DOI 10.1029/2005EO030001; Lipman P.W., 1981, 1250 USGS, DOI [DOI 10.3133/PP1250, 10.3133/pp1250]	3	21	25	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					961	962		10.1126/science.1109684	http://dx.doi.org/10.1126/science.1109684			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890864				2022-12-28	WOS:000229190700024
J	Goldenberg, C; Goldhirsch, I				Goldenberg, C; Goldhirsch, I			Friction enhances elasticity in granular solids	NATURE			English	Article							MODEL; TRANSMISSION	For years, engineers have used elastic and plastic models to describe the properties of granular solids, such as sand piles and grains in silos(1-3). However, there are theoretical(4-6) and experimental(7-14) results that challenge this approach. Specifically, it has been claimed(4-6) that stress in granular solids propagates in a manner described by wave-like ( hyperbolic) equations, rather than the elliptic equations of static elasticity. Here we report numerical simulations of the response of a two-dimensional granular slab to an external load, revealing that both approaches are valid - albeit on different length scales. For small systems that can be considered mesoscopic on the scale of the grains, a hyperbolic-like, strongly anisotropic response is expected. However, in large systems ( those typically considered by engineers), the response is closer to that predicted by traditional isotropic elasticity models. Static friction, often ignored in simple models, plays a key role: it increases the elastic range and renders the response more isotropic, even beyond this range.	Tel Aviv Univ, Fac Engn, Dept Fluid Mech & Heat Transfer, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Goldhirsch, I (corresponding author), Tel Aviv Univ, Fac Engn, Dept Fluid Mech & Heat Transfer, IL-69978 Tel Aviv, Israel.	isaac@eng.tau.ac.il						BATHURST RJ, 1988, J APPL MECH-T ASME, V55, P17, DOI 10.1115/1.3173626; Bouchaud JP, 2001, EUR PHYS J E, V4, P451, DOI 10.1007/s101890170100; Brockbank R, 1997, J PHYS II, V7, P1521, DOI 10.1051/jp2:1997200; CHANG CS, 1992, INT J SOLIDS STRUCT, V29, P1001, DOI 10.1016/0020-7683(92)90071-Z; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47; Da Silva M, 2000, NATURE, V406, P708, DOI 10.1038/35021023; DASILVEIRA R, 2002, CONDMAT0208214; DRESCHER A, 1972, J MECH PHYS SOLIDS, V20, P337, DOI 10.1016/0022-5096(72)90029-4; Duffy J., 1957, J APPL MECH, V24, P585, DOI [10.1115/1.4011605, DOI 10.1115/1.4011605]; Gay C, 2004, EUROPHYS LETT, V68, P51, DOI 10.1209/epl/i2004-10162-1; Geng JF, 2003, PHYSICA D, V182, P274, DOI 10.1016/S0167-2789(03)00137-4; Geng JF, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.035506; Goldenberg C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.084302; Jackson R., 1983, Theory of Dispersed Multiphase Flow. Proceedings of an Advanced Seminar, P291; JOHNSON KL, 1985, CONTACT MECH, P220; Moukarzel CF, 2004, GRANUL MATTER, V6, P61, DOI 10.1007/s10035-004-0156-z; Mueggenburg NW, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031304; Nedderman R. M., 1992, STAT KINEMATICS GRAN; Otto M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031302; Reydellet G, 2001, PHYS REV LETT, V86, P3308, DOI 10.1103/PhysRevLett.86.3308; SAVAGE SB, 1998, NATO ASI SER, P25; Serero D, 2001, EUR PHYS J E, V6, P169, DOI 10.1007/s101890170019; SMID J, 1981, P 1981 POWT C I CHEM, V63; Tournat V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.085502; Vanel L, 1999, PHYS REV E, V60, pR5040, DOI 10.1103/PhysRevE.60.R5040; Wittmer JP, 1996, NATURE, V382, P336, DOI 10.1038/382336a0	27	229	240	5	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					188	191		10.1038/nature03497	http://dx.doi.org/10.1038/nature03497			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889087				2022-12-28	WOS:000229021100035
J	Kawakami, Y; Raya, A; Raya, RM; Rodriguez-Esteban, C; Belmonte, JCI				Kawakami, Y; Raya, A; Raya, RM; Rodriguez-Esteban, C; Belmonte, JCI			Retinoic acid signalling links left-right asymmetric patterning and bilaterally symmetric somitogenesis in the zebrafish embryo	NATURE			English	Article							SEGMENTATION CLOCK; NODAL EXPRESSION; VERTEBRATE SEGMENTATION; PRESOMITIC MESODERM; SOMITE SEGMENTATION; AXIS FORMATION; MOTOR PROTEIN; EARLY STEP; GENES; OSCILLATOR	During embryogenesis, cells are spatially patterned as a result of highly coordinated and stereotyped morphogenetic events. In the vertebrate embryo, information on laterality is conveyed to the node, and subsequently to the lateral plate mesoderm, by a complex cascade of epigenetic and genetic events, eventually leading to a left - right asymmetric body plan. At the same time, the paraxial mesoderm is patterned along the anterior - posterior axis in metameric units, or somites, in a bilaterally symmetric fashion. Here we characterize a cascade of laterality information in the zebrafish embryo and show that blocking the early steps of this cascade ( before it reaches the lateral plate mesoderm) results in random left - right asymmetric somitogenesis. We also uncover a mechanism mediated by retinoic acid signalling that is crucial in buffering the influence of the flow of laterality information on the left - right progression of somite formation, and thus in ensuring bilaterally symmetric somitogenesis.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	; Raya, Angel/E-6205-2010	Kawakami, Yasuhiko/0000-0002-0043-9705; Raya, Angel/0000-0003-2189-9775				Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Begemann G, 2001, DEVELOPMENT, V128, P3081; Bessho Y, 2003, CURR OPIN GENET DEV, V13, P379, DOI 10.1016/S0959-437X(03)00083-2; Bisgrove BW, 2003, ANNU REV GENOM HUM G, V4, P1, DOI 10.1146/annurev.genom.4.070802.110428; Boettger T, 1999, CURR BIOL, V9, P277, DOI 10.1016/S0960-9822(99)80119-5; Campione M, 1999, DEVELOPMENT, V126, P1225; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Giudicelli F, 2004, CURR OPIN GENET DEV, V14, P407, DOI 10.1016/j.gde.2004.06.014; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Henry CA, 2002, DEVELOPMENT, V129, P3693; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; KANE DA, 1993, DEVELOPMENT, V119, P447; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 2003, BIOESSAYS, V25, P1002, DOI 10.1002/bies.10339; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Oates AC, 2002, DEVELOPMENT, V129, P2929; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Raya A, 2004, CURR OPIN GENET DEV, V14, P575, DOI 10.1016/j.gde.2004.07.011; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; Rodriguez-Esteban C, 2001, DEVELOPMENT, V128, P3189; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Sawada A, 2000, DEVELOPMENT, V127, P1691; Stickney HL, 2000, DEV DYNAM, V219, P287; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; VERMOT J, NATURE; Weinmaster G, 2003, ANNU REV CELL DEV BI, V19, P367, DOI 10.1146/annurev.cellbio.19.111301.115434; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6; Zile MH, 2000, DEV BIOL, V223, P323, DOI 10.1006/dbio.2000.9754	50	208	224	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					165	171		10.1038/nature03512	http://dx.doi.org/10.1038/nature03512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889082				2022-12-28	WOS:000229021100030
J	Moore, P				Moore, P			Simplifying the probe set	NATURE			English	Article																			0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					238	238		10.1038/435238a	http://dx.doi.org/10.1038/435238a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889103	Bronze			2022-12-28	WOS:000229021100052
J	Schwartz, RS				Schwartz, RS			Autoimmune folate deficiency and the rise and fall of "horror autotoxicus"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	11	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1948	1950		10.1056/NEJMp058034	http://dx.doi.org/10.1056/NEJMp058034			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888694				2022-12-28	WOS:000229017100004
J	Berk, DR; Falkovitz-Halpern, MS; Hill, DW; Albin, C; Arrieta, A; Bork, JM; Cohan, D; Nilson, B; Petru, A; Ruiz, J; Weintrub, PS; Wenman, W; Maldonado, YA				Berk, DR; Falkovitz-Halpern, MS; Hill, DW; Albin, C; Arrieta, A; Bork, JM; Cohan, D; Nilson, B; Petru, A; Ruiz, J; Weintrub, PS; Wenman, W; Maldonado, YA		California Pediat HIV Study Grp	Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; PROTEASE INHIBITOR; 1-INFECTED INFANTS; COMBINATION THERAPY; DISEASE PROGRESSION; FOLLOW-UP; CHILDREN; ZIDOVUDINE	Context The effect of early antiretroviral therapy (ART) on the early progression of perinatal human immunodeficiency virus (HIV) infection is not well defined. Objective To examine early disease progression and survival in a population-based cohort with perinatal HIV infection in relation to year of birth and use of ART. Design, Setting, and Patients Retrospective study of temporal trends in early progression of perinatal HIV infection among 205 HIV-infected children in Northern California born between January 1, 1988, and December 31, 2001, and followed up through age 3 years. Main Outcome Measures Prevalence of and age at progression to a first US Centers for Disease Control and Prevention category C diagnosis relative to year of birth, type of ART, and age at initiation of therapy. Results Of 205 children, 134 (65%)received ART and/or Pneumocystis jiroveci pneumonia prophylaxis. By age 3 years, 81 (40%) progressed to a category C diagnosis, 41 (51%) of whom died. Untreated children were significantly more likely to progress to a category C diagnosis (62% [44/71] untreated vs 28% [37/134] treated children, P<.001); none of 23 infants who received triple ART progressed to category C. However, even without triple ART, very early mono/dual ART (by age 2 months vs 3-4 months) was associated with delayed and decreased progression to category C (P=.02). Of 33 children born between January 1, 1996, and December 31, 2001, only 7 (21%) progressed to category C (P=.02 compared with 1988-1995), 6 of 7 of whom received no therapy. More recent year of birth and more advanced therapy were associated with improved survival. Conclusions This population-based cohort demonstrated decreased early HIV progression and improved survival at age 3 years, associated with more advanced therapy. Although limited by small sample size, the findings suggest that very early treatment, even without triple ART, was associated with improved outcome.	Stanford Univ, Sch Med, Dept Pediat, Div Infect Dis, Stanford, CA 94305 USA; Santa Clara Valley Med Ctr, Dept Pediat, San Jose, CA 95128 USA; Childrens Hosp Orange Cty, Orange, CA 92668 USA; Loma Linda Univ, Childrens Hosp, Loma Linda, CA 92350 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco Gen Hosp, Bay Area Perinatal AIDS Ctr, San Francisco, CA USA; Univ Med Ctr, Specialty Serv, Fresno, CA USA; Calif Dept Hlth Serv, Off AIDS, Sacramento, CA USA; Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; Univ Calif Davis, Sacramento, CA 95817 USA	Stanford University; Santa Clara Valley Medical Center; Childrens Hospital of Orange County; Children's Hospital Los Angeles; Loma Linda University; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; California Department of Health Care Services; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Davis	Maldonado, YA (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Div Infect Dis, G312B ID,MC 5208, Stanford, CA 94305 USA.	bonniem@stanford.edu						Aboulker JP, 2004, AIDS, V18, P237, DOI [10.1097/01.aids.0000111388.02002.6b, 10.1097/00002030-200401230-00013]; Aboulker JP, 2001, ARCH DIS CHILD, V84, P230, DOI 10.1136/adc.84.3.230; Abrams EJ, 2003, AIDS, V17, P867, DOI 10.1097/00002030-200304110-00012; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; AUGER I, 1988, NATURE, V336, P575, DOI 10.1038/336575a0; Barnett AA, 1996, LANCET, V347, P678; Blanche S, 1997, J ACQ IMMUN DEF SYND, V14, P442, DOI 10.1097/00042560-199704150-00008; BLANCHE S, 1990, AM J DIS CHILD, V144, P1210, DOI 10.1001/archpedi.1990.02150350042021; Blazevic V, 2001, CLIN DIAGN LAB IMMUN, V8, P943, DOI 10.1128/CDLI.8.5.943-948.2001; *CAL DEP HLTH SERV, 2001, CAL CHILDB WOM COMP; Centers for Disease Control and Prevention, 2005, HIV AIDS SURV REP; Chougnet C, 2001, J INFECT DIS, V184, P201, DOI 10.1086/322006; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cooper ER, 1998, J PEDIATR-US, V132, P808, DOI 10.1016/S0022-3476(98)70308-7; de Martino M, 2000, JAMA-J AM MED ASSOC, V284, P190, DOI 10.1001/jama.284.2.190; DULIEGE AM, 1992, PEDIATR INFECT DIS J, V11, P630; Englund JA, 1997, NEW ENGL J MED, V336, P1704, DOI 10.1056/NEJM199706123362403; Faye A, 2004, CLIN INFECT DIS, V39, P1692, DOI 10.1086/425739; Faye A, 2002, PEDIATR INFECT DIS J, V21, P518, DOI 10.1097/00006454-200206000-00008; *FDA, 1990, ONCOLOGY HUNTINGT, V4, P96; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Hainaut M, 2000, EUR J PEDIATR, V159, P778, DOI 10.1007/PL00008346; Jankelevich S, 2001, J INFECT DIS, V183, P1116, DOI 10.1086/319274; *JOINT UN PROGR HI, 2003, AIDS EP UPD; Krogstad P, 1999, CLIN INFECT DIS, V28, P1109, DOI 10.1086/514759; LOBATO MN, 1995, J PEDIATR-US, V126, P710, DOI 10.1016/S0022-3476(95)70397-7; LOYAL JK, 2002, 14 INT AIDS C JUL 7; Luzuriaga K, 2000, J VIROL, V74, P6984, DOI 10.1128/JVI.74.15.6984-6991.2000; Luzuriaga K, 2004, NEW ENGL J MED, V350, P2471, DOI 10.1056/NEJMoa032706; Luzuriaga K, 1999, J VIROL, V73, P362, DOI 10.1128/JVI.73.1.362-367.1999; Luzuriaga K, 1997, NEW ENGL J MED, V336, P1343, DOI 10.1056/NEJM199705083361902; Magder LS, 2005, JAIDS-J ACQ IMM DEF, V38, P87, DOI 10.1097/00126334-200501010-00016; MALDONADO YA, 1995, J INFECT DIS, V171, P689, DOI 10.1093/infdis/171.3.689; Maldonado YA, 1998, PEDIATR INFECT DIS J, V17, P398, DOI 10.1097/00006454-199805000-00010; MAWHINNEY S, 1993, J ACQ IMMUN DEF SYND, V6, P1139; MCKINNEY RE, 1991, NEW ENGL J MED, V324, P1018, DOI 10.1056/NEJM199104113241503; Mueller BU, 1998, PEDIATRICS, V101, P335, DOI 10.1542/peds.101.3.335; Nachman SA, 2000, JAMA-J AM MED ASSOC, V283, P492, DOI 10.1001/jama.283.4.492; Palumbo P, 2002, CLIN LAB MED, V22, P759, DOI 10.1016/S0272-2712(02)00010-0; Rich KC, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e8; Rouzioux C, 1995, AM J EPIDEMIOL, V142, P1330, DOI 10.1093/oxfordjournals.aje.a117601; SANCHEZ JM, 2003, PEDIATR INFECT DIS J, V22, P863; Starr SE, 1999, NEW ENGL J MED, V341, P1874, DOI 10.1056/NEJM199912163412502; Stephenson J, 1997, JAMA-J AM MED ASSOC, V277, P614, DOI 10.1001/jama.277.8.614; Sullivan JL, 2001, NEW ENGL J MED, V345, P1568, DOI 10.1056/NEJM200111223452111; *US PUBL HLTH SERV, 1995, MMWR-MORBID MORTAL W, V44, P1; Wade NA, 2004, JAIDS-J ACQ IMM DEF, V36, P1075, DOI 10.1097/00126334-200408150-00011; Walker AS, 2004, AIDS, V18, P1915, DOI 10.1097/00002030-200409240-00007; Wiznia A, 2000, AIDS RES HUM RETROV, V16, P1113, DOI 10.1089/088922200414956; *WORK GROUP ANT TH, 2004, GUID US ANT AG PED H; 1994, MMWR MORB MORTAL WKL, V43, P285	52	47	48	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2221	2231		10.1001/jama.293.18.2221	http://dx.doi.org/10.1001/jama.293.18.2221			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886377	Bronze			2022-12-28	WOS:000228981100023
J	Brodsky, RA; Jones, RJ				Brodsky, RA; Jones, RJ			Aplastic anaemia	LANCET			English	Review							BONE-MARROW-TRANSPLANTATION; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; HIGH-DOSE CYCLOPHOSPHAMIDE; HEMATOPOIETIC PROGENITOR CELLS; LINKED DYSKERATOSIS-CONGENITA; SHWACHMAN-DIAMOND-SYNDROME; COLONY-STIMULATING FACTOR; CHRONIC MYELOID-LEUKEMIA; ANTITHYMOCYTE GLOBULIN; ANTILYMPHOCYTE GLOBULIN	Aplastic anaemia is a rare haemopoietic stem-cell disorder that results in pancytopenia and hypocellular bone marrow. Although most cases are acquired, there are unusual inherited forms. The pathophysiology of acquired aplastic anaemia is immune mediated in most cases; autoreactive lymphocytes mediate the destruction of haemopoietic stem cells. Environmental exposures, such as to drugs, viruses, and toxins, are thought to trigger the aberrant immune response in some patients, but most cases are classified as idiopathic. Similarly to other autoimmune diseases, aplastic anaemia has a varied clinical course; some patients have mild symptoms that necessitate little or no therapy, whereas others present with life-threatening pancytopenia representing a medical emergency. Paroxysmal nocturnal haemoglobinuria and myelodysplastic syndrome commonly arise in patients with aplastic anaemia, showing a pathophysiological link between these disorders. Acquired aplastic anaemia can be effectively treated by allogeneic bone-marrow transplantation, immunosuppression (generally antithymocyte globulin and ciclosporin), and high-dose cyclophosphamide.	Johns Hopkins Univ, Sch Med, Div Hematol, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Div Hematol Malignancies, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Brodsky, RA (corresponding author), Ross Res Bldg,Room 1025,720 Rutland Ave, Baltimore, MD 21205 USA.	brodsro@jhmi.edu						Ades L, 2004, BLOOD, V103, P2490, DOI 10.1182/blood-2003-07-2546; Araten DJ, 1999, P NATL ACAD SCI USA, V96, P5209, DOI 10.1073/pnas.96.9.5209; Bacigalupo A, 2000, ACTA HAEMATOL-BASEL, V103, P19, DOI 10.1159/000041000; Bacigalupo A, 2000, BLOOD, V95, P1931, DOI 10.1182/blood.V95.6.1931; BACIGALUPO A, 1995, BLOOD, V85, P1348, DOI 10.1182/blood.V85.5.1348.bloodjournal8551348; Bacigalupo A, 1999, HAEMATOLOGICA, V84, P2; Bagby GC, 2003, CURR OPIN HEMATOL, V10, P68, DOI 10.1097/00062752-200301000-00011; Ballmaier A, 2003, ANN NY ACAD SCI, V996, P17, DOI 10.1111/j.1749-6632.2003.tb03228.x; BARAN DT, 1976, NEW ENGL J MED, V295, P1522, DOI 10.1056/NEJM197612302952708; BEDI A, 1993, BLOOD, V81, P2898; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Brodsky RA, 2004, EXP HEMATOL, V32, P435, DOI 10.1016/j.exphem.2004.02.002; Brodsky RA, 2004, LEUKEMIA, V18, P1740, DOI 10.1038/sj.leu.2403487; Brodsky RA, 1997, P NATL ACAD SCI USA, V94, P8756, DOI 10.1073/pnas.94.16.8756; Brodsky RA, 1996, BLOOD, V87, P491, DOI 10.1182/blood.V87.2.491.bloodjournal872491; Brodsky RA, 2001, ANN INTERN MED, V135, P477, DOI 10.7326/0003-4819-135-7-200110020-00006; Brodsky RA, 2000, AM J CLIN PATHOL, V114, P459, DOI 10.1093/ajcp/114.3.459; Brown KE, 1997, NEW ENGL J MED, V336, P1059, DOI 10.1056/NEJM199704103361504; Burman RW, 1999, HUM MOL GENET, V8, P2293, DOI 10.1093/hmg/8.12.2293; CAMITTA BM, 1979, BLOOD, V53, P504; CAMITTA BM, 1982, NEW ENGL J MED, V306, P712, DOI 10.1056/NEJM198203253061204; CATTRAL MS, 1994, HEPATOLOGY, V20, P813, DOI 10.1002/hep.1840200407; CHAMPLIN RE, 1984, BRIT J HAEMATOL, V56, P455, DOI 10.1111/j.1365-2141.1984.tb03975.x; Chen R, 2000, J CLIN INVEST, V106, P689, DOI 10.1172/JCI8328; DAMESHEK W, 1967, BLOOD-J HEMATOL, V30, P251; Deeg HJ, 2001, BIOL BLOOD MARROW TR, V7, P208, DOI 10.1053/bbmt.2001.v7.pm11349807; DEPLANQUE MM, 1989, BRIT J HAEMATOL, V73, P121; Dokal I, 2003, BLOOD REV, V17, P217, DOI 10.1016/S0268-960X(03)00020-1; Doney K, 1997, ANN INTERN MED, V126, P107, DOI 10.7326/0003-4819-126-2-199701150-00003; Duester G, 2001, CHEM-BIOL INTERACT, V130, P469, DOI 10.1016/S0009-2797(00)00292-1; Dufour C, 2001, BRIT J HAEMATOL, V112, P796, DOI 10.1046/j.1365-2141.2001.02572.x; Ehrlich P., 1888, CHARITE ANN, V13, P301; Elliott AM, 1999, AM J MED GENET, V83, P178, DOI 10.1002/(SICI)1096-8628(19990319)83:3<178::AID-AJMG6>3.0.CO;2-3; FRICKHOFEN N, 1991, NEW ENGL J MED, V324, P1297, DOI 10.1056/NEJM199105093241901; GALE RP, 1981, ANN INTERN MED, V95, P477, DOI 10.7326/0003-4819-95-4-477; Ginzberg H, 1999, J PEDIATR-US, V135, P81, DOI 10.1016/S0022-3476(99)70332-X; GMUR J, 1979, ACTA HAEMATOL-BASEL, V62, P20; HAGLER L, 1975, MEDICINE, V54, P139, DOI 10.1097/00005792-197554020-00003; Hall SE, 1996, BLOOD, V87, P5332, DOI 10.1182/blood.V87.12.5332.bloodjournal87125332; Hassock S, 1999, GENOMICS, V55, P21, DOI 10.1006/geno.1998.5600; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; HILTON J, 1984, CANCER RES, V44, P5156; Hinterberger W, 1997, ANN INTERN MED, V126, P116, DOI 10.7326/0003-4819-126-2-199701150-00004; Hirano N, 2003, BLOOD, V102, P4567, DOI 10.1182/blood-2002-11-3409; HOFFMAN R, 1977, NEW ENGL J MED, V296, P10, DOI 10.1056/NEJM197701062960103; Horowitz MM, 2000, SEMIN HEMATOL, V37, P30; Howard SC, 2004, PEDIATR BLOOD CANCER, V43, P545, DOI 10.1002/pbc.20131; Hsu JW, 2002, BONE MARROW TRANSPL, V30, P255, DOI 10.1038/sj.bmt.1703631; HU R, 2005, BLOOD           0201; Ismail MM, 2003, BRIT J HAEMATOL, V123, P545, DOI 10.1046/j.1365-2141.2003.04643.x; Issaragrisil S, 1997, AM J PUBLIC HEALTH, V87, P1551, DOI 10.2105/AJPH.87.9.1551; Issaragrisil S, 1997, BLOOD, V89, P4034; Jaime-Perez JC, 2001, AM J HEMATOL, V66, P71, DOI 10.1002/1096-8652(200101)66:1<71::AID-AJH1019>3.0.CO;2-D; JONES RJ, 1995, BLOOD, V85, P2742, DOI 10.1182/blood.V85.10.2742.bloodjournal85102742; Jones RJ, 2001, BLOOD, V97, P3681, DOI 10.1182/blood.V97.12.3681a; KASTAN MB, 1990, BLOOD, V75, P1947; Kaufman DW, 1991, DRUG ETIOLOGY AGRANU; Luzzatto L, 1997, CELL, V88, P1, DOI 10.1016/S0092-8674(00)81850-4; Ly H, 2005, BLOOD, V105, P2332, DOI 10.1182/blood-2004-09-3659; MACIEJEWSKI JP, 1995, BRIT J HAEMATOL, V91, P245, DOI 10.1111/j.1365-2141.1995.tb05277.x; MACIEJEWSKI JP, 1994, EXP HEMATOL, V22, P1102; Margolis D, 1996, BRIT J HAEMATOL, V94, P65, DOI 10.1046/j.1365-2141.1996.d01-1772.x; MATHE G, 1970, BMJ-BRIT MED J, V2, P131, DOI 10.1136/bmj.2.5702.131; MAY WS, 1993, BONE MARROW TRANSPL, V11, P459; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Melenhorst JJ, 1997, BRIT J HAEMATOL, V96, P85, DOI 10.1046/j.1365-2141.1997.d01-1989.x; Melenhorst JJ, 1997, BRIT J HAEMATOL, V99, P517; MODAN B, 1975, AM J MED SCI, V270, P441, DOI 10.1097/00000441-197511000-00004; MOORE MAS, 1991, NEW ENGL J MED, V324, P1358, DOI 10.1056/NEJM199105093241909; Moyo VM, 2004, BRIT J HAEMATOL, V126, P133, DOI 10.1111/j.1365-2141.2004.04992.x; Mukhina GL, 2001, BRIT J HAEMATOL, V115, P476, DOI 10.1046/j.1365-2141.2001.03127.x; NAGAFUJI K, 1995, BLOOD, V86, P883, DOI 10.1182/blood.V86.3.883.bloodjournal863883; NAKAO S, 1992, BLOOD, V79, P2532; Nakao S, 1997, BLOOD, V89, P3691, DOI 10.1182/blood.V89.10.3691.3691_3691_3699; NIMER SD, 1994, BLOOD, V84, P923; NISSEN C, 1980, BRIT J HAEMATOL, V45, P233, DOI 10.1111/j.1365-2141.1980.tb07143.x; NISTICO A, 1994, ANN INTERN MED, V120, P463, DOI 10.7326/0003-4819-120-6-199403150-00003; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Ohara A, 1997, BLOOD, V90, P1009, DOI 10.1182/blood.V90.3.1009.1009_1009_1013; Passweg JR, 1997, BLOOD, V90, P858; Rosenfeld S, 2003, JAMA-J AM MED ASSOC, V289, P1130, DOI 10.1001/jama.289.9.1130; ROSENFELD SJ, 1995, BLOOD, V85, P3058, DOI 10.1182/blood.V85.11.3058.bloodjournal85113058; Rosse WF, 1997, MEDICINE, V76, P63, DOI 10.1097/00005792-199703000-00001; Rotoli B, 1989, Baillieres Clin Haematol, V2, P113, DOI 10.1016/S0950-3536(89)80010-1; RUSTEN LS, 1994, BLOOD, V84, P1473; SENSENBRENNER LL, 1977, EXP HEMATOL, V5, P51; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; SOCIE G, 1993, NEW ENGL J MED, V329, P1152, DOI 10.1056/NEJM199310143291603; Stahnke K, 1998, EXP HEMATOL, V26, P844; Storb R, 2001, BIOL BLOOD MARROW TR, V7, P39, DOI 10.1053/bbmt.2001.v7.pm11215697; SZKLO M, 1985, BLOOD, V66, P115; THOMAS ED, 1972, LANCET, V1, P284; THOMAS ED, 1976, EXP HEMATOL, V4, P97; TICHELLI A, 1988, BRIT J HAEMATOL, V69, P413, DOI 10.1111/j.1365-2141.1988.tb02382.x; Tisdale JF, 2000, LANCET, V356, P1554, DOI 10.1016/S0140-6736(00)03126-3; TZAKIS AG, 1988, NEW ENGL J MED, V319, P393, DOI 10.1056/NEJM198808183190702; VanZant G, 1997, EXP HEMATOL, V25, P187; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335; Zeng WH, 2001, J CLIN INVEST, V108, P765, DOI 10.1172/JCI12687; Zeng WH, 1999, BLOOD, V93, P3008; ZOUMBOS NC, 1985, NEW ENGL J MED, V312, P257, DOI 10.1056/NEJM198501313120501	104	183	229	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1647	1656		10.1016/S0140-6736(05)66515-4	http://dx.doi.org/10.1016/S0140-6736(05)66515-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885298				2022-12-28	WOS:000228933700031
J	Kroymann, J; Mitchell-Olds, T				Kroymann, J; Mitchell-Olds, T			Epistasis and balanced polymorphism influencing complex trait variation	NATURE			English	Article							ARABIDOPSIS-THALIANA; GENETIC-VARIATION; DNA POLYMORPHISM; KINASE; ARCHITECTURE; DROSOPHILA; EVOLUTION; ENCODES; LOCUS	Complex traits such as human disease, growth rate, or crop yield are polygenic, or determined by the contributions from numerous genes in a quantitative manner. Although progress has been made in identifying major quantitative trait loci (QTL), experimental constraints have limited our knowledge of small-effect QTL, which may be responsible for a large proportion of trait variation(1-3). Here, we identified and dissected a one-centimorgan chromosome interval in Arabidopsis thaliana without regard to its effect on growth rate, and examined the signature of historical sequence polymorphism among Arabidopsis accessions. We found that the interval contained two growth rate QTL within 210 kilobases. Both QTL showed epistasis; that is, their phenotypic effects depended on the genetic background. This amount of complexity in such a small area suggests a highly polygenic architecture of quantitative variation, much more than previously documented(4). One QTL was limited to a single gene. The gene in question displayed a nucleotide signature indicative of balancing selection, and its phenotypic effects are reversed depending on genetic background. If this region typifies many complex trait loci, then non-neutral epistatic polymorphism may be an important contributor to genetic variation in complex traits.	Max Planck Inst Chem Ecol, Dept Genet & Evolut, D-07745 Jena, Germany	Max Planck Society	Kroymann, J (corresponding author), Max Planck Inst Chem Ecol, Dept Genet & Evolut, Hans Knoell Str 8, D-07745 Jena, Germany.	kroymann@ice.mpg.de	Kroymann, Juergen/AAY-8562-2021; Kroymann, Juergen/B-4317-2013; Mitchell-Olds, Thomas/K-8121-2012	Kroymann, Juergen/0000-0002-4573-6498; Mitchell-Olds, Thomas/0000-0003-3439-9921				Becraft PW, 2002, ANNU REV CELL DEV BI, V18, P163, DOI 10.1146/annurev.cellbio.18.012502.083431; Becraft PW, 1996, SCIENCE, V273, P1406, DOI 10.1126/science.273.5280.1406; Dilda CL, 2002, GENETICS, V162, P1655; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Haubold B, 2002, GENETICS, V161, P1269; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Lauter N, 2002, GENETICS, V160, P333; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; TAJIMA F, 1989, GENETICS, V123, P585; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Wright SI, 2002, MOL BIOL EVOL, V19, P1407, DOI 10.1093/oxfordjournals.molbev.a004204; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2	22	214	221	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2005	435	7038					95	98		10.1038/nature03480	http://dx.doi.org/10.1038/nature03480			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875023				2022-12-28	WOS:000228864600045
J	Panakova, D; Sprong, H; Marois, E; Thiele, C; Eaton, S				Panakova, D; Sprong, H; Marois, E; Thiele, C; Eaton, S			Lipoprotein particles are required for Hedgehog and Wingless signalling	NATURE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CELL-ADHESION MOLECULE; INTERCELLULAR TRANSFER; SONIC HEDGEHOG; MULTIVESICULAR BODY; DROSOPHILA; PROTEIN; RECEPTOR; GRADIENT; DOMAIN	Wnt and Hedgehog family proteins are secreted signalling molecules (morphogens) that act at both long and short range to control growth and patterning during development. Both proteins are covalently modified by lipid, and the mechanism by which such hydrophobic molecules might spread over long distances is unknown. Here we show that Wingless, Hedgehog and glycophosphatidylinositol-linked proteins copurify with lipoprotein particles, and co-localize with them in the developing wing epithelium of Drosophila. In larvae with reduced lipoprotein levels, Hedgehog accumulates near its site of production, and fails to signal over its normal range. Similarly, the range of Wingless signalling is narrowed. We propose a novel function for lipoprotein particles, in which they act as vehicles for the movement of lipid-linked morphogens and glycophosphatidylinositol-linked proteins.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Thiele, C (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	thiele@mpi-cbg.de; eaton@mpi-cbg.de	Marois, Eric/H-9246-2016; Eaton, Suzanne/D-7698-2017; Marois, Eric/AAZ-5549-2021	Marois, Eric/0000-0003-4147-3747; Eaton, Suzanne/0000-0002-8319-284X; Marois, Eric/0000-0003-4147-3747; Panakova, Daniela/0000-0002-8739-6225; Sprong, Hein/0000-0002-0218-4320				Anderson SM, 1996, P NATL ACAD SCI USA, V93, P5894, DOI 10.1073/pnas.93.12.5894; Arrese EL, 2001, INSECT BIOCHEM MOLEC, V31, P7, DOI 10.1016/S0965-1748(00)00102-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Butler SJ, 1997, DEVELOPMENT, V124, P781; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Camejo G, 1998, ATHEROSCLEROSIS, V139, P205, DOI 10.1016/S0021-9150(98)00107-5; CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Denzer K, 2000, J CELL SCI, V113, P3365; Dunn DE, 1996, P NATL ACAD SCI USA, V93, P7938, DOI 10.1073/pnas.93.15.7938; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; HORTSCH M, 1990, J BIOL CHEM, V265, P15104; Incardona JP, 1996, MOL BIOL CELL, V7, P613, DOI 10.1091/mbc.7.4.613; Klueg KM, 1999, J CELL SCI, V112, P3289; Kutty RK, 1996, J BIOL CHEM, V271, P20641, DOI 10.1074/jbc.271.34.20641; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Mahley RW, 1999, J LIPID RES, V40, P1; McCarthy RA, 2002, J BIOL CHEM, V277, P25660, DOI 10.1074/jbc.M201933200; Micchelli CA, 2002, DEVELOPMENT, V129, P843; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; NEUMANN CJ, 1997, DEVELOPMENT, V124, P861; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Strigini M, 1997, DEVELOPMENT, V124, P4697; Sundermeyer K, 1996, INSECT BIOCHEM MOLEC, V26, P735, DOI 10.1016/S0965-1748(96)00060-4; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; TAYLOR AM, 1993, MECH DEVELOP, V42, P89, DOI 10.1016/0925-4773(93)90101-3; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; van der Horst DJ, 2002, MOL CELL BIOCHEM, V239, P113, DOI 10.1023/A:1020541010547; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; Vervoort M, 2000, BIOESSAYS, V22, P460, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;460::AID-BIES8&gt;3.0.CO;2-G; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Williams KP, 1999, J CELL SCI, V112, P4405; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	48	494	513	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					58	65		10.1038/nature03504	http://dx.doi.org/10.1038/nature03504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875013				2022-12-28	WOS:000228864600035
J	Strachan, MWJ; McKnight, JA				Strachan, MWJ; McKnight, JA			Improvement in hypertensive retinopathy after treatment of hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Strachan, MWJ (corresponding author), Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland.								0	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					E17	E17		10.1056/NEJMicm030575	http://dx.doi.org/10.1056/NEJMicm030575			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872195				2022-12-28	WOS:000228858600012
J	Verghese, A				Verghese, A			Becoming a physician: The calling	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Texas, Hlth Sci Ctr, Ctr Med Humanities & Eth, San Antonio, TX 78284 USA	University of Texas System; University of Texas Health San Antonio	Verghese, A (corresponding author), Univ Texas, Hlth Sci Ctr, Ctr Med Humanities & Eth, San Antonio, TX 78284 USA.							Allison Dorothy, 1994, SKIN TALKING SEX CLA; FRASER A, 1992, PELASURE READING, P74; MAUGHAM WS, 1991, HUMAN BONDAGE; TRAUTMANN J, 1982, MOBIUS, V2, P23	4	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1844	1847		10.1056/NEJMp048063	http://dx.doi.org/10.1056/NEJMp048063			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872198				2022-12-28	WOS:000228858600003
J	Jeffcoate, W; Bakker, K				Jeffcoate, W; Bakker, K			World Diabetes Day: footing the bill	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England; Int Diabet Federat, Consultat Sect Diabet Foot, Heemstede, Netherlands		Jeffcoate, W (corresponding author), The Lancet, 32 Jamestown Rd, London NW1 7BY, England.	william.jeffcoate@lancet.com						Apelqvist J, 2000, DIABETES-METAB RES, V16, pS84, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR113>3.0.CO;2-S; *INT WORK GROUP DI, 2003, INT CONS DIAB FOOT P; Meltzer DD, 2002, J AM PODIAT MED ASSN, V92, P425, DOI 10.7547/87507315-92-8-425; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Tennvall GR, 2004, CLIN INFECT DIS, V39, pS132, DOI 10.1086/383275; Tentolouris N, 2004, DIABETES CARE, V27, P1598, DOI 10.2337/diacare.27.7.1598; Tsalikian E, 2004, DIABETES CARE, V27, P722; Vileikyte L, 2004, DIABETES-METAB RES, V20, pS13, DOI 10.1002/dmrr.437	8	43	44	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1527	1527		10.1016/S0140-6736(05)66437-9	http://dx.doi.org/10.1016/S0140-6736(05)66437-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866295				2022-12-28	WOS:000228754800010
J	Ahmed, S; Snelling, A; Bains, M; Whitworth, IH				Ahmed, S; Snelling, A; Bains, M; Whitworth, IH			Breast reconstruction	BRITISH MEDICAL JOURNAL			English	Review							LATISSIMUS-DORSI FLAP; DONOR SITE; IMMEDIATE; MASTECTOMY; TRAM; COMPLICATIONS; IMPLANTS; PREVENTION; CANCER; SEROMA		Salisbury Dist Hosp, Dept Plast & Reconstruct Surg, Salisbury SP2 8BJ, Wilts, England; Norfolk & Norwich Univ Hosp, Dept Plast & Reconstruct Surg, Norwich NR4 7UY, Norfolk, England	Salisbury District Hospital; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Ahmed, S (corresponding author), Salisbury Dist Hosp, Dept Plast & Reconstruct Surg, Salisbury SP2 8BJ, Wilts, England.	salint.ahmed@salisbury.nhs.uk						Al-Ghazal SK, 2000, EUR J CANCER, V36, P1938, DOI 10.1016/S0959-8049(00)00197-0; Al-Ghazal SK, 2000, EUR J SURG ONCOL, V26, P17, DOI 10.1053/ejso.1999.0733; BANIC A, 1995, PLAST RECONSTR SURG, V95, P1195, DOI 10.1097/00006534-199506000-00008; Chawla AK, 2002, INT J RADIAT ONCOL, V54, P520, DOI 10.1016/S0360-3016(02)02951-6; Clough KB, 2001, PLAST RECONSTR SURG, V107, P1702, DOI 10.1097/00006534-200106000-00010; Cunnick GH, 2004, AM J SURG, V188, P78, DOI 10.1016/j.amjsurg.2004.02.004; FUREY PC, 1994, J SURG ONCOL, V55, P194, DOI 10.1002/jso.2930550313; Gill PS, 2004, PLAST RECONSTR SURG, V113, P1153, DOI 10.1097/01.PRS.0000110328.47206.50; Janowsky EC, 2000, NEW ENGL J MED, V342, P781, DOI 10.1056/NEJM200003163421105; Khoo A, 1998, PLAST RECONSTR SURG, V101, P964, DOI 10.1097/00006534-199804040-00011; KROLL SS, 1995, PLAST RECONSTR SURG, V96, P860, DOI 10.1097/00006534-199509001-00015; Kronowitz SJ, 2004, PLAST RECONSTR SURG, V114, P950, DOI 10.1097/01.PRS.0000133200.99826.7F; Losken A, 2004, ANN PLAS SURG, V52, P258, DOI 10.1097/01.sap.0000110560.03010.7c; Malata CM, 1997, BRIT J PLAST SURG, V50, P99, DOI 10.1016/S0007-1226(97)91320-5; Mansel R, 1998, EUR J SURG ONCOL, V24, P464, DOI 10.1016/S0748-7983(98)93104-3; *NAT BREAST IMPL R, 2000, NAT BREAST IMPL REG; Newman LA, 1999, ANN SURG ONCOL, V6, P671, DOI 10.1007/s10434-999-0671-6; NOGUCHI M, 1992, J SURG ONCOL, V50, P241, DOI 10.1002/jso.2930500409; NOONE RB, 1994, PLAST RECONSTR SURG, V93, P96, DOI 10.1097/00006534-199401000-00014; Reece GP, 1998, CLIN PLAST SURG, V25, P235; Schwabegger A, 1997, ANN PLAS SURG, V38, P594, DOI 10.1097/00000637-199706000-00005; Shaikh-Naidu N, 2004, ANN PLAS SURG, V52, P465, DOI 10.1097/01.sap.0000123901.06133.b7; Spear SL, 2001, PLAST RECONSTR SURG, V107, P177, DOI 10.1097/00006534-200101000-00029; Titley OG, 1997, BRIT J PLAST SURG, V50, P106, DOI 10.1016/S0007-1226(97)91321-7	24	23	24	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 23	2005	330	7497					943	948		10.1136/bmj.330.7497.943	http://dx.doi.org/10.1136/bmj.330.7497.943			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15845976	Green Published			2022-12-28	WOS:000228715900022
J	Ismail, A; Shingler, W; Seneviratne, J; Burrows, G				Ismail, A; Shingler, W; Seneviratne, J; Burrows, G			Lesson of the week - In vitro and in vivo haemolysis and potassium measurement	BRITISH MEDICAL JOURNAL			English	Review									Stepping Hill Hosp, Dept Rheumatol, Stockport SK2 7JE, Lancs, England		Ismail, A (corresponding author), Stepping Hill Hosp, Dept Rheumatol, Stockport SK2 7JE, Lancs, England.	abbas.ismail@stockport-tr.nwest.nhs.uk						FRANK JJ, 1978, CLIN CHEM, V24, P1966; KERR DJ, 1985, BRIT MED J, V291, P890, DOI 10.1136/bmj.291.6499.890; MATHER A, 1960, CLIN CHEM, V6, P227; World Health Organization, 2002, 99 WHODILLAB	4	23	23	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 23	2005	330	7497					949	949		10.1136/bmj.330.7497.949	http://dx.doi.org/10.1136/bmj.330.7497.949			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15845977	Green Published			2022-12-28	WOS:000228715900023
J	Allen, E; Xie, ZX; Gustafson, AM; Carrington, JC				Allen, E; Xie, ZX; Gustafson, AM; Carrington, JC			microRNA-directed phasing during trans-acting siRNA biogenesis in plants	CELL			English	Article							DEPENDENT RNA-POLYMERASE; DSRNA-BINDING-PROTEIN; ARABIDOPSIS-THALIANA; NUCLEAR EXPORT; CAENORHABDITIS-ELEGANS; MESSENGER-RNAS; LEAF POLARITY; GENES; INITIATION; MIRNA	Plants and animals use small RNAs (microRNAs [miRNAs] and siRNAs) as guides for posttranscriptional and epigenetic regulation. In plants, miRNAs and trans-acting (ta) siRNAs form through distinct biogenesis pathways, although they both interact with target transcripts and guide cleavage. An integrated approach to identify targets of Arabidopsis thaliana miRNAs and ta-siRNAs revealed several new classes of small RNA-regulated genes, including conventional genes such as Argonaute2 and an E2-ubiquitin conjugating enzyme. Surprisingly, five tasiRNA-generating transcripts were identified as targets of miR173 or miR390. Rather than functioning as negative regulators, miR173- and miR390-guided cleavage was shown to set the 21-nucleotide phase for ta-siRNA precursor processing. These data support a model in which miRNA-guided formation of a 5' or 3' terminus within pre-ta-siRNA transcripts, followed by RDR6-dependent formation of dsRNA and Dicer-like processing, yields phased ta-siRNAs that negatively regulate other genes.	Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Carrington, JC (corresponding author), Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA.	carrington@cgrb.oregonstate.edu	Carrington, James/A-4656-2012	Carrington, James/0000-0003-3572-129X; Allen, Edwards/0000-0002-8318-6319; Xie, Zhixin/0000-0002-6191-5170	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI043288, R37AI043288, R01AI043288] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43288] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Guan HC, 2000, P NATL ACAD SCI USA, V97, P12451, DOI 10.1073/pnas.97.23.12451; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lappartient AG, 1999, PLANT J, V18, P89, DOI 10.1046/j.1365-313X.1999.00416.x; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; RAO ALN, 1989, P NATL ACAD SCI USA, V86, P5335, DOI 10.1073/pnas.86.14.5335; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sessions A, 1997, DEVELOPMENT, V124, P4481; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	66	1648	1827	8	252	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 22	2005	121	2					207	221		10.1016/j.cell.2005.04.004	http://dx.doi.org/10.1016/j.cell.2005.04.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851028	Bronze			2022-12-28	WOS:000228705000009
J	Cook, AJ; Fox, AJ; Vaughan, DG; Ferrigno, JG				Cook, AJ; Fox, AJ; Vaughan, DG; Ferrigno, JG			Retreating glacier fronts on the Antarctic Peninsula over the past half-century	SCIENCE			English	Article							LARSEN ICE SHELF	The continued retreat of ice shelves on the Antarctic Peninsula has been widely attributed to recent atmospheric warming, but there is little published work describing changes in glacier margin positions. We present trends in 244 marine glacier fronts on the peninsula and associated islands over the past 61 years. Of these glaciers, 87% have retreated and a clear boundary between mean advance and retreat has migrated progressively southward. The pattern is broadly compatible with retreat driven by atmospheric warming, but the rapidity of the migration suggests that this may not be the sole driver of glacier retreat in this region.	British Antarctic Survey, NERC, Cambridge CB3 0ET, England; US Geol Survey, Natl Ctr 926A, Reston, VA 20192 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; United States Department of the Interior; United States Geological Survey	Cook, AJ (corresponding author), British Antarctic Survey, NERC, Madingley Rd, Cambridge CB3 0ET, England.	acook@bas.ac.uk	Vaughan, David/C-8348-2011	Vaughan, David/0000-0002-9065-0570				Cooper A. P. R., 1997, POLAR REC, V33, P285, DOI [DOI 10.1017/S0032247400025389, 10.1017/S0032247400025389]; De Angelis H, 2003, SCIENCE, V299, P1560, DOI 10.1126/science.1077987; DOAKE CSM, 1991, NATURE, V350, P328, DOI 10.1038/350328a0; Domack E. A., 2001, EOS, V82, P13, DOI [DOI 10.1029/01EO00009, DOI 10.1029/01E000009]; FERRIGNO JG, 2002, FS01702 US GEOL SURV; FERRIGNO JG, IN PRESS COASTAL CHA; FOX A, UNPUB; Lucchitta BK, 1998, ANN GLACIOL-SER, V27, P41; Morris EM, 2003, ANTARCT RES SER, V79, P61; Mosley-Thompson E, 1999, J GEOPHYS RES-ATMOS, V104, P3877, DOI 10.1029/1998JD200092; Pfeffer WT, 2003, NATURE, V426, P602, DOI 10.1038/426602b; Pudsey CJ, 2001, GEOLOGY, V29, P787, DOI 10.1130/0091-7613(2001)029<0787:FSOASI>2.0.CO;2; Rott H, 2002, ANN GLACIOL-SER, V34, P277, DOI 10.3189/172756402781817716; Rott H, 1996, SCIENCE, V271, P788, DOI 10.1126/science.271.5250.788; Scambos TA, 2000, J GLACIOL, V46, P516, DOI 10.3189/172756500781833043; Shepherd A, 2003, SCIENCE, V302, P856, DOI 10.1126/science.1089768; SIEVERS J, 1989, POLARFORSCHUNG, V59, P25; Skvarca P, 1998, ANN GLACIOL-SER, V27, P628; Stone JO, 2003, SCIENCE, V299, P99, DOI 10.1126/science.1077998; van der Veen CJ, 2002, PROG PHYS GEOG, V26, P96, DOI 10.1191/0309133302pp327ra; Vaughan DG, 1996, NATURE, V379, P328, DOI 10.1038/379328a0; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Vieli A, 2002, J GLACIOL, V48, P592, DOI 10.3189/172756502781831089; WARD CG, 1995, ANTARCT SCI, V7, P197, DOI 10.1017/S0954102095000265; WILLIAMS RS, 1995, ANNALS OF GLACIOLOGY, VOL 21, 1995, P284; WILLIAMS RS, 1998, 5098 US GEOL SURV	27	574	592	3	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					541	544		10.1126/science.1104235	http://dx.doi.org/10.1126/science.1104235			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845851				2022-12-28	WOS:000228810500049
J	Freyd, JJ; Putnam, FW; Lyon, TD; Becker-Blease, KA; Cheit, RE; Siegel, NB; Pezdek, K				Freyd, JJ; Putnam, FW; Lyon, TD; Becker-Blease, KA; Cheit, RE; Siegel, NB; Pezdek, K			The science of child sexual abuse	SCIENCE			English	Editorial Material							VICTIMIZATION; PSYCHOPATHOLOGY; MEMORIES; BEHAVIOR; OUTCOMES; RAPE; TWIN		Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; Univ So Calif, Sch Law, Los Angeles, CA 90089 USA; Univ New Hampshire, Family Res Lab, Durham, NH 03824 USA; Brown Univ, Dept Polit Sci, Providence, RI 02912 USA; NBS Associates, Columbia, MD 21046 USA; Claremont Grad Univ, Dept Psychol, Claremont, CA 91711 USA	University of Oregon; Cincinnati Children's Hospital Medical Center; University of Southern California; University System Of New Hampshire; University of New Hampshire; Brown University; Claremont Colleges; Claremont Graduate School	Freyd, JJ (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	jjf@dynamic.uoregon.edu	Freyd, Jennifer J/B-2312-2009; Lyon, Thomas/I-7630-2015; Becker-Blease, Kathryn/E-3410-2012	Becker-Blease, Kathryn/0000-0002-3459-4017	NICHD NIH HHS [R01 HD047290] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD047290] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Battle CL, 2004, J PERS DISORD, V18, P193, DOI 10.1521/pedi.18.2.193.32777; Bolen RM, 1999, SOC SERV REV, V73, P281, DOI 10.1086/514425; BoneyMcCoy S, 1996, J CONSULT CLIN PSYCH, V64, P1406, DOI 10.1037/0022-006X.64.6.1406; BRIERE J, 1992, J CONSULT CLIN PSYCH, V60, P196, DOI 10.1037/0022-006X.60.2.196; Ceci S. J., 1995, JEOPARDY COURTROOM S; Dalenberg C., 1996, J PSYCHIAT LAW, V24, P229, DOI DOI 10.1177/009318539602400206; DEBELLIS MD, 1994, J CLIN ENDOCR METAB, V78, P249, DOI 10.1210/jc.78.2.249; DePrince AP, 2004, PSYCHOL SCI, V15, P488, DOI 10.1111/j.0956-7976.2004.00706.x; Dinwiddie S, 2000, PSYCHOL MED, V30, P41, DOI 10.1017/S0033291799001373; ELLIOTT DM, 1994, BEHAV SCI LAW, V12, P261, DOI 10.1002/bsl.2370120306; Fergusson DM, 1996, J AM ACAD CHILD PSY, V35, P1365, DOI 10.1097/00004583-199610000-00024; Fergusson DM, 2000, PSYCHOL MED, V30, P529, DOI 10.1017/S0033291799002111; Finkelhor D, 1994, Future Child, V4, P31, DOI 10.2307/1602522; Freyd J. J., 2001, J TRAUMA DISSOCIATIO, V2, P5, DOI [10.1300/J229V02N03_02, DOI 10.1300/J229V02N03_02]; Freyd J. J., 1996, BETRAYAL TRAUMA; Goodman GS, 2003, PSYCHOL SCI, V14, P113, DOI 10.1111/1467-9280.01428; Hanson RF, 1999, CHILD ABUSE NEGLECT, V23, P559, DOI 10.1016/S0145-2134(99)00028-9; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Lyon TD, 1999, CORNELL LAW REV, V84, P1004; Miller TR., 1996, VICTIM COSTS CONSEQU; Molnar BE, 2001, AM J PUBLIC HEALTH, V91, P753, DOI 10.2105/AJPH.91.5.753; Molnar BE, 2001, PSYCHOL MED, V31, P965, DOI 10.1017/S0033291701004329; Nelson EC, 2002, ARCH GEN PSYCHIAT, V59, P139, DOI 10.1001/archpsyc.59.2.139; Noll JG, 2003, J INTERPERS VIOLENCE, V18, P1452, DOI 10.1177/0886260503258035; Putnam FW, 2003, J AM ACAD CHILD PSY, V42, P269, DOI 10.1097/00004583-200303000-00006; PUTNAM FW, 2001, COST CHILD MALTREATM, P185; Roberts R, 2004, CHILD ABUSE NEGLECT, V28, P525, DOI 10.1016/j.chiabu.2003.07.006; SIVERS J, 2002, ENCY HUMAN BRAIN, V4, P169; Smith DW, 2000, CHILD ABUSE NEGLECT, V24, P273, DOI 10.1016/S0145-2134(99)00130-1; *US DEP HHS, 2003, CHILD MALTR REP 1990; WIDOM CS, 1994, CHILD ABUSE NEGLECT, V18, P303, DOI 10.1016/0145-2134(94)90033-7; Widom CS, 1997, PSYCHOL ASSESSMENT, V9, P34, DOI 10.1037/1040-3590.9.1.34; WILLIAMS LM, 1995, J TRAUMA STRESS, V8, P649, DOI 10.1007/BF02102893; World Health Organization, 2002, WORLD REPORT VIOLENC	35	75	76	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2005	308	5721					501	501		10.1126/science.1108066	http://dx.doi.org/10.1126/science.1108066			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	922BK	15845837				2022-12-28	WOS:000228810500035
J	Smith, DR				Smith, DR			How to build a superlens	SCIENCE			English	Editorial Material							REFRACTION; INDEX		Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA	Duke University	Smith, DR (corresponding author), Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA.	drsmith@ee.duke.edu	Smith, David R/E-4710-2012					Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Liu ZW, 2003, APPL PHYS LETT, V83, P5184, DOI 10.1063/1.1636250; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699	6	54	57	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2005	308	5721					502	503		10.1126/science.1110900	http://dx.doi.org/10.1126/science.1110900			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845838				2022-12-28	WOS:000228810500036
J	Kwiterovich, PO; Cockrill, SL; Virgil, DG; Garrett, ES; Otvos, J; Knight-Gibson, C; Alaupovic, P; Forte, T; Zhang, L; Farwig, ZN; Macfarlane, RD				Kwiterovich, PO; Cockrill, SL; Virgil, DG; Garrett, ES; Otvos, J; Knight-Gibson, C; Alaupovic, P; Forte, T; Zhang, L; Farwig, ZN; Macfarlane, RD			A large high-density lipoprotein enriched in apolipoprotein C-I - A novel biochemical marker in infants of lower birth weight and younger gestational age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTRAUTERINE GROWTH RESTRICTION; ESTER TRANSFER PROTEIN; HUMAN CORD BLOOD; TRIGLYCERIDE-RICH LIPOPROTEINS; CHOLESTEROL ACYLTRANSFERASE; SUBCLASS DISTRIBUTION; PLACENTAL APOPTOSIS; MASS-SPECTROMETRY; HEPATIC LIPASE; HUMAN-PLASMA	Context Low birth weight is associated with increased cardiovascular disease in adulthood, and differences in the molecular weight, composition, and quantity of lipoprotein subclasses are associated with coronary artery disease. Objective To determine if there are novel patterns of lipoprotein heterogeneity in low-birth-weight infants. Design, Setting, and Participants Prospective study at a US medical center of a representative sample of infants (n = 163; 70 white and 93 black) born at 28 or more weeks of gestational age between January 3, 2000, and September 27, 2000. This sample constituted 20% of all infants born during the study period at this site. Main Outcome Measures Plasma levels and particle sizes of lipoprotein subclasses and plasma concentrations of lipids, lipoproteins (high-density lipoprotein [HDL] and low-density lipoprotein [LDL]), and apolipoproteins. Results An elevated lipoprotein peak of a particle with density between 1.062 and 1.072 g/mL was identified using physical-chemical methods. This subclass of large HDL was enriched in apolipoprotein C-I (apo C-I). Based on the amount of the apo C-I-enriched HDL peak, 156 infants were assigned to 1 of 4 groups: 0 (none detected), 17%; 1 (possibly present), 41%; 2 (probably present), 22%; 3 (elevated), 19%. Infants in group 3, compared with those in the other 3 groups, had significantly (P < .001) lower mean birth weight (2683.7 vs 3307.1 g) and younger mean gestational age (36.2 vs 39.3 wk). After correction for age, infants in group 3 had significantly higher levels of total and large HDL cholesterol and of total and large LDL cholesterol and LDL particle number. However, infants in group 3 had lower levels of small HDL, very low-density lipoproteins, and triglycerides than infants in the other 3 groups. This lipoprotein profile differed from that in infants born small for gestational age, who had significantly higher triglyceride (P < .001) and apo B (P = .04) levels, but lower levels of total and large HDL cholesterol (P < .001) and apo A-I (P < .001). Conclusions Because apo C-l-enriched HDL, and purified apo C-I alone, promotes apoptosis in vitro, increased amounts of this particle may have physiological significance and identify a novel group of low-birth-weight infants apparently distinct from traditionally classified small-for-gestational-age infants.	Johns Hopkins Med Inst, Baltimore, MD 21205 USA; Texas A&M Univ, Lab Cardiovasc Chem, College Stn, TX USA; LipoSci Inc, Raleigh, NC USA; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Univ Calif Berkeley, Donner Lab, Berkeley, CA 94720 USA	Johns Hopkins University; Johns Hopkins Medicine; Texas A&M University System; Texas A&M University College Station; LipoScience, Inc; Oklahoma Medical Research Foundation; University of California System; University of California Berkeley	Kwiterovich, PO (corresponding author), 550 N Broadway,Suite 308, Baltimore, MD 21205 USA.	pkwitero@jhmi.edu		Garrett-Mayer, Elizabeth/0000-0003-4709-0333	NCRR NIH HHS [M01-RR-00052] Funding Source: Medline; NHLBI NIH HHS [HL 68794, HL 18574, HL 54566] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068794, P01HL018574, R01HL054566] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aban M, 2004, TOHOKU J EXP MED, V204, P195, DOI 10.1620/tjem.204.195; ALBERS JJ, 1979, ARTERY, V5, P61; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Bjorkegren J, 2002, ARTERIOSCL THROM VAS, V22, P1470, DOI 10.1161/01.ATV.0000029972.42487.42; Bjorkegren J, 2000, CIRCULATION, V101, P227, DOI 10.1161/01.CIR.101.3.227; BLUM CB, 1985, J LIPID RES, V26, P755; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Conde-Knape K, 2002, J LIPID RES, V43, P2136, DOI 10.1194/jlr.M200210-JLR200; Crocker IP, 2004, J PATHOL, V204, P11, DOI 10.1002/path.1610; CURRY MD, 1981, CLIN CHEM, V27, P543; DAVIS PA, 1983, BIOCHIM BIOPHYS ACTA, V753, P186, DOI 10.1016/0005-2760(83)90006-1; DAVIS PA, 1983, ARTERIOSCLEROSIS, V3, P357, DOI 10.1161/01.ATV.3.4.357; DIAZ M, 1989, METABOLISM, V38, P435, DOI 10.1016/0026-0495(89)90194-7; Farwig ZN, 2003, ANAL CHEM, V75, P3823, DOI 10.1021/ac026273p; Gautier T, 2000, J BIOL CHEM, V275, P37504, DOI 10.1074/jbc.M007210200; GENZELBOROVICZENY O, 1988, PEDIATR RES, V23, P543, DOI 10.1203/00006450-198806000-00001; GENZELBOROVICZENY O, 1986, PEDIATR RES, V20, P487, DOI 10.1203/00006450-198606000-00001; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Kaser S, 2001, METABOLISM, V50, P723, DOI 10.1053/meta.2001.23307; KHERKEULIDZE P, 1991, ACTA PAEDIATR SCAND, V80, P770, DOI 10.1111/j.1651-2227.1991.tb11947.x; KLIMOV AN, 1979, PEDIATR RES, V13, P208, DOI 10.1203/00006450-197903000-00018; Kolmakova A, 2004, ARTERIOSCL THROM VAS, V24, P264, DOI 10.1161/01.ATV.0000112036.72200.ac; Kwiterovich PO, 2004, ETHNIC DIS, V14, P351; Kwiterovich PO, 2002, AM J CARDIOL, V90, p1I, DOI 10.1016/S0002-9149(02)02796-0; LACKO AG, 1972, LIPIDS, V7, P426, DOI 10.1007/BF02531515; Macfarlane RD, 1997, ELECTROPHORESIS, V18, P1796, DOI 10.1002/elps.1150181014; Mayhew TM, 2004, PLACENTA, V25, P829, DOI 10.1016/j.placenta.2004.04.011; Merzouk H, 1997, ACTA PAEDIATR, V86, P528, DOI 10.1111/j.1651-2227.1997.tb08925.x; Nagasaka H, 2002, ATHEROSCLEROSIS, V161, P215, DOI 10.1016/S0021-9150(01)00663-3; Navab M, 2001, J LIPID RES, V42, P1308; NICHOLS AV, 1991, BIOCHIM BIOPHYS ACTA, V1085, P306, DOI 10.1016/0005-2760(91)90134-4; OTVOS JD, 2000, HDB LIPOPROTEIN TEST, P609; Radunovic N, 2000, J CLIN ENDOCR METAB, V85, P85, DOI 10.1210/jc.85.1.85; ROSSENEU M, 1983, PEDIATR RES, V17, P788, DOI 10.1203/00006450-198310000-00004; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; Shachter NS, 2001, CURR OPIN LIPIDOL, V12, P297, DOI 10.1097/00041433-200106000-00009; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; WEISGRABER KH, 1990, J BIOL CHEM, V265, P22453; WINDLER E, 1985, J LIPID RES, V26, P556; WINDLER EET, 1980, J BIOL CHEM, V255, P464; Xu Y, 1999, J LIPID RES, V40, P50; Zambon A, 2003, CURR OPIN LIPIDOL, V14, P179, DOI 10.1097/00041433-200304000-00010; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	43	18	21	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1891	1899		10.1001/jama.293.15.1891	http://dx.doi.org/10.1001/jama.293.15.1891			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840864	Bronze			2022-12-28	WOS:000228401700028
J	Chan, O; Wilson, A; Walsh, M				Chan, O; Wilson, A; Walsh, M			ABC of emergency radiology - Major trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Royal London Hosp, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Chan, O (corresponding author), Royal London Hosp, London E1 1BB, England.	zaideotto@blueyonder.co.uk							0	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2005	330	7500					1136	1138		10.1136/bmj.330.7500.1136	http://dx.doi.org/10.1136/bmj.330.7500.1136			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15891230	Green Published			2022-12-28	WOS:000229166900024
J	Barabasi, AL				Barabasi, AL			The origin of bursts and heavy tails in human dynamics	NATURE			English	Article							MODEL	The dynamics of many social, technological and economic phenomena are driven by individual human actions, turning the quantitative understanding of human behaviour into a central question of modern science. Current models of human dynamics, used from risk assessment to communications, assume that human actions are randomly distributed in time and thus well approximated by Poisson processes(1-3). In contrast, there is increasing evidence that the timing of many human activities, ranging from communication to entertainment and work patterns, follow non-Poisson statistics, characterized by bursts of rapidly occurring events separated by long periods of inactivity(4-8). Here I show that the bursty nature of human behaviour is a consequence of a decision-based queuing process(9,10): when individuals execute tasks based on some perceived priority, the timing of the tasks will be heavy tailed, with most tasks being rapidly executed, whereas a few experience very long waiting times. In contrast, random or priority blind execution is well approximated by uniform inter-event statistics. These finding have important implications, ranging from resource management to service allocation, in both communications and retail.	Univ Notre Dame, Ctr Complex Networks Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Barabasi, AL (corresponding author), Univ Notre Dame, Ctr Complex Networks Res, Notre Dame, IN 46556 USA.	alb@nd.edu	Barabasi, Albert-Laszlo/S-6474-2017	Barabasi, Albert/0000-0002-4028-3522				Anderson HR, 2003, FIXED BROADBAND WIRE; BAK P, 1993, PHYS REV LETT, V71, P4083, DOI 10.1103/PhysRevLett.71.4083; Caldarelli G, 1997, EUROPHYS LETT, V40, P479, DOI 10.1209/epl/i1997-00491-5; COBHAM A, 1954, J OPER RES SOC AM, V2, P70, DOI 10.1287/opre.2.1.70; Cohen J., 1969, SINGLE SERVER QUEUE; Crovella ME, 1997, IEEE ACM T NETWORK, V5, P835, DOI 10.1109/90.650143; DEWES C, 2003, P 2003 ACM SIGCOMM C, P57102; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.035103; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Greene J.H., 1997, PRODUCTION INVENTORY; Haight F. A., 1967, HDB POISSON DISTRIBU; HARDER U, 2004, CORRELATED DYNAMICS; Harris CM, 2000, INFORMS J COMPUT, V12, P261, DOI 10.1287/ijoc.12.4.261.11882; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Henderson T, 2001, P 9 ACM INT C MULT, P212; Jensen Henrik Jeldtoft., 1998, SELF ORG CRITICALITY; KLEBAN SD, 2003, P SC2003; Kleinberg J.M., 2002, P 8 ACM SIGKDD INT C, P91, DOI [DOI 10.1023/A:1024940629314, DOI 10.1145/775047.775061]; LEIGHTON FT, 1994, COMBINATORICA, V14, P167, DOI 10.1007/BF01215349; Manrubia SC, 1999, FRACTALS, V7, P1, DOI 10.1142/S0218348X99000025; Masoliver J, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021112; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; PAXSON V, 1995, IEEE ACM T NETWORK, V3, P226, DOI 10.1109/90.392383; REYNOLDS P, 2003, CALL CTR STAFFING; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Willinger W., 2000, SELF SIMILAR NETWORK, DOI 10.1002/047120644X	28	1410	1530	12	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					207	211		10.1038/nature03459	http://dx.doi.org/10.1038/nature03459			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889093	Green Submitted			2022-12-28	WOS:000229021100041
J	Edwards, J; Whitaker, D; Klionsky, S; Laskowski, MJ				Edwards, J; Whitaker, D; Klionsky, S; Laskowski, MJ			Botany - A record-breaking pollen catapult	NATURE			English	Article							BIOMECHANICS; POLLINATION; MECHANISM		Williams Coll, Dept Biol, Williamstown, MA 01267 USA; Williams Coll, Dept Phys, Williamstown, MA 01267 USA; Oberlin Coll, Dept Biol, Oberlin, OH 44074 USA	Williams College; Williams College; Oberlin College	Edwards, J (corresponding author), Williams Coll, Dept Biol, Williamstown, MA 01267 USA.	joan.edwards@williams.edu						BARRETT SCH, 1987, CAN J BOT, V65, P2036, DOI 10.1139/b87-278; Burrows M, 2003, NATURE, V424, P509, DOI 10.1038/424509a; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kelly D, 1996, NATURE, V384, P615, DOI 10.1038/384615a0; LOVELL JH, 1898, B TORREY BOT CLUB, V25, P382; Marie-Victorin F. E. C., 1935, FLORE LAURENTIENNE; MOSQUIN T, 1985, CAN FIELD NAT, V99, P1; Patek SN, 2004, NATURE, V428, P819, DOI 10.1038/428819a; Voet D., 1995, BIOCHEMISTRY	10	87	92	9	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					164	164		10.1038/435164a	http://dx.doi.org/10.1038/435164a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889081				2022-12-28	WOS:000229021100029
J	Treadway, K				Treadway, K			Notes to the class - First day	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Treadway, K (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Coulehan J, 2001, ACAD MED, V76, P598, DOI 10.1097/00001888-200106000-00008	1	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1943	1944		10.1056/NEJMp048298	http://dx.doi.org/10.1056/NEJMp048298			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888691				2022-12-28	WOS:000229017100001
J	Zykov, V; Mytilinaios, E; Adams, B; Lipson, H				Zykov, V; Mytilinaios, E; Adams, B; Lipson, H			Self-reproducing machines	NATURE			English	Article									Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA; Cornell Univ, Dept Comp Sci, Ithaca, NY 14853 USA; Cornell Univ, Dept Math, Ithaca, NY 14853 USA; Cornell Univ, Dept Comp & Informat Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Zykov, V (corresponding author), Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA.	hod.lipson@cornell.edu						Adams B, 2003, LECT NOTES ARTIF INT, V2801, P1; Butler Z, 2002, DISTRIBUTED AUTONOMOUS ROBOTIC SYSTEMS 5, P37; Chirikjian GS, 2002, IEEE-ASME T MECH, V7, P462, DOI 10.1109/TMECH.2002.806232; EFSTATHIOS M, 2004, P 9 INT C ART LIF, P15; Jackman RJ, 1998, SCIENCE, V280, P2089, DOI 10.1126/science.280.5372.2089; LANGTON CG, 1984, PHYSICA D, V10, P135, DOI 10.1016/0167-2789(84)90256-2; Lohn J. D., 1997, IEEE Transactions on Evolutionary Computation, V1, P165, DOI 10.1109/4235.661547; Merkle R. C, 2004, KINEMATIC SELF REPLI; PENROSE LS, 1959, SCI AM, V200, P105, DOI 10.1038/scientificamerican0659-105; RUBENSTEIN M, 2004, P IROS 2004, P2661; Sipper M, 2001, SCI AM, V285, P34, DOI 10.1038/scientificamerican0801-34; VONNEUMANN J, 1970, ESSAYS CELLULAR AUTO, P4; Yim M, 2002, IEEE SPECTRUM, V39, P30, DOI 10.1109/6.981854	13	207	213	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					163	164		10.1038/435163a	http://dx.doi.org/10.1038/435163a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889080				2022-12-28	WOS:000229021100028
J	Altman, DG				Altman, DG		CONSORT Grp	Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED TRIALS		Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England	University of Oxford	Altman, DG (corresponding author), Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England.	doug.altman@cancer.org.uk						Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Devereaux PJ, 2002, CONTROL CLIN TRIALS, V23, P380, DOI 10.1016/S0197-2456(02)00214-3; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3	5	133	140	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2005	330	7499					1056	1057		10.1136/bmj.330.7499.1056	http://dx.doi.org/10.1136/bmj.330.7499.1056			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925YY	15879389	Bronze, Green Published			2022-12-28	WOS:000229090900018
J	Gomes, ER; Jani, S; Gundersen, GG				Gomes, ER; Jani, S; Gundersen, GG			Nuclear movement regulated by Cdc42, MRCK, myosin, and actin flow establishes MTOC polarization in migrating cells	CELL			English	Article							MICROTUBULE-ORGANIZING CENTER; CYTOPLASMIC DYNEIN; SELECTIVE STABILIZATION; CDC42-BINDING KINASE; MITOTIC SPINDLE; GOLGI-APPARATUS; LEADING-EDGE; PHOSPHORYLATION; CENTROSOME; LIS1	The microtubule-organizing center (MTOC) is reoriented between the nucleus and the leading edge in many migrating cells and contributes to directional migration. Models suggest that the MTOC is moved to its position during reorientation. By direct imaging of wound-edge fibroblasts after triggering MTOC reorientation with soluble factors, we found instead that the nucleus moved away from the leading edge to reorient the MTOC, while the MTOC remained stationary. Rearward nuclear movement was coupled with actin retrograde flow and was regulated by a pathway involving Cdc42, MRCK, myosin, and actin. Nuclear movement was unaffected by the inhibition of dynein, Par6, or PKC zeta, yet these components were essential for MTOC reorientation, as they maintained the MTOC at the cell centroid. These results show that nuclear repositioning is an initial polarizing event in migrating cells and that the positions of the nucleus and the MTOC are established by separate regulatory pathways.	Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Gundersen, GG (corresponding author), Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA.	ggg1@columbia.edu	Gomes, Edgar r/D-9000-2015; Gomes, Edgar/ABH-7441-2020	Gomes, Edgar r/0000-0002-6941-4872; Gomes, Edgar/0000-0002-6941-4872	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062938] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 062938] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Ahringer J, 2003, CURR OPIN CELL BIOL, V15, P73, DOI 10.1016/S0955-0674(02)00018-2; BERGMANN JE, 1983, P NATL ACAD SCI-BIOL, V80, P1367, DOI 10.1073/pnas.80.5.1367; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; EUTENEUER U, 1992, J CELL BIOL, V116, P1157, DOI 10.1083/jcb.116.5.1157; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; GOTLIEB AI, 1981, J CELL BIOL, V91, P589, DOI 10.1083/jcb.91.2.589; GREGORY WA, 1988, J NEUROSCI, V8, P1728; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Ketelaar T, 2002, PLANT CELL, V14, P2941, DOI 10.1105/tpc.005892; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Luo LQ, 1997, P NATL ACAD SCI USA, V94, P12963, DOI 10.1073/pnas.94.24.12963; Mikhailov A, 1998, CELL MOTIL CYTOSKEL, V41, P325, DOI 10.1002/(SICI)1097-0169(1998)41:4<325::AID-CM5>3.0.CO;2-D; MIKHAILOV AV, 1995, CELL MOTIL CYTOSKEL, V32, P173, DOI 10.1002/cm.970320303; Morris NR, 2003, CURR OPIN CELL BIOL, V15, P54, DOI 10.1016/S0955-0674(02)00004-2; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Sakurada K, 1998, AM J PHYSIOL-CELL PH, V274, pC1563, DOI 10.1152/ajpcell.1998.274.6.C1563; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schliwa Manfred, 1993, Trends in Cell Biology, V3, P377; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; VONDASSOW G, 1994, J CELL BIOL, V127, P1637, DOI 10.1083/jcb.127.6.1637; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565	60	451	455	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					451	463		10.1016/j.cell.2005.02.022	http://dx.doi.org/10.1016/j.cell.2005.02.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882626	Bronze			2022-12-28	WOS:000229031600014
J	Wang, YJ; Cheng, H; Edwards, RL; He, YQ; Kong, XG; An, ZS; Wu, JY; Kelly, MJ; Dykoski, CA; Li, XD				Wang, YJ; Cheng, H; Edwards, RL; He, YQ; Kong, XG; An, ZS; Wu, JY; Kelly, MJ; Dykoski, CA; Li, XD			The Holocene Asian monsoon: Links to solar changes and North Atlantic climate	SCIENCE			English	Article							INDIAN MONSOON; COLD EVENT; RECORD; VARIABILITY; CHINA; HISTORY; OCEAN; OMAN	A 5-year-resolution absolute-dated oxygen isotope record from Dongge Cave, southern China, provides a continuous history of the Asian monsoon over the past 9000 years. Although the record broadly follows summer insolation, it is punctuated by eight weak monsoon events tasting similar to 1 to 5 centuries. One correlates with the "8200-year" event, another with the collapse of the Chinese Neolithic culture, and most with North Atlantic ice-rafting events. Cross-correlation of the decadal- to centennial-scale monsoon record with the atmospheric carbon-14 record shows that some, but not all, of the monsoon variability at these frequencies results from changes in solar output.	Nanjing Normal Univ, Coll Geog Sci, Nanjing 210097, Peoples R China; Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA; Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 71005, Peoples R China; Hong Kong Polytech Univ, Dept Civil & Struct Engn, Kowloon, Hong Kong, Peoples R China	Nanjing Normal University; University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences; Hong Kong Polytechnic University	Cheng, H (corresponding author), Nanjing Normal Univ, Coll Geog Sci, Nanjing 210097, Peoples R China.	cheng02l@umn.edu	AN, Zhisheng/F-8834-2012; Edwards, R. Lawrence/I-3124-2014; li, xiang/GWM-6319-2022; Li, Xiangdong/B-2211-2008; hu, jenny/AAK-8712-2020; CHENG, HAI/H-3413-2017	Edwards, R. Lawrence/0000-0002-7027-5881; Li, Xiangdong/0000-0002-4044-2888; CHENG, HAI/0000-0002-5305-9458; an, zhi sheng/0000-0002-9538-9826				Agnihotri R, 2002, EARTH PLANET SC LETT, V198, P521, DOI 10.1016/S0012-821X(02)00530-7; An ZS, 2000, QUATERNARY SCI REV, V19, P171, DOI 10.1016/S0277-3791(99)00060-8; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Baldini JUL, 2002, SCIENCE, V296, P2203, DOI 10.1126/science.1071776; Barber DC, 1999, NATURE, V400, P344, DOI 10.1038/22504; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; DENTON G H, 1973, Quaternary Research (Orlando), V3, P155, DOI 10.1016/0033-5894(73)90040-9; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Gupta AK, 2003, NATURE, V421, P354, DOI 10.1038/nature01340; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hong YT, 2003, EARTH PLANET SC LETT, V211, P371, DOI 10.1016/S0012-821X(03)00207-3; Hu FS, 2003, SCIENCE, V301, P1890, DOI 10.1126/science.1088568; Johnson KR, 2004, EARTH PLANET SC LETT, V220, P365, DOI 10.1016/S0012-821X(04)00036-6; Neff U, 2001, NATURE, V411, P290, DOI 10.1038/35077048; PETER B, 2001, SCIENCE, V292, P667; PORTER SC, 1995, NATURE, V375, P305, DOI 10.1038/375305a0; Rousseau DD, 1998, GEOLOGY, V26, P651, DOI 10.1130/0091-7613(1998)026<0651:BLGAHC>2.3.CO;2; Shindell DT, 2001, SCIENCE, V294, P2149, DOI 10.1126/science.1064363; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Stuiver M., 1993, HOLOCENE, V3, P289, DOI DOI 10.1177/095968369300300401; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wu WX, 2004, QUATERN INT, V117, P153, DOI 10.1016/S1040-6182(03)00125-3; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220	27	1756	2214	49	646	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					854	857		10.1126/science.1106296	http://dx.doi.org/10.1126/science.1106296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879216	Green Submitted			2022-12-28	WOS:000228986500048
J	You, LR; Lin, FJ; Lee, CT; DeMayo, FJ; Tsai, MJ; Tsai, SY				You, LR; Lin, FJ; Lee, CT; DeMayo, FJ; Tsai, MJ; Tsai, SY			Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity	NATURE			English	Article							STEM-CELL NICHE; CARDIOVASCULAR DEVELOPMENT; EMBRYONIC ANGIOGENESIS; VESSEL FORMATION; RECEPTOR; MICE; PATHWAY; LIGAND; MOUSE; DIFFERENTIATION	Arteries and veins are anatomically, functionally and molecularly distinct. The current model of arterial - venous identity proposes that binding of vascular endothelial growth factor to its heterodimeric receptor - Flk1 and neuropilin 1 (NP-1; also called Nrp1) - activates the Notch signalling pathway in the endothelium, causing induction of ephrin B2 expression and suppression of ephrin receptor B4 expression to establish arterial identity(1-4). Little is known about vein identity except that it involves ephrin receptor B4 expression, because Notch signalling is not activated in veins; an unresolved question is how vein identity is regulated. Here, we show that COUP-TFII ( also known as Nr2f2), a member of the orphan nuclear receptor superfamily, is specifically expressed in venous but not arterial endothelium. Ablation of COUP-TFII in endothelial cells enables veins to acquire arterial characteristics, including the expression of arterial markers NP-1 and Notch signalling molecules, and the generation of haematopoietic cell clusters. Furthermore, ectopic expression of COUP-TFII in endothelial cells results in the fusion of veins and arteries in transgenic mouse embryos. Thus, COUP-TFII has a critical role in repressing Notch signalling to maintain vein identity, which suggests that vein identity is under genetic control and is not derived by a default pathway.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dev Biol Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Tsai, MJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	mtsai@bcm.tmc.edu; stsai@bcm.tmc.edu	DeMayo, Francesco/C-6255-2019; Hsiao, Wei-Hung/B-9931-2013	DeMayo, Francesco/0000-0002-9480-7336; You, Li-Ru/0000-0003-1775-0097; LIN, FU-JUNG/0000-0003-4065-0983				Adams RH, 2003, J ANAT, V202, P105, DOI 10.1046/j.1469-7580.2003.00137.x; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hogan B, 1994, MANIPULATING MOUSE E; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Krebs LT, 2000, GENE DEV, V14, P1343; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2001, DEVELOPMENT, V128, P3675; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	27	441	455	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					98	104		10.1038/nature03511	http://dx.doi.org/10.1038/nature03511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875024				2022-12-28	WOS:000228864600046
J	Albertsen, PC; Hanley, JA; Fine, J				Albertsen, PC; Hanley, JA; Fine, J			20-year outcomes following conservative management of clinically localized prostate cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RADICAL PROSTATECTOMY; NATURAL-HISTORY; UNITED-STATES; MEN; TRIAL; DEATH	Context The appropriate therapy for men with clinically localized prostate cancer is uncertain. A recent study suggested an increasing prostate cancer mortality rate for men who are alive more than 15 years following diagnosis. Objective To estimate 20-year survival based on-a competing risk analysis of men who were diagnosed with clinically localized prostate cancer and treated with observation or androgen withdrawal therapy alone, stratified by age at diagnosis and histological findings. Design, Setting, and Patients A retrospective population-based cohort study using Connecticut Tumor Registry data supplemented by hospital record and histology review of 767 men aged 55 to 74 years with clinically localized prostate cancer diagnosed between January 1, 1971, and December 31, 1984. Patients were treated with either observation or immediate or delayed androgen withdrawal therapy, with a median observation of 24 years. Main Outcome Measures Probability of mortality from prostate cancer or other competing medical conditions, given a patient's age at diagnosis and tumor grade. Results The prostate cancer mortality rate was 33 per 1000 person-years during the first 15 years of follow-up (95% confidence interval [CI], 28-38) and 18 per 1000 person-years after 15 years of follow-up (95% Cl, 10-29). The mortality rates for these 2 follow-up periods were not statistically different, after adjusting for differences in tumor histology (rate ratio, 1.1; 95% Cl, 0.6-1.9). Men with low-grade prostate cancers have a minimal risk of dying from prostate cancer during 20 years of follow-up (Gleason score of 2-4, 6 deaths per 1000 person-years; 95% Cl, 2-11). Men with high-grade prostate cancers have a high probability of dying from prostate cancer within 10 years of diagnosis (Gleason score of 8-10, 121 deaths per 1000 person-years; 95% Cl, 90156). Men with Gleason score of 5 or 6 tumors have an intermediate risk of prostate cancer death. Conclusion The annual mortality rate from prostate cancer appears to remain stable after 15 years from diagnosis, which does not support aggressive treatment for localized low-grade prostate cancer.	Univ Connecticut, Ctr Hlth, Div Urol, Farmington, CT 06030 USA; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada	University of Connecticut; McGill University	Albertsen, PC (corresponding author), Univ Connecticut, Ctr Hlth, Div Urol, 263 Farmington Ave, Farmington, CT 06030 USA.	albertsen@nso.uchc.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS009578] Funding Source: NIH RePORTER; AHRQ HHS [HS09578] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Albertsen PC, 1998, JAMA-J AM MED ASSOC, V280, P975, DOI 10.1001/jama.280.11.975; Albertsen PC, 2000, J UROLOGY, V163, P519, DOI 10.1016/S0022-5347(05)67915-3; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948; Donovan J, 2003, Health Technol Assess, V7, P1; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; ESPOSTI P L, 1971, Scandinavian Journal of Urology and Nephrology, V5, P199, DOI 10.3109/00365597109133601; Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; MURPHY GP, 1982, J UROLOGY, V127, P928, DOI 10.1016/S0022-5347(17)54135-X; Penson DF, 2001, J NATL CANCER I, V93, P1822, DOI 10.1093/jnci/93.23.1822; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Schroder FH, 1997, BRIT J UROL, V79, P68, DOI 10.1111/j.1464-410X.1997.tb00804.x; Stamey TA, 2004, J UROLOGY, V172, P1297, DOI 10.1097/01.ju.0000139993.51181.5d; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Wilt T J, 1997, Oncology (Williston Park), V11, P1133	17	894	926	1	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2095	2101		10.1001/jama.293.17.2095	http://dx.doi.org/10.1001/jama.293.17.2095			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870412				2022-12-28	WOS:000228808200018
J	Hibbins, AP; Evans, BR; Sambles, JR				Hibbins, AP; Evans, BR; Sambles, JR			Experimental verification of designer surface plasmons	SCIENCE			English	Article								We studied the microwave reflectivity of a structured, near perfectly conducting substrate that was designed to verify the existence of a theoretically proposed new class of surface mode. Measurements of the mode's dispersion curve show that it correctly approaches the predicted asymptotic frequency; the curve also agrees well with that derived from a computer simulation. Modeling of the field distribution on resonance provides evidence of strong localization of the electric field at the interface and substantial power flow along the interface, thus verifying the surface plasmon-like nature of the mode.	Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England	University of Exeter	Hibbins, AP (corresponding author), Univ Exeter, Sch Phys, Stocker Rd, Exeter EX4 4QL, Devon, England.	a.p.hibbins@exeter.ac.uk	Sambles, John Roy/X-8675-2019; Evans, Benjamin/N-3692-2018	SAMBLES, John/0000-0003-2721-0692; Hibbins, Alastair/0000-0001-5406-0162	Engineering and Physical Sciences Research Council [GR/S11008/01, GR/S96036/01, GR/S96029/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		BARLOW HM, 1953, P I ELECTR ENG, V100, P329, DOI 10.1049/pi-3.1953.0068; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; COLLIN RE, 1990, FIELD THEORY GUIDED, pCH7; Hibbins AP, 2000, J APPL PHYS, V87, P2677, DOI 10.1063/1.372241; Pendry JB, 2004, SCIENCE, V305, P847, DOI 10.1126/science.1098999; RAETHER H, 1988, SURFACE PLASMONS SMO, pCH2; RITCHIE RH, 1957, PHYS REV, V106, P874, DOI 10.1103/PhysRev.106.874	7	692	712	14	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2005	308	5722					670	672		10.1126/science.1109043	http://dx.doi.org/10.1126/science.1109043			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860621				2022-12-28	WOS:000228810900042
J	Nakahara, K; Miyashita, Y				Nakahara, K; Miyashita, Y			Understanding intentions: Through the looking glass	SCIENCE			English	Editorial Material							PARIETAL CORTEX		Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Nakahara, K (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan.	nakahara@m.u-tokyo.ac.jp; yasushi_miyashita@m.u-tokyo.ac.jp	Miyashita, Yasushi/B-7171-2019	Miyashita, Yasushi/0000-0003-3496-8637; Nakahara, Kiyoshi/0000-0001-6701-6216				Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Blakemore SJ, 2005, NEUROPSYCHOLOGIA, V43, P260, DOI 10.1016/j.neuropsychologia.2004.11.012; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060	10	15	18	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2005	308	5722					644	645		10.1126/science.1112174	http://dx.doi.org/10.1126/science.1112174			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860616				2022-12-28	WOS:000228810900035
J	Cameron, PB; Chandra, P; Ray, A; Kulkarni, SR; Frail, DA; Wieringa, MH; Nakar, E; Phinney, ES; Miyazaki, A; Tsuboi, M; Okumura, S; Kawai, N; Menten, KM; Bertoldi, F				Cameron, PB; Chandra, P; Ray, A; Kulkarni, SR; Frail, DA; Wieringa, MH; Nakar, E; Phinney, ES; Miyazaki, A; Tsuboi, M; Okumura, S; Kawai, N; Menten, KM; Bertoldi, F			Detection of a radio counterpart to the 27 December 2004 giant flare from SGR 1806-20	NATURE			English	Article							REPEATER SGR 1806-20; IDENTIFICATION; SGR-1900+14; COINCIDENT; AFTERGLOW; DISTANCE; GALAXY	It was established over a decade ago that the remarkable high-energy transients known as soft gamma-ray repeaters (SGRs) are located in our Galaxy(1,2) and originate from neutron stars with intense (<= 10(15)G) magnetic fields-so-called 'magnetars'(3). On 27 December 2004, a giant flare(4) with a fluence(5) exceeding 0.3 erg cm(-2) was detected from SGR 1806-20. Here we report the detection of a fading radio counterpart to this event. We began a monitoring programme from 0.2 to 250 GHz and obtained a high-resolution 21-cm radio spectrum that traces the intervening interstellar neutral hydrogen clouds. Analysis of the spectrum yields the first direct distance measurement of SGR 1806-20: the source is located at a distance greater than 6.4 kpc and we argue that it is nearer than 9.8 kpc. If correct, our distance estimate lowers the total energy of the explosion and relaxes the demands on theoretical models. The energetics and the rapid decay of the radio source are not compatible with the afterglow model that is usually invoked for gamma-ray bursts. Instead, we suggest that the rapidly decaying radio emission arises from the debris ejected during the explosion.	CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India; Indian Inst Sci, Joint Astron Programme, Bangalore 560012, Karnataka, India; Natl Radio Astron Observ, Socorro, NM 87801 USA; CSIRO, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; Shanghai Astron Observ, Shanghai 200030, Peoples R China; Natl Astron Observ, Nobeyama Radio Observ, Minamisa Ku, Nagano 3841305, Japan; Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan; Max Planck Inst Radioastron, D-53121 Bonn, Germany; Univ Bonn, D-53121 Bonn, Germany	California Institute of Technology; Tata Institute of Fundamental Research (TIFR); Indian Institute of Science (IISC) - Bangalore; National Radio Astronomy Observatory (NRAO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Chinese Academy of Sciences; Shanghai Astronomical Observatory, CAS; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Tokyo Institute of Technology; Max Planck Society; University of Bonn	Cameron, PB (corresponding author), CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA.	pbc@astro.caltech.edu		Nakar, Ehud/0000-0002-4534-7089; Wieringa, Mark/0000-0002-7721-8660; Phinney, Sterl/0000-0002-9656-4032; Chandra, Poonam/0000-0002-0844-6563				BOGGS S, 2005, GRB CIRC NETWORK, V2936; BORKOWSKI J, 2004, GRB CIRC NETWORK, V2920; CAMERON PB, 2005, GRB CIRC NETWORK, V2928; Cheng KS, 2003, ASTROPHYS J, V593, pL85, DOI 10.1086/378216; Corbel S, 2004, ASTRON ASTROPHYS, V419, P191, DOI 10.1051/0004-6361:20034054; Corbel S, 1997, ASTROPHYS J, V478, P624, DOI 10.1086/303807; Feroci M, 2001, ASTROPHYS J, V549, P1021, DOI 10.1086/319441; Figer DF, 2004, ASTROPHYS J, V610, pL109, DOI 10.1086/423306; Frail DA, 2000, ASTROPHYS J, V537, P191, DOI 10.1086/309024; Frail DA, 1999, NATURE, V398, P127, DOI 10.1038/18163; Fuchs Y, 1999, ASTRON ASTROPHYS, V350, P891; Gaensler BM, 2005, ASTROPHYS J, V620, pL95, DOI 10.1086/428725; GAENSLER BM, 2005, GRB CIRC NETWORK, V2933; GARWOOD RW, 1989, ASTROPHYS J, V338, P841, DOI 10.1086/167240; HARTMANN D, 1997, ATLAS GALACTIC NEUTR, P169; Hjellming RM, 2000, ASTROPHYS J, V544, P977, DOI 10.1086/317255; Kaplan DL, 2002, ASTROPHYS J, V564, P935, DOI 10.1086/324339; Kolpak MA, 2002, ASTROPHYS J, V578, P868, DOI 10.1086/342659; KULKARNI SR, 1993, NATURE, V365, P33, DOI 10.1038/365033a0; MURAKAMI T, 1994, NATURE, V368, P127, DOI 10.1038/368127a0; NAKAR E, GIANT FLARES MINI GA; NAKAR E, UNPUB ASTROPHYS J; Pacholczyk A. G., 1970, SERIES BOOKS ASTRONO; SCOTT MA, 1977, MON NOT R ASTRON SOC, V180, P539, DOI 10.1093/mnras/180.4.539; Wang XY, 2005, ASTROPHYS J, V623, pL29, DOI 10.1086/429997; WOODS PM, IN PRESS CAMBRIDGE A	26	108	108	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2005	434	7037					1112	1115		10.1038/nature03605	http://dx.doi.org/10.1038/nature03605			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858569	Green Accepted			2022-12-28	WOS:000228693300038
J	Gaensler, BM; Kouveliotou, C; Gelfand, JD; Taylor, GB; Eichler, D; Wijers, RAMJ; Granot, J; Ramirez-Ruiz, E; Lyubarsky, YE; Hunstead, RW; Campbell-Wilson, D; van der Horst, AJ; McLaughlin, MA; Fender, RP; Garrett, MA; Newton-McGee, KJ; Palmer, DM; Gehrels, N; Woods, PM				Gaensler, BM; Kouveliotou, C; Gelfand, JD; Taylor, GB; Eichler, D; Wijers, RAMJ; Granot, J; Ramirez-Ruiz, E; Lyubarsky, YE; Hunstead, RW; Campbell-Wilson, D; van der Horst, AJ; McLaughlin, MA; Fender, RP; Garrett, MA; Newton-McGee, KJ; Palmer, DM; Gehrels, N; Woods, PM			An expanding radio nebula produced by a giant flare from the magnetar SGR 1806-20	NATURE			English	Article							RAY REPEATER SGR1900+14; SOFT GAMMA-REPEATERS; RADIATIVE MECHANISM; SGR 1806-20; PULSAR; SGR-1900+14; AFTERGLOWS	Soft gamma-ray repeaters (SGRs) are 'magnetars', a small class of slowly spinning neutron stars with extreme surface magnetic fields, B approximate to 10(15) gauss (refs 1-3). On 27 December 2004, a giant flare(4) was detected from the magnetar SGR 1806-20 (ref. 2), only the third such event recorded(5,6). This burst of energy was detected by a variety of instruments(7,8) and even caused an ionospheric disturbance in the Earth's upper atmosphere that was recorded around the globe(9). Here we report the detection of a fading radio afterglow produced by this outburst, with a luminosity 500 times larger than the only other detection of a similar source(10). From day 6 to day 19 after the flare from SGR 1806-20, a resolved, linearly polarized, radio nebula was seen, expanding at approximately a quarter of the speed of light. To create this nebula, at least 4 x 10(43) ergs of energy must have been emitted by the giant flare in the form of magnetic fields and relativistic particles.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35805 USA; Univ Space Res Assoc, NSSTC, Huntsville, AL 35805 USA; Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94309 USA; Natl Radio Astron Observ, Socorro, NM 87801 USA; Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel; Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; Inst Adv Study, Princeton, NJ 08540 USA; Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; Univ Manchester, Jodrell Bank Observ, Macclesfield SK11 9DL, Cheshire, England; Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; Joint Inst VLBI Europe, NL-7990 AA Dwingeloo, Netherlands; CSIRO, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Universities Space Research Association (USRA); Stanford University; National Radio Astronomy Observatory (NRAO); Ben Gurion University; University of Amsterdam; Institute for Advanced Study - USA; University of Sydney; University of Manchester; Jodrell Bank Centre for Astrophysics; University of Southampton; Commonwealth Scientific & Industrial Research Organisation (CSIRO); United States Department of Energy (DOE); Los Alamos National Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Gaensler, BM (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	bgaensler@cfa.harvard.edu	Gehrels, Neil/D-2971-2012; LYUBARSKY, YURY/F-2362-2012; Gaensler, Bryan M/F-8655-2010; Gelfand, Joseph/F-1110-2015	Lyubarsky, Yuri/0000-0002-2316-8899; Wijers, Ralph/0000-0002-3101-1808; Taylor, Greg/0000-0001-6495-7731; Granot, Jonathan/0000-0001-8530-8941; Gelfand, Joseph/0000-0003-4679-1058; McLaughlin, Maura/0000-0001-7697-7422; van der Horst, Alexander/0000-0001-9149-6707; Gaensler, Bryan/0000-0002-3382-9558; Eichler, David/0000-0002-9051-9927				Arzoumanian Z, 2002, ASTROPHYS J, V568, P289, DOI 10.1086/338805; BORKOWSKI J, 2004, 2920 GCN; Brown JC, 2003, ASTROPHYS J SUPPL S, V145, P213, DOI 10.1086/346082; CAMPBELL P, 2005, 2932 GCN; CHANDRA P, 2005, 2947 GCN; Cheng KS, 2003, ASTROPHYS J, V593, pL85, DOI 10.1086/378216; Corbel S, 2004, ASTRON ASTROPHYS, V419, P191, DOI 10.1051/0004-6361:20034054; DUNCAN RC, 1992, APJ, V392, P9; Frail DA, 1999, NATURE, V398, P127, DOI 10.1038/18163; Gaensler BM, 2002, ASTROPHYS J, V580, pL137, DOI 10.1086/345750; Granot J, 1999, ASTROPHYS J, V513, P679, DOI 10.1086/306884; Hurley K, 1999, NATURE, V397, P41, DOI 10.1038/16199; Kaplan DL, 2002, ASTROPHYS J, V564, P935, DOI 10.1086/324339; Kouveliotou C, 1998, NATURE, V393, P235, DOI 10.1038/30410; Kouveliotou C, 2001, ASTROPHYS J, V558, pL47, DOI 10.1086/323496; Lorimer DR, 2000, ASTROPHYS J, V545, P385, DOI 10.1086/317815; MAZETS EP, 1979, NATURE, V282, P587, DOI 10.1038/282587a0; Pacholczyk A. G., 1970, RADIO ASTROPHYSICS, P170; Rhoads JE, 1999, ASTROPHYS J, V525, P737, DOI 10.1086/307907; STAVELEYSMITH L, 1993, P ASTRON SOC AUST, V10, P331, DOI 10.1017/S1323358000025972; Thompson C, 2001, ASTROPHYS J, V561, P980, DOI 10.1086/323256; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255, DOI 10.1093/mnras/275.2.255; Thompson C, 2000, ASTROPHYS J, V543, P340, DOI 10.1086/317072; Wilkin F. P., 1996, APJ, V459, pL31; Woods PM, 2002, ASTROPHYS J, V576, P381, DOI 10.1086/341536; WOODS PM, PREPRINT; WOODS PM, IN PRESS COMPACT STE	27	132	132	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2005	434	7037					1104	1106		10.1038/nature03498	http://dx.doi.org/10.1038/nature03498			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858566	Green Submitted			2022-12-28	WOS:000228693300035
J	Bates, I				Bates, I			Presumptive malaria treatment in immunisation programmes	LANCET			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; SULFADOXINE-PYRIMETHAMINE; INTERMITTENT TREATMENT; ANEMIA; INFANTS		Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Bates, I (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	ibates@liverpool.ac.uk		bates, imelda/0000-0002-0862-8199				Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Haines A, 2004, BMJ-BRIT MED J, V329, P394, DOI 10.1136/bmj.329.7462.394; *IPTI CONS, 2005, IPTI ANT DRUGS DEL E; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; Milen A, 2001, WHAT DO WE KNOW CAPA; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; SCHULTZ LJ, 1994, AM J TROP MED HYG, V51, P515, DOI 10.4269/ajtmh.1994.51.515; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8	8	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1443	1444		10.1016/S0140-6736(05)66395-7	http://dx.doi.org/10.1016/S0140-6736(05)66395-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850614				2022-12-28	WOS:000228651600005
J	Akashi, K; Traver, D; Zon, LI				Akashi, K; Traver, D; Zon, LI			The complex cartography of stem cell commitment	CELL			English	Editorial Material							BONE-MARROW; LYMPHOID PROGENITOR; LINEAGE COMMITMENT; FLT3	In this issue of Cell, a study by Adolfsson and coworkers (Adolfsson et al., 2005) provides insight into the early lineage commitment events of multipotent hematopoietic stem cells (HSCs). These studies demonstrate the importance of the Flt3 receptor tyrosine kinase as the earliest marker of hematopoietic cell fate commitment in that erythrocyte and megakaryocyte potentials are lost first as HSCs; differentiate to lymphocyte progenitors.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Akashi, K (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.							Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Slayton WB, 2001, ANN NY ACAD SCI, V938, P157; Traver D, 2004, ADV IMMUNOL, V83, P1	9	26	28	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 22	2005	121	2					160	162		10.1016/j.cell.2005.04.005	http://dx.doi.org/10.1016/j.cell.2005.04.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851023	Bronze			2022-12-28	WOS:000228705000004
J	Schulze-Lefert, P; Bieri, S				Schulze-Lefert, P; Bieri, S			Recognition at a distance	SCIENCE			English	Editorial Material							CF-2-DEPENDENT DISEASE RESISTANCE; III EFFECTOR; CYSTEINE PROTEASE; ARABIDOPSIS; RIN4; AVRRPT2; CLEAVAGE		Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany; Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland	Max Planck Society; University of Zurich	Schulze-Lefert, P (corresponding author), Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany.	schlef@mpiz-koeln.mpg.de	Schulze-Lefert, Paul/A-7746-2008; Schulze-Lefert, Paul/B-6707-2011					Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Chisholm ST, 2005, P NATL ACAD SCI USA, V102, P2087, DOI 10.1073/pnas.0409468102; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Day B, 2005, PLANT CELL, V17, P1292, DOI 10.1105/tpc.104.030163; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Kasahara M, 2004, TRENDS IMMUNOL, V25, P105, DOI 10.1016/j.it.2003.11.005; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	16	9	13	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					506	508		10.1126/science.1111725	http://dx.doi.org/10.1126/science.1111725			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845841				2022-12-28	WOS:000228810500039
J	Pelkmans, L; Fava, E; Grabner, H; Hannus, M; Habermann, B; Krausz, E; Zerial, M				Pelkmans, L; Fava, E; Grabner, H; Hannus, M; Habermann, B; Krausz, E; Zerial, M			Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis	NATURE			English	Article							MEMBRANE DOMAINS; SIGNAL-TRANSDUCTION; CELL; TRANSPORT; ENTRY; SIMIAN-VIRUS-40; CAVEOLIN-1; RECEPTOR; COMPLEX; FUSION	Endocytosis is a key cellular process, encompassing different entry routes and endocytic compartments. To what extent endocytosis is subjected to high-order regulation by the cellular signalling machinery remains unclear. Using high-throughput RNA interference and automated image analysis, we explored the function of human kinases in two principal types of endocytosis: clathrin- and caveolae/raft-mediated endocytosis. We monitored this through infection of vesicular stomatitis virus, simian virus 40 and transferrin trafficking, and also through cell proliferation and apoptosis assays. Here we show that a high number of kinases are involved in endocytosis, and that each endocytic route is regulated by a specific kinase subset. Notably, one group of kinases exerted opposite effects on the two endocytic routes, suggesting coordinate regulation. Our analysis demonstrates that signalling functions such as those controlling cell adhesion, growth and proliferation, are built into the machinery of endocytosis to a much higher degree than previously recognized.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; MPI CBG High Throughput Technol Dev Studio, D-01307 Dresden, Germany; Scionics Comp Innovat GmbH, D-01307 Dresden, Germany; Ceniix Biosci GmbH, D-01307 Dresden, Germany	Max Planck Society; Max Planck Society	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Habermann, Bianca/N-4886-2016	Habermann, Bianca/0000-0002-2457-7504; Pelkmans, Lucas/0000-0002-6754-9730; Fava, Eugenio/0000-0002-3737-0334				Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; LUCOCQ J, 1991, J CELL SCI, V100, P753; MACE G, UNPUB EMBO J; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Nguyen C, 2003, J CELL BIOL, V163, P697, DOI 10.1083/jcb.200310038; Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; PELKMANS L, UNPUB NATURE; Razani B, 2001, EXP CELL RES, V271, P36, DOI 10.1006/excr.2001.5372; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; TUOMIKOSKI T, 1989, NATURE, V342, P942, DOI 10.1038/342942a0; WARREN G, 1984, EMBO J, V3, P2217, DOI 10.1002/j.1460-2075.1984.tb02119.x; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; WOODMAN PG, 1992, J CELL BIOL, V116, P331, DOI 10.1083/jcb.116.2.331; Xue LZ, 1998, CELL SIGNAL, V10, P339, DOI 10.1016/S0898-6568(98)00011-4; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	51	495	517	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					78	86		10.1038/nature03571	http://dx.doi.org/10.1038/nature03571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	15889048				2022-12-28	WOS:000230296600042
J	Rooney, HCE; van 't Klooster, JW; van der Hoorn, RAL; Joosten, MHAJ; Jones, JDG; de Wit, PJGM				Rooney, HCE; van 't Klooster, JW; van der Hoorn, RAL; Joosten, MHAJ; Jones, JDG; de Wit, PJGM			Cladosporium Avr2 inhibits tomato Rcr3 protease required for Cf-2-dependent disease resistance	SCIENCE			English	Article							FOR-GENE CONCEPT; III EFFECTOR; CYSTEINE PROTEASE; AVIRULENCE GENE; PROTEINS; FULVUM; ARABIDOPSIS; PLANTS; RIN4; AVRRPT2	How plants recognize pathogens and activate defense is still mysterious. Direct interaction between pathogen avirulence (Avr) proteins and plant disease resistance proteins is the exception rather than the rule. During infection, Cladosporium fulvum secretes Avr2 protein into the apoplast of tomato leaves and, in the presence of the extracellular leucine-rich repeat receptor-like Cf-2 protein, triggers a hypersensitive response (HR) that also requires the extracellular tomato cysteine protease Rcr3. We show here that Avr2 binds and inhibits Rcr3 and propose that the Rcr3-Avr2 complex enables the Cf-2 protein to activate an HR.	Univ Wageningen & Res Ctr, Phytopathol Lab, NL-6709 PD Wageningen, Netherlands; John Innes Ctr, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	Wageningen University & Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	de Wit, PJGM (corresponding author), Univ Wageningen & Res Ctr, Phytopathol Lab, Binnenhaven 5, NL-6709 PD Wageningen, Netherlands.	pierre.dewit@wur.nl	van der Hoorn, Renier/E-5346-2011; de Wit, Pierre J. G.M./CAI-9966-2022; de Wit, Pierre/A-1998-2013; van der Hoorn, Renier/AAU-1005-2020; Jones, Jonathan DG/J-5129-2012; Joosten, Matthieu/AAB-5131-2022; Joosten, Matthieu/AAB-5150-2022	de Wit, Pierre/0000-0002-4208-288X; van der Hoorn, Renier/0000-0002-3692-7487; Jones, Jonathan DG/0000-0002-4953-261X; Joosten, Matthieu/0000-0002-6243-4547; 				Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Chang JH, 2004, CURR OPIN MICROBIOL, V7, P11, DOI 10.1016/j.mib.2003.12.006; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; DEWIT P, UNPUB; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; Dixon MS, 2000, P NATL ACAD SCI USA, V97, P8807, DOI 10.1073/pnas.97.16.8807; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; GRIGNON C, 1991, ANNU REV PLANT PHYS, V42, P103, DOI 10.1146/annurev.pp.42.060191.000535; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Joosten MHAJ, 1999, ANNU REV PHYTOPATHOL, V37, P335, DOI 10.1146/annurev.phyto.37.1.335; Kocks C, 2003, MOL CELL PROTEOMICS, V2, P1188, DOI 10.1074/mcp.M300067-MCP200; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Lauge R, 2000, PLANT J, V23, P735, DOI 10.1046/j.1365-313x.2000.00843.x; LAZAROVITS G, 1976, CAN J BOT, V54, P224, DOI 10.1139/b76-022; Luderer R, 2002, MOL MICROBIOL, V45, P875, DOI 10.1046/j.1365-2958.2002.03060.x; Luderer R, 2001, MOL PLANT MICROBE IN, V14, P867, DOI 10.1094/MPMI.2001.14.7.867; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Van der Hoorn RAL, 2002, TRENDS PLANT SCI, V7, P67, DOI 10.1016/S1360-1385(01)02188-4; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; VANKAN JAL, 1992, PLANT MOL BIOL, V20, P513, DOI 10.1007/BF00040610; Wit P. J. G. M. de, 1977, Netherlands Journal of Plant Pathology, V83, P109, DOI 10.1007/BF01981556	28	329	346	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2005	308	5729					1783	1786		10.1126/science.1111404	http://dx.doi.org/10.1126/science.1111404			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15845874				2022-12-28	WOS:000229926800053
J	Gilham, C; Peto, J; Simpson, J; Roman, E; Eden, TOB; Greaves, MF; Alexander, FE				Gilham, C; Peto, J; Simpson, J; Roman, E; Eden, TOB; Greaves, MF; Alexander, FE		UKCCS Investigators	Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHROMOSOME TRANSLOCATIONS; INFECTIONS; VACCINATIONS; ETIOLOGY; EXPOSURE; AGE	Objective To test the hypothesis that reduced exposure to common infections in the first year of life increases the risk of developing acute lymphoblastic leukaemia. Design and setting The United Kingdom childhood cancer study (UKCCS) is a large population based case-control study of childhood cancer across 10 regions of the UK. Participants 6305 children (aged 2-14 years) without cancer; 3140 children with cancer (diagnosed 1991-6), of whom 1286 had acute lymphoblastic leukaemia (ALL). Main outcome measure Day care and social activity during the first year of life were used as proxies for potential exposure to infection in infancy.. Results Increasing levels of social activity were associated with consistent reductions in risk of ALL; a dose-response trend was seen. When children whose mothers reported no regular activity outside the family were used as the reference group, odds ratios for increasing levels of activity were 0.73 (95% confidence interval 0.62 to 0.87) for any social activity, 0.62 (0.51 to 0.75) for regular day care outside the home, and 0.48 (0.37 to 0.62) for formal day care (attendance at facility with at least four children at least twice a week) (P value for trend < 0.001). Although not as striking, results for non-ALL malignancies showed a similar pattern (P value for trend < 0.001). When children with non-ALL malignancies were taken as the reference group, a significant protective effect for ALL was seen only for formal day care (odds ratio = 0.69, 0.51 to 0.93; P = 0.02). Similar results were obtained for B cell precursor common ALL and other subgroups, as well as for cases diagnosed above and below age 5 years. Conclusion These results support the hypothesis that reduced exposure to infection in the first few months of life increases the risk of developing acute lymphoblastic leukaemia.	Christie Hosp, Acad Unit Paediat Oncol, Manchester M20 4BX, Lancs, England; Cent Manchester & Manchester Childrens Univ Hosp, Manchester M20 4BX, Lancs, England; Inst Canc Res, Canc Res UK Epidemiol & Genet Unit, Sutton SM2 5NG, Surrey, England; Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Univ York, Dept Hlth Sci, Leukaemia Res Fund Epidemiol, York YO10 5DD, N Yorkshire, England; Univ York, Genet Unit, York YO10 5DD, N Yorkshire, England; Inst Canc Res, Sect Haemato Oncol, London SW3 6JB, England; Univ Edinburgh, Edinburgh EH8 9AG, Midlothian, Scotland	Christie NHS Foundation Trust; Christie Hospital; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of York - UK; University of York - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Edinburgh	Eden, TOB (corresponding author), Christie Hosp, Acad Unit Paediat Oncol, Manchester M20 4BX, Lancs, England.	tim.eden@manchester.ac.uk		Roman, Eve/0000-0001-7603-3704				[Anonymous], 2000, Br J Cancer, V82, P1073; Auvinen A, 2000, BRIT J CANCER, V83, P956, DOI 10.1054/bjoc.2000.1382; Chan LC, 2002, PAEDIATR PERINAT EP, V16, P154, DOI 10.1046/j.1365-3016.2002.00406.x; Cooke JV, 1942, J AMER MED ASSOC, V119, P547, DOI 10.1001/jama.1942.02830240011004; Dockerty JD, 1999, BRIT J CANCER, V80, P1483, DOI 10.1038/sj.bjc.6690548; FLEMING DW, 1987, PEDIATRICS, V79, P55; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Greaves MF, 1997, LANCET, V349, P344, DOI 10.1016/S0140-6736(96)09412-3; GREAVES MF, 1988, LEUKEMIA, V2, P120; GREAVES MF, 1993, LEUKEMIA, V7, P349; Groves F, 2002, BRIT J CANCER, V87, P511, DOI 10.1038/sj.bjc.6600489; Groves FD, 1999, BRIT J CANCER, V81, P175, DOI 10.1038/sj.bjc.6690668; Infante-Rivard C, 2000, BRIT J CANCER, V83, P1559, DOI 10.1054/bjoc.2000.1495; Jourdan-Da Silva N, 2004, BRIT J CANCER, V90, P139, DOI 10.1038/sj.bjc.6601384; JOURDANDASILVA N, 2004, BRIT J CANCER, V99, P189; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; KINLEN LJ, 1988, BRIT MED J, V297, P1070, DOI 10.1136/bmj.297.6656.1070; KINLEN LJ, 1995, BRIT J CANCER, V71, P1, DOI 10.1038/bjc.1995.1; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Law GR, 2002, BRIT J CANCER, V86, P350, DOI 10.1038/sj/bjc/6600092; LOUHIALA PJ, 1995, AM J PUBLIC HEALTH, V85, P1109, DOI 10.2105/AJPH.85.8_Pt_1.1109; Ma X, 2002, BRIT J CANCER, V86, P1419, DOI 10.1038/sj.bjc.6600274; McKinney PA, 2000, DIABETIC MED, V17, P236, DOI 10.1046/j.1464-5491.2000.00220.x; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Neglia JP, 2000, BRIT J CANCER, V82, P234, DOI 10.1054/bjoc.1999.0905; Perrillat F, 2002, BRIT J CANCER, V86, P1064, DOI [10.1038/sj/bjc/6600091, 10.1038/sj.bjc.6600091]; Petridou E, 1997, BRIT J CANCER, V76, P1241, DOI 10.1038/bjc.1997.541; PETRIDOU E, 1993, BRIT MED J, V307, P774, DOI 10.1136/bmj.307.6907.774; RASMUSSEN F, 1990, ACTA PAEDIATR SCAND, V79, P838, DOI 10.1111/j.1651-2227.1990.tb11563.x; RASMUSSEN F, 1996, ACTA PAEDIATR SCAND, V79, P838; ROMAN E, 2005, IN PRESS EUR J CANC; Rosenbaum PF, 2000, AM J EPIDEMIOL, V152, P1136, DOI 10.1093/aje/152.12.1136; Schuz J, 1999, BRIT J CANCER, V80, P585, DOI 10.1038/sj.bjc.6690395; STEENSELMOLL HA, 1986, AM J EPIDEMIOL, V124, P590; Taylor GM, 2002, HUM MOL GENET, V11, P1585; *UK CHILDH CANC ST, 2000, BRIT J CANCER, V32, P1073; Wiemels JL, 1999, LANCET, V354, P1499, DOI 10.1016/S0140-6736(99)09403-9	37	93	94	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2005	330	7503					1294	1297		10.1136/bmj.38428.521042.8F	http://dx.doi.org/10.1136/bmj.38428.521042.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TL	15849205	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-28	WOS:000229655700019
J	Swaddle, TW; Rosenqvist, J; Yu, P; Bylaska, E; Philiips, BL; Casey, WH				Swaddle, TW; Rosenqvist, J; Yu, P; Bylaska, E; Philiips, BL; Casey, WH			Kinetic evidence for five-coordination in AlOH(aq)(2+) ion	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; AQUEOUS MONONUCLEAR AL(III)-HYDROXO; WATER EXCHANGE; GEOCHEMICAL RELEVANCE; AL(III) COMPLEXES; METAL-IONS; ALUMINUM; HYDROLYSIS; SPECTROSCOPY; SPECIATION	Trivalent aluminum ions are important in natural bodies of water, but the structure of their coordination shell is a complex unsolved problem. In strong acid (pH < 3.0), Al-III exists almost entirely as the octahedral Al(H2O)(6)(3+) ion, whereas in basic conditions (pH > 7), a tetrahedral AI(OH)(4)(-) structure prevails. in the biochemically and geochemically critical pH range of 4.3 to 7.0, the ion structures are less clear. Other hydrolytic species, such as AlOH(aq)(2+), exist and are traditionally assumed to be hexacoordinate. We show, however, that the kinetics of proton and water exchange on aqueous Al-III, coupled with Car-Parrinetto simulations, support a five-coordinate Al(H2O)(4)OH2+ ion as the predominant form of AlOH(aq)(2+) under ambient conditions. This result contrasts Al-III with other trivalent metal aqua ions, for which there is no evidence for stable pentacoordinate hydrolysis products.	Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; Univ Calif Davis, Nucl Magnet Resonance Facil, Davis, CA 95616 USA; Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada; Pacific NW Natl Lab, Richland, WA 99352 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Calgary; United States Department of Energy (DOE); Pacific Northwest National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Casey, WH (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	whcasey@ucdavis.edu		YU, Ping/0000-0001-7610-6512				AKITT JW, 1985, J CHEM SOC FARAD T 1, V81, P1923, DOI 10.1039/f19858101923; AKITT JW, 1989, PROG NUCL MAG RES SP, V21, P1, DOI 10.1016/0079-6565(89)80001-9; APRA E, 2005, NWCHEM VERSION 4 7; CRUICKSHANK MC, 1986, J CHEM SOC CHEM COMM, P23; FAUST BC, 1995, GEOCHIM COSMOCHIM AC, V59, P2651, DOI 10.1016/0016-7037(95)00162-S; FONG DW, 1969, J AM CHEM SOC, V91, P2413, DOI 10.1021/ja01038a001; HAMANN DR, 1989, PHYS REV B, V40, P2980, DOI 10.1103/PhysRevB.40.2980; Helm L, 1999, COORDIN CHEM REV, V187, P151, DOI 10.1016/S0010-8545(99)90232-1; HOLMES LP, 1968, J PHYS CHEM-US, V72, P301, DOI 10.1021/j100847a058; HUGICLEARY D, 1985, HELV CHIM ACTA, V68, P545, DOI 10.1002/hlca.19850680302; KLEINMAN L, 1982, PHYS REV LETT, V48, P1425, DOI 10.1103/PhysRevLett.48.1425; KLOPROGGE JT, 1993, J NON-CRYST SOLIDS, V152, P207; Kowall T, 1998, J AM CHEM SOC, V120, P6569, DOI 10.1021/ja980571f; MARTIN RB, 1991, J INORG BIOCHEM, V44, P141, DOI 10.1016/0162-0134(91)84026-6; MARTIN RB, 1988, MET IONS BIOL SYST, V24, P1; MILLERO FJ, 1972, WATER AQUEOUS SOLUTI, pCH13; Nordin JP, 1998, INORG CHEM, V37, P4760, DOI 10.1021/ic980333l; Ohman LO, 1997, GEOCHIM COSMOCHIM AC, V61, P3257, DOI 10.1016/S0016-7037(97)00064-1; PALMER DA, 1993, GEOCHIM COSMOCHIM AC, V57, P2929, DOI 10.1016/0016-7037(93)90284-4; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; RICHENS DT, 1997, CHEM AQUA IONS, P143; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sigel H., 1988, MET IONS BIOL SYST, V24; Smith RW, 1996, COORDIN CHEM REV, V149, P81, DOI 10.1016/S0010-8545(96)90014-4; SWADDLE TW, 1983, INORG CHEM, V22, P2663, DOI 10.1021/ic00161a002; SWADDLE TW, 1980, INORG CHEM, V19, P3203, DOI 10.1021/ic50212a082; SWADDLE TW, 1981, INORG CHEM, V20, P4212, DOI 10.1021/ic50226a036; Yokel R.A., 2004, ELEMENTS THEIR COMPO, P635	29	153	157	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2005	308	5727					1450	1453		10.1126/science.1110231	http://dx.doi.org/10.1126/science.1110231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933HK	15860592				2022-12-28	WOS:000229619300048
J	Wang, D; Weaver, ND; Kesarwani, M; Dong, XN				Wang, D; Weaver, ND; Kesarwani, M; Dong, XN			Induction of protein secretory pathway is required for systemic acquired resistance	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; ARABIDOPSIS-THALIANA; GENOMIC ANALYSIS; EXPRESSION; GENE; HOMOLOG; NPR1	In plants, systemic acquired resistance (SAR) is established as a result of NPR1-regulated expression of pathogenesis-related (PR) genes. Using gene expression profiling in Arabidopsis, we found that in addition to controlling the expression of PR genes, NPR1 also directly controls the expression of the protein secretory pathway genes. Up-regulation of these genes is essential for SAR, because mutations in some of them diminished the secretion of PR proteins (for example, PR1), resulting in reduced resistance. We provide evidence that NPR1 coordinately,regulates these secretion-related genes through a previously undescribed cis-element. Activation of this cis-element is controlled by a transcription factor that is translocated into the nucleus upon SAR induction.	Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, Durham, NC 27708 USA	Duke University	Dong, XN (corresponding author), Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, POB 91000, Durham, NC 27708 USA.	xdong@duke.edu						Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chu TM, 2002, MATH BIOSCI, V176, P35, DOI 10.1016/S0025-5564(01)00107-9; DENECKE J, 1995, PLANT CELL, V7, P391, DOI 10.1105/tpc.7.4.391; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fu J, 2000, J BIOL CHEM, V275, P3984, DOI 10.1074/jbc.275.6.3984; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Jelitto-Van Dooren EPWM, 1999, PLANT CELL, V11, P1935, DOI 10.2307/3871088; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Lin BL, 2001, CELL STRESS CHAPERON, V6, P201, DOI 10.1379/1466-1268(2001)006<0201:GAOTHS>2.0.CO;2; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Noh SJ, 2003, GENE, V311, P81, DOI 10.1016/S0378-1119(03)00559-6; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vitale A, 1999, PLANT CELL, V11, P615, DOI 10.1105/tpc.11.4.615; WALTHERLARSEN H, 1993, PLANT MOL BIOL, V21, P1097, DOI 10.1007/BF00023606; Wick P, 2003, PLANT PHYSIOL, V132, P343, DOI 10.1104/pp.102.012633; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894	25	400	424	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1036	1040		10.1126/science.1108791	http://dx.doi.org/10.1126/science.1108791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890886				2022-12-28	WOS:000229190700051
J	Weldon, RJ; Fumal, TE; Biasi, GP; Scharer, KM				Weldon, RJ; Fumal, TE; Biasi, GP; Scharer, KM			Geophysics - Past and future earthquakes on the San Andreas fault	SCIENCE			English	Editorial Material							PALEOSEISMIC SITE; CALIFORNIA; WRIGHTWOOD		Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA; US Geol Survey, Earthquake Hazards Team, Menlo Pk, CA 94025 USA; Univ Nevada, Seismol Lab, Reno, NV 89557 USA	University of Oregon; United States Department of the Interior; United States Geological Survey; Nevada System of Higher Education (NSHE); University of Nevada Reno	Weldon, RJ (corresponding author), Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA.	ray@uoregon.edu; tfumal@usgs.gov; glenn@seismo.unr.edu; kscharer@uoregon.edu						Biasi GP, 2002, B SEISMOL SOC AM, V92, P2761, DOI 10.1785/0120000605; BIASI GP, IN PRESS B SEISMOL S; Fumal TE, 2002, B SEISMOL SOC AM, V92, P2726, DOI 10.1785/0120000608; GRANT LB, 2002, B SEISMOL SOC AM, V92; Liu J, 2004, GEOLOGY, V32, P649, DOI 10.1130/G20478.1; SCHARER KM, 2005, THESIS U OREGON; SEITZ GG, 1999, THESIS U OREGON; SIEH K, 1989, J GEOPHYS RES-SOLID, V94, P603, DOI 10.1029/JB094iB01p00603; Weldon R., 2004, GSA TODAY, V14, P4, DOI [10.1130/1052-5173(2004)014%3C4:watecw%3E2.0.co;2, DOI 10.1130/1052-5173(2004)0142.0.CO;2,2004]; Weldon RJ, 2002, B SEISMOL SOC AM, V92, P2704, DOI 10.1785/0120000612; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974	11	56	60	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					966	967		10.1126/science.1111707	http://dx.doi.org/10.1126/science.1111707			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890868				2022-12-28	WOS:000229190700028
J	Amiel, SA; Rela, M				Amiel, SA; Rela, M			Live organ-donation for islet transplantation	LANCET			English	Editorial Material							DONOR; HYPOGLYCEMIA		Kings Coll London, London SE5 9PJ, England; Kings Coll Hosp London, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Amiel, SA (corresponding author), Kings Coll London, London SE5 9PJ, England.	stephanie.amiel@kcl.ac.uk						[Anonymous], 2000, Diabetes Care, V23, P117; Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830; Jassem W, 2003, TRANSPLANTATION, V75, P1386, DOI 10.1097/01.TP.0000062863.06782.89; MACLEOD KM, 1993, DIABETIC MED, V10, P238, DOI 10.1111/j.1464-5491.1993.tb00051.x; Plenz G, 2002, J AM COLL CARDIOL, V39, P1508, DOI 10.1016/S0735-1097(02)01791-6; Robertson RP, 2002, TRANSPLANTATION, V73, P736; Ryan EA, 2004, DIABETES, V53, P955, DOI 10.2337/diabetes.53.4.955; Shapiro AMJ, 2003, IMMUNOL REV, V196, P219, DOI 10.1046/j.1600-065X.2003.00085.x; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107; Sutherland DER, 2001, ANN SURG, V233, P463, DOI 10.1097/00000658-200104000-00003	11	6	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1603	1604		10.1016/S0140-6736(05)66382-9	http://dx.doi.org/10.1016/S0140-6736(05)66382-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885282				2022-12-28	WOS:000228933700007
J	Chinn, S; Jarvis, D; Melotti, R; Luczynska, C; Ackermann-Liebrich, U; Anto, JM; Cerveri, I; de Marco, R; Gislason, T; Heinrich, J; Janson, C; Kunzli, N; Leynaert, B; Neukirch, F; Schouten, J; Sunyer, J; Svanes, C; Vermeire, P; Wjst, M; Burney, P				Chinn, S; Jarvis, D; Melotti, R; Luczynska, C; Ackermann-Liebrich, U; Anto, JM; Cerveri, I; de Marco, R; Gislason, T; Heinrich, J; Janson, C; Kunzli, N; Leynaert, B; Neukirch, F; Schouten, J; Sunyer, J; Svanes, C; Vermeire, P; Wjst, M; Burney, P			Smoking cessation, lung function, and weight gain: a follow-up study	LANCET			English	Article							FORCED EXPIRATORY VOLUME; LONGITUDINAL CHANGES; PULMONARY-FUNCTION; ONE 2ND; DECLINE; ADULTS; SYMPTOMS; HABITS; FEV(1); GENDER	Background Only one population-based study in one country has reported effects of smoking cessation and weight change on lung function, and none has reported the net effect. We estimated the net benefit of smoking cessation, and the independent effects of smoking and weight change on change in ventilatory lung function in the international European Community Respiratory Health Survey. Methods 6654 participants in 27 centres had lung function measured in 1991-93, when aged 20-44 years, and in 1998-2002. Smoking information was obtained from detailed questionnaires. Changes in lung function were analysed by change in smoking and weight, adjusted for age and height, in men and women separately and together with interaction terms. Findings Compared with those who had never smoked, decline in FEV1 was lower in male sustained quitters (mean difference 5.4 mL per year, 95% CI 1.7 to 9.1) and those who quit between surveys (2.5 mL, -1.9 to 7.0), and greater in smokers (-4.8 mL, -7.9 to -1.6). In women, estimates were 1.3 mL per year (-1.5 to 4.1), 2.8 mL (-0.8 to 6.3) and -5.1 mL (-7.5 to -2.8), respectively.. These sex differences were not significant. FEV1 changed by -11.5 mL (-13.3 to -9.6) per kg weight gained in men, and by -3.7 mL per kg (-5.0 to -2.5) in women, which diminished the benefit of quitting by 38% in men, and by 17% in women. Interpretation Smoking cessation is beneficial for lung function, but maximum benefit needs control of weight gain, especially in men.	Kings Coll London, Dept Publ Hlth Sci, London SE1 3QD, England; Univ Verona, Dept Med & Publ Hlth, Div Epidemiol & Stat, I-37100 Verona, Italy; Univ Basel, Inst Social & Prevent Med, CH-4051 Basel, Switzerland; Univ Pompeu Fabra, Inst Med Res, Barcelona, Spain; Univ Pavia, IRCCS San Matteo Hosp, Div Resp Dis, I-27100 Pavia, Italy; Univ Hosp E7, Dept Allergy Resp Med & Sleep, Reykjavik, Iceland; GSF Natl Res Ctr Environm & Hlth, Inst Epidemiol, Neuherberg, Germany; Uppsala Univ, Uppsala, Sweden; Univ So Calif, Keck Sch Med, Los Angeles, CA USA; Univ Paris 07, INSERM, French Inst Hlth & Med Res, Unit 408, Paris, France; Univ Groningen Hosp, Dept Epidemiol, Groningen, Netherlands; Haukeland Hosp, Dept Thorac Med, Bergen, Norway; Univ Antwerp, B-2020 Antwerp, Belgium	University of London; King's College London; University of Verona; University of Basel; Pompeu Fabra University; IRCCS Fondazione San Matteo; University of Pavia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Uppsala University; University of Southern California; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Groningen; University of Bergen; Haukeland University Hospital; University of Antwerp	Chinn, S (corresponding author), Kings Coll London, Dept Publ Hlth Sci, 5th Floor Capital House,42 Weston St, London SE1 3QD, England.	sue.chinn@kcl.ac.uk	SESM, SESM/C-1440-2008; Svanes, Cecilie/N-7556-2017; Kuenzli, Nino/F-7195-2014; Sunyer, Jordi/G-6909-2014; Leynaert, Benedicte/N-5251-2018; de Marco, Roberto/A-5470-2008; Heinrich, Joachim/N-1720-2013; Anto, J M/H-2676-2014; Jarvis, Deborah/E-6494-2011	Svanes, Cecilie/0000-0001-8512-5192; Kuenzli, Nino/0000-0001-8360-080X; Sunyer, Jordi/0000-0002-2602-4110; Heinrich, Joachim/0000-0002-9620-1629; Anto, J M/0000-0002-4736-8529; Jarvis, Deborah/0000-0002-1753-3896; Burney, Peter/0000-0001-8635-5678; Cerveri, Isa/0000-0003-0337-043X; Leynaert, Benedicte/0000-0001-5045-2492; MELOTTI, Roberto/0000-0003-4115-317X	NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005521] Funding Source: NIH RePORTER; NCRR NIH HHS [2 S07 RR05521-28] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		*AM THOR SOC, 1995, AM J RESP CRIT CARE, V152, P1122; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Bottai M, 2002, EUR RESPIR J, V20, P665, DOI 10.1183/09031936.02.01282001; BURCHFIEL CM, 1995, AM J RESP CRIT CARE, V151, P1778, DOI 10.1164/ajrccm.151.6.7767520; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; BURROWS B, 1986, AM REV RESPIR DIS, V133, P974; CAMILLI AE, 1987, AM REV RESPIR DIS, V135, P794, DOI 10.1164/arrd.1987.135.4.794; Carey IM, 1999, INT J OBESITY, V23, P979, DOI 10.1038/sj.ijo.0801029; CHEN Y, 1993, THORAX, V48, P375, DOI 10.1136/thx.48.4.375; Chinn S, 2004, THORAX, V59, P646, DOI 10.1136/thx.2004.021642; Connett JE, 2003, AM J EPIDEMIOL, V157, P973, DOI 10.1093/aje/kwg083; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DOCKERY DW, 1988, AM REV RESPIR DIS, V137, P286, DOI 10.1164/ajrccm/137.2.286; Harik-Khan RI, 2001, J CLIN EPIDEMIOL, V54, P399, DOI 10.1016/S0895-4356(00)00318-8; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; LANGE P, 1989, EUR RESPIR J, V2, P811; LANGE P, 1989, INT J EPIDEMIOL, V18, P882, DOI 10.1093/ije/18.4.882; O'Hara P, 1998, AM J EPIDEMIOL, V148, P821, DOI 10.1093/oxfordjournals.aje.a009706; Thun MJ, 1998, AM J EPIDEMIOL, V148, P831; TOWNSEND MC, 1991, PREV MED, V20, P621, DOI 10.1016/0091-7435(91)90059-D; Varner LM, 1999, J AM DIET ASSOC, V99, P1272, DOI 10.1016/S0002-8223(99)00312-0; Wang ML, 1996, AM J RESP CRIT CARE, V153, P1907, DOI 10.1164/ajrccm.153.6.8665054; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704; Wise RA, 1998, AM J RESP CRIT CARE, V157, P866, DOI 10.1164/ajrccm.157.3.9706076; XU X, 1994, EUR RESPIR J, V7, P1056	25	137	140	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1629	1635		10.1016/S0140-6736(05)66511-7	http://dx.doi.org/10.1016/S0140-6736(05)66511-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885295				2022-12-28	WOS:000228933700027
J	Hippisley-Cox, J; Coupland, C				Hippisley-Cox, J; Coupland, C			Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HORMONE-REPLACEMENT THERAPY; RISK	Objective To determine the effect of combinations of statins, aspirin, beta blockers, and angiotensin converting enzyme inhibitors in the secondary prevention of all cause mortality in patients with ischaemic heart disease. Design Open prospective cohort study with nested case-control analysis. Setting 1.18 million patients registered with 89 general practices across 23 strategic health authority areas within the United Kingdom. Practices had longitudinal data for a minimum of eight years and were contributing to QRESEARCH, a new database. Patients All patients with a first diagnosis of ischaemic heart disease between January 1996 and December 2003. Cases were patients with ischaemic heart disease who died. Controls were patients with ischaemic heart disease who were matched for age, sex, and year of diagnosis and were alive at the time their matched case died. Main outcome measures Odds ratio with 95% confidence interval for risk of death in cases compared with controls. Exposure was current use of different combinations of statins, aspirin, beta blockers, and angiotensin converting enzyme inhibitors before death in cases, or the equivalent date in controls. Results 13 029 patients had a first diagnosis of ischaemic heart disease (incidence rate 338 per 100 000 person years). 2266 cases were matched to 9064 controls. Drug combinations associated with the greatest reduction in all cause mortality were statins, aspirin, and beta blockers (83% reduction, 95% confidence interval 77% to 88%); statins, aspirin, beta blockers, and angiotensin converting enzyme inhibitors (75% reduction, 65% to 82%); and statins, aspirin, and angiotensin converting enzyme inhibitors (71% reduction, 59% to 79%). Treatments associated with the smallest reduction in all cause mortality were beta blockers alone (19% reduction, 37% reduction to 4% increase), angiotensin converting enzyme inhibitors alone (20% reduction, 1% to 35%), and combined statins and angiotensin converting enzyme inhibitors (31% reduction, 57% reduction to 12% increase). Conclusions Combinations of statins, aspirins, and beta blockers improve survival in high risk patients cardiovascular disease, although the addition of an angiotensin converting enzyme inhibitor conferred no additional benefit despite the analysis being adjusted for congestive cardiac failure.	Sch Community Hlth Sci, Div Primary Care, Nottingham NG2 7RD, England		Hippisley-Cox, J (corresponding author), Sch Community Hlth Sci, Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	julia.hippisley-cox@nottinghani.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; CANNON C, 2004, NEW ENGL J MED, V350; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; HAINES A, 1994, BMJ-BRIT MED J, V308, P1488, DOI 10.1136/bmj.308.6942.1488; Hammersley V, 2002, BRIT J GEN PRACT, V52, P463; Hippisley-Cox J, 2003, BRIT J GEN PRACT, V53, P191; Hippisley-Cox J, 2003, BRIT MED J, V326, P1439, DOI 10.1136/bmj.326.7404.1439; Hippisley-Cox J, 2004, HLTH INFORMATICS J, V10, P91, DOI 10.1177/1460458204042230; HIPPISLEYCOX J, 2005, IN PRESS HEART; Jick H, 2000, BMJ-BRIT MED J, V321, P1190, DOI 10.1136/bmj.321.7270.1190; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Lagro-Janssen T, 2003, LANCET, V362, P414, DOI 10.1016/S0140-6736(03)14095-0; McMahon AD, 2003, PHARMACOEPIDEM DR S, V12, P551, DOI 10.1002/pds.883; PEDERSEN TR, 1994, LANCET, V344, P1383; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; WALD N, 2003, BMJ-BRIT MED J, V326, P1149; 1994, LANCET, V344, P417	20	97	105	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2005	330	7499					1059	1063		10.1136/bmj.330.7499.1059	http://dx.doi.org/10.1136/bmj.330.7499.1059			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925YY	15879390	Green Published, Bronze			2022-12-28	WOS:000229090900020
J	Dworkin, J; Losick, R				Dworkin, J; Losick, R			Developmental commitment in a bacterium	CELL			English	Article							BACILLUS-SUBTILIS; TRANSCRIPTION FACTOR; CELL-TYPE; SPORULATION; GENE; ENGULFMENT; COMPARTMENTALIZATION; ACTIVATION; INHIBITOR; SEPTATION	We investigated developmental commitment during sporulation in Bacillus subtilis. Sporulation is initiated by nutrient limitation and involves division of the developing cell into two progeny, the forespore and the mother cell, with different fates. Differentiation becomes irreversible following division when neither the forespore nor the mother cell can resume growth when provided with nutrients. We show that commitment is governed by the transcription factors sigma(F) and sigma(E), which are activated in the forespore and the mother cell, respectively. We further show that commitment involves spollQ, which is under the control of sigma(F), and spollP, which is under the control of both sigma(F) and sigma(E). In the presence of nutrients, the forespore can exhibit rodlike, longitudinal growth when SpollQ and SpollP are absent, whereas the mother cell can do so when SpollP alone is absent. Thus, developmental commitment of this single-celled organism, like that of the cells of complex, multicellular organisms, ensures that differentiation is maintained despite changes in the extracellular milieu.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Harvard University; Columbia University	Dworkin, J (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dworkin@microbiology.columbia.edu; losick@mcb.harvard.edu			NIGMS NIH HHS [GM 18568] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018568, R01GM018568] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; Bernhardt TG, 2001, J BIOL CHEM, V276, P6093, DOI 10.1074/jbc.M007638200; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Eichenberger P, 2003, J MOL BIOL, V327, P945, DOI 10.1016/S0022-2836(03)00205-5; Eichenberger P, 2001, MOL MICROBIOL, V42, P1147, DOI 10.1046/j.1365-2958.2001.02660.x; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; FRANDSEN N, 1995, J BACTERIOL, V177, P716, DOI 10.1128/jb.177.3.716-722.1995; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Fujita M, 2002, MOL MICROBIOL, V43, P27, DOI 10.1046/j.1365-2958.2002.02732.x; Garsin DA, 1998, J MOL BIOL, V284, P569, DOI 10.1006/jmbi.1998.2202; Gilbert S.F., 2000, DEV BIOL; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Harwood C.R., 1990, MOL BIOL METHODS BAC; HO RK, 1993, SCIENCE, V261, P109, DOI 10.1126/science.8316841; Li ZS, 2004, J BACTERIOL, V186, P2221, DOI 10.1128/JB.186.7.2221-2223.2003; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; LondonoVallejo JA, 1997, MOL MICROBIOL, V24, P29, DOI 10.1046/j.1365-2958.1997.3181680.x; LONDONOVALLEJO JA, 1995, GENE DEV, V9, P503, DOI 10.1101/gad.9.4.503; MARGOLIS P, 1991, SCIENCE, V254, P562, DOI 10.1126/science.1948031; Parker GF, 1996, MICROBIOL-UK, V142, P3445, DOI 10.1099/13500872-142-12-3445; Piggot P, 2002, BACILLUS SUBTILIS IT, P483; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Rubio A, 2004, EMBO J, V23, P1636, DOI 10.1038/sj.emboj.7600171; SETLOW B, 1991, J BACTERIOL, V173, P6270, DOI 10.1128/jb.173.19.6270-6278.1991; Spemann H, 1918, ARCH ENTWICKLUNG ORG, V43, P448, DOI 10.1007/BF02267308; STEINMETZ M, 1994, GENE, V142, P79, DOI 10.1016/0378-1119(94)90358-1; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Stragier P., 2002, BACILLUS SUBTILIS IT, P519; STRAUCH M, 1990, P NATL ACAD SCI USA, V87, P1801, DOI 10.1073/pnas.87.5.1801; SUSSMAN MD, 1991, J BACTERIOL, V173, P291, DOI 10.1128/jb.173.1.291-300.1991; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C	34	80	82	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					401	409		10.1016/j.cell.2005.02.032	http://dx.doi.org/10.1016/j.cell.2005.02.032			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882622	Bronze			2022-12-28	WOS:000229031600010
J	Albano, EA; Kanter, J				Albano, EA; Kanter, J			Sister Mary Joseph's nodule	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp, Denver, CO 80218 USA	Children's Hospital Colorado	Albano, EA (corresponding author), Childrens Hosp, Denver, CO 80218 USA.								0	25	30	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1913	1913		10.1056/NEJMicm040708	http://dx.doi.org/10.1056/NEJMicm040708			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872206				2022-12-28	WOS:000228858600011
J	Joyce, DA; Lunt, DH; Bills, R; Turner, GF; Katongo, C; Duftner, N; Sturmbauer, C; Seehausen, O				Joyce, DA; Lunt, DH; Bills, R; Turner, GF; Katongo, C; Duftner, N; Sturmbauer, C; Seehausen, O			An extant cichlid fish radiation emerged in an extinct Pleistocene lake	NATURE			English	Article							EVOLUTION; VICTORIA; DESICCATION; AFRICA; ORIGIN	The haplochromine cichlid fish of the East African Great Lakes represent some of the fastest and most species-rich adaptive radiations known(1), but rivers in most of Africa accommodate only a few morphologically similar species of haplochromine cichlid fish. This has been explained by the wealth of ecological opportunity in large lakes compared with rivers. It is therefore surprising that the rivers of southern Africa harbour many, ecologically diverse haplochromines. Here we present genetic, morphological and biogeographical evidence suggesting that these riverine cichlids are products of a recent adaptive radiation in a large lake that dried up in the Holocene. Haplochromine species richness peaks steeply in an area for which geological data reveal the historical existence of Lake palaeo-Makgadikgadi(2,3). The centre of this extinct lake is now a saltpan north of the Kalahari Desert, but it once hosted a rapidly evolving fish species radiation, comparable in morphological diversity to that in the extant African Great Lakes. Importantly, this lake seeded all major river systems of southern Africa with ecologically diverse cichlids. This discovery reveals how local evolutionary processes operating during a short window of ecological opportunity can have a major and lasting effect on biodiversity on a continental scale.	Univ Hull, Sch Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; Univ Bern, Inst Zool Aquat Ecol & Macroevolut, CH-3012 Bern, Switzerland; Limnol Res Ctr, EAWAG, CH-6047 Kastanienbaum, Switzerland; S African Inst Aquat Biodivers, ZA-6140 Grahamstown, South Africa; Karl Franzens Univ Graz, Dept Zool, A-8010 Graz, Austria	University of Hull; University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; University of Graz	Seehausen, O (corresponding author), Univ Hull, Sch Biol Sci, Cottingham Rd, Kingston Upon Hull HU6 7RX, N Humberside, England.	ole.seehausen@aqua.unibe.ch	Seehausen, Ole/C-8272-2011; Lunt, David/B-2100-2009	Seehausen, Ole/0000-0001-6598-1434; Lunt, David/0000-0002-9000-7470; Turner, George/0000-0003-0099-7261				BAREL CDN, 1977, NETH J ZOOL, V27, P333; EBINGER CJ, 1989, J GEOPHYS RES-SOLID, V94, P15785, DOI 10.1029/JB094iB11p15785; Eccles D. H., 1989, MALAWIAN CICHLID FIS; Fryer G, 1997, HYDROBIOLOGIA, V354, P177, DOI 10.1023/A:1003183432203; Fryer G, 1972, CICHLID FISHES GREAT; Greenwood Peter Humphry, 1993, Bulletin of the British Museum (Natural History) Zoology, V59, P33; GREENWOOD PH, 1980, HAPLOCHROMINE FISHES; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson TC, 1996, SCIENCE, V273, P1091, DOI 10.1126/science.273.5278.1091; KATONGO C, IN PRESS HYDROBIOLOG; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Moore AE, 2001, S AFR J GEOL, V104, P47, DOI 10.2113/104.1.47; Nagl S, 2000, P ROY SOC B-BIOL SCI, V267, P1049, DOI 10.1098/rspb.2000.1109; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Roberts Tyson R., 1994, Ichthyological Exploration of Freshwaters, V5, P97; ROGNON P, 1980, PALAEOECOL AFR, V12, P45; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O., 1996, LAKE VICTORIA ROCK C; Seehausen Ole, 1998, Ichthyological Exploration of Freshwaters, V9, P129; SHAW P, 1988, EARTH-SCI REV, V25, P449, DOI 10.1016/0012-8252(88)90011-6; Skelton P.H., 2001, COMPLETE GUTIDE FRES, V2nd ed.; Sturmbauer C, 2001, MOL BIOL EVOL, V18, P144, DOI 10.1093/oxfordjournals.molbev.a003788; Swofford D.L., 2003, PAUP VERSION 40 B10; Thomas DSG, 2002, QUATERNARY SCI REV, V21, P783, DOI 10.1016/S0277-3791(01)00127-5; Thomas DSG., 1991, KALAHARI ENV; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TURNER GF, 1994, J FISH BIOL, V44, P799, DOI 10.1111/j.1095-8649.1994.tb01256.x	30	143	147	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					90	95		10.1038/nature03489	http://dx.doi.org/10.1038/nature03489			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875022	Green Published			2022-12-28	WOS:000228864600044
J	Kirkland, JI; Zanno, LE; Sampson, SD; Clark, JM; DeBlieux, DD				Kirkland, JI; Zanno, LE; Sampson, SD; Clark, JM; DeBlieux, DD			A primitive therizinosauroid dinosaur from the Early Cretaceous of Utah	NATURE			English	Article							NORTH-AMERICA; CHINA; THEROPODA	Therizinosauroids are an enigmatic group of dinosaurs known mostly from the Cretaceous period of Asia, whose derived members are characterized by elongate necks, laterally expanded pelves, small, leaf-shaped teeth, edentulous rostra and mandibular symphyses that probably bore keratinized beaks(1,2). Although more than a dozen therizinosauroid taxa are known, their relationships within Dinosauria have remained controversial because of fragmentary remains and an unusual suite of characters. The recently discovered 'feathered' therizinosauroid Beipiaosaurus from the Early Cretaceous of China helped to clarify the theropod affinities of the group(3). However, Beipiaosaurus is also poorly represented. Here we describe a new, primitive therizinosauroid from an extensive paucispecific bonebed at the base of the Cedar Mountain Formation ( Early Cretaceous) of east-central Utah(4,5). This new taxon represents the most complete and most basal therizinosauroid yet discovered. Phylogenetic analysis of coelurosaurian theropods incorporating this taxon places it at the base of the clade Therizinosauroiden, indicating that this species documents the earliest known stage in the poorly understood transition from carnivory to herbivory within Therizinosauroidea. The taxon provides the first documentation, to our knowledge, of therizinosauroids in North America during the Early Cretaceous.	Utah Geol Survey, Salt Lake City, UT 84114 USA; Univ Utah, Utah Museum Nat Hist, Salt Lake City, UT 84112 USA; Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; George Washington Univ, Washington, DC 20052 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; George Washington University	Kirkland, JI (corresponding author), Utah Geol Survey, POB 146100, Salt Lake City, UT 84114 USA.	jameskirkland@utah.gov		Zanno, Lindsay/0000-0002-1654-1990				Barsbold R., 1976, T JOINT SOVIET MONGO, V3, P76; Clark James M., 1994, American Museum Novitates, V3115, P1; CLARK JM, 2004, DINOSAURIA, V2, P151; Dong Zhiming, 1997, P90; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Holtz Jr T. R., 2000, GAIA, V15, P5; Kirkland James I., 2001, Journal of Vertebrate Paleontology, V21, p68A; Kirkland JI, 2001, J VERTEBR PALEONTOL, V21, P410, DOI 10.1671/0272-4634(2001)021[0410:FDTDTF]2.0.CO;2; KIRKLAND JI, 2005, UTAH GEOL SURV SURV, V37, P1; KIRKLAND JI, 1999, VERTEBRATE PALEONTOL, V991, P201; Mader B.J., 1989, Journal of Vertebrate Paleontology, V9, P41; Maryanska Teresa, 1997, P234; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; OSMOLSKA H, 2004, DINOSAURIA, V2, P165; Paul GS., 1984, J VERTEBR PALEONTOL, V4, P507, DOI DOI 10.1080/02724634.1984.10012026; PERLE A, 1982, PROBLEMS GEOLOGY MON, V5, P94; Perle A., 1979, T JOINT SOVIET MONGO, V8, P45; PERLE A, 1981, T JOINT SOVIET MONGO, V15, P45; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; Senter Phil, 2004, Bulletin of Gunma Museum of Natural History, V8, P1; Sues HD, 1997, J VERTEBR PALEONTOL, V17, P698, DOI 10.1080/02724634.1997.10011018; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2002, NATURE, V419, P291, DOI 10.1038/nature00966; Xu X, 2001, J VERTEBR PALEONTOL, V21, P477, DOI 10.1671/0272-4634(2001)021[0477:ANTFTL]2.0.CO;2; Xu Xing, 2002, Vertebrata Palasiatica, V40, P228; Zhang ZF, 2001, CHINESE J ELECTRON, V10, P282	28	77	81	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					84	87		10.1038/nature03468	http://dx.doi.org/10.1038/nature03468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875020	Green Published			2022-12-28	WOS:000228864600042
J	Tzou, WS; Douglas, PS; Srinivasan, SR; Chen, W; Berenson, G; Stein, JH				Tzou, WS; Douglas, PS; Srinivasan, SR; Chen, W; Berenson, G; Stein, JH			Advanced lipoprotein testing does not improve identification of subclinical atherosclerosis in young adults: The bogalusa heart study	ANNALS OF INTERNAL MEDICINE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK-FACTORS; CORONARY-ARTERY-DISEASE; MAGNETIC-RESONANCE-SPECTROSCOPY; CAROTID-ARTERY; MYOCARDIAL-INFARCTION; PARTICLE DIAMETER; ROC CURVE; DENSITY; MEN	Background: The clinical value of advanced lipoprotein testing relative to traditional lipid testing remains controversial. To date, no studies have evaluated associations between advanced lipoprotein testing and subclinical atherosclerosis in healthy young adults. Objective: To determine whether advanced lipoprotein testing using vertical-spin density-gradient ultracentrifugation better predicts carotid intima-media thickness, a validated measure of subclinical atherosclerosis, than does traditional lipoprotein testing in asymptornatic young adults. Design: Cross-sectional community-based study. Setting: Bogalusa, Louisiana. Participants: 311 randomly selected adults from the Bogalusa Heart Study who were 20 to 38 years of age. Measurements: The authors performed advanced lipoprotein testing using vertical-spin density-gradient ultracentrifugation, traditional testing using enzymatic methods, and Friedewald formula estimation of low-density lipoprotein cholesterol levels. A certified reader blinded to lipoprotein results determined carotid intimamedia thickness by B-mode ultrasonography. C-statistics from area under the receiver-operating characteristic curves (ALICs) derived from multivariable regression models were compared. Results: Lipid values obtained with advanced lipoprotein testing did not predict carotid intima-media thickness better than traditionally measured lipid values in 236 participants for whom all data were available. A model using traditional lipoprotein measures (AUC, 0.754 [95% Cl, 0.690 to 0.812]) did not differ significantly from a model using advanced lipoprotein measures (AUC, 0.779 [Cl, 0.662 to 0.871]) for prediction of carotid intimamedia thickness (P > 0.2). Subclass pattern of LDL, lipoprotein(a) cholesterol, intermediate-density lipoprotein cholesterol, high-density lipoprotein cholesterol subclasses, and very- low-density lipoprotein subclasses did not improve the performance of models for prediction of carotid intima-media thickness. Limitations: The study was cross-sectional, cardiac events were not determined, and only 1 method of advanced lipoprotein testing was used. Conclusions: Advanced lipoprotein testing using vertical-spin density-gradient ultracentrifugation did not improve prediction of carotid intima-media thickness in young adults and may not be useful for assessing cardiovascular risk in this population.	Univ Wisconsin, Sch Med, Dept Med, Sect Cardiovasc Med, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Stein, JH (corresponding author), Univ Wisconsin, Sch Med, Dept Med, Sect Cardiovasc Med, 600 Highland Ave,G7-341 CSC,MC 3248, Madison, WI 53792 USA.		Tzou, Wen-Shyong/H-4517-2014	Tzou, Wen-Shyong/0000-0002-6726-1390; Stein, James/0000-0002-2770-8223; Douglas, Pamela/0000-0001-9876-4049	NCRR NIH HHS [RR-1617601] Funding Source: Medline; NHLBI NIH HHS [HL-07936, HL-38844] Funding Source: Medline; NIA NIH HHS [AG-16592] Funding Source: Medline; NICHD NIH HHS [HD-043820] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD043820] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016176] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038844, U01HL038844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*ARIC STUD GROUP, 1991, J NEUROIMAGING, V1, P68; BERESON GS, 1980, CARDIOVASCULAR RISK; Blake GJ, 2002, CIRCULATION, V106, P1930, DOI 10.1161/01.CIR.0000033222.75187.B9; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; CHUNG BH, 1986, METHOD ENZYMOL, V128, P181; Colhoun HM, 2002, DIABETES, V51, P1949, DOI 10.2337/diabetes.51.6.1949; CORESH J, 1993, J LIPID RES, V34, P1687; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; Freedman DS, 2004, INT J OBESITY, V28, P159, DOI 10.1038/sj.ijo.0802515; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; GENEST J, 1992, J AM COLL CARDIOL, V19, P792, DOI 10.1016/0735-1097(92)90520-W; Greenland P, 2000, CIRCULATION, V101, P723; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Karpe F, 2001, J LIPID RES, V42, P17; Kieltyka L, 2003, ATHEROSCLEROSIS, V170, P125, DOI 10.1016/S0021-9150(03)00244-2; Knoflach M, 2003, CIRCULATION, V108, P1064, DOI 10.1161/01.CIR.0000085996.95532.FF; Krishnan Priya, 2003, J La State Med Soc, V155, P165; KULKARNI KR, 1995, J LIPID RES, V36, P2291; Kulkarni KR, 1999, ARTERIOSCL THROM VAS, V19, P2749, DOI 10.1161/01.ATV.19.11.2749; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; *NCEP, 1995, 953044 NIH; *NCEP, 2002, 025215 NIH; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Oren A, 2003, ARCH INTERN MED, V163, P1787, DOI 10.1001/archinte.163.15.1787; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rosenson RS, 2002, AM J CARDIOL, V90, P89, DOI 10.1016/S0002-9149(02)02427-X; Soedamah-Muthu SS, 2003, DIABETOLOGIA, V46, P674, DOI 10.1007/s00125-003-1094-8; Srinivasan SR, 2001, ATHEROSCLEROSIS, V159, P391, DOI 10.1016/S0021-9150(01)00514-7; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Stein JH, 1997, ARCH INTERN MED, V157, P1170, DOI 10.1001/archinte.157.11.1170; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7; Welsch R, 1980, REGRESSION DIAGNOSTI	37	13	17	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					742	750		10.7326/0003-4819-142-9-200505030-00009	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922GW	15867406				2022-12-28	WOS:000228825800003
J	Burris, S; Csete, J; Goumei, X; Dan, Z; Loff, B				Burris, S; Csete, J; Goumei, X; Dan, Z; Loff, B			Shanghai plans responses to AIDS	LANCET			English	Editorial Material									Temple Univ, Beasley Sch Law, Philadelphia, PA 19122 USA; Johns Hopkins Sch Hyg & Publ Hlth, Ctr Law & Publ Hlth, Baltimore, MD USA; Canadian HIV AIDS Legal Network, Montreal, PQ, Canada; Shanghai Acad Social Sci, Ctr Publ Policy Study HIV AIDS, Shanghai, Peoples R China; Richard Wang & Co, Shanghai, Peoples R China; Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Johns Hopkins University; Shanghai Academy of Social Sciences; Monash University	Burris, S (corresponding author), Temple Univ, Beasley Sch Law, Philadelphia, PA 19122 USA.	scott.burris@temple.edu	Loff, Bebe/G-9241-2014	Loff, Bebe/0000-0003-1963-6503; Burris, Scott/0000-0002-6013-5842				*STAT COUNC CHIN, 1998, 250 STAT COUNC CHIN; *STAT COUNC CHIN, 1998, GF199838 STAT COUNC; WHO, 2004, UNAIDS WHO POL STAT	3	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 30	2005	365	9470					1524	1525		10.1016/S0140-6736(05)66435-5	http://dx.doi.org/10.1016/S0140-6736(05)66435-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866293				2022-12-28	WOS:000228754800008
J	Posada, JG; Chakmakjian, CG				Posada, JG; Chakmakjian, CG			Von Recklinghausen's disease and breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Scott & White Mem Hosp & Clin, Temple, TX 76508 USA	Scott & White Medical Center	Posada, JG (corresponding author), Scott & White Mem Hosp & Clin, Temple, TX 76508 USA.								0	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1799	1799		10.1056/NEJMicm050008	http://dx.doi.org/10.1056/NEJMicm050008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858189				2022-12-28	WOS:000228689000010
J	Schorlemmer, D; Wiemer, S				Schorlemmer, D; Wiemer, S			Microseismicity data forecast rupture area	NATURE			English	Editorial Material							FREQUENCY-MAGNITUDE DISTRIBUTION; EARTHQUAKES; PARKFIELD		ETH, Swiss Seismol Serv, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Schorlemmer, D (corresponding author), ETH, Swiss Seismol Serv, CH-8093 Zurich, Switzerland.	danijel@sed.ethz.ch	Wiemer, Stefan/E-5033-2015	Wiemer, Stefan/0000-0002-4919-3283				Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185, DOI [DOI 10.1785/BSSA0340040185, 10.1785/BSSA0340040185]; JI C, 2004, EOS T AGU S, V85; ROELOFFS E, 1994, REV GEOPHYS, V32, P315, DOI 10.1029/94RG01114; SCHOLZ CH, 1968, B SEISMOL SOC AM, V58, P399; Schorlemmer D, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003234; Wiemer S, 1997, J GEOPHYS RES-SOL EA, V102, P15115, DOI 10.1029/97JB00726; Wiemer S, 2002, ADV GEOPHYS, V45, P259	7	146	153	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1086	1086		10.1038/4341086a	http://dx.doi.org/10.1038/4341086a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858563	Bronze			2022-12-28	WOS:000228693300029
J	Zhang, GS; Mathura, JR				Zhang, GS; Mathura, JR			Painless loss of vision after vomiting	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Northwestern Univ, Chicago, IL 60611 USA	Northwestern University	Zhang, GS (corresponding author), Northwestern Univ, Chicago, IL 60611 USA.								0	14	15	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					E16	E16		10.1056/NEJMicm040570	http://dx.doi.org/10.1056/NEJMicm040570			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858179				2022-12-28	WOS:000228689000011
J	Zink, MC; Uhrlaub, J; DeWitt, J; Voelker, T; Bullock, B; Mankowski, J; Tarwater, P; Clements, J; Barber, S				Zink, MC; Uhrlaub, J; DeWitt, J; Voelker, T; Bullock, B; Mankowski, J; Tarwater, P; Clements, J; Barber, S			Neuroprotective and anti-human immunodeficiency virus, activity of minocycline	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTRAL-NERVOUS-SYSTEM; ACTIVATED PROTEIN-KINASE; P38 MAP KINASE; ANTIRETROVIRAL THERAPY; CEREBROSPINAL-FLUID; COGNITIVE IMPAIRMENT; HIV-INFECTION; AIDS DEMENTIA; GROWTH-FACTOR; MOUSE MODEL	Context The prevalence of human immunodeficiency virus (HIV) central nervous system (CNS) disease has not decreased despite highly active antiretroviral therapy. Current antiretroviral drugs are expensive, have significant adverse effects including neurotoxicity, and few cross the blood-brain barrier. Objective To examine the ability of minocycline, an antibiotic with potent anti-inflammatory and neuroprotective properties, to protect against encephalitis and neurodegeneration using a rapid, high viral load simian immunodeficiency virus (SIV) model of HIV-associated CNS disease that constitutes a rigorous in vivo test for potential therapeutics. Design and Subjects Five SIV-infected pigtailed macaques were treated with 4 mg/kg per day of minocycline beginning at early asymptomatic infection (21 days after inoculation). Another 6 macaques were inoculated with SIV but remained untreated. Blood and cerebrospinal fluid (CSF) samples were taken on days 7,10,14, 21, 28, 35, 43, 56, 70, 77, and 84, and all macaques were humanely killed at 84 days after inoculation, a time that corresponds to late-stage infection in HIV-infected individuals. Main Outcome Measures Blood and CSF samples were tested for viral load by real-time reverse transcription-polymerase chain reaction and levels of monocyte chemoattractant protein 1 were quantitated by enzyme-linked immunosorbent assay. The presence and severity of encephalitis was determined by microscopic examination of tissues. Central nervous system inflammation was further assessed by measuring infiltration and activation of macrophages, activation of p38 mitogen-activated protein kinase and expression of amyloid precursor protein by quantitative immunohistochemistry.. Results Minocycline-treated macaques had less severe encephalitis (P=.02), reduced CNS expression of neuroinflammatory markers (major histocompatibility complex class II, P=.03; macrophage marker CD68, P=.07; T-cell intracytoplasmic antigen 1, P=.03; CSF monocyte chemoattractant protein 1., P=.001), reduced activation of p38 mitogen-activated protein kinase (P<.001), less axonal degeneration (beta-amyloid precursor protein, P=.03), and lower CNS virus replication (viral RNA, P=.04; Viral antigen, P=.04). In in vitro analysis, minocycline suppression of HIV and SIV replication in cultured primary macrophages did not correlate with suppression of activation of p38-mitogen-activated protein kinase pathways, whereas suppression in primary lymphocytes correlated with suppression of p38 activation. Conclusions In this experimental SIV model of HIV CNS disease, minocycline reduced the severity of encephalitis, suppressed viral load in the brain, and decreased the expression of CNS inflammatory markers. In vitro, minocycline inhibited SIV and, HIV replication. These findings suggest that minocycline, a safe, inexpensive, and readily available antibiotic should be investigated as an anti-HIV therapeutic.	Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA; Univ Texas, Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Epidemiol, El Paso, TX 79968 USA	Johns Hopkins University; University of Texas System; University of Texas El Paso; University of Texas Health Science Center Houston	Zink, MC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Comparat Med, 733 N Broadway,Room 839, Baltimore, MD 21205 USA.	mczink@jhmi.edu	; Aljarah, Ali/Q-7105-2016	Uhrlaub, Jennifer/0000-0002-7745-0179; Aljarah, Ali/0000-0003-0535-090X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044815] Funding Source: NIH RePORTER; NIMH NIH HHS [MH069116] Funding Source: Medline; NINDS NIH HHS [NS44815] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Bahr GM, 2003, J ANTIMICROB CHEMOTH, V51, P1377, DOI 10.1093/jac/dkg244; Barber SA, 2004, AM J PATHOL, V164, P355, DOI 10.1016/S0002-9440(10)63125-2; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Clements JE, 2002, J INFECT DIS, V186, P905, DOI 10.1086/343768; Clifford DB, 2002, NEUROLOGY, V59, P1568, DOI 10.1212/01.WNL.0000034177.47015.DA; Cohen PS, 1997, MOL MED, V3, P339, DOI 10.1007/BF03401812; Colovic M, 2003, J CHROMATOGR B, V791, P337, DOI 10.1016/S1570-0232(03)00247-2; Darcissac ECA, 2000, J VIROL, V74, P7794, DOI 10.1128/JVI.74.17.7794-7802.2000; Dore GJ, 1999, AIDS, V13, P1249, DOI 10.1097/00002030-199907090-00015; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; EVERALL I, 1993, J NEUROPATH EXP NEUR, V52, P561, DOI 10.1097/00005072-199311000-00002; Flaherty MT, 1997, J VIROL, V71, P5790, DOI 10.1128/JVI.71.8.5790-5798.1997; GELBARD HA, 1995, NEUROPATH APPL NEURO, V21, P208, DOI 10.1111/j.1365-2990.1995.tb01052.x; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gordon PH, 2004, NEUROLOGY, V62, P1845, DOI 10.1212/01.WNL.0000125321.92112.7E; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kinlaw WB, 2004, ENDOCRINOLOGY, V145, P484, DOI 10.1210/en.2003-1513; Lin SZ, 2001, NEUROSCI LETT, V315, P61, DOI 10.1016/S0304-3940(01)02324-2; Mankowski JL, 2002, J NEUROPATH EXP NEUR, V61, P85, DOI 10.1093/jnen/61.1.85; Mankowski JL, 2002, J INFECT DIS, V186, pS199, DOI 10.1086/344938; McArthur JC, 2000, NEUROLOGY, V54, P1080, DOI 10.1212/WNL.54.5.1080; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Metz LM, 2004, ANN NEUROL, V55, P756, DOI 10.1002/ana.20111; Montessori V, 2004, CAN MED ASSOC J, V170, P229; MURRAY EA, 1992, SCIENCE, V255, P1246, DOI 10.1126/science.1546323; Neuenburg JK, 2002, JAIDS-J ACQ IMM DEF, V31, P171, DOI 10.1097/00126334-200210010-00007; Sacktor N, 2002, J NEUROVIROL, V8, P136, DOI 10.1080/13550280290049615; Sacktor N, 2000, NEUROLOGY, V54, P233, DOI 10.1212/WNL.54.1.233; Schifitto G, 2001, NEUROLOGY, V57, P1313, DOI 10.1212/WNL.57.7.1313; Shapiro L, 1998, P NATL ACAD SCI USA, V95, P7422, DOI 10.1073/pnas.95.13.7422; SHARER LR, 1988, ANN NEUROL, V23, pS108, DOI 10.1002/ana.410230727; Si QS, 2004, J NEUROVIROL, V10, P284, DOI 10.1080/13550280490499533; Suk K, 2001, BRAIN RES, V900, P342, DOI 10.1016/S0006-8993(01)02326-5; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; YEN PKJ, 1975, J DENT RES, V54, P423; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076; Zink MC, 2001, J INFECT DIS, V184, P1015, DOI 10.1086/323478	43	168	177	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2005	293	16					2003	2011		10.1001/jama.293.16.2003	http://dx.doi.org/10.1001/jama.293.16.2003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XS	15855434	Bronze			2022-12-28	WOS:000228651500026
J	Ruiz, N; Falcone, B; Kahne, D; Silhavy, TJ				Ruiz, N; Falcone, B; Kahne, D; Silhavy, TJ			Chemical conditionality: A genetic strategy to probe organelle assembly	CELL			English	Article							OUTER-MEMBRANE PERMEABILITY; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; RNA POLYMERASE; PROTEIN; LIPOPOLYSACCHARIDE; IDENTIFICATION; IMP/OSTA; HEAD; SURA	The assembly of the Escherichia coli outer membrane (OM) is poorly understood. Although insight into fundamental cellular processes is often obtained from studying mutants, OM-defective mutants have not been very informative because they generally have nonspecific permeability defects. Here we show that toxic small molecules can be used in selections employing strains with permeability defects to create particular chemical conditions that demand specific suppressor mutations. Suppressor phenotypes are correlated with the physical properties of the small molecules, but the mutations are not in their target genes. Instead, mutations allow survival by partially restoring membrane impermeability. Using "chemical conditionality," we identified mutations in yfgL, and, here and in the accompanying paper by Wu et al. published in this issue of Cell (Wu et al., 2005), we show that YfgL is part of a multiprotein complex involved in the assembly of OM (3 barrel proteins. We posit that panels of toxic small molecules will be useful for generating chemical conditionalities that enable identification of genes required for organelle assembly in other organisms.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Harvard Univ, Sch Med, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Princeton University; Princeton University; Harvard University; Harvard University; Harvard Medical School	Silhavy, TJ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	tsilhavy@molbio.princeton.edu		Falcone, Brian/0000-0001-8506-0915; Ruiz, Natividad/0000-0002-6369-2206; Silhavy, Thomas/0000-0001-7672-5153	NIGMS NIH HHS [GM34821, GM66174] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034821, R01GM066174, R01GM034821] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe S, 2003, MICROBIOL-SGM, V149, P1265, DOI 10.1099/mic.0.25927-0; Bockhorst J, 2003, BIOINFORMATICS, V19, pi34, DOI 10.1093/bioinformatics/btg1003; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; EZEKIEL DH, 1968, NATURE, V220, P276, DOI 10.1038/220276a0; Gibson KE, 1999, J BACTERIOL, V181, P563, DOI 10.1128/JB.181.2.563-571.1999; GIGOT D, 1980, J BACTERIOL, V143, P914, DOI 10.1128/JB.143.2.914-920.1980; Hwang J, 2001, J BIOL CHEM, V276, P31415, DOI 10.1074/jbc.M104455200; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; KAMIO Y, 1976, BIOCHEMISTRY-US, V15, P2561, DOI 10.1021/bi00657a012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Narita S, 2004, ARCH MICROBIOL, V182, P1, DOI 10.1007/s00203-004-0682-4; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Ruiz N, 2003, J BACTERIOL, V185, P5984, DOI 10.1128/JB.185.20.5984-5992.2003; SAMPSON BA, 1989, GENETICS, V122, P491; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; SILHAVY TJ, 1984, EXPT GENE FUSION COL; Singh MP, 2003, ANTIMICROB AGENTS CH, V47, P62, DOI 10.1128/AAC.47.1.62-69.2003; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; Tan J, 2002, J BACTERIOL, V184, P2692, DOI 10.1128/JB.184.10.2692-2698.2002; TOCCHINI.GP, 1968, NATURE, V220, P275, DOI 10.1038/220275a0; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	28	228	230	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					307	317		10.1016/j.cell.2005.02.014	http://dx.doi.org/10.1016/j.cell.2005.02.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851036	Bronze			2022-12-28	WOS:000228705000017
J	Tu, CY; Zhou, C; Marsch, E; Xia, LD; Zhao, L; Wang, JX; Wiihelm, K				Tu, CY; Zhou, C; Marsch, E; Xia, LD; Zhao, L; Wang, JX; Wiihelm, K			Solar wind origin in coronal funnels	SCIENCE			English	Article							MAGNETIC-FIELDS; TRANSITION REGION; SUMER TELESCOPE; 2-FLUID MODEL; SOHO; ACCELERATION; NETWORK; HOLES; CHROMOSPHERE; SPECTROMETER	The origin of the solar wind in solar coronal holes has long been unclear. We establish that the solar wind starts flowing out of the corona at heights above the photosphere between 5 megameters and 20 megameters in magnetic funnels. This result is obtained by a correlation of the Doppler-velocity and radiance maps of spectral lines emitted by various ions with the force-free magnetic field as extrapolated from photospheric magnetograms to different attitudes. Specifically, we find that Ne7+ ions mostly radiate around 20 megameters, where they have outflow speeds of about 10 kilometers per second, whereas C3+ ions with no average flow speed mainly radiate around S megameters. Based on these results, a model for understanding the solar wind origin is suggested.	Peking Univ, Dept Geophys, Beijing 100871, Peoples R China; Peking Univ, Dept Atmospher Sci, Beijing 100871, Peoples R China; Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Univ Sci & Technol China, Sch Earth & Space Sci, Hefei 230026, Anhui, Peoples R China; Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China	Peking University; Peking University; Max Planck Society; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; National Astronomical Observatory, CAS	Tu, CY (corresponding author), Peking Univ, Dept Geophys, Beijing 100871, Peoples R China.	cytu@public3.bta.net.cn	Xia, Lidong/B-8836-2011; Zhao, Liang/B-8215-2012	Xia, Lidong/0000-0001-8938-1038; Zhou, Cheng/0000-0001-9095-2846; Zhao, Liang/0000-0002-5975-7476				Axford WI, 1997, SPACE SCI S, P31; AXFORD WI, 1972, SOLAR WIND 7, P1; BIERMANN L, 1951, Z ASTROPHYS, V29, P274; Boyd T. J., 1969, PLASMA DYNAMICS; Dammasch IE, 1999, ASTRON ASTROPHYS, V346, P285; Delaboudiniere JP, 1995, SOL PHYS, V162, P291, DOI 10.1007/BF00733432; DOWDY JF, 1987, SOL PHYS, V112, P255, DOI 10.1007/BF00148781; Feldman WC, 1996, ASTRON ASTROPHYS, V316, P355; Fisk LA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009284; GABRIEL AH, 1976, PHILOS T R SOC A, V281, P339, DOI 10.1098/rsta.1976.0031; Hackenberg P, 2000, ASTRON ASTROPHYS, V360, P1139; HANSTEEN VH, 1995, J GEOPHYS RES-SPACE, V100, P21577, DOI 10.1029/95JA02300; HARTLE RE, 1968, ASTROPHYS J, V151, P1155, DOI 10.1086/149513; Hassler DM, 1999, SCIENCE, V283, P810, DOI 10.1126/science.283.5403.810; HOLLWEG JV, 1986, J GEOPHYS RES-SPACE, V91, P4111, DOI 10.1029/JA091iA04p04111; Hundhausen A.J., 1972, CORONAL EXPANSION SO; LEER E, 1980, J GEOPHYS RES-SPACE, V85, P4681, DOI 10.1029/JA085iA09p04681; LEER E, 1979, SOL PHYS, V63, P143, DOI 10.1007/BF00155705; Lemaire P, 1997, SOL PHYS, V170, P105, DOI 10.1023/A:1004994702333; Lie-Svendsen O, 2003, ASTROPHYS J, V596, P621, DOI 10.1086/377640; Marsch E, 2004, ASTRON ASTROPHYS, V428, P629, DOI 10.1051/0004-6361:20041060; Marsch E, 1997, SOL PHYS, V176, P87, DOI 10.1023/A:1004975703854; McKenzie JF, 1998, ASTRON ASTROPHYS, V330, P1145; NEUGEBAUER M, 1966, J GEOPHYS RES, V71, P4469, DOI 10.1029/JZ071i019p04469; NEUGEBAUER M, 1962, SCIENCE, V138, P1095, DOI 10.1126/science.138.3545.1095-a; PARKER EN, 1958, ASTROPHYS J, V128, P664, DOI 10.1086/146579; Peter H, 2004, ASTROPHYS J, V617, pL85, DOI 10.1086/427168; Peter H, 2001, ASTRON ASTROPHYS, V374, P1108, DOI 10.1051/0004-6361:20010697; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429; SEEHAFER N, 1978, SOL PHYS, V58, P215, DOI 10.1007/BF00157267; TU CY, 1987, SOL PHYS, V109, P149, DOI 10.1007/BF00167405; Tu CY, 1997, SOL PHYS, V171, P363, DOI 10.1023/A:1004968327196; WHANG YC, 1965, J GEOPHYS RES, V70, P4175, DOI 10.1029/JZ070i017p04175; Wiegelmann T, 2002, SOL PHYS, V208, P233, DOI 10.1023/A:1020537403934; Wilhelm K, 2000, ASTRON ASTROPHYS, V353, P749; Wilhelm K, 1997, SOL PHYS, V170, P75, DOI 10.1023/A:1004923511980; Xia LD, 2004, ASTRON ASTROPHYS, V424, P1025, DOI 10.1051/0004-6361:20047027; Xia LD, 2003, ASTRON ASTROPHYS, V399, pL5, DOI 10.1051/0004-6361:20030016	38	240	257	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					519	523		10.1126/science.1109447	http://dx.doi.org/10.1126/science.1109447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845846				2022-12-28	WOS:000228810500044
J	Sako, S; Yamashita, T; Kataza, H; Miyata, T; Okamoto, YK; Honda, M; Fujiyoshi, T; Terada, H; Kamazaki, T; Jiang, ZB; Hanawa, T; Onaka, T				Sako, S; Yamashita, T; Kataza, H; Miyata, T; Okamoto, YK; Honda, M; Fujiyoshi, T; Terada, H; Kamazaki, T; Jiang, ZB; Hanawa, T; Onaka, T			No high-mass protostars in the silhouette young stellar object M17-S01	NATURE			English	Article							HIGH-RESOLUTION; CO EMISSION; M17; ENVELOPES; CAMERA; SCALE; CLOUD; DISKS	The birth of very massive stars is not well understood(1-3), in contrast to the formation process of low-mass stars like our Sun(4,5). It is not even clear that massive stars can form as single entities; rather, they might form through the mergers of smaller ones born in tight groups(6,7). The recent claim of the discovery of a massive protostar in M17 (a nearby giant ionized region) forming through the same mechanism as low-mass stars(8) has therefore generated considerable interest. Here we show that this protostar has an intermediate mass of only 2.5 to 8 solar masses (M.), contrary to the earlier claim of 20. (ref. 8). The surrounding circumstellar envelope contains only 0.09M. and a much more extended local molecular cloud has 4-9M..	Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; Univ Tokyo, Inst Astron, Tokyo 1810015, Japan; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Kanagawa 2298510, Japan; Ibaraki Univ, Inst Astrophys & Planetary Sci, Mito, Ibaraki 3108512, Japan; Chinese Acad Sci, Natl Astron Observ, Purple Mt Observ, Nanjing 210008, Peoples R China; Chiba Univ, Ctr Fontier Sci, Inage Ku, Chiba 2638522, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Tokyo; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Ibaraki University; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; National Astronomical Observatory, CAS; Purple Mountain Observatory, CAS; Chiba University	Sako, S (corresponding author), Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sako@ioa.s.u-tokyo.ac.jp		KAMAZAKI, TAKESHI/0000-0002-2067-629X				Bonnell IA, 1998, MON NOT R ASTRON SOC, V298, P93, DOI 10.1046/j.1365-8711.1998.01590.x; Bonnell IA, 2004, MON NOT R ASTRON SOC, V349, P735, DOI 10.1111/j.1365-2966.2004.07543.x; Calvet N., 2000, Protostars and planets 4, P377; Chini R, 2004, NATURE, V429, P155, DOI 10.1038/nature02507; FELLI M, 1984, ASTRON ASTROPHYS, V136, P53; Hanson MM, 1997, ASTROPHYS J, V489, P698, DOI 10.1086/304808; Hartmann L., 1998, ACCRETION PROCESSES; Hogerheijde MR, 1998, ASTROPHYS J, V502, P315, DOI 10.1086/305885; Howe JE, 2000, ASTROPHYS J, V539, pL137, DOI 10.1086/312850; Jiang ZB, 2002, ASTROPHYS J, V577, P245, DOI 10.1086/342157; Kataza H, 2000, P SOC PHOTO-OPT INS, V4008, P1144, DOI 10.1117/12.395433; Kobayashi N, 2000, PROC SPIE, V4008, P1056, DOI 10.1117/12.395423; Mundy L. G., 2000, Protostars and planets 4, P355; NAKANO T, 1995, ASTROPHYS J, V450, P183, DOI 10.1086/176130; Nielbock M, 2001, ASTRON ASTROPHYS, V377, P273, DOI 10.1051/0004-6361:20011053; Ohashi N, 1997, ASTROPHYS J, V475, P211, DOI 10.1086/303533; Ohashi N, 1996, ASTROPHYS J, V466, P317, DOI 10.1086/177512; Ohashi N, 1997, ASTROPHYS J, V488, P317, DOI 10.1086/304685; Okamoto YK, 2001, ASTROPHYS J, V553, P254, DOI 10.1086/320633; Padgett DL, 1999, ASTRON J, V117, P1490, DOI 10.1086/300781; Park S, 2002, ASTRON J, V123, P3370, DOI 10.1086/340467; Shuping RY, 2004, ASTRON J, V128, P363, DOI 10.1086/421373; Stahler S. W., 2000, Protostars and planets 4, P327; Takami H, 2003, P SOC PHOTO-OPT INS, V4839, P21, DOI 10.1117/12.459239; Tamura M., 1991, APJ, V374, pL25; Thi WF, 2001, ASTROPHYS J, V561, P1074, DOI 10.1086/323361; Wilson CD, 1999, ASTROPHYS J, V517, P174, DOI 10.1086/307180; WOLFIRE MG, 1987, ASTROPHYS J, V319, P850, DOI 10.1086/165503; Yorke HW, 2002, ASTROPHYS J, V569, P846, DOI 10.1086/339264	29	16	16	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					995	998		10.1038/nature03471	http://dx.doi.org/10.1038/nature03471			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846339				2022-12-28	WOS:000228524600031
J	Wang, YX; Botvinick, EL; Zhao, YH; Berns, MW; Usami, S; Tsien, RY; Chien, S				Wang, YX; Botvinick, EL; Zhao, YH; Berns, MW; Usami, S; Tsien, RY; Chien, S			Visualizing the mechanical activation of Src	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; FOCAL ADHESIONS; FAMILY KINASES; LIVING CELLS; V-SRC; CYTOSKELETON; DOMAIN; SPECIFICITY; P130(CAS); MEMBRANE	The mechanical environment crucially influences many cell functions(1). However, it remains largely mysterious how mechanical stimuli are transmitted into biochemical signals. Src is known to regulate the integrin-cytoskeleton interaction(2), which is essential for the transduction of mechanical stimuli(3-5). Using fluorescent resonance energy transfer (FRET), here we develop a genetically encoded Src reporter that enables the imaging and quantification of spatio-temporal activation of Src in live cells. We introduced a local mechanical stimulation to human umbilical vein endothelial cells (HUVECs) by applying laser-tweezer traction on fibronectin-coated beads adhering to the cells. Using the Src reporter, we observed a rapid distal Src activation and a slower directional wave propagation of Src activation along the plasma membrane. This wave propagated away from the stimulation site with a speed (mean +/- s.e.m.) of 18.1 +/- 1.7 nm s(-1). This force-induced directional and long-range activation of Src was abolished by the disruption of actin filaments or microtubules. Our reporter has thus made it possible to monitor mechanotransduction in live cells with spatio-temporal characterization. We find that the transmission of mechanically induced Src activation is a dynamic process that directs signals via the cytoskeleton to spatial destinations.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Whitaker Inst Biomed Engn, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92697 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California Irvine	Chien, S (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	schien@bioeng.ucsd.edu		Berns, Michael/0000-0002-9640-2885				ALENGHAT FJ, 2002, SCI STKE, pE6; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Bradshaw JM, 1999, BIOCHEMISTRY-US, V38, P5147, DOI 10.1021/bi982974y; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000; Hamasaki K, 1996, BIOCHEM BIOPH RES CO, V222, P338, DOI 10.1006/bbrc.1996.0745; Heidemann SR, 1999, J CELL BIOL, V145, P109, DOI 10.1083/jcb.145.1.109; Hu SH, 2003, AM J PHYSIOL-CELL PH, V285, pC1082, DOI 10.1152/ajpcell.00159.2003; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kaplan G, 1996, EMBO J, V15, P4282, DOI 10.1002/j.1460-2075.1996.tb00803.x; Mack PJ, 2004, AM J PHYSIOL-CELL PH, V287, pC954, DOI 10.1152/ajpcell.00567.2003; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vuori K, 1996, MOL CELL BIOL, V16, P2606; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Yang F, 1999, ANAL BIOCHEM, V266, P167, DOI 10.1006/abio.1998.2885; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	30	525	557	6	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1040	1045		10.1038/nature03469	http://dx.doi.org/10.1038/nature03469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846350	Green Published			2022-12-28	WOS:000228524600043
J	Yusa, G; Muraki, K; Takashina, K; Hashimoto, K; Hirayama, Y				Yusa, G; Muraki, K; Takashina, K; Hashimoto, K; Hirayama, Y			Controlled multiple quantum coherences of nuclear spins in a nanometre-scale device	NATURE			English	Article							EXPERIMENTAL REALIZATION	The analytical technique of nuclear magnetic resonance (NMR1,2) is based on coherent quantum mechanical superposition of nuclear spin states. Recently, NMR has received considerable renewed interest in the context of quantum computation and information processing(3-11), which require controlled coherent qubit operations. However, standard NMR is not suitable for the implementation of realistic scalable devices, which would require all-electrical control and the means to detect microscopic quantities of coherent nuclear spins. Here we present a self-contained NMR semiconductor device that can control nuclear spins in a nanometre-scale region. Our approach enables the direct detection of (otherwise invisible) multiple quantum coherences between levels separated by more than one quantum of spin angular momentum. This microscopic high sensitivity NMR technique is especially suitable for probing materials whose nuclei contain multiple spin levels, and may form the basis of a versatile multiple qubit device.	NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; Japan Sci & Technol Agcy, SORST Program, Kawaguchi, Saitama 3310012, Japan	Nippon Telegraph & Telephone Corporation; Japan Science & Technology Agency (JST)	Yusa, G (corresponding author), NTT Corp, NTT Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	yusa@NTTBRL.jp; muraki@will.brl.ntt.co.jp	Takashina, Kei/R-5367-2016; Muraki, Koji/M-3468-2016; Hirayama, Yoshiro/AAE-1598-2019	Takashina, Kei/0000-0003-1146-6984; Muraki, Koji/0000-0003-0289-5496; Yusa, Go/0000-0003-3053-7629; Hirayama, Yoshiro/0000-0003-2638-9133				Ahn J, 2000, SCIENCE, V287, P463, DOI 10.1126/science.287.5452.463; Chuang IL, 1998, NATURE, V393, P143, DOI 10.1038/30181; COHENTANNOUDJI C, 1998, ATOM PHOTON INTERACT, P488; DIVINCENZO DP, 1995, SCIENCE, V270, P255, DOI 10.1126/science.270.5234.255; Eickhoff M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.125301; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; Gammon D, 1997, SCIENCE, V277, P85, DOI 10.1126/science.277.5322.85; Grover LK, 1997, PHYS REV LETT, V79, P4709, DOI 10.1103/PhysRevLett.79.4709; Hashimoto K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.176601; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kikkawa JM, 2000, SCIENCE, V287, P473, DOI 10.1126/science.287.5452.473; Kronmuller S, 1998, PHYS REV LETT, V81, P2526, DOI 10.1103/PhysRevLett.81.2526; Leuenberger MN, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.165317; Leuenberger MN, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.207601; Leuenberger MN, 2001, NATURE, V410, P789, DOI 10.1038/35071024; Levitt MH, 2002, SPIN DYNAMICS; Liang Z.-P., 1999, PRINCIPLES MAGNETIC; Machida T, 2003, APPL PHYS LETT, V82, P409, DOI 10.1063/1.1539903; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Nielsen M. A., 2003, QUANTUM COMPUTATION; Salis G, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195304; Smet JH, 2002, NATURE, V415, P281, DOI 10.1038/415281a; Taylor JM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.206803; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; WALD KR, 1994, PHYS REV LETT, V73, P1011, DOI 10.1103/PhysRevLett.73.1011; WOKAUN A, 1977, J CHEM PHYS, V67, P1752, DOI 10.1063/1.435038; YUSA G, 2004, PHYS REV B, V69, P161	28	169	203	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1001	1005		10.1038/nature03456	http://dx.doi.org/10.1038/nature03456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846341				2022-12-28	WOS:000228524600033
J	Tews, I; Findeisen, F; Sinning, I; Schultz, A; Schultz, JE; Linder, JU				Tews, I; Findeisen, F; Sinning, I; Schultz, A; Schultz, JE; Linder, JU			The structure of a pH-sensing mycobacterial adenylyl cyclase holoenzyme	SCIENCE			English	Article							TUBERCULOSIS; CAMP	Class III adenylyl cyclases contain catalytic and regulatory domains, yet structural insight into their interactions is missing. We show that the mycobacterial adenylyl cyclase Rv1264 is rendered a pH sensor by its N-terminal domain. In the structure of the inhibited state, catalytic and regulatory domains share a large interface involving catalytic residues. In the structure of the active state, the two catalytic domains rotate by 55 degrees to form two catalytic sites at their interface. Two alpha helices serve as molecular switches. Mutagenesis is consistent with a regulatory role of the structural transition, and we suggest that the transition is regulated by pH.	Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; Inst Pharmazeut, D-72076 Tubingen, Germany	Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Tews, I (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ivo.tews@bzh.uni-heidelberg.de; juergen.linder@uni-tuebingen.de	Tews, Ivo/A-2750-2010	Tews, Ivo/0000-0002-4704-1139				Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x; BARZU O, 1994, PROG NUCLEIC ACID RE, V49, P241; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; FINDEISEN F, UNPUB; Linder JU, 2002, J BIOL CHEM, V277, P15271, DOI 10.1074/jbc.M200235200; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Simonds WF, 1999, TRENDS PHARMACOL SCI, V20, P66, DOI 10.1016/S0165-6147(99)01307-3; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Susstrunk U, 1998, MOL MICROBIOL, V30, P33, DOI 10.1046/j.1365-2958.1998.01033.x; Tang WJ, 1998, MOL PHARMACOL, V54, P231, DOI 10.1124/mol.54.2.231; Tesmer JJG, 2000, BIOCHEMISTRY-US, V39, P14464, DOI 10.1021/bi0015562; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tews I., UNPUB; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0	19	96	101	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1020	1023		10.1126/science.1107642	http://dx.doi.org/10.1126/science.1107642			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890882				2022-12-28	WOS:000229190700046
J	Turek, FW; Joshu, C; Kohsaka, A; Lin, E; Ivanova, G; McDearmon, E; Laposky, A; Losee-Olson, S; Easton, A; Jensen, DR; Eckel, RH; Takahashi, JS; Bass, J				Turek, FW; Joshu, C; Kohsaka, A; Lin, E; Ivanova, G; McDearmon, E; Laposky, A; Losee-Olson, S; Easton, A; Jensen, DR; Eckel, RH; Takahashi, JS; Bass, J			Obesity and metabolic syndrome in circadian Clock mutant mice	SCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; ENERGY HOMEOSTASIS; GENE-EXPRESSION; MOUSE; GHRELIN; SLEEP; LIVER; IDENTIFICATION; REPRODUCTION; PATHWAYS	The CLOCK transcription factor is a key component of the molecular circadian clock within pacemaker neurons of the hypothalamic suprachiasmatic nucleus. We found that homozygous Clock mutant mice have a greatly attenuated diurnal feeding rhythm, are hyperphagic and obese, and develop a metabolic syndrome of hyperleptinemia, hyperlipidemia, hepatic steatosis, hyperglycemia, and hypoinsulinemia. Expression of transcripts encoding selected hypothalamic peptides associated with energy balance was attenuated in the Clock mutant mice. These results suggest that the circadian clock gene network plays an important rote in mammalian energy balance.	Northwestern Univ, Feinberg Sch Med, Dept Med, Evanston, IL 60208 USA; Northwestern Univ, Feinberg Sch Med, Dept Neurol, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Evanston NW Healthcare Res Inst, Evanston, IL 60208 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO 80045 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Howard Hughes Medical Institute; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bass, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Evanston, IL 60208 USA.	j-bass@northwestern.edu	Takahashi, Joseph S/E-8482-2012; Jansen, Heiko T./A-5770-2008; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Jansen, Heiko T./0000-0003-0178-396X; Takahashi, Joseph S./0000-0003-0384-8878	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075029, R01HL059598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002675, R01DK026356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412, R01AG018200] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [HL59598, R01 HL075029, R01 HL059598, HL75029] Funding Source: Medline; NIA NIH HHS [R01 AG018200, AG11412, AG18200, P01 AG011412] Funding Source: Medline; NIDDK NIH HHS [K08 DK002675, DK02675, DK26356, R01 DK026356] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Kanamoto N, 2004, ENDOCRINOLOGY, V145, P4144, DOI 10.1210/en.2003-1718; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kitamura Y, 2004, REV ENDOCR METAB DIS, V5, P143, DOI 10.1023/B:REMD.0000021436.91347.93; la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Taheri S, 2002, ANNU REV NEUROSCI, V25, P283, DOI 10.1146/annurev.neuro.25.112701.142826; TAKAHASHI JS, 2001, HDB BEHAV NEUROBIOLO, V12, P770; VANCAUTER E, 2000, HDB PHYSL 7, P313; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamada K, 2002, INT J OBESITY, V26, P132, DOI 10.1038/sj.ijo.0801848; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	27	1737	1809	12	238	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1043	1045		10.1126/science.1108750	http://dx.doi.org/10.1126/science.1108750			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15845877	Green Accepted			2022-12-28	WOS:000229190700053
J	Khan, SY; Hilton-Jones, D; Rigby, SP				Khan, SY; Hilton-Jones, D; Rigby, SP			A swollen calf	LANCET			English	Editorial Material							S-1 RADICULOPATHY; HYPERTROPHY; PSEUDOHYPERTROPHY		Warwick Hosp, Dept Rheumatol, Warwick CV34 5BW, England; John Radcliffe Hosp, Dept Neurol, Oxford OX2 6HE, England	University of Oxford	Khan, SY (corresponding author), Warwick Hosp, Dept Rheumatol, Lakin Rd, Warwick CV34 5BW, England.	sophiaykhan@aol.com						De Beuckeleer L, 1999, SKELETAL RADIOL, V28, P229, DOI 10.1007/s002560050506; Donato G, 2000, CLIN NEUROPATHOL, V19, P142; Gobbele R, 1999, J NEUROL SCI, V170, P64, DOI 10.1016/S0022-510X(99)00200-2; RICKER K, 1988, ARCH NEUROL-CHICAGO, V45, P660, DOI 10.1001/archneur.1988.00520300080023; SWARTZ KR, 2002, SPINE, V18, pE406	5	7	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 7	2005	365	9471					1662	1662		10.1016/S0140-6736(05)66517-8	http://dx.doi.org/10.1016/S0140-6736(05)66517-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885300				2022-12-28	WOS:000228933700033
J	Anthony, TE; Heintz, N				Anthony, TE; Heintz, N			Cre-ating somatic cell genetic mosaics in the mouse	CELL			English	Editorial Material							RECOMBINATION; DROSOPHILA	Generation of somatic mosaics in which mutant cell clones are uniquely and completely labeled has yielded considerable insight into many biological processes in Drosophila. In this issue of Cell, Zong et al. (2005) describe a novel method called MADM that allows the generation of such mosaics in mice.	Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Anthony, TE (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.							GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Perrimon N, 1998, INT J DEV BIOL, V42, P243; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; XU T, 1993, DEVELOPMENT, V117, P1223; Zugates CT, 2004, CURR OPIN NEUROBIOL, V14, P647, DOI 10.1016/j.conb.2004.08.005	7	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					322	323		10.1016/j.cell.2005.04.019	http://dx.doi.org/10.1016/j.cell.2005.04.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882615	Bronze			2022-12-28	WOS:000229031600003
J	Salmon, PS; Martin, RA; Mason, PE; Cuello, GJ				Salmon, PS; Martin, RA; Mason, PE; Cuello, GJ			Topological versus chemical ordering in network glasses at intermediate and extended length scales	NATURE			English	Article							SHARP DIFFRACTION PEAK; MEDIUM-RANGE ORDER; ZINC-CHLORIDE; LIQUID GESE2; SCATTERING; TRANSITION; PRESSURE; SOLIDS; SILICA; MOLTEN	Atomic ordering in network glasses on length scales longer than nearest-neighbour length scales has long been a source of controversy(1-6). Detailed experimental information is therefore necessary to understand both the network properties and the fundamentals of glass formation. Here we address the problem by investigating topological and chemical ordering in structurally disordered AX(2) systems by applying the method of isotopic substitution in neutron diffraction to glassy ZnCl2. This system may be regarded as a prototypical ionic network forming glass, provided that ion polarization effects are taken into account(7), and has thus been the focus of much attention(8-14). By experiment, we show that both the topological and chemical ordering are described by two length scales at distances greater than nearest-neighbour length scales. One of these is associated with the intermediate range, as manifested by the appearance in the measured diffraction patterns of a first sharp diffraction peak at 1.09( 3) angstrom(-1); the other is associated with an extended range, which shows ordering in the glass out to 62( 4) angstrom. We also find that these general features are characteristic of glassy GeSe2, a prototypical covalently bonded network material(15,16). The results therefore offer structural insight into those length scales that determine many important aspects of supercooled liquid and glass phenomenology(11).	Univ Bath, Dept Phys, Bath BA2 7AY, Avon, England; Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France	University of Bath; University of Bristol; Institut Laue-Langevin (ILL)	Salmon, PS (corresponding author), Univ Bath, Dept Phys, Bath BA2 7AY, Avon, England.	p.s.salmon@bath.ac.uk	Martin, Richard/AAG-9489-2020; Cuello, Gabriel/GXM-8593-2022; Mason, Philip E/A-4256-2008; Cuello, Gabriel J/C-5831-2009; Salmon, Philip S/Q-9512-2016	Cuello, Gabriel J/0000-0003-3844-0602; Salmon, Philip S/0000-0001-8671-1011; Martin, Richard/0000-0002-6013-2334; Mason, Philip/0000-0002-3263-2825	Engineering and Physical Sciences Research Council [EP/C003594/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		ANGELL CA, 1970, J CHEM PHYS, V53, P2053, DOI 10.1063/1.1674287; ANGELL CA, 1985, J NON-CRYST SOLIDS, V73, P1, DOI 10.1016/0022-3093(85)90334-5; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Bhatia AB, 1970, PHYS REV B-SOLID ST, V2, P3004, DOI 10.1103/PhysRevB.2.3004; BIGGIN S, 1981, J PHYS C SOLID STATE, V14, P3129, DOI 10.1088/0022-3719/14/22/008; BOOLCHAND P, 2000, INSULATING SEMICONDU; Crichton WA, 2001, NATURE, V414, P622, DOI 10.1038/414622a; DESA JAE, 1982, J NON-CRYST SOLIDS, V51, P57, DOI 10.1016/0022-3093(82)90189-2; ELLIOTT SR, 1995, J NON-CRYST SOLIDS, V182, P40, DOI 10.1016/0022-3093(94)00539-7; ELLIOTT SR, 1991, NATURE, V354, P445, DOI 10.1038/354445a0; Gaskell PH, 1996, PHYS REV LETT, V76, P66, DOI 10.1103/PhysRevLett.76.66; GRIMLEY DI, 1990, J NON-CRYST SOLIDS, V119, P49, DOI 10.1016/0022-3093(90)90240-M; LUDWIG KF, 1987, J CHEM PHYS, V87, P604, DOI 10.1063/1.453553; Martin JD, 2002, NATURE, V419, P381, DOI 10.1038/nature01022; Massobrio C, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.174202; MOSS SC, 1985, PHYSICS DISORDERED M, P77; Petri I, 2000, PHYS REV LETT, V84, P2413, DOI 10.1103/PhysRevLett.84.2413; Polsky CH, 2000, PHYS REV B, V61, P5934, DOI 10.1103/PhysRevB.61.5934; SALMON PS, 1992, P R SOC-MATH PHYS SC, V437, P591, DOI 10.1098/rspa.1992.0081; SALMON PS, 1994, P R SOC-MATH PHYS SC, V445, P351, DOI 10.1098/rspa.1994.0065; Salmon PS, 2003, J PHYS-CONDENS MAT, V15, pS1509, DOI 10.1088/0953-8984/15/16/301; Salmon PS, 2002, NAT MATER, V1, P87, DOI 10.1038/nmat737; Sears V.F., 1992, NEUTRON NEWS, V3, P26, DOI [10.1080/10448639208218770, DOI 10.1080/10448639208218770]; Stolen S, 2002, PHYS CHEM CHEM PHYS, V4, P3396, DOI 10.1039/b201396g; WILSON M, 1993, J PHYS-CONDENS MAT, V5, P6833, DOI 10.1088/0953-8984/5/37/004; Wilson M, 2003, J CHEM PHYS, V118, P9838, DOI 10.1063/1.1570391; Wilson M, 1998, PHYS REV LETT, V80, P532, DOI 10.1103/PhysRevLett.80.532; WRIGHT AC, 1991, J NON-CRYST SOLIDS, V129, P213, DOI 10.1016/0022-3093(91)90098-Q; Zachariasen WH, 1932, J AM CHEM SOC, V54, P3841, DOI 10.1021/ja01349a006; Ziman J.M., 1979, MODELS DISORDER	30	211	212	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2005	435	7038					75	78		10.1038/nature03475	http://dx.doi.org/10.1038/nature03475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875017				2022-12-28	WOS:000228864600039
J	Hartmann, K; Viswanathan, M; Palmieri, R; Gartlehner, G; Thorp, J; Lohr, KN				Hartmann, K; Viswanathan, M; Palmieri, R; Gartlehner, G; Thorp, J; Lohr, KN			Outcomes of routine episiotomy - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; PERINEAL MANAGEMENT TRIAL; VAGINAL DELIVERY; RISK-FACTORS; UNITED-STATES; INCONTINENCE; CHILDBIRTH; TRAUMA; WOMEN; 3RD-DEGREE	Context Episiotomy at the time of vaginal birth is common. Practice patterns vary widely, as do professional opinions about maternal risks and benefits associated with routine use. Objective To systematically review the best evidence available about maternal outcomes of routine vs restrictive use of episiotomy. Evidence Acquisition We searched MEDLINE, Cumulative Index to Nursing and Allied Health Literature, and Cochrane Collaboration resources and performed a hand search for English-language articles from 1950 to 2004. We included randomized controlled trials of routine episiotomy or type of episiotomy that assessed outcomes in the first 3 postpartum months, along with trials and prospective studies that assessed longer-term outcomes. Twenty-six of 986 screened articles provided relevant data. We entered data into abstraction forms and conducted a second review for accuracy. Each article was also scored for research quality. Evidence Synthesis Fair to good. evidence from clinical trials suggests that immediate maternal outcomes of routine episiotomy, including severity of perineal laceration, pain, and pain medication use, are not better than those with restrictive use. Evidence is insufficient to provide guidance on choice of midline vs mediolateral episiotomy. Evidence regarding long-term sequelae is fair to poor. Incontinence and pelvic floor outcomes have not been followed up into the age range in which women are most likely to have sequelae. With this caveat, relevant studies are consistent in demonstrating no benefit from episiotomy for prevention of fecal and urinary incontinence or pelvic floor. relaxation. Likewise, no evidence suggests that episiotomy reduces impaired sexual function-pain with intercourse was more common among women with episiotomy. Conclusions Evidence does not support maternal benefits traditionally ascribed to routine episiotomy. In fact, outcomes with episiotomy can be considered worse since some proportion of women who would have had lesser injury instead had a surgical incision.	Univ N Carolina, Ctr Womens Hlth Res, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA; Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA; Res Triangle Inst, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute	Hartmann, K (corresponding author), Univ N Carolina, Ctr Womens Hlth Res, Campus Box 7521,725 Airport Rd, Chapel Hill, NC 27599 USA.	khartman@med.unc.edu	Gartlehner, Gerald/AAY-2801-2021; Hartmann, Katherine Eubanks/AAV-5288-2020	Gartlehner, Gerald/0000-0001-5531-3678; Weber, Rachel/0000-0001-7119-7734; Hartmann, Katherine/0000-0002-7051-8185; Lohr, Kathleen/0000-0002-3825-0713	PHS HHS [290-02-0016] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BANTA D, 1982, BIRTH-ISS PERINAT C, V9, P25, DOI 10.1111/j.1523-536X.1982.tb01599.x; BELIZAN J, 1993, LANCET, V342, P1517; Bodner-Adler B, 2003, J REPROD MED, V48, P239; Bodner-Adler B, 2001, J REPROD MED, V46, P752; COATS PM, 1980, BRIT J OBSTET GYNAEC, V87, P408, DOI 10.1111/j.1471-0528.1980.tb04569.x; COMBS CA, 1990, AM J OBSTET GYNECOL, V163, P100, DOI 10.1016/S0002-9378(11)90678-4; Dannecker C, 2004, ACTA OBSTET GYN SCAN, V83, P364, DOI 10.1111/j.0001-6349.2004.00366.x; DECLERCQ E, 2002, LISTENING MOTHERS; Eason E, 2002, CAN MED ASSOC J, V166, P326; EASON E, 2004, BMC PREGNANCY CHILDB, V4, P4, DOI DOI 10.1186/1471-2393-4-4); Egger M, 2001, SYSTEMATIC REV HLTH; Eltorkey M. M., 1994, Journal of Obstetrics and Gynaecology (Abingdon), V14, P317, DOI 10.3109/01443619409027599; Fenner DE, 2003, AM J OBSTET GYNECOL, V189, P1543, DOI 10.1016/j.ajog.2003.09.030; Fleming N, 2003, J MIDWIFERY WOM HEAL, V48, P53, DOI 10.1016/S1526-9523(02)00368-9; Gordon B, 1998, BRIT J OBSTET GYNAEC, V105, P435, DOI 10.1111/j.1471-0528.1998.tb10130.x; HARRISON RF, 1984, BRIT MED J, V288, P1971, DOI 10.1136/bmj.288.6435.1971; HOUSE MJ, 1986, J OBSTET GYNAECOL, V7, P107, DOI 10.3109/01443618609112284; Kaczorowski J, 1998, BIRTH-ISS PERINAT C, V25, P11, DOI 10.1046/j.1523-536x.1998.00011.x; Karacam Z, 2003, J ADV NURS, V43, P384, DOI 10.1046/j.1365-2648.2003.02727.x; KLEIN MC, 1994, AM J OBSTET GYNECOL, V171, P591, DOI 10.1016/0002-9378(94)90070-1; KLEIN MC, 1995, CAN MED ASSOC J, V153, P769; Klein MC., 1992, ONLINE J CURR CLIN T, V1, P25, DOI [10.1097/00006254-199404000-00008, DOI 10.1097/00006254-199404000-00008]; Kozak Lola Jean, 2004, Vital Health Stat 13, P1; LARSSON PG, 1991, GYNECOL OBSTET INVES, V31, P213, DOI 10.1159/000293161; Low LK, 2000, J MIDWIFERY WOM HEAL, V45, P87; MacArthur C, 1997, BRIT J OBSTET GYNAEC, V104, P46, DOI 10.1111/j.1471-0528.1997.tb10648.x; McLeod N L, 2003, J Obstet Gynaecol Can, V25, P586; Riskin-Mashiah S, 2002, AM J PERINAT, V19, P225, DOI 10.1055/s-2002-33088; Rockner G, 1990, Scand J Caring Sci, V4, P169; Rockner G, 1988, Scand J Caring Sci, V2, P19; Rockner G, 1991, ACTA OBSTET GYN SCAN, V70, P51, DOI 10.3109/00016349109006178; Sartore A, 2004, OBSTET GYNECOL, V103, P669, DOI 10.1097/01.AOG.0000119223.04441.c9; SHIONO P, 1990, OBSTET GYNECOL, V75, P765; Signorello LB, 2001, AM J OBSTET GYNECOL, V184, P881, DOI 10.1067/mob.2001.113855; SLEEP J, 1987, BRIT MED J, V295, P749, DOI 10.1136/bmj.295.6601.749; SLEEP J, 1984, BRIT MED J, V289, P587, DOI 10.1136/bmj.289.6445.587; THORP JM, 1989, AM J OBSTET GYNECOL, V160, P1027, DOI 10.1016/0002-9378(89)90152-X; Viktrup L, 2001, AM J OBSTET GYNECOL, V185, P82, DOI 10.1067/mob.2001.114501; Viswanathan M, 2005, USE EPISIOTOMY OBSTE; Walsh CJ, 1996, BRIT J SURG, V83, P218, DOI 10.1002/bjs.1800830220; Webb DA, 2002, BIRTH-ISS PERINAT C, V29, P132, DOI 10.1046/j.1523-536X.2002.00173.x; Webb DA, 2002, J EPIDEMIOL COMMUN H, V56, P577, DOI 10.1136/jech.56.8.577; Weber AM, 2002, OBSTET GYNECOL, V100, P1177, DOI 10.1016/S0029-7844(02)02449-3; West S, 2002, AHRQ PUBLICATION, V02-E016; Woolley R J, 1995, Obstet Gynecol Surv, V50, P821, DOI 10.1097/00006254-199511000-00021; Woolley R J, 1995, Obstet Gynecol Surv, V50, P806, DOI 10.1097/00006254-199511000-00020	46	249	269	3	26	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2141	2148		10.1001/jama.293.17.2141	http://dx.doi.org/10.1001/jama.293.17.2141			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870418				2022-12-28	WOS:000228808200024
J	Viner, R; Christie, D				Viner, R; Christie, D			ABC of adolescence - Fatigue and somatic symptoms	BMJ-BRITISH MEDICAL JOURNAL			English	Review									UCL Hosp NHS Fdn Trust, Middlesex Adolescent Unit, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Viner, R (corresponding author), UCL Hosp NHS Fdn Trust, Middlesex Adolescent Unit, London, England.	rviner@ich.ucl.ac.uk	Viner, Russell M/A-1441-2009	Viner, Russell M/0000-0003-3047-2247				McGregor, 1997, Adolesc Med, V8, P15; *ROYAL COLL PHYS, 1996, CHRON FAT SYNDR; *WHO, 2002, HLTH BEH SCH AG CHIL; 1994, ANN INTERN MED, V121, P953; 2002, EFFECTIVE HLTH CARE, V7, P1	5	27	31	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2005	330	7498					1012	1015		10.1136/bmj.330.7498.1012	http://dx.doi.org/10.1136/bmj.330.7498.1012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UP	15860829	Green Published			2022-12-28	WOS:000228935100025
J	Xia, KW; Rosakis, AJ; Kanamori, H; Rice, JR				Xia, KW; Rosakis, AJ; Kanamori, H; Rice, JR			Laboratory earthquakes along inhomogeneous faults: Directionality and supershear	SCIENCE			English	Article							SLIP-PULSE; RUPTURE; INTERFACE; VELOCITY; TURKEY; CRACKS; MODEL	We report on the experimental observation of spontaneously nucleated ruptures occurring on frictionally held bimaterial interfaces with small amounts of wave speed mismatch. Rupture is always found to be asymmetric bilateral. In one direction, rupture always propagates at the generalized Rayleigh wave speed, whereas in-the opposite direction it is subshear or it transitions to supershear. The lack of a preferred rupture direction and the conditions leading to supershear are discussed in relation to existing theory and to the earthquake sequence in Parkfield, California, and in North Anatolia.	CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA; CALTECH, Seismol Lab, Pasadena, CA 91125 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	California Institute of Technology; California Institute of Technology; Harvard University; Harvard University	Rosakis, AJ (corresponding author), CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA.	rosakis@aero.caltech.edu		Rice, James R./0000-0001-6151-4310; Rosakis, Ares/0000-0003-0559-0794				Adams GG, 1998, J APPL MECH-T ASME, V65, P470, DOI 10.1115/1.2789077; Adams GG, 1995, J APPL MECH-T ASME, V62, P867, DOI 10.1115/1.2896013; Adams GG, 2001, J APPL MECH-T ASME, V68, P81, DOI 10.1115/1.1349119; ANDREWS DJ, 1976, J GEOPHYS RES, V81, P5679, DOI 10.1029/JB081i032p05679; Andrews DJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014126; Andrews DJ, 1997, J GEOPHYS RES-SOL EA, V102, P553, DOI 10.1029/96JB02856; Anooshehpoor A, 1999, GEOPHYS RES LETT, V26, P2025, DOI 10.1029/1999GL900397; ARCHULETA RJ, 1984, J GEOPHYS RES, V89, P4559, DOI 10.1029/JB089iB06p04559; Ben-Zion Y, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000254; Ben-Zion Y, 2001, J MECH PHYS SOLIDS, V49, P2209, DOI 10.1016/S0022-5096(01)00036-9; Bouchon M, 2003, SCIENCE, V301, P824, DOI 10.1126/science.1086832; Bouchon M, 2001, GEOPHYS RES LETT, V28, P2723, DOI 10.1029/2001GL013112; BOUCHON M, 2002, GEOPHYS RES LETT, V29, DOI DOI 10.1026/2002GL015096; Cochard A, 2000, J GEOPHYS RES-SOL EA, V105, P25891, DOI 10.1029/2000JB900230; DAY SM, 1982, B SEISMOL SOC AM, V72, P1881; Dunham EM, 2004, B SEISMOL SOC AM, V94, pS256, DOI 10.1785/0120040616; Ellsworth W. L., 2004, 11 INT C SOIL DYN EA; Harris RA, 1997, B SEISMOL SOC AM, V87, P1267; Harris RA, 2002, B SEISMOL SOC AM, V92, P245, DOI 10.1785/0120000825; McGuire JJ, 2002, B SEISMOL SOC AM, V92, P3309, DOI 10.1785/0120010293; Ranjith K, 2001, J MECH PHYS SOLIDS, V49, P341, DOI 10.1016/S0022-5096(00)00029-6; Rice J.R., 2001, MECH NEW MILLENNIUM, P1; Rosakis AJ, 1999, SCIENCE, V284, P1337, DOI 10.1126/science.284.5418.1337; Rosakis AJ, 2002, ADV PHYS, V51, P1189, DOI 10.1080/00018730210122328; Thurber C, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016004; WALD DJ, 1994, B SEISMOL SOC AM, V84, P668; Weertman J, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013916; WEERTMAN J, 1980, J GEOPHYS RES, V85, P1455, DOI 10.1029/JB085iB03p01455; Xia KW, 2004, SCIENCE, V303, P1859, DOI 10.1126/science.1094022; ZOR E, 2003, GEOPHYS RES LETT, V30, DOI DOI 10.1029/2003GL018129	30	123	129	5	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					681	684		10.1126/science.1108193	http://dx.doi.org/10.1126/science.1108193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860624				2022-12-28	WOS:000228810900046
J	Lucchetta, EM; Lee, JH; Fu, LA; Patel, NH; Ismagilov, RF				Lucchetta, EM; Lee, JH; Fu, LA; Patel, NH; Ismagilov, RF			Dynamics of Drosophila embryonic patterning network perturbed in space and time using microfluidics	NATURE			English	Article							EXPRESSION PATTERNS; POLY(DIMETHYLSILOXANE); PROTEIN; DEVICES	Biochemical networks are perturbed both by fluctuations in environmental conditions and genetic variation. These perturbations must be compensated for, especially when they occur during embryonic pattern formation. Complex chemical reaction networks displaying spatiotemporal dynamics have been controlled and understood by perturbing their environment in space and time(1-3). Here, we apply this approach using microfluidics to investigate the robust network in Drosophila melanogaster that compensates for variation in the Bicoid morphogen gradient. We show that the compensation system can counteract the effects of extremely unnatural environmental conditions-a temperature step-in which the anterior and posterior halves of the embryo are developing at different temperatures and thus at different rates. Embryonic patterning was normal under this condition, suggesting that a simple reciprocal gradient system is not the mechanism of compensation. Time-specific reversals of the temperature step narrowed down the critical period for compensation to between 65 and 100 min after onset of embryonic development. The microfluidic technology used here may prove useful to future studies, as it allows spatial and temporal regulation of embryonic development.	Univ Chicago, Dept Chem, Chicago, IL 60637 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Integrat Biol Mol & Cell Biol, Berkeley, CA 94720 USA	University of Chicago; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ismagilov, RF (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	nipam@uclink.berkeley.edu; r-ismagilov@uchicago.edu		Fu, Lydia/0000-0003-2800-3388; Patel, Nipam/0000-0003-4328-654X	NIGMS NIH HHS [R01 GM077331, R01 GM077331-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077331] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JR, 2000, ANAL CHEM, V72, P3158, DOI 10.1021/ac9912294; DiGregorio PJ, 2001, J BIOL CHEM, V276, P1930, DOI 10.1074/jbc.M003911200; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FOE VE, 1993, DEV DROSOPHILA MELAN; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; Furlong EEM, 2001, NAT BIOTECHNOL, V19, P153, DOI 10.1038/84422; Hatch A, 2001, NAT BIOTECHNOL, V19, P461, DOI 10.1038/88135; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Myasnikova E, 2001, BIOINFORMATICS, V17, P3, DOI 10.1093/bioinformatics/17.1.3; NIEMUTH J, 1995, ROUX ARCH DEV BIOL, V204, P444, DOI 10.1007/BF00360852; PATEL NH, 1994, NATURE, V367, P429, DOI 10.1038/367429a0; Sakurai T, 2002, SCIENCE, V296, P2009, DOI 10.1126/science.1071265; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Stasiek JA, 2002, OPTO-ELECTRON REV, V10, P1; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Vanag VK, 2000, NATURE, V406, P389, DOI 10.1038/35019038; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170; Wolff J, 2001, SCIENCE, V294, P134, DOI 10.1126/science.1063597	21	345	358	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1134	1138		10.1038/nature03509	http://dx.doi.org/10.1038/nature03509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858575	Green Accepted, Bronze			2022-12-28	WOS:000228693300044
J	Perrier, A; Roy, P; Sanchez, O; Le Gal, G; Meyer, G; Gourdier, A; Furber, A; Revel, M; Howarth, N; Davido, A; Bounameaux, H				Perrier, A; Roy, P; Sanchez, O; Le Gal, G; Meyer, G; Gourdier, A; Furber, A; Revel, M; Howarth, N; Davido, A; Bounameaux, H			Multidetector-row computed tomography in suspected pulmonary embolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							D-DIMER; CLINICAL PROBABILITY; SPIRAL CT; LUNG-SCAN; DIAGNOSIS; OUTPATIENTS; PREDICTION; MANAGEMENT; EMERGENCY; VALIDITY	BACKGROUND: Single-detector-row computed tomography (CT) has a low sensitivity for pulmonary embolism and must be combined with venous-compression ultrasonography of the lower limbs. We evaluated whether the use of D-dimer measurement and multidetector-row CT, without lower-limb ultrasonography, might safely rule out pulmonary embolism. METHODS: We included 756 consecutive patients with clinically suspected pulmonary embolism from the emergency departments of three teaching hospitals and managed their cases according to a standardized sequential diagnostic strategy. All patients were followed for three months. RESULTS: Pulmonary embolism was detected in 194 of the 756 patients (26 percent). Among the 82 patients with a high clinical probability of pulmonary embolism, multidetector-row CT showed pulmonary embolism in 78, and 1 patient had proximal deep venous thrombosis and a CT scan that was negative for pulmonary embolism. Of the 674 patients without a high probability of pulmonary embolism, 232 (34 percent) had a negative D-dimer assay and an uneventful follow-up; CT showed pulmonary embolism in 109 patients. CT and ultrasonography were negative in 318 patients, of whom 3 had a definite thromboembolic event and 2 died of possible pulmonary embolism during follow-up (three-month risk of thromboembolism, 1.7 percent; 95 percent confidence interval, 0.7 to 3.9). Two patients had proximal deep venous thrombosis and a negative CT scan (risk, 0.6 percent; 95 percent confidence interval, 0.2 to 2.2). The overall three-month risk of thromboembolism in patients without pulmonary embolism would have been 1.5 percent (95 percent confidence interval, 0.8 to 3.0) if the D-dimer assay and multidetector-row CT had been the only tests used to rule out pulmonary embolism and ultrasonography had not been performed. CONCLUSIONS: Our data indicate the potential clinical use of a diagnostic strategy for ruling out pulmonary embolism on the basis of D-dimer testing and multidetector-row CT without lower-limb ultrasonography. A larger outcome study is needed before this approach can be adopted.	Univ Hosp Geneva, Serv Gen Internal Med, CH-1211 Geneva, Switzerland; Geneva Fac Med, Serv Gen Internal Med, Geneva, Switzerland; Geneva Fac Med, Dept Internal Med, Div Angiol & Hemostasis, Geneva, Switzerland; Geneva Fac Med, Serv Med Radiodiag & Intervent Radiol, Dept Med Radiol & Informat, Geneva, Switzerland; Angers Univ Hosp, Emergency Dept, Angers, France; Angers Univ Hosp, Serv Radiol, Angers, France; Angers Univ Hosp, Serv Cardiol, Angers, France; Hop Europeen Georges Pompidou, Serv Pneumol, Paris, France; Hop Europeen Georges Pompidou, Serv Radiol, Paris, France; Hop Europeen Georges Pompidou, Emergency Dept, Paris, France	University of Geneva; University of Geneva; University of Geneva; University of Geneva; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Perrier, A (corresponding author), Univ Hosp Geneva, Serv Gen Internal Med, Rue Micheli du Crest 24, CH-1211 Geneva, Switzerland.	arnaud.perrier@medecine.unige.ch	Perrier, Arnaud/M-2263-2014; LE GAL, Gregoire/K-1077-2012	SANCHEZ, Olivier/0000-0003-1633-8391; revel, marie-pierre/0000-0001-8213-7817; LE GAL, Gregoire/0000-0002-9253-248X				BOUNAMEAUX H, 1991, LANCET, V337, P196, DOI 10.1016/0140-6736(91)92158-X; Campbell IA, 2003, THORAX, V58, P470; Chagnon I, 2002, AM J MED, V113, P269, DOI 10.1016/S0002-9343(02)01212-3; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; deMoerloose P, 1996, THROMB HAEMOSTASIS, V75, P11; Fedullo PF, 2003, NEW ENGL J MED, V349, P1247, DOI 10.1056/NEJMcp035442; Ghaye B, 2001, RADIOLOGY, V219, P629, DOI 10.1148/radiology.219.3.r01jn32629; Goldhaber SZ, 2004, LANCET, V363, P1295, DOI 10.1016/S0140-6736(04)16004-2; HULL RD, 1990, CHEST, V97, P23, DOI 10.1378/chest.97.1.23; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; Kruip MJHA, 2002, ARCH INTERN MED, V162, P1631, DOI 10.1001/archinte.162.14.1631; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Musset D, 2002, LANCET, V360, P1914, DOI 10.1016/S0140-6736(02)11914-3; Perrier A, 2000, ARCH INTERN MED, V160, P512, DOI 10.1001/archinte.160.4.512; Perrier A, 1996, ARCH INTERN MED, V156, P531, DOI 10.1001/archinte.156.5.531; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Perrier A, 2001, ANN INTERN MED, V135, P88, DOI 10.7326/0003-4819-135-2-200107170-00008; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; Righini M, 2004, ARCH INTERN MED, V164, P2483, DOI 10.1001/archinte.164.22.2483; Schoepf UJ, 2004, CIRCULATION, V109, P2160, DOI 10.1161/01.CIR.0000128813.04325.08; van Beek EJR, 2001, CLIN RADIOL, V56, P838, DOI 10.1053/crad.2001.0778; van Strijen MJL, 2005, J THROMB HAEMOST, V3, P17, DOI 10.1111/j.1538-7836.2004.01064.x; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92	28	475	497	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1760	1768		10.1056/NEJMoa042905	http://dx.doi.org/10.1056/NEJMoa042905			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858185	Bronze			2022-12-28	WOS:000228689000006
J	Groves, T; Croot, J				Groves, T; Croot, J			Using pictures in the BMJ - We want lots of pictures, but have policies on using them ethically	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSENT; INFORMATION					tgroves@bmj.com	Groves, Trish/A-9119-2009	Groves, Trish/0000-0001-7915-6419				General Medical Council, 2002, MAK US VIS AUD REC P; NYLENNA M, 1991, BRIT MED J, V302, P1182, DOI 10.1136/bmj.302.6786.1182; Singer PA, 2004, BRIT MED J, V329, P566, DOI 10.1136/bmj.329.7465.566; SMITH J, 1991, BRIT MED J, V302, P1168, DOI 10.1136/bmj.302.6786.1168; SMITH R, 1995, BRIT MED J, V311, P1240, DOI 10.1136/bmj.311.7015.1240	5	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 23	2005	330	7497					916	916		10.1136/bmj.330.7497.916	http://dx.doi.org/10.1136/bmj.330.7497.916			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15845954	Green Published			2022-12-28	WOS:000228715900003
J	Piola, P; Fogg, C; Bajunirwe, F; Biraro, S; Grandesso, F; Ruzagira, E; Babigumira, J; Kigozi, I; Kiguli, J; Kyomuhendo, J; Ferradini, L; Taylor, W; Checchi, F; Guthmann, JP				Piola, P; Fogg, C; Bajunirwe, F; Biraro, S; Grandesso, F; Ruzagira, E; Babigumira, J; Kigozi, I; Kiguli, J; Kyomuhendo, J; Ferradini, L; Taylor, W; Checchi, F; Guthmann, JP			Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial	LANCET			English	Article							SULFADOXINE-PYRIMETHAMINE; ANTIMALARIAL-DRUG; ARTEMISININ DERIVATIVES; ARTESUNATE-MEFLOQUINE; EAST-AFRICA; EFFICACY; BENFLUMETOL; CHLOROQUINE; CHILDREN; COMBINATION	Background The six-dose regimen of artemether-lumefantrine is effective and is among combination therapies prioritised to replace antimalarials that no longer work in Africa. However, its effectiveness has not been assessed in the field, and could be compromised by poor adherence, incorrect timing of doses, and insufficient intake of fatty foods with every dose. Our aim, therefore, was to assess the effectiveness of artemether-lumefantrine prescribed under routine outpatient conditions, compared with its efficacy when given under supervision to inpatients with acute uncomplicated falciparum. malaria. Methods We did a randomised trial to compare the efficacy, safety, and pharmacokinetics of artemetherlumefantrine when given in a supervised (all doses observed with fatty-food intake; n=313) or unsupervised (first dose supervised followed by outpatient treatment with nutritional advice; n=644) setting to patients of all ages (weight >10 kg) with acute, uncomplicated falciparum malaria in Mbarara, Uganda. Our primary endpoint was 28-day, PCR-adjusted, parasitological cure rate. Analysis was by intention to treat and evalutability analysis. Findings 38 patients were lost to follow-up and one withdrew consent. Day-28 cure rates were 97.7% (296 of 303) and 98.0% (603 of 615) in the supervised and unsupervised groups, respectively. We recorded 15 non-severe, drug-related adverse events, all of which resolved. Interpretation Artemether-lumefantrine has a high cure rate irrespective of whether given tinder supervision with food or under conditions of routine clinic practice. If used as first-line treatment, artemether-lumefantrine could make a substantial contribution to malaria control in Africa, though cost is an issue.	Epicentre, F-75011 Paris, France; Mbarara Univ Sci & Technol, Mbarara, Uganda; WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland	Mbarara University of Science & Technology; World Health Organization	Piola, P (corresponding author), Epicentre, 8 Rue St Sabin, F-75011 Paris, France.	uganda@epicentre.msf.org	Kiguli, James/HGE-8561-2022; Babigumira, Joseph/T-4208-2019	Ruzagira, Eugene/0000-0002-7291-1693; Grandesso, Francesco/0000-0001-9909-0285; Checchi, Francesco/0000-0001-9030-5382; Fogg, Carole/0000-0002-3000-6185				Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; [Anonymous], 2003, AFR MAL REP 2003; Bakshi R, 2000, T ROY SOC TROP MED H, V94, P419, DOI 10.1016/S0035-9203(00)90126-3; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; CAMPBELL CC, 1979, LANCET, V2, P1151; Checchi F, 2004, TROP MED INT HEALTH, V9, P445, DOI 10.1111/j.1365-3156.2004.01217.x; DIECKMANN A, 1986, MOL BIOCHEM PARASIT, V19, P143, DOI 10.1016/0166-6851(86)90119-2; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; Ezzet F, 1998, BRIT J CLIN PHARMACO, V46, P553, DOI 10.1046/j.1365-2125.1998.00830.x; Fogg C, 2004, AM J TROP MED HYG, V71, P525, DOI 10.4269/ajtmh.2004.71.525; Hatz C, 1998, TROP MED INT HEALTH, V3, P498, DOI 10.1046/j.1365-3156.1998.00250.x; Kamya MR, 2001, T ROY SOC TROP MED H, V95, P50, DOI 10.1016/S0035-9203(01)90331-1; Lefevre G, 2001, AM J TROP MED HYG, V64, P247, DOI 10.4269/ajtmh.2001.64.247; Legros D, 2002, T ROY SOC TROP MED H, V96, P199, DOI 10.1016/S0035-9203(02)90304-4; Mansor SM, 1996, J CHROMATOGR B, V682, P321, DOI 10.1016/0378-4347(96)00086-2; Ndayiragije A, 2004, TROP MED INT HEALTH, V9, P673, DOI 10.1111/j.1365-3156.2004.01255.x; Priotto G, 2003, T ROY SOC TROP MED H, V97, P325, DOI 10.1016/S0035-9203(03)90161-1; Ronn AM, 1996, T ROY SOC TROP MED H, V90, P179, DOI 10.1016/S0035-9203(96)90129-7; Snounou Georges, 2002, Methods Mol Med, V72, P103, DOI 10.1385/1-59259-271-6:103; Staedke SG, 2004, LANCET, V364, P1950, DOI 10.1016/S0140-6736(04)17478-3; Stepniewska K, 2004, ANTIMICROB AGENTS CH, V48, P4271, DOI 10.1128/AAC.48.11.4271-4280.2004; Talisuna AO, 2004, TROP MED INT HEALTH, V9, P222, DOI 10.1046/j.1365-3156.2003.01187.x; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; Van Vugt M, 2000, AM J TROP MED HYG, V62, P65, DOI 10.4269/ajtmh.2000.62.65; van Vugt M, 1999, AM J TROP MED HYG, V61, P964, DOI 10.4269/ajtmh.1999.61.964; van Vugt M, 1998, ANTIMICROB AGENTS CH, V42, P135, DOI 10.1128/AAC.42.1.135; Von Seidlein L, 1998, AM J TROP MED HYG, V58, P638; Wernsdorfer WH, 1998, ACTA TROP, V70, P9, DOI 10.1016/S0001-706X(97)00141-1; WERNSDORFER WH, 2004, EXPERT REV ANTI INFE, V4, P181; White NJ, 1996, PARASITOL TODAY, V12, P399, DOI 10.1016/0169-4758(96)10055-7; White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002; WHO, 2003, POS WHOS ROLL BACK M; *WHO, GLOB AMDP DAT AFRO; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010	35	149	149	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1467	1473		10.1016/S0140-6736(05)66416-1	http://dx.doi.org/10.1016/S0140-6736(05)66416-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850630	Green Accepted			2022-12-28	WOS:000228651600024
J	Elachi, C; Wall, S; Allison, M; Anderson, Y; Boehmer, R; Callahan, P; Encrenaz, P; Flamini, E; Franceschetti, G; Gim, Y; Hamilton, G; Hensley, S; Janssen, M; Johnson, W; Kelleher, K; Kirk, R; Lopes, R; Lorenz, R; Lunine, J; Muhleman, D; Ostro, S; Paganelli, F; Picardi, G; Posa, F; Roth, L; Seu, R; Shaffer, S; Soderblom, L; Stiles, B; Stofan, E; Vetrella, S; West, R; Wood, C; Wye, L; Zebker, H				Elachi, C; Wall, S; Allison, M; Anderson, Y; Boehmer, R; Callahan, P; Encrenaz, P; Flamini, E; Franceschetti, G; Gim, Y; Hamilton, G; Hensley, S; Janssen, M; Johnson, W; Kelleher, K; Kirk, R; Lopes, R; Lorenz, R; Lunine, J; Muhleman, D; Ostro, S; Paganelli, F; Picardi, G; Posa, F; Roth, L; Seu, R; Shaffer, S; Soderblom, L; Stiles, B; Stofan, E; Vetrella, S; West, R; Wood, C; Wye, L; Zebker, H			Cassini radar views the surface of Titan	SCIENCE			English	Article							SATELLITES; GANYMEDE	The Cassini Titan Radar Mapper imaged about 1% of Titan's surface at a resolution of similar to 0.5 kilometer, and larger areas of the globe in lower resolution modes. The images reveal a complex surface, with areas of low relief and a variety of geologic features suggestive of dome-like volcanic constructs, flows, and sinuous channels. The surface appears to be young, with few impact craters. Scattering and dielectric properties are consistent with porous ice or organics. Dark patches in the radar images show high brightness temperatures and high emissivity and are consistent with frozen hydrocarbons.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Observ Paris, F-75014 Paris, France; Agenzia Spaziale Italiana, I-00198 Rome, Italy; Fac Ingn, I-80125 Naples, Italy; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Roma La Sapienza, I-00184 Rome, Italy; Politecn Bari, INFM, I-70126 Bari, Italy; Politecn Bari, Dipartimento Interateneo Fis, I-70126 Bari, Italy; Proxemy Res, Laytonville, MD 20882 USA; Planetary Sci Inst, Tucson, AZ 85719 USA; Stanford Univ, Stanford, CA 94305 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Agenzia Spaziale Italiana (ASI); United States Department of the Interior; United States Geological Survey; University of Arizona; California Institute of Technology; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Politecnico di Bari; Politecnico di Bari; Stanford University	Wall, S (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	steve.wall@jpl.nasa.gov	Lopes, Rosaly M.C./D-1608-2016; Lorenz, Ralph D/B-8759-2016	Lopes, Rosaly M.C./0000-0002-7928-3167; Lorenz, Ralph D/0000-0001-8528-4644; Lunine, Jonathan/0000-0003-2279-4131; zebker, howard/0000-0001-9931-5237				Black GJ, 2004, SCIENCE, V304, P553, DOI 10.1126/science.1096470; Black GJ, 2001, ICARUS, V151, P167, DOI 10.1006/icar.2001.6616; BOTT DC, 1986, HDB CONDUCTING POLYM, P1191; BUTLER BJ, 2004, B AM ASTRON SOC, V36, P1075; Campbell BA., 2002, RADAR REMOTE SENSING; Campbell DB, 2003, SCIENCE, V302, P431, DOI 10.1126/science.1088969; ENGEL S, 1995, PLANET SPACE SCI, V43, P1059, DOI 10.1016/0032-0633(95)00044-6; GROSSMAN AW, 1992, B AM ASTRON SOC, V24, P954; Harmon JK, 1999, PLANET SPACE SCI, V47, P1409, DOI 10.1016/S0032-0633(99)00068-9; JANKOWSKI DG, 1988, SCIENCE, V241, P1322, DOI 10.1126/science.241.4871.1322; Lorenz RD, 1996, PLANET SPACE SCI, V44, P1021, DOI 10.1016/0032-0633(95)00139-5; Lorenz RD, 2003, PLANET SPACE SCI, V51, P353, DOI 10.1016/S0032-0633(02)00148-4; Lorenz RD, 1997, PLANET SPACE SCI, V45, P1009, DOI 10.1016/S0032-0633(97)00085-8; LUNINE J, 2005, 36 ANN LUN PLAN SCI; LUNINE JI, 1993, REV GEOPHYS, V31, P133, DOI 10.1029/92RG02794; MCCAULEY JF, 1982, SCIENCE, V218, P1004, DOI 10.1126/science.218.4576.1004; MUHLEMAN DO, 1995, ANNU REV EARTH PL SC, V23, P337, DOI 10.1146/annurev.earth.23.1.337; OSTRO SJ, 1992, J GEOPHYS RES-PLANET, V97, P18227, DOI 10.1029/92JE01992; OSTRO SJ, 1993, REV MOD PHYS, V65, P1235, DOI 10.1103/RevModPhys.65.1235; Pappalardo RT, 2004, CAMB PLANET, P363; Patel JG, 1999, J GEOPHYS RES-PLANET, V104, P24057, DOI 10.1029/1998JE001021; PETERS KJ, 1992, PHYS REV B, V46, P801, DOI 10.1103/PhysRevB.46.801; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; SAUNDERS RS, 1992, J GEOPHYS RES-PLANET, V97, P13067, DOI 10.1029/92JE01397; Seidelmann PK, 2002, CELEST MECH DYN ASTR, V82, P83, DOI 10.1023/A:1013939327465; THOMPSON WR, 1990, ICARUS, V86, P336, DOI 10.1016/0019-1035(90)90224-W; TOMASKO M, IN PRESS NATURE	27	187	189	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					970	974		10.1126/science.1109919	http://dx.doi.org/10.1126/science.1109919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890871				2022-12-28	WOS:000229190700031
J	Tanaka, Y; Okada, Y; Hirokawa, N				Tanaka, Y; Okada, Y; Hirokawa, N			FGF-induced vesicular release of Sonic hedgehog and retinoic acid in leftward nodal flow is critical for left-right determination	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; INTRAFLAGELLAR TRANSPORT; MOUSE; SHH; PATHWAYS; MICE; PROTEINS; POPULATIONS; INDUCTION; RECEPTOR	The precise specification of left - right asymmetry is an essential process for patterning internal organs in vertebrates. In mouse embryonic development, the symmetry-breaking process in left - right determination is initiated by a leftward extraembryonic fluid flow on the surface of the ventral node. However, it is not known whether the signal transduction mechanism of this flow is chemical or mechanical. Here we show that fibroblast growth factor (FGF) signalling triggers secretion of membrane-sheathed objects 0.3 - 5 mu m in diameter termed 'nodal vesicular parcels' (NVPs) that carry Sonic hedgehog and retinoic acid. These NVPs are transported leftward by the fluid flow and eventually fragment close to the left wall of the ventral node. The silencing effects of the FGF-receptor inhibitor SU5402 on NVP secretion and on a downstream rise in Ca2+ were sufficiently reversed by exogenous Sonic hedgehog peptide or retinoic acid, suggesting that FGF-triggered surface accumulation of cargo morphogens may be essential for launching NVPs. Thus, we propose that NVP flow is a new mode of extracellular transport that forms a left - right gradient of morphogens.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Okada, Yasushi/N-5067-2015	Okada, Yasushi/0000-0003-2601-3689; Tanaka, Yosuke/0000-0001-5376-5726				Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Hirokawa N, 2000, TRAFFIC, V1, P29, DOI 10.1034/j.1600-0854.2000.010105.x; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Kawakami T, 2002, DEVELOPMENT, V129, P5753, DOI 10.1242/dev.00178; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Kos FJ, 2002, IMMUNOL CELL BIOL, V80, P364, DOI 10.1046/j.1440-1711.2002.01098.x; Mathieu J, 2004, DEVELOPMENT, V131, P629, DOI 10.1242/dev.00964; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Scherz PJ, 2004, SCIENCE, V305, P396, DOI 10.1126/science.1096966; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; STURM K, 1993, METHOD ENZYMOL, V225, P164; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; TANAKA Y, 1992, BRAIN RES, V596, P269, DOI 10.1016/0006-8993(92)91557-U; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yokoyama Takahiko, 2004, Anatomical Science International, V79, P47, DOI 10.1111/j.1447-073x.2004.00072.x; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	32	395	411	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					172	177		10.1038/nature03494	http://dx.doi.org/10.1038/nature03494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889083				2022-12-28	WOS:000229021100031
J	Hoepfner, S; Severin, F; Cabezas, A; Habermann, B; Runge, A; Giilooly, D; Stenmark, H; Zerial, M				Hoepfner, S; Severin, F; Cabezas, A; Habermann, B; Runge, A; Giilooly, D; Stenmark, H; Zerial, M			Modulation of receptor recycling and degradation by the endosomal kinesin KIF16B	CELL			English	Article							MEMBRANE-TRANSPORT; SUPERFAMILY PROTEINS; AXONAL-TRANSPORT; CELL-SURFACE; MOTOR; MICROTUBULES; DYNACTIN; IDENTIFICATION; MYOSIN; OVEREXPRESSION	Different classes of endosomes exhibit a characteristic intracellular steady-state distribution governed by interactions with the cytoskeleton. We found a kinesin-3, KIF16B, that transports early endosomes to the plus end of microtubules in a process regulated by the small GTPase Rab5 and its effector, the phosphatidylinositol-3-OH kinase hVPS34. In vivo, KIF16B overexpression relocated early endosomes to the cell periphery and inhibited transport to the degradative pathway. Conversely, expression of dominant-negative mutants or ablation of KIF16B by RNAi caused the clustering of early endosomes to the perinuclear region, delayed receptor recycling to the plasma membrane, and accelerated degradation. These results suggest that KIF16B, by regulating the plus end motility of early endosomes, modulates the intracellular localization of early endosomes and the balance between receptor recycling and degradation. We propose that this mechanism could have important implications for signaling.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Norwegian Radium Hosp, Dept Biochem, N-0310 Oslo, Norway; Univ Penn, Ctr Canc, HHMI, Philadelphia, PA 19104 USA	Max Planck Society; University of Oslo; Howard Hughes Medical Institute; University of Pennsylvania	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Habermann, Bianca/N-4886-2016; Stenmark, Harald/B-8868-2008; Cabezas, Alicia/K-6564-2014; Severin, Fedor/AAD-5444-2019	Habermann, Bianca/0000-0002-2457-7504; Cabezas, Alicia/0000-0002-2908-9147; Severin, Fedor/0000-0001-6703-1256				Allan V, 2000, CURR BIOL, V10, pR432, DOI 10.1016/S0960-9822(00)00550-9; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Aschenbrenner L, 2004, MOL BIOL CELL, V15, P2253, DOI 10.1091/mbc.E04-01-0002; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Dalby B., 1996, Molecular Biology of the Cell, V7, p487A; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goldstein LSB, 2001, TRENDS CELL BIOL, V11, P477, DOI 10.1016/S0962-8924(01)02143-2; Goodson HV, 1997, CURR OPIN CELL BIOL, V9, P18, DOI 10.1016/S0955-0674(97)80147-0; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HYMAN AA, 1991, J CELL SCI, P125; JIN MJ, 1993, J BIOL CHEM, V268, P18390; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miki H, 2003, GENOME RES, V13, P1455, DOI 10.1101/gr.984503; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Pollock N, 1999, J CELL BIOL, V147, P493, DOI 10.1083/jcb.147.3.493; Reilein AR, 2001, INT REV CYTOL, V204, P179, DOI 10.1016/S0074-7696(01)04005-0; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; SORKIN A, 1991, J CELL BIOL, V112, P55, DOI 10.1083/jcb.112.1.55; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; VONMASSOW A, 1989, CELL MOTIL CYTOSKEL, V14, P562, DOI 10.1002/cm.970140413; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Yang ZH, 2001, MOL CELL BIOL, V21, P2463, DOI 10.1128/MCB.21.7.2463-2466.2001; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	52	236	246	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					437	450		10.1016/j.cell.2005.02.017	http://dx.doi.org/10.1016/j.cell.2005.02.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882625	Bronze			2022-12-28	WOS:000229031600013
J	Hampel, H; Frankel, WL; Martin, E; Arnold, M; Khanduja, K; Kuebler, P; Nakagawa, H; Sotamaa, K; Prior, TW; Westman, J; Panescu, J; Fix, D; Lockman, J; Comeras, I; de la Chapelle, A; Ellison, C; Melvin, S; Winston, J; Adeli, A; Burak, W; Chadwick, R; Elkhatib, I; Hemingway, T; Jamieson, K; Johnson, C; LaJeunesse, J; Liyanarachchi, S; Rangel, P; Soble, D; Walker, M; Wise, T; Zhang, Y; Schlanger, R; Aguilar, P; Hura, D; Keith, J; Kerner, B; Lavalle, G; Taylor, C; Vara, T; Zangmeister, J; DeVictor, S; Hines, L; Lindsey, M; Madhavan, J; Padmanabhan, A; Hamelberg, K; Niemann, T; Behrens, BC; Blair, SC; Brimer, M; George, CS; Hicks, WJ; Hofmeister, JK; Kourlas, PJ; Matyas, JA; Mitchell, J; Nichols, KE; Sweeney, TJ; Toscano, RL; Wheeler, WL; Wise, W; Williams, T; Miller, S; Moore, TD; Dunlop, CLM; Kammesheidt, A; Schymick, J; Papadopoulos, N				Hampel, H; Frankel, WL; Martin, E; Arnold, M; Khanduja, K; Kuebler, P; Nakagawa, H; Sotamaa, K; Prior, TW; Westman, J; Panescu, J; Fix, D; Lockman, J; Comeras, I; de la Chapelle, A; Ellison, C; Melvin, S; Winston, J; Adeli, A; Burak, W; Chadwick, R; Elkhatib, I; Hemingway, T; Jamieson, K; Johnson, C; LaJeunesse, J; Liyanarachchi, S; Rangel, P; Soble, D; Walker, M; Wise, T; Zhang, Y; Schlanger, R; Aguilar, P; Hura, D; Keith, J; Kerner, B; Lavalle, G; Taylor, C; Vara, T; Zangmeister, J; DeVictor, S; Hines, L; Lindsey, M; Madhavan, J; Padmanabhan, A; Hamelberg, K; Niemann, T; Behrens, BC; Blair, SC; Brimer, M; George, CS; Hicks, WJ; Hofmeister, JK; Kourlas, PJ; Matyas, JA; Mitchell, J; Nichols, KE; Sweeney, TJ; Toscano, RL; Wheeler, WL; Wise, W; Williams, T; Miller, S; Moore, TD; Dunlop, CLM; Kammesheidt, A; Schymick, J; Papadopoulos, N			Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer).	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DNA MISMATCH REPAIR; MICROSATELLITE-INSTABILITY; COLON-CANCER; BETHESDA GUIDELINES; GENOMIC MEDICINE; MUTATION; TUMORS; HMLH1; POPULATION; DISEASE	BACKGROUND: Germ-line mutations in the mismatch-repair genes MLH1, MSH2, MSH6, and PMS2 lead to the development of the Lynch syndrome (hereditary nonpolyposis colorectal cancer), conferring a strong susceptibility to cancer. We assessed the frequency of such mutations in patients with colorectal cancer and examined strategies for molecular screening to identify patients with the syndrome. METHODS: Patients with a new diagnosis of colorectal adenocarcinoma at the major hospitals in metropolitan Columbus, Ohio, were eligible for the study. Genotyping of the tumor for microsatellite instability was the primary screening method. Among patients whose screening results were positive for microsatellite instability, we searched for germ-line mutations in the MLH1, MSH2, MSH6, and PMS2 genes with the use of immunohistochemical staining for mismatch-repair proteins, genomic sequencing, and deletion studies. Family members of carriers of the mutations were counseled, and those found to be at risk were offered mutation testing. RESULTS: Of 1066 patients enrolled in the study, 208 (19.5 percent) had microsatellite instability, and 23 of these patients had a mutation causing the Lynch syndrome (2.2 percent). Among the 23 probands with the Lynch syndrome, 10 were more than 50 years of age and 5 did not meet the Amsterdam criteria or the Bethesda guidelines for the diagnosis of hereditary nonpolyposis colorectal cancer (including the use of age and family history to identify patients at high risk for the Lynch syndrome). Genotyping for microsatellite instability alone and immunohistochemical analysis alone each failed to identify two probands. In the families of 21 of the probands, 117 persons at risk were tested, and of these, 52 had Lynch syndrome mutations and 65 did not. CONCLUSIONS: Routine molecular screening of patients with colorectal adenocarcinoma for the Lynch syndrome identified mutations in patients and their family members that otherwise would not have been detected. These data suggest that the effectiveness of screening with immunohistochemical analysis of the mismatch-repair proteins would be similar to that of the more complex strategy of genotyping for microsatellite instability.	Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Med Res Facil 646, Columbus, OH 43210 USA; Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; Ohio State Univ, Dept Med, Columbus, OH 43210 USA; Mt Carmel Hlth Syst, Columbus, OH USA; Riverside Methodist Hosp, Columbus, OH 43214 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	de la Chapelle, A (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Med Res Facil 646, 420 W 12th Ave, Columbus, OH 43210 USA.	delachapelle-1@medctr.osu.edu	Papadopoulos, Nickolas/K-7272-2012; Hampel, Heather/AAV-4041-2020; Westman, Judith/E-4294-2011; Nichols, Kim/AAP-8592-2020; Martin Jr, Edward/E-3604-2011	Hampel, Heather/0000-0001-7558-9794; Nichols, Kim/0000-0002-5581-6555; Arnold, Mark/0000-0002-7583-6959; Frankel, Wendy/0000-0003-1658-1009	NATIONAL CANCER INSTITUTE [R01CA067941, U01CA067941, P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHS [CA16058, CA67941] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Beaudet AL, 1999, AM J HUM GENET, V64, P1, DOI 10.1086/302217; Boland CR, 1998, CANCER RES, V58, P5248; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; Carethers JM, 2004, GASTROENTEROLOGY, V126, P394, DOI 10.1053/j.gastro.2003.12.023; *CENS BUR, 2005, OH QUICKFACTS; Chadwick RB, 2001, J MED GENET, V38, P461, DOI 10.1136/jmg.38.7.461; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; Cunningham JM, 2001, AM J HUM GENET, V69, P780, DOI 10.1086/323658; CUNNINGHAM JM, 2001, AM J HUM GENET, V69, P1160; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Deng GR, 1999, CANCER RES, V59, P2029; Desai DC, 2000, J MED GENET, V37, P646, DOI 10.1136/jmg.37.9.646; Goodfellow PJ, 2003, P NATL ACAD SCI USA, V100, P5908, DOI 10.1073/pnas.1030231100; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Kane MF, 1997, CANCER RES, V57, P808; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Lynch PM, 1999, CANCER-AM CANCER SOC, V86, P2533, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2533::AID-CNCR10>3.0.CO;2-3; Motulsky AG, 1997, NEW ENGL J MED, V336, P1314, DOI 10.1056/NEJM199705013361810; Nakagawa H, 2001, CANCER RES, V61, P6991; Nakagawa H, 2004, CANCER RES, V64, P4721, DOI 10.1158/0008-5472.CAN-03-2879; Nakagawa Hidewaki, 2003, Hum Mutat, V22, P258, DOI 10.1002/humu.9171; Percesepe A, 2001, J CLIN ONCOL, V19, P3944, DOI 10.1200/JCO.2001.19.19.3944; Ravnik-Glavac M, 2000, J MED GENET, V37, P533, DOI 10.1136/jmg.37.7.533; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Salovaara, 2000, J CLIN ONCOL, V18, P3456; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Samowitz WS, 2001, GASTROENTEROLOGY, V121, P830, DOI 10.1053/gast.2001.27996; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699	37	1003	1027	0	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1851	1860		10.1056/NEJMoa043146	http://dx.doi.org/10.1056/NEJMoa043146			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872200	Bronze			2022-12-28	WOS:000228858600005
J	Steinbrook, R				Steinbrook, R			Public access to NIH-funded research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*NIH, 2005, FIN NIH PUBL ACC POL; *NIH, 2005, PUBL ACC QUEST ANSW; Terry R, 2005, PLOS BIOL, V3, P364, DOI 10.1371/journal.pbio.0030097; 2004, FED REG, V69, P56074; 2005, FED REG, V70, P6891	5	18	18	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1739	1741		10.1056/NEJMp058088	http://dx.doi.org/10.1056/NEJMp058088			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858180				2022-12-28	WOS:000228689000001
J	Cundiff, GW				Cundiff, GW			An 80-year-old woman with vaginal prolapse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PELVIC ORGAN PROLAPSE; ABDOMINAL SACRAL COLPOPEXY; SACROSPINOUS LIGAMENT FIXATION; VAULT SUSPENSION; GENITAL PROLAPSE; RISK-FACTORS; SEXUAL FUNCTION; UTEROVAGINAL PROLAPSE; URINARY-INCONTINENCE; MAGNETIC-RESONANCE		Johns Hopkins Bayview Med Ctr, Dept Obstet & Gynecol, Baltimore, MD 21224 USA; Johns Hopkins Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Cundiff, GW (corresponding author), Johns Hopkins Bayview Med Ctr, Dept Obstet & Gynecol, 4940 Eastern Ave,Room 125A1C, Baltimore, MD 21224 USA.	gcundiff@jhmil.edu	Cundiff, Geoffrey/HGD-1512-2022	Cundiff, Geoffrey/0000-0002-5777-7836				ACOG technical bulletin, 1996, INT J GYNECOL OBSTET, V52, P197, DOI 10.1016/S0020-7292(96)90069-7; ALLEN RE, 1990, BRIT J OBSTET GYNAEC, V97, P770, DOI 10.1111/j.1471-0528.1990.tb02570.x; Amundsen CL, 2003, J UROLOGY, V169, P1770, DOI 10.1097/01.ju.0000061472.94183.26; Barber MD, 2002, OBSTET GYNECOL, V99, P281, DOI 10.1016/S0029-7844(01)01727-6; Barber MD, 1999, AM J OBSTET GYNECOL, V181, P87, DOI 10.1016/S0002-9378(99)70440-0; Barber MD, 2000, AM J OBSTET GYNECOL, V183, P1402, DOI 10.1067/mob.2000.111298; BARTOLO DCC, 1983, GASTROENTEROLOGY, V85, P68; Benson JT, 1996, AM J OBSTET GYNECOL, V175, P1418, DOI 10.1016/S0002-9378(96)70084-4; BRINK CA, 1994, NURS RES, V43, P352; Brubaker L, 2003, CONTROL CLIN TRIALS, V24, P629, DOI 10.1016/S0197-2456(03)00073-4; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Bump RC, 1998, OBSTET GYN CLIN N AM, V25, P723, DOI 10.1016/S0889-8545(05)70039-5; Burrows LJ, 2003, INT UROGYNECOL J, V14, P160, DOI 10.1007/s00192-002-1019-y; Clemons JL, 2004, AM J OBSTET GYNECOL, V190, P345, DOI 10.1016/j.ajog.2003.08.034; CRUIKSHANK SH, 1990, AM J OBSTET GYNECOL, V162, P1611, DOI 10.1016/0002-9378(90)90927-Y; Culligan PJ, 2002, AM J OBSTET GYNECOL, V187, P1473, DOI 10.1067/mob.2002.129160; Cundiff GW, 1998, OBSTET GYN CLIN N AM, V25, P907, DOI 10.1016/S0889-8545(05)70049-8; Cundiff GW, 2000, OBSTET GYNECOL, V95, P931, DOI 10.1016/S0029-7844(00)00788-2; DeLancey JOL, 1997, AM J OBSTET GYNECOL, V176, P1228, DOI 10.1016/S0002-9378(97)70339-9; Dietz HP, 2003, OBSTET GYNECOL, V102, P223, DOI 10.1016/S0029-7844(03)00476-9; Ellerkmann RM, 2001, AM J OBSTET GYNECOL, V185, P1332, DOI 10.1067/mob.2001.119078; Fitzgerald MP, 2003, AM J OBSTET GYNECOL, V189, P1241, DOI 10.1067/S0002-9378(03)00642-2; Flood C G, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P200, DOI 10.1007/BF01901604; Fornell EU, 2004, ACTA OBSTET GYN SCAN, V83, P383, DOI 10.1111/j.0001-6349.2004.00367.x; Geomini PMAJ, 2001, EUR J OBSTET GYN R B, V94, P234, DOI 10.1016/S0301-2115(00)00323-7; GOLDSTEIN I, 1990, AM J OBSTET GYNECOL, V163, P589, DOI 10.1016/0002-9378(90)91204-P; Guner H, 2001, INT J GYNECOL OBSTET, V74, P165, DOI 10.1016/S0020-7292(01)00420-9; Gurel H, 1999, ACTA OBSTET GYN SCAN, V78, P290, DOI 10.1034/j.1600-0412.1999.780403.x; GUTMAN RE, IN PRESS OBSTET GYNE; Hagen S, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004010.pub2., DOI 10.1002/14651858.CD004010.PUB2]; Hall AF, 1996, AM J OBSTET GYNECOL, V175, P1467, DOI 10.1016/S0002-9378(96)70091-1; Handa VL, 2004, AM J OBSTET GYNECOL, V191, P751, DOI 10.1016/j.ajog.2003.11.017; Handa VL, 2004, AM J OBSTET GYNECOL, V190, P27, DOI 10.1016/j.ajog.2003.07.017; Handa VL, 2003, OBSTET GYNECOL, V102, P1283, DOI 10.1016/j.obstetgynecol.2003.08.022; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; HENRY MM, 1982, BRIT J SURG, V69, P470, DOI 10.1002/bjs.1800690813; Hilger WS, 2003, AM J OBSTET GYNECOL, V189, P1606, DOI 10.1016/j.ajog.2003.10.689; HO YH, 1995, INT J COLORECTAL DIS, V10, P107, DOI 10.1007/BF00341208; HUDSON CN, 1988, INT J COLORECTAL DIS, V3, P181, DOI 10.1007/BF01648364; IOSIF CS, 1993, ACTA OBSTET GYN SCAN, V72, P214; Jackson SR, 1996, LANCET, V347, P1658, DOI 10.1016/S0140-6736(96)91489-0; Jenkins V, 1997, AM J OBSTET GYNECOL, V177, P1337, DOI 10.1016/S0002-9378(97)70073-5; JORGENSEN S, 1994, OCCUP MED-OXFORD, V44, P47, DOI 10.1093/occmed/44.1.47; Julian TM, 1996, AM J OBSTET GYNECOL, V175, P1472, DOI 10.1016/S0002-9378(96)70092-3; Karram M, 2001, AM J OBSTET GYNECOL, V185, P1339, DOI 10.1067/mob.2001.119077; Kaufman HS, 2001, DIS COLON RECTUM, V44, P1575, DOI 10.1007/BF02234374; KEGEL AH, 1948, AM J OBSTET GYNECOL, V56, P238, DOI 10.1016/0002-9378(48)90266-X; Kelvin FM, 2003, RADIOL CLIN N AM, V41, P395, DOI 10.1016/S0033-8389(02)00118-5; Kohli N, 2003, INT UROGYNECOL J PEL, V14, P146, DOI 10.1007/s00192-002-1013-4; Lefranc JP, 2002, J AM COLL SURGEONS, V195, P352, DOI 10.1016/S1072-7515(02)01234-6; Luber KM, 2001, AM J OBSTET GYNECOL, V184, P1496, DOI 10.1067/mob.2001.114868; Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603; Maher CF, 2004, AM J OBSTET GYNECOL, V190, P20, DOI 10.1016/j.ajog.2003.08.031; Maher CF, 2001, OBSTET GYNECOL, V98, P40, DOI 10.1016/S0029-7844(01)01378-3; MAKINEN J, 1986, ARCH GYNECOL OBSTET, V239, P17, DOI 10.1007/BF02134283; Mathews RI, 2003, BJU INT, V91, P845, DOI 10.1046/j.1464-410X.2003.04244.x; MEEKS GR, 1994, AM J OBSTET GYNECOL, V171, P1444, DOI 10.1016/0002-9378(94)90386-7; MORLEY GW, 1988, AM J OBSTET GYNECOL, V158, P872, DOI 10.1016/0002-9378(88)90088-9; MURAM D, 1990, J REPROD MED, V35, P303; NICHOLS DH, 1982, AM J OBSTET GYNECOL, V142, P901, DOI 10.1016/S0002-9378(16)32539-X; Nichols DH, 1989, VAGINAL SURG; Nieminen K, 2003, ACTA OBSTET GYN SCAN, V82, P471, DOI 10.1080/j.1600-0412.2003.00137.x; NORTON PA, 1993, CLIN OBSTET GYNECOL, V36, P926, DOI 10.1097/00003081-199312000-00017; Nygaard IE, 2004, OBSTET GYNECOL, V104, P805, DOI 10.1097/01.AOG.0000139514.90897.07; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; OTT R, 1993, BRIT J SURG, V80, P1157; Pannu HK, 2003, INT UROGYNECOL J PEL, V14, P89, DOI 10.1007/s00192-003-1037-4; RICHARDSON AC, 1976, AM J OBSTET GYNECOL, V126, P568, DOI 10.1016/0002-9378(76)90751-1; RIDLEY JH, 1972, AM J OBSTET GYNECOL, V113, P1114, DOI 10.1016/0002-9378(72)90745-4; Samuelsson EC, 1999, AM J OBSTET GYNECOL, V180, P299, DOI 10.1016/S0002-9378(99)70203-6; SHULL BL, 1992, AM J OBSTET GYNECOL, V166, P1764, DOI 10.1016/0002-9378(92)91567-T; Shull BL, 2000, AM J OBSTET GYNECOL, V183, P1365, DOI 10.1067/mob.2000.110910; SHULL BL, 1993, AM J OBSTET GYNECOL, V168, P1669, DOI 10.1016/0002-9378(93)90676-A; SNOOKS SJ, 1986, INT J COLORECTAL DIS, V1, P20, DOI 10.1007/BF01648831; SNYDER TE, 1991, OBSTET GYNECOL, V77, P944; SPENCEJONES C, 1994, BRIT J OBSTET GYNAEC, V101, P147, DOI 10.1111/j.1471-0528.1994.tb13081.x; SULAK PJ, 1993, J REPROD MED, V38, P919; Swift SE, 2001, INT UROGYNECOL J, V12, P187, DOI 10.1007/s001920170062; Sze EHM, 2002, OBSTET GYNECOL, V100, P981, DOI 10.1016/S0029-7844(02)02246-9; TIMMONS MC, 1991, OBSTET GYNECOL, V78, P313; Visco AG, 2001, AM J OBSTET GYNECOL, V184, P297, DOI 10.1067/mob.2001.109654; von Pechmann WS, 2003, AM J OBSTET GYNECOL, V189, P121, DOI 10.1067/mob.2003.546; WEBER AM, 1995, OBSTET GYNECOL, V85, P483, DOI 10.1016/0029-7844(94)00434-F; Weber AM, 1998, AM J OBSTET GYNECOL, V179, P1446, DOI 10.1016/S0002-9378(98)70008-0; Wester C, 1998, OBSTET GYN CLIN N AM, V25, P707, DOI 10.1016/S0889-8545(05)70038-3	85	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2005	293	16					2018	2027		10.1001/jama.293.16.2018	http://dx.doi.org/10.1001/jama.293.16.2018			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XS	15855436				2022-12-28	WOS:000228651500028
J	Taatjes, CA; Hansen, N; McIlroy, A; Miller, JA; Senosiain, JP; Klippenstein, SJ; Qi, F; Sheng, LS; Zhang, YW; Cool, TA; Wang, J; Westmoreland, PR; Law, ME; Kasper, T; Kohse-Hoinghaus, K				Taatjes, CA; Hansen, N; McIlroy, A; Miller, JA; Senosiain, JP; Klippenstein, SJ; Qi, F; Sheng, LS; Zhang, YW; Cool, TA; Wang, J; Westmoreland, PR; Law, ME; Kasper, T; Kohse-Hoinghaus, K			Enols are common intermediates in hydrocarbon oxidation	SCIENCE			English	Article							OXIDE FUEL-CELL; VINYL ALCOHOL; COMBUSTION; ISOMERS; ETHANOL; FLAME; ACETALDEHYDE; EMISSIONS; KINETICS; SYSTEMS	Models for chemical mechanisms of hydrocarbon oxidation rely on spectrometric identification of molecular structures in flames. Carbonyl (keto) compounds are well-established combustion intermediates. However, their less-stable enol tautomers, bearing OH groups adjacent to carbon-carbon double bonds, are not included in standard models. We observed substantial quantities of two-, three-, and four-carbon enols by photoionization mass spectrometry of flames burning representative compounds from modern fuel blends. Concentration profiles demonstrate that enol flame chemistry cannot be accounted for purely by keto-enol tautomerization. Currently accepted hydrocarbon oxidation mechanisms will likely require revision to explain the formation and reactivity, of these unexpected compounds.	Sandia Natl Labs, Combust Res Facil, Livermore, CA 94551 USA; Univ Colorado, JILA, Natl Inst Stand & Technol, Boulder, CO 80309 USA; Univ Sci & Technol China, Natl Synchrotron Radiat Lab, Hefei 230026, Anhui, Peoples R China; Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA; Univ Bielefeld, D-33615 Bielefeld, Germany	United States Department of Energy (DOE); Sandia National Laboratories; National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Cornell University; University of Massachusetts System; University of Massachusetts Amherst; University of Bielefeld	Taatjes, CA (corresponding author), Sandia Natl Labs, Combust Res Facil, Mail Stop 9055, Livermore, CA 94551 USA.	cataatj@sandia.gov	Hansen, Nils/G-3572-2012; Qi, Fei/A-3722-2012; Klippenstein, Stephen/AAF-1741-2021; Kohse-Höinghaus, Katharina/A-3867-2012; Kasper, Tina/A-2975-2017	Qi, Fei/0000-0003-3638-714X; Kasper, Tina/0000-0003-3993-5316; Klippenstein, Stephen/0000-0001-6297-9187; Westmoreland, Phillip/0000-0002-8189-9809; Taatjes, Craig/0000-0002-9271-0282; Senosiain, Juan Pablo/0000-0003-1578-5886				BLANK B, 1973, HELV CHIM ACTA, V56, P506, DOI 10.1002/hlca.19730560147; BOUMA WJ, 1977, J AM CHEM SOC, V99, P6443, DOI 10.1021/ja00461a047; Cool TA, 2005, P COMBUST INST, V30, P1681, DOI 10.1016/j.proci.2004.08.103; Cool TA, 2003, J CHEM PHYS, V119, P8356, DOI 10.1063/1.1611173; ERLENMEYER E, 1880, CHEM BER, V13, P305; Hartlieb AT, 2000, COMBUST FLAME, V121, P610, DOI 10.1016/S0010-2180(99)00176-5; He BQ, 2003, ATMOS ENVIRON, V37, P4965, DOI 10.1016/j.atmosenv.2003.08.029; Hibino T, 2000, SCIENCE, V288, P2031, DOI 10.1126/science.288.5473.2031; Hippler H, 2000, PHYS CHEM CHEM PHYS, V2, P3591, DOI 10.1039/b003646n; Kaiser RI, 2001, ASTROPHYS J, V548, P852, DOI 10.1086/319009; Linstrom PJ., 2003, NIST CHEM WEBB; Miller JA, 2005, P COMBUST INST, V30, P43, DOI 10.1016/j.proci.2004.08.281; Naidja A, 2003, PROG ENERG COMBUST, V29, P155, DOI 10.1016/S0360-1285(03)00018-2; Park SD, 2000, NATURE, V404, P265, DOI 10.1038/35005040; Poulopoulos SG, 2001, ATMOS ENVIRON, V35, P4399, DOI 10.1016/S1352-2310(01)00248-5; RANZI E, 1994, COMBUST FLAME, V99, P201, DOI 10.1016/0010-2180(94)90123-6; Ricca A, 2001, ICARUS, V154, P516, DOI 10.1006/icar.2001.6694; RUSCIC B, 1994, J CHEM PHYS, V101, P10936, DOI 10.1063/1.467843; SAITO S, 1976, CHEM PHYS LETT, V42, P399, DOI 10.1016/0009-2614(76)80638-0; SENOSIAIN JP, IN PRESS J PHYS CH A; SMITH BJ, 1991, J AM CHEM SOC, V113, P6452, DOI 10.1021/ja00017a015; Sullivan PA, 2004, PHYS CHEM CHEM PHYS, V6, P4310, DOI 10.1039/b402743d; Taatjes CA, 2005, PHYS CHEM CHEM PHYS, V7, P806, DOI 10.1039/b417160h; Werner JH, 2000, COMBUST FLAME, V120, P125, DOI 10.1016/S0010-2180(99)00087-5; Westbrook CK, 2000, P COMBUST INST, V28, P1563, DOI 10.1016/S0082-0784(00)80554-8; Yamada T, 1999, J PHYS CHEM A, V103, P7646, DOI 10.1021/jp990193g; Zhu L, 2000, J PHYS CHEM A, V104, P9197, DOI 10.1021/jp001531c	27	277	294	11	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1887	1889		10.1126/science.1112532	http://dx.doi.org/10.1126/science.1112532			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15890844				2022-12-28	WOS:000230120000033
J	Gros, J; Manceau, M; Thome, V; Marcelle, C				Gros, J; Manceau, M; Thome, V; Marcelle, C			A common somitic origin for embryonic muscle progenitors and satellite cells	NATURE			English	Article							MYOGENIC PROGENITORS; SKELETAL-MUSCLE; CHICK; REGENERATION; MYOTOME	In the embryo and in the adult, skeletal muscle growth is dependent on the proliferation and the differentiation of muscle progenitors present within muscle masses. Despite the importance of these progenitors, their embryonic origin is unclear(1,2). Here we use electroporation of green fluorescent protein in chick somites(3), video confocal microscopy analysis of cell movements, and quail-chick grafting experiments to show that the dorsal compartment of the somite, the dermomyotome, is the origin of a population of muscle progenitors that contribute to the growth of trunk muscles during embryonic and fetal life. Furthermore, long-term lineage analyses indicate that satellite cells, which are known progenitors of adult skeletal muscles(4), derive from the same dermomyotome cell population. We conclude that embryonic muscle progenitors and satellite cells share a common origin that can be traced back to the dermomyotome.	Univ Mediterranee, CNRS,UMR 6545, Dev Biol Inst Marseille, Lab Genet & Physiol Dev, F-13288 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Marcelle, C (corresponding author), Univ Mediterranee, CNRS,UMR 6545, Dev Biol Inst Marseille, Lab Genet & Physiol Dev, Campus Luminy,Case 907, F-13288 Marseille, France.	marcelle@ibdm.univ-mrs.fr		Gros, Jerome/0000-0002-2264-2851				ARMAND O, 1983, ARCH ANAT MICROSC MO, V72, P163; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; FELDMAN JL, 1992, DEV BIOL, V153, P217, DOI 10.1016/0012-1606(92)90107-R; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gros J, 2004, DEV CELL, V6, P875, DOI 10.1016/j.devcel.2004.05.006; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HARTLEY RS, 1992, DEV BIOL, V153, P206, DOI 10.1016/0012-1606(92)90106-Q; HAUSCHKA SD, 1994, MYOLOGY, P3; Huang RJ, 2000, ANAT EMBRYOL, V202, P369, DOI 10.1007/s004290000130; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Olivera-Martinez I, 2000, DEVELOPMENT, V127, P4611; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Scaal M, 2004, ANAT EMBRYOL, V208, P411, DOI 10.1007/s00429-004-0417-y; Scaal M, 2004, DEV DYNAM, V229, P643, DOI 10.1002/dvdy.10433; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; TOSNEY KW, 1994, DEV BIOL, V163, P389, DOI 10.1006/dbio.1994.1157	20	417	458	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					954	958		10.1038/nature03572	http://dx.doi.org/10.1038/nature03572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15843802				2022-12-28	WOS:000229799700049
J	Greenhalgh, T				Greenhalgh, T			Commentary: Barriers to concordance with antidiabetic drugs-cultural differences or human nature?	BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICINES		UCL, London N19 5LW, England	University of London; University College London	Greenhalgh, T (corresponding author), UCL, London N19 5LW, England.	p.greenhalgh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				Britten N, 2004, SOC SCI MED, V59, P1495, DOI 10.1016/j.socscimed.2004.01.019; Lawton J, 2005, BMJ-BRIT MED J, V330, P1247, DOI 10.1136/bmj.38460.642789.E0; Sihota  Saranjit, 2004, HLTH LIT BEING ABL M; Stevenson FA, 2004, HEALTH EXPECT, V7, P235, DOI 10.1111/j.1369-7625.2004.00281.x; tain RPS of G, 1997, COMPLIANCE CONCORDAN	5	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 28	2005	330	7502					1250	1250		10.1136/bmj.38464.595741.AE	http://dx.doi.org/10.1136/bmj.38464.595741.AE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930WX	15883138	Green Published, Bronze			2022-12-28	WOS:000229448900020
J	Ware, DM; Thomson, RE				Ware, DM; Thomson, RE			Bottom-up ecosystem trophic dynamics determine fish production in the northeast Pacific	SCIENCE			English	Article							WEST-COAST; WATERS	We addressed the question of bottom-up versus top-down control of marine ecosystem trophic interactions by using annual fish catch data and satellite-derived (SeaWiFS) chlorophyll a measurements for the continental margin of western North America. Findings reveal a marked alongshore variation in retained primary production that is highly correlated with the alongshore variation in resident fish yield. The highest productivity occurs off, the coasts of Washington and southern British Columbia. Zooplankton data for coastal British Columbia confirm strong bottom-up trophic linkages between phytoplankton, zooplankton, and resident fish, extending to regional areas as small as 10,000 square kilometers.	Fisheries Oceans Canada Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; Aquat Ecosyst Associates, Nanaimo, BC V9T 1M2, Canada; Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada; Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada	Fisheries & Oceans Canada; University of British Columbia; Simon Fraser University; University of Victoria	Thomson, RE (corresponding author), Fisheries Oceans Canada Inst Ocean Sci, 9860 W Saanich Rd, Sidney, BC V8L 4B2, Canada.	thomsonr@pac.dfo-mpo.gc.ca						DORMAN CE, 1995, J GEOPHYS RES-OCEANS, V100, P16029, DOI 10.1029/95JC00964; Gregg WW, 2004, REMOTE SENS ENVIRON, V93, P463, DOI 10.1016/j.rse.2003.12.012; *I OC SCI, UNPUB; IVERSON RL, 1990, LIMNOL OCEANOGR, V35, P1593, DOI 10.4319/lo.1990.35.7.1593; Logerwell EA, 2003, FISH OCEANOGR, V12, P554, DOI 10.1046/j.1365-2419.2003.00238.x; LYNDE MVH, 1986, NMFSNWC103 NOAA; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Perry M. J., 1989, COASTAL OCEANOGRAPHY, P117, DOI DOI 10.1016/S0422-9894(08)70347-7; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; ROYER TC, 1982, J GEOPHYS RES-OCEANS, V87, P2017, DOI 10.1029/JC087iC03p02017; Ruddick KG, 2000, APPL OPTICS, V39, P897, DOI 10.1364/AO.39.000897; Scheffer M, 2000, CAN J FISH AQUAT SCI, V57, P1208, DOI 10.1139/cjfas-57-6-1208; Stabeno PJ, 2004, CONT SHELF RES, V24, P859, DOI 10.1016/j.csr.2004.02.007; STRUB PT, 1991, J GEOPHYS RES-OCEANS, V96, P14743, DOI 10.1029/91JC01024; TANASICHUK RW, 1991, CAN J FISH AQUAT SCI, V48, P2118, DOI 10.1139/f91-251; TASSAN S, 1994, APPL OPTICS, V33, P2369, DOI 10.1364/AO.33.002369; Ware D.M., 1989, CAN SPEC PUBL FISH A, V108, P359	17	509	535	8	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1280	1284		10.1126/science.1109049	http://dx.doi.org/10.1126/science.1109049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15845876				2022-12-28	WOS:000229482300038
J	Ciliberto, H; Ciliberto, M; Briend, A; Ashorn, P; Bier, D; Manary, M				Ciliberto, H; Ciliberto, M; Briend, A; Ashorn, P; Bier, D; Manary, M			Antioxidant supplementation for the prevention of kwashiorkor in Malawian children: randomised, double blind, placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TO-USE FOOD; SEVERE MALNUTRITION; EDEMA; PATHOGENESIS; GLUTATHIONE	Objective To evaluate the efficacy of antioxidant supplementation in preventing kwashiorkor in a population of Malawian children at high risk of developing kwashiorkor. Design Prospective, double blind, placebo controlled trial randomised by household. Setting 8 villages in rural southern Malawi. Participants 2372 children in 2156 households aged 1-4 years were enrolled; 2332 completed the trial. Intervention Daily supplementation with an antioxidant powder containing riboflavin, vitamin E, selenium, and N-acetylcysteine in a dose that provided about three times the recommended dietary allowance of each nutrient or placebo for 20 weeks. Main outcome measures The primary outcome was the incidence of oedema. Secondary outcomes were the rates of change for weight and length and the number of days of infectious symptoms. Results 62 children developed kwashiorkor (defined by the presence of oedema); 39/1184 (3.3%) were in the antioxidant group and 23/1188 (1.9%) were in the placebo group (relative risk 1.70, 95% confidence interval 0.98 to 2.42). The two groups did not differ in rates of weight or height gain. Children who received antioxidant supplementation did not experience less fever, cough, or diarrhoea. Conclusions Antioxidant supplementation at the dose provided did not prevent the onset of kwashiorkor. This finding does not support the hypothesis that depletion of vitamin E, selenium, cysteine, or riboflavin has a role in the development of kwashiorkor.	Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA; Washington Univ, St Louis Childrens Hosp, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Inst Rech Dev, F-75010 Paris, France; Tampere Univ Hosp, Paediat Res Ctr, FIN-33521 Tampere, Finland	Baylor College of Medicine; St. Louis Children's Hospital; Washington University (WUSTL); Institut de Recherche pour le Developpement (IRD); Tampere University; Tampere University Hospital	Manary, M (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA.	manary@kids.wustl.edu		Ashorn, Per/0000-0003-2311-2593; Manary, Mark/0000-0003-2733-9568				[Anonymous], 1970, LANCET, V2, P302; Badaloo A, 2002, AM J CLIN NUTR, V76, P646, DOI 10.1093/ajcn/76.3.646; BECKER K, 1994, INT J VITAM NUTR RES, V64, P306; Bendich A, 2001, DIETARY REFERENCE IN, DOI [10.1016/s0899-9007(00)00596-7, DOI 10.1016/S0899-9007(00)00596-7]; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; COURTRIGHT P, 1995, ANN TROP PAEDIATR, V15, P221, DOI 10.1080/02724936.1995.11747776; GOLDEN MHN, 1987, P NUTR SOC, V46, P53, DOI 10.1079/PNS19870008; GOLDEN MHN, 1980, LANCET, V1, P114, DOI 10.1016/S0140-6736(80)90603-0; GOLDEN MHN, 1982, LANCET, V1, P1261; Gopalan C., 1968, CALORIE DEFICIENCIES; Institute of Medicine, 1998, DIET REF INT THIAM R; JACKSON AA, 1986, T ROY SOC TROP MED H, V80, P911, DOI 10.1016/0035-9203(86)90256-7; JONES HI, 1967, MED J AUSTRALIA, V1, P202; Klar N, 2001, STAT MED, V20, P3729, DOI 10.1002/sim.1115; Lenbartz H, 1998, J PEDIATR-US, V132, P879, DOI 10.1016/S0022-3476(98)70324-5; LIPSITZ SR, 1994, STAT MED, V13, P1149, DOI 10.1002/sim.4780131106; Maleta T, 2004, J PEDIATR GASTR NUTR, V38, P152; Manary MJ, 2000, J PEDIATR-US, V137, P421, DOI 10.1067/mpd.2000.107512; Manary MJ, 2004, ARCH DIS CHILD, V89, P557, DOI 10.1136/adc.2003.034306; *MED COUNC MAL, 1992, STAND TREATM COMM IL; Phadke M A, 1995, Indian Pediatr, V32, P301; SIVE AA, 1993, ANN TROP PAEDIATR, V13, P33, DOI 10.1080/02724936.1993.11747622; WATERLOW JC, 1984, T ROY SOC TROP MED H, V78, P436, DOI 10.1016/0035-9203(84)90053-1; WILLIAMS Cicely D., 1935, Lancet, P1151	24	51	51	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2005	330	7500					1109	1111		10.1136/bmj.38427.404259.8F	http://dx.doi.org/10.1136/bmj.38427.404259.8F			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15851401	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000229166900015
J	Chyba, CF				Chyba, CF			Atmospheric science - Rethinking Earth's early atmosphere	SCIENCE			English	Editorial Material							PRIMITIVE EARTH; LIFE		SETI Inst, Mountain View, CA 94043 USA; Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA	Stanford University	Chyba, CF (corresponding author), SETI Inst, Mountain View, CA 94043 USA.	chyba@seti.org						ABELSON PH, 1966, P NATL ACAD SCI USA, V55, P1365, DOI 10.1073/pnas.55.6.1365; Bronowski Jacob, 1973, ASCENT MAN, P374; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; Holland H.D., 1962, PETROLOGIC STUDIES V, P447; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; MILLER SL, 1957, ANN NY ACAD SCI, V69, P260, DOI 10.1111/j.1749-6632.1957.tb49662.x; Monnard PA, 2002, ASTROBIOLOGY, V2, P139, DOI 10.1089/15311070260192237; Moorbath S, 2005, NATURE, V434, P155, DOI 10.1038/434155a; Sagan C, 1997, SCIENCE, V276, P1217, DOI 10.1126/science.276.5316.1217; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; Tian F, 2005, SCIENCE, V308, P1014, DOI 10.1126/science.1106983; WACHTERSHAUSER G, 1988, MICROBIOL REV, V52, P452; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71	13	22	22	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					962	963		10.1126/science.1113157	http://dx.doi.org/10.1126/science.1113157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890865				2022-12-28	WOS:000229190700025
J	Nakayama, M; Abiru, N; Moriyama, H; Babaya, N; Liu, E; Miao, DM; Yu, LP; Wegmann, DR; Hutton, JC; Elliott, JF; Eisenbarth, GS				Nakayama, M; Abiru, N; Moriyama, H; Babaya, N; Liu, E; Miao, DM; Yu, LP; Wegmann, DR; Hutton, JC; Elliott, JF; Eisenbarth, GS			Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice	NATURE			English	Article							T-CELL-CLONES; MOUSE; TOLERANCE; MELLITUS; PEPTIDE; SUSCEPTIBILITY; DECARBOXYLASE; POPULATION; EXPRESSION; PREVENT	A fundamental question about the pathogenesis of spontaneous autoimmune diabetes is whether there are primary autoantigens. For type 1 diabetes it is clear that multiple islet molecules are the target of autoimmunity in man and animal models(1,2). It is not clear whether any of the target molecules are essential for the destruction of islet beta cells. Here we show that the proinsulin/ insulin molecules have a sequence that is a primary target of the autoimmunity that causes diabetes of the non-obese diabetic ( NOD) mouse. We created insulin 1 and insulin 2 gene knockouts combined with a mutated proinsulin transgene ( in which residue 16 on the B chain was changed to alanine) in NOD mice. This mutation abrogated the T-cell stimulation of a series of the major insulin autoreactive NOD T-cell clones(3). Female mice with only the altered insulin did not develop insulin autoantibodies, insulitis or autoimmune diabetes, in contrast with mice containing at least one copy of the native insulin gene. We suggest that proinsulin is a primary autoantigen of the NOD mouse, and speculate that organ-restricted autoimmune disorders with marked major histocompatibility complex (MHC) restriction of disease are likely to have specific primary autoantigens.	Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA; Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528501, Japan; Kobe Univ, Grad Sch Med, Kobe, Hyogo 6500017, Japan; Univ Alberta, Edmonton, AB T6G 2S2, Canada	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Nagasaki University; Kobe University; University of Alberta	Eisenbarth, GS (corresponding author), Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA.	george.eisenbarth@uchsc.edu		Babaya, Naru/0000-0003-2466-1228	NIAID NIH HHS [R01 AI039213, U19 AI050864] Funding Source: Medline; NIDDK NIH HHS [R01 DK055969, R01 DK032083, R01 DK062718] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039213, U19AI050864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032083, R01DK062718, R01DK055969] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abiru N, 2000, J AUTOIMMUN, V14, P231, DOI 10.1006/jaut.2000.0369; Birk OS, 1996, P NATL ACAD SCI USA, V93, P1032, DOI 10.1073/pnas.93.3.1032; Bluestone JA, 2004, P NATL ACAD SCI USA, V101, P14622, DOI 10.1073/pnas.0405234101; Chatenoud L, 1997, J IMMUNOL, V158, P2947; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; DiLorenzo TP, 2002, CLIN IMMUNOL, V105, P332, DOI 10.1006/clim.2002.5298; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Ellerman KE, 2000, DIABETOLOGIA, V43, P890, DOI 10.1007/s001250051466; French MB, 1997, DIABETES, V46, P34, DOI 10.2337/diabetes.46.1.34; Jaeckel E, 2004, NAT IMMUNOL, V5, P1028, DOI 10.1038/ni1120; Jaeckel E, 2003, J EXP MED, V197, P1635, DOI 10.1084/jem.20030215; Kash SF, 1999, HORM METAB RES, V31, P340, DOI 10.1055/s-2007-978750; Kubosaki A, 2004, DIABETES, V53, P1684, DOI 10.2337/diabetes.53.7.1684; Kubosaki A, 2004, DIABETOLOGIA, V47, P149, DOI 10.1007/s00125-003-1252-z; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Moriyama H, 2003, P NATL ACAD SCI USA, V100, P10376, DOI 10.1073/pnas.1834450100; Mukherjee R, 2003, J AUTOIMMUN, V21, P221, DOI 10.1016/S0896-8411(03)00114-8; Nakayama M, 2004, ANN NY ACAD SCI, V1037, P193, DOI 10.1196/annals.1337.031; Peterson JD, 1996, DIABETES, V45, P328, DOI 10.2337/diabetes.45.3.328; Simone E, 1997, P NATL ACAD SCI USA, V94, P2518, DOI 10.1073/pnas.94.6.2518; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Thebault-Baumont K, 2003, J CLIN INVEST, V111, P851, DOI 10.1172/JCI200316584; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; Wong FS, 2002, P NATL ACAD SCI USA, V99, P5551, DOI 10.1073/pnas.072037299; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697	28	541	572	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					220	223		10.1038/nature03523	http://dx.doi.org/10.1038/nature03523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889095	Green Accepted			2022-12-28	WOS:000229021100044
J	Vestrand, WT; Wozniak, PR; Wren, JA; Fenimore, EE; Sakamoto, T; White, RR; Casperson, D; Davis, H; Evans, S; Galassi, M; McGowan, KE; Schier, JA; Asa, JW; Barthelmy, SD; Cummings, JR; Gehrels, N; Hullinger, D; Krimm, HA; Markwardt, CB; McLean, K; Palmer, D; Parsons, A; Tueller, J				Vestrand, WT; Wozniak, PR; Wren, JA; Fenimore, EE; Sakamoto, T; White, RR; Casperson, D; Davis, H; Evans, S; Galassi, M; McGowan, KE; Schier, JA; Asa, JW; Barthelmy, SD; Cummings, JR; Gehrels, N; Hullinger, D; Krimm, HA; Markwardt, CB; McLean, K; Palmer, D; Parsons, A; Tueller, J			A link between prompt optical and prompt gamma-ray emission in gamma-ray bursts	NATURE			English	Article							EARLY AFTERGLOW; DISCOVERY; RADIATION; RAPTOR; SKY	The prompt optical emission that arrives with the gamma-rays from a cosmic gamma-ray burst (GRB) is a signature of the engine powering the burst, the properties of the ultra-relativistic ejecta of the explosion, and the ejecta's interactions with the surroundings(1-5). Until now, only GRB 990123 had been detected(6) at optical wavelengths during the burst phase. Its prompt optical emission was variable and uncorrelated with the prompt gamma-ray emission, suggesting that the optical emission was generated by a reverse shock arising from the ejecta's collision with surrounding material. Here we report prompt optical emission from GRB 041219a. It is variable and correlated with the prompt gamma-rays, indicating a common origin for the optical light and the gamma-rays. Within the context of the standard fireball model of GRBs, we attribute this new optical component to internal shocks driven into the burst ejecta by variations of the inner engine. The correlated optical emission is a direct probe of the jet isolated from the medium. The timing of the uncorrelated optical emission is strongly dependent on the nature of the medium.	Los Alamos Natl Lab, Space Sci & Applicat Grp, Los Alamos, NM 87545 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Pilot Grp, Unit C, Monrovia, CA 91016 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Vestrand, WT (corresponding author), Los Alamos Natl Lab, Space Sci & Applicat Grp, ISR-1,MS-D466, Los Alamos, NM 87545 USA.	vestrand@lanl.gov	Parsons, Ann/I-6604-2012; Tueller, Jack/D-5334-2012; Gehrels, Neil/D-2971-2012; Barthelmy, Scott D/D-2943-2012; Evans, Stuart/ABG-6915-2021	Evans, Stuart/0000-0002-1873-0752				Akerlof C, 1999, NATURE, V398, P400, DOI 10.1038/18837; BARTHELMY S, 2004, 2874 GRB; BLAKE C, 2004, 2870 GRB; Blake CH, 2005, NATURE, V435, P181, DOI 10.1038/nature03520; CENKO SB, 2004, 2886 GRB; FENIMORE E, 2004, 2906 GRB; Fox DW, 2003, ASTROPHYS J, V586, pL5, DOI 10.1086/374683; GOTZ D, 2004, 2866 GRB; HEARTY F, 2004, 2916 GRB; HENDEN A, 2004, 2871 GRB; Hjorth J, 2003, NATURE, V423, P847, DOI 10.1038/nature01750; KATZ JI, 1994, ASTROPHYS J, V432, pL107, DOI 10.1086/187523; Kulkarni S., 1999, APJ, V522, P97; Li WD, 2003, ASTROPHYS J, V586, pL9, DOI 10.1086/374684; Liang EP, 1999, ASTROPHYS J, V519, pL21, DOI 10.1086/312100; Meszaros P, 1997, ASTROPHYS J, V476, P232, DOI 10.1086/303625; Meszaros P, 1999, MON NOT R ASTRON SOC, V306, pL39, DOI 10.1046/j.1365-8711.1999.02800.x; Nakar E, 2004, MON NOT R ASTRON SOC, V353, P647, DOI 10.1111/j.1365-2966.2004.08099.x; Paciesas WS, 1999, ASTROPHYS J SUPPL S, V122, P465, DOI 10.1086/313224; Panaitescu A, 2004, MON NOT R ASTRON SOC, V353, P511, DOI 10.1111/j.1365-2966.2004.08083.x; Sari R, 1999, ASTROPHYS J, V520, P641, DOI 10.1086/307508; Sari R, 1998, ASTROPHYS J, V497, pL17, DOI 10.1086/311269; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Stanek KZ, 2003, ASTROPHYS J, V591, pL17, DOI 10.1086/376976; van Paradijs J, 2000, ANNU REV ASTRON ASTR, V38, P379, DOI 10.1146/annurev.astro.38.1.379; Vestrand WT, 2004, ASTRON NACHR, V325, P549, DOI 10.1002/asna.200410277; Vestrand WT, 2002, PROC SPIE, V4845, P126, DOI 10.1117/12.459515; Waxman E, 1997, ASTROPHYS J, V485, pL5, DOI 10.1086/310809; Zhang B, 2003, ASTROPHYS J, V595, P950, DOI 10.1086/377363	30	171	173	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					178	180		10.1038/nature03515	http://dx.doi.org/10.1038/nature03515			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889084				2022-12-28	WOS:000229021100032
J	Chan, O; Hughes, T				Chan, O; Hughes, T			ABC of emergency radiology - Hand	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Royal London Hosp, London E1 1BB, England; Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA	Barts Health NHS Trust; Royal London Hospital; University of California System; University of California San Diego	Chan, O (corresponding author), Royal London Hosp, London E1 1BB, England.	zaideotto@blueyonder.co.uk		Hughes, Tudor/0000-0001-9385-6956					0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2005	330	7499					1073	1075		10.1136/bmj.330.7499.1073	http://dx.doi.org/10.1136/bmj.330.7499.1073			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925YY	15879399	Green Published			2022-12-28	WOS:000229090900028
J	Genin, A; Jaffe, JS; Reef, R; Richter, C; Franks, PJS				Genin, A; Jaffe, JS; Reef, R; Richter, C; Franks, PJS			Swimming against the flow: A mechanism of zooplankton aggregation	SCIENCE			English	Article							NEAR-BOTTOM DEPLETION; HYDROSTATIC-PRESSURE; VANCOUVER-ISLAND; GEORGES BANK; CORAL-REEFS; PLANKTON; SHELF; SEA; INVERTEBRATES; CIRCULATION	Zooplankton reside in a constantly flowing environment. However, information about their response to ambient flow has remained elusive, because of the difficulties of following the individual motions of these minute, nearly transparent animals in the ocean. Using a three-dimensional acoustic imaging system, we tracked >375,000 zooplankters at two coastal sites in the Red Sea. Resolution of their motion from that of the water showed that the animals effectively maintained their depth by swimming against upwelling and downwelling currents moving at rates of up to tens of body lengths per second, causing their accumulation at frontal zones. This mechanism explains how oceanic fronts become major feeding grounds for predators and targets for fishermen.	Interuniv Inst Marine Sci, Elat, Israel; Hebrew Univ Jerusalem, Elat, Israel; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Ctr Trop Marine Ecol, Bremen, Germany	Hebrew University of Jerusalem; University of California System; University of California San Diego; Scripps Institution of Oceanography; Leibniz Zentrum fur Marine Tropenforschung (ZMT)	Genin, A (corresponding author), Interuniv Inst Marine Sci, Elat, Israel.	amatzia@vms.huji.ac.il	Richter, Claudio/AAT-1212-2020	Richter, Claudio/0000-0002-8182-6896; Reef, Ruth/0000-0001-6639-520X				Bottger R., 1987, Biological Oceanography, V4, P383; BULLOCK TH, 1997, MAR FRESHW BEHAV PHY, V28, P1; Cowles T.J., 1998, OCEANOGRAPHY, V11, P4, DOI [DOI 10.5670/OCEANOG.1998.08, DOI 10.5670/0CEAN0G.1998.08]; Dandonneau Y, 2003, SCIENCE, V302, P1548, DOI 10.1126/science.1090729; ENRIGHT JT, 1962, COMP BIOCHEM PHYSIOL, V7, P131, DOI 10.1016/0010-406X(62)90035-X; Epstein AW, 2001, DEEP-SEA RES PT II, V48, P395, DOI 10.1016/S0967-0645(00)00086-2; Etnoyer Peter, 2004, Oceanography, V17, P90; FORWARD RB, 1988, OCEANOGR MAR BIOL, V26, P361; FORWARD RB, 1989, MAR ECOL PROG SER, V57, P267, DOI 10.3354/meps057267; FRANKS PJS, 1992, MAR ECOL PROG SER, V82, P1, DOI 10.3354/meps082001; Gallager SM, 2004, MAR ECOL PROG SER, V267, P27, DOI 10.3354/meps267027; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Genin Amatzia, 2002, Oceanography, V15, P90; HARDY AC, 1954, J MAR BIOL ASSOC UK, V33, P409, DOI 10.1017/S0025315400008456; HARDY AC, 1936, DISCOVERY REP, V11, P513; HEALEY MC, 1990, CAN J FISH AQUAT SCI, V47, P1846, DOI 10.1139/f90-210; JAFFE JS, 1995, DEEP-SEA RES PT I, V42, P1495, DOI 10.1016/0967-0637(95)00030-A; LASKER R, 1970, MAR BIOL, V5, P345; Lavoie D, 2000, CAN J FISH AQUAT SCI, V57, P1853, DOI 10.1139/cjfas-57-9-1853; LINCOLN RJ, 1971, J EXP BIOL, V54, P677; Macdonald AG, 1999, COMP BIOCHEM PHYS A, V122, P13, DOI 10.1016/S1095-6433(98)10173-3; MACDONALD AG, 1972, J MAR BIOL ASSOC UK, V52, P213, DOI 10.1017/S002531540001866X; Mackas DL, 1997, CAN J FISH AQUAT SCI, V54, P2080, DOI 10.1139/f97-113; Mauchline J., 1998, ADV MARINE BIOL, V33; Mohammadian MA, 1997, MAR ECOL PROG SER, V150, P113, DOI 10.3354/meps150113; Motro R, 2005, CORAL REEFS, V24, P95, DOI 10.1007/s00338-004-0451-5; Niemann H, 2004, MAR ECOL PROG SER, V269, P91, DOI 10.3354/meps269091; Olson D., 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; Pershing AJ, 2001, DEEP-SEA RES PT II, V48, P283, DOI 10.1016/S0967-0645(00)00122-3; Shanks AL, 2000, LIMNOL OCEANOGR, V45, P230, DOI 10.4319/lo.2000.45.1.0230; SIMARD Y, 1986, MAR ECOL PROG SER, V32, P203, DOI 10.3354/meps032203; WISHNER KF, 1995, CONT SHELF RES, V15, P475, DOI 10.1016/0278-4343(94)00057-T; Yahel R, 2005, CORAL REEFS, V24, P75, DOI 10.1007/s00338-004-0449-z; YODER JA, 1994, NATURE, V371, P689, DOI 10.1038/371689a0	34	182	185	0	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					860	862		10.1126/science.1107834	http://dx.doi.org/10.1126/science.1107834			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879218				2022-12-28	WOS:000228986500050
J	Wielicki, BA; Wong, TM; Loeb, N; Minnis, P; Priestley, K; Kandel, R				Wielicki, BA; Wong, TM; Loeb, N; Minnis, P; Priestley, K; Kandel, R			Changes in Earth's albedo measured by satellite	SCIENCE			English	Article							CLIMATE; RADIATION; CLOUDS; CERES		NASA, Langley Res Ctr, Hampton, VA 23681 USA; Hampton Univ, Dept Atmospher Sci, Hampton, VA 23668 USA; CNRS, Meteorol Dynam Lab, Palisades, NY USA	National Aeronautics & Space Administration (NASA); NASA Langley Research Center; Hampton University	Wielicki, BA (corresponding author), NASA, Langley Res Ctr, 21 Langley Blvd, Hampton, VA 23681 USA.	b.a.wielicki@nasa.gov	Keyes, Dennis/AAZ-9285-2021; Wong, Takmeng/AHD-3210-2022; Wielicki, Bruce/AAX-3676-2020; Loeb, Norman/ABC-7817-2021; Minnis, Patrick/G-1902-2010	Minnis, Patrick/0000-0002-4733-6148				Hansen J, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001143; MINNIS P, 1993, SCIENCE, V259, P1411, DOI 10.1126/science.259.5100.1411; Palle E, 2004, SCIENCE, V304, P1299, DOI 10.1126/science.1094070; Priestley KJ, 2003, P SOC PHOTO-OPT INS, V5151, P282, DOI 10.1117/12.507520; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; WIELICKI BA, 1995, B AM METEOROL SOC, V76, P2125, DOI 10.1175/1520-0477(1995)076<2125:MTPERO>2.0.CO;2; Willis JK, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002260	7	113	121	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					825	825		10.1126/science.1106484	http://dx.doi.org/10.1126/science.1106484			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879211				2022-12-28	WOS:000228986500040
J	Johnson, TV; Lunine, JI				Johnson, TV; Lunine, JI			Saturn's moon Phoebe as a captured body from the outer Solar System	NATURE			English	Article							SATELLITES; NEBULA; ABUNDANCES; ELEMENTS	The orbital properties of Phoebe, one of Saturn's irregular moons, suggest that it was captured by the ringed planet's gravitational field rather than formed in situ. Phoebe's generally dark surface shows evidence of water ice(1), but otherwise the surface most closely resembles that of C-type asteroids(2) and small outer Solar System bodies such as Chiron and Pholus that are thought to have originated in the Kuiper belt(3). A close fly-by of Phoebe by the Cassini-Huygens spacecraft on 11 June 2004 ( 19 days before the spacecraft entered orbit around Saturn) provided an opportunity to test the hypothesis that this moon did not form in situ during Saturn's formation, but is instead a product of the larger protoplanetary disk or 'solar nebula'. Here we derive the rock-to-ice ratio of Phoebe using its density(4,5) combined with newly measured oxygen and carbon abundances in the solar photosphere(6,7). Phoebe's composition is close to that derived for other solar nebula bodies such as Triton and Pluto, but is very different from that of the regular satellites of Saturn, supporting Phoebe's origin as a captured body from the outer Solar System.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Lunine, JI (corresponding author), Univ Arizona, Lunar & Planetary Lab, 1629 E Univ Blvd, Tucson, AZ 85721 USA.	jlunine@lpl.arizona.edu		Lunine, Jonathan/0000-0003-2279-4131				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Asplund M, 2004, ASTRON ASTROPHYS, V417, P751, DOI 10.1051/0004-6361:20034328; Brown ME, 2000, ASTRON J, V119, P977, DOI 10.1086/301202; Cruikshank DP, 1998, ICARUS, V135, P389, DOI 10.1006/icar.1998.5997; ELUSZKIEWICZ J, 1990, ICARUS, V84, P215, DOI 10.1016/0019-1035(90)90167-8; Jacobson RA, 2004, ASTRON J, V128, P492, DOI 10.1086/421738; JACOBSON RA, 2004, P AM ASTRON SOC DPS, V36; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; MCKINNON WB, 1996, NEPTUNE TRITON, P807; Merline WJ, 1999, NATURE, V401, P565, DOI 10.1038/44089; Mosqueira I, 2003, ICARUS, V163, P232, DOI 10.1016/S0019-1035(03)00077-0; OWEN TC, 1993, SCIENCE, V261, P745, DOI 10.1126/science.261.5122.745; PORCO C, IN PRESS SCIENCE; Prieto CA, 2002, ASTROPHYS J, V573, pL137, DOI 10.1086/342095; Prinn R.G.P., 1989, ORIGIN EVOLUTION PLA, P78; PRINN RG, 1993, PROTOSTARS PLANETS, V3, P1005; RANSFORD GA, 1981, NATURE, V289, P21, DOI 10.1038/289021a0; Simonelli DP, 1999, ICARUS, V138, P249, DOI 10.1006/icar.1999.6077; SIMONELLI DP, 1989, ICARUS, V82, P1, DOI 10.1016/0019-1035(89)90020-1; Stern S. A., 1997, PLUTO CHARON, P605; [No title captured]	22	85	85	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					69	71		10.1038/nature03384	http://dx.doi.org/10.1038/nature03384			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875015				2022-12-28	WOS:000228864600037
J	Normand, SLT; Sykora, K; Li, P; Mamdani, M; Rochon, PA; Anderson, GM				Normand, SLT; Sykora, K; Li, P; Mamdani, M; Rochon, PA; Anderson, GM			Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FRACTURES		Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada; Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto	Anderson, GM (corresponding author), Inst Clin Evaluat Sci, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	geoff.anderson@utoronto.ca	Rochon, Paula A/J-2918-2016	Rochon, Paula A/0000-0002-5973-4151; Normand, Sharon-Lise/0000-0001-7027-4769				Ensrud KE, 2003, ARCH INTERN MED, V163, P949, DOI 10.1001/archinte.163.8.949; Evans S, 2003, BRIT MED J, V326, P360; GREENLAND S, 1990, AM J EPIDEMIOL, V131, P151, DOI 10.1093/oxfordjournals.aje.a115469; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Rochon PA, 2005, BMJ-BRIT MED J, V330, P895, DOI 10.1136/bmj.330.7496.895; ROSENBAUM PR, 1987, BIOMETRIKA, V74, P13, DOI 10.2307/2336017; Rosner B., 2000, FUNDAMENTALS BIOSTAT; Schneeweiss S, 2004, J CLIN PSYCHOPHARM, V24, P632, DOI 10.1097/01.jcp.0000145344.76288.39	8	115	118	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2005	330	7498					1021	1023		10.1136/bmj.330.7498.1021	http://dx.doi.org/10.1136/bmj.330.7498.1021			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UP	15860831	Green Published			2022-12-28	WOS:000228935100027
J	Opelz, G				Opelz, G		Gerhard Opelz Collaborative Transp	Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies	LANCET			English	Article							CLASS-I; CROSS-MATCH; PRESENSITIZATION; ALLOANTIBODIES; RECIPIENTS; ANTIGENS; ELISA; ASSAY	Background The presence of panel-reactive antibodies (PRA) against HLA antigens before transplantation is associated with early rejection of kidney grafts from cadaver donors. Transplants from HLA-identical sibling donors do not provide a target for antibodies to HLA antigens and should therefore not be affected by PRA. Methods Data from the Collaborative Transplant Study were used to examine the influence of PRA on graft survival. Uncensored graft survival and death-censored graft survival were calculated, and the data were analysed by multivariate Cox's regression methods. Findings Among recipients of HLA-identical sibling transplants, 3001 patients with no PRA had significantly higher 10-year graft survival (72.4% [SE 1.1]) than 803 patients with 1-50% PRA (63.3% [2.5]; p=0.0006) or 244 patients with more than 50% PRA (55.5% [4.0]; p<0.0001). The effect of PRA became apparent after the first post-transplant year and was, therefore, strikingly different from the early steep decline in graft survival during the first year associated with PRA in recipients of cadaver kidneys. We could not discern whether graft loss was a direct effect of non-HLA humoral sensitisation or whether PRA served as an indicator of heightened immunity against non-HLA transplantation antigens. Interpretation PRA reactivity is strongly associated with long-term graft loss in kidney transplants from HLA-identical sibling donors. Relevance to practice Our findings suggest that non-HLA immunity has a much stronger role in clinical transplantation than previously thought. In contrast to immunity against HLA mediated by antibodies present before transplantation, which leads to early acute graft rejection, non-HLA immunity is associated with chronic graft loss. The possibility of identifying recipients at increased risk of late graft loss before transplantation could be used to devise specific immunosuppressive strategies for these patients.	Heidelberg Univ, Inst Immunol, Dept Transplantat Immunol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Opelz, G (corresponding author), Heidelberg Univ, Inst Immunol, Dept Transplantat Immunol, Neuenheimer Feld 305, D-69120 Heidelberg, Germany.	gerhard.opelz@med.uni-heidelberg.de						BARGER B, 1989, TRANSPLANTATION, V47, P240; Bryan CF, 2001, CLIN TRANSPLANT, V15, P28, DOI 10.1034/j.1399-0012.2001.00005.x; Buelow R, 1995, TRANSPLANTATION, V60, P1594, DOI 10.1097/00007890-199560120-00037; COX DR, 1972, J R STAT SOC B, V34, P187; DUNN OJ, 1974, APPLIED STATISTICS A, P236; Fuller TC, 1997, HUM IMMUNOL, V56, P94, DOI 10.1016/S0198-8859(97)00174-2; GALE RP, 1978, LANCET, V1, P170; KAO KJ, 1993, TRANSPLANTATION, V55, P192, DOI 10.1097/00007890-199301000-00036; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KATZNELSON S, 1998, CLIN TRANS, P285; OPELZ G, 1987, TRANSPLANT P, V19, P3737; OPELZ G, 1992, REV IMMUNOGENET, V1, P334; Pei R, 2003, TRANSPLANTATION, V75, P43, DOI 10.1097/00007890-200301150-00008; Perez-Rodriguez M, 2002, TISSUE ANTIGENS, V59, P440, DOI 10.1034/j.1399-0039.2002.590516.x; PETTAWAY CA, 1987, TRANSPLANTATION, V44, P529, DOI 10.1097/00007890-198710000-00014; RODEY GE, 1994, HUM IMMUNOL, V39, P272, DOI 10.1016/0198-8859(94)90270-4; Simpson E, 2001, EUR J IMMUNOGENET, V28, P505, DOI 10.1046/j.0960-7420.2001.00252.x; Susal C, 2002, TRANSPLANTATION, V73, P1269; TALBOT D, 1989, TRANSPLANTATION, V47, P552, DOI 10.1097/00007890-198903000-00030; TERASAKI PI, 1971, POSTGRAD MED J, V47, P89, DOI 10.1136/pgmj.47.544.89; TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0; *U HEID, COLL TRANSPL STUD; Zachary AA, 2001, HUM IMMUNOL, V62, P236, DOI 10.1016/S0198-8859(00)00253-6	23	259	269	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1570	1576		10.1016/S0140-6736(05)66458-6	http://dx.doi.org/10.1016/S0140-6736(05)66458-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866311				2022-12-28	WOS:000228754800029
J	Falsey, AR; Hennessey, PA; Formica, MA; Cox, C; Walsh, EE				Falsey, AR; Hennessey, PA; Formica, MA; Cox, C; Walsh, EE			Respiratory syncytial virus infection in elderly and high-risk adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REVERSE TRANSCRIPTION-PCR; DISEASE BURDEN; VIRAL CULTURE; UNITED-STATES; INFLUENZA; COMMUNITY; PNEUMONIA; MORTALITY; ILLNESS; VACCINATION	BACKGROUND: Respiratory syncytial virus (RSV) is an increasingly recognized cause of illness in adults. Data on the epidemiology and clinical effects in community-dwelling elderly persons and high-risk adults can help in assessing the need for vaccine development. METHODS: During four consecutive winters, we evaluated all respiratory illnesses in prospective cohorts of healthy elderly patients (greater/equal 65 years of age) and high-risk adults (those with chronic heart or lung disease) and in patients hospitalized with acute cardiopulmonary conditions. RSV infection and influenza A were diagnosed on the basis of culture, reverse-transcriptase polymerase chain reaction, and serologic studies. RESULTS: A total of 608 healthy elderly patients and 540 high-risk adults were enrolled in prospective surveillance, and 1388 hospitalized patients were enrolled. A total of 2514 illnesses were evaluated. RSV infection was identified in 102 patients in the prospective cohorts and 142 hospitalized patients, and influenza A was diagnosed in 44 patients in the prospective cohorts and 154 hospitalized patients. RSV infection developed annually in 3 to 7 percent of healthy elderly patients and in 4 to 10 percent of high-risk adults. Among healthy elderly patients, RSV infection generated fewer office visits than influenza; however, the use of health care services by high-risk adults was similar in the two groups. In the hospitalized cohort, RSV infection and influenza A resulted in similar lengths of stay, rates of use of intensive care (15 percent and 12 percent, respectively), and mortality (8 percent and 7 percent, respectively). On the basis of the diagnostic codes of the International Classification of Diseases, 9th Revision, Clinical Modification at discharge, RSV infection accounted for 10.6 percent of hospitalizations for pneumonia, 11.4 percent for chronic obstructive pulmonary disease, 5.4 percent for congestive heart failure, and 7.2 percent for asthma. CONCLUSIONS: RSV infection is an important illness in elderly and high-risk adults, with a disease burden similar to that of nonpandemic influenza A in a population in which the prevalence of vaccination for influenza is high. An effective RSV vaccine may offer benefits for these adults.	Rochester Gen Hosp, Infect Dis Unit, Dept Med, Rochester, NY 14621 USA; Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; NICHHD, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD 20892 USA	Rochester General Hospital; University of Rochester; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Falsey, AR (corresponding author), Rochester Gen Hosp, Infect Dis Unit, Dept Med, 1425 Portland Ave, Rochester, NY 14621 USA.	ann.falsey@viahealth.org			NIAID NIH HHS [R01-AI-45969] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045969] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRAUNWALD E, 2001, HEART DIS TXB CARDIO, P640; *CDCP, INFL SEAS SUMM 1999; Centers for Disease Control and Prevention, INFL SEAS SUMM; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Falsey AR, 2003, J CLIN MICROBIOL, V41, P4160, DOI 10.1128/JCM.41.9.4160-4165.2003; FALSEY AR, 1995, J INFECT DIS, V172, P389, DOI 10.1093/infdis/172.2.389; Falsey AR, 2002, J CLIN MICROBIOL, V40, P817, DOI 10.1128/JCM.40.3.817-820.2002; FALSEY AR, 1992, J AM GERIATR SOC, V40, P115, DOI 10.1111/j.1532-5415.1992.tb01929.x; Fleiss J, 1981, STAT METHODS RATES P, V2nd, P113; FLEMING DM, 1993, LANCET, V342, P1507, DOI 10.1016/S0140-6736(05)80082-0; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Griffin MR, 2002, ARCH INTERN MED, V162, P1229, DOI 10.1001/archinte.162.11.1229; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567; Harmon M., 1989, DIAGNOSTIC PROCEDURE, P631; HART RJC, 1984, J INFECTION, V8, P259, DOI 10.1016/S0163-4453(84)94075-1; JOHNSON KM, 1962, NEW ENGL J MED, V267, P68, DOI 10.1056/NEJM196207122670204; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; LaMontagne JR, 1997, LANCET, V349, P149, DOI 10.1016/S0140-6736(05)60974-9; LAWTON MP, 1971, J AM GERIATR SOC, V19, P465, DOI 10.1111/j.1532-5415.1971.tb01206.x; MCINTOSH K, 1970, AM J EPIDEMIOL, V91, P585, DOI 10.1093/oxfordjournals.aje.a121171; Morens DM, 2003, JAMA-J AM MED ASSOC, V289, P227, DOI 10.1001/jama.289.2.227; Neuzil KM, 2003, CLIN INFECT DIS, V37, P201, DOI 10.1086/375604; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; Nicholson KG, 1997, BRIT MED J, V315, P1060, DOI 10.1136/bmj.315.7115.1060; POPOVIC JR, 2001, DHHS PUBLICATION; Simoes EAF, 2001, LANCET, V358, P1382, DOI 10.1016/S0140-6736(01)06488-1; SORVILLO FJ, 1984, J INFECTION, V9, P252, DOI 10.1016/S0163-4453(84)90530-9; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; VIKERFORS T, 1987, AM REV RESPIR DIS, V136, P561, DOI 10.1164/ajrccm/136.3.561; Walsh EE, 2002, J AM GERIATR SOC, V50, P1498, DOI 10.1046/j.1532-5415.2002.50404.x; Walsh EE, 2001, J MED VIROL, V63, P259, DOI 10.1002/1096-9071(200103)63:3&lt;259::AID-JMV1010&gt;3.0.CO;2-X; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X; 1983, BR MED J CLIN RES ED, V287, P1618	38	1274	1320	2	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1749	1759		10.1056/NEJMoa043951	http://dx.doi.org/10.1056/NEJMoa043951			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858184				2022-12-28	WOS:000228689000005
J	Mamdani, M; Sykora, K; Li, P; Normand, SLT; Streiner, DL; Austin, PC; Rochon, PA; Anderson, GM				Mamdani, M; Sykora, K; Li, P; Normand, SLT; Streiner, DL; Austin, PC; Rochon, PA; Anderson, GM			Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIP FRACTURE; RISK-FACTORS; TRIALS		Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Univ Toronto, Dept Psychiat, Toronto, ON, Canada; Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada; Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; Harvard University; Harvard Medical School; University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto	Anderson, GM (corresponding author), Inst Clin Evaluat Sci, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	geoff.anderson@utoronto.ca	Streiner, David/E-6563-2011; Rochon, Paula A/J-2918-2016	Streiner, David/0000-0003-0610-6271; Rochon, Paula A/0000-0002-5973-4151; Austin, Peter/0000-0003-3337-233X; Normand, Sharon-Lise/0000-0001-7027-4769				Altman DG, 1999, BRIT MED J, V318, P1209; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Ensrud KE, 2003, ARCH INTERN MED, V163, P949, DOI 10.1001/archinte.163.8.949; Feskanich D, 2002, JAMA-J AM MED ASSOC, V288, P2300, DOI 10.1001/jama.288.18.2300; Haentjens P, 2002, J ORTHOP TRAUMA, V16, P379, DOI 10.1097/00005131-200207000-00003; Humphrey LL, 2002, ANN INTERN MED, V137, P273, DOI 10.7326/0003-4819-137-4-200208200-00012; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; LAWLOR DA, 2003, BMJ-BRIT MED J, P327; Masud T, 2001, AGE AGEING, V30, P3, DOI 10.1093/ageing/30.suppl_4.3; NORMAND SLT, IN PRESS BMJ; Rochon PA, 2005, BMJ-BRIT MED J, V330, P895, DOI 10.1136/bmj.330.7496.895; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Schneeweiss S, 2004, J CLIN PSYCHOPHARM, V24, P632, DOI 10.1097/01.jcp.0000145344.76288.39	15	420	424	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2005	330	7497					960	962		10.1136/bmj.330.7497.960	http://dx.doi.org/10.1136/bmj.330.7497.960			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15845982	Green Published			2022-12-28	WOS:000228715900028
J	Renehan, AG				Renehan, AG			Preventing cancer, cardiovascular disease, and diabetes	LANCET			English	Editorial Material							BREAST-CANCER; RISK; MECHANISMS; SERUM		Christie Hosp NHS Trust, Dept Surg, Manchester M20 4BX, Lancs, England; Christie Hosp NHS Trust, Canc Res UK Dept Med Oncol, Manchester M20 4BX, Lancs, England	Christie NHS Foundation Trust; Christie Hospital; Cancer Research UK; Christie NHS Foundation Trust; Christie Hospital	Renehan, AG (corresponding author), Christie Hosp NHS Trust, Dept Surg, Manchester M20 4BX, Lancs, England.	arenehan@picr.man.ac.uk	; Renehan, Andrew/K-5992-2015	Howell, Anthony/0000-0002-6233-719X; Renehan, Andrew/0000-0003-4309-4396				*AM CANC SOC, CANC FACTS FIG 2005; American Diabetes Association, DIAB STAT; American Stroke Association American Heart Association, HEART DIS STROK STAT; Amir E, 2003, J MED GENET, V40, P807, DOI 10.1136/jmg.40.11.807; ANDERSON RM, 2002, NATL VITAL STAT REPO, V53; *BHF, BHF COR HEART DIS ST; *BHF, EC COSTS CHD; Bianchini F, 2002, WEIGHT CONTROL PHYS; Bosanquet N, 2004, LANCET ONCOL, V5, P568, DOI 10.1016/S1470-2045(04)01569-4; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; *CANC RES UK, 2004, CANCERSTATS INC UK; *DIAB UK, 3 DIAB UK; *DIAB UK, GETS DIAB WHAT CAUS; Doll R, 1998, Stat Methods Med Res, V7, P87, DOI 10.1191/096228098668199908; Dowsett M, 2002, NAT MED, V8, P1341, DOI 10.1038/nm1202-1341; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Eyre H, 2004, CA-CANCER J CLIN, V54, P190, DOI 10.3322/canjclin.54.4.190; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; Kreeger Karen, 2003, Nature, V424, P1090, DOI 10.1038/nj6952-1090a; McTiernan A, 1998, CANCER CAUSE CONTROL, V9, P487, DOI 10.1023/A:1008853601471; *NAT CANC RES I, 2002, STRAT AN OV CANC RES; *NAT CANC RES I, 2004, PREV RISK RES UK REP; *OFF NAT STAT, 2003, MORT STAT CAUS DH2, V30; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	26	29	30	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1449	1451		10.1016/S0140-6736(05)66399-4	http://dx.doi.org/10.1016/S0140-6736(05)66399-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850618				2022-12-28	WOS:000228651600009
J	Skilton, MR; Evans, N; Griffiths, KA; Harmer, JA; Celermajer, DS				Skilton, MR; Evans, N; Griffiths, KA; Harmer, JA; Celermajer, DS			Aortic wall thickness in newborns with intrauterine growth restriction	LANCET			English	Article							MEDIA THICKNESS; HEART-DISEASE; RISK-FACTORS; ATHEROSCLEROSIS; CHILDREN; WEIGHT; INTIMA; ADULTS; ARTERY	Much epidemiological evidence has linked low birthweight with late cardiovascular risk. We measured aortic wall thickness (a marker of early atherosclerosis) by ultrasonography in 25 newborn babies with intrauterine growth restriction and 25 with normal birthweight. Maximum aortic thicknesses were significantly higher in the babies with intrauterine growth restriction (810 mu m [SD 113]) than in those without (743 mu m [76], p=0.02), more so after adjustment for birthweight (300 mu m/kg [45] vs 199 mu m/kg [29], p<0.0001). Newborn babies with growth restriction have significant aortic thickening, suggesting that prenatal events might predispose to later cardiovascular risk.	Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Royal Prince Alfred Hosp, Dept Newborn Care, Sydney, NSW, Australia; Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney	Celermajer, DS (corresponding author), Univ Sydney, Dept Med, Sydney, NSW 2006, Australia.	david.celermajer@email.cs.nsw.gov.au		Skilton, Michael/0000-0003-2793-2388				BARKER DJP, 1989, LANCET, V2, P577; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Jarvisalo MJ, 2001, CIRCULATION, V104, P2943, DOI 10.1161/hc4901.100522; Leeson CPM, 2001, CIRCULATION, V103, P1264; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P836, DOI 10.1161/01.ATV.20.3.836; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103	6	217	228	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1484	1486		10.1016/S0140-6736(05)66419-7	http://dx.doi.org/10.1016/S0140-6736(05)66419-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850633				2022-12-28	WOS:000228651600027
J	Bichot, NP; Rossi, AF; Desimone, R				Bichot, NP; Rossi, AF; Desimone, R			Parallel and serial neural mechanisms for visual search in macaque area V4	SCIENCE			English	Article							SELECTIVE ATTENTION; PREFRONTAL CORTEX; WORKING-MEMORY; RESPONSES; SYNCHRONIZATION; SPACE; V2	To find a target object in a crowded scene, a face in a crowd for example, the visual system might turn the neural representation of each object on and off in a serial fashion, testing each representation against a template of the target item. Alternatively, it might allow the processing of all objects in parallel but bias activity in favor of those neurons that represent critical features of the target, until the target emerges from the background. To test these possibilities, we recorded neurons in area V4 of monkeys freely scanning a complex array to find a target defined by color, shape, or both. Throughout the period of searching, neurons gave enhanced responses and synchronized their activity in the gamma range whenever a preferred stimulus in their receptive field matched a feature of the target, as predicted by parallel models. Neurons also gave enhanced responses to candidate targets that were selected for saccades, or foveation, reflecting a serial component of visual search. Thus, serial and parallel mechanisms of response enhancement and neural synchrony work together to identify objects in a scene.	NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Vanderbilt University; Massachusetts Institute of Technology (MIT)	Bichot, NP (corresponding author), NIMH, Neuropsychol Lab, NIH, Bldg 9, Bethesda, MD 20892 USA.	bichotn@mail.nih.gov	Desimone, Robert/G-1121-2018		NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002036] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; BUFFALO EA, UNPUB; Cave Kyle R., 2005, P547, DOI 10.1016/B978-012375731-9/50094-X; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Hamker FH, 2005, CEREB CORTEX, V15, P431, DOI 10.1093/cercor/bhh146; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; Miller EK, 1996, J NEUROSCI, V16, P5154; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2178; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419	27	463	468	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					529	534		10.1126/science.1109676	http://dx.doi.org/10.1126/science.1109676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845848				2022-12-28	WOS:000228810500046
J	Tu, D; Blaha, G; Moore, PB; Steitz, TA				Tu, D; Blaha, G; Moore, PB; Steitz, TA			Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance	CELL			English	Article							PEPTIDYL TRANSFERASE CENTER; ESCHERICHIA-COLI RIBOSOMES; ERYTHROMYCIN RESISTANCE; BACTERIAL-RIBOSOMES; MACROLIDE ANTIBIOTICS; BOND FORMATION; BINDING-SITE; RNA; MUTANTS; VIRGINIAMYCIN	Crystal structures of H. marismortui large ribosomal subunits containing the mutation G2099A (A2058 in E. coli) with erythromycin, azithromycin, clindamycin, virginiamycin S, and telithromycin bound explain why eubacterial ribosomes containing the mutation A2058G are resistant to them. Azithromycin binds almost identically to both G2099A and wild-type subunits, but the erythromycin affinity increases by more than 10(4)-fold, implying that desolvation of the N2 of 62099 accounts for the low wild-type affinity for macrolides. All macrolides bind similarly to the H. marismortui subunit, but their binding differs significantly from what has been reported in the D. radioidurans subunit. The synergy in the binding of streptogramins A and B appears to result from a reorientation of the base of A2103 (A2062, E. coli) that stacks between them. The structure of large subunit containing a three residue deletion mutant of L22 shows a change in the L22 structure and exit tunnel shape that illuminates its macrolide resistance phenotype.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009		NIGMS NIH HHS [GM022778] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agouridas C, 1998, J MED CHEM, V41, P4080, DOI 10.1021/jm980240d; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Berisio R, 2003, J BACTERIOL, V185, P4276, DOI 10.1128/JB.185.14.4276-4279.2003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CHITTUM HS, 1994, J BACTERIOL, V176, P6192, DOI 10.1128/jb.176.20.6192-6198.1994; Clark C, 2002, ANTIMICROB AGENTS CH, V46, P2956, DOI 10.1128/AAC.46.9.2956-2962.2002; COCITO C, 1978, MOL GEN GENET, V166, P53, DOI 10.1007/BF00379729; COCITO C, 1979, MICROBIOL REV, V43, P145, DOI 10.1128/MMBR.43.2.145-192.1979; Das K, 1996, J MOL BIOL, V264, P1085, DOI 10.1006/jmbi.1996.0698; DECLERCQ JP, 1978, ACTA CRYSTALLOGR B, V34, P3644, DOI 10.1107/S0567740878011796; DOUTHWAITE S, 1993, J MOL BIOL, V232, P725, DOI 10.1006/jmbi.1993.1426; ENNIS HL, 1971, BIOCHEMISTRY-US, V10, P1265, DOI 10.1021/bi00783a025; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Garza-Ramos G, 2001, J BACTERIOL, V183, P6898, DOI 10.1128/JB.183.23.6898-6907.2001; Gregory ST, 1999, J MOL BIOL, V289, P827, DOI 10.1006/jmbi.1999.2839; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Hansen LH, 1999, MOL MICROBIOL, V31, P623, DOI 10.1046/j.1365-2958.1999.01202.x; Harms JM, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARLE IL, 1990, ACTA CRYSTALLOGR C, V46, P303, DOI 10.1107/S0108270189006906; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Kosutic-Hulita N, 2001, CROAT CHEM ACTA, V74, P327; KREBS MP, 1993, P NATL ACAD SCI USA, V90, P1987, DOI 10.1073/pnas.90.5.1987; LEBAN I, 1994, ACTA CHIM SLOV, V0041; Malbruny B, 2002, ANTIMICROB AGENTS CH, V46, P2200, DOI 10.1128/AAC.46.7.2200-2207.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARFAIT R, 1978, MOL GEN GENET, V166, P45, DOI 10.1007/BF00379728; PESTKA S, 1974, ANTIMICROB AGENTS CH, V6, P474, DOI 10.1128/AAC.6.4.474; SANZ JL, 1993, CAN J MICROBIOL, V39, P311, DOI 10.1139/m93-044; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; Stephenson GA, 1997, J PHARM SCI, V86, P1239, DOI 10.1021/js9701667; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; VANNUFFEL P, 1992, J BIOL CHEM, V267, P16114; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; WITTMANN HG, 1973, MOL GEN GENET, V127, P175, DOI 10.1007/BF00333665; Xiong LQ, 1999, MOL MICROBIOL, V31, P633, DOI 10.1046/j.1365-2958.1999.01203.x	44	335	347	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					257	270		10.1016/j.cell.2005.02.005	http://dx.doi.org/10.1016/j.cell.2005.02.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851032	Bronze			2022-12-28	WOS:000228705000013
J	Nundy, S; Gulhati, CM				Nundy, S; Gulhati, CM			A new colonialism? Conducting clinical trials in India	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Sir Ganga Ram Hosp, Dept Surg Gastroenterol, New Delhi, India; Monthly Index Med Specialties, New Delhi, India		Nundy, S (corresponding author), Sir Ganga Ram Hosp, Dept Surg Gastroenterol, New Delhi, India.			Nundy, Samiran/0000-0002-1757-3919				BANERJEE A, 2004, EC TIMES        1117, P5; GULHATI CM, 2004, INDIAN J MED ETH JAN; JAMES M, 2004, EC TIMES        0916, P11; LOTTE A, 1964, Bull World Health Organ, V31, P247; Sinha G, 2004, SCI AM ONLINE   0816	5	113	116	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1633	1636		10.1056/NEJMp048361	http://dx.doi.org/10.1056/NEJMp048361			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843665				2022-12-28	WOS:000228515200004
J	Russ, S; Wrenn, K				Russ, S; Wrenn, K			Disseminated gonococcal infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University	Russ, S (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.		Wrenn, Keith/AAI-7651-2020						0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					E15	E15		10.1056/NEJMicm040620	http://dx.doi.org/10.1056/NEJMicm040620			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843662				2022-12-28	WOS:000228515200012
J	Ram, RJ; VerBerkmoes, NC; Thelen, MP; Tyson, GW; Baker, BJ; Blake, RC; Shah, M; Hettich, RL; Banfield, JF				Ram, RJ; VerBerkmoes, NC; Thelen, MP; Tyson, GW; Baker, BJ; Blake, RC; Shah, M; Hettich, RL; Banfield, JF			Community proteomics of a natural microbial biofilm	SCIENCE			English	Article							ACID-MINE DRAINAGE; LEPTOSPIRILLUM-FERROOXIDANS; SHOTGUN PROTEOMICS; MASS-SPECTROMETRY; YEAST PROTEOME; IRON; IDENTIFICATION; CHROMATOGRAPHY; METABOLISM; PEPTIDE	Using genomic and mass spectrometry-based proteomic methods, we evaluated gene expression, identified key activities, and examined partitioning of metabolic functions in a natural acid mine drainage (AMD) microbial biofilm community. We detected 2033 proteins from the five most abundant species in the biofilm, including 48% of the predicted proteins from the dominant biofilm organism, Leptospirillum group II. Proteins involved in protein refolding and response to oxidative stress appeared to be highly expressed, which suggests that damage to biomolecules is a key challenge for survival. We validated and estimated the relative abundance and cellular localization of 357 unique and 215 conserved novel proteins and determined that one abundant novel protein is a cytochrome central to iron oxidation and AMD formation.	Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Tennessee, Grad Sch Genome Sci & Technol, Oak Ridge Natl Lab, Oak Ridge, TN 37830 USA; Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA; Oak Ridge Natl Lab, Div Life Sci, Oak Ridge, TN 37831 USA; Lawrence Livermore Natl Lab, Biosci Directorate, Livermore, CA 94551 USA; Xavier Univ, Coll Pharm, New Orleans, LA 70125 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Xavier University of Louisiana	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	jill@seismo.berkeley.edu	Hettich, Robert L/N-1458-2016; Baker, Brett/P-1783-2014; Thelen, Michael/C-6834-2008; Tyson, Gene/C-6558-2013	Hettich, Robert L/0000-0001-7708-786X; Baker, Brett/0000-0002-5971-1021; Thelen, Michael/0000-0002-2479-5480; Tyson, Gene/0000-0001-8559-9427; Banfield, Jill/0000-0001-8203-8771				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLAKE R, 2000, ENV MICROBE METAL IN, P53; BLAKE RC, 1993, FEMS MICROBIOL REV, V11, P9; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; Druschel GK, 2004, GEOCHEM T, V5, P13, DOI 10.1186/1467-4866-5-13; Essader AS, 2005, PROTEOMICS, V5, P24, DOI 10.1002/pmic.200400888; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; HART A, 1991, FEMS MICROBIOL LETT, V81, P89; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; LUTHER GW, 1987, GEOCHIM COSMOCHIM AC, V51, P3193, DOI 10.1016/0016-7037(87)90127-X; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Olsen JV, 2004, P NATL ACAD SCI USA, V101, P13417, DOI 10.1073/pnas.0405549101; Parro V, 2003, P NATL ACAD SCI USA, V100, P7883, DOI 10.1073/pnas.1230487100; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; RAM RS, UNPUB; Standing KG, 2003, CURR OPIN STRUC BIOL, V13, P595, DOI 10.1016/j.sbi.2003.09.005; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; VerBerkmoes NC, 2002, J PROTEOME RES, V1, P239, DOI 10.1021/pr025508a; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Zhu WH, 2004, J PROTEOME RES, V3, P538, DOI 10.1021/pr034109s	26	501	539	0	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1915	1920		10.1126/science. 1109070	http://dx.doi.org/10.1126/science. 1109070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15879173				2022-12-28	WOS:000230120000042
J	Locker, TE; Mason, SM				Locker, TE; Mason, SM			Analysis of the distribution of time that patients spend in emergency departments	BRITISH MEDICAL JOURNAL			English	Article									Univ Sheffield, Sch Hlth & Related Res, Med Care Res Unit, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield	Locker, TE (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Med Care Res Unit, Sheffield S1 4DA, S Yorkshire, England.	t.locker@sheffield.ac.uk	Locker, Thomas/G-7104-2011	Locker, Thomas/0000-0002-7960-0572; Mason, Suzanne/0000-0002-1701-0577				*COMM HLTH IMPR, 2003, WHAT CHI HAS FOUND A; Department of Health, 2000, NHS PLAN PLAN INV PL; Department of Health, 2003, CLIN EXC 4 HOUR EM C; *HOSP ACT STAT, TOT TIM A E; National Audit Office, 2004, IMPR EM CAR ENGL REP	5	45	45	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 21	2005	330	7501					1188	1189		10.1136/bmj.38440.588449.AE	http://dx.doi.org/10.1136/bmj.38440.588449.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929CU	15843426	Green Published, Bronze			2022-12-28	WOS:000229320500021
J	Mansour, D; Fraser, IS				Mansour, D; Fraser, IS			Missed contraceptive pills and the critical pill-free interval	LANCET			English	Editorial Material									Newcastle Primary Care Trust, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Sydney, Dept Obstet & Gynaecol, Sydney, NSW 2006, Australia	University of Sydney	Mansour, D (corresponding author), Newcastle Primary Care Trust, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	diana.mansour@newcastle-pct.nhs.uk						[Anonymous], 2004, SEL PRACT REC CONTR; Baer WC, 2004, J AM PLANN ASSOC, V70, P371; Costello A, 2004, BMJ-BRIT MED J, V329, P1166, DOI 10.1136/bmj.329.7475.1166; Creinin MD, 2002, CONTRACEPTION, V66, P147, DOI 10.1016/S0010-7824(02)00344-X; HAMILTON CJCM, 1989, AM J OBSTET GYNECOL, V161, P1159, DOI 10.1016/0002-9378(89)90655-8; KORVER T, 1995, BRIT J OBSTET GYNAEC, V102, P601; LANDGREN BM, 1991, CONTRACEPTION, V43, P149, DOI 10.1016/0010-7824(91)90042-E; Pierson RA, 2003, FERTIL STERIL, V80, P34, DOI 10.1016/S0015-0282(03)00556-9; Trussell J, 2004, CONTRACEPTION, V70, P89, DOI 10.1016/j.contraception.2004.03.009; *WHO, 2004, MED EL CRIT CONTR; 2005, J FAM PLANN REPROD H, V31, P153	11	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1670	1671		10.1016/S0140-6736(05)66527-0	http://dx.doi.org/10.1016/S0140-6736(05)66527-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894085				2022-12-28	WOS:000229082300007
J	Colaprete, A; Barnes, JR; Haberle, RM; Hollingsworth, JL; Kieffer, HH; Titus, TN				Colaprete, A; Barnes, JR; Haberle, RM; Hollingsworth, JL; Kieffer, HH; Titus, TN			Albedo of the south pole on Mars determined by topographic forcing of atmosphere dynamics	NATURE			English	Article							CARBON-DIOXIDE; TES; BEHAVIOR; WAVES; MODEL; CAPS; ICE	The nature of the martian south polar cap has remained enigmatic since the first spacecraft observations(1-6). In particular, the presence of a perennial carbon dioxide ice cap, the formation of a vast area of black 'slab ice' known as the Cryptic region and the asymmetric springtime retreat of the cap have eluded explanation. Here we present observations and climate modelling that indicate the south pole of Mars is characterized by two distinct regional climates that are the result of dynamical forcing by the largest southern impact basins, Argyre and Hellas. The style of surface frost deposition is controlled by these regional climates. In the cold and stormy conditions that exist poleward of 60 degrees S and extend 180 degrees in longitude west from the Mountains of Mitchel (similar to 30 degrees W), surface frost accumulation is dominated by precipitation. In the opposite hemisphere, the polar atmosphere is relatively warm and clear and frost accumulation is dominated by direct vapour deposition. It is the differences in these deposition styles that determine the cap albedo.	NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; NASA, Ames Res Ctr, San Jose State Univ Fdn, Moffett Field, CA 94035 USA; US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Oregon State University; California State University System; San Jose State University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of the Interior; United States Geological Survey	Colaprete, A (corresponding author), NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA.	Anthony.Colaprete-1@nasa.gov		Kieffer, Hugh/0000-0002-2485-0339				Banfield D, 2003, ICARUS, V161, P319, DOI 10.1016/S0019-1035(02)00044-1; Byrne S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017597; Byrne S, 2003, SCIENCE, V299, P1051, DOI 10.1126/science.1080148; Colaprete A, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001967; Colaprete A, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002053; COLAPRETE A, 2002, J GEOPHYS RES, V107, DOI DOI 10.1029/2001JE01758; Forget F, 1998, ICARUS, V131, P302, DOI 10.1006/icar.1997.5874; Haberle RM, 1999, J GEOPHYS RES-PLANET, V104, P8957, DOI 10.1029/1998JE900040; Hinson DP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014103; Hinson DP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001949; Hollingsworth JL, 1996, J ATMOS SCI, V53, P428, DOI 10.1175/1520-0469(1996)053<0428:FSPWIM>2.0.CO;2; Holton J. R., 1992, INTRO DYNAMIC METEOR; Ivanov AB, 2001, ICARUS, V154, P190, DOI 10.1006/icar.2001.6686; JAKOSKY BM, 1990, J GEOPHYS RES-SOLID, V95, P1359, DOI 10.1029/JB095iB02p01359; James PB, 1996, ICARUS, V123, P87, DOI 10.1006/icar.1996.0143; Kieffer HH, 2000, J GEOPHYS RES-PLANET, V105, P9653, DOI 10.1029/1999JE001136; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; LINDNER BL, 1993, J GEOPHYS RES-PLANET, V98, P3339, DOI 10.1029/92JE02975; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; PAIGE DA, 1985, SCIENCE, V228, P1160, DOI 10.1126/science.228.4704.1160; Pettengill GH, 2000, GEOPHYS RES LETT, V27, P609, DOI 10.1029/1999GL010896; Thomas PC, 2000, NATURE, V404, P161, DOI 10.1038/35004528; Titus TN, 2001, J GEOPHYS RES-PLANET, V106, P23181, DOI 10.1029/2000JE001284	23	62	63	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					184	188		10.1038/nature03561	http://dx.doi.org/10.1038/nature03561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889086	Green Published			2022-12-28	WOS:000229021100034
J	Ramaekers, VT; Rothenberg, SP; Sequeira, JM; Opladen, T; Blau, N; Quadros, EV; Selhub, J				Ramaekers, VT; Rothenberg, SP; Sequeira, JM; Opladen, T; Blau, N; Quadros, EV; Selhub, J			Autoantibodies to folate receptors in the cerebral folate deficiency syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CEREBROSPINAL-FLUID; BINDING-PROTEIN; ACID; 5-METHYLTETRAHYDROFOLATE; TRANSPORT	In infantile-onset cerebral folate deficiency, 5-methyltetrahydrofolate (5MTHF) levels in the cerebrospinal fluid are low, but folate levels in the serum and erythrocytes are normal. We examined serum specimens from 28 children with cerebral folate deficiency, 5 of their mothers, 28 age-matched control subjects, and 41 patients with an unrelated neurologic disorder. Serum from 25 of the 28 patients and 0 of 28 control subjects contained high-affinity blocking autoantibodies against membrane-bound folate receptors that are present on the choroid plexus. Oral folinic acid normalized 5MTHF levels in the cerebrospinal fluid and led to clinical improvement. Cerebral folate deficiency is a disorder in which autoantibodies can prevent the transfer of folate from the plasma to the cerebrospinal fluid.	Univ Klinikum Aachen, Dept Pediat, Div Pediat Neurol, D-52074 Aachen, Germany; SUNY Downstate Med Ctr, Dept Med, Brooklyn, NY USA; Univ Childrens Hosp, Div Clin Chem & Biochem, Zurich, Switzerland; Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Vitamin Metab & Aging Lab, Boston, MA 02111 USA	RWTH Aachen University; RWTH Aachen University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University Children's Hospital Zurich; Tufts University; United States Department of Agriculture (USDA)	Ramaekers, VT (corresponding author), Univ Klinikum Aachen, Dept Pediat, Div Pediat Neurol, Pauwelsstr 30, D-52074 Aachen, Germany.	vramaekers@ukaachen.de		Blau, Nenad/0000-0003-4347-3230				ANTONY AC, 1992, BLOOD, V79, P2807; Blau N, 2003, NEUROLOGY, V61, P642, DOI 10.1212/01.WNL.0000082726.08631.E7; BLAU N, 2003, PHYSICIAN GUIDE LAB, P96; HENDERSON GB, 1990, ANNU REV NUTR, V10, P319, DOI [10.1146/annurev.nutr.10.1.319, 10.1146/annurev.nu.10.070190.001535]; HOLM J, 1991, BIOCHEM J, V280, P267, DOI 10.1042/bj2800267; LEVITT M, 1971, J CLIN INVEST, V50, P1301, DOI 10.1172/JCI106609; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Ramaekers VT, 2002, NEUROPEDIATRICS, V33, P301, DOI 10.1055/s-2002-37082; Ramaekers VT, 2004, DEV MED CHILD NEUROL, V46, P843, DOI 10.1017/S0012162204001471; Rothenberg SP, 2004, NEW ENGL J MED, V350, P134, DOI 10.1056/NEJMoa031145; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SVENDSEN IB, 1982, CARLSBERG RES COMMUN, V47, P371, DOI 10.1007/BF02907775; Wang YH, 2001, BBA-BIOMEMBRANES, V1513, P49, DOI 10.1016/S0005-2736(01)00340-6; Wright AJA, 2003, BRIT J NUTR, V90, P363, DOI 10.1079/BJN2003908; Wu DF, 1999, PHARMACEUT RES, V16, P415, DOI 10.1023/A:1018829920158	16	179	186	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1985	1991		10.1056/NEJMoa043160	http://dx.doi.org/10.1056/NEJMoa043160			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888699	Bronze			2022-12-28	WOS:000229017100009
J	Storm, C; Pastore, JJ; MacKintosh, FC; Lubensky, TC; Janmey, PA				Storm, C; Pastore, JJ; MacKintosh, FC; Lubensky, TC; Janmey, PA			Nonlinear elasticity in biological gels	NATURE			English	Article							ACTIN GELS; MODULUS	The mechanical properties of soft biological tissues are essential to their physiological function and cannot easily be duplicated by synthetic materials. Unlike simple polymer gels, many biological materials - including blood vessels(1), mesentery tissue(2), lung parenchyma(3), cornea(4) and blood clots(5) - stiffen as they are strained, thereby preventing large deformations that could threaten tissue integrity. The molecular structures and design principles responsible for this nonlinear elasticity are unknown. Here we report a molecular theory that accounts for strain-stiffening in a range of molecularly distinct gels formed from cytoskeletal and extracellular proteins and that reveals universal stress - strain relations at low to intermediate strains. The input to this theory is the force - extension curve for individual semi-flexible filaments and the assumptions that biological networks composed of these filaments are homogeneous, isotropic, and that they strain uniformly. This theory shows that systems of filamentous proteins arranged in an open crosslinked mesh invariably stiffen at low strains without requiring a specific architecture or multiple elements with different intrinsic stiffness.	Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; Vrije Univ Amsterdam, Div Phys & Astron, NL-1081 HV Amsterdam, Netherlands; Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Vrije Universiteit Amsterdam; University of Pennsylvania	Storm, C (corresponding author), Leiden Univ, LION, Inst Lorentz Theoret Phys, POB 9506, NL-2300 RA Leiden, Netherlands.	cstorm@lorentz.leidenuniv.nl	MacKintosh, Fred C/A-9450-2008; MacKintosh, Frederick/AAB-9332-2021; Storm, Cornelis/K-1486-2013	MacKintosh, Fred C/0000-0002-2607-9541; MacKintosh, Frederick/0000-0002-2607-9541; Storm, Cornelis/0000-0002-4391-8984				FIXMAN M, 1973, J CHEM PHYS, V58, P1564, DOI 10.1063/1.1679396; Fung Y.C., 1994, 1 COURSE CONTINUUM M; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Gittes F, 1998, PHYS REV E, V58, pR1241, DOI 10.1103/PhysRevE.58.R1241; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; Head DA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108102; HJORTDAL JO, 1995, ACTA OPHTHALMOL SCAN, V73, P12; JANMEY PA, 1986, BIOPOLYMERS, V25, P1337, DOI 10.1002/bip.360250712; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; JANMEY PA, 1990, NATURE, V345, P89, DOI 10.1038/345089a0; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; KARAKAPLAN AD, 1980, ASME, V102, P124; Kroy K, 1996, PHYS REV LETT, V77, P306, DOI 10.1103/PhysRevLett.77.306; Landau L. D., 1980, STAT PHYS; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Leterrier JF, 1996, J BIOL CHEM, V271, P15687, DOI 10.1074/jbc.271.26.15687; Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Morse DC, 1998, PHYS REV E, V58, pR1237, DOI 10.1103/PhysRevE.58.R1237; Shadwick RE, 1999, J EXP BIOL, V202, P3305; Shah JV, 1997, RHEOL ACTA, V36, P262, DOI 10.1007/BF00366667; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; TELOAR LRG, 1975, PHYS RUBBER ELASTICI; Wang LZ, 2000, THROMB RES, V100, P537, DOI 10.1016/S0049-3848(00)00362-5; Wilhelm J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108103; Wilhelm J, 1996, PHYS REV LETT, V77, P2581, DOI 10.1103/PhysRevLett.77.2581; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200	29	1182	1194	12	455	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					191	194		10.1038/nature03521	http://dx.doi.org/10.1038/nature03521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889088	Green Submitted			2022-12-28	WOS:000229021100036
J	Xu, F; Zhang, KL; Grunstein, M				Xu, F; Zhang, KL; Grunstein, M			Acetylation in histone H3 globular domain regulates gene expression in yeast	CELL			English	Article							NUCLEOSOME CORE PARTICLE; SACCHAROMYCES-CEREVISIAE; SWI/SNF COMPLEX; ORDERED RECRUITMENT; LYSINE 9; PROMOTER; BINDING; TRANSCRIPTION; HETEROCHROMATIN; PROTEINS	In Saccharomyces cerevisiae, known histone acetylation sites regulating gene activity are located in the N-terminal tails protruding from the nucleosome core. We report lysine 56 in histone H3 as a novel acetylation site that is located in the globular domain, where it extends toward the DNA major groove at the entry-exit points of the DNA superhelix as it wraps around the nucleosome. We show that K56 acetylation is enriched preferentially at certain active genes, such as those coding for histones. SPT10, a putative acetyltransferase, is required for cell cycle-specific K56 acetylation at histone genes. This allows recruitment of the nucleosome remodeling factor Snf5 and subsequent transcription. These findings indicate that histone H3 K56 acetylation at the entry-exit gate enables recruitment of the SWI/SNF nucleosome remodeling complex and so regulates gene activity.	Univ Calif Los Angeles, Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Riverside, Dept Chem, Mass Spectrometry Facil, Riverside, CA 92521 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Riverside	Grunstein, M (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	mg@mbi.ucla.edu		Xu, Feng/0000-0003-2016-7521	NIGMS NIH HHS [GM 23674, GM 42421] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023674, R01GM042421, R37GM023674] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bazett-Jones DP, 1999, MOL CELL BIOL, V19, P1470; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Dimova D, 1999, MOL CELL, V4, P75, DOI 10.1016/S1097-2765(00)80189-6; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Geng FQ, 2004, EMBO J, V23, P127, DOI 10.1038/sj.emboj.7600035; Geng FQ, 2001, MOL CELL BIOL, V21, P4311, DOI 10.1128/MCB.21.13.4311-4320.2001; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hess D, 2004, MOL CELL BIOL, V24, P135, DOI 10.1128/MCB.24.1.135-143.2004; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Langst G, 2001, MOL CELL, V8, P1085, DOI 10.1016/S1097-2765(01)00397-5; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorch Y, 2001, MOL CELL, V7, P89, DOI 10.1016/S1097-2765(01)00157-5; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MANN RK, 1992, EMBO J, V11, P3297, DOI 10.1002/j.1460-2075.1992.tb05408.x; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; MEERSSEMAN G, 1992, EMBO J, V11, P2951, DOI 10.1002/j.1460-2075.1992.tb05365.x; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; TURNER BM, 1989, EUR J BIOCHEM, V179, P131, DOI 10.1111/j.1432-1033.1989.tb14530.x; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Zhang KL, 2004, PROTEOMICS, V4, P3765, DOI 10.1002/pmic.200400819; Zhang KL, 2002, ANAL BIOCHEM, V306, P259, DOI 10.1006/abio.2002.5719; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	52	314	318	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					375	385		10.1016/j.cell.2005.03.011	http://dx.doi.org/10.1016/j.cell.2005.03.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882620	Bronze			2022-12-28	WOS:000229031600008
J	Berciu, M; Rappoport, TG; Janko, B				Berciu, M; Rappoport, TG; Janko, B			Manipulating spin and charge in magnetic semiconductors using superconducting vortices	NATURE			English	Article							QUANTIZED HALL CONDUCTANCE; ELECTRONS	The continuous need for miniaturization and increase in device speed(1) drives the electronics industry to explore new avenues of information processing. One possibility is to use electron spin to store, manipulate and carry information(2). All such 'spintronics' applications are faced with formidable challenges in finding fast and efficient ways to create, transport, detect, control and manipulate spin textures and currents. Here we show how most of these operations can be performed in a relatively simple manner in a hybrid system consisting of a superconducting film and a paramagnetic diluted magnetic semiconductor (DMS) quantum well. Our proposal is based on the observation that the inhomogeneous magnetic fields of the superconducting film create local spin and charge textures in the DMS quantum well, leading to a variety of effects such as Bloch oscillations and an unusual quantum Hall effect. We exploit recent progress in manipulating magnetic flux bundles ( vortices) in superconductors(3,4) and show how these can create, manipulate and control the spin textures in DMSs.	Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA	University of Notre Dame; University of British Columbia; United States Department of Energy (DOE); Argonne National Laboratory	Janko, B (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.	bjanko@nd.edu	Rappoport, Tatiana G./X-5431-2019; Rappoport, Tatiana/J-8626-2014; Berciu, Mona/O-4889-2014	Rappoport, Tatiana/0000-0002-1878-5956				ABRIKOSOV AA, 1957, SOV PHYS JETP-USSR, V5, P1174; Albrecht C, 2001, PHYS REV LETT, V86, P147, DOI 10.1103/PhysRevLett.86.147; BENDING SJ, 1990, PHYS REV LETT, V65, P1060, DOI 10.1103/PhysRevLett.65.1060; Berciu M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.246804; Bloch F, 1929, Z PHYS, V52, P555, DOI 10.1007/BF01339455; CHANG MC, 1994, PHYS REV B, V50, P10843, DOI 10.1103/PhysRevB.50.10843; CLARO FH, 1979, PHYS REV B, V19, P6068, DOI 10.1103/PhysRevB.19.6068; Demikhovskii VY, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.165301; FURDYNA JK, 1988, J APPL PHYS, V64, pR29, DOI 10.1063/1.341700; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Jaroszynski J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.266802; Kawakami RK, 2000, APPL PHYS LETT, V77, P2379, DOI 10.1063/1.1316775; KOHMOTO M, 1985, ANN PHYS-NEW YORK, V160, P343, DOI 10.1016/0003-4916(85)90148-4; LAUGHLIN RB, 1981, PHYS REV B, V23, P5632, DOI 10.1103/PhysRevB.23.5632; Lee CS, 1999, NATURE, V400, P337, DOI 10.1038/22578; Melinte S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.036802; NIELSEN M, 1995, PHYS REV B, V51, P7679, DOI 10.1103/PhysRevB.51.7679; PEARL J, 1964, APPL PHYS LETT, V5, P65, DOI 10.1063/1.1754056; Peercy PS, 2000, NATURE, V406, P1023, DOI 10.1038/35023223; Savel'ev S, 2002, NAT MATER, V1, P179, DOI 10.1038/nmat746; Schlosser T, 1996, EUROPHYS LETT, V33, P683, DOI 10.1209/epl/i1996-00399-6; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Usov N. A., 1988, Soviet Physics - JETP, V67, P2565; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389	25	67	68	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					71	75		10.1038/nature03559	http://dx.doi.org/10.1038/nature03559			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875016	Green Submitted			2022-12-28	WOS:000228864600038
J	Nicholls, D; Viner, R				Nicholls, D; Viner, R			ABC of adolescence - Eating disorders and weight problems	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Great Ormond St Hosp Sick Children, Feeding & Eating Disorders Serv, London, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Nicholls, D (corresponding author), Great Ormond St Hosp Sick Children, Feeding & Eating Disorders Serv, London, England.	rviner@ich.ucl.ac.uk	Viner, Russell M/A-1441-2009	Viner, Russell M/0000-0003-3047-2247; Nicholls, Dasha/0000-0001-7257-6605				CAMPBELL K, 2004, COCHRANE DATABASE SY, P1871; Gowers S, 2004, J CHILD PSYCHOL PSYC, V45, P63, DOI 10.1046/j.0021-9630.2003.00309.x; MULVIHILL C, 2003, REV PREVENTION OBESI	3	42	50	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2005	330	7497					950	953		10.1136/bmj.330.7497.950	http://dx.doi.org/10.1136/bmj.330.7497.950			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15845978	Green Published			2022-12-28	WOS:000228715900024
J	Hua, JY; Smear, MC; Baier, H; Smith, SJ				Hua, JY; Smear, MC; Baier, H; Smith, SJ			Regulation of axon growth in vivo by activity-based competition	NATURE			English	Article							VISUAL-CORTEX; SYNAPTIC COMPETITION; OCULAR DOMINANCE; BRANCH DYNAMICS; NEURAL ACTIVITY; ZEBRAFISH; SYSTEM; REVEALS; ARBORS; BRAIN	The formation of functional neural networks requires precise regulation of the growth and branching of the terminal arbors of axons, processes known to be influenced by early network electrical activity(1-3). Here we show that a rule of activity-based competition between neighbouring axons appears to govern the growth and branching of retinal ganglion cell (RGC) axon arbors in the developing optic tectum of zebrafish. Mosaic expression of an exogenous potassium channel or a dominant-negative SNARE protein was used to suppress electrical or neurosecretory activity in subsets of RGC axons. Imaging in vivo showed that these forms of activity suppression strongly inhibit both net growth and the formation of new branches by individually transfected RGC axon arbors. The inhibition is relieved when the activity of nearby 'competing' RGC axons is also suppressed. These results therefore identify a new form of activity-based competition rule that might be a key regulator of axon growth and branch initiation.	Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94143 USA	Stanford University; Stanford University; University of California System; University of California San Francisco	Hua, JY (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	huayy@stanford.edu		Smith, Stephen/0000-0002-2290-8701				ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Cogen J, 2000, J NEUROBIOL, V45, P120, DOI 10.1002/1097-4695(20001105)45:2<120::AID-NEU6>3.0.CO;2-6; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Drapeau P, 2002, PROG NEUROBIOL, V68, P85, DOI 10.1016/S0301-0082(02)00075-8; Gnuegge L, 2001, J NEUROSCI, V21, P3542, DOI 10.1523/JNEUROSCI.21-10-03542.2001; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Johnson FA, 1999, J COMP NEUROL, V406, P548, DOI 10.1002/(SICI)1096-9861(19990419)406:4<548::AID-CNE8>3.0.CO;2-3; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Li WY, 2003, J NEUROSCI, V23, P10467; LICHTMAN JW, 1990, J NEUROBIOL, V21, P99, DOI 10.1002/neu.480210107; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schmidt JT, 2004, J NEUROBIOL, V58, P328, DOI 10.1002/neu.10286; Schmidt JT, 2000, J NEUROBIOL, V42, P303, DOI 10.1002/(SICI)1097-4695(20000215)42:3<303::AID-NEU2>3.3.CO;2-1; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8	25	172	173	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 21	2005	434	7036					1022	1026		10.1038/nature03409	http://dx.doi.org/10.1038/nature03409			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846347				2022-12-28	WOS:000228524600039
J	Palleroni, A; Miller, CT; Hauser, M; Marler, P				Palleroni, A; Miller, CT; Hauser, M; Marler, P			Predation - Prey plumage adaptation against falcon attack	NATURE			English	Editorial Material							BIRDS		Harvard Univ, Dept Psychol, Primate Cognit Neurosci Lab, Cambridge, MA 02138 USA; Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA; Univ Calif Davis, Anim Commun Lab, Davis, CA 95616 USA	Harvard University; Johns Hopkins University; University of California System; University of California Davis	Palleroni, A (corresponding author), Harvard Univ, Dept Psychol, Primate Cognit Neurosci Lab, 33 Kirkland St, Cambridge, MA 02138 USA.	aliparti@wjh.harvard.edu						Bond AB, 1999, ANIM LEARN BEHAV, V27, P461, DOI 10.3758/BF03209981; Brooke MD, 1998, FUNCT ECOL, V12, P339; Cade T. J., 1982, FALCONS WORLD; Cade TJ, 1988, PEREGRINE FALCON POP; Goodwin D., 1970, PIGEONS DOVES WORLD; Helfman G, 2009, DIVERSITY FISHES BIO; Johnston RF, 1995, FERAL PIGEONS; LIMA SL, 1993, WILSON BULL, V105, P1; Tinbergen N, 1951, STUDY INSTINCT; Tucker VA, 1998, J EXP BIOL, V201, P403	10	29	30	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					973	974		10.1038/434973b	http://dx.doi.org/10.1038/434973b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846334				2022-12-28	WOS:000228524600027
J	Guillou, PJ; Quirke, P; Thorpe, H; Walker, J; Jayne, DG; Smith, AMH; Heath, RM; Brown, JM				Guillou, PJ; Quirke, P; Thorpe, H; Walker, J; Jayne, DG; Smith, AMH; Heath, RM; Brown, JM		MRC CLASICC Trial Grp	Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial	LANCET			English	Article							TOTAL MESORECTAL EXCISION; LOCAL RECURRENCE; OPEN COLECTOMY; COLON-CANCER; ABDOMINOPERINEAL RESECTION; RECTAL ADENOCARCINOMA; METASTASES; CARCINOMA; OUTCOMES	Background Laparoscopic-assisted surgery for colorectal cancer has been widely adopted without data from large-scale randomised trials to support its use. We compared short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer to predict long-term outcomes. Methods Between July, 1996, and July, 2002, we undertook a multicentre, randomised clinical trial in 794 patients with colorectal cancer from 27 UK centres. Patients were allocated to receive laparoscopic-assisted (n=526) or open surgery (n=268). Primary short-term endpoints were positivity rates of circumferential and longitudinal resection margins, proportion of Dukes' C2 tumours, and in-hospital mortality. Analysis was by intention to treat. This trial has been assigned the International Standard Randomised Controlled Trial Number ISRCTN74883561. Findings Six patients (two [open], four [laparoscopic]) had no surgery, and 23 had missing surgical data (nine, 14). 253 and 484 patients actually received open and laparoscopic-assisted treatment, respectively. 143 (29%) patients underwent conversion from laparoscopic to open surgery. Proportion of Dukes' C2 tumours did not differ between treatments (18 [7%] patients, open vs 34 [6%], laparoscopic; difference -0.3%, 95% CI -3.9 to 3.4%, p=0.89), and neither did in-hospital mortality (13 [5%] vs 21 [4%]; -0.9%, -3.9 to 2.2%, p=0.57). Apart from patients undergoing laparoscopic anterior resection for rectal cancer, rates of positive resection margins were similar between treatment groups. Patients with converted treatment had raised complication rates. Interpretation Laparoscopic-assisted surgery for cancer of the colon is as effective as open surgery in the short term and is likely to produce similar long-term outcomes. However, impaired short-term outcomes after laparoscopic-assisted anterior resection for cancer of the rectum do not yet justify its routine use.	St James Univ Hosp, Acad Surg Unit, Leeds LS9 7TF, W Yorkshire, England; Univ Leeds, Acad Unit Pathol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Clin Trials Res Unit, Acad Unit Epidemiol & Hlth Serv Res, Leeds LS2 9JT, W Yorkshire, England	Saint James's University Hospital; University of Leeds; University of Leeds	Guillou, PJ (corresponding author), St James Univ Hosp, Acad Surg Unit, Leeds LS9 7TF, W Yorkshire, England.	p.j.guillou@leeds.ac.uk	Quirke, Philip/AAI-1362-2019	brown, julia/0000-0002-2719-7064; Quirke, Philip/0000-0002-3597-5444; Jayne, David/0000-0002-8725-3283; Marshall, Helen/0000-0003-0944-0152				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; ADAM IJ, 1994, LANCET, V344, P707, DOI 10.1016/S0140-6736(94)92206-3; Baker RP, 2002, DIS COLON RECTUM, V45, P1481, DOI 10.1007/s10350-004-6454-z; BERENDS FJ, 1994, LANCET, V344, P58, DOI 10.1016/S0140-6736(94)91079-0; Cirrocco W. C., 1994, SURGERY, V116, P563; FALK PM, 1993, DIS COLON RECTUM, V36, P28, DOI 10.1007/BF02050298; FLESHMAN JW, 1996, DIS COLON RECTUM S, V39, P53; FRANKLIN ME, 1996, DIS COLON RECTUM S, V39, P35; FUSCO MA, 1993, DIS COLON RECTUM, V36, P858, DOI 10.1007/BF02047384; Hartley JE, 2001, DIS COLON RECTUM, V44, P315, DOI 10.1007/BF02234726; HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Kerr DJ, 2001, SEMIN ONCOL, V28, P31, DOI 10.1053/sonc.2001.19720; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Leung KL, 2004, LANCET, V363, P1187, DOI 10.1016/S0140-6736(04)15947-3; Lumley J, 2002, DIS COLON RECTUM, V45, P867, DOI 10.1007/s10350-004-6318-6; Milsom JW, 1998, J AM COLL SURGEONS, V187, P46, DOI 10.1016/S1072-7515(98)00132-X; MONSON JRT, 1992, LANCET, V340, P831, DOI 10.1016/0140-6736(92)92694-B; *MRC CLASICC TRIAL, 2000, COLORECTAL DIS S1, V2, P77; Nelson H, 2004, NEW ENGL J MED, V350, P2050; PHILLIPS EH, 1992, ANN SURG, V216, P703, DOI 10.1097/00000658-199212000-00015; Pikarsky AJ, 2002, SURG ENDOSC, V16, P855, DOI 10.1007/s004640080069; QUIRKE P, 1986, LANCET, V2, P996, DOI 10.1016/s0140-6736(86)92612-7; QUIRKE P, 1988, INT J COLORECTAL DIS, V3, P127, DOI 10.1007/BF01645318; Reilly WT, 1996, DIS COLON RECTUM, V39, P200; Scheidbach H, 2002, SURG ENDOSC, V16, P7, DOI 10.1007/s00464-001-8314-4; SIMONS AJ, 1995, DIS COLON RECTUM, V38, P600, DOI 10.1007/BF02054118; SLIM K, 1995, BRIT J SURG, V82, P1406, DOI 10.1002/bjs.1800821036; Stocchi L, 2000, ARCH SURG-CHICAGO, V135, P948, DOI 10.1001/archsurg.135.8.948; Weeks JC, 2002, JAMA-J AM MED ASSOC, V287, P321, DOI 10.1001/jama.287.3.321; WEXNER SD, 1995, BRIT J SURG, V82, P295, DOI 10.1002/bjs.1800820305; Wood J, 1999, J Health Serv Res Policy, V4, P226	32	2287	2474	1	86	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1718	1726		10.1016/S0140-6736(05)66545-2	http://dx.doi.org/10.1016/S0140-6736(05)66545-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894098				2022-12-28	WOS:000229082300023
J	Kmietowicz, Z				Kmietowicz, Z			Revalidation in the UK	BMJ-BRITISH MEDICAL JOURNAL			English	Article												zosia@blueyonder.co.uk						Dyer C, 1998, BRIT MED J, V317, P965, DOI 10.1136/bmj.317.7164.965; DYER O, 1995, BRIT MED J, V310, P960, DOI 10.1136/bmj.310.6985.960; Esmail A, 2005, BRIT MED J, V330, P1144, DOI 10.1136/bmj.330.7500.1144; *SHIPM INQ, SAF PAT LESS PAST PR	4	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2005	330	7500					1145	1145		10.1136/bmj.330.7500.1145	http://dx.doi.org/10.1136/bmj.330.7500.1145			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15891234	Green Published			2022-12-28	WOS:000229166900032
J	Pop, VJ; Vulsma, T				Pop, VJ; Vulsma, T			Maternal hypothyroxinaemia during (early) gestation	LANCET			English	Editorial Material							SUBCLINICAL THYROID-DYSFUNCTION; CLINICAL ENDOCRINOLOGISTS; AMERICAN ASSOCIATION; JOINT STATEMENT; FOLLOW-UP; PREGNANCY; DEFICIENCY; MANAGEMENT; DISORDERS		Tilburg Univ, Dept Clin Hlth Psychol, NL-5000 LE Tilburg, Netherlands; Univ Amsterdam, Emma Childrens Hosp AMC, Dept Paediat Endocrinol, Amsterdam, Netherlands	Tilburg University; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Pop, VJ (corresponding author), Tilburg Univ, Dept Clin Hlth Psychol, NL-5000 LE Tilburg, Netherlands.	v.j.m.pop@uvt.nl						de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25, DOI 10.1530/eje.0.151u025; Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Mandel SJ, 2005, THYROID, V15, P44, DOI 10.1089/thy.2005.15.44; Pop VJ, 2003, CLIN ENDOCRINOL, V59, P282, DOI 10.1046/j.1365-2265.2003.01822.x; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Utiger RD, 1999, NEW ENGL J MED, V341, P601, DOI 10.1056/NEJM199908193410809; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Vermiglio F, 2004, J CLIN ENDOCR METAB, V89, P6054, DOI 10.1210/jc.2004-0571; ZIMMERMANN M, 2005, P WHO TECHN CONS CON	10	34	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1604	1606		10.1016/S0140-6736(05)66489-6	http://dx.doi.org/10.1016/S0140-6736(05)66489-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885283	Green Submitted			2022-12-28	WOS:000228933700008
J	Feldman, BJ; Rosenthal, SM; Vargas, GA; Fenwick, RG; Huang, EA; Matsuda-Abedini, M; Lustig, RH; Mathias, RS; Portale, AA; Miller, WL; Gitelman, SE				Feldman, BJ; Rosenthal, SM; Vargas, GA; Fenwick, RG; Huang, EA; Matsuda-Abedini, M; Lustig, RH; Mathias, RS; Portale, AA; Miller, WL; Gitelman, SE			Nephrogenic syndrome of inappropriate antidiuresis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTEIN-COUPLED RECEPTORS; DIABETES-INSIPIDUS; CONSTITUTIVE ACTIVITY; V2 RECEPTOR; ORAL UREA; VASOPRESSIN; MUTATIONS; SECRETION; HORMONE; ANTAGONISTS	The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a common cause of hyponatremia. We describe two infants whose clinical and laboratory evaluations were consistent with the presence of SIADH, yet who had undetectable arginine vasopressin (AVP) levels. We hypothesized that they had gain-of-function mutations in the V2 vasopressin receptor (V2R). DNA sequencing of each patient's V2R gene (AVPR2) identified missense mutations in both, with resultant changes in codon 137 from arginine to cysteine or leucine. These novel mutations cause constitutive activation of the receptor and are the likely cause of the patients' SIADH-like clinical picture, which we have termed ``nephrogenic syndrome of inappropriate antidiuresis.''	Univ Calif San Francisco, Dept Pediat, Div Endocrinol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, Div Nephrol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Nichols Institute	Gitelman, SE (corresponding author), Univ Calif San Francisco, Div Pediat Endocrinol, 513 Parnassus Ave,Rm S679,Box 0434, San Francisco, CA 94143 USA.	sgitelma@peds.ucsf.edu	Lustig, Robert/O-9380-2019; Miller, Walter L/J-3696-2012	Lustig, Robert/0000-0001-6983-2639; 	NCRR NIH HHS [M01RR01271, M01 RR001271] Funding Source: Medline; NIDDK NIH HHS [T32 DK007161, T32DK07161] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007161] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; BARTTER FC, 1967, AM J MED, V42, P790, DOI 10.1016/0002-9343(67)90096-4; BICHET DG, 1993, J CLIN INVEST, V92, P1262, DOI 10.1172/JCI116698; BICHET DG, 1988, NEW ENGL J MED, V318, P881, DOI 10.1056/NEJM198804073181403; BIRNBAUMER M, 1994, MOL ENDOCRINOL, V8, P886, DOI 10.1210/me.8.7.886; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; DECAUX G, 1993, NEPHRON, V63, P468, DOI 10.1159/000187255; Fluck CE, 2002, J CLIN ENDOCR METAB, V87, P4318, DOI 10.1210/jc.2002-020501; HIRSCH AT, 1989, J CLIN INVEST, V84, P418, DOI 10.1172/JCI114182; Huang EA, 2004, PEDIATR RES, V55, p161A; Kaufmann JE, 2003, J THROMB HAEMOST, V1, P821, DOI 10.1046/j.1538-7836.2003.00197.x; Luttrell LM, 2002, J CELL SCI, V115, P455; MANNUCCI PM, 1977, LANCET, V1, P869; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Morin D, 1998, FEBS LETT, V441, P470, DOI 10.1016/S0014-5793(98)01585-3; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Robertson GL, 2001, ENDOCRIN METAB CLIN, V30, P671, DOI 10.1016/S0889-8529(05)70207-3; ROSENTHAL W, 1993, J BIOL CHEM, V268, P13030; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Stables J, 1999, J RECEPT SIGNAL TR R, V19, P395, DOI 10.3109/10799899909036660; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Verbalis JG, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290001; ZERBE R, 1980, ANNU REV MED, V31, P315, DOI 10.1146/annurev.me.31.020180.001531	26	224	233	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1884	1890		10.1056/NEJMoa042743	http://dx.doi.org/10.1056/NEJMoa042743			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872203	Green Accepted			2022-12-28	WOS:000228858600008
J	Hayden, JA; van Tulder, MW; Malmivaara, AV; Koes, BW				Hayden, JA; van Tulder, MW; Malmivaara, AV; Koes, BW			Meta-analysis: Exercise therapy for nonspecific low back pain	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; 3 ACTIVE THERAPIES; 2-YEAR FOLLOW-UP; CLINICAL-TRIAL; CONSERVATIVE TREATMENT; FUNCTIONAL RESTORATION; PHYSICAL-THERAPY; GRADED ACTIVITY; CONVENTIONAL PHYSIOTHERAPY; PROPHYLACTIC MANAGEMENT	Background: Exercise therapy is widely used as an intervention in low back pain. Objective: To evaluate the effectiveness of exercise therapy in adult nonspecific acute, subacute, and chronic low back pain versus no treatment and other conservative treatments. Data Sources: MEDLINE, EMBASE, Psychinfo, CINAHL, and Cochrane Library databases to October 2004; citation searches and bibliographic reviews of previous systematic reviews. Study Selection: Randomized, controlled trials evaluating exercise therapy for adult nonspecific low back pain and measuring pain, function, return to work or absenteeism, and global improvement outcomes. Data Extraction: Two reviewers independently selected studies and extracted data on study characteristics, quality, and outcomes at short-, intermediate-, and long-term follow-up. Data Synthesis: 61 randomized, controlled trials (6390 participants) met inclusion criteria: acute (11 trials), subacute (6 trials), and chronic (43 trials) low back pain (1 trial was unclear). Evidence suggests that exercise therapy is effective in chronic back pain relative to comparisons at all follow-up periods. Pooled mean improvement (of 100 points) was 7.3 points (95% Cl, 3.7 to 10.9 points) for pain and 2.5 points (Cl, 1.0 to 3.9 points) for function at earliest follow-up. In studies investigating patients (people seeking care for back pain), mean improvement was 13.3 points (Cl, 5.5 to 21.1 points) for pain and 6.9 points (Cl, 2.2 to 11.7 points) for function, compared with studies where some participants had been recruited from a general population (for example, with advertisements). Some evidence suggests effectiveness of a graded-activity exercise program in subacute low back pain in occupational settings, although the evidence for other types of exercise therapy in other populations is inconsistent. In acute low back pain, exercise therapy and other programs were equally effective (pain, 0.03 point [Cl, -1.3 to 1.4 points]). Limitations: Limitations of the literature, including low-quality studies with heterogeneous outcome measures inconsistent and poor reporting, and possibility of publication bias. Conclusions: Exercise therapy seems to be slightly effective at decreasing pain and improving function in adults with chronic low back pain, particularly in health care populations. In subacute low back pain populations, some evidence suggests that a graded-activity program improves absenteeism outcomes, although evidence for other types of exercise is unclear. In acute low back pain populations, exercise therapy is as effective as either no treatment or other conservative treatments.	Inst Work & Hlth, Toronto, ON M5G 2E9, Canada; Univ Toronto, Toronto, ON, Canada; Vrije Univ Amsterdam, Inst Res Extramural Med, NL-1081 HV Amsterdam, Netherlands; Natl Res & Dev Ctr Welf & Hlth, Finnish Off Hlth Care Technol Assessment, Helsinki, Finland; Erasmus Univ, Med Ctr, Rotterdam, Netherlands	Institute for Work & Health; University of Toronto; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Hayden, JA (corresponding author), Inst Work & Hlth, 481 Univ Ave,Suite 800,8th Floor, Toronto, ON M5G 2E9, Canada.	jhayden@iwh.on.ca	Koes, Bart w/K-4614-2016; van Tulder, Maurits/AAB-9785-2022	Koes, Bart w/0000-0002-0450-9969; van Tulder, Maurits/0000-0002-7589-8471; Hayden, Jill Alison/0000-0001-7026-144X				Abenhaim L, 2000, SPINE, V25, p1S, DOI 10.1097/00007632-200002151-00001; Albright J, 2001, PHYS THER, V81, P1641; Alexandre NMC, 2001, REV SAUDE PUBL, V35, P356, DOI 10.1590/S0034-89102001000400004; Aure OF, 2003, SPINE, V28, P525, DOI 10.1097/00007632-200303150-00002; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bendix A F, 1995, Eur Spine J, V4, P148, DOI 10.1007/BF00298239; Bendix AF, 1998, SPINE, V23, P717, DOI 10.1097/00007632-199803150-00013; Bendix AF, 1997, SCAND J REHABIL MED, V29, P81; Bendix T, 2000, SPINE, V25, P2494, DOI 10.1097/00007632-200010010-00012; Bentsen H, 1997, SPINE, V22, P1494, DOI 10.1097/00007632-199707010-00014; Bombardier C, 2001, J RHEUMATOL, V28, P431; Bronfort G, 1996, J Manipulative Physiol Ther, V19, P570; BUSWELL J, 1982, NZ J PHYSIOTHER, V10, P13; Calmels P., 2004, Annales de Readaptation et de Medecine Physique, V47, P20, DOI 10.1016/j.annrmp.2003.07.001; Cherkin DC, 1998, NEW ENGL J MED, V339, P1021, DOI 10.1056/NEJM199810083391502; Chok B, 1999, PHYS THER, V79, P1032, DOI 10.1093/ptj/79.11.1032; Dalichau S, 2000, Z ORTHOP GRENZGEB, V138, P8, DOI 10.1055/s-2000-10106; DAVIES JE, 1979, RHEUMATOL REHABIL, V18, P243, DOI 10.1093/rheumatology/18.4.243; DELITTO A, 1993, PHYS THER, V73, P216, DOI 10.1093/ptj/73.4.216; DELITTO A, 1993, PHYS THER, V73, P226, DOI 10.1093/ptj/73.4.226; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Descarreaux M, 2002, J MANIP PHYSIOL THER, V25, P497, DOI 10.1067/mmt.2002.127078; DEYO RA, 1990, NEW ENGL J MED, V322, P1627, DOI 10.1056/NEJM199006073222303; Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELNAGGAR IM, 1991, SPINE, V16, P967, DOI 10.1097/00007632-199108000-00018; Ernst E, 2003, FORSCH KOMP KLAS NAT, V10, P325, DOI 10.1159/000075886; EVANS C, 1987, Physiotherapy Canada, V39, P96; FAAS A, 1995, SPINE, V20, P941, DOI 10.1097/00007632-199504150-00012; FAAS A, 1993, SPINE, V18, P1388; FARRELL JP, 1982, MED J AUSTRALIA, V1, P160, DOI 10.5694/j.1326-5377.1982.tb132242.x; Frost H, 2004, BRIT MED J, V329, P708, DOI 10.1136/bmj.38216.868808.7C; Frost H, 1998, PAIN, V75, P273, DOI 10.1016/S0304-3959(98)00005-0; FROST H, 1995, BRIT MED J, V310, P151, DOI 10.1136/bmj.310.6973.151; Galantino ML, 2004, ALTERN THER HEALTH M, V10, P56; GILBERT JR, 1985, BRIT MED J, V291, P791, DOI 10.1136/bmj.291.6498.791; Glomsrod B, 2001, J REHABIL MED, V33, P26; Gur A, 2003, LASER SURG MED, V32, P233, DOI 10.1002/lsm.10134; HANSEN FR, 1993, SPINE, V18, P98, DOI 10.1097/00007632-199301000-00015; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Hemmila HM, 1997, ARCH PHYS MED REHAB, V78, P571, DOI 10.1016/S0003-9993(97)90420-2; Hemmila HM, 2002, J MANIP PHYSIOL THER, V25, P99, DOI 10.1067/mmt.2002.122329; Hides J A, 2001, Spine (Phila Pa 1976), V26, pE243, DOI 10.1097/00007632-200106010-00004; Hides JA, 1996, SPINE, V21, P2763, DOI 10.1097/00007632-199612010-00011; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HILDE G, 1998, PHYS THER REV, V3, P107; Hildebrandt V H, 2000, Ned Tijdschr Geneeskd, V144, P2258; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JOHANNSEN F, 1995, J ORTHOP SPORT PHYS, V22, P52, DOI 10.2519/jospt.1995.22.2.52; Jousset N, 2004, SPINE, V29, P487, DOI 10.1097/01.BRS.0000102320.35490.43; Kankaanpaa M, 1999, SPINE, V24, P1034, DOI 10.1097/00007632-199905150-00019; Kendall PH, 1968, PHYSIOTHERAPY, V54, P154; Kool J, 2004, J REHABIL MED, V36, P49, DOI 10.1080/16501970310020104; Kopec JA, 2000, SPINE, V25, P3110, DOI 10.1097/00007632-200012150-00005; Kuukkanen TM, 2000, CLIN REHABIL, V14, P192, DOI 10.1191/026921500667300454; Liddle SD, 2004, PAIN, V107, P176, DOI 10.1016/j.pain.2003.10.017; Lidstrom A, 1970, Scand J Rehabil Med, V2, P37; Lie Hakon, 1999, Tidsskrift for den Norske Laegeforening, V119, P2051; LINDSTROM I, 1992, SPINE, V17, P641, DOI 10.1097/00007632-199206000-00003; LINDSTROM I, 1992, PHYS THER, V72, P279, DOI 10.1093/ptj/72.4.279; LINDSTROM I, 1994, THESIS GOTEBERG SWED; Ljunggren AE, 1997, SPINE, V22, P1610, DOI 10.1097/00007632-199707150-00017; Lonn JH, 1999, SPINE, V24, P865, DOI 10.1097/00007632-199905010-00006; MALMIVAARA A, 1995, NEW ENGL J MED, V332, P351, DOI 10.1056/NEJM199502093320602; MANNICHE C, 1988, LANCET, V2, P1473; MANNICHE C, 1991, PAIN, V47, P53, DOI 10.1016/0304-3959(91)90011-L; Mannion AF, 1999, SPINE, V24, P2435, DOI 10.1097/00007632-199912010-00004; Mannion AF, 2001, SPINE, V26, P920, DOI 10.1097/00007632-200104150-00015; Mannion AF, 2001, RHEUMATOLOGY, V40, P772, DOI 10.1093/rheumatology/40.7.772; Moffett JK, 1999, BRIT MED J, V319, P279, DOI 10.1136/bmj.319.7205.279; Moseley L, 2002, AUST J PHYSIOTHER, V48, P297, DOI 10.1016/S0004-9514(14)60169-0; Niemisto L, 2003, SPINE, V28, P2185, DOI 10.1097/01.BRS.0000085096.62603.61; Pengel HM, 2002, CLIN REHABIL, V16, P811, DOI 10.1191/0269215502cr562oa; Petersen T, 2002, SPINE, V27, P1702, DOI 10.1097/00007632-200208150-00004; Preyde M, 2000, CAN MED ASSOC J, V162, P1815; Rasmussen-Barr E, 2003, MANUAL THER, V8, P233, DOI 10.1016/S1356-689X(03)00053-5; RISCH SV, 1993, SPINE, V18, P232, DOI 10.1097/00007632-199302000-00010; Rittweger J, 2002, SPINE, V27, P1829, DOI 10.1097/00007632-200209010-00003; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; Seferlis T, 1998, Eur Spine J, V7, P461; Seferlis T, 2000, SCAND J PRIM HEALTH, V18, P53; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Soukup M G, 2001, Physiother Res Int, V6, P27, DOI 10.1002/pri.211; Soukup MG, 1999, SPINE, V24, P1585, DOI 10.1097/00007632-199908010-00013; Staal JB, 2004, ANN INTERN MED, V140, P77, DOI 10.7326/0003-4819-140-2-200401200-00007; STANKOVIC R, 1995, SPINE, V20, P469, DOI 10.1097/00007632-199502001-00010; STANKOVIC R, 1990, SPINE, V15, P120, DOI 10.1097/00007632-199002000-00014; Storheim K, 2003, J REHABIL MED, V35, P132, DOI 10.1080/16501970310010484; Torstensen TA, 1998, SPINE, V23, P2616, DOI 10.1097/00007632-199812010-00017; Tritilanunt Tipawan, 2001, Journal of the Medical Association of Thailand, V84, pS528; TURNER JA, 1990, J CONSULT CLIN PSYCH, V58, P573, DOI 10.1037/0022-006X.58.5.573; Underwood MR, 1998, FAM PRACT, V15, P9, DOI 10.1093/fampra/15.1.9; van Tulder M, 2000, SPINE, V25, P2784, DOI 10.1097/00007632-200011010-00011; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; Waddell G, 1997, BRIT J GEN PRACT, V47, P647; WATERWORTH RF, 1985, NEW ZEAL MED J, V98, P372; Yelland MJ, 2004, SPINE, V29, P9, DOI 10.1097/01.BRS.0000105529.07222.5B; Yeung CKN, 2003, J ALTERN COMPLEM MED, V9, P479, DOI 10.1089/107555303322284767; Yozbatiran Nuray, 2004, Pain Clinic, V16, P35, DOI 10.1163/156856904322858684; ZYLBERGOLD RS, 1981, ARCH PHYS MED REHAB, V62, P176	101	352	371	2	57	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					765	775		10.7326/0003-4819-142-9-200505030-00013	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00013			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922GW	15867409	Green Published			2022-12-28	WOS:000228825800006
J	Schellenberg, D; Menendez, C; Aponte, JJ; Kahigwa, E; Tanner, M; Mshinda, H; Alonso, P				Schellenberg, D; Menendez, C; Aponte, JJ; Kahigwa, E; Tanner, M; Mshinda, H; Alonso, P			Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial	LANCET			English	Article							MALARIA	Stopping antimalarial chemoprophylaxis can be followed by increased risk of malaria, suggesting that it interferes with the development of antimalarial immunity. We report analysis of extended follow-up until age 2 years of a randomised, placebo-controlled double-blind trial of intermittent preventive antimalarial treatment in infants. The rate of clinical malaria (events per person-year at risk, starting 1 month after final dose of intermittent treatment) was 0.28 in the sulfadoxine-pyrimethamine group and 0.43 in the placebo group (protective effect 36%, 95% Cl 11-53). Intermittent treatment produced a sustained reduction in the risk of clinical malaria extending well beyond the duration of the pharmacological effects of the drugs, excluding a so-called rebound effect and suggesting that such treatment could facilitate development of immunity against Plasmodium falciparum.	Hosp Clin Barcelona, IDIBAPS, Ctr Int Hlth, Barcelona, Spain; Ifakara Hlth Res & Dev Ctr, Kilombero, Tanzania; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; Swiss Trop Inst, CH-4002 Basel, Switzerland	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Ifakara Health Institute; University of London; London School of Hygiene & Tropical Medicine; University of Basel; Swiss Tropical & Public Health Institute	Schellenberg, D (corresponding author), IHRDC, POB 78373, Dar Es Salaam, Tanzania.	dmschellenberg@aol.com	Alonso, Pedro L/AAZ-3645-2020; Menéndez, Clara/Q-3446-2016	Alonso, Pedro L/0000-0003-3292-3443; Menéndez, Clara/0000-0002-2641-6907; Schellenberg, David/0000-0001-8222-0186				Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; Schellenberg D, 2002, AM J TROP MED HYG, V67, P17, DOI 10.4269/ajtmh.2002.67.17; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg DM, 2003, T ROY SOC TROP MED H, V97, P647, DOI 10.1016/S0035-9203(03)80096-2; 1999, COMPENDIUM DATA SHEE	7	122	124	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1481	1483		10.1016/S0140-6736(05)66418-5	http://dx.doi.org/10.1016/S0140-6736(05)66418-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850632				2022-12-28	WOS:000228651600026
J	Adolfsson, J; Mansson, R; Buza-Vidas, N; Hultquist, A; Liuba, K; Jensen, CT; Bryder, D; Yang, LP; Borge, OJ; Thoren, LAM; Anderson, K; Sitnicka, E; Sasaki, Y; Sigvardsson, M; Jacobsen, SEW				Adolfsson, J; Mansson, R; Buza-Vidas, N; Hultquist, A; Liuba, K; Jensen, CT; Bryder, D; Yang, LP; Borge, OJ; Thoren, LAM; Anderson, K; Sitnicka, E; Sasaki, Y; Sigvardsson, M; Jacobsen, SEW			Identification of Flt3(+) lympho-myeloid stem cells lacking erythro-megakaryocytic potential: A revised road map for adult blood lineage commitment	CELL			English	Article							HEMATOPOIETIC PROGENITOR CELLS; MOUSE BONE-MARROW; SELF-RENEWAL; B-CELL; TRANSCRIPTION FACTORS; REPOPULATING ACTIVITY; DENDRITIC CELLS; DEFICIENT MICE; FETAL LIVER; IN-VITRO	All blood cell lineages derive from a common hematopoietic stem cell (HSC). The current model implicates that the first lineage commitment step of adult pluripotent HSCs results in a strict separation into common lymphoid and common myeloid precursors. We present evidence for a population of cells which, although sustaining a high proliferative and combined lympho-myeloid differentiation potential, have lost the ability to adopt erythroid and megakaryocyte lineage fates. Cells in the Lin-Sca-1+c-kit+ HSC compartment coexpressing high levels of the tyrosine kinase receptor Flt3 sustain granulocyte, monocyte, and B and T cell potentials but in contrast to Lin-Sca-1(+)ckit(+)Flt3(-) HSCs fail to produce significant erythroid and megakaryocytic progeny. This distinct lineage restriction site is accompanied by downregulation of genes for regulators of erythroid and megakaryocyte development. In agreement with representing a lymphoid primed progenitor, Lin(-)Sca-l(+)c-kit(+)CD34(+)Flt3(+) cells display upregulated IL-7 receptor gene expression. Based on these observations, we propose a revised road map for adult blood lineage development.	Lund Univ, Hematopoiet Stem Cell Lab, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, S-22184 Lund, Sweden	Lund University	Jacobsen, SEW (corresponding author), Lund Univ, Hematopoiet Stem Cell Lab, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, S-22184 Lund, Sweden.	sten.jacobsen@med.lu.se	Jacobsen, Sten Eirik W/D-3974-2018; Bryder, David/Q-6292-2019; Mansson, Robert/D-4372-2014	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Mansson, Robert/0000-0003-0738-0328; Sigvardsson, Mikael/0000-0001-8527-7276; Hultquist, Anne/0000-0003-4355-230X; Bryder, David/0000-0002-8761-4237				Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bryder D, 2000, BLOOD, V96, P1748, DOI 10.1182/blood.V96.5.1748.h8001748_1748_1755; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Cumano A, 2001, CURR OPIN IMMUNOL, V13, P166, DOI 10.1016/S0952-7915(00)00200-4; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Delassus S, 1999, BLOOD, V94, P1495, DOI 10.1182/blood.V94.5.1495.417a08_1495_1503; Ema H, 2003, CURR OPIN GENET DEV, V13, P508, DOI 10.1016/j.gde.2003.08.011; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Hansen JD, 1998, IMMUNOL REV, V166, P199, DOI 10.1111/j.1600-065X.1998.tb01264.x; HARRISON DE, 1988, P NATL ACAD SCI USA, V85, P822, DOI 10.1073/pnas.85.3.822; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; KEMPF RA, 1980, INT J RADIAT ONCOL, V6, P252, DOI 10.1016/0360-3016(80)90047-4; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Lu M, 2002, J IMMUNOL, V169, P3519, DOI 10.4049/jimmunol.169.7.3519; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; METCALF D, 1993, BLOOD, V82, P3515; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; NAKAHATA T, 1982, J CELL PHYSIOL, V113, P455, DOI 10.1002/jcp.1041130314; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; OGAWA M, 1993, BLOOD, V81, P2844; Orkin S H, 1998, Stem Cells, V16 Suppl 2, P79; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; Veiby OP, 1996, BLOOD, V88, P1256, DOI 10.1182/blood.V88.4.1256.bloodjournal8841256; Vieira Paulo, 2004, Methods Mol Biol, V271, P67; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; WHITNEY JB, 1978, BIOCH GENET, V271, P67; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	54	873	893	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					295	306		10.1016/j.cell.2005.02.013	http://dx.doi.org/10.1016/j.cell.2005.02.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851035	Bronze			2022-12-28	WOS:000228705000016
J	Saunders, MA; Lea, AS				Saunders, MA; Lea, AS			Seasonal prediction of hurricane activity reaching the coast of the United States	NATURE			English	Article							EL-NINO; ATLANTIC; DAMAGES	Much of the property damage from natural hazards in the United States is caused by landfalling hurricanes(1-3)-strong tropical cyclones that reach the coast. For the southeastern Atlantic coast of the US, a statistical method for forecasting the occurrence of landfalling hurricanes for the season ahead has been reported(4), but the physical mechanisms linking the predictor variables to the frequency of hurricanes remain unclear. Here we present a statistical model that uses July wind anomalies between 1950 and 2003 to predict with significant and useful skill the wind energy of US landfalling hurricanes for the following main hurricane season (August to October). We have identified six regions over North America and over the east Pacific and North Atlantic oceans where July wind anomalies, averaged between heights of 925 and 400 mbar, exhibit a stationary and significant link to the energy of landfalling hurricanes during the subsequent hurricane season. The wind anomalies in these regions are indicative of atmospheric circulation patterns that either favour or hinder evolving hurricanes from reaching US shores.	UCL, Dept Space & Climate Phys, Benfield Hazard Res Ctr, Dorking RH5 6NT, Surrey, England	University of London; University College London	Saunders, MA (corresponding author), UCL, Dept Space & Climate Phys, Benfield Hazard Res Ctr, Holmbury St Mary, Dorking RH5 6NT, Surrey, England.	mas@mssl.ucl.ac.uk		Saunders, Mark/0000-0001-9606-7389				*BENF IND AN RES T, 2004, CATASTROPHE LOSSES; Bove MC, 1998, B AM METEOROL SOC, V79, P2477, DOI 10.1175/1520-0477(1998)079<2477:EOENOO>2.0.CO;2; CHEN WY, 1982, MON WEATHER REV, V110, P808, DOI 10.1175/1520-0493(1982)110<0808:FINHMH>2.0.CO;2; Collins DJ, 2001, MACROVALIDATION DATA, P217; DAVIS RE, 1976, J PHYS OCEANOGR, V6, P249, DOI 10.1175/1520-0485(1976)006<0249:POSSTA>2.0.CO;2; Diaz H.F., 1997, HURRICANES CLIMATE S; ELSNER JB, 1994, WEATHER FORECAST, V9, P619, DOI 10.1175/1520-0434(1994)009<0619:AFSTCV>2.0.CO;2; Franklin JL, 1996, MON WEATHER REV, V124, P64, DOI 10.1175/1520-0493(1996)124<0064:TCMASF>2.0.CO;2; Freund R.J., 1998, REGRESSION ANAL STAT; GRAY WM, 1993, WEATHER FORECAST, V8, P73, DOI 10.1175/1520-0434(1993)008<0073:PABSTC>2.0.CO;2; GRAY WM, 1984, MON WEATHER REV, V112, P1669, DOI 10.1175/1520-0493(1984)112<1669:ASHFPI>2.0.CO;2; HILTI N, 2004, GLOB REINSURANCE JUL, P6; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KEQIN D, 1986, MON WEATHER REV, V114, P115, DOI 10.1175/1520-0493(1986)114<0115:TRBTCM>2.0.CO;2; Klotzbach PJ, 2003, WEATHER FORECAST, V18, P1109, DOI 10.1175/1520-0434(2003)018<1109:FSABTC>2.0.CO;2; Lehmiller GS, 1997, MON WEATHER REV, V125, P1780, DOI 10.1175/1520-0493(1997)125<1780:SPMFNA>2.0.CO;2; Lyons SW, 2004, WEATHER FORECAST, V19, P473, DOI 10.1175/1520-0434(2004)019<0473:UTCLV>2.0.CO;2; NEUMANN CJ, 1999, HIST CLIMATOLOGY SER, V62; Pielke RA, 1998, WEATHER FORECAST, V13, P621, DOI 10.1175/1520-0434(1998)013<0621:NHDITU>2.0.CO;2; Pielke RA, 1999, B AM METEOROL SOC, V80, P2027, DOI 10.1175/1520-0477(1999)080<2027:LNAENO>2.0.CO;2; Saunders MA, 2000, GEOPHYS RES LETT, V27, P1147, DOI 10.1029/1999GL010948; *SVS LRF, 2002, WMO485 SVS LRF, V1; Waple AM, 2002, B AM METEOROL SOC, V83, pS1; Wilks A. A., 1995, STAT METHODS ATMOSPH	24	63	66	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1005	1008		10.1038/nature03454	http://dx.doi.org/10.1038/nature03454			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846342				2022-12-28	WOS:000228524600034
J	Wright, P				Wright, P			Sir John Vivian Dacie - Obituary	LANCET			English	Biographical-Item												pearce.wright@dial.pipex.com							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 16	2005	365	9468					1382	1382		10.1016/S0140-6736(05)66362-3	http://dx.doi.org/10.1016/S0140-6736(05)66362-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QY	15864858				2022-12-28	WOS:000228401900015
J	Evans, JMM; Donnelly, LA; Emslie-Smith, AM; Alessi, DR; Morris, AD				Evans, JMM; Donnelly, LA; Emslie-Smith, AM; Alessi, DR; Morris, AD			Metformin and reduced risk of cancer in diabetic patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RECORD LINKAGE		Univ Dundee, Div Community Hlth Sci, Sect Publ Hlth, Dundee DD2 4BF, Scotland; Univ Dundee, Sch Life Sci, Dundee, Scotland; Univ Dundee, Div Med, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee	Evans, JMM (corresponding author), Univ Dundee, Div Community Hlth Sci, Sect Publ Hlth, Dundee DD2 4BF, Scotland.	j.m.mstansfield@dundee.ac.uk	Morris, Andrew D/C-2837-2009	Alessi, Dario/0000-0002-2140-9185	Medical Research Council [MC_U127070193] Funding Source: Medline; MRC [MC_U127070193] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		EVANS JMM, 1995, BMJ-BRIT MED J, V311, P22, DOI 10.1136/bmj.311.6996.22; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Merom D, 2004, J SCI MED SPORT, V7, P32, DOI 10.1016/S1440-2440(04)80041-0; Morris AD, 1997, BMJ-BRIT MED J, V315, P524, DOI 10.1136/bmj.315.7107.524	5	1704	1817	4	169	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2005	330	7503					1304	1305		10.1136/bmj.38415.708634.F7	http://dx.doi.org/10.1136/bmj.38415.708634.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TL	15849206	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000229655700023
J	Lee, SJ; Matsuura, Y; Liu, SM; Stewart, M				Lee, SJ; Matsuura, Y; Liu, SM; Stewart, M			Structural basis for nuclear import complex dissociation by RanGTP	NATURE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; EXPORT; KARYOPHERINS; DOMAIN; BIND	Nuclear protein import is mediated mainly by the transport factor importin-beta that binds cytoplasmic cargo, most often via the importin-alpha adaptor, and then transports it through nuclear pore complexes. This active transport is driven by disassembly of the import complex by nuclear RanGTP(1-4). The switch I and II loops of Ran change conformation with nucleotide state(5-7), and regulate its interactions with nuclear trafficking components. Importin-beta consists of 19 HEAT repeats that are based on a pair of antiparallel alpha-helices ( referred to as the A- and B-helices). The HEAT repeats stack to yield two C-shaped arches, linked together to form a helicoidal molecule that has considerable conformational flexibility(1,8) (-12). Here we present the structure of full-length yeast importin-beta (Kap95p or karyopherin-beta) complexed with RanGTP, which provides a basis for understanding the crucial cargo-release step of nuclear import. We identify a key interaction site where the RanGTP switch I loop binds to the carboxy-terminal arch of Kap95p. This interaction produces a change in helicoidal pitch that locks Kap95p in a conformation that cannot bind importin-alpha or cargo. We suggest an allosteric mechanism for nuclear import complex disassembly by RanGTP.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ms@mrc-lmb.cam.ac.uk						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cingolani G, 2000, FEBS LETT, V484, P291, DOI 10.1016/S0014-5793(00)02154-2; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Fukuhara N, 2004, J BIOL CHEM, V279, P2176, DOI 10.1074/jbc.M309112200; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Stewart M, 1998, J MOL BIOL, V284, P1517, DOI 10.1006/jmbi.1998.2204; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	23	164	168	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					693	696		10.1038/nature03578	http://dx.doi.org/10.1038/nature03578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15864302				2022-12-28	WOS:000229476200054
J	Lawton, J; Ahmad, N; Hallowell, N; Hanna, L; Douglas, M				Lawton, J; Ahmad, N; Hallowell, N; Hanna, L; Douglas, M			Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICATION; ADHERENCE; KNOWLEDGE; HEALTH	Objective To explore British Pakistani and British. Indian patients' perceptions and experiences of taking oral hypoglycaemic agents (OHAs). Design Observational cross sectional study using in-depth interviews in English or Punjabi. Setting and participants 32 patients of Pakistani and Indian origin with type 2 diabetes, recruited from primary care and community sources in Edinburgh, Scotland. Results Respondents reported complex and ambivalent views about OHAs, which reflected their ambivalent attitudes towards Western drugs in general. Respondents considered OHAs to be an important part of the diabetic regimen because they perceived British healthcare professionals to be competent and trustworthy prescribers, and they considered the medicines available in Britain to be superior to those on the Indian subcontinent. Despite this, some respondents made deliberate efforts to reduce their tablet intake without being advised to do so. Reasons for this included perceptions that drugs worked by providing relief of symptoms and concerns that OHAs could be detrimental to health if taken for long periods, in conjunction with other drugs, or without traditional foods. Conclusions British Pakistani and Indian patients' perceptions of their ORAs may partly derive from popular ideas about drugs on the Indian subcontinent. Cultural factors need to be understood and taken into consideration to ensure that these patients are given appropriate advice and to avoid unnecessary changes to prescriptions.	Univ Edinburgh, Sch Clin Sci & Community Hlth, Res Unit Hlth Behav & Change, Edinburgh EH8 9AG, Midlothian, Scotland; Lothian NHS Board, Edinburgh EH8 9RS, Midlothian, Scotland	University of Edinburgh	Lawton, J (corresponding author), Univ Edinburgh, Sch Clin Sci & Community Hlth, Res Unit Hlth Behav & Change, Edinburgh EH8 9AG, Midlothian, Scotland.	J.Lawton@ed.ac.uk		Douglas, Margaret/0000-0003-1560-5451				Aadil N, 2004, BMJ-BRIT MED J, V329, P778, DOI 10.1136/bmj.329.7469.778; [Anonymous], [No title captured]; BENSON J, 2002, BRIT MED J, V325, P1314; BHOPAL RS, 1988, COMMUNITY MED, V10, P215; Cambridge Jan, 1999, TRANSLATOR, V5, P201, DOI DOI 10.1080/13556509.1999.10799041; CONRAD P, 1985, SOC SCI MED, V20, P29, DOI 10.1016/0277-9536(85)90308-9; DCOSTA FD, 2000, PRACTICAL DIABETES, V8, P64, DOI DOI 10.1002/PDI.1960080208; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Evans JMM, 2002, DIABETIC MED, V19, P685, DOI 10.1046/j.1464-5491.2002.00749.x; Gillam S, 1999, BRIT MED J, V319, P1215, DOI 10.1136/bmj.319.7219.1215; HUNTE PA, 1992, SOC SCI MED, V34, P1385, DOI 10.1016/0277-9536(92)90147-I; Lau DT, 2004, DIABETES CARE, V27, P2149, DOI 10.2337/diacare.27.9.2149; McLean CA, 2003, ETHNIC HEALTH, V8, P41, DOI 10.1080/13557850303558; Miller N H, 1997, Am J Med, V102, P43; NICHTER N, 1996, ANTHR INT HLTH ASIAN; Pardhan S, 2004, EYE, V18, P509, DOI 10.1038/sj.eye.6700680; Ponnusankar S, 2004, PATIENT EDUC COUNS, V54, P55, DOI 10.1016/s0738-3991(03)00193-9; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; QIDWAI W, 2002, JCPSP-J COLL PHYSICI, V12, P651; Saradamma RD, 2000, SOC SCI MED, V50, P891, DOI 10.1016/S0277-9536(99)00380-9; Sin CH, 2004, AGEING SOC, V24, P257, DOI 10.1017/S0144686X03001545; Strauss A., 1990, BASICS QUALITATIVE R; Sudha G, 2003, TROP MED INT HEALTH, V8, P336, DOI 10.1046/j.1365-3156.2003.01010.x; tain RPS of G, 1997, COMPLIANCE CONCORDAN	24	68	69	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2005	330	7502					1247	1249		10.1136/bmj.38460.642789.E0	http://dx.doi.org/10.1136/bmj.38460.642789.E0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930WX	15883139	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000229448900019
J	Latvala, J; von Hertzen, L; Lindholm, H; Haahtela, T				Latvala, J; von Hertzen, L; Lindholm, H; Haahtela, T			Trends in prevalence of asthma and allergy in Finnish young men: nationwide study, 1966-2003	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RHINITIS		Finnish Inst Occupat Hlth, Res Inst Mil Med, Oulu 90220, Finland; Univ Helsinki, Cent Hosp, Skin & Allergy Hosp, Helsinki 00029, Finland; Finnish Inst Occupat Hlth, Helsinki 00250, Finland	Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital; Finnish Institute of Occupational Health	Latvala, J (corresponding author), Finnish Inst Occupat Hlth, Res Inst Mil Med, Aapistie 1, Oulu 90220, Finland.	jari.latvala@ttl.fi						Braback L, 2004, CLIN EXP ALLERGY, V34, P38, DOI 10.1111/j.1365-2222.2004.01841.x; Braun-Fahrlander C, 2004, EUR RESPIR J, V23, P407, DOI 10.1183/09031936.04.00074004; HAAHTELA T, 1990, BRIT MED J, V301, P266, DOI 10.1136/bmj.301.6746.266; Haahtela T, 2001, THORAX, V56, P806, DOI 10.1136/thorax.56.10.806; Verlato G, 2003, J ALLERGY CLIN IMMUN, V111, P1232, DOI 10.1067/mai.2003.1484	5	82	86	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2005	330	7501					1186	1187		10.1136/bmj.38448.603924.AE	http://dx.doi.org/10.1136/bmj.38448.603924.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	929CU	15849204	Bronze, Green Published			2022-12-28	WOS:000229320500019
J	Chia, S; Bryce, C; Gelmon, K				Chia, S; Bryce, C; Gelmon, K			The 2000 EBCTCG overview: a widening gap	LANCET			English	Editorial Material							EARLY BREAST-CANCER; RANDOMIZED-TRIALS		British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada	British Columbia Cancer Agency	Gelmon, K (corresponding author), British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada.	kgelmon@bccancer.bc.ca						Abe O, 1998, LANCET, V352, P930; ALBAIN K, 2004, BREAST CANC RES T S1, V88; CHIA SKL, 2003, P AN M AM SOC CLIN, V22, P6; Clarke M, 1996, LANCET, V348, P1189; Clarke M, 1998, LANCET, V351, P1451; MUSS HB, 2005, JAMA-J AM MED ASSOC, V239, P1073; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967	10	40	41	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2005	365	9472					1665	1666		10.1016/S0140-6736(05)66524-5	http://dx.doi.org/10.1016/S0140-6736(05)66524-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894082				2022-12-28	WOS:000229082300004
J	Kemper, AR; Cohn, LM; Fant, KE; Dombkowski, KJ; Hudson, SR				Kemper, AR; Cohn, LM; Fant, KE; Dombkowski, KJ; Hudson, SR			Follow-up testing among children with elevated screening blood lead levels	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION; GUIDELINES; HEALTH	Context Follow-up testing after an abnormal screening blood lead level is a key component of lead poisoning prevention. Objectives To measure the proportion of children with elevated screening lead levels who have follow-up testing and to determine factors associated with such care. Design, Setting, and Participants Retrospective, observational cohort study of 3682 Michigan Medicaid-enrolled children aged 6 years or younger who had a screening blood lead level of at least 10 mu g/dL (0.48 mu mol/L) between,January 1, 2002, and June 30, 2003. Main Outcome Measure Testing within 180 days of an elevated screening lead level. Results Follow-up testing was received by 53.9% (95% confidence interval [01, 52.2%-55.5%) of the children. In multivariate analysis adjusting for age, screening blood lead level results, and local health department catchment area, the relative risk of follow-up testing was lower for Hispanic or nonwhite children than for white children (0.91; 95% Cl, 0.87-0.94), for children living in urban compared with rural areas (0.92; 95% Cl, 0.89-0.96), and for children living in high- compared with low-risk lead areas (0.94; 95% Cl, 0.92-0.96). Among children who did not have follow-up testing, 58.6% (95% Cl, 56.3%-61.0%) had at least 1 medical encounter in the 6-month period after the elevated screening blood lead level, including encounters for evaluation and management (39.3 %; 95% Cl, 36.9%-41.6%) or preventive care (13.2 %; 95% Cl, 11.6%-14.8%). Conclusions The rate of follow-up testing after an abnormal screening blood lead level was low, and children with increased likelihood of lead poisoning were less likely to receive follow-up testing. At least half of the children had a missed opportunity for follow-up testing. The observed disparities of care may increase the burden of cognitive impairment among at-risk children.	Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; Michigan Dept Community Hlth, Childhood Lead Poisoning Prevent Program, Lansing, MI USA	University of Michigan System; University of Michigan; MDHHS - Michigan Department of Health & Human Services	Kemper, AR (corresponding author), 6E18 300 N Ingalls Bldg, Ann Arbor, MI 48109 USA.	kempera@med.umich.edu		Kemper, Alex/0000-0001-5491-3997				*AM MED ASS, 2003, CURR PROC TERM 2004; BRODY DJ, 1994, JAMA-J AM MED ASSOC, V272, P277, DOI 10.1001/jama.272.4.277; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; *CDCP, 2002, MAN EL BLOOD LEADS L; *CDCP, 1997, SCREEN YYOUNG CHILDR; Hoyle T, 2004, J PUBLIC HEALTH MAN, V10, pS66; Kaufmann RB, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.6.e79; Meyer Pamela A, 2003, MMWR Surveill Summ, V52, P1; Papadouka Vikki, 2004, J Public Health Manag Pract, VSuppl, pS72; Piecoro LT, 2001, HEALTH SERV RES, V36, P357; ROPER WL, PREVENTING LEAD POIS; Sox CM, 2003, JAMA-J AM MED ASSOC, V290, P1057, DOI 10.1001/jama.290.8.1057; *US DEP COMM CENS, METR MICR STAT AR; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; *US GAO, 1998, MED EL BLOOD LEAD LE; Wall TC, 2002, AMBUL PEDIATR, V2, P449, DOI 10.1367/1539-4409(2002)002<0449:CWVSGA>2.0.CO;2; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	17	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2232	2237		10.1001/jama.293.18.2232	http://dx.doi.org/10.1001/jama.293.18.2232			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886378	Bronze			2022-12-28	WOS:000228981100024
J	Ley, TJ				Ley, TJ			Stanley Joel Korsmeyer (1950-2005)	SCIENCE			English	Biographical-Item									Washington Univ, Dept Med, St Louis, MO 63110 USA; Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Dept Med, St Louis, MO 63110 USA.	tley@im.wustl.edu							0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					803	804		10.1126/science.1113842	http://dx.doi.org/10.1126/science.1113842			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879200				2022-12-28	WOS:000228986500029
J	Hampton, T				Hampton, T			Breaking barriers in transdermal drug delivery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								The first successful method of transdermal drug administration was in the formof a skin patch. Since then the use of patches has constantly progressed as new, less irritating chemical permeation enhancers are developed. This form of drug delivery is now applied in areas such as contraception, hormone-replacement and smoking cessation.										Karande P, 2005, P NATL ACAD SCI USA, V102, P4688, DOI 10.1073/pnas.0501176102	1	13	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2083	2083		10.1001/jama.293.17.2083	http://dx.doi.org/10.1001/jama.293.17.2083			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870404				2022-12-28	WOS:000228808200005
J	Joosten, SA; van Kooten, C				Joosten, SA; van Kooten, C			Non-HLA humoral immunity and chronic kidney-graft loss	LANCET			English	Editorial Material							CHRONIC ALLOGRAFT NEPHROPATHY; MYCOPHENOLATE-MOFETIL; TRANSPLANTATION; REJECTION; SURVIVAL		Leiden Univ, Med Ctr, Dept Nephrol, NL-2333 ZA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Kooten, C (corresponding author), Leiden Univ, Med Ctr, Dept Nephrol, C3-P, NL-2333 ZA Leiden, Netherlands.	kooten@lumc.nl	Joosten, Simone A/F-1357-2011; van Kooten, Cees/E-5694-2018; Joosten, Simone/E-4731-2011	Joosten, Simone A/0000-0002-9878-0863; van Kooten, Cees/0000-0002-6257-0899; 				Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Joosten SA, 2005, AM J TRANSPLANT, V5, P383, DOI 10.1111/j.1600-6143.2005.00690.x; Mauiyyedi S, 2001, J AM SOC NEPHROL, V12, P574, DOI 10.1681/ASN.V123574; Meier-Kriesche HU, 2001, TRANSPLANT P, V33, P1005, DOI 10.1016/S0041-1345(00)02305-8; Meier-Kriesche HU, 2001, TRANSPLANTATION, V71, P398, DOI 10.1097/00007890-200102150-00010; Merville P, 2004, AM J TRANSPLANT, V4, P1769, DOI 10.1111/j.1600-6143.2004.00533.x; MIETTINEN A, 1986, J EXP MED, V163, P1064, DOI 10.1084/jem.163.5.1064; Paul LC, 1999, KIDNEY INT, V56, P783, DOI 10.1046/j.1523-1755.1999.00611.x; Sarwal M, 2003, NEW ENGL J MED, V349, P125, DOI 10.1056/NEJMoa035588; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418	10	13	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1522	1523		10.1016/S0140-6736(05)66434-3	http://dx.doi.org/10.1016/S0140-6736(05)66434-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866292				2022-12-28	WOS:000228754800007
J	Block, BA; Teo, SLH; Walli, A; Boustany, A; Stokesbury, MJW; Farwell, CJ; Weng, KC; Dewar, H; Williams, TD				Block, BA; Teo, SLH; Walli, A; Boustany, A; Stokesbury, MJW; Farwell, CJ; Weng, KC; Dewar, H; Williams, TD			Electronic tagging and population structure of Atlantic bluefin tuna	NATURE			English	Article							THUNNUS-THYNNUS; EAST ATLANTIC; TEMPERATURE; SATELLITE; GULF; MOVEMENTS; BIOLOGY; FISH	Electronic tags that archive or transmit stored data to satellites have advanced the mapping of habitats used by highly migratory fish in pelagic ecosystems(1-6). Here we report on the electronic tagging of 772 Atlantic bluefin tuna in the western Atlantic Ocean in an effort to identify population structure. Reporting electronic tags provided accurate location data(7-9) that show the extensive migrations of individual fish (n = 330). Geoposition data delineate two populations, one using spawning grounds in the Gulf of Mexico and another from the Mediterranean Sea. Transatlantic movements of western-tagged bluefin tuna reveal site fidelity to known spawning areas in the Mediterranean Sea. Bluefin tuna that occupy western spawning grounds move to central and eastern Atlantic foraging grounds. Our results are consistent with two populations of bluefin tuna with distinct spawning areas that overlap on North Atlantic foraging grounds. Electronic tagging locations, when combined with US pelagic longline observer and logbook catch data, identify hot spots for spawning bluefin tuna in the northern slope waters of the Gulf of Mexico. Restrictions on the time and area where longlining occurs would reduce incidental catch mortalities on western spawning grounds.	Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA; Monterey Bay Aquarium, Monterey, CA 93940 USA; Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada	Stanford University; Monterey Bay Aquarium Research Institute; Dalhousie University	Block, BA (corresponding author), Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA.	bblock@stanford.edu	Weng, Kevin Chi-Ming/C-4709-2013	Weng, Kevin Chi-Ming/0000-0002-7069-7152				Apostolaki Panayiota, 2004, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V56, P1121; Atwood TC, 2003, CAN J ZOOL, V81, P1589, DOI 10.1139/Z03-144; BAGLIN RE, 1982, FISH B-NOAA, V80, P121; Blank JM, 2004, J EXP BIOL, V207, P881, DOI 10.1242/jeb.00820; Block BA, 1998, MAR TECHNOL SOC J, V32, P37; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; CAREY FG, 1973, COMP BIOCHEM PHYSIOL, V44, P375, DOI 10.1016/0300-9629(73)90490-8; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Cort J.L., 1991, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V35, P213; EKSTROM PA, 2004, NATL I POLAR RES, V58, P210; Fromentin JM, 2003, SCI MAR, V67, P51, DOI 10.3989/scimar.2003.67s151; Hill C., 2001, ELECT TAGGING TRACKI, P315, DOI DOI 10.1007/978-94-017-1402-0_17; Landeira-Fernandez AM, 2004, AM J PHYSIOL-REG I, V286, pR398, DOI 10.1152/ajpregu.00392.2003; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Mather F. J., 1995, 370 NOAA; MCGOWAN MF, 1989, FISH B-NOAA, V87, P615; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; National Research Council, 1994, ASS ATL BLUEF TUN; Nemerson D, 2000, FISH B-NOAA, V98, P118; Rivas L. R., 1954, Bulletin of Marine Science of the Gulf and Caribbean, V4, P302; Rooker JR, 2003, FISH OCEANOGR, V12, P75, DOI 10.1046/j.1365-2419.2003.00223.x; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Stokesbury MJW, 2004, CAN J FISH AQUAT SCI, V61, P1976, DOI 10.1139/F04-130; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; TURNER SC, 1994, ICCAT COLL VOL SCI P, V42, P170; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; [No title captured]	30	574	593	3	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1121	1127		10.1038/nature03463	http://dx.doi.org/10.1038/nature03463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858572				2022-12-28	WOS:000228693300041
J	Goldman, JM				Goldman, JM			A unifying mutation in chronic myeloproliferative disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NHLBI, Hematol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Goldman, JM (corresponding author), NHLBI, Hematol Branch, Bethesda, MD 20892 USA.							Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; JAMES C, IN PRESS NATURE; LEVINE RL, IN PRESS CANC CELL; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253	4	30	36	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1744	1746		10.1056/NEJMp058083	http://dx.doi.org/10.1056/NEJMp058083			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858182				2022-12-28	WOS:000228689000003
J	Naranjo, B; Gimzewski, JK; Putterman, S				Naranjo, B; Gimzewski, JK; Putterman, S			Observation of nuclear fusion driven by a pyroelectric crystal	NATURE			English	Article							INERTIAL-ELECTROSTATIC CONFINEMENT; EMISSION; FERROELECTRICS	While progress in fusion research continues with magnetic(1) and inertial(2) confinement, alternative approaches-such as Coulomb explosions of deuterium clusters(3) and ultrafast laser-plasma interactions(4)-also provide insight into basic processes and technological applications. However, attempts to produce fusion in a room temperature solid-state setting, including 'cold' fusion(5) and 'bubble' fusion(6), have met with deep scepticism(7). Here we report that gently heating a pyroelectric crystal in a deuterated atmosphere can generate fusion under desktop conditions. The electrostatic field of the crystal is used to generate and accelerate a deuteron beam (>100 keV and >4 nA), which, upon striking a deuterated target, produces a neutron flux over 400 times the background level. The presence of neutrons from the reaction D + D -> He-3 (820 keV) + n (2.45 MeV) within the target is confirmed by pulse shape analysis and proton recoil spectroscopy. As further evidence for this fusion reaction, we use a novel time-of-flight technique to demonstrate the delayed coincidence between the outgoing alpha-particle and the neutron. Although the reported fusion is not useful in the power-producing sense, we anticipate that the system will find application as a simple palm-sized neutron generator.	Univ Calif Los Angeles, Dept Phys, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, CNSI, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Naranjo, B (corresponding author), Univ Calif Los Angeles, Dept Phys, Los Angeles, CA 90095 USA.	naranjo@physics.ucla.edu		gimzewski, james/0000-0003-4333-6957				Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; BOSCH HS, 1992, NUCL FUSION, V32, P611, DOI 10.1088/0029-5515/32/4/I07; Brownridge JD, 2001, APPL PHYS LETT, V78, P1158, DOI 10.1063/1.1342209; Ditmire T, 1999, NATURE, V398, P489, DOI 10.1038/19037; Farnsworth P. T., 1968, U.S. Patent, Patent No. [3,386,883, 3386883]; Farnsworth P T., 1966, US Patent, Patent No. [3,258,402, 3258402]; GLASS AM, 1968, PHYS REV, V172, P564, DOI 10.1103/PhysRev.172.564; HIRSCH RL, 1967, J APPL PHYS, V38, P4522, DOI 10.1063/1.1709162; Miller GS, 2004, HEADACHE, V44, P238, DOI 10.1111/j.1526-4610.2004.04053.x; Mitterauer J, 2004, SURF INTERFACE ANAL, V36, P380, DOI 10.1002/sia.1693; NEVINS WM, 1995, PHYS PLASMAS, V2, P3804, DOI 10.1063/1.871080; Pretzler G, 1998, PHYS REV E, V58, P1165, DOI 10.1103/PhysRevE.58.1165; RIEGE H, 1994, NUCL INSTRUM METH A, V340, P80, DOI 10.1016/0168-9002(94)91282-3; ROSENBLUM B, 1974, APPL PHYS LETT, V25, P17, DOI 10.1063/1.1655260; Rosenman G, 2000, J APPL PHYS, V88, P6109, DOI 10.1063/1.1319378; Saltmarsh MJ, 2002, SCIENCE, V297; Shimomura Y, 2004, IEEE T APPL SUPERCON, V14, P1369, DOI 10.1109/TASC.2004.830580; Taleyarkhan RP, 2002, SCIENCE, V295, P1868, DOI 10.1126/science.1067589; Taubes G., 1993, BAD SCI SHORT LIFE W; VERBINSKI VV, 1968, NUCL INSTRUM METHODS, V65, P8, DOI 10.1016/0029-554X(68)90003-7; ZIEGLER JF, 1980, NUCL INSTRUM METHODS, V168, P17, DOI 10.1016/0029-554X(80)91225-2	21	157	166	6	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1115	1117		10.1038/nature03575	http://dx.doi.org/10.1038/nature03575			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858570				2022-12-28	WOS:000228693300039
J	Ofri, D				Ofri, D			They sent me here	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, Sch Med, New York, NY 10003 USA	New York University	Ofri, D (corresponding author), NYU, Sch Med, New York, NY 10003 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1746	1748		10.1056/NEJMp038252	http://dx.doi.org/10.1056/NEJMp038252			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858183				2022-12-28	WOS:000228689000004
J	Palmer, DM; Barthelmy, S; Gehrels, N; Kippen, RM; Cayton, T; Kouveliotou, C; Eichler, D; Wijers, RAMJ; Woods, PM; Granot, J; Lyubarsky, YE; Ramirez-Ruiz, E; Barbier, L; Chester, M; Cummings, J; Fenimore, EE; Finger, MH; Gaensler, BM; Hullinger, D; Krimm, H; Markwardt, CB; Nousek, JA; Parsons, A; Patel, S; Sakamoto, T; Sato, G; Suzuki, M; Tueller, J				Palmer, DM; Barthelmy, S; Gehrels, N; Kippen, RM; Cayton, T; Kouveliotou, C; Eichler, D; Wijers, RAMJ; Woods, PM; Granot, J; Lyubarsky, YE; Ramirez-Ruiz, E; Barbier, L; Chester, M; Cummings, J; Fenimore, EE; Finger, MH; Gaensler, BM; Hullinger, D; Krimm, H; Markwardt, CB; Nousek, JA; Parsons, A; Patel, S; Sakamoto, T; Sato, G; Suzuki, M; Tueller, J			A giant gamma-ray flare from the magnetar SGR 1806-20	NATURE			English	Article							REPEATER SGR 1900+14; 1998 AUGUST 27; RADIATIVE MECHANISM; BURST; OUTBURSTS; MISSION	Two classes of rotating neutron stars-soft gamma-ray repeaters (SGRs) and anomalous X-ray pulsars-are magnetars(1), whose X-ray emission is powered by a very strong magnetic field (B approximate to 10(15) G). SGRs occasionally become 'active', producing many short X-ray bursts. Extremely rarely, an SGR emits a giant flare with a total energy about a thousand times higher than in a typical burst(2-4). Here we report that SGR 1806-20 emitted a giant flare on 27 December 2004. The total (isotropic) flare energy is 2 x 10(46) erg, which is about a hundred times higher than the other two previously observed giant flares. The energy release probably occurred during a catastrophic reconfiguration of the neutron star's magnetic field. If the event had occurred at a larger distance, but within 40 megaparsecs, it would have resembled a short, hard gamma-ray burst, suggesting that flares from extragalactic SGRs may form a subclass of such bursts.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA; NASA, Goddard Space Flight Ctr, Univ Space Res Assoc, Greenbelt, MD 20771 USA; NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35805 USA; Univ Space Res Assoc, NSSTC, Huntsville, AL 35805 USA; Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel; Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94309 USA; Inst Adv Study, Princeton, NJ 08540 USA; Penn State Univ, University Pk, PA 16802 USA; CNR, Washington, DC 20001 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Maryland, College Pk, MD 20742 USA; Inst Space & Astronaut Sci, JAXA, Kanagawa 2298510, Japan; Saitama Univ, Sakura Ku, Saitama 3388570, Japan	United States Department of Energy (DOE); Los Alamos National Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Universities Space Research Association (USRA); Ben Gurion University; University of Amsterdam; Stanford University; Institute for Advanced Study - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University System of Maryland; University of Maryland College Park; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Saitama University	Palmer, DM (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	palmer@lanl.gov	Barthelmy, Scott D/D-2943-2012; Parsons, Ann/I-6604-2012; Gaensler, Bryan M/F-8655-2010; Tueller, Jack/D-5334-2012; LYUBARSKY, YURY/F-2362-2012; Gehrels, Neil/D-2971-2012	Gaensler, Bryan/0000-0002-3382-9558; Eichler, David/0000-0002-9051-9927; Lyubarsky, Yuri/0000-0002-2316-8899; Wijers, Ralph/0000-0002-3101-1808				Barthelmy SD, 2004, P SOC PHOTO-OPT INS, V5165, P175, DOI 10.1117/12.506779; BELIAN RD, 1992, J GEOPHYS RES-SPACE, V97, P16897, DOI 10.1029/92JA01139; BORKOWSKI D, 2004, 2920 GCN; Corbel S, 2004, ASTRON ASTROPHYS, V419, P191, DOI 10.1051/0004-6361:20034054; Eichler D, 2002, MON NOT R ASTRON SOC, V335, P883, DOI 10.1046/j.1365-8711.2002.05571.x; Fenimore EE, 1996, ASTROPHYS J, V460, P964, DOI 10.1086/177024; Feroci M, 2001, ASTROPHYS J, V549, P1021, DOI 10.1086/319441; GALLEGO J, 1995, APJ, V455, P1; Hurley K, 1999, NATURE, V397, P41, DOI 10.1038/16199; Hurley K, 1999, ASTROPHYS J, V510, pL107, DOI 10.1086/311821; KENNICUTT RC, 1989, ASTROPHYS J, V344, P685, DOI 10.1086/167834; KOUVELIOTOU C, 1993, ASTROPHYS J, V413, pL101, DOI 10.1086/186969; MAZETS EP, 1979, NATURE, V282, P587, DOI 10.1038/282587a0; MEIER MM, 1996, AIP C P, V383, P203, DOI DOI 10.1063/1.51533; PALMER D, 2004, 2925 GCN; Thompson C, 2001, ASTROPHYS J, V561, P980, DOI 10.1086/323256; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255, DOI 10.1093/mnras/275.2.255; Woods PM, 1999, ASTROPHYS J, V524, pL55, DOI 10.1086/312297; Woods PM, 2002, ASTROPHYS J, V576, P381, DOI 10.1086/341536; WOODS PM, 2005, ASTRON TELEGR, V407; WOODS PM, 2004, ASTRON TELEGR, V313	22	393	400	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2005	434	7037					1107	1109		10.1038/nature03525	http://dx.doi.org/10.1038/nature03525			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858567				2022-12-28	WOS:000228693300036
J	Kravitz, RL; Epstein, RM; Feldman, MD; Franz, CE; Azari, R; Wilkes, MS; Hinton, L; Franks, P				Kravitz, RL; Epstein, RM; Feldman, MD; Franz, CE; Azari, R; Wilkes, MS; Hinton, L; Franks, P			Influence of patients' requests for direct-to-consumer advertised antidepressants - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY IMPROVEMENT PROGRAMS; STANDARDIZED PATIENTS; PRIMARY-CARE; PRESCRIPTION DRUGS; OFFICE PRACTICE; DEPRESSION; GUIDELINES; PHYSICIAN; DISORDERS; PROMOTION	Context Direct-to-consumer (DTC) advertising of prescription drugs in the United States is both ubiquitous and controversial. Critics charge that it leads to overprescribing, while proponents counter that it helps avert underuse of effective treatments, especially for conditions that are poorly recognized or stigmatized. Objective To ascertain the effects of patients' DTC-related requests on physicians' initial treatment decisions in patients with depressive symptoms. Design Randomized trial using standardized patients (SPs). Six SP roles were created by crossing 2 conditions (major depression or adjustment disorder with depressed mood) with 3 request types (brand-specific, general, or none). Setting Off ices of primary care physicians in Sacramento, Calif; San Francisco, Calif; and Rochester, NY, between May 2003 and May 2004. Participants One hundred fifty-two family physicians and general internists recruited from solo and group practices and health maintenance organizations; cooperation rates ranged from 53% to 61%. Interventions The SPs were randomly assigned to make 298 unannounced visits, with assignments constrained so physicians saw 1 SP with major depression and 1 with adjustment disorder. The SPs. made a brand-specific drug request, a general drug request, or no request (control condition) in approximately one third of visits. Main Outcome Measures Data on prescribing, mental health referral, and primary care follow-up obtained from SP written reports, visit audiorecordings, chart review, and analysis of written prescriptions and drug samples. The effects of request type on prescribing were evaluated using contingency tables and confirmed in generalized linear mixed models that accounted for clustering and adjusted for site, physician, and visit characteristics. Results Standardized patient role fidelity was excellent, and the suspicion rate that physicians had seen an SP was 13%. In major depression, rates of antidepressant prescribing were 53%, 76%, and 31% for SPs making brand-specific, general, and no requests, respectively (P<.001). In adjustment disorder, antidepressant prescribing rates were 55%, 39%, and 10%, respectively (P<.001). The results were confirmed in multivariate models. Minimally acceptable initial care (any combination of an antidepressant, mental health referral, or follow-up within 2 weeks) was offered to 98% of SPs in the major depression role making a general request, 90% of those making a brand-specific request, and 56% of those,making no request (P<.001). Conclusions Patients' requests have a profound effect on physician prescribing in major depression and adjustment disorder. Direct-to-consumer advertising may have competing effects on quality, potentially both averting underuse and promoting overuse.	Univ Calif Davis, Ctr Hlth Serv Res Primary Care, Sacramento, CA 95817 USA; Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA; Univ Calif Davis, Dept Stat, Sacramento, CA 95817 USA; Univ Calif Davis, Dept Psychiat, Sacramento, CA 95817 USA; Univ Calif Davis, Dept Family & Community Med, Sacramento, CA 95817 USA; Univ Rochester, Sch Med & Dent, Dept Family Med, Rochester, NY USA; Univ Rochester, Sch Med & Dent, Dept Psychiat, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Ctr Improve Commun Hlth Care, Rochester, NY USA; Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Rochester; University of Rochester; University of Rochester; University of California System; University of California San Francisco	Kravitz, RL (corresponding author), Univ Calif Davis, Ctr Hlth Serv Res, 2103 Stockton Blvd,Suite 2224,GB, Sacramento, CA 95817 USA.	rlkravitz@ucdavis.edu	Kravitz, Richard/AAF-7425-2021	Kravitz, Richard/0000-0001-5575-529X; Franz, Carol/0000-0002-8987-1755	NIA NIH HHS [K23 AG019809, K23-AG19809] Funding Source: Medline; NIMH NIH HHS [R01 MH064683-03, R01 MH064683-02, R01 MH064683-01A1, R01 MH064683] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG019809] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; *AM PSYCH ASS, 2000, DIAGN STAT MAN MENT, P775; *AM PSYCH ASS, 2000, DIAGN STAT MAN MENT, P349; Anderson IM, 2000, J PSYCHOPHARMACOL, V14, P3, DOI 10.1177/026988110001400101; Barbey JT, 1998, J CLIN PSYCHIAT, V59, P42; Barret JE, 2001, J FAM PRACTICE, V50, P405; Becker H, 2003, WESTERN J NURS RES, V25, P746, DOI 10.1177/0193945903253002; Bell RA, 2000, J FAM PRACTICE, V49, P329; Bell RA, 1999, J GEN INTERN MED, V14, P651, DOI 10.1046/j.1525-1497.1999.01049.x; Bell RA, 1999, J FAM PRACTICE, V48, P446; Beullens J, 1997, FAM PRACT, V14, P58, DOI 10.1093/fampra/14.1.58; Carney PA, 1999, J FAM PRACTICE, V48, P958; Cohen LJ, 1997, ANN PHARMACOTHER, V31, P782, DOI 10.1177/106002809703100620; CooperPatrick L, 1997, J GEN INTERN MED, V12, P431, DOI 10.1046/j.1525-1497.1997.00075.x; Donohue JM, 2004, MED CARE, V42, P1176, DOI 10.1097/00005650-200412000-00004; Ferguson JM, 2001, J CLIN PSYCHIAT, V62, P22; Glassman P A, 2000, Jt Comm J Qual Improv, V26, P644; Gorter S, 2002, J RHEUMATOL, V29, P1496; Guiton G, 2004, ADV HEALTH SCI EDUC, V9, P179, DOI 10.1023/B:AHSE.0000038174.87790.7b; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Hollon MF, 1999, JAMA-J AM MED ASSOC, V281, P382, DOI 10.1001/jama.281.4.382; Holmer AF, 1999, JAMA-J AM MED ASSOC, V281, P380, DOI 10.1001/jama.281.4.380; Judd LL, 2004, AM J PSYCHIAT, V161, P1864, DOI 10.1176/appi.ajp.161.10.1864; *KAIS FAM FDN, 2004, PRESCR DRUG TRENDS; Kramer PD, 1997, LISTENING PROZAC; Kravitz RL, 2000, WESTERN J MED, V173, P221, DOI 10.1136/ewjm.173.4.221; Kravitz RL, 2003, ARCH INTERN MED, V163, P1673, DOI 10.1001/archinte.163.14.1673; Kravitz RL, 2002, HEALTH SERV RES, V37, P217; Kravitz RL, 2002, MED CARE, V40, P38, DOI 10.1097/00005650-200201000-00006; Luck J, 2002, BMJ-BRIT MED J, V325, P679, DOI 10.1136/bmj.325.7366.679; *MAN MAJ DEPR DIS, 2000, VET HLTH ADM DEP DEF; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Mello MM, 2003, JAMA-J AM MED ASSOC, V289, P477, DOI 10.1001/jama.289.4.477; Mintzes B, 2002, BRIT MED J, V324, P278, DOI 10.1136/bmj.324.7332.278; *NAT I HLTH CAR MA, 2000, RES BRIEF PRESCR DRU, P8; *OFF MED POL DIV D, ATT BEH ASS DIR TO C; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Raingruber B, 2002, ARCH PSYCHIAT NURS, V16, P201, DOI 10.1053/apnu.2002.36230; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; Rost K, 1993, J Rural Health, V9, P57, DOI 10.1111/j.1748-0361.1993.tb00495.x; Simon GE, 2002, GEN HOSP PSYCHIAT, V24, P213, DOI 10.1016/S0163-8343(02)00198-6; TAMBLYN RM, 1992, ACAD MED, V67, pS22, DOI 10.1097/00001888-199210000-00027; Unutzer J, 2001, ARCH GEN PSYCHIAT, V58, P935, DOI 10.1001/archpsyc.58.10.935; van der Klink JJL, 2003, SCAND J WORK ENV HEA, V29, P478, DOI 10.5271/sjweh.756; Weissman JS, 2004, HEALTH AFFAIR, V23, pW4219, DOI 10.1377/hlthaff.W4.219; WEISSMAN JS, 2003, HLTH AFF MILLWO 0226, DOI DOI 10.1377/HLTHAFF.W3.28; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Wells KB, 1999, ARCH FAM MED, V8, P529, DOI 10.1001/archfami.8.6.529; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110; ZAMANIYAN F, 2003, DRUG ADVERTISING SPE	50	425	428	0	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2005	293	16					1995	2002		10.1001/jama.293.16.1995	http://dx.doi.org/10.1001/jama.293.16.1995			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919XS	15855433	Green Accepted, Bronze			2022-12-28	WOS:000228651500025
J	Kiernan, AE; Pelling, AL; Leung, KKH; Tang, ASP; Bell, DM; Tease, C; Lovell-Badge, R; Steel, KP; Cheah, KSE				Kiernan, AE; Pelling, AL; Leung, KKH; Tang, ASP; Bell, DM; Tease, C; Lovell-Badge, R; Steel, KP; Cheah, KSE			Sox2 is required for sensory organ development in the mammalian inner ear	NATURE			English	Article							HAIR-CELLS; STEM-CELLS; EXPRESSION; DROSOPHILA; MATH1; GENERATION; CHICKEN; GENES; DIFFERENTIATION; EPITHELIUM	Sensory hair cells and their associated non-sensory supporting cells in the inner ear are fundamental for hearing and balance. They arise from a common progenitor(1), but little is known about the molecular events specifying this cell lineage. We recently identified two allelic mouse mutants, light coat and circling (Lcc) and yellow submarine (Ysb), that show hearing and balance impairment(2). Lcc/Lcc mice are completely deaf, whereas Ysb/Ysb mice are severely hearing impaired(2). We report here that inner ears of Lcc/Lcc mice fail to establish a prosensory domain and neither hair cells nor supporting cells differentiate, resulting in a severe inner ear malformation, whereas the sensory epithelium of Ysb/Ysb mice shows abnormal development with disorganized and fewer hair cells. These phenotypes are due to the absence (in Lcc mutants) or reduced expression (in Ysb mutants) of the transcription factor SOX2, specifically within the developing inner ear. SOX2 continues to be expressed in the inner ears of mice lacking Math1 (also known as Atoh1 and HATH1), a gene essential for hair cell differentiation, whereas Math1 expression is absent in Lcc mutants, suggesting that Sox2 acts upstream of Math1.	Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England; Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England	University of Hong Kong; University of Nottingham; MRC National Institute for Medical Research; MRC Harwell	Cheah, KSE (corresponding author), Univ Hong Kong, Dept Biochem, Fac Med Bldg,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	hrmbdkc@hkusua.hku.hk	Cheah, Kathryn/C-4222-2009; Leung, Keith/C-4491-2009	Lovell-Badge, Robin/0000-0001-9364-4179; Bell, Donald/0000-0002-3788-1580	MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Buescher M, 2002, DEVELOPMENT, V129, P4193; Cai JL, 2002, DEV BIOL, V251, P221, DOI 10.1006/dbio.2002.0828; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; CHEAH KSE, 1995, J CELL BIOL, V128, P223, DOI 10.1083/jcb.128.1.223; Chen P, 2002, DEVELOPMENT, V129, P2495; Chen P, 1999, DEVELOPMENT, V126, P1581; Cole LK, 2000, J COMP NEUROL, V424, P509, DOI 10.1002/1096-9861(20000828)424:3<509::AID-CNE8>3.0.CO;2-Q; Dong S, 2002, GENOMICS, V79, P777, DOI 10.1006/geno.2002.6783; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Fekete DM, 1998, J NEUROSCI, V18, P7811; Jan Yuh Nung, 1994, Current Opinion in Neurobiology, V4, P8, DOI 10.1016/0959-4388(94)90025-6; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kishi M, 2000, DEVELOPMENT, V127, P791; KNOWLTON VY, 1967, J MORPHOL, V121, P179, DOI 10.1002/jmor.1051210302; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; LYON MF, 1979, MUTAT RES, V63, P161, DOI 10.1016/0027-5107(79)90113-1; Morsli H, 1998, J NEUROSCI, V18, P3327; Overton PM, 2002, DEVELOPMENT, V129, P4219; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Tsai H, 2001, HUM MOL GENET, V10, P507, DOI 10.1093/hmg/10.5.507; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753	30	396	415	3	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1031	1035		10.1038/nature03487	http://dx.doi.org/10.1038/nature03487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846349				2022-12-28	WOS:000228524600041
J	Lin, XR; Hull, CM; Heitman, J				Lin, XR; Hull, CM; Heitman, J			Sexual reproduction between partners of the same mating type in Cryptococcus neoformans	NATURE			English	Article							PNEUMOCYSTIS-CARINII; FILOBASIDIELLA-NEOFORMANS; SACCHAROMYCES-CEREVISIAE; ALPHA; YEAST; GENE; ASSOCIATION; TOXOPLASMA; ACTIVATION; EVOLUTION	Cryptococcus neoformans is a globally distributed human fungal pathogen that causes life-threatening meningoencephalitis in immunocompromised patients(1). It has a defined sexual cycle involving haploid cells of a and a mating types(2), yet the vast majority of environmental and clinical isolates are a (ref. 3). Sexual recombination is normally expected to occur between isolates of opposite mating type in organisms with two mating types (or sexes). How sexual reproductive potential can be maintained in an organism with a largely unisexual, nearly clonal population genetic structure is unknown. One clue, however, is that a strains undergo fruiting, a process that resembles sexual mating(4) but is thought to be strictly mitotic and asexual. We report here that hallmarks of mating occur during fruiting, including diploidization and meiosis. Pheromone response pathway elements and the key meiotic regulator Dmc1 are required for efficient fruiting. Furthermore, fusion and meiosis can occur between non-isogenic a strains, enabling genetic exchange. These studies reveal how sexual reproduction can occur between partners of the same mating type. These findings have implications for the evolution of microbial pathogens, as well as for parthenogenesis, cell fusion events and transitions between self-fertilizing and outcrossing modes of reproduction observed in both fungi and other kingdoms.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Lin, XR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	xrlin@duke.edu; heitm001@duke.edu	Lin, Xiaorong/ABC-4163-2021; Heitman, Joseph/ABC-6006-2021	Lin, Xiaorong/0000-0002-3390-8387; 				Anderson JB, 2004, GENETICS, V168, P1915, DOI 10.1534/genetics.104.033266; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hull CM, 2002, GENE DEV, V16, P3046, DOI 10.1101/gad.1041402; Hull CM, 2002, ANNU REV GENET, V36, P557, DOI 10.1146/annurev.genet.36.052402.152652; Johnson A, 2003, NAT REV MICROBIOL, V1, P106, DOI 10.1038/nrmicro752; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P821, DOI 10.2307/3758800; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Marra RE, 2004, GENETICS, V167, P619, DOI 10.1534/genetics.103.023408; MATSUMOTO Y, 1984, J PROTOZOOL, V31, P420, DOI 10.1111/j.1550-7408.1984.tb02989.x; McClelland CM, 2004, TRENDS MICROBIOL, V12, P208, DOI 10.1016/j.tim.2004.03.003; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; ROSE MD, 1986, MOL CELL BIOL, V6, P3490, DOI 10.1128/MCB.6.10.3490; Sauvageau S, 2004, BIOESSAYS, V26, P1151, DOI 10.1002/bies.20150; Shen WC, 2002, EUKARYOT CELL, V1, P366, DOI 10.1128/EC.1.3.366-377.2002; Shimizu KK, 2004, SCIENCE, V306, P2081, DOI 10.1126/science.1103776; Sia RA, 2000, FUNGAL GENET BIOL, V29, P153, DOI 10.1006/fgbi.2000.1192; Smulian AG, 2001, GENETICS, V157, P991; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang P, 2000, MOL CELL BIOL, V20, P352, DOI 10.1128/MCB.20.1.352-362.2000; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Wyder MA, 1998, J EUKARYOT MICROBIOL, V45, P233, DOI 10.1111/j.1550-7408.1998.tb04531.x; Zeyl C, 2004, FEMS MICROBIOL LETT, V233, P187, DOI 10.1016/j.femsle.2004.02.007; Zeyl C, 2003, SCIENCE, V299, P555, DOI 10.1126/science.1078417	30	293	307	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1017	1021		10.1038/nature03448	http://dx.doi.org/10.1038/nature03448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846346				2022-12-28	WOS:000228524600038
J	Archer, JC; Norcini, J; Davies, HA				Archer, JC; Norcini, J; Davies, HA			Use of SPRAT for peer review of paediatricians in training	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICIAN PERFORMANCE; RATINGS; FACULTY	Objective To determine whether a multisource feedback questionnaire, SPRAT (Sheffield peer review assessment tool), is a feasible and reliable assessment method to inform the record of in-training assessment for paediatric senior house officers and specialist registrars. Design Trainees' clinical performance was evaluated using SPRAT sent to clinical colleagues of their choosing. Responses were analysed to determine variables that affected ratings and their measurement characteristics. Setting Three tertiary hospitals and five secondary hospitals across a UK deanery. Participants 112 paediatric senior house officers and middle grades. Main outcome measures 95% confidence intervals for mean ratings; linear and hierarchical regression to explore potential biasing factors; time needed for the process per doctor. Results 20 middle grades and 92 senior house officers were assessed using SPRAT to inform their record of in-training assessment; 921/1120 (82%) of their proposed raters completed a SPRAT form. As a group, specialist registrars (mean 5.22, SD 0.34) scored significantly higher (t = - 4.765) than did senior house officers (mean 4.81, SD 0.35) (P < 0.001). The grade of the doctor accounted for 7.6% of the variation in the mean ratings. The hierarchical regression showed that only 3.4% of the variation in the means could be additionally attributed to three main factors (occupation of rater, length of working relationship, and environment in which the relationship took place) when the doctor's grade was controlled for (significant F change < 0.001). 93 (83%) of the doctors in this study would have needed only four raters to achieve a reliable score if the intent was to determine if they were satisfactory. The mean time taken to complete the questionnaire by a rater was six minutes. Just over an hour of administrative time is needed for each doctor. Conclusions SPRAT seems to be a valid way of assessing large numbers of doctors to support quality assurance procedures for training programmes. The feedback from SPRAT can also be used to inform personal development planning and focus quality improvements.	Sheffield Childrens Hosp, Postgrad Med Educ Dept, Sheffield S10 2HT, S Yorkshire, England; Sheffield Childrens Hosp, Acad Unit Child Hlth, Sheffield S10 2HT, S Yorkshire, England; FAIMER, Philadelphia, PA 19104 USA	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital	Davies, HA (corresponding author), Sheffield Childrens Hosp, Postgrad Med Educ Dept, Sheffield S10 2HT, S Yorkshire, England.	h.davies@sheffield.ac.uk		Norcini, John/0000-0002-8464-4115				Archer J, 2003, SHEFFIELD PEER REV A; Archer Julian C, 2004, Health Serv J, V114, P26; Cronbach LJ, 2004, EDUC PSYCHOL MEAS, V64, P391, DOI 10.1177/0013164404266386; Davis JD, 2002, OBSTET GYNECOL, V99, P647, DOI 10.1016/S0029-7844(02)01658-7; Evans R, 2004, BMJ-BRIT MED J, V328, P1240, DOI 10.1136/bmj.328.7450.1240; General Medical Council, 2001, GOOD MED PRACT; Hall W, 1999, CAN MED ASSOC J, V161, P52; Holmboe ES, 2004, ACAD MED, V79, P16, DOI 10.1097/00001888-200401000-00006; Lipner RS, 2002, ACAD MED, V77, pS64, DOI 10.1097/00001888-200210001-00021; RAMSEY PG, 1993, JAMA-J AM MED ASSOC, V269, P1655, DOI 10.1001/jama.269.13.1655; *ROYAL COLL PAED C, 2002, GOOD MED PRACT PAED; Thomas PA, 1999, J GEN INTERN MED, V14, P551, DOI 10.1046/j.1525-1497.1999.10148.x; Violato C, 2003, BMJ-BRIT MED J, V326, P546, DOI 10.1136/bmj.326.7388.546; VIOLATO C, 1997, ACAD MED, V72, P82	14	108	108	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2005	330	7502					1251	1253		10.1136/bmj.38447.610451.8F	http://dx.doi.org/10.1136/bmj.38447.610451.8F			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930WX	15883137	Bronze, Green Published			2022-12-28	WOS:000229448900021
J	Veronesi, U; Boyle, P; Goldhirsch, A; Orecchia, R; Viale, G				Veronesi, U; Boyle, P; Goldhirsch, A; Orecchia, R; Viale, G			Breast cancer	LANCET			English	Review							CARCINOMA IN-SITU; ADJUVANT ENDOCRINE THERAPY; POSITIVE PREMENOPAUSAL WOMEN; ESTROGEN-RECEPTOR STATUS; SENTINEL LYMPH-NODES; POOLED ANALYSIS; AXILLARY DISSECTION; HIGH-RISK; INTRAOPERATIVE RADIOTHERAPY; POSTOPERATIVE RADIOTHERAPY	Breast cancer remains a public-health issue on a global scale. We report new information about the disease from the past 5 years. Early age at first birth, increasing parity, and tamoxifen use are related to long-term lifetime reduction in breast-cancer risk. Ductal carcinomas in situ has been suggested to be renamed ductal intraepithelial neoplasia to emphasise its non-life-threatening nature. An alternative approach, the progenitor/stem cell theory, predicts that only some tumour cells cause cancer progression and that these should be targeted by treatment. Mammography and ultrasonography are still the most effective for women with non-dense and dense breast tissues, respectively. Additionally, MRI, lymphatic mapping, the nipple-sparing mastectomy, partial breast irradiation, neoadjuvant systemic therapy, and adjuvant treatments are promising for subgroups of breast-cancer patients. Although tamoxifen can be offered for endocrine-responsive disease, aromatase inhibitors are increasingly used. Assessment of potential molecular targets is now important in primary diagnosis. Tyrosine-kinase inhibitors and other drugs with anti-angiogenesis properties are currently undergoing preclinical investigations.	European Inst Oncol, I-20141 Milan, Italy; Int Agcy Res Canc, F-69372 Lyon, France; Oncol Inst So Switzerland, Bellinzona, Switzerland; Oncol Inst So Switzerland, Lugano, Switzerland; Univ Milan, Sch Med, Milan, Italy	IRCCS European Institute of Oncology (IEO); World Health Organization; International Agency for Research on Cancer (IARC); Institute of Oncology Research (IOR); University of Milan	Veronesi, U (corresponding author), European Inst Oncol, I-20141 Milan, Italy.	umberto.veronesi@ieo.it	Viale, Giuseppe/AAE-8921-2019; Wolff, Antonio C./T-8796-2019; Ursin, Giske/U-6637-2017; Ozyigit, Gokhan/I-9471-2013; Hudis, Clifford/AAW-9482-2021; Marcom, Paul/M-4516-2019; Carlson, Robert/AAQ-8098-2020; Boyle, Peter/A-4380-2014; Hayes, Daniel/ABE-1129-2020; Ronckers, Cecile/GWN-0737-2022	Wolff, Antonio C./0000-0003-3734-1063; Ursin, Giske/0000-0002-0835-9507; Ozyigit, Gokhan/0000-0002-7497-4348; Hudis, Clifford/0000-0001-7144-8791; Boyle, Peter/0000-0001-6251-0610; 				Agus D, 2003, P AN M AM SOC CLIN, V22, P192; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Albain K, 2002, BREAST CANCER RES TR, V76, pS33; Albain KS, 2002, P AN M AM SOC CLIN, V21, p37a; Allen LF, 2003, SEMIN ONCOL, V30, P65, DOI 10.1053/j.seminoncol.2003.08.009; [Anonymous], 2003, WHO CLASSIFICATION T; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099; Barnes DM, 1996, BRIT J CANCER, V74, P1445, DOI 10.1038/bjc.1996.563; Baroni G, 2004, INT J RADIAT ONCOL, V59, P861, DOI 10.1016/j.ijrobp.2004.02.043; Bartelink H, 2001, NEW ENGL J MED, V345, P1378, DOI 10.1056/NEJMoa010874; Bartelink H, 2000, CANCER J SCI AM, V6, P2; BASSET LW, 1998, BREAST; Baum M, 2003, Cancer, V98, P1802; Baxter NN, 2004, JNCI-J NATL CANCER I, V96, P443, DOI 10.1093/jnci/djh069; Bear HD, 2003, J CLIN ONCOL, V21, P4165, DOI 10.1200/JCO.2003.12.005; Benson SRC, 2004, AM J SURG, V188, P381, DOI 10.1016/j.amjsurg.2004.06.032; Beral V, 2004, LANCET, V363, P1007, DOI 10.1016/S0140-6736(04)15835-2; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; BOICE JD, 1978, LATE BIOL EFFECTS IO, V1, P231; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Boyle P, 2003, ANN ONCOL, V14, P973, DOI 10.1093/annonc/mdg305; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Britz-Cunningham SH, 2003, J NUCL MED, V44, P1945; Buchholz TA, 2002, ONCOLOGIST, V7, P539, DOI 10.1634/theoncologist.7-6-539; Burbank F, 1996, AM SURGEON, V62, P738; Burris HA, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-suppl_3-10; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Castiglione-Gertsch M, 2003, JNCI-J NATL CANCER I, V95, P1833, DOI 10.1093/jnci/djg119; Chang J, 2000, CLIN CANCER RES, V6, P616; Chawla AK, 2002, INT J RADIAT ONCOL, V54, P520, DOI 10.1016/S0360-3016(02)02951-6; Chen AM, 2005, CANCER-AM CANCER SOC, V103, P689, DOI 10.1002/cncr.20815; Cho EY, 2003, JNCI-J NATL CANCER I, V95, P1079, DOI 10.1093/jnci/95.14.1079; Clarke M, 1998, LANCET, V351, P1451; Coates AS, 2002, LANCET ONCOL, V3, P525, DOI 10.1016/S1470-2045(02)00842-2; Colditz GA, 2003, BRIT J CANCER, V89, P847, DOI 10.1038/sj.bjc.6601175; Colleoni M, 2000, J CLIN ONCOL, V18, P584, DOI 10.1200/JCO.2000.18.3.584; Colleoni M, 2004, CLIN CANCER RES, V10, P6622, DOI 10.1158/1078-0432.CCR-04-0380; Colleoni M, 2003, ANN ONCOL, V14, P1477, DOI 10.1093/annonc/mdg411; Colleoni M, 2002, ANN ONCOL, V13, P273, DOI 10.1093/annonc/mdf039; Colleoni M, 2002, ANN ONCOL, V13, P73, DOI 10.1093/annonc/mdf013; Colleoni M, 2000, ANN ONCOL, V11, P1057, DOI 10.1023/A:1008334404825; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Crivellari D, 2003, J CLIN ONCOL, V21, P4517, DOI 10.1200/JCO.2003.03.559; Crystal P, 2003, AM J ROENTGENOL, V181, P177, DOI 10.2214/ajr.181.1.1810177; Cutuli B, 2002, INT J RADIAT ONCOL, V53, P868, DOI 10.1016/S0360-3016(02)02834-1; CUZICK J, 1994, J CLIN ONCOL, V12, P447, DOI 10.1200/JCO.1994.12.3.447; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Deutsch M, 2002, INT J RADIAT ONCOL, V53, P687, DOI 10.1016/S0360-3016(02)02785-2; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ellis M, 2004, ONCOLOGIST, V9, P20, DOI 10.1634/theoncologist.9-suppl_3-20; Ellis MJ, 2001, J CLIN ONCOL, V19, P3808, DOI 10.1200/JCO.2001.19.18.3808; Emens LA, 2003, CLIN CANCER RES, V9, p486S; Ernster VL, 2000, ARCH INTERN MED, V160, P953, DOI 10.1001/archinte.160.7.953; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Fisher B, 2004, JNCI-J NATL CANCER I, V96, P1823, DOI 10.1093/jnci/djh338; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fountzilas George, 2003, Clin Breast Cancer, V4, P120, DOI 10.3816/CBC.2003.n.017; Fuss M, 2004, ANN SURG ONCOL, V11, P130, DOI 10.1245/ASO.2004.10.907; Geisler S, 2001, CANCER RES, V61, P2505; Giuliano AE, 1996, J AM COLL SURGEONS, V183, P185; Goldhirsch A, 2001, J Natl Cancer Inst Monogr, P44; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; GORDON PB, 1993, RADIOLOGY, V189, P573, DOI 10.1148/radiology.189.2.8210392; GORDON PB, 1995, CANCER, V76, P626, DOI 10.1002/1097-0142(19950815)76:4<626::AID-CNCR2820760413>3.0.CO;2-Z; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Hartman AR, 2004, CANCER-AM CANCER SOC, V100, P479, DOI 10.1002/cncr.11926; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; HELVIE MA, 1994, AM J ROENTGENOL, V163, P1371, DOI 10.2214/ajr.163.6.7992731; HENDERSON BE, 1996, CANC EPIDEMIOLOGY PR; Heywang-Korunner SH, 2001, EUR RADIOL, V11, P531, DOI 10.1007/s003300000745; Hutcheon AW, 2003, BREAST CANCER RES TR, V79, pS19; IARC, 2004, IARC MON EV CARC RIS, V83; Isaacs C, 2004, BREAST CANCER RES TR, V84, P99, DOI 10.1023/B:BREA.0000018406.03679.2e; JENSEN EV, 1971, NATL CANCER I MONOGR, P55; KAUFMANN M, 2003, J CLIN ONCOL, V21, P4469; Key TJ, 1999, AM J CLIN NUTR, V70, p516S, DOI 10.1093/ajcn/70.3.516s; Kneeshaw PJ, 2003, BRIT J CANCER, V88, P4, DOI 10.1038/sj.bjc.6600713; Kroman N, 2000, BRIT MED J, V320, P474, DOI 10.1136/bmj.320.7233.474; Laden F, 2001, JNCI-J NATL CANCER I, V93, P768, DOI 10.1093/jnci/93.10.768; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; Leyland-Jones B, 2003, J CLIN ONCOL, V21, P3965, DOI 10.1200/JCO.2003.12.109; Liljegren G, 1999, J CLIN ONCOL, V17, P2326, DOI 10.1200/JCO.1999.17.8.2326; LIPPMAN ME, 1980, CANCER, V46, P2829, DOI 10.1002/1097-0142(19801215)46:12+<2829::AID-CNCR2820461419>3.0.CO;2-M; Love RR, 2003, J CLIN ONCOL, V21, P453, DOI 10.1200/JCO.2003.10.133; MACMAHON B, 1993, CANCER, V71, P3185, DOI 10.1002/1097-0142(19930515)71:10<3185::AID-CNCR2820711047>3.0.CO;2-C; Mano MS, 2004, ANN ONCOL, V15, P1161, DOI 10.1093/annonc/mdh302; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Melbye M, 1997, NEW ENGL J MED, V336, P81, DOI 10.1056/NEJM199701093360201; Missmer SA, 2002, INT J EPIDEMIOL, V31, P78, DOI 10.1093/ije/31.1.78; MODAN B, 1989, LANCET, V1, P629, DOI 10.1016/S0140-6736(89)92140-5; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Nahta R, 2003, ONCOLOGIST, V8, P5, DOI 10.1634/theoncologist.8-1-5; NEVILLE AM, 1992, J CLIN ONCOL, V10, P696, DOI 10.1200/JCO.1992.10.5.696; Nixon AJ, 1998, J CLIN ONCOL, V16, P1374, DOI 10.1200/JCO.1998.16.4.1374; Nooij MA, 2003, EUR J CANCER, V39, P614, DOI 10.1016/S0959-8049(02)00869-9; Nowak AK, 2004, LANCET ONCOL, V5, P372, DOI 10.1016/S1470-2045(04)01494-9; O'Shaughnessy JA, 2002, CANCER, V94, P292, DOI 10.1002/cncr.10238; Orlando L, 2001, ANTICANCER RES, V21, P4135; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; PAGE DL, 1992, HUM PATHOL, V23, P1095, DOI 10.1016/0046-8177(92)90026-Y; Patchell RA, 2003, CANCER TREAT REV, V29, P533, DOI 10.1016/S0305-7372(03)00105-1; Pegram MD, 2004, JNCI-J NATL CANCER I, V96, P739, DOI 10.1093/jnci/djh131; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petit JY, 2003, TUMORI J, V89, P288, DOI 10.1177/030089160308900311; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Poortmans P, 2004, RADIOTHER ONCOL, V72, P25, DOI 10.1016/j.radonc.2004.03.007; Presta LG, 1997, CANCER RES, V57, P4593; Ragaz J, 1997, NEW ENGL J MED, V337, P956, DOI 10.1056/NEJM199710023371402; Reis JS, 2003, BREAST CANCER RES, V5, P313, DOI 10.1186/bcr650; Reitsamer R, 2004, STRAHLENTHER ONKOL, V180, P38, DOI 10.1007/s00066-004-1190-9; Sainsbury R, 2004, BRIT J CANCER, V90, P1733, DOI 10.1038/sj.bjc.6601731; Schairer C, 2004, JNCI-J NATL CANCER I, V96, P1311, DOI 10.1093/jnci/djh253; Schwartz GF, 2002, CANCER, V94, P2542, DOI 10.1002/cncr.10539; Schwartz Gordon F., 2000, Cancer, V88, P946, DOI 10.1002/(SICI)1097-0142(20000215)88:4<946::AID-CNCR26>3.0.CO;2-5; SHAPIRO S, 1982, JNCI-J NATL CANCER I, V69, P349; Smith IE, 2004, NEW ENGL J MED, V351, P1021, DOI 10.1056/NEJMe048173; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Smith-Warner SA, 2001, JAMA-J AM MED ASSOC, V285, P769, DOI 10.1001/jama.285.6.769; Smith-Warner SA, 2001, INT J CANCER, V92, P767, DOI 10.1002/1097-0215(20010601)92:5&lt;767::AID-IJC1247&gt;3.0.CO;2-0; Sobin, 2009, UICC TNM CLASSIFICAT; Stearns V, 2003, CLIN CANCER RES, V9, P124; Szabo BK, 2003, ACTA RADIOL, V44, P379, DOI 10.1034/j.1600-0455.2003.00084.x; Tabar L, 2003, LANCET, V361, P1405, DOI 10.1016/S0140-6736(03)13143-1; Tripathy D, 2004, J CLIN ONCOL, V22, P1063, DOI 10.1200/JCO.2004.06.557; Truong PT, 2004, CAN MED ASSOC J, V170, P1263, DOI 10.1503/cmaj.1031000; Vaidya JS, 2001, ANN ONCOL, V12, P1075, DOI 10.1023/A:1011609401132; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; Van't Veer LJ, 2002, NAT MED, V8, P13, DOI 10.1038/nm0102-13; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Veronesi U, 2001, EUR J CANCER, V37, P2178, DOI 10.1016/S0959-8049(01)00285-4; Veronesi U, 2001, ANN ONCOL, V12, P997, DOI 10.1023/A:1011136326943; VERONESI U, 1995, EUR J CANCER, V31A, P1574, DOI 10.1016/0959-8049(95)00271-J; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Veronesi U, 2003, ARCH SURG-CHICAGO, V138, P1253, DOI 10.1001/archsurg.138.11.1253; VERONESI U, 1981, NEW ENGL J MED, V305, P6, DOI 10.1056/NEJM198107023050102; Veronesi U, 1997, LANCET, V349, P1864, DOI 10.1016/S0140-6736(97)01004-0; Viale G, 2004, J SURG ONCOL, V85, P123, DOI 10.1002/jso.20024; Viale G, 2005, CANCER-AM CANCER SOC, V103, P492, DOI 10.1002/cncr.20809; Vogel C, 1998, BREAST CANC RES TREA, V;50, P232; von Minckwitz G, 2001, J CLIN ONCOL, V19, P3506, DOI 10.1200/JCO.2001.19.15.3506; Wahl RL, 2004, J CLIN ONCOL, V22, P277, DOI 10.1200/JCO.2004.04.148; Wai MS, 2004, COCHRANE DB SYST REV, V2; Wallner P, 2004, JNCI-J NATL CANCER I, V96, P175, DOI 10.1093/jnci/djh023; Whelan T, 2002, J NATL CANCER I, V94, P1143; Whelan TJ, 2000, J CLIN ONCOL, V18, P1220, DOI 10.1200/JCO.2000.18.6.1220; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121; Zurrida S, 2002, ANN SURG ONCOL, V9, P156, DOI 10.1245/aso.2002.9.2.156; 2002, IARC HDB CANC PREVEN, V6, P144	160	392	414	2	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2005	365	9472					1727	1741		10.1016/S0140-6736(05)66546-4	http://dx.doi.org/10.1016/S0140-6736(05)66546-4			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894099				2022-12-28	WOS:000229082300024
J	Bill-Axelson, A; Holmberg, L; Ruutu, M; Haggman, M; Andersson, SO; Bratell, S; Spangberg, A; Busch, C; Nordling, S; Garmo, H; Palmgren, J; Adami, HO; Norlen, BJ; Johansson, JE				Bill-Axelson, A; Holmberg, L; Ruutu, M; Haggman, M; Andersson, SO; Bratell, S; Spangberg, A; Busch, C; Nordling, S; Garmo, H; Palmgren, J; Adami, HO; Norlen, BJ; Johansson, JE		Scandinavian Prostate Canc Grp Stu	Radical prostatectomy versus watchful waiting in early prostate cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MANAGEMENT; RISK	BACKGROUND: In 2002, we reported the initial results of a trial comparing radical prostatectomy with watchful waiting in the management of early prostate cancer. After three more years of follow-up, we report estimated 10-year results. METHODS: From October 1989 through February 1999, 695 men with early prostate cancer (mean age, 64.7 years) were randomly assigned to radical prostatectomy (347 men) or watchful waiting (348 men). The follow-up was complete through 2003, with blinded evaluation of the causes of death. The primary end point was death due to prostate cancer; the secondary end points were death from any cause, metastasis, and local progression. RESULTS: During a median of 8.2 years of follow-up, 83 men in the surgery group and 106 men in the watchful-waiting group died (P=0.04). In 30 of the 347 men assigned to surgery (8.6 percent) and 50 of the 348 men assigned to watchful waiting (14.4 percent), death was due to prostate cancer. The difference in the cumulative incidence of death due to prostate cancer increased from 2.0 percentage points after 5 years to 5.3 percentage points after 10 years, for a relative risk of 0.56 (95 percent confidence interval, 0.36 to 0.88; P=0.01 by Gray's test). For distant metastasis, the corresponding increase was from 1.7 to 10.2 percentage points, for a relative risk in the surgery group of 0.60 (95 percent confidence interval, 0.42 to 0.86; P=0.004 by Gray's test), and for local progression, the increase was from 19.1 to 25.1 percentage points, for a relative risk of 0.33 (95 percent confidence interval, 0.25 to 0.44; P<0.001 by Gray's test). CONCLUSIONS: Radical prostatectomy reduces disease-specific mortality, overall mortality, and the risks of metastasis and local progression. The absolute reduction in the risk of death after 10 years is small, but the reductions in the risks of metastasis and local tumor progression are substantial.	Univ Uppsala Hosp, Dept Urol, SE-75185 Uppsala, Sweden; Univ Uppsala Hosp, Reg Oncol Ctr, SE-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Pathol, SE-75185 Uppsala, Sweden; Univ Helsinki, Dept Urol, Helsinki, Finland; Univ Helsinki, Dept Pathol, Helsinki, Finland; Univ Helsinki Hosp, Helsinki, Finland; Orebro Univ Hosp, Dept Urol, Orebro, Sweden; Orebro Univ Hosp, Ctr Assessment Med Technol, Orebro, Sweden; Boras Hosp, Dept Urol, Boras, Sweden; Linkoping Univ Hosp, Dept Urol, S-58185 Linkoping, Sweden; Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Orebro University; Orebro University; Linkoping University; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health	Bill-Axelson, A (corresponding author), Univ Uppsala Hosp, Dept Urol, SE-75185 Uppsala, Sweden.	anna.bill.axelson@akademiska.se		Adolfsson, Jan/0000-0003-2992-1869; Palmgren, Juni/0000-0002-9031-8615; Garmo, Hans/0000-0001-7181-7083				ADOLFSSON J, 1993, CANCER-AM CANCER SOC, V72, P310, DOI 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T; BRENDLER CB, 1980, J UROLOGY, V124, P849, DOI 10.1016/S0022-5347(17)55696-7; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Harmer M., 1982, TNM CLASSIFICATION M, VThird; Hermanek P, 1992, TNM CLASSIFICATION M; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Johansson JE, 1997, JAMA-J AM MED ASSOC, V277, P467, DOI 10.1001/jama.277.6.467; Johansson JE, 1997, JAMA-J AM MED ASSOC, V278, P206; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; MOSTOFI FK, 1980, HISTOLOGICAL TYPING; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; WALSH PC, 1987, CANCER, V60, P526, DOI 10.1002/1097-0142(19870801)60:3+<526::AID-CNCR2820601515>3.0.CO;2-9	15	930	952	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1977	1984		10.1056/NEJMoa043739	http://dx.doi.org/10.1056/NEJMoa043739			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888698	Bronze			2022-12-28	WOS:000229017100008
J	Korkegian, A; Black, ME; Baker, D; Stoddard, BL				Korkegian, A; Black, ME; Baker, D; Stoddard, BL			Computational thermostabilization of an enzyme	SCIENCE			English	Article							PROTEIN DESIGN; CYTOSINE DEAMINASE; GENE-THERAPY; STABILITY; YEAST; SPECIFICITY; SEQUENCES; RECEPTOR; CANCER; ANALOG	Thermostabilizing an enzyme while maintaining its activity for industrial or biomedical applications can be difficult with traditional selection methods. We describe a rapid computational approach that identified three mutations within a model enzyme that produced a 10 degrees C increase in apparent melting temperature T(m) and a 30-fold increase in half-life at 50 degrees C, with no reduction in catalytic efficiency. The effects of the mutations were synergistic, giving an increase in excess of the sum of their individual effects. The redesigned enzyme induced an increased, temperature-dependent bacterial growth rate under conditions that required its activity, thereby coupling molecular and metabolic engineering.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Pullman, WA 99164 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Washington State University	Stoddard, BL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	bstoddar@fhcrc.org	Black, Margaret/I-2957-2015; Baker, David/K-8941-2012	Black, Margaret/0000-0002-3152-5112; Baker, David/0000-0001-7896-6217	NCI NIH HHS [CA85939, CA97328, R01 CA097328, R01 CA085939] Funding Source: Medline; NIGMS NIH HHS [R01 GM059224, T32-GM08268, R01 GM049857, GM59224, T32 GM008268, GM49857] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085939, R01CA097328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268, R01GM059224] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benson DE, 2002, BIOCHEMISTRY-US, V41, P3262, DOI 10.1021/bi011359i; Berg DT, 2003, P NATL ACAD SCI USA, V100, P4423, DOI 10.1073/pnas.0736918100; Black ME, 2001, GENET ENG P, V23, P113; Dahiyat BI, 1999, CURR OPIN BIOTECH, V10, P387, DOI 10.1016/S0958-1669(99)80070-6; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; Eidsness MK, 1997, BIOCHEMISTRY-US, V36, P10406, DOI 10.1021/bi970110r; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Gordon DB, 1999, CURR OPIN STRUC BIOL, V9, P509, DOI 10.1016/S0959-440X(99)80072-4; Greco O, 2001, J CELL PHYSIOL, V187, P22, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1060>3.0.CO;2-H; Hubbard S., 1993, NACCESS DEP BIOCH MO; Ireton GC, 2003, STRUCTURE, V11, P961, DOI 10.1016/S0969-2126(03)00153-9; KATSURAGI T, 1989, AGR BIOL CHEM TOKYO, V53, P1313, DOI 10.1080/00021369.1989.10869490; Kievit E, 1999, CANCER RES, V59, P1417; KORKEGIAN A, UNPUB; Kraemer-Pecore CM, 2001, CURR OPIN CHEM BIOL, V5, P690, DOI 10.1016/S1367-5931(01)00267-8; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Luo P, 2002, PROTEIN SCI, V11, P1218, DOI 10.1110/ps.4580102; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Mendes J, 2002, CURR OPIN STRUC BIOL, V12, P441, DOI 10.1016/S0959-440X(02)00345-7; REES DC, 1995, STRUCTURE, V3, P251, DOI 10.1016/S0969-2126(01)00155-1; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Scandurra R, 1998, BIOCHIMIE, V80, P933, DOI 10.1016/S0300-9084(00)88890-2; Schramm VL, 1998, ANNU REV BIOCHEM, V67, P693, DOI 10.1146/annurev.biochem.67.1.693; Shifman JM, 2002, J MOL BIOL, V323, P417, DOI 10.1016/S0022-2836(02)00881-1; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Street AG, 1999, STRUCTURE, V7, pR105, DOI 10.1016/S0969-2126(99)80062-8; Venclovas C, 2003, PROTEINS, V53, P585, DOI 10.1002/prot.10530	35	283	307	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					857	860		10.1126/science.1107387	http://dx.doi.org/10.1126/science.1107387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879217	Green Accepted			2022-12-28	WOS:000228986500049
J	Wang, F; Dukovic, G; Brus, LE; Heinz, TF				Wang, F; Dukovic, G; Brus, LE; Heinz, TF			The optical resonances in carbon nanotubes arise from excitons	SCIENCE			English	Article							ABSORPTION; SPECTRA	Optical transitions in carbon nanotubes are of central importance for nanotube characterization. They also provide insight into the nature of excited states in these one-dimensional systems. Recent work suggests that light absorption produces strongly correlated electron-hole states in the form of excitons. However, it has been difficult to rule out a simpler model in which resonances arise from the van Hove singularities associated with the one-dimensional bond structure of the nanotubes. Here, two-photon excitation spectroscopy bolsters the exciton picture. We found binding energies of similar to 400 millielectron volts for semi-conducting single-walled nanotubes with 0.8-nanometer diameters. The results demonstrate the dominant role of many-body interactions in the excited-state properties of one-dimensional systems.	Columbia Univ, Dept Phys, New York, NY 10027 USA; Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Heinz, TF (corresponding author), Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA.	tony.heinz@columbia.edu	Heinz, Tony/K-7797-2015; wang, Feng/I-5727-2015; bartelsdoe, ludwig/F-8008-2011	Heinz, Tony/0000-0003-1365-9464; wang, Feng/0000-0001-8369-6194; 				Ando T, 1997, J PHYS SOC JPN, V66, P1066, DOI 10.1143/JPSJ.66.1066; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Bockrath M, 1999, NATURE, V397, P598, DOI 10.1038/17569; Bockrath M, 1997, SCIENCE, V275, P1922, DOI 10.1126/science.275.5308.1922; Callis PR, 1997, ANNU REV PHYS CHEM, V48, P271, DOI 10.1146/annurev.physchem.48.1.271; Chang E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.196401; Dresselhaus MS, 2004, ANNU REV MATER RES, V34, P247, DOI 10.1146/annurev.matsci.34.040203.114607; Dukovic G, 2004, J AM CHEM SOC, V126, P15269, DOI 10.1021/ja046526r; ELLIOTT RJ, 1957, PHYS REV, V108, P1384, DOI 10.1103/PhysRev.108.1384; Freitag M, 2003, NANO LETT, V3, P1067, DOI 10.1021/nl034313e; Hagen A, 2003, NANO LETT, V3, P383, DOI 10.1021/nl020237o; Htoon H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.027401; Ishii H, 2003, NATURE, V426, P540, DOI 10.1038/nature02074; Kane CL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.207401; Karl N., 2001, ORGANIC ELECT MAT, VII; Ma YZ, 2004, J CHEM PHYS, V120, P3368, DOI 10.1063/1.1640339; Misewich JA, 2003, SCIENCE, V300, P783, DOI 10.1126/science.1081294; Nygard J, 2000, NATURE, V408, P342, DOI 10.1038/35042545; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Odom TW, 2000, SCIENCE, V290, P1549, DOI 10.1126/science.290.5496.1549; OGAWA T, 1991, PHYS REV B, V44, P8138, DOI 10.1103/PhysRevB.44.8138; Pedersen TG, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.073401; Perebeinos V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257402; Saito R, 1998, PHYS PROPERTIES CARB; Sfeir MY, 2004, SCIENCE, V306, P1540, DOI 10.1126/science.1103294; Shen Y. R., 1984, PRINCIPLES NONLINEAR; SHIMIZU A, 1992, PHYS REV B, V45, P11338, DOI 10.1103/PhysRevB.45.11338; Spataru CD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.077402; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; Zhao HB, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.157402	30	1014	1020	9	307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					838	841		10.1126/science.1110265	http://dx.doi.org/10.1126/science.1110265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879212				2022-12-28	WOS:000228986500043
J	Bennett, CL; Nebeker, JR; Lyons, EA; Samore, MH; Feldman, MD; McKoy, JM; Carson, KR; Belknap, SM; Trifilio, SM; Schumock, GT; Yarnold, PR; Davidson, CJ; Evens, AM; Kuzel, TM; Parada, JP; Cournoyer, D; West, DP; Sartor, O; Tallman, MS; Raisch, DW				Bennett, CL; Nebeker, JR; Lyons, EA; Samore, MH; Feldman, MD; McKoy, JM; Carson, KR; Belknap, SM; Trifilio, SM; Schumock, GT; Yarnold, PR; Davidson, CJ; Evens, AM; Kuzel, TM; Parada, JP; Cournoyer, D; West, DP; Sartor, O; Tallman, MS; Raisch, DW			The Rresearch on Adverse Drug Events and Reports (RADAR) project	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; CONFLICT-OF-INTEREST; RED-CELL APLASIA; POSTMARKETING SURVEILLANCE; COX-2 INHIBITORS; TICLOPIDINE; SAFETY; ANTIBODIES; RISK; NEED	Context In 1 998, a multidisciplinary team of investigators initiated RADAR (Research on Adverse Drug events And Reports), a clinically based postmarketing surveillance program that systematically investigates and disseminates information describing serious and previously unrecognized adverse drug and device reactions (ADRs). Objective To describe the structure, operations, and preliminary findings from the RADAR project and related dissemination efforts by pharmaceutical suppliers and the US Food and Drug Administration (FDA). Design After identifying a serious and unexpected clinical event suitable for further investigation, RADAR collaborators postulated clinical hypotheses and derived case series and incidence estimates from physician queries, published and unpublished clinical trials, published case reports, FDA databases, and manufacturer sales figures. Results RADAR investigators identified 16 types of serious ADRs among 1699 patients, of whom 169 (10%) died as a result of the reaction. Initial cases were identified by 7 RADAR investigators, 4 collaborating physicians, 2 attorneys, and by reviewing 3 published reports. Additional sources included queries of occupational health programs and medical directors of interventional cardiology laboratories Q types of ADRs), published manuscripts and clinical trials (111 types of ADRs), review of medical records at a RADAR site (2 types of ADRs), unpublished clinical trial reports Q types of ADRs), and reports from attorneys, family members, or patients (4 types of ADRs). Incidence estimates, ranging from 0.4% to 33 %, were derived from 5 clinical trial reports, 2 physician queries, and 2 observational databases. Laboratory support for hypotheses included identification of 3 neutralizing antibodies and 3 histopathological findings. ADR reports were disseminated as 8 revised package inserts, 7 "dear doctor" letters, and 9 peer-reviewed articles. Conclusion A new, clinically based, hypothesis-driven approach to postmarketing surveillance may supplement existing regulatory surveillance systems and improve patient safety.	Northwestern Univ, Feinberg Sch Med, Jesse Brown VA Med Ctr, Div Hematol Oncol,Mid W Ctr Hlth Serv & Policy Re, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Cardiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Emergency Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Gen Internal Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Geriatr Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Dermatol, Chicago, IL 60611 USA; NW Mem Hosp, Dept Pharm, Chicago, IL 60611 USA; Northwestern Univ, Inst Hlth Serv Res & Policy Studies, Evanston, IL USA; Univ Illinois, Coll Pharm, Ctr Pharmacoecon Res, Chicago, IL USA; Univ Texas, San Antonio VA, San Antonio, TX 78285 USA; Univ Texas, Dept Med, San Antonio, TX 78285 USA; Univ New Mexico, VA Cooperat Studies Program, Clin Res Pharm Coordinating Ctr, Albuquerque, NM 87131 USA; Univ Utah, Sch Med, Salt Lake City, UT USA; Salt Lake City VA, Salt Lake City, UT USA; McGill Univ, Dept Med, Montreal, PQ, Canada; McGill Univ, Dept Oncol, Montreal, PQ, Canada; Louisiana State Univ, Sch Med, Div Hematol Oncol, New Orleans, LA USA; Louisiana State Univ, Sch Med, Stanley Scott Canc Ctr, New Orleans, LA USA	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern Memorial Hospital; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Texas System; University of Texas System; University of New Mexico; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; McGill University; McGill University; Louisiana State University System; Louisiana State University System	Bennett, CL (corresponding author), Northwestern Univ, Feinberg Sch Med, Jesse Brown VA Med Ctr, Div Hematol Oncol,Mid W Ctr Hlth Serv & Policy Re, 333 E Huron St,Suite 277, Chicago, IL 60611 USA.	cbenne@northwestern.edu	MCKOY, JUNE/GRJ-5660-2022; Bennett, Charles L/C-2050-2008	Evens, Andrew/0000-0002-6900-1824; Yarnold, Paul/0000-0002-1648-739X; West, Dennis Paul/0000-0002-9107-6697; Belknap, Steven/0000-0002-3670-7409	NCI NIH HHS [1R01CA 102713-01, P30 CA60533] Funding Source: Medline; NHLBI NIH HHS [HL 69717-O1A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102713] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069717] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BELKNAP SM, 2004, J CLIN ONCOL S, V22, P6002; Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Bennett CL, 2002, AM J MED, V113, P603, DOI 10.1016/S0002-9343(02)01300-1; Bennett CL, 2002, ANN INTERN MED, V137, P625, DOI 10.7326/0003-4819-137-7-200210010-00029; Bennett CL, 1998, ANN INTERN MED, V128, P541, DOI 10.7326/0003-4819-128-7-199804010-00004; Bennett CL, 1998, LANCET, V352, P1036, DOI 10.1016/S0140-6736(05)60079-7; Brewer T, 1999, JAMA-J AM MED ASSOC, V281, P824, DOI 10.1001/jama.281.9.824; Califf RM, 2002, PHARMACOEPIDEM DR S, V11, P319, DOI 10.1002/pds.699; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P256; Chacko R, 2004, J CLIN ONCOL, V22, p244S; Cournoyer D, 2004, J AM SOC NEPHROL, V15, P2728, DOI 10.1097/01.ASN.0000140219.28618.9F; *CTR ED RES THER, FACT SHEET; Drazen JM, 2005, NEW ENGL J MED, V352, P1131, DOI 10.1056/NEJMe058038; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Evens AM, 2004, BLOOD, V104, p79A; Evens AM, 2002, TRANSPLANTATION, V74, P885, DOI 10.1097/00007890-200209270-00026; *FDA, 2001, MEDWATCH IND SAF REL; *FDA, PUBL HLTH WEB NOT FI; *FDA, MEDWATCH IND SAF REL; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; Johnson S, 2002, ANN INTERN MED, V137, P146, DOI 10.7326/0003-4819-137-2-200207160-00025; Jonas S, 2004, STROKE, V35, P537, DOI 10.1161/str.35.2.537; KLINGE SA, 2004, J CLIN ONCOL S, V22, P6616; KOTULAK R, 2005, CHICAGO TRIBUNE 0227, P24; Kuter DJ, 2002, BLOOD, V100, P3457, DOI 10.1182/blood.V100.10.3457; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Lyons EA, 2004, BLOOD, V104, p79A; MacDonald Lee A, 2003, J Invasive Cardiol, V15, P60; Nebeker JR, 2004, ANN INTERN MED, V140, P795, DOI 10.7326/0003-4819-140-10-200405180-00009; PASSMAN R, 2005, ANN SCI SESS AM COLL; Patel SM, 2004, JAIDS-J ACQ IMM DEF, V35, P120, DOI 10.1097/00126334-200402010-00003; Psaty BM, 2005, NEW ENGL J MED, V352, P1133, DOI 10.1056/NEJMe058042; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622; Rajvanshi P, 2002, BLOOD, V99, P2310, DOI 10.1182/blood.V99.7.2310; Samore MH, 2004, JAMA-J AM MED ASSOC, V291, P325, DOI 10.1001/jama.291.3.325; SLIMACK SA, 2004, J CLIN ONCOL S, V22, P7229; Steinbrook R, 2004, NEW ENGL J MED, V351, P315, DOI 10.1056/NEJMp048191; Steinhubl SR, 1999, JAMA-J AM MED ASSOC, V281, P806, DOI 10.1001/jama.281.9.806; Strom BL, 2004, JAMA-J AM MED ASSOC, V292, P2643, DOI 10.1001/jama.292.21.2643; Temple RJ, 2002, JAMA-J AM MED ASSOC, V287, P2273, DOI 10.1001/jama.287.17.2273; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; Trontell A, 2004, NEW ENGL J MED, V351, P1385, DOI 10.1056/NEJMp048187; Tsai HM, 2000, ANN INTERN MED, V132, P794, DOI 10.7326/0003-4819-132-10-200005160-00005; *US FDA, ZOM PACK INS; *US FDA, NOV ONC LETT DOCT PR; *US FDA, MEDWATCH 2005 SAF RE; *US FDA, AR PACK INS; *US FDA, 1999, MEDWATCH SUMM SAF RE; *US FDA, 2003, MEDWATCH DET VIEW SA; *US FDA, 2005, BACKGR INF ONC DRUGS; *US FDA, MEDWATCH RET TEXT LE; *US FDA, 2000, MEDWATCH SUMM SAF RE; *US GEN ACC OFF, 1991, OFF LAB DRUGS IN RES; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Wood AJJ, 1998, NEW ENGL J MED, V339, P1851, DOI 10.1056/NEJM199812173392512; Zeldis JB, 1999, CLIN THER, V21, P319, DOI 10.1016/S0149-2918(00)88289-2; 2004, FDA CONSUMER MAG JAN; WHAT IS RA DAR RISK	61	95	98	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2131	2140		10.1001/jama.293.17.2131	http://dx.doi.org/10.1001/jama.293.17.2131			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870417				2022-12-28	WOS:000228808200023
J	Jeremias, A; Gibson, CM				Jeremias, A; Gibson, CM			Narrative review: Alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded	ANNALS OF INTERNAL MEDICINE			English	Review							LEFT-VENTRICULAR DYSFUNCTION; CRITICALLY-ILL PATIENTS; I LEVELS; MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; ARTERY-DISEASE; SEPTIC SHOCK; SUBARACHNOID HEMORRHAGE; RENAL-INSUFFICIENCY; AMERICAN-COLLEGE	Current guidelines for the diagnosis of non-ST-segment elevation myocardial infarction are largely based on an elevated troponin level. While this rapid and sensitive blood test is certainly valuable in the appropriate setting, its widespread use in a variety of clinical scenarios may lead to the detection of troponin elevation in the absence of thrombotic acute coronary syndromes. Many diseases, such as sepsis, hypovolemia, atrial fibrillation, congestive heart failure, pulmonary embolism, myocarditis, myocardial contusion, and renal failure, can be associated with an increase in troponin level. These elevations may arise from various causes other than thrombotic coronary artery occlusion. Given the lack of any supportive data at present, patients with nonthrombotic troponin elevation should not be treated with antithrombotic and antiplatelet agents. Rather, the underlying cause of the troponin elevation should be targeted. However, troponin elevation in the absence of thrombotic acute coronary syndromes still retains prognostic value. Thus, cardiac troponin elevations are common in numerous disease states and do not necessarily indicate the presence of a thrombotic acute coronary syndrome. While troponin is a sensitive biomarker to "rule out" non-ST-segment elevation myocardial infarction, it is less useful to "rule in" this event because it may lack specificity for acute coronary syndromes.	Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Jeremias, A (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiol, 1 Deaconess Rd,Baker 4, Boston, MA 02215 USA.	ajeremia@bidmc.harvard.edu	Gibson, C. Michael/AAE-8212-2019					Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Ammann P, 2001, INTENS CARE MED, V27, P965, DOI 10.1007/s001340100920; Ammann P, 2003, J AM COLL CARDIOL, V41, P2004, DOI 10.1016/S0735-1097(03)00421-2; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Apple FS, 2002, AM HEART J, V144, P981, DOI 10.1067/mhj.2002.124048; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Arlati S, 2000, INTENS CARE MED, V26, P31, DOI 10.1007/s001340050008; Aviles RJ, 2002, NEW ENGL J MED, V346, P2047, DOI 10.1056/NEJMoa013456; Baillard C, 2003, INTENS CARE MED, V29, P584, DOI 10.1007/s00134-003-1635-0; Bakshi TK, 2002, INTERN MED J, V32, P520, DOI 10.1046/j.1445-5994.2002.00270.x; Benamer H, 1999, AM HEART J, V137, P815, DOI 10.1016/S0002-8703(99)70404-7; Brandt RR, 2001, AM J CARDIOL, V87, P1326, DOI 10.1016/S0002-9149(01)01536-3; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Cantwell RV, 2002, CLIN CARDIOL, V25, P33, DOI 10.1002/clc.4950250109; Cardinale D, 2000, J AM COLL CARDIOL, V36, P517, DOI 10.1016/S0735-1097(00)00748-8; CHENG W, 1995, J CLIN INVEST, V96, P2247, DOI 10.1172/JCI118280; deFilippi C, 2003, JAMA-J AM MED ASSOC, V290, P353, DOI 10.1001/jama.290.3.353; Diris JHC, 2004, CIRCULATION, V109, P23, DOI 10.1161/01.CIR.0000109483.45211.8F; Feng J, 2001, CIRCULATION, V103, P2035; Freda BJ, 2002, J AM COLL CARDIOL, V40, P2065, DOI 10.1016/S0735-1097(02)02608-6; GUEST TM, 1995, JAMA-J AM MED ASSOC, V273, P1945, DOI 10.1001/jama.273.24.1945; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; Hamwi SM, 2003, AM J CARDIOL, V92, P88, DOI 10.1016/S0002-9149(03)00477-6; Hasdemir C, 2002, J CARDIOVASC ELECTR, V13, P144, DOI 10.1046/j.1540-8167.2002.00144.x; Heeschen C, 1999, CIRCULATION, V100, P1509, DOI 10.1161/01.CIR.100.14.1509; Heidenreich PA, 2001, J AM COLL CARDIOL, V38, P478, DOI 10.1016/S0735-1097(01)01388-2; Higgins JP, 2003, CLIN INVEST MED, V26, P133; Homma S, 2004, STROKE, V35, P552, DOI 10.1161/01.STR.0000117566.64450.DD; Horwich TB, 2003, CIRCULATION, V108, P833, DOI 10.1161/01.CIR.0000084543.79097.34; Kontos MC, 2003, AM HEART J, V146, P446, DOI 10.1016/S0002-8703(03)00245-X; Labarrere CA, 2000, JAMA-J AM MED ASSOC, V284, P457, DOI 10.1001/jama.284.4.457; Logeart D, 2001, AM HEART J, V141, P247, DOI 10.1067/mhj.2001.111767; Neumayr G, 2001, AM J CARDIOL, V87, P369, DOI 10.1016/S0002-9149(00)01382-5; Ng SM, 2001, AM J CARDIOL, V87, P994, DOI 10.1016/S0002-9149(01)01436-9; Nunes JPL, 2003, INT J CARDIOL, V89, P281, DOI 10.1016/S0167-5273(02)00502-8; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Rifai N, 1999, AM J CARDIOL, V83, P1085, DOI 10.1016/S0002-9149(99)00020-X; Smith SC, 1997, CIRCULATION, V95, P163, DOI 10.1161/01.CIR.95.1.163; Torbicki A, 2003, CIRCULATION, V108, P844, DOI 10.1161/01.CIR.0000084544.54513.E2; Trooyen M, 2001, Tidsskr Nor Laegeforen, V121, P421; Tung P, 2004, STROKE, V35, P548, DOI 10.1161/01.STR.0000114874.96688.54; Van Lente F, 1999, J AM COLL CARDIOL, V33, P471, DOI 10.1016/S0735-1097(98)00592-0; Velmahos GC, 2003, J TRAUMA, V54, P45, DOI 10.1097/00005373-200301000-00006; Wang CH, 2002, AM HEART J, V144, P275, DOI 10.1067/mhj.2002.123843; Wong GC, 2002, CIRCULATION, V106, P202, DOI 10.1161/01.CIR.0000021921.14653.28; Wu AHB, 2001, INTENS CARE MED, V27, P959, DOI 10.1007/s001340100970; Yalamanchili K, 2004, AM J CARDIOL, V93, P263, DOI 10.1016/j.amjcard.2003.09.058; Zellweger MF, 2003, SWISS MED WKLY, V133, P439	48	340	360	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					786	791		10.7326/0003-4819-142-9-200505030-00015	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00015			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922GW	15867411				2022-12-28	WOS:000228825800008
J	Junge, W; Nelson, N				Junge, W; Nelson, N			Nature's rotary electromotors	SCIENCE			English	Editorial Material							ATP SYNTHASE; MOLECULAR ARCHITECTURE; NA+-ATPASE; SUBUNIT C; F-ATPASE; ROTOR; ROTATION; TORQUE; MODEL		Univ Osnabruck, Div Biophys, D-49069 Osnabruck, Germany; Tel Aviv Univ, Dept Biochem, IL-69978 Tel Aviv, Israel	University Osnabruck; Tel Aviv University	Junge, W (corresponding author), Univ Osnabruck, Div Biophys, D-49069 Osnabruck, Germany.	junge@uos.de; nelson@post.tau.ac.il						ARAI H, 1988, J BIOL CHEM, V263, P8796; Dimroth P, 1999, P NATL ACAD SCI USA, V96, P4924, DOI 10.1073/pnas.96.9.4924; Dimroth P, 2000, BBA-BIOENERGETICS, V1459, P506, DOI 10.1016/S0005-2728(00)00190-0; Fillingame RH, 2000, BBA-BIOENERGETICS, V1458, P387, DOI 10.1016/S0005-2728(00)00089-X; Fillingame RH, 2002, BBA-BIOMEMBRANES, V1565, P232, DOI 10.1016/S0005-2736(02)00572-2; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; Junge W, 2004, PHOTOSYNTH RES, V80, P198; Junge W, 2001, FEBS LETT, V504, P152, DOI 10.1016/S0014-5793(01)02745-4; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; LAUGER P, 1988, BIOPHYS J, V53, P53, DOI 10.1016/S0006-3495(88)83065-0; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 2003, J BIOL CHEM, V278, P21162, DOI 10.1074/jbc.M301620200; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1	20	50	52	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					642	644		10.1126/science.1112617	http://dx.doi.org/10.1126/science.1112617			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860615				2022-12-28	WOS:000228810900034
J	Meier, T; Polzer, P; Diederichs, K; Welte, W; Dimroth, P				Meier, T; Polzer, P; Diederichs, K; Welte, W; Dimroth, P			Structure of the rotor ring of F-type Na+-ATPase from Ilyobacter tartaricus	SCIENCE			English	Article							ESCHERICHIA-COLI; SUBUNIT C; MOLECULAR ARCHITECTURE; ROTARY MOTOR; O MOTOR; SYNTHASE; ROTATION; MECHANISM; SELECTIVITY; GENERATION	In the crystal structure of the membrane-embedded rotor ring of the sodium ion-translocating adenosine 5'-triphosphate (ATP) synthase of llyobacter tartaricus at 2.4 angstrom resolution, 11 c subunits are assembled into an hourglass-shaped cylinder with 11-fold symmetry. Sodium ions are bound in a locked conformation close to the outer surface of the cylinder near the middle of the membrane. The structure supports an ion-translocation mechanism in the intact ATP synthase in which the binding site converts from the locked conformation into one that opens toward subunit a as the rotor ring moves through the subunit a/c interface.	Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; ETH, Inst Mikrobiol, CH-8093 Zurich, Switzerland	University of Konstanz; Swiss Federal Institutes of Technology Domain; ETH Zurich	Diederichs, K (corresponding author), Univ Konstanz, Fachbereich Biol, M656, D-78457 Constance, Germany.	kay.diederichs@uni-konstanz.de; dimroth@micro.biol.ethz.ch						ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Aksimentiev A, 2004, BIOPHYS J, V86, P1332, DOI 10.1016/S0006-3495(04)74205-8; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Dimroth P, 2003, STRUCTURE, V11, P1469, DOI 10.1016/j.str.2003.11.011; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Feniouk BA, 2004, BIOPHYS J, V86, P4094, DOI 10.1529/biophysj.103.036962; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; FRAUENFELDER H, 1979, NATURE, V280, P558, DOI 10.1038/280558a0; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; Hermolin J, 1999, J BIOL CHEM, V274, P17011, DOI 10.1074/jbc.274.24.17011; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Junge W, 2001, FEBS LETT, V504, P152, DOI 10.1016/S0014-5793(01)02745-4; KAIM G, 1993, EUR J BIOCHEM, V218, P937, DOI 10.1111/j.1432-1033.1993.tb18450.x; Kaim G, 1997, BIOCHEMISTRY-US, V36, P9185, DOI 10.1021/bi970831q; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Meier T, 2001, FEBS LETT, V505, P353, DOI 10.1016/S0014-5793(01)02837-X; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P898, DOI 10.1073/pnas.031564198; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1; WARSHEL A, 1991, ANNU REV BIOPHYS BIO, V20, P267, DOI 10.1146/annurev.biophys.20.1.267; WATTS SD, 1995, FEBS LETT, V368, P235, DOI 10.1016/0014-5793(95)00658-V; Wehrle F, 2002, J MOL BIOL, V322, P369, DOI 10.1016/S0022-2836(02)00731-3; Xing JH, 2004, BIOPHYS J, V87, P2148, DOI 10.1529/biophysj.104.042093	34	316	326	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					659	662		10.1126/science.1111199	http://dx.doi.org/10.1126/science.1111199			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860619	Green Submitted			2022-12-28	WOS:000228810900039
J	Berlin, JA				Berlin, JA			Commentary: Why industry should register and disclose results of clinical studies-perspective of a recovering academic	BRITISH MEDICAL JOURNAL			English	Editorial Material							LARGE TRIALS		Johnson & Johnson Pharmaceut Res & Dev LLC, Titusville, NJ 08560 USA	Johnson & Johnson; Johnson & Johnson USA	Berlin, JA (corresponding author), Johnson & Johnson Pharmaceut Res & Dev LLC, 1125 Trenton Harbourton Rd,POB 200, Titusville, NJ 08560 USA.	jberlin@prdus.jnj.com						Cappelleri JC, 1996, JAMA-J AM MED ASSOC, V276, P1332, DOI 10.1001/jama.276.16.1332; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; *INT ALL PHARM ASS, 2005, JOINT POS DISCL CLIN; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P1089, DOI 10.1001/jama.279.14.1089; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; *PHARM RES MAN AM, 2004, PRINC COND CLIN TRIA	6	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 23	2005	330	7497					959	959		10.1136/bmj.330.7497.959	http://dx.doi.org/10.1136/bmj.330.7497.959			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15845981	Green Published			2022-12-28	WOS:000228715900027
J	Tilley, SJ; Orlova, EV; Gilbert, RJC; Andrew, PW; Saibil, HR				Tilley, SJ; Orlova, EV; Gilbert, RJC; Andrew, PW; Saibil, HR			Structural basis of pore formation by the bacterial toxin pneumolysin	CELL			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; PERFRINGOLYSIN-O; CLOSTRIDIUM-PERFRINGENS; THETA-TOXIN; TRYPTOPHAN RESIDUES; MEMBRANE INSERTION; PREPORE COMPLEX; STREPTOLYSIN-O; FORMING TOXIN; BINDING	The bacterial toxin pneumolysin is released as a soluble monomer that kills target cells by assembling into large oligomeric rings and forming pores in cholesterol-containing membranes. Using cryo-EM and image processing, we have determined the structures of membrane-surface bound (prepore) and inserted-pore oligomer forms, providing a direct observation of the conformational transition into the pore form of a cholesterol-dependent cytolysin. In the pore structure, the domains of the monomer separate and double over into an arch, forming a wall sealing the bilayer around the pore. This transformation is accomplished by substantial refolding of two of the four protein domains along with deformation of the membrane. Extension of protein density into the bilayer supports earlier predictions that the protein inserts beta hairpins into the membrane. With an oligomer size of up to 44 subunits in the pore, this assembly creates a transmembrane channel 260 angstrom in diameter lined by 176 beta strands.	Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England; Univ London Birkbeck Coll, Inst Struct Mol Biol, London WC1E 7HX, England; Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Ctr Mol Sci, Cent Chem Lab, Oxford OX1 3QU, England; Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England	University of London; Birkbeck University London; University of London; Birkbeck University London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Leicester	Saibil, HR (corresponding author), Univ London Birkbeck Coll, Sch Crystallog, Malet St, London WC1E 7HX, England.	h.saibil@mail.cryst.bbk.ac.uk	Orlova, Elena/CAF-8290-2022; Andrew, Peter W/G-7526-2012	Orlova, Elena/0000-0003-3371-415X	Biotechnology and Biological Sciences Research Council [B13531] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alexander JE, 1998, MICROB PATHOGENESIS, V24, P167, DOI 10.1006/mpat.1997.0185; Alouf JE, 2000, INT J MED MICROBIOL, V290, P351; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Gilbert RJC, 1998, J MOL BIOL, V284, P1223, DOI 10.1006/jmbi.1998.2258; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Gilbert RJC, 2002, CELL MOL LIFE SCI, V59, P832, DOI 10.1007/s00018-002-8471-1; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; HILL J, 1994, INFECT IMMUN, V62, P757, DOI 10.1128/IAI.62.2.757-758.1994; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Jacobs T, 1998, MOL MICROBIOL, V28, P1081, DOI 10.1046/j.1365-2958.1998.00858.x; Korchev YE, 1998, BIOCHEM J, V329, P571; MITCHELL TJ, 1991, MOL MICROBIOL, V5, P1883, DOI 10.1111/j.1365-2958.1991.tb00812.x; MITCHELL TJ, 1992, ZBL BAKT, V23, P429; MORGAN PJ, 1995, FEBS LETT, V371, P77, DOI 10.1016/0014-5793(95)00887-F; NAKAMURA M, 1995, BIOCHEMISTRY-US, V34, P6513, DOI 10.1021/bi00019a032; Nakamura M, 1998, J BIOCHEM, V123, P1145; Nollmann M, 2004, BIOPHYS J, V86, P3141, DOI 10.1016/S0006-3495(04)74362-3; OHNOIWASHITA Y, 1988, EUR J BIOCHEM, V176, P95, DOI 10.1111/j.1432-1033.1988.tb14255.x; OLOFSSON A, 1993, FEBS LETT, V319, P125, DOI 10.1016/0014-5793(93)80050-5; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; Palmer M, 2001, TOXICON, V39, P1681, DOI 10.1016/S0041-0101(01)00155-6; PATON JC, 1984, INFECT IMMUN, V43, P1085, DOI 10.1128/IAI.43.3.1085-1087.1984; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; SekinoSuzuki N, 1996, EUR J BIOCHEM, V241, P941, DOI 10.1111/j.1432-1033.1996.00941.x; SEKIYA K, 1993, J BACTERIOL, V175, P5953, DOI 10.1128/JB.175.18.5953-5961.1993; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Smith JM, 1999, J STRUCT BIOL, V125, P223, DOI 10.1006/jsbi.1998.4073; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015	40	316	326	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					247	256		10.1016/j.cell.2005.02.033	http://dx.doi.org/10.1016/j.cell.2005.02.033			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851031	Bronze			2022-12-28	WOS:000228705000012
J	Backes, H; Neubauer, FM; Dougherty, MK; Achilleos, N; Andre, N; Arridge, CS; Bertucci, C; Jones, GH; Khurana, KK; Russell, CT; Wennmacher, A				Backes, H; Neubauer, FM; Dougherty, MK; Achilleos, N; Andre, N; Arridge, CS; Bertucci, C; Jones, GH; Khurana, KK; Russell, CT; Wennmacher, A			Titan's magnetic field signature during the first Cassini encounter	SCIENCE			English	Article							MHD MODEL; IONOSPHERE; MAGNETOSPHERE; SIMULATION; SATURN	The magnetic field signature obtained by Cassini during its first close encounter with Titan on 26 October 2004 is presented and explained in terms of an advanced model. Titan was inside the saturnian magnetosphere. A magnetic field minimum before closest approach marked Cassini's entry into the magnetic ionopause layer. Cassini then left the northern and entered the southern magnetic tail lobe. The magnetic field before and after the encounter was approximately constant for &SIM; 20 Titan radii, but the field orientation changed exactly at the location of Titan's orbit. No evidence of an internal magnetic field at Titan was detected.	Univ Cologne, Inst Geophys & Meteorol, D-50678 Cologne, Germany; Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England; Univ Toulouse 3, Ctr Etud Spatiale Rayonnements, F-31062 Toulouse, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	University of Cologne; Imperial College London; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles	Backes, H (corresponding author), Univ Cologne, Inst Geophys & Meteorol, Albertus Magnus Pl, D-50678 Cologne, Germany.	backes@geo.uni-koeln.de	Wennmacher, Lex/HHM-2644-2022; Bertucci, Cesar/GOG-8941-2022; Russell, Christopher T/E-7745-2012; Achilleos, Nicholas/C-1647-2008; Arridge, Christopher S/A-2894-2009; Jones, Geraint H./C-1682-2008	Russell, Christopher T/0000-0003-1639-8298; Arridge, Christopher S/0000-0002-0431-6526; Jones, Geraint H./0000-0002-5859-1136; Khurana, Krishan/0000-0002-2856-1171; Achilleos, Nicholas/0000-0002-5886-3509; Bertucci, Cesar/0000-0002-2540-5384				ALFVEN H, 1957, TELLUS, V9, P92, DOI 10.1111/j.2153-3490.1957.tb01855.x; BACKES H, 2004, THESIS U COLOGNE GER; Brecht SH, 2000, J GEOPHYS RES-SPACE, V105, P13119, DOI 10.1029/1999JA900490; Cravens TE, 1998, PLANET SPACE SCI, V46, P1193, DOI 10.1016/S0032-0633(98)00051-8; Dougherty MK, 2004, SPACE SCI REV, V114, P331, DOI 10.1007/s11214-004-1432-2; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; HARTLE RE, 1982, J GEOPHYS RES-SPACE, V87, P1383, DOI 10.1029/JA087iA03p01383; IP WH, 1990, ASTROPHYS J, V362, P354, DOI 10.1086/169271; Kabin K, 1999, J GEOPHYS RES-SPACE, V104, P2451, DOI 10.1029/1998JA900080; KELLER CN, 1994, J GEOPHYS RES-SPACE, V99, P6511, DOI 10.1029/93JA02680; KELLER CN, 1992, J GEOPHYS RES-SPACE, V97, P12117, DOI 10.1029/92JA00231; KIVELSON MG, 1983, J GEOPHYS RES-SPACE, V88, P49, DOI 10.1029/JA088iA01p00049; Ledvina SA, 1998, PLANET SPACE SCI, V46, P1175, DOI 10.1016/S0032-0633(98)00052-X; Nagy AF, 2001, J GEOPHYS RES-SPACE, V106, P6151, DOI 10.1029/2000JA000183; NESS NF, 1982, J GEOPHYS RES-SPACE, V87, P1369, DOI 10.1029/JA087iA03p01369; Neubauer F.M., 1984, SATURN, P760; RICHARDS PG, 1994, J GEOPHYS RES-SPACE, V99, P8981, DOI 10.1029/94JA00518; SCHARDT AW, 1984, SATURN, P417; Wahlund JE, 2005, SCIENCE, V308, P986, DOI 10.1126/science.1109807	19	116	116	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					992	995		10.1126/science.1109763	http://dx.doi.org/10.1126/science.1109763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890875				2022-12-28	WOS:000229190700037
J	Bhattacharjee, Y				Bhattacharjee, Y			Sensitive technology - Schools fear impact of proposed license changes	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					938	939						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890853				2022-12-28	WOS:000229190700008
J	Mahaffy, PR				Mahaffy, PR			Intensive Titan exploration begins	SCIENCE			English	Article								The Cassini Orbiter spacecraft first skimmed through the tenuous upper atmosphere of Titan on 26 October 2004. This moon of Saturn is unique in our solar system, with a dense nitrogen atmosphere that is cold enough in places to rain methane, the feedstock for the atmospheric chemistry that produces hydrocarbons, nitrite compounds, and Titan's orange haze. The data returned from this flyby supply new information on the magnetic field and plasma environment around Titan, expose new facets of the dynamics and chemistry of Titan's atmosphere, and provide the first glimpses of what appears to be a complex, fluid-processed, geologically young Titan surface.	NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Mahaffy, PR (corresponding author), NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Code 661, Greenbelt, MD 20771 USA.	paul.r.mahaffy@nasa.gov	Mahaffy, Paul/E-4609-2012	Mahaffy, Paul/0000-0003-1896-1726				Backes H, 2005, SCIENCE, V308, P992, DOI 10.1126/science.1109763; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; Kivelson MG, 2000, SCIENCE, V289, P1340, DOI 10.1126/science.289.5483.1340; Lorenz R. D., 2002, LIFTING TITANS VEIL; Mitchell DG, 2005, SCIENCE, V308, P989, DOI 10.1126/science.1109805; Niemann HB, 2002, SPACE SCI REV, V104, P553, DOI 10.1023/A:1023680305259; Owen T, 2002, SPACE SCI REV, V104, P347, DOI 10.1023/A:1023684406168; Shemansky DE, 2005, SCIENCE, V308, P978, DOI 10.1126/science.1111790; Wahlund JE, 2005, SCIENCE, V308, P986, DOI 10.1126/science.1109807; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; Wolf AA, 2002, SPACE SCI REV, V104, P101, DOI 10.1023/A:1023692724823	12	18	19	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					969	970		10.1126/science.1113205	http://dx.doi.org/10.1126/science.1113205			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890870				2022-12-28	WOS:000229190700030
J	Arribas, J				Arribas, J			Matrix metalloproteases and tumor invasion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER CELLS; RECEPTOR		Vall Hebron Univ Hosp Res Inst, Med Oncol Res Program, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Arribas, J (corresponding author), Vall Hebron Univ Hosp Res Inst, Med Oncol Res Program, Barcelona, Spain.		Arribas, Joaquin/M-4482-2014	Arribas, Joaquin/0000-0002-0504-0664				Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Kamath L, 2001, CANCER RES, V61, P5933	5	14	16	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					2020	2021		10.1056/NEJMcibr055002	http://dx.doi.org/10.1056/NEJMcibr055002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888705				2022-12-28	WOS:000229017100016
J	Nielsen, SB; Thomsen, E; Hansen, DL; Clausen, OR				Nielsen, SB; Thomsen, E; Hansen, DL; Clausen, OR			Plate-wide stress relaxation explains European Palaeocene basin inversions	NATURE			English	Article							TECTONIC EVOLUTION; ALPINE FORELAND; TORNQUIST ZONE; NORTH-SEA; DEFORMATION; PALEOGENE; ENGLAND	During Late Cretaceous and Cenozoic times, many Palaeozoic and Mesozoic rifts and basin structures in the interior of the European continent underwent several phases of inversion ( the process of shortening a previously extensional basin)(1). The main phases occurred during the Late Cretaceous and Middle Palaeocene, and have been previously explained by pulses of compression, mainly from the Alpine orogen(2-5). Here we show that the main phases differed both in structural style and cause. The Cretaceous phase was characterized by narrow uplift zones, reverse activation of faults, crustal shortening, and the formation of asymmetric marginal troughs. In contrast, the Middle Palaeocene phase was characterized by dome-like uplift of a wider area with only mild fault movements, and formation of more distal and shallow marginal troughs. A simple flexural model explains how domal, secondary inversion follows inevitably from primary, convergence-related inversion on relaxation of the in-plane tectonic stress. The onset of relaxation inversions was plate-wide and simultaneous, and may have been triggered by stress changes caused by elevation of the North Atlantic lithosphere by the Iceland plume(6) or the drop in the north - south convergence rate between Africa and Europe(7).	Univ Aarhus, Dept Earth Sci, DK-8200 Aarhus, Denmark	Aarhus University	Nielsen, SB (corresponding author), Univ Aarhus, Dept Earth Sci, Finlandsgade 8, DK-8200 Aarhus, Denmark.	sbn@geo.au.dk	Thomsen, Erik/A-4842-2012; Clausen, Ole Rønø/A-5290-2012; Nielsen, Søren/A-5288-2012; Egholm, David/G-8227-2011	Egholm, David Lundbek/0000-0003-4045-240X; Clausen, Ole Rono/0000-0002-6825-9065				Baldschuhn R., 1991, GENERATION ACCUMULAT, V1, P149; CLAUSEN OR, 1993, TERRA NOVA, V5, P233, DOI 10.1111/j.1365-3121.1993.tb00254.x; Clemmensen A, 2005, PALAEOGEOGR PALAEOCL, V219, P351, DOI 10.1016/j.palaeo.2005.01.005; Dadlez R, 1995, TECTONOPHYSICS, V252, P179, DOI 10.1016/0040-1951(95)00104-2; Dadlez R., 2000, GEOLOGICAL MAP POLAN; de Lugt IR, 2003, TECTONOPHYSICS, V373, P141, DOI 10.1016/S0040-1951(03)00284-1; DEJAGER J, 2003, NETH J GEOSCI, V4, P355; Erlstrom M, 1997, TECTONOPHYSICS, V271, P191, DOI 10.1016/S0040-1951(96)00247-8; Gregersen S, 2002, TECTONOPHYSICS, V360, P61, DOI 10.1016/S0040-1951(02)00347-5; Hansen DL, 2003, TECTONOPHYSICS, V373, P5, DOI 10.1016/S0040-1951(03)00280-4; Hansen DL, 2000, TECTONOPHYSICS, V328, P245, DOI 10.1016/S0040-1951(00)00216-X; Jolley DW, 1998, REV PALAEOBOT PALYNO, V99, P265, DOI 10.1016/S0034-6667(97)00039-0; Kockel F, 2003, NETH J GEOSCI, V82, P351, DOI 10.1017/S0016774600020187; LAKE SD, 1987, TECTONOPHYSICS, V137, P347, DOI 10.1016/0040-1951(87)90328-3; Lamarche J, 2003, TECTONOPHYSICS, V373, P75, DOI 10.1016/S0040-1951(03)00285-3; LAMBECK K, 1987, CANADIAN SOC PETROLE, V12, P259; Mortimore R, 1997, P GEOLOGIST ASSOC, V108, P231, DOI 10.1016/S0016-7878(97)80031-4; Nielsen SB, 2000, GEOLOGY, V28, P875, DOI 10.1130/0091-7613(2000)28<875:PEOTFA>2.0.CO;2; Rosenbaum G, 2002, TECTONOPHYSICS, V359, P117, DOI 10.1016/S0040-1951(02)00442-0; Steurbaut Etienne, 1998, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V247, P91; VANHOORN B, 1987, TECTONOPHYSICS, V137, P239, DOI 10.1016/0040-1951(87)90322-2; Vejbaek OV, 2002, B GEOL SOC DENMARK, V49, P129; Vinken R., 1988, GEOL JB A, V100, P1; Voigt E., 1962, Z DTSCH GEOL GES, V114, P378, DOI DOI 10.1127/ZDGG/114/1963/378; White N, 1997, NATURE, V387, P888, DOI 10.1038/43151; Worum G, 2005, J GEOL SOC LONDON, V162, P73, DOI 10.1144/0016-764904-011; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Ziegler P. A., 1990, GEOLOGICAL ATLAS W C; Ziegler PA, 1998, TECTONOPHYSICS, V300, P103, DOI 10.1016/S0040-1951(98)00236-4; Ziegler PA, 1995, TECTONOPHYSICS, V252, P7, DOI 10.1016/0040-1951(95)00102-6; ZIEGLER PA, 1987, TECTONOPHYSICS, V137, P389, DOI 10.1016/0040-1951(87)90330-1	31	65	65	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					195	198		10.1038/nature03599	http://dx.doi.org/10.1038/nature03599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889089	Green Published			2022-12-28	WOS:000229021100037
J	Hakonarson, H; Thorvaldsson, S; Helgadottir, A; Gudbjartsson, D; Zink, F; Andresdottir, M; Manolescu, A; Arnar, DO; Andersen, K; Sigurdsson, A; Thorgeirsson, G; Jonsson, A; Agnarsson, U; Bjornsdottir, H; Gottskalksson, G; Einarsson, A; Gudmundsdottir, H; Adalsteinsdottir, AE; Gudmundsson, K; Kristjansson, K; Hardarson, T; Kristinsson, A; Topol, EJ; Gulcher, J; Kong, A; Thorgeirsson, G; Stefansson, K				Hakonarson, H; Thorvaldsson, S; Helgadottir, A; Gudbjartsson, D; Zink, F; Andresdottir, M; Manolescu, A; Arnar, DO; Andersen, K; Sigurdsson, A; Thorgeirsson, G; Jonsson, A; Agnarsson, U; Bjornsdottir, H; Gottskalksson, G; Einarsson, A; Gudmundsdottir, H; Adalsteinsdottir, AE; Gudmundsson, K; Kristjansson, K; Hardarson, T; Kristinsson, A; Topol, EJ; Gulcher, J; Kong, A; Thorgeirsson, G; Stefansson, K			Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; INTERCELLULAR-ADHESION MOLECULE-1; ACTIVATING-FACTOR-ACETYLHYDROLASE; LEUKOTRIENE B-4 PRODUCTION; ACUTE CORONARY SYNDROMES; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; ASTHMATIC SUBJECTS; HEART-DISEASE; CONFERS RISK	Context Myocardial infarction (MI) is the leading cause of death in the world. Variants in the 5-lipoxygenase-activating protein (FLAP) gene are associated with risk of MI. Objective To determine the effect of an inhibitor of FLAP on levels of biomarkers associated with MI risk. Design, Setting, and Patients A randomized, prospective, placebo-controlled, crossover trial of an inhibitor of FLAP (DG-031) in MI patients who carry at-risk variants in the FLAP gene or in the leukotriene A(4) hydrolase gene. Of 268 patients screened, 191 were carriers of at-risk variants in FLAP (87%) or leukotriene A4 hydrolase (13%). Individuals were enrolled in April 2004 and were followed up by designated cardiologists from a university hospital in Iceland until September 2004. Interventions Patients were first randomized to receive 250 mg/d of DG-031, 500 mg/d of DG-031, 750 mg/d of DG-031, or placebo. After a 2-week washout period, patients received DG-031 if they had received placebo first or placebo if they had received DG-031 first. Treatment periods lasted for 4 weeks. Main Outcome Measures Changes in levels of biomarkers associated with risk of MI. Results In response to 750 mg/d of DG-031, production of leukotriene B-4 was significantly reduced by 26% (95% confidence interval [CI], 10%-39%; P=.003) and myeloperoxidase was significantly reduced by 12% (95% Cl, 2%-21%; P=.02). The higher 2 doses of DG-031 produced a nonsignificant reduction in C-reactive protein (16%; 95% Cl, -2% to 31 %; P=.07) at 2 weeks. However, there was a more pronounced reduction (25%; 95% Cl, 5%-40%; P=.02) in C-reactive protein at the end of the washout period that persisted for another 4 weeks thereafter. The FLAP inhibitor DG-031 was well tolerated and was not associated with any serious adverse events. Conclusion In patients with specific at-risk variants of 2 genes in the leukotriene pathway, DG-031 led to significant and dose-dependent suppression of biomarkers that are associated with increased risk of MI events.	Decode Genet Inc, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, Reykjavik, Iceland; Iceland Heart Assoc, Reykjavik, Iceland; Cleveland Clin Fdn, Cleveland, OH 44195 USA	Landspitali National University Hospital; Icelandic Heart Association; Cleveland Clinic Foundation	Hakonarson, H (corresponding author), Decode Genet Inc, Sturlugata 8, IS-101 Reykjavik, Iceland.	hakonh@decode.is; kstefans@decode.is	Manolescu, Andrei/G-4565-2014; Stefansson, Kari/AAE-7187-2019	Manolescu, Andrei/0000-0002-0713-4664; Gudbjartsson, Daniel/0000-0002-5222-9857; Topol, Eric/0000-0002-1478-4729				Andersen GN, 2000, ARTHRITIS RHEUM-US, V43, P1085; Blum A, 2000, AM J CARDIOL, V86, P892, DOI 10.1016/S0002-9149(00)01116-4; Blum A, 2000, J AM COLL CARDIOL, V35, P271, DOI 10.1016/S0735-1097(99)00553-7; Bonow RO, 2002, CIRCULATION, V106, P1602, DOI 10.1161/01.CIR.0000035036.22612.2B; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Caslake MJ, 2003, CURR OPIN LIPIDOL, V14, P347, DOI 10.1097/00041433-200308000-00002; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Dada N, 2002, EXPERT REV MOL DIAGN, V2, P17; Dahlen B, 1997, THORAX, V52, P342, DOI 10.1136/thx.52.4.342; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Ellsworth Darrell L, 2004, Prev Cardiol, V7, P168, DOI 10.1111/j.1520-037X.2004.3332.x; FORDHUTCHINSON AW, 1990, CRIT REV IMMUNOL, V10, P1; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; Goulet JL, 2000, J IMMUNOL, V164, P4899, DOI 10.4049/jimmunol.164.9.4899; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Haim M, 2002, J AM COLL CARDIOL, V39, P1133, DOI 10.1016/S0735-1097(02)01728-X; Hamilton AL, 1997, THORAX, V52, P348, DOI 10.1136/thx.52.4.348; Helgadottir A, 2005, AM J HUM GENET, V76, P505, DOI 10.1086/428066; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Klein A, 2001, J IMMUNOL, V167, P524, DOI 10.4049/jimmunol.167.1.524; LAROSA JC, 2005, N ENGL J MED    0308; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Link AA, 2000, J IMMUNOL, V164, P436, DOI 10.4049/jimmunol.164.1.436; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Malik I, 2001, LANCET, V358, P971, DOI 10.1016/S0140-6736(01)06104-9; MCDONALD TL, 1991, J IMMUNOL METHODS, V144, P149, DOI 10.1016/0022-1759(91)90081-P; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Mohamed-Ali V, 2001, J CLIN ENDOCR METAB, V86, P5864, DOI 10.1210/jc.86.12.5864; Morrow DA, 2000, J AM COLL CARDIOL, V35, P358, DOI 10.1016/S0735-1097(99)00574-4; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Profita M, 2002, J PHARMACOL EXP THER, V300, P868, DOI 10.1124/jpet.300.3.868; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Roberts WL, 2001, CLIN CHEM, V47, P418; Ryan LA, 2001, J INFECT DIS, V184, P699, DOI 10.1086/323036; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Schmitt D, 1999, BIOCHEMISTRY-US, V38, P16904, DOI 10.1021/bi991623w; Sigurdardottir V, 2002, J INTERN MED, V252, P440, DOI 10.1046/j.1365-2796.2002.01054.x; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; STRATFORD N, 1986, ATHEROSCLEROSIS, V59, P271, DOI 10.1016/0021-9150(86)90122-X; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Topol EJ, 2002, AM J MED, V113, P1, DOI 10.1016/S0002-9343(02)01145-2; Tselepis AD, 2002, ATHEROSCLEROSIS SUPP, V3, P57, DOI 10.1016/S1567-5688(02)00045-4; Tsen YC, 2003, CLIN CHEM, V49, P810, DOI 10.1373/49.5.810; van der Vliet A, 2000, Respir Res, V1, P67; Yang SK, 2002, AM J GASTROENTEROL, V97, P126; ZHANG R, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI DOI 10.1001/JAMA.286.17.2136	49	188	274	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2245	2256		10.1001/jama.293.18.2245	http://dx.doi.org/10.1001/jama.293.18.2245			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886380				2022-12-28	WOS:000228981100026
J	Watzl, B				Watzl, B			Consumption of vegetables and fruits and risk of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Fed Res Ctr Nutr & Food, Inst Nutr Physiol, Karlsruhe, Germany		Watzl, B (corresponding author), Fed Res Ctr Nutr & Food, Inst Nutr Physiol, Karlsruhe, Germany.	bernhard.watzl@bfe.uka.de		Riboli, Elio/0000-0001-6795-6080				Agudo A, 2002, PUBLIC HEALTH NUTR, V5, P1179, DOI 10.1079/PHN2002398; Mensink G B, 1999, Gesundheitswesen, V61 Spec No, pS200; USDA and US Department of Health and Human Services, 2005, DIET GUID AM 2005; van Gils CH, 2005, JAMA-J AM MED ASSOC, V293, P183, DOI 10.1001/jama.293.2.183; *WHO, 2003, FRUIT VEG PROM IN EX	5	4	5	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2209	2210		10.1001/jama.293.18.2209-b	http://dx.doi.org/10.1001/jama.293.18.2209-b			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886371	Green Published			2022-12-28	WOS:000228981100014
J	Schulz, KF; Grimes, DA				Schulz, KF; Grimes, DA			Multiplicity in randomised trials II: subgroup and interim analyses	LANCET			English	Article							CLINICAL-TRIALS	Subgroup analyses can pose serious multiplicity concerns. By testing enough subgroups, a false-positive result will probably emerge by chance alone. Investigators might undertake many analyses but only report the significant effects, distorting the medical literature. In general, we discourage subgroup analyses. However, if they are necessary, researchers should do statistical tests of interaction, rather than analyse every separate subgroup. Investigators cannot avoid interim analyses when data monitoring is indicated. However, repeatedly testing at every interim raises multiplicity concerns, and not accounting for multiplicity escalates the false-positive error. Statistical stopping methods must be used. The O'Brien-Fleming and Peto group sequential stopping methods are easily implemented and preserve the intended alpha level and power. Both adopt stringent criteria (low nominal p values) during the interim analyses. Implementing a trial under these stopping rules resembles a conventional trial, with the exception that it can be terminated early should a treatment prove greatly superior. investigators and readers, however, need to grasp that the estimated treatment effects are prone to exaggeration, a random high, with early stopping.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Schulz, KF (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	KSchulz@fhi.org						Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; [Anonymous], 1988, LANCET, V2, P349; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; DYSON DC, 1991, AM J OBSTET GYNECOL, V164, P756, DOI 10.1016/0002-9378(91)90510-X; Ellenberg SS., 2002, DATA MONITORING COMM; FREEDMAN LS, 1994, STAT MED, V13, P1371, DOI 10.1002/sim.4780131312; GELLER NL, 1987, BIOMETRICS, V43, P213, DOI 10.2307/2531962; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Horton R, 2000, LANCET, V355, P1033, DOI 10.1016/S0140-6736(00)02031-6; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; MCPHERSON K, 1990, STAT MED, V9, P595, DOI 10.1002/sim.4780090605; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Oei SG, 1999, BRIT MED J, V318, P1008; Parmar MKB, 2001, LANCET, V358, P375, DOI 10.1016/S0140-6736(01)05558-1; PARMAR MKB, 1994, STAT MED, V13, P1297, DOI 10.1002/sim.4780131304; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; PIANTADOSI S, 1997, CLIN TRIALS METHODOL; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; POCOCK SJ, 1992, BMJ-BRIT MED J, V305, P235, DOI 10.1136/bmj.305.6847.235; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; SPIEGELHALTER DJ, 1993, STAT MED, V12, P1501, DOI 10.1002/sim.4780121516; Sydes Matthew R, 2004, Clin Trials, V1, P60, DOI 10.1191/1740774504cn004rr; Sydes Matthew R, 2004, Clin Trials, V1, P48, DOI 10.1191/1740774504cn003oa; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	27	227	231	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1657	1661		10.1016/S0140-6736(05)66516-6	http://dx.doi.org/10.1016/S0140-6736(05)66516-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885299				2022-12-28	WOS:000228933700032
J	Bosl, WJ; Li, R				Bosl, WJ; Li, R			Mitotic-exit control as an evolved complex system	CELL			English	Review							IN-VITRO REGULATION; CELL-CYCLE; BUDDING YEAST; POLO KINASE; CDC14; LTE1; COORDINATION; LOCALIZATION; NETWORKS; DESIGN	The exit from mitosis is the last critical decision during a cell-division cycle. A complex regulatory system has evolved to evaluate the success of mitotic events and control this decision. Whereas outstanding genetic work in yeast has led to rapid discovery of a large number of interacting genes involved in the control of mitotic exit, it has also become increasingly difficult to comprehend the logic and mechanistic features embedded in the complex molecular network. Our view is that this difficulty stems in part from the attempt to explain mitotic-exit control using concepts from traditional top-down engineering design, and that exciting new results from evolutionary engineering design applied to networks and electronic circuits may lend better insights. We focus on four particularly intriguing features of the mitotic-exit control system and attempt to examine these features from the perspective of evolutionary design and complex system engineering.	Univ Calif Davis, Davis Canc Ctr, Sacramento, CA 95817 USA; Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Harvard University; Harvard Medical School	Bosl, WJ (corresponding author), Univ Calif Davis, Davis Canc Ctr, Sacramento, CA 95817 USA.	bosl@llnl.gov; rong_li@hms.harvard.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG003418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059964] Funding Source: NIH RePORTER; NHGRI NIH HHS [K01 HG003418-02] Funding Source: Medline; NIGMS NIH HHS [GM 059964-06S1, GM 059964] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; ANTONSSON EK, 2001, FORMAL ENG DESIGN SY; ANTONSSON EK, 2003, DETC 03 ASME 2003 DE; Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bentley P.J., 1999, EVOLUTIONARY DESIGN; BERNERSLEE T, 2000, WEAVING WEB; BERYAM Y, 2003, INT C SYST MAN CYB, V2, P2021; Bloecher A, 2000, NAT CELL BIOL, V2, P556, DOI 10.1038/35019601; BOURNE HR, 1995, PHILOS T R SOC B, V349, P283, DOI 10.1098/rstb.1995.0114; D'Amours D, 2004, GENE DEV, V18, P2581, DOI 10.1101/gad.1247304; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; Geymonat M, 2003, J BIOL CHEM, V278, P14591, DOI 10.1074/jbc.C300059200; Geymonat M, 2002, CURR BIOL, V12, pR482, DOI 10.1016/S0960-9822(02)00963-6; Geymonat M, 2002, J BIOL CHEM, V277, P28439, DOI 10.1074/jbc.M202540200; Hartmann M, 2004, IEE P-COMPUT DIG T, V151, P287, DOI 10.1049/ip-cdt:20040014; HARTMANN M, 2002, 4 GEN EV COMP C NEW; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hofken T, 2004, J CELL BIOL, V164, P219, DOI 10.1083/jcb.200309080; Hofken T, 2002, EMBO J, V21, P4851, DOI 10.1093/emboj/cdf481; Holland J. H., 1995, HIDDEN ORDER ADAPTAT; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; HUFFAKER TC, 1988, J CELL BIOL, V106, P1997, DOI 10.1083/jcb.106.6.1997; Ingolia NT, 2004, CURR BIOL, V14, pR771, DOI 10.1016/j.cub.2004.09.018; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jensen S, 2002, J CELL SCI, V115, P4977, DOI 10.1242/jcs.00189; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; Mitra S, 2002, IEEE T COMPUT, V51, P498, DOI 10.1109/TC.2002.1004589; Molk JN, 2004, MOL BIOL CELL, V15, P1519, DOI 10.1091/mbc.E03-09-0708; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Pereira G, 2002, J CELL BIOL, V157, P367, DOI 10.1083/jcb.200112085; Prinz S, 1999, NATURE, V402, P133, DOI 10.1038/45949; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Richards KL, 2000, MOL BIOL CELL, V11, P1887, DOI 10.1091/mbc.11.5.1887; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; SCHMID A, 2004, 2004 IEEE INT S CIRC; Seshan A, 2004, CURR OPIN CELL BIOL, V16, P41, DOI 10.1016/j.ceb.2003.11.003; Seshan A, 2002, CURR BIOL, V12, P2098, DOI 10.1016/S0960-9822(02)01388-X; Simanis V, 2003, J CELL SCI, V116, P4261, DOI 10.1242/jcs.00777; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Thompson A, 1999, COMMUN ACM, V42, P71, DOI 10.1145/299157.299174; Thompson A, 2000, INT J CIRC THEOR APP, V28, P585, DOI 10.1002/1097-007X(200011/12)28:6<585::AID-CTA129>3.0.CO;2-3; THOMPSON A, 1996, IEE C PUBLICATION, V427, P693; THOMPSON A, 1999, IEEE C EV HARDW SYST; THOMPSON A, 1997, 4 EUR C ART LIF ECAL; THOMPSON A, 1998, ICES 98; Torres-Rosell J, 2005, CELL CYCLE, V4, P109, DOI 10.4161/cc.4.1.1356; TOYN JH, 1993, GENETICS, V135, P963; TYRRELL AM, 2001, 3 NASA DOD WORKSH EV; Visintin R, 2003, MOL BIOL CELL, V14, P4486, DOI 10.1091/mbc.E03-02-0095; Yoshida S, 2003, J CELL BIOL, V161, P889, DOI 10.1083/jcb.200301128	53	44	44	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					325	333		10.1016/j.cell.2005.04.006	http://dx.doi.org/10.1016/j.cell.2005.04.006			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882616	Green Submitted, Bronze			2022-12-28	WOS:000229031600004
J	Brinton, LA; Lacey, JV; Trimble, EL				Brinton, LA; Lacey, JV; Trimble, EL			Hormones and endometrial cancer - new data from the Million Women Study	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ESTROGEN PLUS PROGESTIN; POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; SYMPTOMS		NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brinton, LA (corresponding author), NCI, Bethesda, MD 20892 USA.	brinton@nih.gov	Trimble, Edward/J-9647-2019; Brinton, Louise A/G-7486-2015	Trimble, Edward/0000-0001-5028-0598; Brinton, Louise A/0000-0003-3853-8562				Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Barrett-Connor E, 2005, ANNU REV PUBL HEALTH, V26, P115, DOI 10.1146/annurev.publhealth.26.021304.144637; Col NF, 2004, ARCH INTERN MED, V164, P1634, DOI 10.1001/archinte.164.15.1634; FERENCZY A, 1989, AM J OBSTET GYNECOL, V160, P126, DOI 10.1016/0002-9378(89)90103-8; Grady D, 1997, J NATL CANCER I, V89, P1088, DOI 10.1093/jnci/89.15.1088; Grady D, 2003, NEW ENGL J MED, V348, P1835, DOI 10.1056/NEJMp030038; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Nelson HD, 2004, JAMA-J AM MED ASSOC, V291, P1610, DOI 10.1001/jama.291.13.1610; Newcomb PA, 2003, CANCER CAUSE CONTROL, V14, P195, DOI 10.1023/A:1023066304473; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rymer J, 2003, BRIT MED J, V326, P322, DOI 10.1136/bmj.326.7384.322; Rymer J, 2000, BMJ-BRIT MED J, V321, P1516, DOI 10.1136/bmj.321.7275.1516	13	12	13	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 30	2005	365	9470					1517	1518		10.1016/S0140-6736(05)66431-8	http://dx.doi.org/10.1016/S0140-6736(05)66431-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866289				2022-12-28	WOS:000228754800004
J	Porthouse, J; Cockayne, S; King, C; Saxon, L; Steele, E; Aspray, T; Baverstock, M; Birks, Y; Dumville, J; Francis, RM; Iglesias, C; Puffer, S; Sutcliffe, A; Watt, I; Torgerson, DJ				Porthouse, J; Cockayne, S; King, C; Saxon, L; Steele, E; Aspray, T; Baverstock, M; Birks, Y; Dumville, J; Francis, RM; Iglesias, C; Puffer, S; Sutcliffe, A; Watt, I; Torgerson, DJ			Randomised controlled trial of supplementation with calcium and cholecalciferol (vitamin D) for prevention of fractures in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOUBLE-BLIND; WOMEN; RISK; COMMUNITY; MEN	Objective To assess whether supplementation with calcium and cholecaliferol (vitamin D-3) reduces the risk of fracture in women with one or more risk factors for fracture of the hip. Design Pragmatic open randomised controlled trial. Setting Practice nurse led clinics in primary care. Participants 3314 women aged 70 and over with one or more risk factors for hip fracture: any previous fracture, low body weight (< 58 kg), smoker, family history of hip fracture, or fair or poor self reported health. Intervention Daily oral supplementation using 1000 mg calcium with 800 IU cholecaliferol and information leaflet on dietary calcium intake and prevention of falls, or leaflet only (control group). Main outcome measures Primary outcome measure was all clinical fractures and secondary outcome measures were adherence to treatment, falls, and quality of life (measured with the SF-12). Results 69% of the women who completed the follow-up questionnaire at 24 months were still taking supplements (55% with inclusion of randomised participants known to be alive). After a median follow-up of 25 months (range 18 to 42 months), clinical fracture rates were lower than expected in both groups but did not significantly differ for all clinical fractures (odds ratio for fracture in supplemented group 1.01, 95% confidence interval 0.71 to 1.43). The odds ratio for hip fracture was 0.75 (0.31 to 1.78). The odds of a woman having a fall at six and 12 months was 0.99 and 0.98, respectively. Quality of life did not significantly differ between the groups. Conclusion We found no evidence that calcium and vitamin D supplementation reduces the risk of clinical fractures in women with one or more risk factors for hip fracture. Registration ISRCTNT26118436, controlled trials registry.	Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England; Freeman Rd Hosp, Bone Clin, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; Hertfordshire Primary Care Network, Ware, Herts, England	University of York - UK; Newcastle Freeman Hospital; Newcastle University - UK	Torgerson, DJ (corresponding author), Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England.	djt6@york.ac.uk	Torgerson, David/L-4566-2019; Dumville, Jo/O-7867-2014	Torgerson, David/0000-0002-1667-4275; Aspray, Terry/0000-0001-9522-6069; Dumville, Jo/0000-0002-6546-3685				BARRETCONNOR E, 1993, AM J MED S2A, V98, pS3; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Birks YF, 2004, OSTEOPOROSIS INT, V15, P701, DOI 10.1007/s00198-004-1599-0; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Dolan P, 1998, OSTEOPOROSIS INT, V8, P611, DOI 10.1007/s001980050107; EDDY DM, 1998, OSTEOPOROS INT S, V4; GRIMLEYEVANS J, 1997, J EPIDEMIOL COMMUNIT, V51, P424; Iglesias CP, 2001, QJM-INT J MED, V94, P695, DOI 10.1093/qjmed/94.12.695; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Larsen ER, 2004, J BONE MINER RES, V19, P370, DOI 10.1359/JBMR.0301240; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; Meyer HE, 2002, J BONE MINER RES, V17, P709, DOI 10.1359/jbmr.2002.17.4.709; *MRC RECORD TRIAL, 2005, IN PRESS LANCET; Porthouse J, 2004, QJM-INT J MED, V97, P569, DOI 10.1093/qjmed/hch097; Schurch MA, 1996, J BONE MINER RES, V11, P1935; Smith H, 2004, OSTEOPOROSIS INT, V15, pS8; Torgerson D, 1997, J Health Serv Res Policy, V2, P81; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469	21	351	370	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2005	330	7498					1003	1006		10.1136/bmj.330.7498.1003	http://dx.doi.org/10.1136/bmj.330.7498.1003			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UP	15860827	Green Published, Bronze			2022-12-28	WOS:000228935100023
J	Umina, PA; Weeks, AR; Kearney, MR; McKechnie, SW; Hoffmann, AA				Umina, PA; Weeks, AR; Kearney, MR; McKechnie, SW; Hoffmann, AA			A rapid shift in a classic clinal pattern in Drosophila reflecting climate change	SCIENCE			English	Article							METABOLICALLY RELATED ADH; ALCOHOL-DEHYDROGENASE; NATURAL-POPULATIONS; INVERSION POLYMORPHISMS; LATITUDINAL CLINES; TPI POLYMORPHISMS; MELANOGASTER; GENETICS; GPDH; ASSOCIATIONS	Geographical clines in genetic polymorphisms are widely used as evidence of climatic selection and are expected to shift with climate change. We show that the classic latitudinal cline in the alcohol dehydrogenase polymorphism of Drosophila melanogaster has shifted over 20 years in eastern coastal Austratia. Southern high-latitude populations now have the genetic constitution of more northerly populations, equivalent to a shift of 40 in latitude. A similar shift was detected for a genetically independent inversion polymorphism, whereas two other linked polymorphisms exhibiting weaker clinal patterns have remained relatively stable. These genetic changes are likely to reflect increasingly warmer and drier conditions and may serve as sensitive biomarkers for climate change.	La Trobe Univ, Ctr Environm Stress & Adaptat Res, Bundoora, Vic 3086, Australia; Monash Univ, Sch Biol Sci, Ctr Environm Stress & Adaptat Res, Clayton, Vic 3800, Australia	La Trobe University; Monash University	Hoffmann, AA (corresponding author), La Trobe Univ, Ctr Environm Stress & Adaptat Res, Bundoora, Vic 3086, Australia.	ary@unimelb.edu.au	Kearney, Michael/R-3404-2017; Hoffmann, Ary/C-2961-2011; Weeks, Andrew/ABC-3048-2020; Hoffmann, Ary/R-2972-2019	Kearney, Michael/0000-0002-3349-8744; Hoffmann, Ary/0000-0001-9497-7645; Umina, Paul/0000-0002-1835-3571; Weeks, Andrew/0000-0003-3081-135X				ALAHIOTIS SN, 1982, GENETICA, V59, P81, DOI 10.1007/BF00133290; ANDERSON AR, IN PRESS MOL ECOL; ANDERSON PR, 1987, GENETICA, V75, P81, DOI 10.1007/BF00055251; ANDERSON PR, 1984, NATURE, V308, P729, DOI 10.1038/308729a0; Andolfatto P, 1999, GENETICS, V153, P1297; BERRY A, 1993, GENETICS, V134, P869; BOCK IR, 1981, GENET BIOL DROSOPHIL, P299; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; COYNE JA, 1987, GENETICS, V117, P727; DAVID JR, 1975, EXPERIENTIA, V31, P164, DOI 10.1007/BF01990682; Dobzhansky T, 1943, GENETICS, V28, P162; Endler J.A., 1986, Monographs in Population Biology, pviii; Etges WJ, 2004, BIOL J LINN SOC, V81, P395, DOI 10.1111/j.1095-8312.2004.00306.x; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Houghton J. T., 2001, CLIMATE CHANGE 2001; Kamping A, 1999, J EVOLUTION BIOL, V12, P809, DOI 10.1046/j.1420-9101.1999.00083.x; Kennington WJ, 2003, GENETICS, V165, P667; KNIBB WR, 1982, GENETICA, V58, P213, DOI 10.1007/BF00128015; MCKENZIE JA, 1983, GENETIC STUDIES DROS, P201; NIELSEN KM, 1985, GENET SEL EVOL, V17, P41, DOI 10.1186/1297-9686-17-1-41; OAKESHOTT JG, 1984, GENETICA, V63, P21, DOI 10.1007/BF00137461; OAKESHOTT JG, 1982, EVOLUTION, V36, P86, DOI 10.1111/j.1558-5646.1982.tb05013.x; Rodriguez-Trelles F, 1998, EVOL ECOL, V12, P829, DOI 10.1023/A:1006546616462; 't Land JV, 2000, EVOLUTION, V54, P201, DOI 10.1554/0014-3820(2000)054[0201:LVFTEL]2.0.CO;2; VANDELDEN W, 1978, GENETICS, V90, P161; VANDELDEN W, 1984, POPULATION BIOL EVOL, P127; VIGUE CL, 1973, BIOCHEM GENET, V9, P213, DOI 10.1007/BF00485735; Weeks AR, 2002, ECOL LETT, V5, P756, DOI 10.1046/j.1461-0248.2002.00380.x; ZILLMAN JW, 2003, YB AUSTR	29	288	305	3	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					691	693		10.1126/science.1109523	http://dx.doi.org/10.1126/science.1109523			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860627				2022-12-28	WOS:000228810900049
J	Lawrence, T; Bebien, M; Liu, GY; Nizet, V; Karin, M				Lawrence, T; Bebien, M; Liu, GY; Nizet, V; Karin, M			IKK alpha limits macrophage NF-kappa B activation and contributes to the resolution of inflammation	NATURE			English	Article							C-REL; PHOSPHORYLATION; KINASE; TRANSCRIPTION; RECOGNITION; UBIQUITINATION; DEGRADATION; EXPRESSION; RECEPTORS; EXCHANGE	Inflammation and innate immunity involve signalling pathways leading to the production of inflammatory mediators. Usually such responses are self-limiting, but aberrant resolution of inflammation results in chronic diseases(1). Much attention has focused on pro-inflammatory signalling but little is known about the mechanisms that resolve inflammation. The I kappa B kinase (IKK) complex contains two catalytic subunits, IKK alpha and IKK beta, and controls the activation of NF-kappa B transcription factors, which play a pivotal role in inflammation(2). Ample evidence indicates that IKK beta mediates NF-kappa B activation in response to pro-inflammatory cytokines and microbial products. IKK alpha regulates an alternative pathway important for lymphoid organogenesis(2), but the role of IKK alpha in inflammation is unknown. Here we describe a new role for IKK alpha in the negative regulation of macrophage activation and inflammation. IKK alpha contributes to suppression of NF-kappa B activity by accelerating both the turnover of the NF-kappa B subunits RelA and c-Rel, and their removal from pro-inflammatory gene promoters. Inactivation of IKK alpha in mice enhances inflammation and bacterial clearance. Hence, the two IKK catalytic subunits have evolved opposing but complimentary roles needed for the intricate control of inflammation and innate immunity.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Div Paediat Infect Dis, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Lawrence, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Rheumatol, Kennedy Inst, 1 Aspenlea Rd, London W6 8LH, England.	t.lawrence@imperial.ac.uk	Nizet, Victor/AAF-3190-2019; Lawrence, Toby/GLU-3895-2022	Lawrence, Toby/0000-0003-0967-6122; Nizet, Victor/0000-0003-3847-0422				Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen E, 1998, J BIOL CHEM, V273, P35201, DOI 10.1074/jbc.273.52.35201; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Fognani C, 2000, ONCOGENE, V19, P2224, DOI 10.1038/sj.onc.1203543; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Martin AG, 2000, J BIOL CHEM, V275, P24383, DOI 10.1074/jbc.M909396199; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Puliti M, 2004, INFECT IMMUN, V72, P4891, DOI 10.1128/IAI.72.8.4891-4894.2004; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576	30	537	570	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1138	1143		10.1038/nature03491	http://dx.doi.org/10.1038/nature03491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858576				2022-12-28	WOS:000228693300045
J	Sharp, SP; McGowan, A; Wood, MJ; Hatchwell, BJ				Sharp, SP; McGowan, A; Wood, MJ; Hatchwell, BJ			Learned kin recognition cues in a social bird	NATURE			English	Article							LONG-TAILED TITS; AEGITHALOS-CAUDATUS; SEYCHELLES WARBLER; KINSHIP; DISCRIMINATION; BEHAVIOR; FITNESS; HELPERS; CALLS	In many cooperatively breeding birds, kin selection has an important role in the evolution and maintenance of social behaviour, and 'helpers' can maximize indirect fitness gains by preferentially allocating care to close relatives(1-3). Although there is evidence for kin-biased helping behaviour in several species(1,4,5), the mechanism of kin recognition underlying this behaviour is poorly understood(2). Vocalizations are the most commonly used cues in avian recognition systems(6,7), but the effectiveness of vocal signals as reliable recognition cues must depend on how they are acquired(6-9). However, there have been no experimental studies of the development of vocal recognition cues in cooperative birds; indeed, the ontogeny of all bird vocalizations other than song is poorly known in any species(10-12). Here, we show that cooperatively breeding long-tailed tits (Aegithalos caudatus) can discriminate between kin and non-kin according to the individual-specific characteristics of contact calls, and show experimentally that individuals learn these calls from provisioning adults during the nestling period. Finally, we show that the pattern of cooperative behaviour in this species is consistent with the use of recognition cues learned through association.	Univ Sheffield, Dept Anim & Plant Sci, Evolut & Behav Grp, Sheffield S10 2TN, S Yorkshire, England; Univ Exeter Cornwall, Ctr Ecol & Conservat, Marine Turtle Res Grp, Penryn TR10 9EZ, England; Univ Oxford, Dept Zool, Edward Grey Inst Field Ornithol, Oxford OX1 3PS, England	University of Sheffield; University of Exeter; University of Oxford	Sharp, SP (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Evolut & Behav Grp, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	s.sharp@sheffield.ac.uk	Hatchwell, Ben J/C-5433-2016; Sharp, Stuart P/F-8246-2014; Wood, Matthew/HDN-1469-2022; Wood, Matthew J/B-6124-2011	Hatchwell, Ben J/0000-0002-1039-4782; Sharp, Stuart P/0000-0002-3059-2532; Wood, Matthew J/0000-0003-0920-8396; Wood, Matthew/0000-0002-5436-6011	Natural Environment Research Council [NER/A/S/2002/00779] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Baptista Luis F., 1996, P39; BEECHER MD, 1988, BEHAV GENET, V18, P465, DOI 10.1007/BF01065515; BrittanPowell EF, 1997, J COMP PSYCHOL, V111, P226; Dickinson Janis L., 2004, P48, DOI 10.1017/CBO9780511606816.004; EMLEN ST, 1988, BEHAV ECOL SOCIOBIOL, V23, P305, DOI 10.1007/BF00300577; GASTON AJ, 1973, IBIS, V115, P330, DOI 10.1111/j.1474-919X.1973.tb01974.x; HALPIN ZT, 1991, KIN RECOGNITION, P220; Hatchwell BJ, 2004, BEHAV ECOL, V15, P1, DOI 10.1093/beheco/arg091; Hatchwell BJ, 2002, ANIM BEHAV, V64, P55, DOI 10.1006/anbe.2002.3033; Hatchwell BJ, 2001, J ANIM ECOL, V70, P820, DOI 10.1046/j.0021-8790.2001.00541.x; Hatchwell BJ, 2001, P ROY SOC B-BIOL SCI, V268, P885, DOI 10.1098/rspb.2001.1598; Hughes M, 1998, ETHOLOGY, V104, P232; Komdeur J, 2004, P ROY SOC B-BIOL SCI, V271, P963, DOI 10.1098/rspb.2003.2665; Komdeur J, 1999, TRENDS ECOL EVOL, V14, P237, DOI 10.1016/S0169-5347(98)01573-0; KOMDEUR J, 1994, P ROY SOC B-BIOL SCI, V256, P47, DOI 10.1098/rspb.1994.0047; Maccoll ADC, 2004, J ANIM ECOL, V73, P1137, DOI 10.1111/j.0021-8790.2004.00887.x; MacColl ADC, 2003, ANIM BEHAV, V66, P955, DOI 10.1006/anbe.2003.2268; MacColl ADC, 2002, AM NAT, V160, P186, DOI 10.1086/341013; Marler P., 1971, P389; Price JJ, 1998, P ROY SOC B-BIOL SCI, V265, P497, DOI 10.1098/rspb.1998.0322; Russell AF, 2001, P ROY SOC B-BIOL SCI, V268, P2169, DOI 10.1098/rspb.2001.1790; Sherman Paul W., 1997, P69; WALDMAN B, 1987, J THEOR BIOL, V128, P159, DOI 10.1016/S0022-5193(87)80167-4	23	191	197	2	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2005	434	7037					1127	1130		10.1038/nature03522	http://dx.doi.org/10.1038/nature03522			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858573				2022-12-28	WOS:000228693300042
J	Lindor, NM; Rabe, K; Petersen, GM; Haile, R; Casey, G; Baron, J; Gallinger, S; Bapat, B; Aronson, M; Hopper, J; Jass, J; LeMarchand, L; Grove, J; Potter, J; Newcomb, P; Terdiman, JP; Conrad, P; Moslein, G; Goldberg, R; Ziogas, A; Anton-Culver, H; de Andrade, M; Siegmund, K; Thibodeau, SN; Boardman, LA; Seminara, D				Lindor, NM; Rabe, K; Petersen, GM; Haile, R; Casey, G; Baron, J; Gallinger, S; Bapat, B; Aronson, M; Hopper, J; Jass, J; LeMarchand, L; Grove, J; Potter, J; Newcomb, P; Terdiman, JP; Conrad, P; Moslein, G; Goldberg, R; Ziogas, A; Anton-Culver, H; de Andrade, M; Siegmund, K; Thibodeau, SN; Boardman, LA; Seminara, D			Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency - Familial colorectal cancer type X	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MICROSATELLITE INSTABILITY; MUTATION CARRIERS; KINDREDS; GENES	Context Approximately 60% of families that meet the Amsterdam-I criteria (AC-I) for hereditary nonpolyposis colorectal cancer (HNPCC) have a hereditary abnormality in a DNA mismatch repair (MMR) gene. Cancer incidence in AC-I families with MMR gene mutations is reported to be very high, but cancer incidence for individuals in AC-I families with no evidence of an MMR defect is unknown. Objective To determine if cancer risks in AC-I families with no apparent deficiency in DNA MMR are different from cancer risks in AC-I families with DNA MMR abnormalities. Design, Setting, and Participants Identification (1997-2001) of 161 AC-I pedigrees from multiple population- and clinic-based sources,in North America and Germany, with families grouped into those with (group A) or without (group B) MMR deficiency by tumor testing. A total of 3422 relatives were included in the analyses. Main Outcome Measures Cancer incidence in groups A and B (excluding the 3 affected members used to define each pedigree as AC-I) and computed age- and sex-adjusted standardized incidence ratios (SIRs) using Surveillance, Epidemiology, and End Results data. Results Group A families from both population- and clinic-based series showed increased incidence of the HNPCC-related cancers. Group B families showed increased incidence only for colorectal cancer (SIR, 2.3; 95% confidence interval,. 1.7-3.0) and to a lesser extent than group A (SIR, 6.1; 95% confidence interval, 5.2-7.2) (P<.001). Conclusions Families who fulfill AC-I criteria but who have no evidence of a DNA MMR defect do not share the same cancer incidence as families with HNPCC-Lynch syndrome (ie, hereditary MMR deficiency). Relatives in such families have a lower incidence of colorectal cancer than those in families with HNPCC-Lynch syndrome, and incidence may not be increased for other cancers. These families should not be described or counseled as having HNPCC-Lynch syndrome. To facilitate distinguishing these entities, the designation of "familial colorectal cancer type V is suggested to describe this type of familial aggregation of colorectal cancer.	Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Gastroenterol, Rochester, MN 55905 USA; Univ So Calif, Los Angeles, CA USA; Cleveland Clin, Cleveland, OH 44106 USA; Dartmouth Coll Sch Med, Hanover, NH USA; Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Melbourne, Melbourne, Vic, Australia; McGill Univ, Montreal, PQ, Canada; Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA; Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; Univ San Francisco, Dept Canc Biol, San Francisco, CA 94117 USA; Univ Dusseldorf, Dept Surg, D-4000 Dusseldorf, Germany; Univ N Carolina, Chapel Hill, NC USA; Univ Calif Irvine, Irvine, CA USA; NCI, Div Canc Control & Populat Sci, Clin & Genet Epidemiol Res Branch, NIH, Bethesda, MD 20892 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Southern California; Cleveland Clinic Foundation; Dartmouth College; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Melbourne; McGill University; Cancer Research Center of Hawaii; University of Hawaii System; Fred Hutchinson Cancer Center; University of San Francisco; Heinrich Heine University Dusseldorf; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lindor, NM (corresponding author), Mayo Clin & Mayo Fdn, Dept Med Genet, 200 1st St SW, Rochester, MN 55905 USA.	nlindor@mayo.edu	Gallinger, Steven/E-4575-2013; Bapat, Bharati/B-5839-2014	de Andrade, Mariza/0000-0003-2329-2686; Potter, John/0000-0001-5439-1500	NATIONAL CANCER INSTITUTE [U01CA074799, U01CA078296, U01CA074794, K22CA095011, U01CA074783, U01CA074806, U01CA074800, U24CA074800, U01CA097735] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA074799, UO1 CA074800, UO1 CA074799, U01 CA074794, UO1 CA074806, UO1 CA078296, U01 CA097735, U24 CA074800-13, UO1 CA074794, CA-95-011, U01 CA074783, U01 CA074806, U24 CA074800, U01 CA078296, U01 CA074800, UO1 CA097735, UO1 CA074783] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; BERGSTALH EJ, 1986, SAS I INC TECHNICAL, V31; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; Buttin BM, 2004, AM J HUM GENET, V74, P1262, DOI 10.1086/421332; COX DR, 1953, BIOMETRIKA, V40, P354, DOI 10.1093/biomet/40.3-4.354; Efron B., 1982, REGIONAL C SERIES AP, V38; Jarvinen HJ, 2000, ANN CHIR GYNAECOL, V89, P207; JASS JR, 1995, LANCET, V346, P1200, DOI 10.1016/S0140-6736(95)92902-9; Kakar S, 2003, CANCER-AM CANCER SOC, V97, P1421, DOI 10.1002/cncr.11206; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Lucci-Cordisco E, 2001, Fam Cancer, V1, P93; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; *NAT CANC I, 2003, SURV EP END RES SEER; *NAT COMPR CANC NE, 2005, NAT COMPR CANC NETW; Scott RJ, 2001, AM J HUM GENET, V68, P118, DOI 10.1086/316942; Smith RA, 2004, CA-CANCER J CLIN, V54, P41, DOI 10.3322/canjclin.54.1.41; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#	18	407	422	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2005	293	16					1979	1985		10.1001/jama.293.16.1979	http://dx.doi.org/10.1001/jama.293.16.1979			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XS	15855431	Green Accepted, Bronze			2022-12-28	WOS:000228651500023
J	Emerson, BC; Kolm, N				Emerson, BC; Kolm, N			Species diversity can drive speciation	NATURE			English	Article							ADAPTIVE RADIATION; ISLANDS; AREA; ENDEMISM	A fundamental question in evolutionary ecology and conservation biology is: why do some areas contain greater species diversity than others? Island biogeographic theory has identified the roles of immigration and extinction in relation to area size and proximity to source areas(1,2), and the role of speciation is also recognized as an important factor(3-6). However, one as yet unexplored possibility is that species diversity itself might help to promote speciation, and indeed the central tenets of island biogeographic theory support such a prediction. Here we use data for plants and arthropods of the volcanic archipelagos of the Canary and Hawaiian Islands to address whether there is a positive relationship between species diversity and rate of diversification. Our index of diversification for each island is the proportion of species that are endemic, and we test our prediction that this increases with increasing species number. We show that even after controlling for several important physical features of islands, diversification is strongly related to species number.	Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Emerson, BC (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	b.emerson@uea.ac.uk		Kolm, Niclas/0000-0001-5791-336X; Emerson, Brent/0000-0003-4067-9858				Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; Carson Hampton L., 1995, P14; DRAPER NR, 1979, COMMUN STAT A-THEOR, V8, P99, DOI 10.1080/03610927908827741; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; GINOVES JRA, IN PRESS LISTA ESPEC; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Hobohm C, 2000, FLORA, V195, P9; Hubbell Stephen P., 2001, V32, pi; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Nishida G. M., 2002, BISHOP MUSEUM HAWAII; OROMI P, IN PRESS LISTA ESPEC; Price Jonathan Paul, 2004, Pacific Science, V58, P27, DOI 10.1353/psc.2004.0008; Price JP, 2004, J BIOGEOGR, V31, P487, DOI 10.1046/j.0305-0270.2003.00990.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Roos MC, 2004, J BIOGEOGR, V31, P1893, DOI 10.1111/j.1365-2699.2004.01154.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Tokeshi M., 1999, SPECIES COEXISTENCE	21	224	235	0	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1015	1017		10.1038/nature03450	http://dx.doi.org/10.1038/nature03450			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846345				2022-12-28	WOS:000228524600037
J	Perry, AL; Low, PJ; Ellis, JR; Reynolds, JD				Perry, AL; Low, PJ; Ellis, JR; Reynolds, JD			Climate change and distribution shifts in marine fishes	SCIENCE			English	Article								We show that the distributions of both exploited and nonexploited North Sea fishes have responded markedly to recent increases in sea temperature, with nearly two-thirds of species shifting in mean latitude or depth or both over 25 years. For species with northerly or southerly range margins in the North Sea, half have shown boundary shifts with warming, and all but one shifted northward. Species with shifting distributions have faster life cycles and smaller body sizes than nonshifting species. Further temperature rises are likely to have profound impacts on commercial fisheries through continued shifts in distribution and alterations in community interactions.	Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft NR33 0HT, Suffolk, England	University of East Anglia; Centre for Environment Fisheries & Aquaculture Science	Perry, AL (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	a.perry@uea.ac.uk; reynolds@uea.ac.uk	Reynolds, John D/L-6345-2015	Reynolds, John D/0000-0002-0459-0074				Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Brander K, 2003, ICES MARINE SCI S, V219, P261; DAAN N, 2003, N10 ICES; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; *ICES ADV COMM FIS, 2004, 2004ACFM24; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Jennings S, 1999, FISH RES, V40, P125, DOI 10.1016/S0165-7836(98)00208-2; Knijn RJ, 1993, ICES COOPERATIVE RES, P194; MURAWSKI SA, 1993, T AM FISH SOC, V122, P647, DOI 10.1577/1548-8659(1993)122<0647:CCAMFD>2.3.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; REYNOLDS JD, 2001, CONSERVATION EXPLOIT, P145; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; Strahler A., 1997, PHYS GEOGRAPHY SCI S; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas M, 1998, REHABILITATED ESTUARINE ECOSYSTEMS, P115; *UK CLIM IMP PROGR, UKCIPO2 SCEN GAT MAP; Wood C.M., 1997, GLOBAL WARMING IMPLI	19	2014	2090	25	973	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1912	1915		10.1126/science.1111322	http://dx.doi.org/10.1126/science.1111322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15890845	Green Submitted			2022-12-28	WOS:000230120000041
J	Abe, O; Abe, R; Enomoto, K; Kikuchi, K; Koyama, H; Masuda, H; Nomura, Y; Sakai, K; Sugimachi, K; Tominaga, T; Uchino, J; Yoshida, M; Haybittle, JL; Davies, C; Harvey, VJ; Holdaway, TM; Kay, RG; Mason, BH; Forbes, JF; Wilcken, N; Gnant, M; Jakesz, R; Ploner, M; Yosef, HMA; Focan, C; Lobelle, JP; Peek, U; Oates, GD; Powell, J; Durand, M; Mauriac, L; Di Leo, A; Dolci, S; Piccart, MJ; Masood, MB; Parker, D; Price, JJ; Hupperets, PSGJ; Jackson, S; Ragaz, J; Berry, D; Broadwater, G; Cirrincione, C; Muss, H; Norton, L; Weiss, RB; Abu-Zahra, HT; Portnoj, SM; Baum, M; Cuzick, J; Houghton, J; Riley, D; Gordon, NH; Davis, HL; Beatrice, A; Mihura, J; Naja, A; Lehingue, Y; Romestaing, P; Dubois, JB; Delozier, T; Mace-Lesec'h, J; Rambert, P; Andrysek, O; Barkmanova, J; Owen, JR; Meier, P; Howell, A; Ribeiro, GC; Swindell, R; Alison, R; Boreham, J; Clarke, M; Collins, R; Darby, S; Davies, C; Elphinstone, P; Evans, V; Godwin, J; Gray, R; Harwood, C; Hicks, C; James, S; MacKinnon, E; McGale, P; McHugh, T; Mead, G; Peto, R; Wang, Y; Albano, J; de Oliveira, CF; Gervasio, H; Gordilho, J; Johansen, H; Mouridsen, HT; Gelman, RS; Harris, JR; Henderson, IC; Shapiro, CL; Andersen, KW; Axelsson, CK; Blichert-Toft, M; Moller, S; Mouridsen, HT; Overgaard, J; Overgaard, M; Rose, C; Cartensen, B; Palshof, T; Trampisch, HJ; Dalesio, O; de Vries, EGE; Rodenhuis, S; van Tinteren, H; Comis, RL; Davidson, NE; Gray, R; Robert, N; Sledge, G; Tormey, DC; Wood, W; Cameron, D; Chetty, U; Forrest, P; Jack, W; Rossbach, J; Klijn, JGM; Treurniet-Donker, AD; van Putten, WLJ; Costa, A; Veronesi, U; Bartelink, H; Duchateau, L; Legrand, C; Sylvester, R; van der Hage, JA; van de Velde, CJH; Cunningham, MP; Catalano, R; Creech, RH; Bonneterre, J; Fargeot, P; Fumoleau, P; Kerbrat, P; Namer, M; Jonat, W; Kaufmann, M; Schumacher, M; von Minckwitz, G; Bastert, G; Rauschecker, H; Sauer, R; Sauerbrei, W; Schauer, A; Schumacher, M; de Schryver, A; Vakaet, L; Belfiglio, M; Nicolucci, A; Pellegrini, F; Sacco, M; Valentini, M; McArdle, CS; Smith, DC; Galligioni, E; Boccardo, F; Rubagotti, A; Dent, DM; Gudgeon, CA; Hacking, A; Erazo, A; Medina, JY; Izuo, M; Morishita, Y; Takei, H; Fentiman, IS; Hayward, JL; Rubens, RD; Skilton, D; Graeff, H; Janicke, F; Meisner, C; Scheurlen, H; Kaufmann, M; von Fournier, D; Dafni, U; Fountzilas, G; Klefstrom, P; Blomqvist, C; Saarto, T; Margreiter, R; Asselain, B; Salmon, RJ; Vilcoq, JR; Arriagada, R; Hill, C; Laplanche, A; Le, MG; Spielmann, M; Bruzzi, P; Montanaro, E; Rosso, R; Sertoli, MR; Venturini, M; Amadori, D; Benraadt, J; Kooi, M; van de Velde, AO; van Dongen, JA; Vermorken, JB; Castiglione, M; Cavalli, F; Coates, A; Collins, J; Forbes, J; Gelber, RD; Goldhirsch, A; Lindtner, J; Price, KN; Rudenstam, CM; Senn, HJ; Bliss, JM; Chilvers, CED; Coombes, RC; Hall, E; Marty, M; Borovik, R; Brufman, G; Hayat, H; Robinson, E; Wigler, N; Bonadonna, G; Camerini, T; De Palo, G; Del Vecchio, M; Formelli, F; Valagussa, P; Martoni, A; Pannuti, F; Cocconi, G; Colozza, A; Camisa, R; Aogi, K; Takashima, S; Abe, O; Ikeda, T; Inokuchi, K; Kikuchi, K; Sawa, K; Sonoo, H; Korzeniowski, S; Skolyszewski, J; Ogawa, M; Yamashita, J; Bonte, J; Christiaens, R; Paridaens, R; Van den Boegart, W; Martin, P; Romain, S; Hakes, T; Hudis, CA; Norton, L; Wittes, R; Giokas, G; Kondylis, D; Lissaios, B; de la Huerta, R; Sainz, MG; Altemus, R; Cowan, K; Danforth, D; Lichter, A; Lippman, M; O'Shaughnessy, J; Pierce, LJ; Steinberg, S; Venzon, D; Zujewski, J; Paradiso, A; De Lena, M; Schittulli, F; Myles, JD; Pater, JL; Pritchard, KI; Nomura, Y; Anderson, S; Bass, G; Brown, A; Bryant, J; Costantino, J; Dignam, J; Fisher, B; Redmond, C; Wieand, S; Wolmark, N; Baum, M; Jackson, IM; Palmer, MK; Ingle, JN; Suman, VJ; Bengtsson, NO; Jonsson, H; Larsson, LG; Lythgoe, JP; Swindell, R; Kissin, M; Erikstein, B; Hannisdal, E; Jacobsen, AB; Varhaug, JE; Erikstein, B; Gundersen, S; Hauer-Jensen, M; Host, H; Jacobsen, AB; Nissen-Meyer, R; Blamey, RW; Mitchell, AK; Morgan, DAL; Robertson, JFR; Di Palma, M; Mathe, G; Misset, JL; Clark, RM; Levine, M; Morimoto, K; Sawa, K; Takatsuka, Y; Crossley, E; Harris, A; Talbot, D; Taylor, M; Cocconi, G; di Blasio, B; Ivanov, V; Semiglazov, V; Brockschmidt, J; Cooper, MR; Ueo, H; Falkson, CI; A'Hern, R; Ashley, S; Powles, TJ; Smith, IE; Yarnold, JR; Gazet, JC; Cocoran, N; Deshpande, N; di Martino, L; Douglas, P; Hacking, A; Host, H; Lindtner, A; Notter, G; Bryant, AJS; Ewing, GH; Firth, LA; Krushen-Kosloski, JL; Nissen-Meyer, R; Foster, L; George, WD; Stewart, HJ; Stroner, P; Malmstrom, P; Moller, TR; Ryden, S; Tengrup, I; Tennvall-Nittby, L; Carstenssen, J; Dufmats, M; Hatschek, T; Nordenskjold, B; Soderberg, M; Carpenter, JT; Albain, K; Crowley, J; Green, S; Martino, S; Osborne, CK; Ravdin, PM; Glas, U; Johansson, U; Rutqvist, LE; Singnomklao, T; Wallgren, A; Castiglione, M; Goldhirsch, A; Maibach, R; Senn, HJ; Thurlimann, B; Brenner, H; Hercbergs, A; Yoshimoto, M; DeBoer, G; Paterson, AHG; Pritchard, KI; Meakin, JW; Panzarella, T; Pritchard, KI; Shan, Y; Shao, YF; Wang, X; Zhao, DB; Boreham, J; Chen, ZM; Pan, HC; Peto, R; Bahi, J; Reid, M; Spittle, M; Deutsch, GP; Senanayake, F; Kwong, DLW; Bianco, AR; Carlomagno, C; De Laurentiis, M; De Placido, S; Buzdar, AU; Smith, T; Bergh, J; Holmberg, L; Liljegren, G; Nilsson, J; Seifert, M; Sevelda, P; Zielinsky, CC; Buchanan, RB; Cross, M; Royle, GT; Dunn, JA; Hills, RK; Lee, M; Morrison, JM; Spooner, D; Litton, A; Chlebowski, RT; Caffier, H				Abe, O; Abe, R; Enomoto, K; Kikuchi, K; Koyama, H; Masuda, H; Nomura, Y; Sakai, K; Sugimachi, K; Tominaga, T; Uchino, J; Yoshida, M; Haybittle, JL; Davies, C; Harvey, VJ; Holdaway, TM; Kay, RG; Mason, BH; Forbes, JF; Wilcken, N; Gnant, M; Jakesz, R; Ploner, M; Yosef, HMA; Focan, C; Lobelle, JP; Peek, U; Oates, GD; Powell, J; Durand, M; Mauriac, L; Di Leo, A; Dolci, S; Piccart, MJ; Masood, MB; Parker, D; Price, JJ; Hupperets, PSGJ; Jackson, S; Ragaz, J; Berry, D; Broadwater, G; Cirrincione, C; Muss, H; Norton, L; Weiss, RB; Abu-Zahra, HT; Portnoj, SM; Baum, M; Cuzick, J; Houghton, J; Riley, D; Gordon, NH; Davis, HL; Beatrice, A; Mihura, J; Naja, A; Lehingue, Y; Romestaing, P; Dubois, JB; Delozier, T; Mace-Lesec'h, J; Rambert, P; Andrysek, O; Barkmanova, J; Owen, JR; Meier, P; Howell, A; Ribeiro, GC; Swindell, R; Alison, R; Boreham, J; Clarke, M; Collins, R; Darby, S; Davies, C; Elphinstone, P; Evans, V; Godwin, J; Gray, R; Harwood, C; Hicks, C; James, S; MacKinnon, E; McGale, P; McHugh, T; Mead, G; Peto, R; Wang, Y; Albano, J; de Oliveira, CF; Gervasio, H; Gordilho, J; Johansen, H; Mouridsen, HT; Gelman, RS; Harris, JR; Henderson, IC; Shapiro, CL; Andersen, KW; Axelsson, CK; Blichert-Toft, M; Moller, S; Mouridsen, HT; Overgaard, J; Overgaard, M; Rose, C; Cartensen, B; Palshof, T; Trampisch, HJ; Dalesio, O; de Vries, EGE; Rodenhuis, S; van Tinteren, H; Comis, RL; Davidson, NE; Gray, R; Robert, N; Sledge, G; Tormey, DC; Wood, W; Cameron, D; Chetty, U; Forrest, P; Jack, W; Rossbach, J; Klijn, JGM; Treurniet-Donker, AD; van Putten, WLJ; Costa, A; Veronesi, U; Bartelink, H; Duchateau, L; Legrand, C; Sylvester, R; van der Hage, JA; van de Velde, CJH; Cunningham, MP; Catalano, R; Creech, RH; Bonneterre, J; Fargeot, P; Fumoleau, P; Kerbrat, P; Namer, M; Jonat, W; Kaufmann, M; Schumacher, M; von Minckwitz, G; Bastert, G; Rauschecker, H; Sauer, R; Sauerbrei, W; Schauer, A; Schumacher, M; de Schryver, A; Vakaet, L; Belfiglio, M; Nicolucci, A; Pellegrini, F; Sacco, M; Valentini, M; McArdle, CS; Smith, DC; Galligioni, E; Boccardo, F; Rubagotti, A; Dent, DM; Gudgeon, CA; Hacking, A; Erazo, A; Medina, JY; Izuo, M; Morishita, Y; Takei, H; Fentiman, IS; Hayward, JL; Rubens, RD; Skilton, D; Graeff, H; Janicke, F; Meisner, C; Scheurlen, H; Kaufmann, M; von Fournier, D; Dafni, U; Fountzilas, G; Klefstrom, P; Blomqvist, C; Saarto, T; Margreiter, R; Asselain, B; Salmon, RJ; Vilcoq, JR; Arriagada, R; Hill, C; Laplanche, A; Le, MG; Spielmann, M; Bruzzi, P; Montanaro, E; Rosso, R; Sertoli, MR; Venturini, M; Amadori, D; Benraadt, J; Kooi, M; van de Velde, AO; van Dongen, JA; Vermorken, JB; Castiglione, M; Cavalli, F; Coates, A; Collins, J; Forbes, J; Gelber, RD; Goldhirsch, A; Lindtner, J; Price, KN; Rudenstam, CM; Senn, HJ; Bliss, JM; Chilvers, CED; Coombes, RC; Hall, E; Marty, M; Borovik, R; Brufman, G; Hayat, H; Robinson, E; Wigler, N; Bonadonna, G; Camerini, T; De Palo, G; Del Vecchio, M; Formelli, F; Valagussa, P; Martoni, A; Pannuti, F; Cocconi, G; Colozza, A; Camisa, R; Aogi, K; Takashima, S; Abe, O; Ikeda, T; Inokuchi, K; Kikuchi, K; Sawa, K; Sonoo, H; Korzeniowski, S; Skolyszewski, J; Ogawa, M; Yamashita, J; Bonte, J; Christiaens, R; Paridaens, R; Van den Boegart, W; Martin, P; Romain, S; Hakes, T; Hudis, CA; Norton, L; Wittes, R; Giokas, G; Kondylis, D; Lissaios, B; de la Huerta, R; Sainz, MG; Altemus, R; Cowan, K; Danforth, D; Lichter, A; Lippman, M; O'Shaughnessy, J; Pierce, LJ; Steinberg, S; Venzon, D; Zujewski, J; Paradiso, A; De Lena, M; Schittulli, F; Myles, JD; Pater, JL; Pritchard, KI; Nomura, Y; Anderson, S; Bass, G; Brown, A; Bryant, J; Costantino, J; Dignam, J; Fisher, B; Redmond, C; Wieand, S; Wolmark, N; Baum, M; Jackson, IM; Palmer, MK; Ingle, JN; Suman, VJ; Bengtsson, NO; Jonsson, H; Larsson, LG; Lythgoe, JP; Swindell, R; Kissin, M; Erikstein, B; Hannisdal, E; Jacobsen, AB; Varhaug, JE; Erikstein, B; Gundersen, S; Hauer-Jensen, M; Host, H; Jacobsen, AB; Nissen-Meyer, R; Blamey, RW; Mitchell, AK; Morgan, DAL; Robertson, JFR; Di Palma, M; Mathe, G; Misset, JL; Clark, RM; Levine, M; Morimoto, K; Sawa, K; Takatsuka, Y; Crossley, E; Harris, A; Talbot, D; Taylor, M; Cocconi, G; di Blasio, B; Ivanov, V; Semiglazov, V; Brockschmidt, J; Cooper, MR; Ueo, H; Falkson, CI; A'Hern, R; Ashley, S; Powles, TJ; Smith, IE; Yarnold, JR; Gazet, JC; Cocoran, N; Deshpande, N; di Martino, L; Douglas, P; Hacking, A; Host, H; Lindtner, A; Notter, G; Bryant, AJS; Ewing, GH; Firth, LA; Krushen-Kosloski, JL; Nissen-Meyer, R; Foster, L; George, WD; Stewart, HJ; Stroner, P; Malmstrom, P; Moller, TR; Ryden, S; Tengrup, I; Tennvall-Nittby, L; Carstenssen, J; Dufmats, M; Hatschek, T; Nordenskjold, B; Soderberg, M; Carpenter, JT; Albain, K; Crowley, J; Green, S; Martino, S; Osborne, CK; Ravdin, PM; Glas, U; Johansson, U; Rutqvist, LE; Singnomklao, T; Wallgren, A; Castiglione, M; Goldhirsch, A; Maibach, R; Senn, HJ; Thurlimann, B; Brenner, H; Hercbergs, A; Yoshimoto, M; DeBoer, G; Paterson, AHG; Pritchard, KI; Meakin, JW; Panzarella, T; Pritchard, KI; Shan, Y; Shao, YF; Wang, X; Zhao, DB; Boreham, J; Chen, ZM; Pan, HC; Peto, R; Bahi, J; Reid, M; Spittle, M; Deutsch, GP; Senanayake, F; Kwong, DLW; Bianco, AR; Carlomagno, C; De Laurentiis, M; De Placido, S; Buzdar, AU; Smith, T; Bergh, J; Holmberg, L; Liljegren, G; Nilsson, J; Seifert, M; Sevelda, P; Zielinsky, CC; Buchanan, RB; Cross, M; Royle, GT; Dunn, JA; Hills, RK; Lee, M; Morrison, JM; Spooner, D; Litton, A; Chlebowski, RT; Caffier, H		EBCTCG	Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials	LANCET			English	Article							TAMOXIFEN	Background Quinquennial overviews (1985-2000) of the randomised trials in early breast cancer have assessed the 5-year and 10-year effects of various systemic adjuvant therapies on breast cancer recurrence and survival. Here, we report the 10-year and 15-year effects. Methods Collaborative meta-analyses were undertaken of 194 unconfounded randomised trials of adjuvant chemotherapy or hormonal therapy that began by 1995. Many trials involved CMF (cyclophosphamide, methotrexate, fluorouracil), anthracycline-based combinations such as FAC (fluorouracil, doxombicin, cyclophosphamide) or FEC (fluorouracil, epirubicin, cyclophosphamide), tamoxifen, or ovarian suppression: none involved taxanes, trastuzumab, raloxifene, or modem aromatase inhibitors. Findings Allocation to about 6 months of anthracycline-based polychemotherapy (eg, with FAC or FEC) reduces the annual breast cancer death rate by about 38% (SE 5) for women younger than 50 years of age when diagnosed and by about 20% (SE 4) for those of age 50-69 years when diagnosed, largely irrespective of the use of tamoxifen and of oestrogen receptor (ER) status, nodal status, or other tumour characteristics. Such regimens are significantly (2p=0 . 0001 for recurrence, 2p<0 . 00001 for breast cancer mortality) more effective than CMF chemotherapy. Few women of age 70 years or older entered these chemotherapy trials. For ER-positive disease only, allocation to about 5 years of adjuvant tamoxifen reduces the annual breast cancer death rate by 31% (SE 3), largely irrespective of the use of chemotherapy and of age (<50, 50-69, >= 70 years), progesterone receptor status, or other tumour characteristics. 5 years is significantly (2p<0 . 00001 for recurrence, 2p=0 . 01 for breast cancer mortality) more effective than just 1-2 years of tamoxifen. For ER-positive tumours, the annual breast cancer mortality rates are similar during years 0-4 and 5-14, as are the proportional reductions in them by 5 years of tamoxifen, so the cumulative reduction in mortality is more than twice as big at 15 years as at 5 years after diagnosis. These results combine six meta-analyses: anthracycline-based versus no chemotherapy (8000 women); CMF-based versus no chemotherapy (14 000); anthracycline-based versus CMF-based chemotherapy (14 000); about 5 years of tamoxifen versus none (15 000); about 1-2 years of tamoxifen versus none (33 000); and about 5 years versus 1-2 years of tamoxifen (18 000). Finally, allocation to ovarian ablation or suppression (8000 women) also significantly reduces breast cancer mortality, but appears to do so only in the absence of other systemic treatments. For middle-aged women with ER-positive disease (the commonest type of breast cancer), the breast cancer mortality rate throughout the next 15 years would be approximately halved by 6 months of anthracycline-based chemotherapy (with a combination such as FAC or FEC) followed by 5 years of adjuvant tamoxifen. For, if mortality reductions of 38% (age <50 years) and 20% (age 50-69 years) from such chemotherapy were followed by a further reduction of 31% from tamoxifen in the risks that remain, the final mortality reductions would be 57% and 45%, respectively (and, the trial results could well have been somewhat stronger if there had been full compliance with the allocated treatments). Overall survival would be comparably improved, since these treatments have relatively small effects on mortality from the aggregate of all other causes. Interpretation Some of the widely practicable adjuvant drug treatments that were being tested in the 1980s, which substantially reduced 5-year recurrence rates (but had somewhat less effect on 5-year mortality rates), also substantially reduce 15-year mortality rates. Further improvements in long-term survival could well be available from newer drugs, or better use of older drugs.	Radcliffe Infirm, Clin Trial Serv Unit, EBCTCG Secretariat, Oxford OX2 6HE, England; ACETBC, Tokyo, Japan; Addenbrookes Hosp, Cambridge, England; ATLAS Trial Collaborat Study Grp, Oxford, England; Auckland Breast Canc Study Grp, Auckland, New Zealand; Australian New Zealand Breast Canc Trials Grp, Sydney, NSW, Australia; Austrian Breast Canc Study Grp, Vienna, Austria; Western Infirm & Associated Hosp, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland; Belgian Adjuvant Breast Canc Project, Liege, Belgium; Berlin Buch Akad Wissensch, Berlin, Germany; Birmingham Gen Hosp, Birmingham, W Midlands, England; Bordeaux Inst Bergonie, Bordeaux, France; Inst Jules Bordet, B-1000 Brussels, Belgium; Bradford Royal Infirm, Bradford, W Yorkshire, England; Ctr Comprehens Canc, Breast Canc Study Grp, Limburg, Netherlands; British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; Canc & Leukemia Grp B, Washington, DC USA; Canc Care Ontario, Toronto, ON, Canada; Russian Acad Med Sci, Canc Res Ctr, Moscow, Russia; Canc Res UK, London, England; Case Western Reserve Univ, Cleveland, OH 44106 USA; Cent Oncol Grp, Milwaukee, WI USA; Ctr Claudius Regaud, Toulouse, France; Ctr Leon Berard, F-69373 Lyon, France; Ctr Paul Lamarque, Montpellier, France; Ctr Reg Francois Baclesse, Caen, France; Ctr Rene Huguenin, St Cloud, France; Charles Univ Prague, Prague, Czech Republic; Cheltenham Gen Hosp, Cheltenham, Glos, England; Univ Chicago, Chicago, IL 60637 USA; Christie Hosp & Holt Radium Inst, Manchester M20 9BX, Lancs, England; Coimbra Inst Oncol, Coimbra, Portugal; Copenhagen Radium Ctr, Copenhagen, Denmark; Dana Farber Canc Inst, Boston, MA 02115 USA; Danish Breast Canc Cooperat Grp, Copenhagen, Denmark; Danish Canc Registry, Copenhagen, Denmark; Univ Dusseldorf, D-4000 Dusseldorf, Germany; Univ Groningen, Univ Med Ctr Groningen, Dutch Working Party Autologous Bone Marrow Transp, Groningen, Netherlands; Eastern Cooperat Oncol Grp, Boston, MA USA; Edinburgh Breast Unit, Edinburgh, Midlothian, Scotland; Elim Hosp, Hamburg, Germany; Dr Daniel den Hoed Canc Ctr, Erasmus MC, NL-3008 AE Rotterdam, Netherlands; European Inst Oncol, Milan, Italy; European Org Res Treatment Canc, Brussels, Belgium; Northwestern Univ, Evanston Hosp, Evanston, IL 60201 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; French Adjuvant Study Grp, Guyancourt, France; GABG, Frankfurt, Germany; German Breast Canc Study Grp, Freiburg, Germany; Ghent Univ Hosp, Ghent, Belgium; GIVIO Interdisciplinary Grp Canc Care Evaluat, Chieti, Italy; Glasgow Victoria Infirm, Glasgow, Lanark, Scotland; Grp Oncol Clin Cooperat Nord Est, Aviano, Italy; Grp Ric Ormono Chemio Terapia Adiuvante, Genoa, Italy; Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; Guadalajara Hosp 20 Noviembre, Mexico City, DF, Mexico; Gunma Univ, Gunma, Japan; Guys Hosp, London SE1 9RT, England; Univ Hamburg, Hamburg, Germany; Heidelberg Univ I, Heidelberg, Germany; Heidelberg Univ II, Heidelberg, Germany; Hellen Cooperat Oncol Grp, Athens, Greece; Helsinki Deaconess Med Ctr, Helsinki, Finland; Univ Helsinki, FIN-00014 Helsinki, Finland; Univ Innsbruck, A-6020 Innsbruck, Austria; Inst Curie, Paris, France; Inst Gustave Roussy, Paris, France; Inst Nazl Ric Canc, Genoa, Italy; Inst Oncol Romagnolo, Forli, Italy; Integraal Kankerctr, Amsterdam, Netherlands; Int Breast Canc Study Grp Ludwig, Bern, Switzerland; Charing Cross Hosp, Int Collaborat Canc Grp, London, England; Israel NSABC, Tel Aviv, Israel; Ist Nazl Studio & Cura Tumori, I-20133 Milan, Italy; Italian Cooperat Chemoradiosurg Grp, Bologna, Italy; Italian Oncol Grp Clin Res, Parma, Italy; Japan Clin Oncol Grp, Breast Canc Study Grp, Matsuyama, Ehime, Japan; Japanese Fdn Multidisciplinary Treatment Canc, Tokyo, Japan; Kawasaki Med Sch, Kawasaki, Kanagawa, Japan; Krakow Inst Oncol, Krakow, Poland; Kumamoto Univ Grp, Kumamoto, Japan; Leuven Akad Ziekenhuis, Gasthuisberg, Belgium; Marseille Lab Cancerol Biol APM, Marseille, France; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Metaxas Mem Canc Hosp, Athens, Greece; Mexican Natl Med Ctr, Mexico City, DF, Mexico; NCI, Bethesda, MD 20892 USA; Natl Canc Inst, Bari, Italy; Natl Canc Inst Canada Clin Trials Grp, Kingston, ON, Canada; NSABP, Pittsburgh, PA USA; Nolvadex Adjuvant Trial Org, London, England; Mayo Clin, N Cent Canc Treatment Grp, Rochester, MN USA; N Sweden Breast Canc Grp, Umea, Sweden; NW British Surg, Manchester, Lancs, England; Northwick Pk Hosp & Clin Res Ctr, London, England; Norwegian Breast Canc Grp, Oslo, Norway; Norwegian Radium Hosp, Oslo, Norway; City Hosp Nottingham, Nottingham, England; Oncofrance, Paris, France; Ontario Clin Oncol Grp, Toronto, ON, Canada; Osaka City Univ, Osaka, Japan; Osaka Natl Hosp, Osaka, Japan; Churchill Hosp, Oxford OX3 7LJ, England; Parma Hosp, Parma, Italy; NN Petrov Oncol Res Inst, St Petersburg, Russia; Piedmont Oncol Assoc, Winston Salem, NC USA; Prefectural Hosp, Oita, Japan; Univ Pretoria, ZA-0002 Pretoria, South Africa; Royal Marsden Hosp, Inst Canc Res, London SW3 6JJ, England; Univ London St Georges Hosp, London, England; St Lukes Hosp, Dublin, Ireland; Sardinia Oncol Hosp A Businico, Cagliari, Italy; SASIB Int Trialists, Cape Town, South Africa; Saskatchewan Canc Fdn, Regina, SK, Canada; Scandinavian Adjuvant Chemotherapy Study Grp, Oslo, Norway; Scottish Canc Therapy Network, Edinburgh, Midlothian, Scotland; S Sweden Breast Canc Grp, Lund, Sweden; SE Sweden Breast Canc Grp, Linkoping, Sweden; SE Canc Study Grp, Birmingham, AL USA; Alabama Breast Canc Project, Birmingham, AL USA; SW Oncol Grp, San Antonio, TX USA; Stockholm Breast Canc Study Grp, Stockholm, Sweden; Swiss Grp Clin Canc Res, Bern, Switzerland; OSAKO, St Gallen, Switzerland; Tel Aviv Univ, IL-69978 Tel Aviv, Israel; Tokyo Canc Inst Hosp, Tokyo, Japan; Toronto Edmonton Breast Canc Study Grp, Toronto, ON, Canada; Toronto Princess Margaret Hosp, Toronto, ON, Canada; Chinese Acad Med Sci, Tumour Hosp, Beijing 100037, Peoples R China; Tunis Inst Salah Azaiz, Tunis, Tunisia; UK Multictr Canc Chemotherapy Study Grp, London, England; UK Asia Collaborat Breast Canc Grp, London, England; Univ Naples Federico II, Naples, Italy; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Uppsala Orebro Breast Canc Study Grp, Uppsala, Sweden; Univ Hosp Vienna, Dept Gynaecol 1, Vienna, Austria; Wessex Radiotherapy Ctr, Southampton, Hants, England; W Midlands Oncol Assoc, Birmingham, W Midlands, England; W Scotland Breast Trial Grp, Glasgow, Lanark, Scotland; Western Canc Study Grp, Torrance, CA USA; Univ Wurzburg, D-97070 Wurzburg, Germany	Radcliffe Infirmary; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Beatson Oncology Centre; University of Birmingham; UNICANCER; Institut Bergonie; Institut Jules Bordet; Bradford Royal Infirmary; British Columbia Cancer Agency; Cancer Care Ontario; Russian Academy of Medical Sciences; Cancer Research UK; Case Western Reserve University; UNICANCER; Institut Claudius Regaud; UNICANCER; Centre Leon Berard; Universite de Montpellier; UNICANCER; Centre Francois Baclesse; Rene Huguenin Hospital; Charles University Prague; Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital; University of Chicago; Christie NHS Foundation Trust; Christie Hospital; Harvard University; Dana-Farber Cancer Institute; Danish Breast Cancer Cooperative Group (DBCG); Heinrich Heine University Dusseldorf; University of Groningen; University of Edinburgh; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; IRCCS European Institute of Oncology (IEO); European Organisation for Research & Treatment of Cancer; NorthShore University Health System; Northwestern University; Fox Chase Cancer Center; Ghent University; Ghent University Hospital; University of Cape Town; Gunma University; Guy's & St Thomas' NHS Foundation Trust; University of Hamburg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Hellenic Cooperative Oncology Group; University of Helsinki; University of Innsbruck; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Gustave Roussy; University of Genoa; IRCCS AOU San Martino IST; International Breast Cancer Study Group; Imperial College London; Fondazione IRCCS Istituto Nazionale Tumori Milan; Kawasaki Medical School; Kumamoto University; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); IRCCS Istituto Tumori Bari Giovanni Paolo II; Queens University - Canada; Canadian Cancer Trials Group; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Mayo Clinic; Imperial College London; University of Oslo; Nottingham University Hospital NHS Trust; Nottingham City Hospital; Osaka Metropolitan University; Osaka National Hospital; University of Oxford; University of Parma; University Hospital of Parma; N.N. Petrov Research Institute of Oncology; University of Pretoria; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; St Georges University London; Trinity College Dublin; Southwest Oncology Group; Swiss Group for Clinical Cancer Research (SAKK); Tel Aviv University; Japanese Foundation for Cancer Research; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Chinese Academy of Medical Sciences - Peking Union Medical College; Universite de Tunis-El-Manar; Institut Salah Azaiez; University of Naples Federico II; University of Texas System; UTMD Anderson Cancer Center; University Hospital Vienna; University of Birmingham; University of Wurzburg	Clarke, M (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, EBCTCG Secretariat, Oxford OX2 6HE, England.	bc.overview@ctsu.ox.ac.uk	Pritchard, Kathleen I/I-2184-2014; Fountzilas, George/ABF-2139-2020; Fentiman, Ian/AAB-9886-2020; Vakaet, Luc/A-6467-2010; De Laurentiis, Michelino/AAC-6321-2022; Fentiman, Ian S/I-7644-2019; Brenner, Hermann/B-4627-2017; Nicolucci, Antonio/ABI-6234-2020; Barkmanova, Jaroslava/A-1411-2017; paradiso, angelo V/J-9457-2018; Martoni, Andrea/AAC-1707-2021; Hudis, Clifford/AAW-9482-2021; Gkiokas, Georgios/AAE-6312-2020; van+der+Hage, Jos/AAG-3541-2021; Dafni, Ourania/AAH-4453-2019; Bruzzi, Paolo/AAU-3363-2021; Brenner, Hermann/ABE-6383-2020; Boccardo, Francesco Mario/AAF-2654-2019; Gnant, Michael/AAN-7054-2020; Jonat, Walter/E-3024-2010	Pritchard, Kathleen I/0000-0003-0758-9666; De Laurentiis, Michelino/0000-0001-9009-1572; Brenner, Hermann/0000-0002-6129-1572; Barkmanova, Jaroslava/0000-0003-1406-7292; Hudis, Clifford/0000-0001-7144-8791; van+der+Hage, Jos/0000-0001-9040-1323; Dafni, Ourania/0000-0003-4367-4497; Brenner, Hermann/0000-0002-6129-1572; Boccardo, Francesco Mario/0000-0002-5392-4077; Gnant, Michael/0000-0003-1002-2118; Anderson, Stewart/0000-0001-8948-0650; de Vries, Elisabeth/0000-0002-8949-7425; Hall, Emma/0000-0001-5999-5020; Bergh, Jonas/0000-0001-5526-1847; Norton, Larry/0000-0003-3701-9250; Wang, Xiang/0000-0002-1522-9532; Bliss, Judith/0000-0001-7957-7424; Hills, Robert/0000-0003-0166-0062; Hans, Trampisch/0000-0001-9136-1079; RUBAGOTTI, Alessandra/0000-0002-4009-8829; Coombes, Raoul Charles/0000-0002-4811-1100; Arriagada, Rodrigo/0000-0002-3134-1735				ABE O, 1992, LANCET, V339, P71; ABE O, 1995, NEW ENGL J MED, V333, P1444; Abe O, 1998, LANCET, V352, P930; ALBAIN K, 2004, BREAST CANC RES T S1, V88; [Anonymous], 1996, Lancet, V348, P1189; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; [Anonymous], 1984, Lancet, V2, P1205; [Anonymous], 1992, Lancet, V339, P1; Clarke M, 1998, LANCET, V351, P1451; Cocconi G, 2003, BREAST CANCER RES TR, V80, P313, DOI 10.1023/A:1024955408785; COLLINS R, 2003, OXFORD TXB MED, P24; *EARL BREAST CANC, 1990, TREATM EARL BREAST C, V1; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Gray R, 2000, ANN ONCOL, V11, P505, DOI 10.1023/A:1008323116265; Mariotto A, 2002, J NATL CANCER I, V94, P1626; *NAT CANC I, 1995, CLIN AL ADJ THER BRE; *NIH, CONS STAT 114 ADJ TH; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Rutqvist LE, 1996, J NATL CANCER I, V88, P1543; Walsh BW, 2001, ANN NY ACAD SCI, V949, P163	22	5364	5446	28	235	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2005	365	9472					1687	1717		10.1016/s0140-6736(05)66544-0	http://dx.doi.org/10.1016/s0140-6736(05)66544-0			31	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894097				2022-12-28	WOS:000229082300022
J	Lakhani, M				Lakhani, M			Commentary: Excellent review scheme for critical incidents but insufficient for revalidation	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Gen Practitioners, London SW1 7PU, England		Lakhani, M (corresponding author), Royal Coll Gen Practitioners, London SW1 7PU, England.	MLakhani@rcgp.org.uk						*GEN MED COUNC, 2004, IN PRESS LIC REV FOR; *POSTGR MED TRAIN, 2004, PRINC ASS SYST POSTG; *ROYAL COLL SURG, 2004, GUID SURG PRACT CRIT; Thompson AM, 2005, BRIT MED J, V330, P1139, DOI 10.1136/bmj.330.7500.1139; 2004, 5 REPORT SAFEGUARDIN	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 14	2005	330	7500					1143	1143		10.1136/bmj.330.7500.1143	http://dx.doi.org/10.1136/bmj.330.7500.1143			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15891232	Green Published			2022-12-28	WOS:000229166900026
J	Savage, E; Ramsay, M; White, J; Beard, S; Lawson, H; Hunjan, R; Brown, D				Savage, E; Ramsay, M; White, J; Beard, S; Lawson, H; Hunjan, R; Brown, D			Mumps outbreaks across England and Wales in 2004: observational, study	BRITISH MEDICAL JOURNAL			English	Article									Hlth Protect Agcy, Ctr Infect, Ctr Communicable Dis Surveillance, Immunisat Dept, London NW9 5EQ, England; Hlth Protect Agcy, Ctr Infect, Enter Resp & Neurol Virus Lab, London NW9 5EQ, England	Health Protection Agency; Health Protection Agency	Savage, E (corresponding author), Hlth Protect Agcy, Ctr Infect, Ctr Communicable Dis Surveillance, Immunisat Dept, London NW9 5EQ, England.	Emma.Savage@HPA.org.uk	Ramsay, Mary Elizabeth/S-8281-2016	Ramsay, Mary Elizabeth/0000-0002-7156-7640; White, Joanne/0000-0001-7786-4462				*COMM DIS SURV CTR, 2002, COMMUN DIS REP CDR W, V12; *COMM DIS SURV CTR, 1999, COMMUN DIS REP CDR W, V9, P227; *COMM DIS SURV CTR, 1999, COMMUN DIS REP CDR W, V9, P230; GAY N, 1997, COMMUNICAB DIS REP, V7, P21; Gay N J, 1994, Commun Dis Rep CDR Rev, V4, pR77; HARLING R, 2005, IN PRESS VACCINE	6	64	64	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 14	2005	330	7500					1119	1120		10.1136/bmj.330.7500.1119	http://dx.doi.org/10.1136/bmj.330.7500.1119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15891227	Green Published, Bronze			2022-12-28	WOS:000229166900018
J	Shemansky, DE; Stewart, AIF; West, RA; Esposito, LW; Hallett, JT; Liu, XM				Shemansky, DE; Stewart, AIF; West, RA; Esposito, LW; Hallett, JT; Liu, XM			The Cassini UVIS stellar probe of the Titan atmosphere	SCIENCE			English	Article							PHOTOABSORPTION CROSS-SECTIONS; VACUUM ULTRAVIOLET; ABSORPTION; METHANE; TEMPERATURE; PHOTOCHEMISTRY; THERMOSPHERE; SPECTROSCOPY; ACETYLENE; SPECTRA	The Cassini Ultraviolet Imaging Spectrometer (UVIS) observed the extinction of photons from two stars by the atmosphere of Titan during the Titan flyby. Six species were identified and measured: methane, acetylene, ethylene, ethane, diacetylene, and hydrogen cyanide. The observations cover altitudes from 450 to 1600 kilometers above the surface. A mesopause is inferred from extraction of the temperature structure of methane, located at 615 km with a temperature minimum of 114 kelvin. The asymptotic kinetic temperature at the top of the atmosphere determined from this experiment is 151 kelvin. The higher order hydrocarbons and hydrogen cyanide peak sharply in abundance and are undetectable below altitudes ranging from 750 to 600 km, leaving methane as the only identifiable carbonaceous molecule in this experiment below 600 km.	Univ So Calif, Dept Aerosp Engn, Los Angeles, CA 90089 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Southern California; University of Colorado System; University of Colorado Boulder; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Shemansky, DE (corresponding author), Univ So Calif, Dept Aerosp Engn, Univ Pk, Los Angeles, CA 90089 USA.	dons@hippolyta.usc.edu	ESPOSITO, LARRY W/AAB-3673-2021	ESPOSITO, LARRY W/0000-0003-3381-2016				AU JW, 1993, CHEM PHYS, V173, P209, DOI 10.1016/0301-0104(93)80142-V; Chen FZ, 2004, J QUANT SPECTROSC RA, V85, P195, DOI 10.1016/S0022-4073(03)00225-5; COOPER G, 1995, J ELECTRON SPECTROSC, V73, P139, DOI 10.1016/0368-2048(94)02271-2; Esposito LW, 2005, SCIENCE, V307, P1251, DOI 10.1126/science.1105606; Flasar FM, 1998, PLANET SPACE SCI, V46, P1109, DOI 10.1016/S0032-0633(97)00182-7; Flasar FM, 1998, PLANET SPACE SCI, V46, P1125, DOI 10.1016/S0032-0633(97)00223-7; FRIEDSON AJ, 1984, J GEOPHYS RES-SPACE, V89, P85, DOI 10.1029/JA089iA01p00085; LELLOUCH E, 1990, ICARUS, V83, P308, DOI 10.1016/0019-1035(90)90070-P; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; MOUNT GH, 1977, ASTROPHYS J, V214, pL47, DOI 10.1086/182440; MOUNT GH, 1978, ASTROPHYS J, V224, pL35, DOI 10.1086/182753; Muller-Wodarg ICF, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016100; NAGATA T, 1981, CHEM PHYS, V57, P45, DOI 10.1016/0301-0104(81)80019-5; NUTH JA, 1982, J QUANT SPECTROSC RA, V28, P223, DOI 10.1016/0022-4073(82)90025-5; OKABE H, 1981, J CHEM PHYS, V75, P2772, DOI 10.1063/1.442348; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; SAMSON JAR, 1989, J CHEM PHYS, V90, P6925, DOI 10.1063/1.456267; SAMSON JAR, 1974, J OPT SOC AM, V64, P47, DOI 10.1364/JOSA.64.000047; SICARDY B, 2004, 362206S AASDPS; SMITH GR, 1982, J GEOPHYS RES-SPACE, V87, P1351, DOI 10.1029/JA087iA03p01351; STROBEL DF, 1992, ICARUS, V100, P512, DOI 10.1016/0019-1035(92)90114-M; STROBEL DF, COMMUNICATION; SUN H, 1955, J CHEM PHYS, V23, P1160, DOI 10.1063/1.1742205; Vervack RJ, 2004, ICARUS, V170, P91, DOI 10.1016/j.icarus.2004.03.005; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; Wilson EH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002181; Wu CYR, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002180; Wu CYR, 2001, J GEOPHYS RES-PLANET, V106, P7629, DOI 10.1029/2000JE001292; YELLE R, COMMUNICATION; YELLE RV, 1997, ESA SP PUBL, V1177, P243; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	31	113	113	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					978	982		10.1126/science.1111790	http://dx.doi.org/10.1126/science.1111790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890872				2022-12-28	WOS:000229190700033
J	Buetow, KH				Buetow, KH			Cyberinfrastructure: Empowering a "third way" in biomedical research	SCIENCE			English	Article							SCIENCE	Biomedicine has experienced explosive growth, fueled in parts by the substantial increase of government support, continued development of the biotechnology industry, and the increasing adoption of molecutar-based medicine. At its core, it is composed of fiercely independent, innovative, entrepreneurial individuals, organizations, and institutions. The field has developed unprecedented capacity to characterize biologic systems at their most fundamental levels with the use of toots and technologies almost unimaginable a generation ago. Biomedicine is at the precipice of unlocking the very essence of biologic life and enabling a new generation of medicine. Development and deployment of cyberinfrastructure may prove to be on the critical path to obtaining these goals.	NCI, Ctr Bioinformat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Buetow, KH (corresponding author), NCI, Ctr Bioinformat, NIH, Bethesda, MD 20892 USA.	buetowk@nih.gov	Hoek, Carien/K-9106-2013					Foster I, 2005, SCIENCE, V308, P814, DOI 10.1126/science.1110411; Foster I, 2003, SCI AM, V288, P78, DOI 10.1038/scientificamerican0403-78; Foster I, 1997, INT J SUPERCOMPUT AP, V11, P115, DOI 10.1177/109434209701100205; Hey T, 2005, SCIENCE, V308, P817, DOI 10.1126/science.1110410; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227	5	99	104	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					821	824		10.1126/science.1112120	http://dx.doi.org/10.1126/science.1112120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879210				2022-12-28	WOS:000228986500039
J	Schousboe, JT; Nyman, JA; Kane, RL; Ensrud, KE				Schousboe, JT; Nyman, JA; Kane, RL; Ensrud, KE			Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; VERTEBRAL FRACTURES; HIP FRACTURE; POPULATION HEALTH; ECONOMIC-EVALUATION; CLINICAL-PRACTICE; BONE-DENSITY; BACK-PAIN; OSTEOPOROSIS; RISK	Background: Treatment guidelines recommend drug treatment to prevent fractures for some postmenopausal women who have low bone mass (osteopenia) but do not have osteoporosis or a history of clinical fractures. Objective: To estimate the societal costs and health benefits of alendronate drug treatment to prevent fractures in postmenopausal women with osteopenia. Design: Markov model with 8 health states: no fracture, post-distal forearm fracture, post-clinical vertebral fracture, post-radiographic (but clinically inapparent) vertebral fracture, post-hip fracture, post-hip and vertebral fractures, post-other fracture, and death. Data Sources: Population -based studies of age-specific fracture rates and costs, prospectively measured estimates of disutility after fractures, and the Fracture Intervention Trial of alendronate versus placebo to prevent fracture. Target Population: Postmenopausal women 55 to 75 years of age with femoral neck T-scores between -1.5 and -2.4. Time Horizon: Lifetime. Perspective: Societal. Interventions: Five years of alendronate therapy or no drug treatment. Outcome Measures: Costs, quality-adjusted life-years, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: For women with no additional fracture risk factors, the cost per quality-adjusted life-year gained ranged from $70 000 to $332 000, depending on age and femoral neck bone density. Limitations: Results apply only to postmenopausal white women residing in the United States. Conclusion: Alendronate therapy for postmenopausal women with femoral neck T-scores better than -2.5 and no history of clinical fractures or other bone mineral density-independent risk factors for fracture is not cost-effective, assuming U.S. costs of alendronate and currently available estimates of alendronate efficacy in osteopenic women.	Univ Minnesota, Pk Nicollet Hlth Serv, Minneapolis, MN USA; Vet Adm Med Ctr, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Schousboe, JT (corresponding author), Pk Nicollet Clin, 3800 Pk Nocollet Blvd, Minneapolis, MN 55416 USA.	schouj@parknicollet.com		Ensrud, Kristine/0000-0002-9069-3036				American Association of Clinical Endocrinologists Osteoporosis Task Force, 2001, Endocr Pract, V7, P293; American College of Obstetricians and Gynecologists Women's Health Care Physicians, 2004, Obstet Gynecol, V103, P203; Anderson Robert N, 2002, Natl Vital Stat Rep, V50, P1; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Brecht JG, 2003, INT J CLIN PHARM RES, V23, P93; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Burstrom K, 2001, QUAL LIFE RES, V10, P621, DOI 10.1023/A:1013171831202; CHESTNUT CH, 1995, AM J MED, V99, P144, DOI 10.1016/S0002-9343(99)80134-X; *CTR MED MED SERV, 2005, NAT PHYS FEE SCH REL; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; De Laet CEDH, 1998, J BONE MINER RES, V13, P1587, DOI 10.1359/jbmr.1998.13.10.1587; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Ensrud K, 2003, J BONE MINER RES, V18, pS90; Ettinger M, 2004, ARTHRITIS RHEUM, V50, pS513; Gabriel SE, 2002, OSTEOPOROSIS INT, V13, P323, DOI 10.1007/s001980200033; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; Halpern EF, 2000, MED DECIS MAKING, V20, P314, DOI 10.1177/0272989X0002000308; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Huopio J, 2000, OSTEOPOROSIS INT, V11, P219, DOI 10.1007/s001980050284; Iglesias CP, 2002, QJM-INT J MED, V95, P305, DOI 10.1093/qjmed/95.5.305; Johannesson M, 1998, HEALTH ECON, V7, P1, DOI 10.1002/(SICI)1099-1050(199802)7:1<1::AID-HEC327>3.0.CO;2-U; Johannesson M, 1996, J INTERN MED, V240, P23, DOI 10.1046/j.1365-2796.1996.491830000.x; Johnell O, 2003, PHARMACOECONOMICS, V21, P305, DOI 10.2165/00019053-200321050-00002; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P15, DOI 10.1007/s00198-004-1688-0; Kanis JA, 2002, BONE, V31, P26, DOI 10.1016/S8756-3282(02)00813-X; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Kanis JA, 2002, J BONE MINER RES, V17, pS146; Kanis JA, 2002, OSTEOPOROSIS INT, V13, P765, DOI 10.1007/s001980200106; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Macran S, 2003, MED CARE, V41, P218; *MED EC, 2001, 2001 DRUG TOPICS RED; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Melton LJ, 2000, J AM GERIATR SOC, V48, P338, DOI 10.1111/j.1532-5415.2000.tb02658.x; Melton LJ, 1999, OSTEOPOROSIS INT, V9, P29, DOI 10.1007/s001980050113; Meunier PJ, 1999, CLIN THER, V21, P1025, DOI 10.1016/S0149-2918(99)80022-8; Miller PD, 2004, ARCH INTERN MED, V164, P1113, DOI 10.1001/archinte.164.10.1113; National Osteoporosis Foundation, 2003, PHYS GUID PREV TREAT; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; O'Neill TW, 2004, OSTEOPOROSIS INT, V15, P760, DOI 10.1007/s00198-004-1615-4; Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384; OSTER G, 1994, STROKE, V25, P1149, DOI 10.1161/01.STR.25.6.1149; Rosner AJ, 1998, PHARMACOECONOMICS, V14, P559, DOI 10.2165/00019053-199814050-00007; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Siris ES, 2004, ARCH INTERN MED, V164, P1108, DOI 10.1001/archinte.164.10.1108; Tosteson ANA, 2001, OSTEOPOROSIS INT, V12, P1042, DOI 10.1007/s001980170015; Tosteson ANA, 2001, OSTEOPOROSIS INT, V12, P849, DOI 10.1007/s001980170036; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; Wainwright SA, 2001, J BONE MINER RES, V16, pS155; Wehren LE, 2004, CURR MED RES OPIN, V20, P525, DOI 10.1185/030079904125003269; 1998, OSTEOPOROS INT S, V4, pS7	57	88	89	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					734	741		10.7326/0003-4819-142-9-200505030-00008	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	922GW	15867405				2022-12-28	WOS:000228825800002
J	Wormser, GP; McKenna, D; Carlin, J; Nadelman, RB; Cavaliere, LF; Holmgren, D; Byrne, DW; Nowakowski, J				Wormser, GP; McKenna, D; Carlin, J; Nadelman, RB; Cavaliere, LF; Holmgren, D; Byrne, DW; Nowakowski, J			Brief communication: Hematogenous dissemination in early Lyme disease	ANNALS OF INTERNAL MEDICINE			English	Article							BORRELIA-BURGDORFERI; ERYTHEMA MIGRANS; GENETIC DIVERSITY; BLOOD CULTURES; ASSOCIATION; EVOLUTION; YIELD; PCR	Background: Bloodstream invasion in Lyme disease has been difficult to study because until recently blood culture methods were too insensitive to detect spirochetemia. Objective: To evaluate the clinical and laboratory features of spirochetemic patients. Design: Cross-sectional study. Setting: Lyme Disease Diagnostic Center in Valhalla, New York, 1997 to 2002. Patients: 213 untreated adults with erythema migrans. Intervention: Blood culture for Borrelia burgdorferi. Measurements: Symptom scores and selected laboratory measures. Results: Spirocheternia was found in 93 (43.7%) patients. Spirochetemic patients were more often symptomatic (89.2% vs. 74.2%; P = 0.006) and more often had multiple erythema migrans lesions (41.9% vs. 15.0%; P < 0.001) than patients without spirochetemia. However, 8 (22.9%) of the 35 asymptomatic patients with a single skin lesion nevertheless had a positive blood culture. Risk for spirochetemia was present the day the patient noticed the lesion and continued for more than 2 weeks. Limitations: Long-term outcome data were not available. Conclusions: The high rate, early onset, and prolonged duration of risk for spirochetemia explain why untreated patients with erythema migrans are at risk for dissemination of B. burgdorferi to anatomic sites beyond the lesion site. Differences in the strain of the infecting spirochete, as well as host factors, may be important determinants of hematogenous dissemination.	New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA; Vanderbilt Univ, Ctr Med, Nashville, TN 37232 USA	New York Medical College; Vanderbilt University	Wormser, GP (corresponding author), New York Med Coll, Div Infect Dis, Munger Pavil,Room 245, Valhalla, NY 10595 USA.	gary_wormser@nymc.edu			ODCDC CDC HHS [U50/CCU219613, U50/CCU219612] Funding Source: Medline	ODCDC CDC HHS		AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1; Bakken JS, 2001, CLIN INFECT DIS, V32, P862, DOI 10.1086/319350; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P20; Harrel F.E., 2001, REGRESSION MODELING; Kim N, 1998, CLIN INFECT DIS, V26, P1218, DOI 10.1086/520302; Lagal V, 2003, J CLIN MICROBIOL, V41, P5059, DOI 10.1128/JCM.41.11.5059-5065.2003; Liveris D, 1999, J CLIN MICROBIOL, V37, P565, DOI 10.1128/JCM.37.3.565-569.1999; Luft BJ, 1996, ANN INTERN MED, V124, P785, DOI 10.7326/0003-4819-124-9-199605010-00002; NADELMAN RB, 1990, AM J MED, V88, P21, DOI 10.1016/0002-9343(90)90122-T; Piesman J, 2001, J CLIN MICROBIOL, V39, P4145, DOI 10.1128/JCM.39.11.4145-4148.2001; SCHWARTZ I, 1992, J CLIN MICROBIOL, V30, P3082, DOI 10.1128/JCM.30.12.3082-3088.1992; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; Wormser GP, 1998, J CLIN MICROBIOL, V36, P296, DOI 10.1128/JCM.36.1.296-298.1998; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922; Wormser GP, 2001, J INFECT DIS, V184, P1070, DOI 10.1086/323424	18	80	83	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					751	755		10.7326/0003-4819-142-9-200505030-00011	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922GW	15867407				2022-12-28	WOS:000228825800004
J	Cooper, JG; Harboe, K; Frost, SK; Skadberg, O				Cooper, JG; Harboe, K; Frost, SK; Skadberg, O			Ciprofloxacin interacts with thyroid replacement therapy	BRITISH MEDICAL JOURNAL			English	Article							LEVOTHYROXINE		Stavanger Univ Hosp, Dept Med, N-4068 Stavanger, Norway; Stavanger Univ Hosp, Dept Orthopaed Surg, N-4068 Stavanger, Norway; Stavanger Univ Hosp, Dept Med Biochem, N-4068 Stavanger, Norway; Haukeland Univ Hosp, Reg Drug Informat Ctr, N-5021 Bergen, Norway	Stavanger University Hospital; Stavanger University Hospital; Stavanger University Hospital; University of Bergen; Haukeland University Hospital	Cooper, JG (corresponding author), Stavanger Univ Hosp, Dept Med, POB 8100, N-4068 Stavanger, Norway.	john.cooper@isf.uib.no						Mersebach H, 1999, PHARMACOL TOXICOL, V84, P107, DOI 10.1111/j.1600-0773.1999.tb00883.x; Siraj ES, 2003, ARCH INTERN MED, V163, P1367, DOI 10.1001/archinte.163.11.1367; SURKS MI, 1995, NEW ENGL J MED, V333, P1688, DOI 10.1056/NEJM199512213332507	3	10	10	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 30	2005	330	7498					1002	1002		10.1136/bmj.330.7498.1002	http://dx.doi.org/10.1136/bmj.330.7498.1002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UP	15860826	Green Published, Bronze			2022-12-28	WOS:000228935100022
J	Shaw, M; Smith, GD; Dorling, D				Shaw, M; Smith, GD; Dorling, D			Health inequalities and New Labor: how the promises compare with real progress	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England	University of Bristol; University of Sheffield	Shaw, M (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	Mary.Shaw@bristol.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314				Acheson D., 1998, INDEPENDENT INQUIRY; Bajekal Madhavi, 2005, Health Stat Q, P18; BROMLEY C, 2003, BRIT SOCIAL ATTITUDE; *CAB OFF, 2005, STRAT AUD PROGR CHAL; *DEP HLTH, TACKL HLTH IN 2002 C; *DEP HLTH, 2002, HLTH IN NAT TARG INF; *DEP HLTH SOC SEC, 1980, IN HLTH REP WORK GRO; Department of Health, 2003, TACKL HLTH IN PROGR; Department of Health, 2004, CHOOS HLTH MAK HLTH; Donkin A, 2002, HLTH STAT Q, V15, P5; Dorling D, 2000, BRIT MED J, V321, P1547, DOI 10.1136/bmj.321.7276.1547; Dorling D, 2016, PEOPLE PLACES 21 CEN; DORLING D, 2004, KNOW YOUR PLACE HOUS; DORLING D, 1997, DEATH BRIT LOCAL MOR; EXWORTHY M, 2003, TACKLING HLTH INEQUA; GOODMAN A, 2002, INEQUALITY LIVING ST; Gordon D, 1995, J EPIDEMIOL COMMUN H, V49, pS39, DOI 10.1136/jech.49.Suppl_2.S39; HILLS J, 2004, 100 YEARS POVERTY PO; LAKIN C, 2004, EC TRENDS, V0607; Low A, 2004, J PUBLIC HEALTH-UK, V26, P388, DOI 10.1093/pubmed/fdh175; Morris JN, 2000, J EPIDEMIOL COMMUN H, V54, P885, DOI 10.1136/jech.54.12.885; Morris JN, 2004, POLICY POLIT, V32, P441, DOI 10.1332/0305573042009507; *OFF NAT STAT, POP EST ENGL WAL; *OFF NAT STAT, 2004, LIF EXP BIRTH HLTH L; Shaw, 2001, POVERTY INEQUALITY H; Shaw M, 1999, WIDENING GAP HLTH IN; Smith GD, 1998, BMJ-BRIT MED J, V317, P1465, DOI 10.1136/bmj.317.7171.1465; Smith GD, 2002, J EPIDEMIOL COMMUN H, V56, P434; *SOC EXCL UN, 1998, CM4045 SOC EXCL UN; Szreter S, 1998, ECON HIST REV, V51, P84, DOI 10.1111/1468-0289.00084; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; *WHO, 1998, HLTH EUR 1997; WHO World Health Organisation, 1985, TARG HLTH ALL	33	101	104	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2005	330	7498					1016	1021		10.1136/bmj.330.7498.1016	http://dx.doi.org/10.1136/bmj.330.7498.1016			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UP	15860830	Green Published			2022-12-28	WOS:000228935100026
J	Fleming, RE; Bacon, BR				Fleming, RE; Bacon, BR			Orchestration of iron homeostasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METABOLISM; HEPCIDIN		St Louis Univ, Sch Med, St Louis, MO 63103 USA	Saint Louis University	Fleming, RE (corresponding author), St Louis Univ, Sch Med, St Louis, MO 63103 USA.							Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Miret S, 2003, ANNU REV NUTR, V23, P283, DOI 10.1146/annurev.nutr.23.011702.073139; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573	5	141	149	2	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1741	1744		10.1056/NEJMp048363	http://dx.doi.org/10.1056/NEJMp048363			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858181				2022-12-28	WOS:000228689000002
J	Friedman, RS; McAlpine, MC; Ricketts, DS; Ham, D; Lieber, CM				Friedman, RS; McAlpine, MC; Ricketts, DS; Ham, D; Lieber, CM			High-speed integrated nanowire circuits	NATURE			English	Editorial Material							TRANSISTORS; ELECTRONICS; LOGIC		Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Friedman, RS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	cml@cmliris.harvard.edu		McAlpine, Michael/0000-0001-7869-7598; Ham, Donhee/0000-0001-6925-2466				Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Clemens W, 2004, J MATER RES, V19, P1963, DOI 10.1557/JMR.2004.0263; Cui Y, 2003, NANO LETT, V3, P149, DOI 10.1021/nl025875l; Duan XF, 2003, NATURE, V425, P274, DOI 10.1038/nature01996; Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061; HIRANAKA K, 1984, IEEE ELECTR DEVICE L, V5, P224, DOI 10.1109/EDL.1984.25897; Javey A, 2002, NANO LETT, V2, P929, DOI [10.1021/nl025647r, 10.1021/n1025647r]; Jin S, 2004, NANO LETT, V4, P915, DOI 10.1021/nl049659j; McAlpine MC, 2003, NANO LETT, V3, P1531, DOI 10.1021/nl0346427; Shimoda T, 2001, PROC SPIE, V4295, P52, DOI 10.1117/12.424888; Street R., 2000, TECHNOLOGY APPL AMOR	11	294	344	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1085	1085		10.1038/4341085a	http://dx.doi.org/10.1038/4341085a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858562	Bronze			2022-12-28	WOS:000228693300028
J	Hampton, J; Sibert, JR; Kleiber, P; Maunder, MN; Harley, SJ				Hampton, J; Sibert, JR; Kleiber, P; Maunder, MN; Harley, SJ			Decline of Pacific tuna populations exaggerated?	NATURE			English	Editorial Material							THUNNUS-OBESUS; BIGEYE TUNA; MODEL; OCEAN		Secretariat Pacific Community, Ocean Fisheries Programme, Noumea 98848, New Caledonia; Univ Hawaii, Pelag Fisheries Res Program, Honolulu, HI 96822 USA; Natl Marine Fisheries Serv, Pacific Isl Fisheries Sci Ctr, Honolulu, HI 96822 USA; Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA	University of Hawaii System; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Hampton, J (corresponding author), Secretariat Pacific Community, Ocean Fisheries Programme, BP D5, Noumea 98848, New Caledonia.	johnh@spc.int		Worm, Boris/0000-0002-5742-8716				Bigelow KA, 2002, FISH OCEANOGR, V11, P143, DOI 10.1046/j.1365-2419.2002.00196.x; Brill RW, 2001, AM FISH S S, V25, P179; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Hampton J, 2001, MAR FRESHWATER RES, V52, P937, DOI 10.1071/MF01049; HAMPTON J, 2003, 16 M STAND COMM TUN; HARLEY SJ, 2004, INTERAM TROP TUNA CO, V4, P120; Kleiber P, 2003, MAR FRESHWATER RES, V54, P349, DOI 10.1071/MF01246; Labelle M., 2003, 16 M STAND COMM TUN; Lehodey P, 2003, FISH OCEANOGR, V12, P483, DOI 10.1046/j.1365-2419.2003.00244.x; MAUNDER MN, 2003, INTERAM TROP TUNA CO, V23, P433; MAUNDER MN, 2004, INTERAM TROP TUNA CO, V4, P5; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Ravier C, 2004, FISH OCEANOGR, V13, P145, DOI 10.1111/j.1365-2419.2004.00284.x; SAKAGAWA GT, 1987, MAR FISH REV, V49, P57	14	97	102	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					E1	E2		10.1038/nature03581	http://dx.doi.org/10.1038/nature03581			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858533				2022-12-28	WOS:000228693300030
J	Quiroz, R; Kucher, N; Zou, KH; Kipfmueller, F; Costello, P; Goldhaber, SZ; Schoepf, UJ				Quiroz, R; Kucher, N; Zou, KH; Kipfmueller, F; Costello, P; Goldhaber, SZ; Schoepf, UJ			Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DEEP VENOUS THROMBOSIS; SPIRAL CT; HELICAL CT; DIAGNOSTIC STRATEGY; ANGIOGRAPHY; RISK; OUTCOMES; BIAS; ANTICOAGULATION; METAANALYSES	Context The clinical validity of using computed tomography (CT) to diagnose peripheral pulmonary embolism is uncertain. Insufficient sensitivity for peripheral pulmonary embolism is considered the principal limitation of CT. Objective To review studies that used a CT-based approach to rule out a diagnosis of pulmonary embolism. Data Sources The medical literature databases of PubMed, MEDLINE, EMBASE, CRISP, metaRegister of Controlled Trials, and Cochrane were searched for articles published in the English language from January 1990 to May 2004. Study Selection We included studies that used contrast-enhanced chest CT to rule out the diagnosis of acute pulmonary embolism, had a minimum follow-up of 3 months, and had study populations of more than 30 patients. Data Extraction Two reviewers independently abstracted patient demographics, frequency of venous thromboembolic events (VTEs), CT modality (single-slice CT, multidetector-row CT, or electron-beam CT), false-negative results,,and deaths attributable to pulmonary embolism. To calculate the overall negative likelihood ratio (NLR) of a VTE after a negative or inconclusive chest CT scan for pulmonary embolism, we included VTEs that were objectively confirmed by an additional imaging test despite a negative or inconclusive CT scan and objectively confirmed VTEs that occurred during clinical follow-up of at least 3 months. Data Synthesis Fifteen studies met the inclusion criteria and contained a total of 3500 patients who were evaluated from October 1994 through April 2002. the overall NLR of a VTE after a negative chest CT scan for pulmonary embolism was 0.07 (95% confidence interval [CI], 0.05-0.11); and the negative predictive value (NPV) was 99.1% (95% Cl, 98.7%-99.5%). The NLR of a VTE after a negative single-slice spiral CT scan for pulmonary embolism was 0.08 (95% Cl, 0.05-0.13); and after a negative multidetector-row CT scan, 0.15 (95% Cl, 0.05-0.43). There was no difference in risk of VTEs based on CT modality used (relative risk, 1.66; 95% Cl, 0.47-5.94; P=.50). The overall NLR of mortality attributable to pulmonary embolism was 0.01 (95% CI, 0.01-0.02) and the overall NPV was 99.4% (95% Cl, 98.7%-99.9%). Conclusion The clinical validity of using a CT scan to rule out pulmonary embolism is similar to that reported for conventional pulmonary angiography.	Med Univ S Carolina, Dept Radiol, Charleston, SC 29425 USA; Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Medical University of South Carolina; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Schoepf, UJ (corresponding author), Med Univ S Carolina, Dept Radiol, 169 Ashley Ave, Charleston, SC 29425 USA.	schoepf@musc.edu	Schoepf, U. Joseph/A-6870-2009					BEGG CB, 1989, J NATL CANCER I, V81, P107, DOI 10.1093/jnci/81.2.107; Blachere H, 2000, AM J ROENTGENOL, V174, P1041, DOI 10.2214/ajr.174.4.1741041; Bourriot K, 2003, CHEST, V123, P359, DOI 10.1378/chest.123.2.359; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; Cham MD, 2000, RADIOLOGY, V216, P744, DOI 10.1148/radiology.216.3.r00se44744; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; Deeks JJ., 2001, SYSTEMATIC REV HLTH, P248, DOI DOI 10.1002/9780470693926.CH14; Diffin DC, 1998, AM J ROENTGENOL, V171, P1085, DOI 10.2214/ajr.171.4.9763002; Donato AA, 2003, ARCH INTERN MED, V163, P2033, DOI 10.1001/archinte.163.17.2033; Drucker EA, 1998, RADIOLOGY, V209, P235, DOI 10.1148/radiology.209.1.9769837; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferretti GR, 1997, RADIOLOGY, V205, P453, DOI 10.1148/radiology.205.2.9356628; Garg K, 1998, RADIOLOGY, V208, P201, DOI 10.1148/radiology.208.1.9646814; Garg K, 1999, AM J ROENTGENOL, V172, P1627, DOI 10.2214/ajr.172.6.10350303; Ghaye B, 2001, RADIOLOGY, V219, P629, DOI 10.1148/radiology.219.3.r01jn32629; Goodman LR, 2000, RADIOLOGY, V215, P535, DOI 10.1148/radiology.215.2.r00ma23535; GOODMAN LR, 1995, AM J ROENTGENOL, V164, P1369, DOI 10.2214/ajr.164.6.7754875; Gottsater A, 2001, EUR RADIOL, V11, P65, DOI 10.1007/s003300000539; HENRY JW, 1995, CHEST, V107, P1375, DOI 10.1378/chest.107.5.1375; IRWIG L, 1995, J CLIN EPIDEMIOL, V48, P119, DOI 10.1016/0895-4356(94)00099-C; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; Irwin GAL, 2002, ACAD RADIOL, V9, P1013, DOI 10.1016/S1076-6332(03)80476-2; Kavanagh EC, 2004, AM J ROENTGENOL, V182, P499, DOI 10.2214/ajr.182.2.1820499; Krestan CR, 2004, EUR RADIOL, V14, P93, DOI 10.1007/s00330-003-2016-3; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lombard J, 2003, CAN ASSOC RADIOL J, V54, P147; Lomis NNT, 1999, J VASC INTERV RADIOL, V10, P707, DOI 10.1016/S1051-0443(99)70104-1; Lorut C, 2000, AM J RESP CRIT CARE, V162, P1413, DOI 10.1164/ajrccm.162.4.9909109; Loud PA, 2001, RADIOLOGY, V219, P498, DOI 10.1148/radiology.219.2.r01ma26498; Musset D, 2002, LANCET, V360, P1914, DOI 10.1016/S0140-6736(02)11914-3; Nilsson T, 2002, ACTA RADIOL, V43, P486; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Ost D, 2001, AM J MED, V110, P16, DOI 10.1016/S0002-9343(00)00641-0; Patel S, 2003, RADIOLOGY, V227, P455, DOI 10.1148/radiol.2272011139; Perrier A, 2001, ANN INTERN MED, V135, P88, DOI 10.7326/0003-4819-135-2-200107170-00008; Remy-Jardin M, 2002, EUR RADIOL, V12, P1971, DOI 10.1007/s00330-002-1485-0; Schoepf UJ, 2004, CIRCULATION, V109, P2160, DOI 10.1161/01.CIR.0000128813.04325.08; Schoepf UJ, 2002, RADIOLOGY, V222, P483, DOI 10.1148/radiol.2222001802; Stein PD, 2004, AM J CARDIOL, V93, P1316, DOI 10.1016/j.amjcard.2004.02.022; Stein PD, 1999, RADIOLOGY, V210, P689, DOI 10.1148/radiology.210.3.r99mr41689; STEIN PD, 1994, CHEST, V106, P727, DOI 10.1378/chest.106.3.727; Swensen SJ, 2002, MAYO CLIN PROC, V77, P130; Thompson S.G., 2001, SYSTEMATIC REV HLTH, P157; THOMPSON SG, 1991, LANCET, V338, P1127, DOI 10.1016/0140-6736(91)91975-Z; Tillie-Leblond I, 2002, RADIOLOGY, V223, P461, DOI 10.1148/radiol.2232010913; Tobias A., 1999, STATA TECHNICAL B, V8, P15; van Strijen MJL, 2003, EUR RADIOL, V13, P1501, DOI 10.1007/s00330-002-1709-3; van Strijen MJL, 2003, ANN INTERN MED, V138, P307, DOI 10.7326/0003-4819-138-4-200302180-00009; vanBeek EJR, 1996, EUR RADIOL, V6, P415, DOI 10.1007/BF00182453; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wolfe TR, 2001, ANN EMERG MED, V37, P504, DOI 10.1067/mem.2001.111764; Zuckerman DA, 1996, J VASC INTERV RADIOL, V7, P199, DOI 10.1016/S1051-0443(96)70762-5	52	210	220	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2005	293	16					2012	2017		10.1001/jama.293.16.2012	http://dx.doi.org/10.1001/jama.293.16.2012			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XS	15855435				2022-12-28	WOS:000228651500027
J	Greenwood, BM; Bojang, K; Whitty, CJM; Targett, GAT				Greenwood, BM; Bojang, K; Whitty, CJM; Targett, GAT			Malaria	LANCET			English	Review							PLASMODIUM-FALCIPARUM MALARIA; PLUS SULFADOXINE-PYRIMETHAMINE; CIRCUMSPOROZOITE PROTEIN VACCINE; INSECTICIDE-TREATED NETS; DRUG-RESISTANT MALARIA; YOUNG AFRICAN CHILDREN; ARTEMETHER-LUMEFANTRINE; DOUBLE-BLIND; CHLORPROGUANIL-DAPSONE; INTERMITTENT TREATMENT	Malaria is the most important parasitic infection in people, accounting for more than 1 million deaths a year. Malaria has become a priority for the international health community and is now the focus of several new initiatives. Prevention and treatment of malaria could be greatly improved with existing methods if increased financial and labour resources were available. However, new approaches for prevention and treatment are needed. Several new drugs are under development, which are likely to be used in combinations to slow the spread of resistance, but the high cost of treatments would make sustainability difficult. Insecticide-treated bed-nets provide a simple but effective means of preventing malaria, especially with the development of longlasting nets in which insecticide is incorporated into the net fibres. One malaria vaccine, RTS,S/AS02, has shown promise in endemic areas and will shortly enter further trials. Other vaccines are being studied in clinical trials, but it will probably be at least 10 years before a malaria vaccine is ready for widespread use.	London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1B 3DP, England; MRC Labs, Banjul, Gambia	University of London; London School of Hygiene & Tropical Medicine; MRC Laboratory Molecular Biology	Greenwood, BM (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1B 3DP, England.	brian.greenwood@lshtm.ac.uk	Whitty, Christopher/C-7740-2012	Whitty, Christopher/0000-0002-6076-5027; Bojang, Kalifa/0000-0001-7506-0938				Abeku TA, 2004, TRENDS PARASITOL, V20, P400, DOI 10.1016/j.pt.2004.07.005; Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Anderson RJ, 2004, J IMMUNOL, V172, P3094, DOI 10.4049/jimmunol.172.5.3094; Arrow Kenneth J., 2004, SAV LIV BUYING TIM E; Barat LM, 2004, AM J TROP MED HYG, V71, P174, DOI 10.4269/ajtmh.2004.71.174; Barnes KI, 2004, LANCET, V363, P1598, DOI 10.1016/S0140-6736(04)16203-X; Bates I, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-38; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Binka FN, 2002, T ROY SOC TROP MED H, V96, P597, DOI 10.1016/S0035-9203(02)90321-4; Bloland P.B., 2003, MALARIA CONTROL MASS; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Boutlis CS, 2004, INFECT IMMUN, V72, P6932, DOI 10.1128/IAI.72.12.6932-6938.2004; Brey PT, 2003, MOL CELLS, V15, P133; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Carter JA, 2005, TROP MED INT HEALTH, V10, P3, DOI 10.1111/j.1365-3156.2004.01345.x; Centers for Disease Control and Prevention, MAL; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Chen A, 2003, EMERG INFECT DIS, V9, P960; Chima RI, 2003, HEALTH POLICY, V63, P17, DOI 10.1016/S0168-8510(02)00036-2; CISSE B, 2004, 53 M AM SOC TROP MED; Coleman PG, 2004, TROP MED INT HEALTH, V9, P433, DOI 10.1111/j.1365-3156.2004.01225.x; Connor J, 2004, B WORLD HEALTH ORGAN, V82, P935; Craig MH, 2002, T ROY SOC TROP MED H, V96, P258, DOI 10.1016/S0035-9203(02)90092-1; Crawley J, 2001, ARCH DIS CHILD, V84, P247, DOI 10.1136/adc.84.3.247; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; De Savigny D, 2004, AM J TROP MED HYG, V71, P224, DOI 10.4269/ajtmh.2004.71.224; Diallo DA, 2004, B WORLD HEALTH ORGAN, V82, P85; DICKO A, 2004, 53 M AM SOC TROP MED; Djimde AA, 2003, AM J TROP MED HYG, V69, P558, DOI 10.4269/ajtmh.2003.69.558; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; Dondorp AM, 2004, CRIT CARE MED, V32, P1683, DOI 10.1097/01.CCM.0000132901.86681.CA; Duke T, 2004, LANCET, V363, P1922, DOI 10.1016/S0140-6736(04)16438-6; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Felger I, 2003, TRENDS PARASITOL, V19, P60, DOI 10.1016/S1471-4922(02)00066-1; Fernando SD, 2003, AM J TROP MED HYG, V69, P582, DOI 10.4269/ajtmh.2003.69.582; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Greenwood B, 2004, AM J TROP MED HYG, V70, P1; Greenwood B, 2002, CHEM IMMUNOL, V80, P366; Guyatt HL, 2001, T ROY SOC TROP MED H, V95, P569, DOI 10.1016/S0035-9203(01)90082-3; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hallett RL, 2004, ANTIMICROB AGENTS CH, V48, P3940, DOI 10.1128/AAC.48.10.3940-3943.2004; Hastings IM, 2004, TRENDS PARASITOL, V20, P512, DOI 10.1016/j.pt.2004.08.006; Hastings IM, 2002, PHILOS T ROY SOC B, V357, P505, DOI 10.1098/rstb.2001.1036; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hien TT, 2004, LANCET, V363, P18, DOI 10.1016/S0140-6736(03)15163-X; *HLTH PROT AG, MAL GUID; *INT PREV TREATM I, INT PREV TREAT INF A; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Jones COH, 2004, AM J TROP MED HYG, V71, P156, DOI 10.4269/ajtmh.2004.71.156; Kaslow DC, 2002, CHEM IMMUNOL, V80, P287; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Kremsner PG, 2004, LANCET, V364, P285, DOI 10.1016/S0140-6736(04)16680-4; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; Lengeler C, 2004, COCHRANE DB SYST REV, V2; Litsios Socrates, 1996, TOMORROW MALARIA; *LOND SCH HYG TROP, DER MORT MORB EST CO; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Maitland K, 2005, TRENDS PARASITOL, V21, P11, DOI 10.1016/j.pt.2004.10.010; Makani J, 2003, QJM-INT J MED, V96, P355, DOI 10.1093/qjmed/hcg059; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; Mayxay M, 2004, CLIN INFECT DIS, V39, P1139, DOI 10.1086/424512; Mita T, 2003, AM J TROP MED HYG, V68, P413, DOI 10.4269/ajtmh.2003.68.413; Monasch R, 2004, AM J TROP MED HYG, V71, P232, DOI 10.4269/ajtmh.2004.71.232; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Moorthy VS, 2004, LANCET, V363, P150, DOI 10.1016/S0140-6736(03)15267-1; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Muller O, 2001, BMJ-BRIT MED J, V322, P1567, DOI 10.1136/bmj.322.7302.1567; Mutabingwa T, 2001, LANCET, V358, P1218, DOI 10.1016/S0140-6736(01)06344-9; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Obonyo CO, 2003, T ROY SOC TROP MED H, V97, P585, DOI 10.1016/S0035-9203(03)80038-X; OMARI AA, 2003, COCHRANE DB SYST REV, V2, P3125; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; Planche T, 2004, PLOS MED, V1, P56, DOI 10.1371/journal.pmed.0010018; Plowe CV, 2004, BRIT MED J, V328, P545, DOI 10.1136/bmj.37977.653750.EE; Polley SD, 2004, TRENDS PARASITOL, V20, P99, DOI 10.1016/j.pt.2003.12.003; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Rapuoda B, 2003, TROP MED INT HEALTH, V8, P860, DOI 10.1046/j.1360-2276.2003.01114.x; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rogerson SJ, 2000, T ROY SOC TROP MED H, V94, P549, DOI 10.1016/S0035-9203(00)90083-X; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Rowland M, 2004, TROP MED INT HEALTH, V9, P335, DOI 10.1111/j.1365-3156.2004.01198.x; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; SCHULTZ LJ, 1994, AM J TROP MED HYG, V51, P515, DOI 10.4269/ajtmh.1994.51.515; Shankar AH, 1999, LANCET, V354, P203, DOI 10.1016/S0140-6736(98)08293-2; Shankar AH, 2000, AM J TROP MED HYG, V62, P663, DOI 10.4269/ajtmh.2000.62.663; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Snow RW, 2001, TRENDS PARASITOL, V17, P593, DOI 10.1016/S1471-4922(01)02031-1; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Staedke SG, 2004, LANCET, V364, P1950, DOI 10.1016/S0140-6736(04)17478-3; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Sutherland CJ, 2002, AM J TROP MED HYG, V67, P578, DOI 10.4269/ajtmh.2002.67.578; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Teklehaimanot HD, 2004, EMERG INFECT DIS, V10, P1220, DOI 10.3201/eid1007.030722; Thomson MC, 2001, TRENDS PARASITOL, V17, P438, DOI 10.1016/S1471-4922(01)02077-3; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P351, DOI 10.1111/j.1365-3156.2004.01196.x; Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779; Verhoef H, 2002, LANCET, V360, P908, DOI 10.1016/S0140-6736(02)11027-0; Vernick KD, 2004, NEW ENGL J MED, V351, P1901, DOI 10.1056/NEJMcibr042899; Whitty CJM, 2004, B WORLD HEALTH ORGAN, V82, P381; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; *WHO, 2004, PORTF CAND MAL VACC; *WHO, 2004, SCAL HOM BAS CAR MAL; WHO, 2005, WHOCDSWHOPESGCDPP200; World Health Organization (WHO), 2003, ASS SAF ART COMP PRE; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	137	463	480	0	136	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1487	1498		10.1016/S0140-6736(05)66420-3	http://dx.doi.org/10.1016/S0140-6736(05)66420-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850634				2022-12-28	WOS:000228651600028
J	Abraham, RT; Tibbetts, RS				Abraham, RT; Tibbetts, RS			Guiding ATM to broken DNA	SCIENCE			English	Editorial Material							MRE11 COMPLEX; ACTIVATION; DAMAGE; CHECKPOINT		Burnham Inst, Signal Transduct Program, La Jolla, CA 92037 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Wisconsin System; University of Wisconsin Madison	Abraham, RT (corresponding author), Burnham Inst, Signal Transduct Program, La Jolla, CA 92037 USA.	abraham@burnham.org; rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297				Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; FATCK J, 2005, NATURE, V434, P605; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	11	44	50	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2005	308	5721					510	511		10.1126/science.1112069	http://dx.doi.org/10.1126/science.1112069			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845843				2022-12-28	WOS:000228810500041
J	Goes, JI; Thoppil, PG; Gomes, HD; Fasullo, JT				Goes, JI; Thoppil, PG; Gomes, HD; Fasullo, JT			Warming of the Eurasian landmass is making the Arabian Sea more productive	SCIENCE			English	Article							INDIAN-SUMMER MONSOON; DIPOLE MODE; SNOW COVER; OCEAN; OCEANOGRAPHY; VARIABILITY; CIRCULATION; MECHANISMS; DYNAMICS; SURFACE	The recent trend of declining winter and spring snow cover over Eurasia is causing a land-ocean thermal gradient that is particularly favorable to stronger southwest (summer) monsoon winds. Since 1997, sea surface winds have been strengthening over the western Arabian Sea. This escalation in the intensity of summer monsoon winds, accompanied by enhanced upwelling and an increase of more than 350% in average summertime phytoplankton biomass along the coast and over 300% offshore, raises the possibility that the current warming trend of the Eurasian landmass is making the Arabian Sea more productive.	Bigelow Lab Ocean Sci, W Boothbay Harbor, ME 04575 USA; USN, Dept Oceanog, Postgrad Sch, Monterey, CA 93943 USA; Univ Colorado, Program Atmospher & Ocean Sci, Boulder, CO 80309 USA	Bigelow Laboratory for Ocean Sciences; United States Department of Defense; United States Navy; Naval Postgraduate School; University of Colorado System; University of Colorado Boulder	Goes, JI (corresponding author), Bigelow Lab Ocean Sci, W Boothbay Harbor, ME 04575 USA.	jgoes@bigelow.org	Fasullo, John/H-4552-2019	Fasullo, John/0000-0003-1216-892X; Thoppil, Prasad/0000-0003-2240-9782; DO ROSARIO GOMES, MARIA HELGA/0000-0002-6287-354X; Goes, Joaquim/0000-0002-9785-6985				Bamzai AS, 1999, J CLIMATE, V12, P3117, DOI 10.1175/1520-0442(1999)012<3117:RBESCS>2.0.CO;2; Banse K, 2000, DEEP-SEA RES PT II, V47, P1623, DOI 10.1016/S0967-0645(99)00157-5; BARNETT TP, 1989, J ATMOS SCI, V46, P661, DOI 10.1175/1520-0469(1989)046<0661:TEOESC>2.0.CO;2; Blanford HF., 1884, P R SOC LOND, V37, P3, DOI DOI 10.1098/RSPL.1884.0003; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; Fasham MJR, 2001, AMBIO, P4; FINDLATER J, 1969, Q J ROY METEOR SOC, V95, P362, DOI 10.1002/qj.49709540409; Hitchcock GL, 2000, DEEP-SEA RES PT II, V47, P1605, DOI 10.1016/S0967-0645(99)00156-3; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kumar KK, 1999, SCIENCE, V284, P2156, DOI 10.1126/science.284.5423.2156; Lee CM, 2000, DEEP-SEA RES PT II, V47, P1177, DOI 10.1016/S0967-0645(99)00141-1; MEEHL GA, 1994, J CLIMATE, V7, P1033, DOI 10.1175/1520-0442(1994)007<1033:IOTLSI>2.0.CO;2; MEEHL GA, 1994, SCIENCE, V266, P263, DOI 10.1126/science.266.5183.263; Morrison JM, 1999, DEEP-SEA RES PT II, V46, P1903, DOI 10.1016/S0967-0645(99)00048-X; Murtugudde R, 2000, J GEOPHYS RES-OCEANS, V105, P3295, DOI 10.1029/1999JC900294; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Overland JE, 2001, FISH OCEANOGR, V10, P69, DOI 10.1046/j.1365-2419.2001.00154.x; Parthasarathy B, 1995, Advances in Atmospheric Sciences, V12, P143, DOI 10.1007/BF02656828; Prasad TG, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001872; Prasad TG, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002000; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; SCHOTT F, 1983, PROG OCEANOGR, V12, P357, DOI 10.1016/0079-6611(83)90014-9; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Schott FA, 2002, PROG OCEANOGR, V53, P57, DOI 10.1016/S0079-6611(02)00039-3; SENGUPTA R, 1984, DEEP-SEA RES, V31, P671; SHINODA TM, 2004, J CLIMATOL, V7, P929; Slingo JM, 2000, MON WEATHER REV, V128, P1778, DOI 10.1175/1520-0493(2000)128<1778:TENOOT>2.0.CO;2; Smith SL, 1998, DEEP-SEA RES PT II, V45, P1905, DOI 10.1016/S0967-0645(98)00058-7; SWALLOW JC, 1984, DEEP-SEA RES, V31, P639, DOI 10.1016/0198-0149(84)90032-3; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; WHITE WB, 1988, EOS, V69, P122; Wiggert JD, 2002, DEEP-SEA RES PT II, V49, P2319, DOI 10.1016/S0967-0645(02)00039-5	34	169	175	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2005	308	5721					545	547		10.1126/science.1106610	http://dx.doi.org/10.1126/science.1106610			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845852				2022-12-28	WOS:000228810500050
J	Okada, Y; Feng, Q; Lin, YH; Jiang, Q; Li, YQ; Coffield, VM; Su, LS; Xu, GL; Zhang, Y				Okada, Y; Feng, Q; Lin, YH; Jiang, Q; Li, YQ; Coffield, VM; Su, LS; Xu, GL; Zhang, Y			hDOT1L links histone methylation to leukemogenesis	CELL			English	Article							PROTO-ONCOPROTEIN MLL; HOX GENE-EXPRESSION; BONE-MARROW-CELLS; HOMEOBOX GENES; SET DOMAIN; METHYLTRANSFERASE COMPLEX; MYELOID PROGENITORS; LYSINE METHYLATION; LEUCINE-ZIPPER; FAMILY	Epigenetic modifications play an important role in human cancer. One such modification, histone methylation, contributes to human cancer through deregulation of cancer-relevant genes. The yeast Dot1 and its human counterpart, hDOT1L, methylate lysine 79 located within the globular domain of histone H3. Here we report that hDOT1L interacts with AF10, an MLL (mixed lineage leukemia) fusion partner involved in acute myeloid leukemia, through the OM-LZ region of AF10 required for MLL-AF10-mediated leukemogenesis. We demonstrate that direct fusion of hDOT1L to MLL results in leukemic transformation in an hDOT1L methyltransferase activity-dependent manner. Transformation by MLL-hDOT1L and MLL-AF10 results in upregulation of a number of leukemia-relevant genes, such as Hoxa9, concomitant with hypermethylation of H3-K79. Our studies thus establish that mistargeting of hDOT1L to Hoxa9 plays an important role in MLLAF10-mediated leukemogenesis and suggests that the enzymatic activity of hDOT1L may provide a potential target for therapeutic intervention.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu		Zhang, Yi/0000-0002-2789-0811	NATIONAL CANCER INSTITUTE [R01CA119133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI053804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA119133-01A1] Funding Source: Medline; NIAID NIH HHS [AI5380402, AI04840704] Funding Source: Medline; NIGMS NIH HHS [GM68804, GM63076] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Buske C, 2000, INT J HEMATOL, V71, P301; Caslini C, 2000, LEUKEMIA, V14, P1898, DOI 10.1038/sj.leu.2401933; CHAPLIN T, 1995, BLOOD, V86, P2073, DOI 10.1182/blood.V86.6.2073.bloodjournal8662073; Coffield VM, 2003, NAT BIOTECHNOL, V21, P1321, DOI 10.1038/nbt889; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; DiMartino JF, 1999, BRIT J HAEMATOL, V106, P614, DOI 10.1046/j.1365-2141.1999.01439.x; DiMartino JF, 2002, BLOOD, V99, P3780, DOI 10.1182/blood.V99.10.3780; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nakamura T, 1996, ONCOGENE, V13, P2235; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	35	613	635	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					167	178		10.1016/j.cell.2005.02.020	http://dx.doi.org/10.1016/j.cell.2005.02.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851025	Bronze, Green Published			2022-12-28	WOS:000228705000006
J	Sachs, K; Perez, O; Pe'er, D; Lauffenburger, DA; Nolan, GP				Sachs, K; Perez, O; Pe'er, D; Lauffenburger, DA; Nolan, GP			Causal protein-signaling networks derived from multiparameter single-cell data	SCIENCE			English	Article							FLOW-CYTOMETRY; RAF-1; ACTIVATION; EXPRESSION	Machine learning was applied for the automated derivation of causal influences in cellular signaling networks. This derivation relied on the simultaneous measurement of multiple phosphorylated protein and phospholipid components in thousands of individual primary human immune system cells. Perturbing these cells with molecular interventions drove the ordering of connections between pathway components, wherein Bayesian network computational methods automatically elucidated most of the traditionally reported signaling relationships and predicted novel interpathway network causalities, which we verified experimentally. Reconstruction of network models from physiologically relevant primary single cells might be applied to understanding native-state tissue signaling biology, complex drug actions, and dysfunctional signaling in diseased cells.	MIT, Biol Engn Div, Cambridge, MA 02139 USA; Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Stanford University; Harvard University; Harvard Medical School	Lauffenburger, DA (corresponding author), MIT, Biol Engn Div, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lauffen@mit.edu; gnotan@stanford.edu	Califano, Andrea/F-7239-2012; Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039646, R01AI035304] Funding Source: NIH RePORTER; NIAID NIH HHS [P01-AI39646, AI35304] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CARROLL MP, 1994, J BIOL CHEM, V269, P1249; FRIEDMAN KMN, 1998, P 14 ANN C UNC ART I; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Fukuda R, 2003, CANCER RES, V63, P2330; Hartemink A J, 2001, Pac Symp Biocomput, P422; Heckerman D, 1998, NATO ADV SCI I D-BEH, V89, P301; Herzenberg LA, 2002, CLIN CHEM, V48, P1819; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; IRENE JDG, 2002, BIOINFORMATICS, V18, pS241; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Kelley BP, 2004, NUCLEIC ACIDS RES, V32, pW83, DOI 10.1093/nar/gkh411; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; PEER D, 2005, SCI STKE 2005; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Roederer M, 2004, CLIN IMMUNOL, V110, P199, DOI 10.1016/j.clim.2003.11.015; Sachs Karen, 2002, Sci STKE, V2002, ppe38, DOI 10.1126/stke.2002.148.pe38; Steffen M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-34; Woolf PJ, 2005, BIOINFORMATICS, V21, P741, DOI 10.1093/bioinformatics/bti056; Zhang WM, 1998, AM J PHYSIOL-CELL PH, V274, pC82, DOI 10.1152/ajpcell.1998.274.1.C82	26	964	1009	7	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					523	529		10.1126/science.1105809	http://dx.doi.org/10.1126/science.1105809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845847				2022-12-28	WOS:000228810500045
J	Winn, MP; Conlon, PJ; Lynn, KL; Farrington, MK; Creazzo, T; Hawkins, AF; Daskalakis, N; Kwan, SY; Ebersviller, S; Burchette, JL; Pericak-Vance, MA; Howel, DN; Vance, JM; Rosenberg, PB				Winn, MP; Conlon, PJ; Lynn, KL; Farrington, MK; Creazzo, T; Hawkins, AF; Daskalakis, N; Kwan, SY; Ebersviller, S; Burchette, JL; Pericak-Vance, MA; Howel, DN; Vance, JM; Rosenberg, PB			A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis	SCIENCE			English	Article							NEPHROTIC SYNDROME; SLIT DIAPHRAGM; GENETIC-HETEROGENEITY; GLOMERULAR-DISEASE; PODOCIN; ALPHA-ACTININ-4; EXPRESSION; INSERTION; NEPHRIN; PROTEIN	Focal and segmental glomerulosclerosis (FSGS) is a kidney disorder of unknown etiology, and up to 20% of patients on dialysis have been diagnosed with it. Here we show that a large family with hereditary FSGS carries a missense mutation in the TRPC6 gene on chromosome 11q, encoding the ion-channel protein transient receptor potential cation channel 6 (TRPC6). The proline-to-glutamine substitution at position 112, which occurs in a highly conserved region of the protein, enhances TRPC6-mediated calcium signals in response to agonists such as angiotensin II and appears to alter the intracellular distribution of TRPC6 protein. Previous work has emphasized the importance of cytosketetal and structural proteins in proteinuric kidney diseases. Our findings suggest an alternative mechanism for the pathogenesis of glomerular disease.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; Beaumont Hosp, Dept Nephrol, Dublin, Ireland; Christchurch Hosp, Dept Nephrol, Christchurch, New Zealand; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Durham VA Med Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Christchurch Hospital New Zealand; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Winn, MP (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	michelle.winn@duke.edu; jeff@chg.duhs.duke.edu; rosen029@mc.duke.edu	Ebersviller, Seth/ABA-7279-2021	Ebersviller, Seth/0000-0002-3035-5000; Vance, Jeffery/0000-0003-3815-8199; Rosenberg, Paul/0000-0002-5659-160X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074748] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK074748] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balla T, 1998, ENDOCR RES, V24, P335, DOI 10.3109/07435809809032613; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Conlon PJ, 1999, KIDNEY INT, V56, P1863, DOI 10.1046/j.1523-1755.1999.00727.x; Facemire CS, 2004, AM J PHYSIOL-RENAL, V286, pF546, DOI 10.1152/ajprenal.00338.2003; Garcia RL, 1997, BIOCHEM BIOPH RES CO, V239, P279, DOI 10.1006/bbrc.1997.7458; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hurtado A, 2000, CLIN NEPHROL, V53, P325; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Korbet SM, 1996, AM J KIDNEY DIS, V27, P647, DOI 10.1016/S0272-6386(96)90098-0; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Srivastava T, 1999, PEDIATR NEPHROL, V13, P13, DOI 10.1007/s004670050555; Taal MW, 2000, KIDNEY INT, V57, P1803, DOI 10.1046/j.1523-1755.2000.00031.x; Winn MP, 1999, GENOMICS, V58, P113, DOI 10.1006/geno.1999.5828; Winn MP, 1999, KIDNEY INT, V55, P1241, DOI 10.1046/j.1523-1755.1999.00384.x	23	778	851	6	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1801	1804		10.1126/science.1106215	http://dx.doi.org/10.1126/science.1106215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15879175				2022-12-28	WOS:000229926800059
J	Piercy, J				Piercy, J			10-minute consultation - Hyperhidrosis	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Warwick, Warwick Med Sch, Div Med Educ, Coventry CV4 7AL, W Midlands, England	University of Warwick	Piercy, J (corresponding author), Univ Warwick, Warwick Med Sch, Div Med Educ, Coventry CV4 7AL, W Midlands, England.	ann.mcpherson@dphpc.ox.ac.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2005	330	7500					1127	1127		10.1136/bmj.330.7500.1127	http://dx.doi.org/10.1136/bmj.330.7500.1127			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15891228	Bronze, Green Published			2022-12-28	WOS:000229166900021
J	Yuan, XL; Xiao, SH; Taylor, TN				Yuan, XL; Xiao, SH; Taylor, TN			Lichen-like symbiosis 600 million years ago	SCIENCE			English	Article							NEOPROTEROZOIC DOUSHANTUO FORMATION; FUNGI; EVOLUTION	The fossil record of fungi and lichens is scarce. Here we report the discovery of lichen-like fossils, involving filamentous hyphae closely associated with coccoidal cyanobacteria or algae, preserved in marine phosphorite of the Doushantuo Formation (between 551 and 635 million years old) at Weng'an, South China. These fossils indicate that fungi developed symbiotic partnerships with photoautotrophs before the evolution of vascular plants.	Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA; Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China; Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	Virginia Polytechnic Institute & State University; Chinese Academy of Sciences; University of Kansas	Xiao, SH (corresponding author), Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA.	xiao@vt.edu	Xiao, Shuhai/A-2190-2009	Xiao, Shuhai/0000-0003-4655-2663				Alexopoulos C. J., 1996; Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Berbee ML, 2001, MYCOTA, V7, P229; Butterfield NJ, 2005, PALEOBIOLOGY, V31, P165, DOI 10.1666/0094-8373(2005)031<0165:PPF>2.0.CO;2; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; DePriest PT, 2004, ANNU REV MICROBIOL, V58, P273, DOI 10.1146/annurev.micro.58.030603.123730; GARGAS A, 1995, SCIENCE, V268, P1492, DOI 10.1126/science.7770775; Gehrig H, 1996, J MOL EVOL, V43, P71, DOI 10.1007/BF02352301; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; KNOLL AH, 1979, PRECAMBRIAN RES, V10, P115, DOI 10.1016/0301-9268(79)90022-6; Kohlmeyer J., 1979, Marine mycology. The higher fungi.; Liu YJ, 2004, P NATL ACAD SCI USA, V101, P4507, DOI 10.1073/pnas.0400938101; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Peterson KJ, 2003, INTEGR COMP BIOL, V43, P127, DOI 10.1093/icb/43.1.127; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; RETALLACK GJ, 1994, PALEOBIOLOGY, V20, P523, DOI 10.1017/S0094837300012975; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; TAYLOR TN, 1995, MYCOLOGIA, V87, P560, DOI 10.2307/3760776; Taylor TN, 2004, T ROY SOC EDIN-EARTH, V94, P457, DOI 10.1017/S026359330000081X; Taylor TN, 1997, AM J BOT, V84, P992, DOI 10.2307/2446290; TAYLOR TN, 1995, NATURE, V378, P244, DOI 10.1038/378244a0; Tehler A, 2003, MYCOL RES, V107, P901, DOI 10.1017/S0953756203008128; Wedin M, 2004, NEW PHYTOL, V164, P459, DOI 10.1111/j.1469-8137.2004.01198.x; Xiao SH, 2004, AM J BOT, V91, P214, DOI 10.3732/ajb.91.2.214; ZHANG XG, 1989, LETHAIA, V22, P13, DOI 10.1111/j.1502-3931.1989.tb01164.x; ZHANG Y, 1998, PALEONTOL SOC MEM, V50, P1	26	195	240	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1017	1020		10.1126/science.1111347	http://dx.doi.org/10.1126/science.1111347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890881				2022-12-28	WOS:000229190700045
J	Kent, SC; Chen, YH; Bregoli, L; Clemmings, SM; Kenyon, NS; Ricordi, C; Hering, BJ; Hafler, DA				Kent, SC; Chen, YH; Bregoli, L; Clemmings, SM; Kenyon, NS; Ricordi, C; Hering, BJ; Hafler, DA			Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope	NATURE			English	Article							CLASS-II MOLECULES; GENE USAGE; MICE; MELLITUS; RESPONSES; ANTIGENS; DISEASE; CLONES; IDENTIFICATION; AUTOANTIGENS	In autoimmune type 1 diabetes, pathogenic T lymphocytes are associated with the specific destruction of insulin-producing beta-islet cells(1,2). Identification of the autoantigens involved in triggering this process is a central question. Here we examined T cells from pancreatic draining lymph nodes, the site of islet-cell-specific self-antigen presentation(3). We cloned single T cells in a non-biased manner from pancreatic draining lymph nodes of subjects with type 1 diabetes and from non-diabetic controls. A high degree of T-cell clonal expansion was observed in pancreatic lymph nodes from long-term diabetic patients but not from control subjects. The oligoclonally expanded T cells from diabetic subjects with DR4, a susceptibility allele for type 1 diabetes(4), recognized the insulin A 1 - 15 epitope restricted by DR4. These results identify insulin-reactive, clonally expanded T cells from the site of autoinflammatory drainage in long-term type 1 diabetics, indicating that insulin may indeed be the target antigen causing autoimmune diabetes.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Minnesota, Dept Surg, Diabet Inst Immunol & Transplantat, Minneapolis, MN 55455 USA; Univ Miami, Diabet Res Inst, Cell Transplant Ctr, Miami, FL 33136 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of Miami	Hafler, DA (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	dhafler@rics.bwh.harvard.edu	RICORDI, CAMILLO/AAA-4740-2019	Ricordi, Camillo/0000-0001-8092-7153; Bregoli, Lisa/0000-0001-9376-1914				ACHAORBEA H, 1990, CURR TOP MICROBIOL, V156, P103; Akatsuka Y, 1999, TISSUE ANTIGENS, V53, P122, DOI 10.1034/j.1399-0039.1999.530202.x; Astill TP, 2003, DIABETOLOGIA, V46, P496, DOI 10.1007/s00125-003-1070-3; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; CANDEIAS S, 1991, P NATL ACAD SCI USA, V88, P6167, DOI 10.1073/pnas.88.14.6167; DAYAN CM, 1991, P NATL ACAD SCI USA, V88, P7415, DOI 10.1073/pnas.88.16.7415; Eisenbarth George S., 2002, Autoimmunity Reviews, V1, P139, DOI 10.1016/S1568-9972(02)00035-6; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Endl J, 1997, J CLIN INVEST, V99, P2405, DOI 10.1172/JCI119423; HAFLER DA, 1988, J EXP MED, V167, P1313, DOI 10.1084/jem.167.4.1313; Han M, 1999, J IMMUNOL, V163, P301; HARRISON LC, 1992, J CLIN INVEST, V89, P1161, DOI 10.1172/JCI115698; HASKINS K, 1989, P NATL ACAD SCI USA, V86, P8000, DOI 10.1073/pnas.86.20.8000; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Jaeckel E, 2004, NAT IMMUNOL, V5, P1028, DOI 10.1038/ni1120; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; LONDEI M, 1989, P NATL ACAD SCI USA, V86, P636, DOI 10.1073/pnas.86.2.636; MIYAZAKI A, 1985, CLIN EXP IMMUNOL, V60, P622; Mycko MP, 2004, J IMMUNOL, V173, P1689, DOI 10.4049/jimmunol.173.3.1689; NAKANO N, 1991, J EXP MED, V173, P1091, DOI 10.1084/jem.173.5.1091; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Peakman M, 2001, DIABETES, V50, P1749, DOI 10.2337/diabetes.50.8.1749; Roep BO, 1996, DIABETES, V45, P1147, DOI 10.2337/diabetes.45.9.1147; Schloot NC, 2003, J AUTOIMMUN, V21, P365, DOI 10.1016/S0896-8411(03)00111-2; SIBLEY RK, 1985, LAB INVEST, V53, P132; THOMSON G, 1988, AM J HUM GENET, V43, P799; Tian J, 1997, J EXP MED, V186, P2039, DOI 10.1084/jem.186.12.2039; TODD JA, 1988, NATURE, V333, P710, DOI 10.1038/333710a0; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183	32	315	335	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					224	228		10.1038/nature03625	http://dx.doi.org/10.1038/nature03625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889096				2022-12-28	WOS:000229021100045
J	Sugasawa, K; Okuda, Y; Saijo, M; Nishi, R; Matsuda, N; Chu, G; Mori, T; Iwai, S; Tanaka, K; Tanaka, K; Hanaoka, F				Sugasawa, K; Okuda, Y; Saijo, M; Nishi, R; Matsuda, N; Chu, G; Mori, T; Iwai, S; Tanaka, K; Tanaka, K; Hanaoka, F			UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; PIGMENTOSUM GROUP-C; DNA-BINDING PROTEIN; GLOBAL GENOMIC REPAIR; GROUP-E CELLS; CYCLOBUTANE PYRIMIDINE DIMERS; DAMAGED-DNA; ULTRAVIOLET-LIGHT; GENE-PRODUCT; IN-VIVO	The xeroderma pigmentosum group C (XPC) protein complex plays a key role in recognizing DNA damage throughout the genome for mammalian nucleotide excision repair (NER). Ultraviolet light (UV)-damaged DNA binding protein (UV-DDB) is another complex that appears to be involved in the recognition of NER-inducing damage, although the precise role it plays and its relationship to XPC remain to be elucidated. Here we show that XPC undergoes reversible ubiquitylation upon UV irradiation of cells and that this depends on the presence of functional UV-DDB activity. XPC and UV-DDB were demonstrated to interact physically, and both are polyubiquitylated by the recombinant UV-DDB-ubiquitin ligase complex. The polyubiquitylation altered the DNA binding properties of XPC and UV-DDB and appeared to be required for cell-free NER of UV-induced (6-4) photoproducts specifically when UV-DDB was bound to the lesion. Our results strongly suggest that ubiquitylation plays a critical role in the transfer of the UV-induced lesion from UVDDB to XPC.	RIKEN, Discovery Drug Res, Cellular Physiol Lab, Wako, Saitama 3510198, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Wako, Saitama 3510198, Japan; Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138613, Japan; Stanford Univ, Dept Med & Biochem, Stanford, CA 94305 USA; Nara Med Univ, Radioisotope Ctr, Kashihara, Nara 6348521, Japan; Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	RIKEN; Japan Science & Technology Agency (JST); Osaka University; Osaka University; Tokyo Metropolitan Institute of Medical Science; Stanford University; Nara Medical University; Osaka University	Sugasawa, K (corresponding author), RIKEN, Discovery Drug Res, Cellular Physiol Lab, Wako, Saitama 3510198, Japan.	sugasawa@riken.jp	Nishi, Ryotaro/AAA-3372-2019; Matsuda, Noriyuki/AAI-3156-2020	Matsuda, Noriyuki/0000-0001-8199-952X; Mori, Toshio/0000-0002-8321-0710; Nishi, Ryotaro/0000-0001-8179-5818				ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Araki M, 2001, J BIOL CHEM, V276, P18665, DOI 10.1074/jbc.M100855200; Araujo SJ, 2000, GENE DEV, V14, P349; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; BOOTSMA D, 1997, METABOLIC BASIS INHE, P245; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Fitch ME, 2003, DNA REPAIR, V2, P819, DOI 10.1016/S1568-7864(03)00066-1; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Itoh T, 2004, P NATL ACAD SCI USA, V101, P2052, DOI 10.1073/pnas.0306551101; Itoh T, 2000, J INVEST DERMATOL, V114, P1022, DOI 10.1046/j.1523-1747.2000.00952.x; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; MATSUMOTO Y, 1983, FEBS LETT, V151, P139, DOI 10.1016/0014-5793(83)80359-7; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Nichols AF, 1996, J BIOL CHEM, V271, P24317, DOI 10.1074/jbc.271.40.24317; Okuda Y, 2004, DNA REPAIR, V3, P1285, DOI 10.1016/j.dnarep.2004.06.010; Otrin VR, 1997, J CELL SCI, V110, P1159; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Rapic-Otrin V, 2003, HUM MOL GENET, V12, P1507, DOI 10.1093/hmg/ddg174; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; REARDON JT, 1993, J BIOL CHEM, V268, P21301; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; SHIVJI MKK, 1994, J BIOL CHEM, V269, P22749; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Tornaletti S, 1999, BIOCHIMIE, V81, P139, DOI 10.1016/S0300-9084(99)80046-7; TREIBER DK, 1992, NUCLEIC ACIDS RES, V20, P5805, DOI 10.1093/nar/20.21.5805; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; Wakasugi M, 2001, J BIOL CHEM, V276, P15434, DOI 10.1074/jbc.M011177200	39	441	459	3	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					387	400		10.1016/j.cell.2005.02.035	http://dx.doi.org/10.1016/j.cell.2005.02.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882621	Bronze			2022-12-28	WOS:000229031600009
J	Esmail, A				Esmail, A			Physician as serial killer - The Shipman case	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Manchester, Div Primary Care, Manchester, Lancs, England	University of Manchester	Esmail, A (corresponding author), Univ Manchester, Div Primary Care, Manchester, Lancs, England.		Esmail, Aneez/I-6903-2013						0	14	14	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1843	1844		10.1056/NEJMp048331	http://dx.doi.org/10.1056/NEJMp048331			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872197				2022-12-28	WOS:000228858600002
J	Osterholm, MT				Osterholm, MT			Preparing for the next pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFLUENZA		Ctr Infect Dis Res & Policy, Minneapolis, MN USA; Natl Ctr Food Protect & Def, Minneapolis, MN USA; Univ Minnesota, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Osterholm, MT (corresponding author), Ctr Infect Dis Res & Policy, Minneapolis, MN USA.							Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; SANDMAN PM, 2005, PANDEMIC INFLUENZA R; Stohr K, 2005, NEW ENGL J MED, V352, P405, DOI 10.1056/NEJMe048344	5	364	407	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2005	352	18					1839	1842		10.1056/NEJMp058068	http://dx.doi.org/10.1056/NEJMp058068			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922SM	15872196	Green Submitted, Bronze			2022-12-28	WOS:000228858600001
J	Hayden, JA; van Tulder, MW; Tomlinson, G				Hayden, JA; van Tulder, MW; Tomlinson, G			Systematic review: Strategies for using exercise therapy to improve outcomes in chronic low back pain	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; 1-YEAR FOLLOW-UP; PHYSICAL-THERAPY; CLINICAL-TRIAL; CONVENTIONAL PHYSIOTHERAPY; FUNCTIONAL RESTORATION; PROGRAM; SUBACUTE; MANIPULATION; INTENSITY	Background: Exercise therapy encompasses a heterogeneous group of interventions. There continues to be uncertainty about the most effective exercise approach in chronic low back pain. Purpose: To identify particular exercise intervention characteristics that decrease pain and improve function in adults with nonspecific chronic low back pain. Data Sources: MEDLINE, EMBASE, Psychinfo, CINAHL, and Cochrane Library databases to October 2004 and citation searches and bibliographic reviews of previous systematic reviews. Study Selection: Randomized, controlled trials evaluating exercise therapy in populations with chronic (> 12 weeks duration) low back pain. Data Extraction: Two reviewers independently extracted data on exercise intervention characteristics: program design (individually designed or standard program), delivery type (independent home exercises, group, or individual supervision), dose or intensity (hours of intervention time), and inclusion of additional conservative interventions. Data Synthesis: 43 trials of 72 exercise treatment and 31 comparison groups were included. Bayesian multivariable randomeffects meta-regression found improved pain scores for individually designed programs (5.4 points [95% credible interval (Cri), 1.3 to 9.5 points]), supervised home exercise (6.1 points [Crl, -0.2 to 12.4 points]), group (4.8 points [Crl, 0.2 to 9.4 points]), and individually supervised programs (5.9 points [Crl, 2.1 to 9.8 points]) compared with home exercises only. High-dose exercise programs fared better than low-dose exercise programs (1.8 points [Cri, -2.1 to 5.5 points]). Interventions that included additional conservative care were better (5.1 points [Crl, 1.8 to 8.4 points]). A model including these most effective intervention characteristics would be expected to demonstrate important improvement in pain (18.1 points [Crl, 11.1 to 25.0 points] compared with no treatment and 13.0 points [CrI, 6.0 to 19.9 points] compared with other conservative treatment) and small improvement in function (5.5 points [CrI, 0.5 to 10.5 points] compared with no treatment and 2.7 points [Cri, -1.7 to 7.1 points] compared with other conservative treatment). Stretching and strengthening demonstrated the largest improvement over comparisons. Limitations: Limitations of the literature, including low-quality studies with heterogeneous outcome measures and inconsistent and poor reporting; publication bias. Conclusions: Exercise therapy that consists of individually designed programs, including stretching or strengthening, and is delivered with supervision may improve pain and function in chronic nonspecific low back pain. Strategies should be used to encourage adherence. Future studies should test this multivariable model and further assess specific patient-level characteristics and exercise types.	Inst Work & Hlth, Toronto, ON M5G 2E9, Canada; Univ Toronto, Toronto, ON, Canada; Vrije Univ Amsterdam, Med Ctr, Inst Res Extramural Med, NL-1081 HV Amsterdam, Netherlands	Institute for Work & Health; University of Toronto; Vrije Universiteit Amsterdam	Hayden, JA (corresponding author), Inst Work & Hlth, 481 Univ Ave,Suite 800,8th Floor, Toronto, ON M5G 2E9, Canada.	jhayden@iwh.on.ca	Tomlinson, George A/L-5432-2016; van Tulder, Maurits/AAB-9785-2022	Tomlinson, George A/0000-0002-9328-6399; van Tulder, Maurits/0000-0002-7589-8471; Hayden, Jill Alison/0000-0001-7026-144X				Abenhaim L, 2000, SPINE, V25, p1S, DOI 10.1097/00007632-200002151-00001; Albright J, 2001, PHYS THER, V81, P1641; Alexandre NMC, 2001, REV SAUDE PUBL, V35, P356, DOI 10.1590/S0034-89102001000400004; Aure OF, 2003, SPINE, V28, P525, DOI 10.1097/00007632-200303150-00002; Bendix A F, 1995, Eur Spine J, V4, P148, DOI 10.1007/BF00298239; Bendix T, 2000, SPINE, V25, P2494, DOI 10.1097/00007632-200010010-00012; Bentsen H, 1997, SPINE, V22, P1494, DOI 10.1097/00007632-199707010-00014; Berlin JA, 2002, STAT MED, V21, P371, DOI 10.1002/sim.1023; Bombardier C, 2001, J RHEUMATOL, V28, P431; Bronfort G, 1996, J Manipulative Physiol Ther, V19, P570; BUSWELL J, 1982, NZ J PHYSIOTHER, V10, P13; Calmels P., 2004, Annales de Readaptation et de Medecine Physique, V47, P20, DOI 10.1016/j.annrmp.2003.07.001; Cherkin DC, 1998, NEW ENGL J MED, V339, P1021, DOI 10.1056/NEJM199810083391502; Dalichau S, 2000, Z ORTHOP GRENZGEB, V138, P8, DOI 10.1055/s-2000-10106; Descarreaux M, 2002, J MANIP PHYSIOL THER, V25, P497, DOI 10.1067/mmt.2002.127078; DEYO RA, 1990, NEW ENGL J MED, V322, P1627, DOI 10.1056/NEJM199006073222303; ELNAGGAR IM, 1991, SPINE, V16, P967, DOI 10.1097/00007632-199108000-00018; Faas A, 1996, SPINE, V21, P2874, DOI 10.1097/00007632-199612150-00016; Frost H, 2004, BRIT MED J, V329, P708, DOI 10.1136/bmj.38216.868808.7C; FROST H, 1995, BRIT MED J, V310, P151, DOI 10.1136/bmj.310.6973.151; Galantino ML, 2004, ALTERN THER HEALTH M, V10, P56; Gelman A., 2004, BAYESIAN DATA ANAL; Gur A, 2003, LASER SURG MED, V32, P233, DOI 10.1002/lsm.10134; HANSEN FR, 1993, SPINE, V18, P98, DOI 10.1097/00007632-199301000-00015; Hayden JA, 2005, ANN INTERN MED, V142, P765, DOI 10.7326/0003-4819-142-9-200505030-00013; Hemmila HM, 1997, ARCH PHYS MED REHAB, V78, P571, DOI 10.1016/S0003-9993(97)90420-2; HILDE G, 1998, PHYS THER REV, V3, P107; Hildebrandt V H, 2000, Ned Tijdschr Geneeskd, V144, P2258; JOHANNSEN F, 1995, J ORTHOP SPORT PHYS, V22, P52, DOI 10.2519/jospt.1995.22.2.52; Jousset N, 2004, SPINE, V29, P487, DOI 10.1097/01.BRS.0000102320.35490.43; Kankaanpaa M, 1999, SPINE, V24, P1034, DOI 10.1097/00007632-199905150-00019; Kendall PH, 1968, PHYSIOTHERAPY, V54, P154; KOES BW, 1991, BRIT MED J, V302, P1572, DOI 10.1136/bmj.302.6792.1572; Kuukkanen TM, 2000, CLIN REHABIL, V14, P192, DOI 10.1191/026921500667300454; Lidstrom A, 1970, Scand J Rehabil Med, V2, P37; Lie Hakon, 1999, Tidsskrift for den Norske Laegeforening, V119, P2051; Ljunggren AE, 1997, SPINE, V22, P1610, DOI 10.1097/00007632-199707150-00017; MANNICHE C, 1988, LANCET, V2, P1473; Mannion AF, 1999, SPINE, V24, P2435, DOI 10.1097/00007632-199912010-00004; Moseley L, 2002, AUST J PHYSIOTHER, V48, P297, DOI 10.1016/S0004-9514(14)60169-0; Niemisto L, 2003, SPINE, V28, P2185, DOI 10.1097/01.BRS.0000085096.62603.61; Nordin M, 1999, NEUROL CLIN, V17, P75, DOI 10.1016/S0733-8619(05)70115-8; Petersen T, 2002, SPINE, V27, P1702, DOI 10.1097/00007632-200208150-00004; Preyde M, 2000, CAN MED ASSOC J, V162, P1815; Rasmussen-Barr E, 2003, MANUAL THER, V8, P233, DOI 10.1016/S1356-689X(03)00053-5; RISCH SV, 1993, SPINE, V18, P232, DOI 10.1097/00007632-199302000-00010; Rittweger J, 2002, SPINE, V27, P1829, DOI 10.1097/00007632-200209010-00003; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; Soukup MG, 1999, SPINE, V24, P1585, DOI 10.1097/00007632-199908010-00013; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Torstensen TA, 1998, SPINE, V23, P2616, DOI 10.1097/00007632-199812010-00017; Tritilanunt Tipawan, 2001, Journal of the Medical Association of Thailand, V84, pS528; TURNER JA, 1990, J CONSULT CLIN PSYCH, V58, P573, DOI 10.1037/0022-006X.58.5.573; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Yelland MJ, 2004, SPINE, V29, P9, DOI 10.1097/01.BRS.0000105529.07222.5B; Yeung CKN, 2003, J ALTERN COMPLEM MED, V9, P479, DOI 10.1089/107555303322284767; Yozbatiran Nuray, 2004, Pain Clinic, V16, P35, DOI 10.1163/156856904322858684; ZYLBERGOLD RS, 1981, ARCH PHYS MED REHAB, V62, P176	59	523	536	2	92	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2005	142	9					776	785		10.7326/0003-4819-142-9-200505030-00014	http://dx.doi.org/10.7326/0003-4819-142-9-200505030-00014			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922GW	15867410				2022-12-28	WOS:000228825800007
J	Pinol, V; Castells, A; Andreu, M; Castellvi-Bel, S; Alenda, C; Llor, X; Xicola, RM; Rodriguez-Moranta, F; Paya, A; Jover, R; Bessa, X				Pinol, V; Castells, A; Andreu, M; Castellvi-Bel, S; Alenda, C; Llor, X; Xicola, RM; Rodriguez-Moranta, F; Paya, A; Jover, R; Bessa, X		Gastrointestinal Oncology Grp Span	Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPAIR PROTEIN EXPRESSION; REPLICATION ERROR PHENOTYPE; MISMATCH-REPAIR; COLON-CANCER; COST-EFFECTIVENESS; GENE-MUTATIONS; HMLH1; FAMILIES; MLH1; CARCINOMA	Context The selection of individuals for hereditary nonpolyposis colorectal cancer (HNPCC) genetic testing is challenging. Recently, the National Cancer Institute outlined a new set of recommendations, the revised Bethesda guidelines, for the identification of individuals with HNPCC who should be tested for microsatellite instability. Objective To establish the most effective and efficient strategy for the detection of MSH2/MLH1 gene carriers. Design, Setting, and Patients A prospective, multicenter, nationwide study (the EPICOLON study) in 20 hospitals in the general community in Spain of 1222 patients with newly diagnosed colorectal cancer, between November 1, 2000, and October 31, 2001. Interventions Microsatellite instability testing and MSH2/MLH1 immunostaining in all patients regardless of age, personal or family history, and tumor characteristics. Patients whose tumors exhibited microsatellite instability and/or lack of protein expression underwent MSH2/MLH1 germline testing. Main Outcome Measures Effectiveness and efficiency of both microsatellite instability testing and immunostaining, either directly or previous selection of patients according to the revised Bethesda guidelines, were evaluated with respect to the presence of MSH2/MLH1 germline mutations. Results Two hundred eighty-seven patients (23.5%) fulfilled the revised Bethesda guidelines. Ninety-one patients (7.4%) had a mismatch repair deficiency, with tumors exhibiting either microsatellite instability (n = 83) or loss of protein expression (n = 81). Germ-line testing identified 11 mutations (0.9%) in either MSH2 (7 cases) or MLH1 (4 cases) genes. Strategies based on either microsatellite instability testing or immunostaining previous selection of patients according to the revised Bethesda guidelines were the most effective (sensitivity, 81.8% and 81.8%; specificity, 98.0% and 98.2%; positive predictive value, 27.3% and 29.0%, respectively) to identify MSH2/MLH1 gene carriers. Logistic regression analysis confirmed the revised Bethesda guidelines as the most discriminating set of clinical parameters (odds ratio, 33.3; 95% confidence interval, 4.3-250; P=.001). Conclusion The revised Bethesda. guidelines constitute a useful approach to identify patients at risk for HNPCC. In patients fulfilling these criteria, both microsatellite instability testing and immunostaining are equivalent and highly effective strategies to further select those patients who should be tested for MSH2/MLH1 germline mutations.	Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Inst Malalties Digest,Dept Gastroenterol, E-08036 Barcelona, Spain; Hosp del Mar, Dept Gastroenterol, Barcelona, Spain; Hosp Gen Univ Alicante, Dept Pathol, Alicante, Spain; Hosp Gen Univ Alicante, Dept Gastroenterol, Alicante, Spain; Hosp Univ Germans Trias & Pujol, Dept Gastroenterol, Badalona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; General University Hospital of Alicante; General University Hospital of Alicante; Hospital Germans Trias i Pujol	Castells, A (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Inst Malalties Digest,Dept Gastroenterol, Villarroel 170, E-08036 Barcelona, Spain.	castells@clinic.ub.es	Jover, Rodrigo/ABC-3258-2021; Castells, Antoni/ABC-1002-2021; Alenda, Cristina/AAR-3433-2020; Rodriguez-Moranta, Francisco/AAB-8082-2019; Andreu, Montserrat/D-9911-2015; RODRIGUEZ MORANTA, FRANCISCO/H-9333-2015; Payá, Artemio/AFX-6518-2022; Piñol, Virginia/AAB-7346-2019	Jover, Rodrigo/0000-0003-3742-3413; Castells, Antoni/0000-0001-8431-2033; Rodriguez-Moranta, Francisco/0000-0003-4025-5510; Andreu, Montserrat/0000-0003-4286-1098; RODRIGUEZ MORANTA, FRANCISCO/0000-0003-4025-5510; Pinol, Virginia/0000-0003-3669-6989; Bessa Caserras, Xavier/0000-0003-4680-1228; Alenda, Cristina/0000-0002-0560-1759; Castellvi-Bel, Sergi/0000-0003-1217-5097				Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; American Joint Committee on Cancer, 1997, MAN STAG CANC; [Anonymous], 2001, GASTROENTEROLOGY, V121, P195, DOI 10.1053/gast.2001.25580; Boland CR, 1998, CANCER RES, V58, P5248; Caldes T, 2002, INT J CANCER, V98, P774, DOI 10.1002/ijc.10240; Christensen M, 2002, CANCER-AM CANCER SOC, V95, P2422, DOI 10.1002/cncr.10979; Cunningham JM, 2001, AM J HUM GENET, V69, P780, DOI 10.1086/323658; de Jong AE, 2004, CLIN CANCER RES, V10, P972, DOI 10.1158/1078-0432.CCR-0956-3; de la Chapelle A, 2002, J CLIN ONCOL, V20, P897, DOI 10.1200/JCO.2002.20.4.897; Dietmaier W, 1997, CANCER RES, V57, P4749; Furukawa T, 2002, CANCER, V94, P911, DOI 10.1002/cncr.10332; Giardiello FM, 2001, GASTROENTEROLOGY, V121, P198, DOI 10.1053/gast.2001.25581; Gille JJP, 2002, BRIT J CANCER, V87, P892, DOI 10.1038/sj.bjc.6600565; Gonzalez-Garcia I, 2000, JNCI-J NATL CANCER I, V92, P544, DOI 10.1093/jnci/92.7.544; HEMMINKI A, 1994, NAT GENET, V8, P405, DOI 10.1038/ng1294-405; Hoang JM, 1997, CANCER RES, V57, P300; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Kariola R, 2003, HUM GENET, V112, P105, DOI 10.1007/s00439-002-0866-4; Lamberti C, 1999, GUT, V44, P839, DOI 10.1136/gut.44.6.839; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; Liu T, 1999, HUM GENET, V105, P437, DOI 10.1007/s004390051127; Loukola A, 2001, CANCER RES, V61, P4545; Muller W, 2001, Fam Cancer, V1, P87, DOI 10.1023/A:1013840907881; Palicio M, 2002, J Med Genet, V39, pE29, DOI 10.1136/jmg.39.6.e29; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Percesepe A, 2001, J CLIN ONCOL, V19, P3944, DOI 10.1200/JCO.2001.19.19.3944; Pinol V, 2004, EUR J GASTROEN HEPAT, V16, P39, DOI 10.1097/00042737-200401000-00007; Ramsey SD, 2001, ANN INTERN MED, V135, P577, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00008; Ravnik-Glavac M, 2000, J MED GENET, V37, P533, DOI 10.1136/jmg.37.7.533; Reyes CM, 2002, CANCER, V95, P1848, DOI 10.1002/cncr.10910; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; RUSTGI AK, 1994, NEW ENGL J MED, V331, P1694, DOI 10.1056/NEJM199412223312507; Salahshor S, 2001, LAB INVEST, V81, P535, DOI 10.1038/labinvest.3780262; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Samowitz WS, 2001, GASTROENTEROLOGY, V121, P830, DOI 10.1053/gast.2001.27996; Scartozzi M, 2002, J CLIN ONCOL, V20, P1203, DOI 10.1200/JCO.20.5.1203; Syngal S, 2000, J MED GENET, V37, P641, DOI 10.1136/jmg.37.9.641; Terdiman JP, 2001, GASTROENTEROLOGY, V120, P21, DOI 10.1053/gast.2001.20874; Thibodeau SN, 1998, CANCER RES, V58, P1713; Thibodeau SN, 1996, CANCER RES, V56, P4836; Umar A, 2004, NAT REV CANCER, V4, P153, DOI 10.1038/nrc1278; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1998, CANCER, V82, P1632, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1632::AID-CNCR6>3.3.CO;2-X; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wahlberg SS, 2002, CANCER RES, V62, P3485; Ward R, 2002, J CANCER RES CLIN, V128, P403, DOI 10.1007/s00432-002-0361-2; Wijnen J, 1997, AM J HUM GENET, V61, P329, DOI 10.1086/514847; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; Zhou XP, 1998, GENE CHROMOSOME CANC, V21, P101, DOI 10.1002/(SICI)1098-2264(199802)21:2<101::AID-GCC4>3.0.CO;2-4	52	394	409	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2005	293	16					1986	1994		10.1001/jama.293.16.1986	http://dx.doi.org/10.1001/jama.293.16.1986			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XS	15855432	Bronze			2022-12-28	WOS:000228651500024
J	Norman, M; Bonamy, AKE				Norman, M; Bonamy, AKE			Aortic wall thickening in utero	LANCET			English	Editorial Material							LOW-BIRTH-WEIGHT; ENDOTHELIAL FUNCTION; BLOOD-FLOW; CHILDREN; INTRAUTERINE; 9-YEAR-OLD; GROWTH		Karolinska Inst, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden	Karolinska Institutet	Norman, M (corresponding author), Karolinska Inst, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden.	mikael.norman@kbh.ki.se	Bonamy, Anna-Karin E/B-7106-2012	Bonamy, Anna-Karin E/0000-0003-4552-9912; Norman, Mikael/0000-0003-4191-3781				ANDERSON TJ, 1995, J AM COLL CARDIOL, V26, P1235, DOI 10.1016/0735-1097(95)00327-4; Barker DJP, 1998, MOTHERS BABIES HLTH; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Hansell J, 2004, CLIN PHYSIOL FUNCT I, V24, P317, DOI 10.1111/j.1475-097X.2004.00575.x; LANGILLE BL, 1990, AM J PHYSIOL, V259, pH1247, DOI 10.1152/ajpheart.1990.259.4.H1247; Leeson CPM, 2001, CIRCULATION, V103, P1264; Leeson CPM, 1997, CIRCULATION, V96, P2233; Ley D, 1997, ACTA PAEDIATR, V86, P299, DOI 10.1111/j.1651-2227.1997.tb08894.x; Martin H, 2000, CIRCULATION, V102, P2739, DOI 10.1161/01.CIR.102.22.2739; Martin H, 2000, PEDIATR RES, V47, P457, DOI 10.1203/00006450-200004000-00008; WALSH SZ, 1974, HUMAN FETAL NEONATAL, P209	11	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1444	1446		10.1016/S0140-6736(05)66396-9	http://dx.doi.org/10.1016/S0140-6736(05)66396-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850615				2022-12-28	WOS:000228651600006
J	Akerman, J				Akerman, J			Toward a universal memory	SCIENCE			English	Editorial Material							ROOM-TEMPERATURE; MAGNETORESISTANCE		Freescale Semicond, Chandler, AZ 85224 USA	NXP Semiconductors; Freescale Semiconductor	Akerman, J (corresponding author), Freescale Semicond, 1300 N Alma Sch Rd, Chandler, AZ 85224 USA.	johan.akerman@freescale.com	Åkerman, Johan/B-5726-2008	Åkerman, Johan/0000-0002-3513-6608				Engel BN, 2005, IEEE T MAGN, V41, P132, DOI 10.1109/TMAG.2004.840847; Johnson M., 2004, MAGNETOELECTRONICS; Katine JA, 2000, PHYS REV LETT, V84, P3149, DOI 10.1103/PhysRevLett.84.3149; Masuoka F., 1984, International Electron Devices Meeting. Technical Digest (Cat. No. 84CH2099-0), P464; Parkin SSP, 2004, NAT MATER, V3, P862, DOI 10.1038/nmat1256; Savtchenko L., 2003, U.S. patent, Patent No. [6545906B1, 6545906]; Yuasa S, 2004, NAT MATER, V3, P868, DOI 10.1038/nmat1257	7	364	384	7	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2005	308	5721					508	510		10.1126/science.1110549	http://dx.doi.org/10.1126/science.1110549			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845842				2022-12-28	WOS:000228810500040
J	Brent, R; Lok, L				Brent, R; Lok, L			A fishing buddy for hypothesis generators	SCIENCE			English	Editorial Material							DROSOPHILA; NETWORKS		Inst Mol Sci, Berkeley, CA 94704 USA	The Molecular Sciences Institute	Brent, R (corresponding author), Inst Mol Sci, Berkeley, CA 94704 USA.	brent@molsci.org; lok@molsci.org						Beadle GW, 1936, GENETICS, V21, P225; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; Brent R, 1999, CURR BIOL, V9, pR338, DOI 10.1016/S0960-9822(99)80208-5; Ephrussi B, 1937, GENETICS, V22, P479; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809	9	15	15	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					504	506		10.1126/science.1110535	http://dx.doi.org/10.1126/science.1110535			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845840				2022-12-28	WOS:000228810500038
J	Mocuta, C; Reichert, H; Mecke, K; Dosch, H; Drakopoulos, M				Mocuta, C; Reichert, H; Mecke, K; Dosch, H; Drakopoulos, M			Scaling in the time domain: Universal dynamics of order fluctuations in Fe3Al	SCIENCE			English	Article							X-RAYS; CRITICAL-POINT; SCATTERING; SPECTROSCOPY; DIFFRACTION	By focusing a highly brilliant synchrotron x-ray beam to a micrometer spot on a sample, we measured in real time the x-ray intensity fluctuations associated with order fluctuations in crystalline materials. We applied this method to the binary alloy Fe3Al near its continuous A2-B2 phase transformation and determined a specific four-point time correlation function for the order parameter. From a detailed theoretical analysis, dynamical scaling in the time domain with a transition from noncritical to critical dynamics is disclosed.	Max Planck Inst Met Res, D-70569 Stuttgart, Germany; Univ Stuttgart, Inst Theoret & Angew Phys, D-70569 Stuttgart, Germany; European Synchrotron Radiat Facil, F-38043 Grenoble, France	Max Planck Society; University of Stuttgart; European Synchrotron Radiation Facility (ESRF)	Reichert, H (corresponding author), Max Planck Inst Met Res, D-70569 Stuttgart, Germany.	reichert@mf.mpg.de	Mecke, Klaus R/C-5562-2013; Reichert, Harald/AAZ-9105-2021; MOCUTA, Cristian/AAZ-9342-2020	Reichert, Harald/0000-0001-7730-6962; 				ALLEN M, 1976, SCRIPTA METALL, V10, P451; ALSNIELSEN J, 1967, PHYS REV, V153, P706, DOI 10.1103/PhysRev.153.706; Binder K., 1983, PHASE TRANSITIONS CR, V8, P1; BRAUER S, 1995, PHYS REV LETT, V74, P2010, DOI 10.1103/PhysRevLett.74.2010; Diehl H. W., 1986, Phase transition and critical phenomena. Vol.10, P75; DIETRICH OW, 1976, PHYS REV B, V14, P4923, DOI 10.1103/PhysRevB.14.4923; DOSCH H, 1992, TRACTS MODERN PHYS, V126; Fisher M.E., 1971, CRITICAL PHENOMENA C; FISHER ME, 1967, PHYS REV, V156, P583, DOI 10.1103/PhysRev.156.583; GUTTMAN L, 1969, PHYS REV LETT, V22, P517, DOI 10.1103/PhysRevLett.22.517; GUTTMAN L, 1969, PHYS REV LETT, V22, P520, DOI 10.1103/PhysRevLett.22.520; HALPERIN BI, 1967, PHYS REV LETT, V19, P700, DOI 10.1103/PhysRevLett.19.700; HOHENBERG PC, 1977, REV MOD PHYS, V49, P435, DOI 10.1103/RevModPhys.49.435; Lengeler B, 1999, APPL PHYS LETT, V74, P3924, DOI 10.1063/1.124225; MECKE KR, UNPUB; MEHRER SM, 1997, MAT SCI ENG A-STRUCT, V239, P889; Onuki A, 2002, PHASE TRANSITION DYN; PARK B, 1992, PHYS REV LETT, V68, P1742, DOI 10.1103/PhysRevLett.68.1742; Pelissetto A, 2002, PHYS REP, V368, P549, DOI 10.1016/S0370-1573(02)00219-3; SUTTON M, 1991, NATURE, V352, P608, DOI 10.1038/352608a0; Wang J, 1998, PHYS REV LETT, V80, P1110, DOI 10.1103/PhysRevLett.80.1110	21	15	15	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2005	308	5726					1287	1291		10.1126/science.1110001	http://dx.doi.org/10.1126/science.1110001			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931JT	15845875				2022-12-28	WOS:000229482300040
J	Aluwihare, LI; Repeta, DJ; Pantoja, S; Johnson, CG				Aluwihare, LI; Repeta, DJ; Pantoja, S; Johnson, CG			Two chemically distinct pools of organic nitrogen accumulate in the ocean	SCIENCE			English	Article							PACIFIC SUBTROPICAL GYRE; MARINE-BACTERIA; AMINO-ACIDS; SEA-WATER; MATTER; PROTEIN; SAMPLES; PROTEOBACTERIA; CHROMATOGRAPHY; PARTICULATE	The chemical dynamics of marine dissolved organic nitrogen (DON), a reservoir featuring surface accumulations even in areas where nitrogen limits productivity, have yet to be resolved. We exploited differences in the acid lability of amide bonds within high-molecular-weight (HMW) DON to show that vertical DON profiles result in part from the presence of two chemically distinct pools of amide. Half of HMWDON in surface waters is present as N-acetyl amino polysaccharides. In contrast, nearly all deep-sea HMWDON, and therefore, most HMWDON, is present in amides that resist both chemical hydrolysis and biological degradation.	Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Univ Concepcion, Dept Oceanog, Concepcion, Chile; Univ Concepcion, FONDAP, Ctr Invest Oceanog Pacifico SurOriental, Concepcion, Chile	University of California System; University of California San Diego; Scripps Institution of Oceanography; Woods Hole Oceanographic Institution; Universidad de Concepcion; Universidad de Concepcion	Aluwihare, LI (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA.	laluwihare@ucsd.edu						Abell J, 2000, J MAR RES, V58, P203, DOI 10.1357/002224000321511142; Albert DB, 1997, MAR CHEM, V56, P27, DOI 10.1016/S0304-4203(96)00083-7; Aluwihare LI, 2002, DEEP-SEA RES PT II, V49, P4421, DOI 10.1016/S0967-0645(02)00124-8; Aluwihare LI, 1997, NATURE, V387, P166, DOI 10.1038/387166a0; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; Berman T, 2003, AQUAT MICROB ECOL, V31, P279, DOI 10.3354/ame031279; Boon JJ, 1998, ORG GEOCHEM, V29, P1051, DOI 10.1016/S0146-6380(98)00121-1; BRONK DA, 2002, BIOGEOCHEMISTRY MARI, P163; Church MJ, 2002, LIMNOL OCEANOGR, V47, P1, DOI 10.4319/lo.2002.47.1.0001; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P1195, DOI 10.1128/AEM.66.3.1195-1201.2000; HADJA O, 1974, ANAL BIOCHEM, V60, P512; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; HENRICHS SM, 1985, MAR CHEM, V17, P141, DOI 10.1016/0304-4203(85)90070-2; Kaiser K, 2000, ANAL CHEM, V72, P2566, DOI 10.1021/ac991407t; KEIL RG, 1994, MAR CHEM, V45, P187, DOI 10.1016/0304-4203(94)90002-7; Knicker H, 1997, NATURWISSENSCHAFTEN, V84, P231, DOI 10.1007/s001140050384; Leenheer JA, 2004, BIOGEOCHEMISTRY, V69, P125, DOI 10.1023/B:BIOG.0000031044.16410.27; Libby PS, 1997, DEEP-SEA RES PT I, V44, P345; Martinez JS, 2000, SCIENCE, V287, P1245, DOI 10.1126/science.287.5456.1245; McCarthy M, 1997, NATURE, V390, P150, DOI 10.1038/36535; McCarthy MD, 1998, SCIENCE, V281, P231, DOI 10.1126/science.281.5374.231; Nagata Y, 1998, BBA-GEN SUBJECTS, V1379, P76, DOI 10.1016/S0304-4165(97)00084-6; Palenik B, 1997, LIMNOL OCEANOGR, V42, P1544, DOI 10.4319/lo.1997.42.7.1544; Popham DL, 1996, J BACTERIOL, V178, P6451, DOI 10.1128/jb.178.22.6451-6458.1996; Svitil AL, 1998, MICROBIOL-SGM, V144, P1299, DOI 10.1099/00221287-144-5-1299; TANOUE E, 1995, GEOCHIM COSMOCHIM AC, V59, P2643, DOI 10.1016/0016-7037(95)00134-4; ZHAO MX, 1995, J CHROMATOGR A, V690, P55, DOI 10.1016/0021-9673(94)00927-2	28	137	138	8	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1007	1010		10.1126/science.1108925	http://dx.doi.org/10.1126/science.1108925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890880				2022-12-28	WOS:000229190700042
J	Sobel, RK				Sobel, RK			MSL - Medicine as a second language	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sobel, RK (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							Harber RJ, 2001, J GEN INTERN MED, V16, P308, DOI 10.1046/j.1525-1497.2001.00233.x	1	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1945	1946		10.1056/NEJMp048342	http://dx.doi.org/10.1056/NEJMp048342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888692				2022-12-28	WOS:000229017100002
J	Charlson, RJ; Valero, FPJ; Seinfeld, JH				Charlson, RJ; Valero, FPJ; Seinfeld, JH			In search of balance	SCIENCE			English	Editorial Material							SOLAR-RADIATION; EARTHS ALBEDO; SURFACE		Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Calif San Diego, Scripps Inst Oceanog, Ctr Atmospher Sci, La Jolla, CA 92093 USA; CALTECH, Dept Chem Engn, Pasadena, CA 91125 USA; CALTECH, Dept Environm Sci & Engn, Pasadena, CA 91125 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; Scripps Institution of Oceanography; California Institute of Technology; California Institute of Technology	Charlson, RJ (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	fvalero@ucsd.edu; seinfetd@caltech.edu						Anderson TL, 2003, SCIENCE, V300, P1103, DOI 10.1126/science.1084777; Arrhenius S., 1896, LOND EDINB DUBLIN PH, V41, P237, DOI [10.1080/14786449608620846, DOI 10.1080/14786449608620846]; BENDER F, 2005, IPCC MOD AN WORKSH H; KEELING CD, 1960, TELLUS, V12, P200, DOI 10.1111/j.2153-3490.1960.tb01300.x; *NAT AC SCI, 2001, SPAC STUD BOARD ANN, P93; Palle E, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003611; Palle E, 2004, SCIENCE, V304, P1299, DOI 10.1126/science.1094070; Pinker RT, 2005, SCIENCE, V308, P850, DOI 10.1126/science.1103159; Sun MG, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019876; Wielicki BA, 2005, SCIENCE, V308, P825, DOI 10.1126/science.1106484; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Zhang YC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004457	12	38	41	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					806	807		10.1126/science.1108162	http://dx.doi.org/10.1126/science.1108162			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879202				2022-12-28	WOS:000228986500031
J	Durr, H; Korner, C; Muller, M; Hickmann, V; Hopfner, KP				Durr, H; Korner, C; Muller, M; Hickmann, V; Hopfner, KP			X-ray structures of the Sulfolobus solfataricus SWI2/SNF2 ATPase core and its complex with DNA	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; CRYSTAL-STRUCTURE; SUPERHELICAL TORSION; FUNCTIONAL-ANALYSIS; NUCLEOSOME; HELICASE; REPAIR; RAD54; RECOMBINATION; TRANSCRIPTION	SWI2/SNF2 ATPases remodel chromatin or other DNA:protein complexes by a poorly understood mechanism that involves ATP-dependent DNA translocation and generation of superhelical torsion. Crystal structures of a dsDNA-translocating SWI2/SNF2 ATPase core from Sulfolobus solfataricus reveal two helical SWI2/SNF2 specific subdomains, fused to a DExx box helicase-related ATPase core. Fully base paired duplex DNA binds along a central cleft via both minor groove strands, indicating that SWI2/SNF2 ATPases travel along the dsDNA minor groove without strand separation. A structural switch, linking DNA binding and the active site DExx motif, may account for the stimulation of ATPase activity by dsDNA. Our results suggest that torque in remodeling processes is generated by an ATP-driven screw motion of DNA along the active site cleft. The structures also redefine SWI2/SNF2 functional motifs and uncover unexpected structural correlation of mutations in Cockayne and X-linked mental retardation syndromes.	Univ Munich, Gene Ctr, D-81377 Munich, Germany; Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany	University of Munich; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	hopfner@lmb.uni-muenchen.de	Hopfner, Karl-Peter/B-6864-2014	Hopfner, Karl-Peter/0000-0002-4528-8357; Hickmann, Volker/0000-0003-2625-0414				Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Asturias FJ, 2004, METHOD ENZYMOL, V376, P48; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Beerens N, 2005, J BIOL CHEM, V280, P4722, DOI 10.1074/jbc.M409147200; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Firman K, 2000, EMBO J, V19, P2094, DOI 10.1093/emboj/19.9.2094; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Lammens A, 2004, CURR BIOL, V14, P1778, DOI 10.1016/j.cub.2004.09.044; Langst G, 2004, BBA-GENE STRUCT EXPR, V1677, P58, DOI 10.1016/j.bbaexp.2003.10.011; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Manzan A, 2004, EMBO REP, V5, P54, DOI 10.1038/sj.embor.7400037; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Owen-Hughes T, 2003, BIOCHEM SOC T, V31, P893; Peterson CL, 2002, EMBO REP, V3, P319, DOI 10.1093/embo-reports/kvf075; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Richmond E, 1996, NUCLEIC ACIDS RES, V24, P3685, DOI 10.1093/nar/24.19.3685; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Seitz EM, 2001, ADV APPL MICROBIOL, V50, P101, DOI 10.1016/S0065-2164(01)50005-2; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Smith GD, 1998, ACTA CRYSTALLOGR D, V54, P799, DOI 10.1107/S0907444997018805; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Sukhodolets MV, 2001, GENE DEV, V15, P3330, DOI 10.1101/gad.936701; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; TURCK D, 1992, THESIS TECHNICAL U M; van den Boom V, 2002, BIOESSAYS, V24, P780, DOI 10.1002/bies.10150; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yu SR, 2004, DNA REPAIR, V3, P277, DOI 10.1016/j.dnarep.2003.11.004; Zofall M, 2004, MOL CELL BIOL, V24, P10047, DOI 10.1128/MCB.24.22.10047-10057.2004	56	209	213	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					363	373		10.1016/j.cell.2005.03.026	http://dx.doi.org/10.1016/j.cell.2005.03.026			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882619	Bronze, Green Submitted			2022-12-28	WOS:000229031600007
J	Cauley, JA; Lui, LY; Ensrud, KE; Zmuda, JM; Stone, KL; Hochberg, MC; Cummings, SR				Cauley, JA; Lui, LY; Ensrud, KE; Zmuda, JM; Stone, KL; Hochberg, MC; Cummings, SR			Bone mineral density and the risk of incident nonspinal fractures in black and white women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIP FRACTURE; OSTEOPOROTIC FRACTURES; AFRICAN-AMERICAN; VOLUMETRIC DENSITY; RACIAL-DIFFERENCES; OLDER WOMEN; MASS; AGE; PREDICTION; CURVES	Context Black women have a lower rate of fracture than white women, but whether bone mineral density (BMD) predicts fracture risk as well in black women as it does in white women is not established. Objective To examine the association between BMD and incident nonspinal fractures in older black and white women. Design, Setting, and Participants Prospective cohort study of baseline data collected from 1986 through 1990 (7334 white women aged 67-99 years) and from 1996 through 1998 (636 black women aged 65-94 years) at 4 US clinical centers in the Study of Osteoporotic Fractures; mean (SD) follow-up of 6.1 (1.5) years until October 1, 2004. Main Outcome Measures Incident nonspinal fractures were confirmed by radiograpic report. Total hip and femoral neck BMD and bone mineral content were measured by dual energy x-ray absorptiometry. Results A total of 58 black women had a combined total of 61 fractures and 1606 white women had a combined total of 1712 fractures. In age-adjusted proportional hazard models, a 1-SD decrease in femoral neck BMD was associated with a 37% increased risk of fracture in black women (relative risk [RR], 1.37; 95% confidence interval [CI], 1.08-1.74) and a 49% increase in fracture in white women (RR, 1.49; 95% Cl, 1.40-1.58). Adjustment for body weight and other risk factors for fracture weakened the association between BMD and fracture, especially among black women (multivariable adjusted RR per 1-SD decrease in femoral neck BMD for black vs white women: RR, 1.20 [95% Cl, 0.93-1.55) vs RR, 1.42 [95% Cl, 1.32-1.52]). The absolute incidence of fracture across the pooled BMD distribution was 30% to 40% lower among black women at every BMD tertile. The lower risk of fracture among black compared with white women was independent of BMD and other risk factors (RR, 0.48; 95% Cl, 0.36-0.64). Conclusions Decreased total hip and femoral neck BMD is associated with an increased risk of fracture in both older black and white women, but this relationship was largely explained by other risk factors in black women. Black women have a lower fracture risk than white women at every level of BMD. Race-specific normative data-bases may be appropriate for the densitometric definition of osteoporosis.	Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Minnesota, Vet Affairs Med Ctr, Minneapolis, MN USA; Univ Minnesota, Dept Med & Epidemiol, Minneapolis, MN USA; Univ Maryland, Dept Med, Baltimore, MD 21201 USA; Univ Maryland, Dept Epidemiol, Baltimore, MD 21201 USA; Univ Maryland, Dept Prevent Med, Baltimore, MD 21201 USA; Calif Pacific Med Ctr, San Francisco, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; California Pacific Medical Center	Cauley, JA (corresponding author), Univ Pittsburgh, Dept Epidemiol, 130 DeSoto St,Crabtree Hall A543, Pittsburgh, PA 15261 USA.	jcauley@pitt.edu	Cauley, Jane A/N-4836-2015; YAMAMOTO, MASAHIRO/F-9094-2011	Cauley, Jane A/0000-0003-0752-4408; YAMAMOTO, MASAHIRO/0000-0003-3859-0125; Ensrud, Kristine/0000-0002-9069-3036	NIAMS NIH HHS [AR44811, AR35582, AR35583, AR35584] Funding Source: Medline; NIA NIH HHS [AG05407] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035583, P60AR044811, R01AR035582, R01AR035584] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arias Elizabeth, 2004, Natl Vital Stat Rep, V53, P1; BARON JA, 1994, EPIDEMIOLOGY, V5, P42, DOI 10.1097/00001648-199401000-00008; Barrett-Connor E, 2005, J BONE MINER RES, V20, P185, DOI 10.1359/JBMR.041007; Binkley Neil C, 2002, J Clin Densitom, V5 Suppl, pS19, DOI 10.1385/JCD:5:3S:S19; BLACK DM, 1992, J BONE MINER RES, V7, P633; BLOCK G, 1992, J AM DIET ASSOC, V92, P969; Bohannon AD, 1999, AM J EPIDEMIOL, V149, P1002; Cauley JA, 1997, OSTEOPOROSIS INT, V7, P100, DOI 10.1007/BF01623683; Cauley JA, 2005, J AM GERIATR SOC, V53, P183, DOI 10.1111/j.1532-5415.2005.53101.x; Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889; CUMMINGS SR, 1994, OSTEOPOROSIS INT, V4, P226, DOI 10.1007/BF01623243; CUMMINGS SR, 1994, J BONE MINER RES, V9, P1429; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Duan YB, 1999, J BONE MINER RES, V14, P1796, DOI 10.1359/jbmr.1999.14.10.1796; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; Finkelstein JS, 2002, J CLIN ENDOCR METAB, V87, P3051, DOI 10.1210/jc.87.7.3051; GRISSO JA, 1994, NEW ENGL J MED, V330, P1555, DOI 10.1056/NEJM199406023302202; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HUI SL, 1988, J CLIN INVEST, V81, P1804, DOI 10.1172/JCI113523; KATZMAN DK, 1991, J CLIN ENDOCR METAB, V73, P1332, DOI 10.1210/jcem-73-6-1332; KLEEREKOPER M, 1994, J BONE MINER RES, V9, P1267; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; MCNEIL BJ, 1984, MED DECIS MAKING, V4, P137, DOI 10.1177/0272989X8400400203; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Orwoll ES, 1996, ANN INTERN MED, V124, P187, DOI 10.7326/0003-4819-124-2-199601150-00001; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Robbins J, 2004, J NATL MED ASSOC, V96, P1609; Seeman E, 2001, J BONE MINER RES, V16, P120, DOI 10.1359/jbmr.2001.16.1.120; STEIGER P, 1992, J BONE MINER RES, V7, P625; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; *US DEP HHS, 2004, BONE HLTH OST REP SU; Zmuda JM, 1999, GENET EPIDEMIOL, V16, P356, DOI 10.1002/(SICI)1098-2272(1999)16:4<356::AID-GEPI3>3.0.CO;2-I	35	194	204	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2005	293	17					2102	2108		10.1001/jama.293.17.2102	http://dx.doi.org/10.1001/jama.293.17.2102			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922AO	15870413	Green Published, Bronze			2022-12-28	WOS:000228808200019
J	Ma, L; Chen, ZB; Erdjument-Bromage, H; Tempst, P; Pandolfi, PP				Ma, L; Chen, ZB; Erdjument-Bromage, H; Tempst, P; Pandolfi, PP			Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis	CELL			English	Article							INITIATION-FACTOR 4E; P70 S6 KINASE; TUMOR-SUPPRESSOR PROTEINS; CELL-GROWTH; MAP KINASE; GENE-PRODUCTS; IN-VIVO; TRANSLATIONAL CONTROL; 3-KINASE/AKT PATHWAY; SIGNALING PATHWAY	Tuberous sclerosis (TSC) is a tumor syndrome caused by mutation in TSC1 or TSC2genes. TSC tumorigenesis is not always accompanied by loss of heterozygosity (LOH). Recently, extracellular signal-regulated kinase (Erk) has been found activated in TSC lesions lacking TSC1 or TSC2 LOH. Here, we show that Erk may play a critical role in TSC progression through posttranslational inactivation of TSC2. Erk-dependent phosphorylation leads to TSC1-TSC2 dissociation and markedly impairs TSC2 ability to inhibit mTOR signaling, cell proliferation, and oncogenic transformation. Importantly, expression of an Erk nonphosphorylatable TSC2 mutant in TSC2(+/-) tumor cells where Erk is constitutively activated blocks tumori-genecity in vivo, while wild-type TSC2 is ineffective. Our findings position the Ras/MAPK pathway upstream of the TSC complex and suggest that Erk may modulate mTOR signaling and contribute to disease progression through phosphorylation and inactivation of TSC2.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Physiol Biophys & Syst Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Ma, Li/GQR-1313-2022	Ma, Li/0000-0001-9965-989X; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI NIH HHS [U01 CA-84292, P30 CA08748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA084292, P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gomez M. R., 1999, TUBEROUS SCLEROSIS C; Gomez MR, 1988, TUBEROUS SCLEROSIS; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Govindarajan B, 2003, CLIN CANCER RES, V9, P3469; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; Han S, 2004, CANCER RES, V64, P812, DOI 10.1158/0008-5472.CAN-03-3277; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Henske EP, 1996, AM J HUM GENET, V59, P400; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kobayashi T, 1999, CANCER RES, V59, P1206; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Niida Y, 2001, AM J HUM GENET, V69, P493, DOI 10.1086/321972; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Plank TL, 1998, CANCER RES, V58, P4766; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shah OJ, 2002, BIOCHEM J, V366, P57, DOI 10.1042/BJ20020198; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	60	978	1013	3	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					179	193		10.1016/j.cell.2005.02.031	http://dx.doi.org/10.1016/j.cell.2005.02.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851026	Bronze			2022-12-28	WOS:000228705000007
J	Fein, JD; Hamann, KL				Fein, JD; Hamann, KL			Stevens-Johnson syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Fein, JD (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.								0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1696	1696		10.1056/NEJMicm031127	http://dx.doi.org/10.1056/NEJMicm031127			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843672				2022-12-28	WOS:000228515200011
J	Grayston, JT; Kronmal, RA; Jackson, LA; Parisi, AF; Muhlestein, JB; Cohen, JD; Rogers, WJ; Crouse, JR; Borrowdale, SL; Schron, E; Knirsch, C				Grayston, JT; Kronmal, RA; Jackson, LA; Parisi, AF; Muhlestein, JB; Cohen, JD; Rogers, WJ; Crouse, JR; Borrowdale, SL; Schron, E; Knirsch, C		ACES Investigators	Azithromycin for the secondary prevention of coronary events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Meeting of the European-Society-for-Chlamydia-Research	SEP   02, 2004	Budapest, HUNGARY	European Soc Chlamydia Res			CHLAMYDIA-PNEUMONIAE INFECTION; MYCOBACTERIUM-AVIUM COMPLEX; CONTROLLED-TRIAL; DOUBLE-BLIND; ATHEROSCLEROTIC LESIONS; CARDIOVASCULAR-DISEASE; ANTIBIOTIC-TREATMENT; HEART-DISEASE; RABBIT MODEL; CLARITHROMYCIN	BACKGROUND: Epidemiologic, laboratory, animal, and clinical studies suggest that there is an association between Chlamydia pneumoniae infection and atherogenesis. We evaluated the efficacy of one year of azithromycin treatment for the secondary prevention of coronary events. METHODS: In this randomized, prospective trial, we assigned 4012 patients with documented stable coronary artery disease to receive either 600 mg of azithromycin or placebo weekly for one year. The participants were followed for a mean of 3.9 years at 28 clinical centers throughout the United States. RESULTS: The primary end point, a composite of death due to coronary heart disease, nonfatal myocardial infarction, coronary revascularization, or hospitalization for unstable angina, occurred in 446 of the participants who had been randomly assigned to receive azithromycin and 449 of those who had been randomly assigned to receive placebo. There was no significant risk reduction in the azithromycin group as compared with the placebo group with regard to the primary end point (risk reduction, 1 percent [95 percent confidence interval, -13 to 13 percent]). There were also no significant risk reductions with regard to any of the components of the primary end point, death from any cause, or stroke. The results did not differ when the participants were stratified according to sex, age, smoking status, presence or absence of diabetes mellitus, or C. pneumoniae serologic status at baseline. CONCLUSIONS: A one-year course of weekly azithromycin did not alter the risk of cardiac events among patients with stable coronary artery disease.	Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Miriam Hosp, Providence, RI 02906 USA; Latter Day St Hosp, Salt Lake City, UT 84143 USA; St Louis Univ, Med Ctr, St Louis, MO 63103 USA; Univ Alabama, Birmingham, AL USA; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; Axio Res, Seattle, WA USA; NHLBI, Bethesda, MD 20892 USA; Pfizer, New York, NY USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Lifespan Health Rhode Island; Miriam Hospital; Saint Louis University; University of Alabama System; University of Alabama Birmingham; Wake Forest University; Wake Forest Baptist Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pfizer	Grayston, JT (corresponding author), Univ Washington, Dept Epidemiol, Box 357236, Seattle, WA 98195 USA.							Cannon CP, 2005, NEW ENGL J MED, V352, P1646, DOI 10.1056/NEJMoa043528; Fong IW, 2002, ANTIMICROB AGENTS CH, V46, P2321, DOI 10.1128/AAC.46.8.2321-2326.2002; FONG IW, 2003, INFECT CARDIOVASCULA, P139; FONG IW, 2003, INFECT CARDIOVASCULA, P144; Gimenez-Sanchez F, 2001, CLIN INFECT DIS, V33, P171, DOI 10.1086/321810; Grayston JT, 2000, J INFECT DIS, V181, pS402, DOI 10.1086/315596; Grayston JT, 2003, CIRCULATION, V107, P1228, DOI 10.1161/01.CIR.0000056032.56396.89; Havlir DV, 1996, NEW ENGL J MED, V335, P392, DOI 10.1056/NEJM199608083350604; Jackson LA, 1997, J INFECT DIS, V176, P292, DOI 10.1086/517270; KUO CC, 1993, J INFECT DIS, V167, P841, DOI 10.1093/infdis/167.4.841; KUO CC, 1995, P NATL ACAD SCI USA, V92, P6911, DOI 10.1073/pnas.92.15.6911; Mosorin M, 2001, J VASC SURG, V34, P606, DOI 10.1067/mva.2001.117891; Muhlestein JB, 1998, CIRCULATION, V97, P633, DOI 10.1161/01.CIR.97.7.633; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; Pierce M, 1996, NEW ENGL J MED, V335, P384, DOI 10.1056/NEJM199608083350603; Rothstein NM, 2001, J INFECT DIS, V183, P232, DOI 10.1086/317941; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Sander D, 2002, CIRCULATION, V106, P2428, DOI 10.1161/01.CIR.0000036748.26775.8D; THOM DH, 1992, JAMA-J AM MED ASSOC, V268, P68, DOI 10.1001/jama.268.1.68; Tseng AL, 1997, CLIN INFECT DIS, V24, P76, DOI 10.1093/clinids/24.1.76; Vammen S, 2002, BRIT J SURG, V89, P120; Vammen S, 2001, BRIT J SURG, V88, P1066, DOI 10.1046/j.0007-1323.2001.01845.x; WALLACE MR, 1994, LANCET, V343, P241, DOI 10.1016/S0140-6736(94)91030-8; Wang SP, 2000, J INFECT DIS, V181, pS421, DOI 10.1086/315622; Wiesli P, 2002, CIRCULATION, V105, P2646, DOI 10.1161/01.CIR.0000017862.08503.15	25	263	280	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1637	1645		10.1056/NEJMoa043526	http://dx.doi.org/10.1056/NEJMoa043526			9	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843666				2022-12-28	WOS:000228515200005
J	Okie, S				Okie, S			Physician-assisted suicide - Oregon and beyond	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		COLBURN D, 2005, OREGONIAN       0304, pA1; Ganzini L, 2001, JAMA-J AM MED ASSOC, V285, P2363, DOI 10.1001/jama.285.18.2363; Tolle SW, 2004, J CLIN ETHIC, V15, P111	3	23	23	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1627	1630		10.1056/NEJMp058004	http://dx.doi.org/10.1056/NEJMp058004			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843663				2022-12-28	WOS:000228515200001
J	Rohling, EJ; Palike, H				Rohling, EJ; Palike, H			Centennial-scale climate cooling with a sudden cold event around 8,200 years ago	NATURE			English	Article							NORTH-ATLANTIC CLIMATE; HIGH-RESOLUTION RECORD; GREENLAND ICE CORE; HOLOCENE CLIMATE; LAST DEGLACIATION; SOLAR VARIABILITY; MONSOON; OCEAN; EUROPE; SEA	The extent of climate variability during the current interglacial period, the Holocene, is still debated. Temperature records derived from central Greenland ice cores show one significant temperature anomaly between 8,200 and 8,100 years ago, which is often attributed to a meltwater outflow into the North Atlantic Ocean and a slowdown of North Atlantic Deep Water formation-this anomaly provides an opportunity to study such processes with relevance to present-day freshening of the North Atlantic. Anomalies in climate proxy records from locations around the globe are often correlated with this sharp event in Greenland. But the anomalies in many of these records span 400 to 600 years, start from about 8,600 years ago and form part of a repeating pattern within the Holocene. More sudden climate changes around 8,200 years ago appear superimposed on this longer-term cooling. The compounded nature of the signals implies that far-field climate anomalies around 8,200 years ago cannot be used in a straightforward manner to assess the impact of a slowdown of North Atlantic Deep Water formation, and the geographical extent of the rapid cooling event 8,200 years ago remains to be determined.	Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England	NERC National Oceanography Centre; University of Southampton	Rohling, EJ (corresponding author), Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England.	E.Rohling@soc.soton.ac.uk	Palike, Heiko/A-6560-2008; Rohling, Eelco J/B-9736-2008	Palike, Heiko/0000-0003-3386-0923; Rohling, Eelco J/0000-0001-5349-2158	Natural Environment Research Council [NER/T/S/2002/00453] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allen A, 1997, BIOCHEM SOC T, V25, P486, DOI 10.1042/bst0250486; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Baldini JUL, 2002, SCIENCE, V296, P2203, DOI 10.1126/science.1071776; Barber DC, 1999, NATURE, V400, P344, DOI 10.1038/22504; BAUER E, 2004, PALEOCEANOGRAPHY, V19; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; Cacho I, 2002, J MARINE SYST, V33, P253, DOI 10.1016/S0924-7963(02)00061-1; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; Curry R, 2003, NATURE, V426, P826, DOI 10.1038/nature02206; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; DENTON G H, 1973, Quaternary Research (Orlando), V3, P155, DOI 10.1016/0033-5894(73)90040-9; DEVERNAL A, 1997, EOS, V78, P247; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Haigh JD, 1996, SCIENCE, V272, P981, DOI 10.1126/science.272.5264.981; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hong YT, 2003, EARTH PLANET SC LETT, V211, P371, DOI 10.1016/S0012-821X(03)00207-3; Hughen KA, 1996, NATURE, V380, P51, DOI 10.1038/380051a0; JOHNSEN SJ, 1992, NATURE, V359, P311, DOI 10.1038/359311a0; JUNG SJA, 2002, GEOCHEM GEOPHYS GEOS, V3; Kuijpers A, 2003, MAR GEOL, V195, P109, DOI 10.1016/S0025-3227(02)00684-9; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; Mayewski PA, 1997, J GEOPHYS RES-OCEANS, V102, P26345, DOI 10.1029/96JC03365; McDermott F, 2001, SCIENCE, V294, P1328, DOI 10.1126/science.1063678; Moros M, 2004, QUATERNARY SCI REV, V23, P2113, DOI 10.1016/j.quascirev.2004.08.003; Muscheler R, 2004, QUATERNARY SCI REV, V23, P2101, DOI 10.1016/j.quascirev.2004.08.007; MUSCHELER R, IN PRESS QUAT SCI RE; Neff U, 2001, NATURE, V411, P290, DOI 10.1038/35077048; Nesje A, 2004, HOLOCENE, V14, P299, DOI 10.1191/0959683604hl708fa; Nesje A, 2001, HOLOCENE, V11, P267, DOI 10.1191/095968301669980885; OBRIEN SR, 1995, SCIENCE, V270, P1962, DOI 10.1126/science.270.5244.1962; RENSSEN H, 2002, PALEOCEANOGRAPHY, V17; Risebrobakken B., 2003, PALEOCEANOGRAPHY, V18; Rohling EJ, 2004, MAR MICROPALEONTOL, V50, P89, DOI 10.1016/S0377-8398(03)00068-9; Rohling EJ, 2002, EARTH PLANET SC LETT, V202, P61, DOI 10.1016/S0012-821X(02)00775-6; Rohling EJ, 2002, CLIM DYNAM, V18, P587, DOI 10.1007/s00382-001-0194-8; Shindell D, 1999, SCIENCE, V284, P305, DOI 10.1126/science.284.5412.305; Sprovieri R, 2003, PALAEOGEOGR PALAEOCL, V202, P119, DOI 10.1016/S0031-0182(03)00632-1; Spurk M, 2002, HOLOCENE, V12, P707, DOI 10.1191/0959683602hl583rp; St-Onge G, 2003, EARTH PLANET SC LETT, V209, P113, DOI 10.1016/S0012-821X(03)00079-7; Staubwasser M, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000608; TAYLOR K, 1992, J GLACIOL, V38, P325, DOI 10.3189/S0022143000002215; TAYLOR KC, 1993, NATURE, V361, P432, DOI 10.1038/361432a0; van Geel B, 1999, QUATERNARY SCI REV, V18, P331, DOI 10.1016/S0277-3791(98)00088-2; Veski S, 2004, GEOLOGY, V32, P681, DOI 10.1130/G20683.1; von Grafenstein U, 1999, SCIENCE, V284, P1654, DOI 10.1126/science.284.5420.1654; Weaver AJ, 2004, SCIENCE, V304, P400, DOI 10.1126/science.1096503; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220	50	493	511	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 21	2005	434	7036					975	979		10.1038/nature03421	http://dx.doi.org/10.1038/nature03421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846336				2022-12-28	WOS:000228524600028
J	Weil, M; Bressler, J; Parsons, P; Bolla, K; Glass, T; Schwartz, B				Weil, M; Bressler, J; Parsons, P; Bolla, K; Glass, T; Schwartz, B			Blood mercury levels and neurobehavioral function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; FATTY-ACIDS; METHYLMERCURY; POPULATION; PERFORMANCE; PRESSURE; EXPOSURE; HEALTH	Context Due to its cardiovascular benefits, fish consumption is widely encouraged among older Americans. However, this fast-growing population is at increased risk of cognitive impairment and may be particularly sensitive to methylmercury, a neurotoxicant found in fish. Objective To describe associations of blood mercury levels with neurobehavioral test scores in an urban adult population. Design, Setting, and Participants Cross-sectional analysis to determine the effect of mercury levels on neurobehavior in 474 randomly selected participants in the Baltimore Memory Study, a longitudinal study of cognitive decline involving 1140 Baltimore residents aged 50 to 70 years. We measured total mercury in whole blood samples and used multiple linear regression to examine its associations with neurobehavioral test scores. First-visit data were obtained in 2001-2002. Main Outcome Measures Twenty scores from 12 neurobehavioral tests. Results The median blood mercury level was 2.1 mu g/L (range, 0-16 mu g/L). After adjustment for covariates, increasing blood mercury was associated with worse performance on Rey complex figure delayed recall, a test of visual memory (beta, -0.224; 95% confidence interval, -0.402 to -0.047). However, increasing blood mercury levels were associated with better performance on finger tapping, a test of manual dexterity (beta for dominant hand, 0.351; 95% confidence interval, 0.017-0.686). Conclusion Overall, the data do not provide strong evidence that blood mercury levels are associated with worse neurobehavioral performance in this population of older urban adults.	Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Kennedy Krieger Inst, Baltimore, MD USA; New York State Dept Hlth, Wadsworth Ctr, Trace Met Lab, Albany, NY USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Kennedy Krieger Institute; State University of New York (SUNY) System; Wadsworth Center	Weil, M (corresponding author), Assoc State & Terr Hlth Officials, 1275 K St NW,Suite 800, Washington, DC 20005 USA.	mweil@jhsph.edu	Parsons, Patrick/ABE-2655-2020; Parsons, Patrick J/I-2985-2015	Parsons, Patrick/0000-0001-9133-875X; Parsons, Patrick J/0000-0001-9133-875X; Glass, Thomas/0000-0003-4399-612X	NATIONAL INSTITUTE ON AGING [R01AG019604] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG19604] Funding Source: Medline; NIEHS NIH HHS [ES-07141] Funding Source: Medline; ODCDC CDC HHS [T42/CCT310419] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ODCDC CDC HHS		Agency for Toxic Substances and Disease Registry, 1999, TOX PROF MERC UPD; Ahlqwist M, 1999, ACTA ODONTOL SCAND, V57, P168; *AM DIAB ASS, SPEC TYP FAT; Bannon DI, 2001, CLIN CHEM, V47, P1703; Barbosa F, 2004, J ANAL ATOM SPECTROM, V19, P1000, DOI 10.1039/b400315b; Beuter A, 1998, NEUROTOXICOL TERATOL, V20, P581, DOI 10.1016/S0892-0362(98)00021-X; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; Block G, 1998, REVISION BLOCK DIETA; *BMDP STAT SOFTW I, 1991, POW AN SOLO; Breteler MMB, 1998, HAEMOSTASIS, V28, P167; CALNE DB, 1986, LANCET, V2, P1067, DOI 10.1016/S0140-6736(86)90469-1; *CDCP, 2003, 2 NAT CTR ENV HLTH; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dolbec J, 2000, INT ARCH OCC ENV HEA, V73, P195, DOI 10.1007/s004200050027; Eto K, 2000, NEUROPATHOLOGY, V20, pS14; Ferraro FR, 2002, BRAIN COGNITION, V50, P139; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; GORMAN J, 2003, NY TIMES F      0729, P5; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; Halstead WC, 1985, HALSTEADREITAN NEURO; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hightower JM, 2003, ENVIRON HEALTH PERSP, V111, P604, DOI 10.1289/ehp.5837; Johansson N, 2002, BIOMETALS, V15, P189, DOI 10.1023/A:1015202301127; JONES DP, 1992, NUTR CANCER, V17, P57, DOI 10.1080/01635589209514173; Kales SN, 2002, J OCCUP ENVIRON MED, V44, P143, DOI 10.1097/00043764-200202000-00009; Kaplan E, 2001, BOSTON NAMING TEST; KAPUR N, 1977, J STUD ALCOHOL, V38, P2025, DOI 10.15288/jsa.1977.38.2025; KERSHAW TG, 1980, ARCH ENVIRON HEALTH, V35, P28; Kleinbaum D. G., 1998, APPL REGRESSION ANAL; *LAF INSTR CO, 1999, 32020 LAF INSTR CO; Lebel J, 1996, NEUROTOXICOLOGY, V17, P157; Lebel J, 1998, ENVIRON RES, V79, P20, DOI 10.1006/enrs.1998.3846; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1394, DOI 10.1001/archneur.60.10.1394; MacKay AJ, 2002, J INT NEUROPSYCH SOC, V8, P764, DOI 10.1017/S1355617702860040; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; National Academy of Sciences, 2000, TOX EFF METH; PHELPS RW, 1980, ARCH ENVIRON HEALTH, V35, P161, DOI 10.1080/00039896.1980.10667486; PLAISIER MK, 2005, COMMUNICATION   0131; RAINES B, 2003, HEALTH, P120; Raven J. C., 1965, COLOURED PROGR MATRI; RAVEN JC, 1965, MANUAL RAVENS COLOUR; Rice DC, 2003, RISK ANAL, V23, P107, DOI 10.1111/1539-6924.00294; Rice DC, 1996, NEUROTOXICOLOGY, V17, P583; Sadowski M, 2004, NEUROCHEM RES, V29, P1257, DOI 10.1023/B:NERE.0000023612.66691.e6; Schafer JH, 2005, J AM GERIATR SOC, V53, P381, DOI 10.1111/j.1532-5415.2005.53153.x; Schmidt M., 1996, W PSYCHOL SERVICES; Schober SE, 2003, JAMA-J AM MED ASSOC, V289, P1667, DOI 10.1001/jama.289.13.1667; Schwartz BS, 2004, ENVIRON HEALTH PERSP, V112, P314, DOI 10.1289/ehp.6727; SIMON JA, 1995, AM J EPIDEMIOL, V142, P469, DOI 10.1093/oxfordjournals.aje.a117662; Skoog I, 1997, BIOMED PHARMACOTHER, V51, P367, DOI 10.1016/S0753-3322(97)89428-0; Starr JM, 1999, CURR OPIN NEPHROL HY, V8, P347, DOI 10.1097/00041552-199905000-00012; UCHINO M, 1995, J ENVIRON SCI HEAL B, V30, P699, DOI 10.1080/03601239509372961; *US EPA, 2003, MERC FREQ ASK QUEST; *US EPA, NAT LIST FISH ADV FA; US FDA, 2001, RAT ISS REV ADV METH; Uttl B, 1997, J CLIN EXP NEUROPSYC, V19, P405, DOI 10.1080/01688639708403869; VALCIUKAS JA, 1980, ENVIRON RES, V21, P275, DOI 10.1016/0013-9351(80)90029-8; WEAVER V, 2003, J HOPK BLOOMB SCH PU; Weiss B, 2002, ENVIRON HEALTH PERSP, V110, P851, DOI 10.1289/ehp.02110s5851; Weiss B, 1996, NEUROTOXICOLOGY, V17, P257; WHO, 1990, METH; WILKINSON RT, 1982, HUM FACTORS, V24, P487, DOI 10.1177/001872088202400409; Yokoo Edna M, 2003, Environ Health, V2, P8, DOI 10.1186/1476-069X-2-8	64	69	76	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1875	1882		10.1001/jama.293.15.1875	http://dx.doi.org/10.1001/jama.293.15.1875			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	916QW	15840862	Bronze			2022-12-28	WOS:000228401700026
J	Hallenbeck, J				Hallenbeck, J			Palliative care in the final days of life - "They were expecting it at any time"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ILL CANCER-PATIENTS; LAST 48 HOURS; END-OF-LIFE; TERMINALLY-ILL; CULTURAL CONSIDERATIONS; HOSPITALIZED-PATIENTS; CONTROLLED-TRIAL; UNITED-STATES; DEATH RATTLE; BAD-NEWS	Providing care to actively dying patients presents unique challenges for the clinician. Patients, in their final days require careful symptom management. Families need support and coaching as death approaches. Care does not end with the death of the patient but continues through death pronouncement, family notification of the death, discussion of autopsy, and immediate bereavement support. Skills in these and related areas are discussed in the context of one man's death, as illuminated by comments made after death by his daughter and his physician. This case also highlights the often differing perspectives of families and clinicians as they work to deal with a patient's death. A goal of mastering the palliative skills necessary to competently care for an actively dying patient is to enable a patient to die peacefully and relatively free of discomfort. Achieving such competency should also help to relieve clinician stress attendant to caring for dying patients.	Stanford Univ, Sch Med, VA Palto Alto HCS, Palo Alto, CA 94304 USA	Stanford University	Hallenbeck, J (corresponding author), Stanford Univ, Sch Med, VA Palto Alto HCS, 1002C,3801 Miranda Ave, Palo Alto, CA 94304 USA.	james.hallenbeck@med.va.gov						[Anonymous], 1999, DEATH FORETOLD PROPH; Back IN, 2001, PALLIATIVE MED, V15, P329, DOI 10.1191/026921601678320313; Baile WF, 2002, J CLIN ONCOL, V20, P2189, DOI 10.1200/JCO.2002.08.004; Breitbart W, 2002, PSYCHOSOMATICS, V43, P183, DOI 10.1176/appi.psy.43.3.183; Breitbart W, 2000, CLIN GERIATR MED, V16, P357, DOI 10.1016/S0749-0690(05)70061-6; Bruera E, 1990, J Pain Symptom Manage, V5, P341, DOI 10.1016/0885-3924(90)90027-H; Byock I., 1997, DYING WELL; BYOCK IR, 2004, 4 THINS MATTER MOST; Campbell ML, 2004, CRIT CARE CLIN, V20, P403, DOI 10.1016/j.ccc.2004.03.015; Chandler S, 1999, Am J Hosp Palliat Care, V16, P418, DOI 10.1177/104990919901600113; CHERNY NJ, 1995, CANCER-AM CANCER SOC, V76, P1283, DOI 10.1002/1097-0142(19951001)76:7<1283::AID-CNCR2820760728>3.0.CO;2-0; Conill C, 1997, J PAIN SYMPTOM MANAG, V14, P328, DOI 10.1016/S0885-3924(97)00263-7; COYLE N, 1990, J PAIN SYMPTOM MANAG, V5, P83; Dalal Shalini, 2004, J Support Oncol, V2, P467; Ellershaw J, 2001, J PAIN SYMPTOM MANAG, V21, P12, DOI 10.1016/S0885-3924(00)00240-2; Ellershaw J, 2003, BRIT MED J, V326, P30, DOI 10.1136/bmj.326.7379.30; FAINSINGER R, 1991, J PALLIATIVE CARE, V7, P5; FAINSINGER RL, 1998, TOPICS PALLIATIVE CA, V4, P261; Hall P, 2002, J AM GERIATR SOC, V50, P501, DOI 10.1046/j.1532-5415.2002.50117.x; Hallenbeck J, 1996, CLIN GERIATR MED, V12, P393; Hallenbeck J, 1999, GENERATIONS, V23, P24; HALLENBECK J, 2002, PRINCIPLES PRACTICE, P661; HALLENBECK J, END OF LIFE CARE CUR; Hallenbeck J. L., 2003, PALLIATIVE CARE PERS; Herndon CM, 2001, J PAIN SYMPTOM MANAG, V22, P1027, DOI 10.1016/S0885-3924(01)00365-7; Jennings AL, 2002, THORAX, V57, P939, DOI 10.1136/thorax.57.11.939; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KOENIG BA, 1997, APPROACHING DEATH IM; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; Lichter I, 1990, J Palliat Care, V6, P7; Lo RSK, 2002, J PAIN SYMPTOM MANAG, V24, P388, DOI 10.1016/S0885-3924(02)00504-3; LYNN J, 1999, HDB MORTALS GUIDANCE; Marchand Lucille, 2004, J Palliat Med, V7, P80, DOI 10.1089/109662104322737322; Mazzocato C, 1999, ANN ONCOL, V10, P1511, DOI 10.1023/A:1008337624200; McPhee SJ, 1996, ARCH PATHOL LAB MED, V120, P743; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; MENKIN E, 2000, WRITING CONDOLENCE L; Morita T, 2004, ANN ONCOL, V15, P1551, DOI 10.1093/annonc/mdh386; Morita T, 2004, PSYCHOSOMATICS, V45, P107, DOI 10.1176/appi.psy.45.2.107; Morita T, 2002, J PAIN SYMPTOM MANAG, V24, P447, DOI 10.1016/S0885-3924(02)00499-2; Morita T, 2001, J PAIN SYMPTOM MANAG, V21, P282, DOI 10.1016/S0885-3924(01)00258-5; Morita T, 1998, Am J Hosp Palliat Care, V15, P217, DOI 10.1177/104990919801500407; ONeill B, 1997, BRIT MED J, V315, P801, DOI 10.1136/bmj.315.7111.801; Penson R T, 2000, Oncologist, V5, P425; PICKETT M, 1993, CANCER NURS, V16, P102; Prigerson HG, 2001, JAMA-J AM MED ASSOC, V286, P1369, DOI 10.1001/jama.286.11.1369; Puchalski Christina M, 2002, J Palliat Med, V5, P289, DOI 10.1089/109662102753641287; QUILL TE, 1990, ARCH INTERN MED, V150, P1857, DOI 10.1001/archinte.150.9.1857; Rando T. A., 1993, TREATMENT COMPLICATE; ROUSSEAU P, 2003, J PALLIAT MED, V4, P255; SCHNEIDERMAN H, 1985, POSTGRAD MED, V77, P153, DOI 10.1080/00325481.1985.11698924; Sinard JH, 2001, EXP MOL PATHOL, V70, P333, DOI 10.1006/exmp.2001.2371; STEINHAUSER KE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI DOI 10.1001/JAMA.284.19.2476; STOREY P, 1998, PRINCIPLES PRACTICE, P741; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Vandekieft GK, 2001, AM FAM PHYSICIAN, V64, P1975; Ventafridda V, 1990, J Palliat Care, V6, P7; Wildiers H, 2002, J PAIN SYMPTOM MANAG, V23, P310, DOI 10.1016/S0885-3924(01)00421-3; Zeitlin SV, 2001, PRIMARY CARE, V28, P415, DOI 10.1016/S0095-4543(05)70031-2	60	28	29	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2265	2271		10.1001/jama.293.18.2265	http://dx.doi.org/10.1001/jama.293.18.2265			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	924LU	15886382				2022-12-28	WOS:000228981100028
J	Ye, XQ; Hama, K; Contos, JJA; Anliker, B; Inoue, A; Skinner, MK; Suzuki, H; Amano, T; Kennedy, G; Arai, H; Aoki, J; Chun, J				Ye, XQ; Hama, K; Contos, JJA; Anliker, B; Inoue, A; Skinner, MK; Suzuki, H; Amano, T; Kennedy, G; Arai, H; Aoki, J; Chun, J			LPA(3)-mediated lysophosphatidic acid signalling in embryo implantation and spacing	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; OBVIOUS PHENOTYPIC ABNORMALITY; MOUSE UTERUS; MICE LACKING; EXPRESSION; INITIATION; PREGNANCY; DEFICITS; CELLS; GENE	Every successful pregnancy requires proper embryo implantation. Low implantation rate is a major problem during infertility treatments using assisted reproductive technologies(1). Here we report a newly discovered molecular influence on implantation through the lysophosphatidic acid (LPA) receptor LPA(3) (refs 2 - 4). Targeted deletion of LPA(3) in mice resulted in significantly reduced litter size, which could be attributed to delayed implantation and altered embryo spacing. These two events led to delayed embryonic development, hypertrophic placentas shared by multiple embryos and embryonic death. An enzyme demonstrated to influence implantation, cyclooxygenase 2 (COX2) (ref. 5), was downregulated in LPA(3)-deficient uteri during preimplantation. Downregulation of COX2 led to reduced levels of prostaglandins E-2 and I-2 (PGE(2) and PGI(2)), which are critical for implantation(1). Exogenous administration of PGE(2) or carbaprostacyclin ( a stable analogue of PGI(2)) into LPA(3)-deficient female mice rescued delayed implantation but did not rescue defects in embryo spacing. These data identify LPA(3) receptor-mediated signalling as having an influence on implantation, and further indicate linkage between LPA signalling and prostaglandin biosynthesis.	Scripps Res Inst, Dept Mol Biol, Helen L Dorris Child & Adolescent Neuropsychiat D, La Jolla, CA 92037 USA; Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Dev Med Technol Sankyo, Bunkyo Ku, Tokyo 1130033, Japan; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA; Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan	Scripps Research Institute; University of Tokyo; University of Tokyo; Fred Hutchinson Cancer Center; Washington State University; Obihiro University of Agriculture & Veterinary Medicine	Chun, J (corresponding author), Scripps Res Inst, Dept Mol Biol, Helen L Dorris Child & Adolescent Neuropsychiat D, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jchun@scripps.edu	Chun, Jerold/Y-4670-2019; Kennedy, Grace/GRS-1071-2022	Aoki, Junken/0000-0001-9435-1896	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001723] Funding Source: NIH RePORTER; NIMH NIH HHS [K02 MH001723] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Cleary-Goldman J, 2004, OBSTET GYNECOL SURV, V59, P285, DOI 10.1097/01.OGX.0000120165.52159.04; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Contos JJA, 2001, GENE, V267, P243, DOI 10.1016/S0378-1119(01)00410-3; Daniel Y, 2000, FERTIL STERIL, V74, P683, DOI 10.1016/S0015-0282(00)01491-6; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Frenkian M, 2001, PROSTAG OTH LIPID M, V65, P11, DOI 10.1016/S0090-6980(01)00116-2; Gabardi Steven, 2004, Prog Transplant, V14, P148; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; KENNEDY TG, 1977, BIOL REPROD, V16, P286, DOI 10.1095/biolreprod16.3.286; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Kinoshita K, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P605; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Paria BC, 2001, INT J DEV BIOL, V45, P597; Reese J, 1999, MOL CELL ENDOCRINOL, V150, P23, DOI 10.1016/S0303-7207(99)00033-7; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Song H, 2002, DEVELOPMENT, V129, P2879; TOKUMURA A, 1980, ARCH INT PHARMACOD T, V245, P74; Umstad MP, 2003, MED J AUSTRALIA, V178, P613, DOI 10.5694/j.1326-5377.2003.tb05384.x; Wang HB, 2004, J BIOL CHEM, V279, P10649, DOI 10.1074/jbc.M312203200; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Yang ZM, 1997, BIOL REPROD, V56, P368, DOI 10.1095/biolreprod56.2.368	30	401	429	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					104	108		10.1038/nature03505	http://dx.doi.org/10.1038/nature03505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875025	Green Accepted			2022-12-28	WOS:000228864600047
J	de Letona, JM				de Letona, JM			Aortic aneurysm: the physician as patient	LANCET			English	Editorial Material									Univ Autonoma Madrid, Hosp Puerta de Hierro, Madrid, Spain	Autonomous University of Madrid; Hospital Puerta de Hierro-Majadahonda	de Letona, JM (corresponding author), Univ Autonoma Madrid, Hosp Puerta de Hierro, Madrid, Spain.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 30	2005	365	9470					1590	1590		10.1016/S0140-6736(05)66460-4	http://dx.doi.org/10.1016/S0140-6736(05)66460-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866313				2022-12-28	WOS:000228754800031
J	Bernhardt, ES; Palmer, MA; Allan, JD; Alexander, G; Barnas, K; Brooks, S; Carr, J; Clayton, S; Dahm, C; Follstad-Shah, J; Galat, D; Gloss, S; Goodwin, P; Hart, D; Hassett, B; Jenkinson, R; Katz, S; Kondolf, GM; Lake, PS; Lave, R; Meyer, JL; O'Donnell, TK; Pagano, L; Powell, B; Sudduth, E				Bernhardt, ES; Palmer, MA; Allan, JD; Alexander, G; Barnas, K; Brooks, S; Carr, J; Clayton, S; Dahm, C; Follstad-Shah, J; Galat, D; Gloss, S; Goodwin, P; Hart, D; Hassett, B; Jenkinson, R; Katz, S; Kondolf, GM; Lake, PS; Lave, R; Meyer, JL; O'Donnell, TK; Pagano, L; Powell, B; Sudduth, E			Ecology - Synthesizing US river restoration efforts	SCIENCE			English	Editorial Material							FRESH-WATER		Univ Maryland, College Pk, MD 20742 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; NOAA, Natl Fisheries Sci Ctr, Seattle, WA USA; Monash Univ, Clayton, Vic 3168, Australia; Natl Acad Sci, Philadelphia, PA USA; Univ Idaho, Boise, ID USA; Univ New Mexico, Albuquerque, NM 87131 USA; US Geol Survey, Cooperat Res Unit, Columbia, MO USA; Univ Missouri, Columbia, MO USA; USGS, SW Biol Sci Ctr, Tucson, AZ USA; Univ Idaho, Moscow, ID 83843 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ Georgia, Athens, GA 30602 USA; USGS, Ctr Biol Informat, Denver, CO USA	University System of Maryland; University of Maryland College Park; University of Michigan System; University of Michigan; National Oceanic Atmospheric Admin (NOAA) - USA; Monash University; National Academies of Sciences, Engineering & Medicine; Idaho; University of Idaho; University of New Mexico; United States Department of the Interior; United States Geological Survey; University of Missouri System; University of Missouri Columbia; United States Department of the Interior; United States Geological Survey; Idaho; University of Idaho; University of California System; University of California Berkeley; University System of Georgia; University of Georgia; United States Department of the Interior; United States Geological Survey	Bernhardt, ES (corresponding author), Duke Univ, Durham, NC 27706 USA.	emily.bernhardt@duke.edu	Bernhardt, Emily S/D-9940-2011; Goodwin, Peter/AAP-1649-2021; Bernhardt, Emily/B-4541-2010	Bernhardt, Emily S/0000-0003-3031-621X; Sudduth, Elizabeth/0000-0001-8274-8159; Lave, Rebecca/0000-0001-5335-9058; Brooks, Shane/0000-0002-5636-1783				Baron JS, 2002, ECOL APPL, V12, P1247; Buijse AD, 2002, FRESHWATER BIOL, V47, P889, DOI 10.1046/j.1365-2427.2002.00915.x; Cohn JP, 2001, BIOSCIENCE, V51, P998, DOI 10.1641/0006-3568(2001)051[0998:RTDALA]2.0.CO;2; G.A.O, 2002, GAO02612; GAO (United States General Accounting Office), 2003, GAO03515; GILLILAN S, IN PRESS J APPL ECOL; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; KOEBEL JW, 1995, RESTOR ECOL, V3, P149, DOI 10.1111/j.1526-100X.1995.tb00167.x; Lavendel B., 2002, ECOL RES, V20, P173, DOI DOI 10.3368/ER.20.3.173; Malakoff D, 2004, SCIENCE, V305, P937, DOI 10.1126/science.305.5686.937; ( National Research Council) NRC, 1996, UPSTR SALM SOC PAC N; *NRC, 1999, DOWNSTR AD MAN GLEN; NRC, 1999, OUR COMM JOURN TRANS; Palmer M, 2004, SCIENCE, V304, P1251, DOI 10.1126/science.1095780; PALMER MA, IN PRESS J APPL ECOL; Postel S, 2003, RIVERS LIFE MANAGING; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Sand-Jensen Kaj, 2001, P89; *US EPA, 2000, EPA PUBL; Whalen PJ, 2002, WATER SCI TECHNOL, V45, P55, DOI 10.2166/wst.2002.0379	20	1303	1341	20	617	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2005	308	5722					636	637		10.1126/science.1109769	http://dx.doi.org/10.1126/science.1109769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860611				2022-12-28	WOS:000228810900030
J	Cirelli, C; Bushey, D; Hill, S; Huber, R; Kreber, R; Ganetzky, B; Tononi, G				Cirelli, C; Bushey, D; Hill, S; Huber, R; Kreber, R; Ganetzky, B; Tononi, G			Reduced sleep in Drosophila shaker mutants	NATURE			English	Article							POTASSIUM CHANNELS; HEALTHY INSOMNIA; NERVOUS-SYSTEM; K+ CHANNEL; MELANOGASTER; GENE; MICE; HOMEOSTASIS; REST; DEPRIVATION	Most of us sleep 7-8 h per night, and if we are deprived of sleep our performance suffers greatly; however, a few do well with just 3-4 h of sleep-a trait that seems to run in families. Determining which genes underlie this phenotype could shed light on the mechanisms and functions of sleep. To do so, we performed mutagenesis in Drosophila melanogaster, because flies also sleep for many hours and, when sleep deprived, show sleep rebound and performance impairments. By screening 9,000 mutant lines, we found minisleep (mns), a line that sleeps for one-third of the wild-type amount. We show that mns flies perform normally in a number of tasks, have preserved sleep homeostasis, but are not impaired by sleep deprivation. We then show that mns flies carry a point mutation in a conserved domain of the Shaker gene. Moreover, after crossing out genetic modifiers accumulated over many generations, other Shaker alleles also become short sleepers and fail to complement the mns phenotype. Finally, we show that short-sleeping Shaker flies have a reduced lifespan. Shaker, which encodes a voltage-dependent potassium channel controlling membrane repolarization and transmitter release, may thus regulate sleep need or efficiency.	Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	gtononi@wisc.edu	Tononi, Giulio/B-8387-2009	Hill, Sean/0000-0001-8055-860X				BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; BENINGTON JH, 1995, BRAIN RES, V692, P86, DOI 10.1016/0006-8993(95)00591-D; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2003, BIOESSAYS, V25, P940, DOI 10.1002/bies.10333; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Dijk DJ, 2002, J APPL PHYSIOL, V92, P852, DOI 10.1152/japplphysiol.00924.2001; Easton A, 2004, SLEEP, V27, P1307, DOI 10.1093/sleep/27.7.1307; Espinosa F, 2004, GENES BRAIN BEHAV, V3, P90, DOI 10.1046/j.1601-183x.2003.00054.x; HEATH AC, 1990, SLEEP, V13, P318, DOI 10.1093/sleep/13.4.318; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2003, J BIOL RHYTHM, V18, P12, DOI 10.1177/0748730402239673; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Horne J., 1989, WHY WE SLEEP; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; JONES HS, 1968, ELECTROEN CLIN NEURO, V24, P378, DOI 10.1016/0013-4694(68)90199-5; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kopp C, 2002, EUR J NEUROSCI, V16, P1099, DOI 10.1046/j.1460-9568.2002.02156.x; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liguori R, 2001, BRAIN, V124, P2417, DOI 10.1093/brain/124.12.2417; Linkowski P, 1999, J SLEEP RES, V8, P11; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; MEDDIS R, 1973, ELECTROEN CLIN NEURO, V35, P213, DOI 10.1016/0013-4694(73)90180-6; Naylor E, 2000, J NEUROSCI, V20, P8138; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; PARTINEN M, 1983, SLEEP, V6, P179, DOI 10.1093/sleep/6.3.179; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rogero O, 1997, J NEUROSCI, V17, P5108; Rorth P, 1998, DEVELOPMENT, V125, P1049; Schenck CH, 2001, SLEEP MED, V2, P531, DOI 10.1016/S1389-9457(01)00114-9; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Shiromani PJ, 2004, AM J PHYSIOL-REG I, V287, pR47, DOI 10.1152/ajpregu.00138.2004; Spradling AC, 1999, GENETICS, V153, P135; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; STUSS D, 1978, WAKING SLEEPING, V2, P101; SUTCLIFFE JG, 1988, TRENDS GENET, V4, P297, DOI 10.1016/0168-9525(88)90105-9; Tafti M, 2002, J APPL PHYSIOL, V92, P1339, DOI 10.1152/japplphysiol.00834.2001; Taheri S, 2002, LANCET NEUROL, V1, P242, DOI 10.1016/S1474-4422(02)00103-5; TIMPE LC, 1987, J NEUROSCI, V7, P1307; TOBLER I, 2000, PRINCIPLES PRACTICE, P72; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vyazovskiy VV, 2002, BRAIN RES, V947, P204, DOI 10.1016/S0006-8993(02)02925-6; Walcourt A, 2001, ANESTH ANALG, V92, P535, DOI 10.1213/00000539-200102000-00047; Webb W B, 1970, Int Psychiatry Clin, V7, P44; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1	50	317	330	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1087	1092		10.1038/nature03486	http://dx.doi.org/10.1038/nature03486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858564				2022-12-28	WOS:000228693300032
J	Stam, J				Stam, J			Current concepts - Thrombosis of the cerebral veins and sinuses	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROTHROMBOTIC RISK-FACTORS; FACTOR-V-LEIDEN; VENOUS THROMBOSIS; ORAL-CONTRACEPTIVES; ANTICARDIOLIPIN ANTIBODIES; CONTROLLED TRIAL; DURAL SINUSES; CHILDREN; MUTATION; HEPARIN		Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1100 DE Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Stam, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, POB 22700, NL-1100 DE Amsterdam, Netherlands.	j.stam@amc.uva.nl						Aidi Saadia, 1999, Headache, V39, P559, DOI 10.1046/j.1526-4610.1999.3908559.x; Ayanzen RH, 2000, AM J NEURORADIOL, V21, P74; Bousser MG, 1999, STROKE, V30, P481, DOI 10.1161/01.STR.30.3.481; BOUSSER MG, 1997, CEREBRAL VENOUS THRO; Canhao P, 2003, CEREBROVASC DIS, V15, P159, DOI 10.1159/000068833; Cantu C, 2004, STROKE, V35, P1790, DOI 10.1161/01.STR.0000132570.24618.78; CANTU C, 1993, STROKE, V24, P1880, DOI 10.1161/01.STR.24.12.1880; Carhuapoma JR, 1997, STROKE, V28, P2363, DOI 10.1161/01.STR.28.12.2363; Corvol JC, 1998, STROKE, V29, P2649, DOI 10.1161/01.STR.29.12.2649; DAIF A, 1995, STROKE, V26, P1193, DOI 10.1161/01.STR.26.7.1193; de Bruijn SFTM, 2001, J NEUROL NEUROSUR PS, V70, P105, DOI 10.1136/jnnp.70.1.105; de Bruijn SFTM, 1999, STROKE, V30, P484, DOI 10.1161/01.STR.30.3.484; de Bruijn SFTM, 1998, BRIT MED J, V316, P589, DOI 10.1136/bmj.316.7131.589; de Bruijn SFTM, 1998, LANCET, V351, P1404, DOI 10.1016/S0140-6736(05)79442-3; de Bruijn SFTM, 1998, BRIT MED J, V316, P822; DEBRUIJN SFT, 1998, THESIS AMSTERDAM; deBruijn SFTM, 1996, LANCET, V348, P1623, DOI 10.1016/S0140-6736(96)07294-7; Deschiens MA, 1996, STROKE, V27, P1724, DOI 10.1161/01.STR.27.10.1724; deVeber G, 2001, NEW ENGL J MED, V345, P417, DOI 10.1056/NEJM200108093450604; DIAZ JM, 1992, ACTA NEUROL SCAND, V86, P390, DOI 10.1111/j.1600-0404.1992.tb05106.x; DORMONT D, 1994, J NEURORADIOLOGY, V21, P81; EINHAUPL KM, 1991, LANCET, V338, P958; ENEVOLDSON TP, 1990, Q J MED, V77, P1255, DOI 10.1093/qjmed/77.3.1255; Farah S, 1998, J NEUROL NEUROSUR PS, V64, P382, DOI 10.1136/jnnp.64.3.382; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Hillier CEM, 1998, QJM-MON J ASSOC PHYS, V91, P677, DOI 10.1093/qjmed/91.10.677; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; ISENSEE C, 1994, STROKE, V25, P29, DOI 10.1161/01.STR.25.1.29; Kesler A, 2004, NEUROLOGY, V63, P1737, DOI 10.1212/01.WNL.0000143067.40281.16; Kothare SV, 1998, J CHILD NEUROL, V13, P300, DOI 10.1177/088307389801300615; Krayenbuhl H A, 1966, Clin Neurosurg, V14, P1; Lafitte F, 1997, CLIN RADIOL, V52, P672, DOI 10.1016/S0009-9260(97)80030-X; Lanska DJ, 2000, STROKE, V31, P1274, DOI 10.1161/01.STR.31.6.1274; Ludemann P, 1998, STROKE, V29, P2507, DOI 10.1161/01.STR.29.12.2507; Majoie CBLM, 2004, AM J NEURORADIOL, V25, P787; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; Nagaraja D, 1995, NIMHANS J, V13, P111; Reuner KH, 1998, STROKE, V29, P1765, DOI 10.1161/01.STR.29.9.1765; STAM J, 2002, COCHRANE DB SYST REV, V4; Stefini R, 1999, NEUROSURGERY, V45, P626, DOI 10.1097/00006123-199909000-00038; Stiefel D, 2000, EUR J PEDIATR SURG, V10, P41, DOI 10.1055/s-2008-1072321; TSE DT, 1999, NEUROOPHTHALMOLOGY, P520; VANDENBELT A, 2002, COCHRANE DATABASE SY, V2; Vandenbroucke JP, 2001, NEW ENGL J MED, V344, P1527, DOI 10.1056/NEJM200105173442007; VIDAILHET M, 1990, STROKE, V21, P1226, DOI 10.1161/01.STR.21.8.1226; Weih M, 2000, NERVENARZT, V71, P936, DOI 10.1007/s001150050690; Wermes C, 1999, KLIN PADIATR, V211, P211, DOI 10.1055/s-2008-1043790; WilderSmith E, 1997, J NEUROL NEUROSUR PS, V63, P351, DOI 10.1136/jnnp.63.3.351; Yoshikawa T, 2002, NEURORADIOLOGY, V44, P481, DOI 10.1007/s00234-002-0772-4	49	875	958	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1791	1798		10.1056/NEJMra042354	http://dx.doi.org/10.1056/NEJMra042354			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858188	Green Published			2022-12-28	WOS:000228689000009
J	Heath, I				Heath, I			Current controversies - Who needs health care - the well or the sick?	BRITISH MEDICAL JOURNAL			English	Article							MEDICINE		Caversham Grp Practice, London NW5 2UP, England		Heath, I (corresponding author), Caversham Grp Practice, London NW5 2UP, England.	iona.heath@dsl.pipex.com						Abraham J, 2002, LANCET, V360, P1498, DOI 10.1016/S0140-6736(02)11477-2; DELBANCO A, 2001, NY REV BOOKS, V48; Eliot G., 1994, MIDDLEMARCH; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Fitzpatrick M., 2001, TYRANNY HLTH DOCTORS; Freemantle N, 2002, BMJ-BRIT MED J, V324, P864, DOI 10.1136/bmj.324.7342.864; Getz L, 2003, BMJ-BRIT MED J, V327, P498, DOI 10.1136/bmj.327.7413.498; Nussbaum M.C.., 1986, FRAGILITY GOODNESS; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Power M., 1997, AUDIT SOC RITUALS VE; Sackett DL, 2002, CAN MED ASSOC J, V167, P363; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860	12	27	28	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 23	2005	330	7497					954	956		10.1136/bmj.330.7497.954	http://dx.doi.org/10.1136/bmj.330.7497.954			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15845979	Green Published			2022-12-28	WOS:000228715900025
J	Blower, MD; Nachury, M; Heald, R; Weis, K				Blower, MD; Nachury, M; Heald, R; Weis, K			A Rae1-containing ribonucleoprotein complex is required for mitotic spindle assembly	CELL			English	Article							NUCLEAR-PORE COMPLEX; MESSENGER-RNA EXPORT; IMPORTIN-BETA; CELL-CYCLE; RAE1; PROTEIN; RAN; MICROTUBULES; NUP98; LOCALIZATION	Centrosome-independent microtubule polymerization around chromosomes has been shown to require a local gradient of RanGTP, which discharges mitotic cargoes from the nuclear import receptor importin beta. Here, we have used an activity-based assay in Xenopus egg extracts to purify the mRNA export protein Rae1 as a spindle assembly factor regulated by this pathway. Rae1 is a microtubule-associated protein that binds directly to importin beta. Depletion of Rae1 from extracts or cells severely inhibits mitotic spindle assembly. A purified Rae1 complex stabilizes microtubules in egg extracts in a RanGTP/importin beta-regulated manner. Interestingly, Rae1 exists in a large ribonucleoprotein complex, which requires RNA for its activity to control microtubule dynamics in vitro. Furthermore, we provide evidence that RNA associates with the mitotic spindle and that it plays a direct, translation-independent role in spindle assembly. Our studies reveal an unexpected function for RNA in spindle morphogenesis.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Heald, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	heald@socrates.berkeley.edu; kweis@berkeley.edu	Nachury, Maxence/H-3695-2019; Weis, Karsten/F-5719-2011; Nachury, Maxence/A-8759-2008	Nachury, Maxence/0000-0003-4918-1562; Weis, Karsten/0000-0001-7224-925X; Nachury, Maxence/0000-0003-4918-1562; Heald, Rebecca/0000-0001-6671-6528; Blower, Michael/0000-0002-5037-1972	NIGMS NIH HHS [GM65232] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065232] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Blevins MB, 2003, J BIOL CHEM, V278, P20979, DOI 10.1074/jbc.M302061200; BROWN JA, 1995, J BIOL CHEM, V270, P7411, DOI 10.1074/jbc.270.13.7411; Budde PP, 2003, CURR TOP DEV BIOL, V56, P85, DOI 10.1016/S0070-2153(03)01008-1; Deshler JO, 1997, SCIENCE, V276, P1128, DOI 10.1126/science.276.5315.1128; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; HAMILL D, 1994, J CELL BIOL, V127, P973, DOI 10.1083/jcb.127.4.973; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Kahana JA, 1999, J CELL BIOL, V146, P1205, DOI 10.1083/jcb.146.6.1205; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kraemer D, 1997, P NATL ACAD SCI USA, V94, P9119, DOI 10.1073/pnas.94.17.9119; Kroll TT, 2002, DEVELOPMENT, V129, P5609, DOI 10.1242/dev.00160; Lieb B, 1998, EXP CELL RES, V245, P272, DOI 10.1006/excr.1998.4249; Murphy R, 1996, MOL BIOL CELL, V7, P1921, DOI 10.1091/mbc.7.12.1921; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Sitterlin D, 2004, GENE, V326, P107, DOI 10.1016/j.gene.2003.10.024; Tekotte H, 2002, TRENDS GENET, V18, P636, DOI 10.1016/S0168-9525(02)02819-6; Whalen WA, 1997, YEAST, V13, P1167, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1167::AID-YEA154>3.3.CO;2-F; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Yoon JH, 2000, MOL CELL BIOL, V20, P8767, DOI 10.1128/MCB.20.23.8767-8782.2000	27	218	225	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					223	234		10.1016/j.cell.2005.02.016	http://dx.doi.org/10.1016/j.cell.2005.02.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851029	Bronze			2022-12-28	WOS:000228705000010
J	Leftowitz, RJ; Shenoy, SK				Leftowitz, RJ; Shenoy, SK			Transduction of receptor signals by beta-arrestins	SCIENCE			English	Review							PROTEIN-COUPLED RECEPTOR; CLATHRIN-MEDIATED ENDOCYTOSIS; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; KINASE ACTIVATION; REGULATED KINASES; TERNARY COMPLEX; ERK ACTIVATION; BETA-ARRESTIN-2; MAPK	The transmission of extracellular signals to the interior of the cell is a function of plasma membrane receptors, of which the seven transmembrane receptor family is by far the largest and most versatile. Classically, these receptors stimulate heterotrimeric G proteins, which control rates of generation of diffusible second messengers and entry of ions at the plasma membrane. Recent evidence, however, indicates another previously unappreciated strategy used by the receptors to regulate intracellutar signaling pathways. They direct the recruitment, activation, and scaffolding of cytoplasmic signaling complexes via two multifunctional adaptor and transducer molecules, beta-arrestins 1 and 2. This mechanism regulates aspects of cell motility, chemotaxis, apoptosis, and likely other cellular functions through a rapidly expanding list of signaling pathways.	Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Durham, NC 27710 USA	Howard Hughes Medical Institute; Duke University	Leftowitz, RJ (corresponding author), Howard Hughes Med Inst, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021; Shenoy, Sudha/AAN-4075-2021	Shenoy, Sudha/0000-0002-2565-4663	NHLBI NIH HHS [HL 70631, HL 16037] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R01HL070631, R37HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; ARSHAVSKY VY, 2003, SCI STKE, pPE43; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Chen W, 2001, P NATL ACAD SCI USA, V98, P14889, DOI 10.1073/pnas.211572798; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; *DEL SCI, 2002, PYMOL MOL GRAPH SYST; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GUDERMANN T, 1995, J MOL MED, V73, P51, DOI 10.1007/BF00270578; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hupfeld CJ, 2005, J BIOL CHEM, V280, P1016, DOI 10.1074/jbc.M403674200; Imamura T, 2001, J BIOL CHEM, V276, P43663, DOI 10.1074/jbc.M105364200; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kenakin T, 2003, TRENDS PHARMACOL SCI, V24, P346, DOI 10.1016/S0165-6147(03)00167-6; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; LUTTRELL LM, 1995, J BIOL CHEM, V270, P16495, DOI 10.1074/jbc.270.28.16495; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; McDonald PH, 1999, J BIOL CHEM, V274, P10677, DOI 10.1074/jbc.274.16.10677; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Pyne NJ, 2003, BIOCHEM SOC T, V31, P1220; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Revankar CM, 2004, J BIOL CHEM, V279, P24578, DOI 10.1074/jbc.M402121200; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101	63	1323	1361	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					512	517		10.1126/science.1109237	http://dx.doi.org/10.1126/science.1109237			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845844				2022-12-28	WOS:000228810500042
J	Shokat, KM				Shokat, KM			Chemicals call bacteria, and a new membrane protein machine answers	CELL			English	Editorial Material							SCREEN; DERIVATIVES; VANCOMYCIN; INHIBITOR; MOLECULES; GENETICS	A major challenge in biology is the discovery of the processes controlled by the roughly one-third of genes with no known function. One approach being explored to address this problem is the use of small molecules in conjunction with genetics-chemical genetics. A short review of this field is provided as an introduction to a series of papers in this issue of Cell in which a new type of chemical genetics revealed the function of a new outer membrane protein complex in bacteria.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94702 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley	Shokat, KM (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	shokat@cmp.ucsf.edu						Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Burdine L, 2004, CHEM BIOL, V11, P593, DOI 10.1016/j.chembiol.2004.05.001; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; DEUTSCHBAUER AM, 2005, GENETICS, V432; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; Ge M, 1999, SCIENCE, V284, P507, DOI 10.1126/science.284.5413.507; Holbeck SL, 2004, EUR J CANCER, V40, P785, DOI 10.1016/j.ejca.2003.11.022; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i	14	2	2	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 22	2005	121	2					163	166		10.1016/j.cell.2005.04.007	http://dx.doi.org/10.1016/j.cell.2005.04.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851024	Bronze			2022-12-28	WOS:000228705000005
J	Dobkin, BH				Dobkin, BH			Rehabilitation after stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; INDUCED MOVEMENT THERAPY; CONSTRAINT-INDUCED THERAPY; MOTOR RECOVERY; WALKING ABILITY; APHASIA THERAPY; LOWER-EXTREMITY; UPPER-LIMB; STIMULATION; METAANALYSIS		Univ Calif Los Angeles, Geffen Sch Med, Dept Neurol, Neurol Rehabil & Res Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dobkin, BH (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Dept Neurol, Neurol Rehabil & Res Program, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	bdobkin@mednet.ucla.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R24HD039629, R01HD046740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007479] Funding Source: NIH RePORTER; NICHD NIH HHS [R24 HD039629, R01 HD046740, HD046740, HD39629, HD07479] Funding Source: Medline; NINDS NIH HHS [T32 NS007479] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baron JC, 2004, CEREBROVASC DIS, V18, P260, DOI 10.1159/000080293; Barreca S, 2003, NEUROREHAB NEURAL RE, V17, P220, DOI 10.1177/0888439003259415; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Binkofski F, 2004, NEUROLOGY, V63, P1223, DOI 10.1212/01.WNL.0000140468.92212.BE; Bolton DAE, 2004, J NEUROL SCI, V223, P121, DOI 10.1016/j.jns.2004.05.005; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Carmichael ST, 2004, STROKE, V35, P758, DOI 10.1161/01.STR.0000117235.11156.55; Davis HF, 2003, JAMA-J AM MED ASSOC, V290, P1023; de Wit DCM, 2004, CLIN REHABIL, V18, P550, DOI 10.1191/0269215504cr770oa; Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8; Dobkin BH, 2003, CURR OPIN NEUROL, V16, P685, DOI 10.1097/00019052-200312000-00007; Dobkin BH, 2004, NEUROIMAGE, V23, P370, DOI 10.1016/j.neuroimage.2004.06.008; Dobkin BH., 2003, CLIN SCI NEUROLOGIC; Doesborgh SJC, 2004, STROKE, V35, P141, DOI 10.1161/01.STR.0000105460.52928.A6; Donnelly M, 2004, STROKE, V35, P127, DOI 10.1161/01.STR.0000106911.96026.8F; Dromerick AW, 2000, STROKE, V31, P2984, DOI 10.1161/01.STR.31.12.2984; Eriksson M, 2004, STROKE, V35, P936, DOI 10.1161/01.STR.0000121643.86762.9a; Gordon NF, 2004, CIRCULATION, V109, P2031, DOI 10.1161/01.CIR.0000126280.65777.A4; Greener J, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000425; GRESHAM GE, 1995, DHHS PUBLICATION; Grotta JC, 2004, STROKE, V35, P2699, DOI 10.1161/01.STR.0000143320.64953.c4; Hendricks HT, 2002, ARCH PHYS MED REHAB, V83, P1629, DOI 10.1053/apmr.2002.35473; Hesse S, 2003, CURR OPIN NEUROL, V16, P705, DOI 10.1097/00019052-200312000-00010; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Johansson BB, 2001, STROKE, V32, P707, DOI 10.1161/01.STR.32.3.707; Kalra L, 2004, BMJ-BRIT MED J, V328, P1099, DOI 10.1136/bmj.328.7448.1099; Kondziolka D, 2002, J CLIN NEUROSCI, V9, P225, DOI 10.1054/jocn.2001.1043; Koski L, 2004, NEUROREHAB NEURAL RE, V18, P230, DOI 10.1177/1545968304269210; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Lai SM, 2002, STROKE, V33, P1840, DOI 10.1161/01.STR.0000019289.15440.F2; Langhorne P, 2001, STROKE, V32, P268, DOI 10.1161/01.STR.32.1.268; Lannin NA, 2003, ARCH PHYS MED REHAB, V84, P297, DOI 10.1053/apmr.2003.50031; Legg L, 2004, LANCET, V363, P352; Lieber RL, 2003, MUSCLE NERVE, V28, P464, DOI 10.1002/mus.10446; Lincoln NB, 1999, STROKE, V30, P573, DOI 10.1161/01.STR.30.3.573; Liu KP, 2004, ARCH PHYS MED REHAB, V85, P1403, DOI 10.1016/j.apmr.2003.12.035; Moseley AM, 2003, STROKE, V34, P3006, DOI 10.1161/01.STR.0000102415.43108.66; Musso M, 1999, BRAIN, V122, P1781, DOI 10.1093/brain/122.9.1781; Narushima K, 2003, AM J PSYCHIAT, V160, P1157, DOI 10.1176/appi.ajp.160.6.1157; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Patten C, 2004, J REHABIL RES DEV, V41, P293, DOI 10.1682/JRRD.2004.03.0293; Peck KK, 2004, STROKE, V35, P554, DOI 10.1161/01.STR.0000110983.50753.9D; Plewnia C, 2004, NEUROLOGY, V62, P2124, DOI 10.1212/01.WNL.0000128041.92710.17; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Robey RR, 1998, J SPEECH LANG HEAR R, V41, P172, DOI 10.1044/jslhr.4101.172; Samsa GP, 2004, J REHABIL RES DEV, V41, P279, DOI 10.1682/JRRD.2003.08.0117; Saunders DH, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.001002/14651858.CD14003316.PUB14651852; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Steultjens EMJ, 2003, STROKE, V34, P676, DOI 10.1161/01.STR.0000057576.77308.30; van der Lee JH, 2001, CURR OPIN NEUROL, V14, P741, DOI 10.1097/00019052-200112000-00010; van Diepen PMJ, 2003, VIS COGN, V10, P79, DOI 10.1080/13506280143000023; WADE DT, 2002, INTERCOLLEGIATE WORK; Wellwood I, 2004, CLIN REHABIL, V18, P529, DOI 10.1191/0269215504cr768oa; Wolf SL, 2002, NEUROLOGIST, V8, P325, DOI 10.1097/00127893-200211000-00001; Yan TB, 2005, STROKE, V36, P80, DOI 10.1161/01.STR.0000149623.24906.63; 2000, COCHRANE DATABASE SY, V2	57	483	519	8	341	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1677	1684		10.1056/NEJMcp043511	http://dx.doi.org/10.1056/NEJMcp043511			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	918CE	15843670	Green Accepted			2022-12-28	WOS:000228515200009
J	Janke, C; Rogowski, K; Wloga, D; Regnard, C; Kajava, AV; Strub, JM; Temurak, N; van Dijk, J; Boucher, D; van Dorsselaer, A; Suryavanshi, S; Gaertig, J; Edde, B				Janke, C; Rogowski, K; Wloga, D; Regnard, C; Kajava, AV; Strub, JM; Temurak, N; van Dijk, J; Boucher, D; van Dorsselaer, A; Suryavanshi, S; Gaertig, J; Edde, B			Tubulin polyglutamylase enzymes are members of the TTL domain protein family	SCIENCE			English	Article							ALPHA-TUBULIN; TYROSINE LIGASE; CELLS; POLYGLYCYLATION; GLUTAMYLATION; TETRAHYMENA; CENTRIOLE; COMPLEX; BRAIN	Polyglutamylation of tubulin has been implicated in several functions of microtubules, but the identification of the responsible enzyme(s) has been challenging, We found that the neuronal tubulin polyglutamylase is a protein complex containing a tubulin tyrosine ligase-like (TTLL) protein, TTLL1. TTLL1 is a member of a large family of proteins with a TTL homology domain, whose members could catalyze ligations of diverse amino acids to tubulins or other substrates. In the model protist Tetrahymena thermophila, two conserved types of polyglutamylases were characterized that differ in substrate preference and subcellular localization.	Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; CNRS, Ctr Rech Biochim Macromol, F-34293 Montpellier, France; Adolf Butenandt Inst, Dept Mol Biol, D-80336 Munich, Germany; Univ Strasbourg 1, F-67087 Strasbourg, France; Univ Paris 06, CNRS, Biochim Cellulaire Lab, F-75252 Paris, France	University System of Georgia; University of Georgia; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Munich; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Gaertig, J (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	jgaertig@cb.uga.edu; bernard.edde@crbm.cnrs	Janke, Carsten/A-7279-2011; Kajava, Andrey V/E-1107-2014; Gaertig, Jacek/F-1553-2010; Włoga, Dorota/R-4078-2016	Janke, Carsten/0000-0001-7053-2000; Kajava, Andrey V/0000-0002-2342-6886; Włoga, Dorota/0000-0003-3314-7773; Strub, Jean-Marc/0000-0001-6224-3428; Regnard, Catherine/0000-0001-9915-7494; Rogowski, Krzysztof/0000-0002-0206-3289				Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.3.CO;2-3; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; Campbell PK, 2002, GENETICS, V162, P307; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Gaertig J, 2000, J EUKARYOT MICROBIOL, V47, P185, DOI 10.1111/j.1550-7408.2000.tb00037.x; Gagnon C, 1996, J CELL SCI, V109, P1545; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Hara T, 1996, BIOCHEMISTRY-US, V35, P11967, DOI 10.1021/bi9605245; *I GEN RES, TETR THERM SEQ BLAST; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Million K, 1999, J CELL SCI, V112, P4357; PRESTON SF, 1979, J MOL EVOL, V13, P233, DOI 10.1007/BF01739482; RAYBIN D, 1977, J CELL BIOL, V73, P492, DOI 10.1083/jcb.73.2.492; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; Regnard C, 2003, J CELL SCI, V116, P4181, DOI 10.1242/jcs.00743; Regnard C, 1998, BIOCHEMISTRY-US, V37, P8395, DOI 10.1021/bi9804131; Regnard C, 2000, J BIOL CHEM, V275, P15969, DOI 10.1074/jbc.M000045200; Regnard C, 1999, J CELL SCI, V112, P4281; ROGOWSKI K, UNPUB; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; Trichet V, 2000, GENE, V257, P109, DOI 10.1016/S0378-1119(00)00383-8	25	222	253	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1758	1762		10.1126/science.1113010	http://dx.doi.org/10.1126/science.1113010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15890843				2022-12-28	WOS:000229926800046
J	Maconochie, I; Redhead, J				Maconochie, I; Redhead, J			The National Service Framework: paediatric emergency care	LANCET			English	Editorial Material									St Marys Hosp, Paediat A&E Dept, London W2 1NY, England	Imperial College London	Maconochie, I (corresponding author), St Marys Hosp, Paediat A&E Dept, Praed St, London W2 1NY, England.	i.maconochie@imperial.ac.uk		Maconochie, Ian/0000-0001-6319-8550				Kerr D, 2002, BMJ-BRIT MED J, V324, P164, DOI 10.1136/bmj.324.7330.164; King W, 2003, EMERG MED J, V20, P222, DOI 10.1136/emj.20.3.222; National Health Service, 2000, NHS CANC PLAN; Salter R, 2005, BMJ-BRIT MED J, V330, P73, DOI 10.1136/bmj.38313.580324.F7; Western Australia Commissioner for Children and Young People, 2020, NAT SERV FRAM CHILDR	5	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 14	2005	365	9472					1673	1674		10.1016/S0140-6736(05)66529-4	http://dx.doi.org/10.1016/S0140-6736(05)66529-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925VV	15894087				2022-12-28	WOS:000229082300009
J	Gardner, TJ; Naef, F; Naef-, F				Gardner, TJ; Naef, F; Naef-, F			Freedom and rules: The acquisition and reprogramming of a bird's learned song	SCIENCE			English	Article							CANARY SONG; ZEBRA FINCHES; SPEECH	Canary song is hierarchically structured: Short stereotyped syllables are repeated to form phrases, which in turn are arranged to form songs. This structure occurs even in the songs of young isolates, which suggests that innate rules govern canary song development. However, juveniles that had never heard normal song imitated abnormal synthetic songs with great accuracy, even when the tutor songs lacked phrasing. As the birds matured, imitated songs were reprogrammed to form typical canary phrasing. Thus, imitation and innate song constraints are separate processes that can be segregated in time: freedom in youth, rules in adulthood.	Rockefeller Univ, Lab Anim Behav, New York, NY 10021 USA; Rockefeller Univ, Phys Math Lab, New York, NY 10021 USA; Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Swiss Inst Bioinformat, CH-1066 Epalinges, Switzerland	Rockefeller University; Rockefeller University; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics	Gardner, TJ (corresponding author), Rockefeller Univ, Lab Anim Behav, 1230 York Ave, New York, NY 10021 USA.	tgardner@mit.edu	Naef, Felix/C-9527-2011	Naef, Felix/0000-0001-9786-3037	NIMH NIH HHS [MH63132, MH18343] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018343, R37MH018343] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson SE, 1996, J ACOUST SOC AM, V100, P1209, DOI 10.1121/1.415968; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Gardner T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.208101; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; GUTTINGER HR, 1981, Z TIERPSYCHOL, V56, P323; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; MARLER P, 1981, SCIENCE, V213, P780, DOI 10.1126/science.213.4509.780; MARLER P, 1982, DEV PSYCHOBIOL, V15, P369, DOI 10.1002/dev.420150409; MARLER P, 1970, AM SCI, V58, P669; MARLER P, 1977, J COMP PHYSIOL PSYCH, V91, P8, DOI 10.1037/h0077303; Marler Peter, 2004, P1, DOI 10.1016/B978-012473070-0/50004-9; Mundinger PC, 1995, ANIM BEHAV, V50, P1491, DOI 10.1016/0003-3472(95)80006-9; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1986, BEHAV NEURAL BIOL, V46, P445, DOI 10.1016/S0163-1047(86)90485-1; Rabiner L., 1993, FUNDAMENTALS SPEECH; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; THORPE W. H., 1958, IBIS, V100, P535, DOI 10.1111/j.1474-919X.1958.tb07960.x; Thorpe W. H., 1955, Ibis, V97, P247, DOI 10.1111/j.1474-919X.1955.tb01911.x; Vu ET, 1998, J NEUROSCI, V18, P9088; VU ET, 1994, J NEUROSCI, V14, P6924; WANCHUN L, IN PRESS P NATL ACAD; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	23	86	86	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					1046	1049		10.1126/science.1108214	http://dx.doi.org/10.1126/science.1108214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890887				2022-12-28	WOS:000229190700054
J	Lastapis, M; Martin, M; Riedel, D; Hellner, L; Comtet, G; Dujardin, G				Lastapis, M; Martin, M; Riedel, D; Hellner, L; Comtet, G; Dujardin, G			Picometer-scale electronic control of molecular dynamics inside a single molecule	SCIENCE			English	Article							VIBRATIONAL SPECTROSCOPY; ROTATIONAL MOTION; MANIPULATION; EXCITATION; ATOMS	Tunneling electrons from a low-temperature (5 kelvin) scanning tunneling microscope were used to control, through resonant electronic excitation, the molecular dynamics of an individual biphenyl molecule adsorbed on a silicon(100) surface. Different reversible molecular movements were selectively activated by tuning the electron energy and by selecting precise locations for the excitation inside the molecule. Both the spatial selectivity and energy dependence of the electronic control are supported by spectroscopic measurements with the scanning tunneling microscope. These experiments demonstrate the feasibility of controlling the molecular dynamics of a single molecule through the localization of the electronic excitation inside the molecule.	Univ Paris 11, Photophys Mol Lab, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay	Lastapis, M (corresponding author), Univ Paris 11, Photophys Mol Lab, Batiment 210, F-91405 Orsay, France.							Bartels L, 1997, PHYS REV LETT, V79, P697, DOI 10.1103/PhysRevLett.79.697; Bartels L, 1998, PHYS REV LETT, V80, P2004, DOI 10.1103/PhysRevLett.80.2004; Gokhale S, 1998, J CHEM PHYS, V108, P5554, DOI 10.1063/1.475945; Joachim C, 2001, STRUCT BOND, V99, P1; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; LANG ND, 1986, PHYS REV B, V34, P5947, DOI 10.1103/PhysRevB.34.5947; Lauhon LJ, 2000, SURF SCI, V451, P219, DOI 10.1016/S0039-6028(00)00030-3; Lorente N, 2000, PHYS REV LETT, V85, P2997, DOI 10.1103/PhysRevLett.85.2997; Mayne AJ, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.045409; Nakamura Y, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.266805; Pascual JI, 2003, NATURE, V423, P525, DOI 10.1038/nature01649; Qiu XH, 2003, SCIENCE, V299, P542, DOI 10.1126/science.1078675; Rabitz H, 2000, SCIENCE, V288, P824, DOI 10.1126/science.288.5467.824; Rice SA, 2000, NATURE, V403, P496, DOI 10.1038/35000695; Riedel D, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.121301; Sloan PA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.118301; Stipe BC, 1998, SCIENCE, V279, P1907, DOI 10.1126/science.279.5358.1907; Stipe BC, 1998, PHYS REV LETT, V81, P1263, DOI 10.1103/PhysRevLett.81.1263; Stipe BC, 1999, PHYS REV LETT, V82, P1724, DOI 10.1103/PhysRevLett.82.1724; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Stipe BC, 1997, PHYS REV LETT, V78, P4410, DOI 10.1103/PhysRevLett.78.4410; Stokbro K, 1998, PHYS REV LETT, V80, P2618, DOI 10.1103/PhysRevLett.80.2618; Teillet-Billy D, 2000, PHYS REV B, V62, pR13306, DOI 10.1103/PhysRevB.62.R13306; WANNIER GH, 1953, PHYS REV, V90, P817, DOI 10.1103/PhysRev.90.817; Yazdani A, 1996, SCIENCE, V272, P1921, DOI 10.1126/science.272.5270.1921; ZEWAIL AH, 2003, NOBEL LECT CHEM 1996, P274	26	189	190	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1000	1003		10.1126/science.1108048	http://dx.doi.org/10.1126/science.1108048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890878				2022-12-28	WOS:000229190700040
J	Waite, JH; Niemann, H; Yelle, RV; Kasprzak, WT; Cravens, TE; Luhmann, JG; McNutt, RL; Ip, WH; Gell, D; De La Haye, V; Muller-Wordag, I; Magee, B; Borggren, N; Ledvina, S; Fletcher, G; Walter, E; Miller, R; Scherer, S; Thorpe, R; Xu, J; Block, B; Arnett, K				Waite, JH; Niemann, H; Yelle, RV; Kasprzak, WT; Cravens, TE; Luhmann, JG; McNutt, RL; Ip, WH; Gell, D; De La Haye, V; Muller-Wordag, I; Magee, B; Borggren, N; Ledvina, S; Fletcher, G; Walter, E; Miller, R; Scherer, S; Thorpe, R; Xu, J; Block, B; Arnett, K			Ion Neutral Mass Spectrometer results from the first flyby of Titan	SCIENCE			English	Article							ISOTOPIC FRACTIONATION; NITROGEN; ATMOSPHERE; ORIGIN; TEMPERATURE; C-12/C-13; CLATHRATE; HCN	The Cassini Ion Neutral Mass Spectrometer (INMS) has obtained the first in situ composition measurements of the neutral densities of molecular nitrogen, methane, molecular hydrogen, argon, and a host of stable carbon-nitrile compounds in Titan's upper atmosphere. INMS in situ mass spectrometry has also provided evidence for atmospheric waves in the upper atmosphere and the first direct measurements of isotopes of nitrogen, carbon, and argon, which reveal interesting clues about the evolution of the atmosphere. The bulk composition and thermal structure of the moon's upper atmosphere do not appear to have changed considerably since the Voyager 1 flyby.	Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; Univ London Imperial Coll Sci Technol & Med, Space & Atmospher Phys Grp, London SW7 2BW, England; SW Res Inst, San Antonio, TX 78228 USA	University of Michigan System; University of Michigan; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Arizona; University of Kansas; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Central University; Imperial College London; Southwest Research Institute	Waite, JH (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA.		McNutt, Ralph L/E-8006-2010	McNutt, Ralph L/0000-0002-4722-9166				ATREYA SK, 1978, SCIENCE, V201, P611, DOI 10.1126/science.201.4356.611; COUSTENIS A, 1989, ICARUS, V80, P54, DOI 10.1016/0019-1035(89)90161-9; Cravens TE, 1997, PLANET SPACE SCI, V45, P889, DOI 10.1016/S0032-0633(97)00064-0; FEGLEY B, 1995, GLOBAL EARTH PHYS HD, P320, DOI DOI 10.1029/RF001P0320; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; Gautier D, 2005, SPACE SCI REV, V116, P25, DOI 10.1007/s11214-005-1946-2; Gurwell MA, 2004, ASTROPHYS J, V616, pL7, DOI 10.1086/423954; Hidayat T, 1997, ICARUS, V126, P170, DOI 10.1006/icar.1996.5640; JOHNS TF, 1957, ATOMIC ENERGY RES ES; Kallenbach R, 1998, ASTROPHYS J, V507, pL185, DOI 10.1086/311702; Kasprzak W, 1996, P SOC PHOTO-OPT INS, V2803, P129, DOI 10.1117/12.253413; LODDERS K, 1999, PLANETARY SCI COMPAN; LUNINE JI, 1987, ICARUS, V70, P61, DOI 10.1016/0019-1035(87)90075-3; LUNINE JI, 1985, ASTROPHYS J SUPPL S, V58, P493, DOI 10.1086/191050; Lunine JI, 1999, PLANET SPACE SCI, V47, P1291, DOI 10.1016/S0032-0633(99)00052-5; MCKAY CP, 1988, NATURE, V332, P520, DOI 10.1038/332520a0; Mousis O, 2002, ICARUS, V156, P162, DOI 10.1006/icar.2001.6782; Owen T, 2001, ASTROPHYS J, V553, pL77, DOI 10.1086/320501; OWEN T, 1982, PLANET SPACE SCI, V30, P833, DOI 10.1016/0032-0633(82)90115-5; Owen TC, 2000, PLANET SPACE SCI, V48, P747, DOI 10.1016/S0032-0633(00)00040-4; Press W., 1986, NUMERICAL RECIPES; STROBEL DF, 1997, ESA SPECIAL PUBLICAT, P299; Terzieva R, 2000, MON NOT R ASTRON SOC, V317, P563, DOI 10.1046/j.1365-8711.2000.03618.x; Vervack RJ, 2004, ICARUS, V170, P91, DOI 10.1016/j.icarus.2004.03.005; Waite JH, 2004, SPACE SCI REV, V114, P113, DOI 10.1007/s11214-004-1408-2; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Yung YL, 1997, SCIENCE, V278, P1778, DOI 10.1126/science.278.5344.1778; YUNG YL, COMMUNICATION	28	348	350	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					982	986		10.1126/science.1110652	http://dx.doi.org/10.1126/science.1110652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890873				2022-12-28	WOS:000229190700034
J	Kathiresan, S; Kelsey, PB; Steere, AC; Foster, CS; Curvelo, MS; Stone, JR; Harris, NL; Stone, JR; Johnsen, AK				Kathiresan, S; Kelsey, PB; Steere, AC; Foster, CS; Curvelo, MS; Stone, JR; Harris, NL; Stone, JR; Johnsen, AK			Case 14-2005: A 38-year-old man with fever and blurred vision - Systemic small-vessel vasculitis involving small vessels and small arteries; probably immune-complex vasculitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LEUKOCYTOCLASTIC VASCULITIS		Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Div Gastroenterol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Div Rheumatol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA.			Steere, Allen/0000-0002-5268-9853				Bansal R, 2003, INT J CARDIOL, V88, P91, DOI 10.1016/S0167-5273(02)00371-6; Blanco R, 1998, MEDICINE, V77, P403, DOI 10.1097/00005792-199811000-00007; BOLOGNA JL, 2001, HARRISONS PRINCIPLES, P329; Costedoat-Chalumeau N, 2002, RHEUMATOLOGY, V41, P708, DOI 10.1093/rheumatology/41.6.708; FAUCI AS, 1978, ANN INTERN MED, V89, P660, DOI 10.7326/0003-4819-89-5-660; HANNEDOUCHE T, 1987, J ANTIMICROB CHEMOTH, V20, P3, DOI 10.1093/jac/20.1.3; Iannone F, 2003, ANN RHEUM DIS, V62, P785, DOI 10.1136/ard.62.8.785; Inoue M, 1998, HUM PATHOL, V29, P223, DOI 10.1016/S0046-8177(98)90039-9; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Levin S, 1995, Curr Clin Top Infect Dis, V15, P19; LIGHTFOOT RW, 1990, ARTHRITIS RHEUM, V33, P1088; Lotti TM, 1999, ADV EXP MED BIOL, V455, P115; Lum PNL, 2000, DIAGN MICR INFEC DIS, V37, P275, DOI 10.1016/S0732-8893(00)00151-6; *MASS GEN HOSP, 2003, NEW ENGL J MED, V348, P834; MORGAN CM, 1986, RETINA-J RET VIT DIS, V6, P205, DOI 10.1097/00006982-198606040-00002; MOUTSOPOULOS HM, 1983, ANN RHEUM DIS, V42, P192, DOI 10.1136/ard.42.2.192; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; SOMER T, 1995, CLIN INFECT DIS, V20, P1010, DOI 10.1093/clinids/20.4.1010; ten Holder SM, 2002, ANN PHARMACOTHER, V36, P130, DOI 10.1345/1542-6270(2002)036<0130:CASMOD>2.0.CO;2	20	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					2003	2012		10.1056/NEJMcpc059010	http://dx.doi.org/10.1056/NEJMcpc059010			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888702				2022-12-28	WOS:000229017100013
J	Riley, JR; Greggers, U; Smith, AD; Reynolds, DR; Menzel, R				Riley, JR; Greggers, U; Smith, AD; Reynolds, DR; Menzel, R			The flight paths of honeybees recruited by the waggle dance	NATURE			English	Article							HARMONIC RADAR; BEES; TRACKING	In the 'dance language' of honeybees(1,2), the dancer generates a specific, coded message that describes the direction and distance from the hive of a new food source, and this message is displaced in both space and time from the dancer's discovery of that source. Karl von Frisch concluded that bees 'recruited' by this dance used the information encoded in it to guide them directly to the remote food source, and this Nobel Prize-winning discovery revealed the most sophisticated example of non-primate communication that we know of(3,4). In spite of some initial scepticism(5-9), almost all biologists are now convinced that von Frisch was correct(3,4,10-14), but what has hitherto been lacking is a quantitative description of how effectively recruits translate the code in the dance into flight to their destinations. Using harmonic radar(15-17) to record the actual flight paths of recruited bees, we now provide that description.	Rothamsted Res, Plant & Invertebrate Ecol Div, Harpenden AL5 2JQ, Herts, England; Free Univ Berlin, Fachbereich Biol Chem Pharm, Inst Biol Neurobiol, D-14195 Berlin, Germany; Univ Greenwich, Nat Resources Inst, Plant Anim & Human Hlth Grp, Chatham ME4 4TB, Kent, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Free University of Berlin; University of Greenwich	Riley, JR (corresponding author), Rothamsted Res, Plant & Invertebrate Ecol Div, Harpenden AL5 2JQ, Herts, England.	joe@radarent.freeserve.co.uk	Reynolds, Donald R/C-7361-2013	Reynolds, Donald/0000-0001-8749-7491				Baker TC, 1996, PHYSIOL ENTOMOL, V21, P20, DOI 10.1111/j.1365-3032.1996.tb00831.x; Carde RT, 1997, INSECT PHEROMONE RESEARCH, P275; CHITTKA L, 1995, ETHOLOGY, V99, P117, DOI 10.1111/j.1439-0310.1995.tb01093.x; Dyer F.C., 1994, ANIM BEHAV, V47, P1242; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; ESCH H, 1970, Z VERGL PHYSIOL, V68, P175, DOI 10.1007/BF00297693; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; GOULD JL, 1975, SCIENCE, V189, P685, DOI 10.1126/science.1154023; GOULD JL, 1976, Q REV BIOL, V51, P211, DOI 10.1086/409309; MAUTZ D, 1971, Z VERGL PHYSIOL, V72, P197, DOI 10.1007/BF00297822; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Reynolds D. R., 1997, P111; Riley Joseph R., 2001, Symposia of the Royal Entomological Society of London, V20, P129, DOI 10.1079/9780851994567.0129; Riley JR, 1999, NATURE, V400, P126, DOI 10.1038/22029; Riley JR, 2003, P ROY SOC B-BIOL SCI, V270, P2421, DOI 10.1098/rspb.2003.2542; Riley JR, 2002, COMPUT ELECTRON AGR, V35, P151, DOI 10.1016/S0168-1699(02)00016-9; Riley JR, 1996, NATURE, V379, P29, DOI 10.1038/379029b0; Riley JR, 1998, J INSECT BEHAV, V11, P287, DOI 10.1023/A:1021004209198; SEELEY T, 1991, NATURE, V349, P114, DOI 10.1038/349114a0; SEELEY TD, 1983, BEHAV ECOL SOCIOBIOL, V12, P253, DOI 10.1007/BF00290778; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Tautz J, 2003, J COMP PHYSIOL A, V189, P293, DOI 10.1007/s00359-003-0402-6; TOWNE W F, 1988, Journal of Insect Behavior, V1, P129, DOI 10.1007/BF01052234; von Frisch K., 1967, DANCE LANGUAGE ORIEN; VONFRISCH K, 1967, SCIENCE, V158, P1072; WELLS PH, 1973, NATURE, V241, P171, DOI 10.1038/241171a0; Wenner AM, 2002, J INSECT BEHAV, V15, P859, DOI 10.1023/A:1021131725124; WENNER AM, 1991, AM ZOOL, V31, P768; Wenner AM., 1990, ANATOMY CONTROVERSY, DOI [10.7312/wenn90330, DOI 10.7312/WENN90330]	30	242	248	23	298	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					205	207		10.1038/nature03526	http://dx.doi.org/10.1038/nature03526			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889092				2022-12-28	WOS:000229021100040
J	McManus, IC; Lissauer, T; Williams, SE				McManus, IC; Lissauer, T; Williams, SE			Detecting cheating in written medical examinations by statistical analysis of similarity of answers: pilot study	BRITISH MEDICAL JOURNAL			English	Article							STUDENTS; SCHOOL	Objective To assess whether a computer program using a variant of Angoff's method can detect anomalous behaviour indicative of cheating in multiple choice medical examinations. Design Statistical analysis of 11 examinations held by the Royal College of Paediatrics and Child Health. Setting UK postgraduate medical examination. Participants Examination candidates. Main outcome measures Detection of anomalous candidate pairs by regression of similarity of correct answers in all possible pairs of candidates on the overall proportion of correct answers. Anomalous pairs were subsequently assessed in terms of examination centres and the seating plan of candidates, to assess adjacency. Results The 11 examinations were taken by a total of 11 518 candidates, and Acinonyx examined 6 178 628 pairs of candidates. Two examinations showed no anomalies, and one examination found an anomaly resulting from a scanning error. The other eight examinations showed 13 anomalies compatible with cheating, and in each pair the two candidates had sat the examination at the same centre, and for six examinations with seating plans, the candidates in the anomalous pairs had been seated side by side. The raw probabilities of the anomalies varied from 3.9 x 10(-11) to 9.3 x 10(-30) (median = 1.1 x 10(-17)), with Bonferroni-corrected probabilities in the range 2.4 x 10(-5) to 4.1 x 10(-24) (median = 16 x 10(-11)). This suggests that one anomalous pair is found for every 1000 or so candidates taking this postgraduate examination. Conclusions This statistical technique identified a small proportion of candidates who had very similar patterns of correctly answered questions. The likelihood is that one candidate has copied from the other, or that there was collusion, or that a technical error occurred in the exams department (as happened in a single case). Analysis of similarities can be used to identify cheating and as part of the quality assurance process of postgraduate medical examinations.	UCL, Dept Psychol, London WC1E 6BT, England; Royal Coll Paediat & Child Hlth, Examinat Dept, London W1W 6DE, England	University of London; University College London	McManus, IC (corresponding author), UCL, Dept Psychol, London WC1E 6BT, England.	i.mcmanus@ucl.ac.uk		McManus, Ian/0000-0003-3510-4814				ANGOFF WH, 1974, J AM STAT ASSOC, V69, P44, DOI 10.2307/2285498; Baldwin DC, 1996, ACAD MED, V71, P267, DOI 10.1097/00001888-199603000-00020; BAY L, 1998, RES HIGH EDUC, V39, P235; Carlova J, 1984, Med Econ, V61, P84; Cizek G.J., 1999, CHEATING TESTS DO IT; General Medical Council, 2001, GOOD MED PRACT; Merwin SE, 2001, HEALTH PHYS, V81, P670, DOI 10.1097/00004032-200112000-00017; Nizer Louis, 1961, MY LIFE COURT; ROZANCE CP, 1991, JAMA-J AM MED ASSOC, V255, P2453; SIERLES F, 1980, J MED EDUC, V55, P124; STEARNS SA, 1997, J ASS COMMUNICATION, P133; STIMMEL B, 1982, AM J MED, V73, P160, DOI 10.1016/0002-9343(82)90172-3; Wesolowsky GO, 2000, J APPL STAT, V27, P909, DOI 10.1080/02664760050120588	13	18	20	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 7	2005	330	7499					1064	1066		10.1136/bmj.330.7499.1064	http://dx.doi.org/10.1136/bmj.330.7499.1064			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925YY	15879391	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000229090900021
J	Foster, I				Foster, I			Service-oriented science	SCIENCE			English	Article							SYSTEM	New information architectures enable new approaches to publishing and accessing valuable data and programs. So-called service-oriented architectures define standard interfaces and protocols that allow developers to encapsulate information tools as services that clients can access without knowledge of, or control over, their internal workings. Thus, tools formerly accessible only to the specialist can be made available to all; previously manual data-processing and analysis tasks can be automated by having services access services. Such service-oriented approaches to science are already being applied successfully, in some cases at substantial scales, but much more effort is required before these approaches are applied routinely across many disciplines. Grid technologies can accelerate the development and adoption of service-oriented science by enabling a separation of concerns between discipline-specific content and domain-independent software and hardware infrastructure.	Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Foster, I (corresponding author), Argonne Natl Lab, Div Math & Comp Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.	foster@mcs.anl.gov						Bavier A, 2004, USENIX ASSOCIATION PROCEEDINGS OF THE FIRST SYMPOSIUM ON NETWORKED SYSTEMS DESIGN AND IMPLEMENTATION (NSDI'04), P253; Berners-Lee T, 2001, SCI AM, V284, P34, DOI 10.1038/scientificamerican0501-34; Bernholdt D, 2005, P IEEE, V93, P485, DOI 10.1109/JPROC.2004.842745; BOOTH D, 2003, IN PRESS WEB SERVICE; Culler DE, 2004, SCI AM, V290, P84, DOI 10.1038/scientificamerican0604-84; DeFanti T, 2003, COMMUN ACM, V46, P34, DOI 10.1145/948383.948407; ELLISMAN M, 2004, GRID2 BLUEPRINT NEW, P109; Foster I, 2004, 13TH IEEE INTERNATIONAL SYMPOSIUM ON HIGH PERFORMANCE DISTRIBUTED COMPUTING, PROCEEDINGS, P236, DOI 10.1109/HPDC.2004.1323544; Foster I, 2002, COMPUTER, V35, P37, DOI 10.1109/MC.2002.1009167; Foster I, 2003, SCI AM, V288, P78, DOI 10.1038/scientificamerican0403-78; GOBLE C, 2004, GRID BLUEPRINT NEW C, P121; Hey T, 2005, SCIENCE, V308, P817, DOI 10.1126/science.1110410; Keahey K, 2002, FUTURE GENER COMP SY, V18, P1005, DOI 10.1016/S0167-739X(02)00081-X; Martone ME, 2004, NAT NEUROSCI, V7, P467, DOI 10.1038/nn1229; Myers JD, 2003, COMPUT SCI ENG, V5, P44, DOI 10.1109/MCISE.2003.1196306; *NAT SCI FDN BLUE, 2003, REV SCI ENG CYB REP; OCHSENBEIN F, 2004, VOTABLE FORMAT DEFIN; Overbeek R, 2000, NUCLEIC ACIDS RES, V28, P123, DOI 10.1093/nar/28.1.123; Pearlman L, 2004, 13TH IEEE INTERNATIONAL SYMPOSIUM ON HIGH PERFORMANCE DISTRIBUTED COMPUTING, PROCEEDINGS, P14; Stein L, 2002, NATURE, V417, P119, DOI 10.1038/417119a; Stevens RD, 2004, BIOINFORMATICS, V20, P303, DOI 10.1093/bioinformatics/bth944; SULAKHE D, IN PRESS J CLIN MONI; Szalay A, 2001, SCIENCE, V293, P2037, DOI 10.1126/science.293.5537.2037; Tsvetanov ZI, 2000, ASTROPHYS J, V531, pL61, DOI 10.1086/312515	24	269	292	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					814	817		10.1126/science.1110411	http://dx.doi.org/10.1126/science.1110411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879208				2022-12-28	WOS:000228986500037
J	Macdonald, PM				Macdonald, PM			Translational repression by bicoid: Competition for the Cap	CELL			English	Editorial Material							CAUDAL MESSENGER-RNA; BINDING	Eggs and embryos have proven to be fertile grounds for discovery and characterization of a variety of mechanisms used in posttranscriptional control of gene expression, mechanisms that are central to embryonic patterning and development. In this issue of Cell, Cho et al. (2005) solve a puzzle surrounding the action of the Drosophila Bicoid morphogen in formation of the Caudal protein gradient and in doing so describe a novel mechanism of translational repression.	Univ Texas, Inst Cellular & Mol Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Macdonald, PM (corresponding author), Univ Texas, Inst Cellular & Mol Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.							Chan SK, 1997, NATURE, V388, P634, DOI 10.1038/41692; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Niessing D, 1999, EMBO J, V18, P1966, DOI 10.1093/emboj/18.7.1966; Niessing D, 2002, GENE DEV, V16, P2576, DOI 10.1101/gad.240002; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704	8	2	2	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 6	2005	121	3					321	322		10.1016/j.cell.2005.04.018	http://dx.doi.org/10.1016/j.cell.2005.04.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882614	Bronze			2022-12-28	WOS:000229031600002
J	Huang, JK; Hu, RF; Rozelle, S; Pray, C				Huang, JK; Hu, RF; Rozelle, S; Pray, C			Insect-resistant GM rice in farmers' fields: Assessing productivity and health effects in China	SCIENCE			English	Article							BIOTECHNOLOGY; PESTICIDES	Although no country to date has released a major genetically modified (GM) food grain crop, China is on the threshold of commercializing GM rice. This paper studies two of the four GM varieties that are now in farm-level pre-production trials, the last step before commercialization. Farm surveys of randomly selected farm households that are cultivating the insect-resistant GM rice varieties, without the aid of experimental station technicians, demonstrate that when compared with households cultivating non-GM rice, small and poor farm households benefit from adopting GM rice by both higher crop yields and reduced use of pesticides, which also contribute to improved health.	Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Ctr Chinese Agr Policy, Beijing 100101, Peoples R China; Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA; Rutgers State Univ, Dept Agr Food & Resource Econ, New Brunswick, NJ 08901 USA	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; University of California System; University of California Davis; Rutgers State University New Brunswick	Huang, JK (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Ctr Chinese Agr Policy, Jia 11,Datun Rd, Beijing 100101, Peoples R China.	jkhuang.ccap@igsnrr.ac.cn						ANTLE JM, 1994, AM J AGR ECON, V76, P418, DOI 10.2307/1243654; Deng CY, 2003, ACTA BOT SIN, V45, P1084; HUANG J, 2001, 2001RR3 EEPSEA IDRC; Huang JK, 2003, AGR ECON, V29, P55, DOI 10.1016/S0169-5150(03)00044-6; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Paarlberg R. L., 2003, ISSUES SCI TECHN SPR; Qaim M, 2003, SCIENCE, V299, P900, DOI 10.1126/science.1080609; Tu JM, 2000, NAT BIOTECHNOL, V18, P1101, DOI 10.1038/80310	8	250	302	3	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					688	690		10.1126/science.1108972	http://dx.doi.org/10.1126/science.1108972			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860626				2022-12-28	WOS:000228810900048
J	Kremsner, PG				Kremsner, PG			Effectiveness trials in African children with malaria?	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM MALARIA; CO-ARTEMETHER; SULFADOXINE-PYRIMETHAMINE; UNCOMPLICATED MALARIA; AMODIAQUINE; CLINDAMYCIN; ARTESUNATE; QUININE		Albert Schweitzer Hosp Lambarene, Med Res Unit, Lambarene, Gabon; Univ Tubingen, Inst Trop Med, Dept Parasitol, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen	Kremsner, PG (corresponding author), Albert Schweitzer Hosp Lambarene, Med Res Unit, Lambarene, Gabon.	peter.kremsner@uni-tuebingen.de						Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; Athan E, 2001, S AFR MED J, V91, P592; Borrmann S, 2004, J INFECT DIS, V190, P1534, DOI 10.1086/424603; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Issifou S, 2004, WIEN KLIN WOCHENSCHR, V116, P332, DOI 10.1007/BF03040905; KREMSNER PG, 1994, J INFECT DIS, V169, P467, DOI 10.1093/infdis/169.2.467; Kremsner PG, 2004, LANCET, V364, P285, DOI 10.1016/S0140-6736(04)16680-4; Lell B, 2004, WIEN KLIN WOCHENSCHR, V116, P286, DOI 10.1007/BF03040897; Mehta U, 2005, T ROY SOC TROP MED H, V99, P313, DOI 10.1016/j.trstmh.2004.11.006; NTOUMI F, 1995, AM J TROP MED HYG, V52, P81, DOI 10.4269/ajtmh.1995.52.81; Olliaro P, 1996, LANCET, V348, P1196, DOI 10.1016/S0140-6736(96)06217-4; Radloff PD, 1996, LANCET, V347, P1511, DOI 10.1016/S0140-6736(96)90671-6; Reinhart H, 2005, T ROY SOC TROP MED H, V99, P315, DOI 10.1016/j.trstmh.2004.11.008; Toovey S, 2004, T ROY SOC TROP MED H, V98, P261, DOI 10.1016/j.trstmh.2003.11.001; van Vugt M, 2000, T ROY SOC TROP MED H, V94, P545, DOI 10.1016/S0035-9203(00)90082-8; Wernsdorfer Walther H, 2004, Expert Rev Anti Infect Ther, V2, P181, DOI 10.1586/14787210.2.2.181	17	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1441	1443						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850613				2022-12-28	WOS:000228651600004
J	Krleza-Jeric, K; Chan, AW; Dickersin, K; Sim, I; Grimshaw, J; Gluud, C				Krleza-Jeric, K; Chan, AW; Dickersin, K; Sim, I; Grimshaw, J; Gluud, C		Ottawa Grp	Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OUTCOME REPORTING BIAS; RANDOMIZED-TRIALS; UNPUBLISHED DATA; CLINICAL-TRIALS		Canadian Inst Hlth Res, Randomised Controlled Trials Unit, Ottawa, ON K1A 0W9, Canada; Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; Copenhagen Univ Hosp, European Clin Res Infrastruct Network, Copenhagen, Denmark	Institute for Work & Health; Brown University; University of California System; University of California San Francisco; University of Ottawa; Ottawa Hospital Research Institute; University of Copenhagen	Krleza-Jeric, K (corresponding author), Canadian Inst Hlth Res, Randomised Controlled Trials Unit, 160 Elgin St, Ottawa, ON K1A 0W9, Canada.	kkrleza-jeric@cihr-irsc.gc.ca	Dickersin, Kay/A-4576-2008; Gluud, Christian/AAY-1027-2021; Grimshaw, Jeremy/D-8726-2013; Gluud, Christian/HGB-3191-2022; Krleza-Jeric, Karmela/M-5253-2018	Gluud, Christian/0000-0002-8861-0799; Krleza-Jeric, Karmela/0000-0001-9377-0917; Grimshaw, Jeremy/0000-0001-8015-8243				Abbasi K, 2004, BRIT MED J, V329, P637, DOI 10.1136/bmj.329.7467.637; *AM MED ASS, 2004, INFL FUND SOURC OUTC; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; COOK DJ, 1993, JAMA-J AM MED ASSOC, V269, P2749, DOI 10.1001/jama.269.21.2749; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Dyer O, 2004, BRIT MED J, V328, P1395, DOI 10.1136/bmj.328.7453.1395; Evans T, 2004, LANCET, V363, P1413, DOI 10.1016/S0140-6736(04)16136-9; Godlee F., 2003, PEER REV HLTH SCI, P91; Hrachovec JB, 2001, JAMA-J AM MED ASSOC, V286, P2398, DOI 10.1001/jama.286.19.2398; *INT ALL PHARM ASS, 2005, JOINT POS DISD CLIN; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2784, DOI 10.1001/jama.287.21.2784; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; MacLean CH, 2003, J CLIN EPIDEMIOL, V56, P44, DOI 10.1016/S0895-4356(02)00520-6; Moher D, 2004, CAN MED ASSOC J, V171, P750, DOI 10.1503/cmaj.1041299; *PHARM RES MAN AM, 2004, PRINC COND CLIN TRIA; Rennie D, 2004, JAMA-J AM MED ASSOC, V292, P1359, DOI 10.1001/jama.292.11.1359; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	20	158	169	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2005	330	7497					956	958		10.1136/bmj.330.7497.956	http://dx.doi.org/10.1136/bmj.330.7497.956			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920UP	15845980	Green Published			2022-12-28	WOS:000228715900026
J	Spiegel, PB				Spiegel, PB			Differences in world responses to natural disasters and complex emergencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; HEALTH; WAR; POPULATIONS; ATTITUDES; KOSOVO; DARFUR; SUDAN		UN High Commissioner Refugees, CH-1211 Geneva, Switzerland		Spiegel, PB (corresponding author), UN High Commissioner Refugees, Case Postale 2500, CH-1211 Geneva, Switzerland.	spiegel@unhcr.ch	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				Anderson Mary B., 1999, DO NO HARM AID CAN S; [Anonymous], 2004, SUDAN DARFUR RAPE WE; [Anonymous], 2004, DEMOCRATIC REPUBLIC; [Anonymous], 1999, DEV FREEDOM; [Anonymous], 1997, PUBLIC HLTH CONSEQUE; BECKER E, 2005, US NEARLY TRIPLES TS; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; CORDER M, 2005, FEARS TSUNAMI DEAD C; de Goyet CD, 2000, LANCET, V356, P762, DOI 10.1016/S0140-6736(00)02642-8; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; Deutsche Presse Agentur, 2005, INDONESIA ACEH REBEL; *EUR PROGR INT EP, RETR MORT SURV INT D; Grandesso F, 2005, JAMA-J AM MED ASSOC, V293, P1490, DOI 10.1001/jama.293.12.1490; GURR T, 2003, EARLY WARNING SYSTEM; HOGE W, 2005, UN OFFICIAL SAYS PLE; *IRC, 2004, IRC STUD REV 31 000; King Dennis, 2002, PAYING ULTIMATE PRIC; LECHAT MF, 1990, EPIDEMIOL REV, V12, P192, DOI 10.1093/oxfordjournals.epirev.a036053; LEWIS D, 2005, 9 UN PEACEKEEPERS KI; MISHIYAMA G, 2005, UNICEF CONF TSUN CHI; NAKASHIMA E, 2005, ACEH REBELS DESCRIBE; *PAN AM HLTH ORG, 1981, EM HLTH MAN NAT DIS, V407; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; PINE A, 1993, US SOLDIERS KILLED 2; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; Sheik M, 2000, BRIT MED J, V321, P166, DOI 10.1136/bmj.321.7254.166; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TOOLE MJ, 1993, JAMA-J AM MED ASSOC, V270, P600, DOI 10.1001/jama.270.5.600; *UN, 2004, PLEDG C UN RAIS 520; *UNICEF, 2005, PROT CHILDR TSUN ZON; World Health Organization, 2003, MENT SOC ASP HLTH PO; 2005, WORLD LEADERS WARNED; 2004, MEASLES MALNUTRITION; SITUATION DARFUR SAV; 2005, SITUATION REPORTS S; 1998, WORLD S ASIA UN WARN	38	23	23	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1915	1918		10.1001/jama.293.15.1915	http://dx.doi.org/10.1001/jama.293.15.1915			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840867				2022-12-28	WOS:000228401700031
J	Spilianakis, CG; Lalioti, MD; Town, T; Lee, GR; Flavell, RA				Spilianakis, CG; Lalioti, MD; Town, T; Lee, GR; Flavell, RA			Interchromosomal associations between alternatively expressed loci	NATURE			English	Article							TH2 CYTOKINE LOCUS; HYPERSENSITIVE SITES; NUCLEAR-LOCALIZATION; HISTONE ACETYLATION; GENE; ENHANCER; HETEROCHROMATIN; TRANSCRIPTION; ORGANIZATION; MOBILITY	The T-helper- cell 1 and 2 (T(H)1 and T(H)2) pathways, defined by cytokines interferon-gamma (IFN-gamma) and interleukin-4 ( IL-4), respectively, comprise two alternative CD4(+) T-cell fates, with functional consequences for the host immune system. These cytokine genes are encoded on different chromosomes. The recently described T(H)2 locus control region (LCR) coordinately regulates the T(H)2 cytokine genes by participating in a complex between the LCR and promoters of the cytokine genes Il4, Il5 and Il13. Although they are spread over 120 kilobases, these elements are closely juxtaposed in the nucleus in a poised chromatin conformation. In addition to these intrachromosomal interactions, we now describe interchromosomal interactions between the promoter region of the IFN-gamma gene on chromosome 10 and the regulatory regions of the T(H)2 cytokine locus on chromosome 11. DNase I hypersensitive sites that comprise the T(H)2 LCR developmentally regulate these interchromosomal interactions. Furthermore, there seems to be a cell-type-specific dynamic interaction between interacting chromatin partners whereby interchromosomal interactions are apparently lost in favour of intrachromosomal ones upon gene activation. Thus, we provide an example of eukaryotic genes located on separate chromosomes associating physically in the nucleus via interactions that may have a function in coordinating gene expression.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Spilianakis, Charalampos G/C-9893-2011	Spilianakis, Charalampos G/0000-0003-0921-1923				Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Carmo-Fonseca M, 2002, TRENDS CELL BIOL, V12, P491, DOI 10.1016/S0962-8924(02)02387-5; Carmo-Fonseca M, 2002, CELL, V108, P513, DOI 10.1016/S0092-8674(02)00650-5; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Eivazova ER, 2004, P NATL ACAD SCI USA, V101, P251, DOI 10.1073/pnas.0303919101; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Parada LA, 2004, EXP CELL RES, V296, P64, DOI 10.1016/j.yexcr.2004.03.013; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Schubeler D, 2000, GENE DEV, V14, P940; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5	37	535	559	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2005	435	7042					637	645		10.1038/nature03574	http://dx.doi.org/10.1038/nature03574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15880101				2022-12-28	WOS:000229476200042
J	Sinclair, J; Green, J				Sinclair, J; Green, J			Understanding resolution of deliberate self harm: qualitative interview study of patients' experiences	BRITISH MEDICAL JOURNAL			English	Article							SUICIDE; DISORDERS; ADOLESCENTS; TRIAL	Objective To explore the accounts of those with a history of deliberate self harm but who no longer do so, to understand how they perceive this resolution and to identify potential implications for provision of health services. Design Qualitative in-depth interview study. Setting Interviews in a community setting. Participants 20 participants selected from a representative cohort identified in 1997 after an episode of deliberate self poisoning that resulted hospital treatment. Participants were included if they had no further episodes for at least two years before interview Results We identified three recurrent themes: the resolution of adolescent distress; the recognition of the role of alcohol as a precipitating and maintaining factor in self harm; and the understanding of deliberate self harm as a symptom of untreated or unrecognised illness. Conclusion Patients with a history of deliberate self harm who no longer harm themselves talk about their experiences in terms of lack of control over their lives, either through alcohol dependence, untreated depression, or, in adolescents, uncertainty within their family relationships. Hospital management of deliberate self harm has a role in the identification and treatment of depression and alcohol misuse, although in adolescents such interventions may be less appropriate.	Univ Oxford, Warneford Hosp, Ctr Suicide Res, Dept Psychiat, Oxford OX3 7JX, England; Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Sinclair, J (corresponding author), Univ Oxford, Warneford Hosp, Ctr Suicide Res, Dept Psychiat, Oxford OX3 7JX, England.	julia.sinclair@psych.ox.ac.uk	Sinclair, Julia/AAD-8049-2019	Sinclair, Julia/0000-0002-1905-2025; Green, Judith/0000-0002-2315-5326; Houston, Mary/0000-0002-8837-4503				Beck A.T., 1974, DEV SUICIDAL INTENT; Bennett S, 2003, SOC SCI MED, V57, P289, DOI 10.1016/S0277-9536(02)00347-7; Channaz K., 1999, QUAL HEALTH RES, V9, P362, DOI DOI 10.1177/104973239900900306; Coggan C, 1997, SOC SCI MED, V45, P1563, DOI 10.1016/S0277-9536(97)00098-1; Crawford M, 2004, LANCET, V364, P1334, DOI 10.1016/S0140-6736(04)17190-0; Everall RD., 2000, CAN J COUNS, V34, P111; Frank A, 1997, WOUNDED STORY TELLER; Green J, 1998, BMJ-BRIT MED J, V316, P1064; Green J., 2004, QUALITATIVE METHODS; Hammersley M, 1992, WHATS WRONG ETHNOGRA, P85; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Haw C, 2001, BRIT J PSYCHIAT, V178, P48, DOI 10.1192/bjp.178.1.48; Hawton K, 2002, BMJ-BRIT MED J, V325, P1207, DOI 10.1136/bmj.325.7374.1207; Hawton K, 2003, J CHILD PSYCHOL PSYC, V44, P1191, DOI 10.1111/1469-7610.00200; Hawton K, 2003, AM J PSYCHIAT, V160, P1494, DOI 10.1176/appi.ajp.160.8.1494; Hawton K, 1998, BRIT MED J, V317, P441; National Institute of Clinical Excellence, 2004, SHORT TERM PHYS PSYC; Pirkola SP, 2004, CNS DRUGS, V18, P423, DOI 10.2165/00023210-200418070-00002; PLATT S, 1992, ACTA PSYCHIAT SCAND, V85, P97, DOI 10.1111/j.1600-0447.1992.tb01451.x; Redley M, 2003, SOCIOL HEALTH ILL, V25, P348, DOI 10.1111/1467-9566.00350; Strauss AL., 1987, QUALITATIVE ANAL SOC, Vxv, P319; Tyrer P, 2003, PSYCHOL MED, V33, P969, DOI 10.1017/S0033291703008171	22	83	84	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 14	2005	330	7500					1112	1115		10.1136/bmj.38441.503333.8F	http://dx.doi.org/10.1136/bmj.38441.503333.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927BH	15843425	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000229166900016
J	Macaulay, V; Hill, C; Achilli, A; Rengo, C; Clarke, D; Meehan, W; Blackburn, J; Semino, O; Scozzari, R; Cruciani, F; Taha, A; Shaari, NK; Raja, JM; Ismail, P; Zainuddin, Z; Goodwin, W; Bulbeck, D; Bandelt, HJ; Oppenheimer, S; Torroni, A; Richards, M				Macaulay, V; Hill, C; Achilli, A; Rengo, C; Clarke, D; Meehan, W; Blackburn, J; Semino, O; Scozzari, R; Cruciani, F; Taha, A; Shaari, NK; Raja, JM; Ismail, P; Zainuddin, Z; Goodwin, W; Bulbeck, D; Bandelt, HJ; Oppenheimer, S; Torroni, A; Richards, M			Single, rapid coastal settlement of Asia revealed by analysis of complete mitochondrial genomes	SCIENCE			English	Article							EARLY HUMAN OCCUPATION; GENETIC-EVIDENCE; HUMAN DISPERSALS; DNA; LINEAGES; SOUTH; POPULATIONS; PHYLOGENY; ORIGIN	A recent dispersal of modern humans out of Africa is now widely accepted, but the routes taken across Eurasia are Still disputed. We show that mitochondrial DNA variation in isolated "relict" populations in southeast Asia supports the view that there was only a single dispersal from Africa, most likely via a southern coastal route, through India and onward into southeast Asia and Australasia. There was an early offshoot, leading ultimately to the settlement of the Near East and Europe, but the main dispersal from India to Australia similar to 65,000 years ago was rapid, most likely taking only a few thousand years.	Univ Glasgow, Dept Stat, Glasgow G12 8QQ, Lanark, Scotland; Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Natl Museum Kuala Lumpur, Kuala Lumpur 50566, Malaysia; Univ Putra Malaysia, Dept Biomed Sci, Serdang 43400, Selangor, Malaysia; Univ Glasgow, Dept Forens Med & Sci, Glasgow G12 8QQ, Lanark, Scotland; Univ Cent Lancashire, Dept Forens & Invest Sci, Preston PR1 2HE, Lancs, England; Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT 0200, Australia; Univ Hamburg, Dept Math, D-20146 Hamburg, Germany; Univ Oxford, Dept Anthropol, Oxford OX1 2JD, England; Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Sch Comp, Leeds LS2 9JT, W Yorkshire, England	University of Glasgow; University of Huddersfield; University of Pavia; Sapienza University Rome; Universiti Putra Malaysia; University of Glasgow; University of Central Lancashire; Australian National University; University of Hamburg; University of Oxford; University of Leeds; University of Leeds	Macaulay, V (corresponding author), Univ Glasgow, Dept Stat, Glasgow G12 8QQ, Lanark, Scotland.	vincent@stats.gla.ac.uk; m.b.richards@leeds.ac.uk	Zainuddin, Zafarina/A-7738-2011; Peng, Bo/A-6920-2009; Cruciani, Fulvio/G-6105-2012; Achilli, Alessandro/I-9236-2012; Zainuddin, Zafarina/AAU-9021-2020; Torroni, Antonio/E-1557-2011	Peng, Bo/0000-0001-8225-2284; Achilli, Alessandro/0000-0001-6871-3451; Zainuddin, Zafarina/0000-0003-3672-5196; Torroni, Antonio/0000-0002-4163-4478; Clarke, Douglas/0000-0001-7281-8766; Goodwin, William/0000-0002-3632-3552; Cruciani, Fulvio/0000-0002-6900-024X; RICHARDS, MARTIN/0000-0003-3118-0967; SEMINO, Ornella/0000-0002-9675-9403				BARKER G, 2002, P PREHIST SOC, V68, P147, DOI [10.1017/s0079497x00001481, DOI 10.1017/S0079497X00001481]; Bellwood P, 1993, ASIAN PERSPECT, V32, P37; Bellwood Peter, 1997, PREHISTORY INDOMALAY; Bulbeck F.D., 2003, CANOPY ARCHAEOLOGY T, P119; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cordaux R, 2003, AM J HUM GENET, V72, P1586, DOI 10.1086/375407; Endicott P, 2003, AM J HUM GENET, V72, P1590, DOI 10.1086/375408; Endicott P, 2003, AM J HUM GENET, V72, P178, DOI 10.1086/345487; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Hazelwood L, 2004, J ARCHAEOL SCI, V31, P669, DOI 10.1016/j.jas.2003.11.009; Housley R.A., 1997, P PREHIST SOC, V63, P25, DOI DOI 10.1017/S0079497X0000236X; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kong, 2004, AM J HUM GENET, V75, P157; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Lewin R, 2004, PRINCIPLES HUMAN EVO; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; NEI M, 1993, MOL BIOL EVOL, V10, P927; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Turney CSM, 2001, QUATERNARY RES, V55, P3, DOI 10.1006/qres.2000.2195; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	35	516	538	1	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2005	308	5724					1034	1036		10.1126/science.1109792	http://dx.doi.org/10.1126/science.1109792			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890885	Green Accepted			2022-12-28	WOS:000229190700050
J	Ito, K; Ito, M; Elliott, WM; Cosio, B; Caramori, G; Kon, OM; Barczyk, A; Hayashi, S; Adcock, IM; Hogg, JC; Barnes, PJ				Ito, K; Ito, M; Elliott, WM; Cosio, B; Caramori, G; Kon, OM; Barczyk, A; Hayashi, S; Adcock, IM; Hogg, JC; Barnes, PJ			Decreased histone deacetylase activity in chronic obstructive pulmonary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THEOPHYLLINE; MACROPHAGES; EXPRESSION; ASTHMA	BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation that is greater in patients with advanced disease. We asked whether there is a link between the severity of disease and the reduction in histone deacetylase (HDAC) activity in the peripheral lung tissue of patients with COPD of varying severity. HDAC is a key molecule in the repression of production of proinflammatory cytokines in alveolar macrophages. METHODS: HDAC activity and histone acetyltransferase (HAT) activity were determined in nuclear extracts of specimens of surgically resected lung tissue from nonsmokers without COPD, patients with COPD of varying severity, and patients with pneumonia or cystic fibrosis. Alveolar macrophages from nonsmokers, smokers, and patients with COPD and bronchial-biopsy specimens from nonsmokers, healthy smokers, patients with COPD, and those with mild asthma were also examined. Total RNA extracted from lung tissue and macrophages was used for quantitative reverse-transcriptase-polymerase-chain-reaction assay of HDAC1 through HDAC8 and interleukin-8. Expression of HDAC2 protein was quantified with the use of Western blotting. Histone-4 acetylation at the interleukin-8 promoter was evaluated with the use of a chromatin immunoprecipitation assay. RESULTS: Specimens of lung tissue obtained from patients with increasing clinical stages of COPD had graded reductions in HDAC activity and increases in interleukin-8 messenger RNA (mRNA) and histone-4 acetylation at the interleukin-8 promoter. The mRNA expression of HDAC2, HDAC5, and HDAC8 and expression of the HDAC2 protein were also lower in patients with increasing severity of disease. HDAC activity was decreased in patients with COPD, as compared with normal subjects, in both the macrophages and biopsy specimens, with no changes in HAT activity, whereas HAT activity was increased in biopsy specimens obtained from patients with asthma. Neither HAT activity nor HDAC activity was changed in lung tissue from patients with cystic fibrosis or pneumonia. CONCLUSIONS: Patients with COPD have a progressive reduction in total HDAC activity that reflects the severity of the disease.	Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, London SW3 6LY, England; St Marys Hosp, Chest & Allergy Clin, London, England; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; St Pauls Hosp, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Vancouver, BC V6Z 1Y6, Canada; Univ Ferrara, Dept Clin & Expt Med, Ctr Ric Asma & Broncopneumopatia Cron Ostrutt, I-44100 Ferrara, Italy; L Warynski Silesian Med Acad, Dept Pneumol, Katowice, Poland	Imperial College London; Imperial College London; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of Ferrara; Medical University Silesia	Barnes, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, Dovehouse St, London SW3 6LY, England.	p.j.barnes@imperial.ac.uk	Ito, Kazuhiro/AAF-5994-2019; Caramori, Gaetano/AAS-8611-2020; Adcock, Ian/L-3217-2019; G.Cosio, Borja/P-4963-2017; Barczyk, Adam/GYV-4487-2022	Caramori, Gaetano/0000-0002-9807-327X; G.Cosio, Borja/0000-0002-6388-8209; Barczyk, Adam/0000-0002-6567-9208; Adcock, Ian/0000-0003-2101-8843; Barnes, Peter/0000-0002-5122-4018				Barnes PJ, 2004, LANCET, V363, P731, DOI 10.1016/S0140-6736(04)15650-X; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Cosio BG, 2004, AM J RESP CRIT CARE, V170, P141, DOI 10.1164/rccm.200305-659OC; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DING L, 2004, J COPD, V1, P191; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; *GOLD, 2001, NIH PUBL; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2002, AM J RESP CRIT CARE, V166, P392, DOI 10.1164/rccm.2110060; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; Ito K, 2001, FASEB J, V15, pA473; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Saetta M, 2001, AM J RESP CRIT CARE, V163, P1304, DOI 10.1164/ajrccm.163.6.2009116; Urnov FD, 2001, ONCOGENE, V20, P2991, DOI 10.1038/sj.onc.1204323	18	706	746	0	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1967	1976		10.1056/NEJMoa041892	http://dx.doi.org/10.1056/NEJMoa041892			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888697	Bronze			2022-12-28	WOS:000229017100007
J	Moore, P				Moore, P			Amplifying the signal	NATURE			English	Article																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2005	435	7039					236	236		10.1038/435236a	http://dx.doi.org/10.1038/435236a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889101	Bronze			2022-12-28	WOS:000229021100050
J	Rowe, SM; Miller, S; Sorscher, EJ				Rowe, SM; Miller, S; Sorscher, EJ			Mechanisms of disease: Cystic fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRANSMEMBRANE CONDUCTANCE REGULATOR; VASOACTIVE-INTESTINAL-PEPTIDE; PREMATURE STOP MUTATIONS; AIRWAY EPITHELIAL-CELLS; LUNG-DISEASE; CHLORIDE CHANNEL; SUBMUCOSAL GLANDS; DRUG DISCOVERY; CFTR; GENE		Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sorscher, EJ (corresponding author), Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, 1530 3rd Ave S,MCLM 796, Birmingham, AL 35294 USA.	sorscher@uab.edu		Sorscher, Eric J./0000-0001-9341-3354				BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; Clancy JP, 2001, AM J RESP CRIT CARE, V163, P1683, DOI 10.1164/ajrccm.163.7.2004001; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; *CYST FIBR FDN, 2004, CYST FIBR FDN NAT PA; DETERDING RR, 2004, PEDIATR PULM, V38, P249; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Frangolias DD, 2003, AM J RESP CELL MOL, V29, P390, DOI 10.1165/rcmb.2002-0271OC; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; GAN KH, 1995, NEW ENGL J MED, V333, P95, DOI 10.1056/NEJM199507133330204; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Gill S, 2003, ASSAY DRUG DEV TECHN, V1, P709, DOI 10.1089/154065803770381066; Grubb BR, 1999, AM J PHYSIOL-GASTR L, V277, pG167, DOI 10.1152/ajpgi.1999.277.1.G167; Haardt M, 1999, J BIOL CHEM, V274, P21873, DOI 10.1074/jbc.274.31.21873; Hilliard Jay B, 2002, Methods Mol Med, V70, P409; Jayaraman S, 2001, P NATL ACAD SCI USA, V98, P8119, DOI 10.1073/pnas.131087598; Joo NS, 2002, J BIOL CHEM, V277, P50710, DOI 10.1074/jbc.M208826200; Joo NS, 2002, J BIOL CHEM, V277, P28167, DOI 10.1074/jbc.M202712200; Keeling KM, 2002, J MOL MED-JMM, V80, P367, DOI 10.1007/s00109-001-0317-z; Keeling KM, 2001, HUM MOL GENET, V10, P291, DOI 10.1093/hmg/10.3.291; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; Koehler DR, 2004, AM J RESP CELL MOL, V31, P377, DOI 10.1165/rcmb.2004-0124TR; Konstan MW, 2002, ADV DRUG DELIVER REV, V54, P1409, DOI 10.1016/S0169-409X(02)00146-1; Kunzelmann K, 2000, PFLUG ARCH EUR J PHY, V440, P193, DOI 10.1007/s004240000255; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; LOWE CU, 1949, AM J DIS CHILD, V78, P349, DOI 10.1001/archpedi.1949.02030050362008; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; Olivier KN, 1996, AM J RESP CRIT CARE, V154, P217, DOI 10.1164/ajrccm.154.1.8680683; Puchelle E, 2001, PEDIATR PULM, P143; QUINTON PM, 1986, AM J PHYSIOL, V251, pC649, DOI 10.1152/ajpcell.1986.251.4.C649; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1437; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sagel SD, 2002, CLIN REV ALLERG IMMU, V23, P41, DOI 10.1385/CRIAI:23:1:041; Sagel SD, 2002, J PEDIATR-US, V141, P811, DOI 10.1067/mpd.2002.129847; SCHOUMACHER RA, 1987, NATURE, V330, P752, DOI 10.1038/330752a0; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Verkman AS, 2004, AM J PHYSIOL-CELL PH, V286, pC465, DOI 10.1152/ajpcell.00397.2003; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; VERKMAN AS, 2003, PEDIATR PULM, V36, P290; Wagner KR, 2001, ANN NEUROL, V49, P706, DOI 10.1002/ana.1023.abs; WELSH MJ, 1986, SCIENCE, V232, P1648, DOI 10.1126/science.2424085; WELSH MJ, 1986, NATURE, V322, P467, DOI 10.1038/322467a0; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Wyckoff TJO, 2002, MICROBIOL-SGM, V148, P3423, DOI 10.1099/00221287-148-11-3423; Xu Y, 2003, J BIOL CHEM, V278, P7674, DOI 10.1074/jbc.M210277200; Yankaskas JR, 2004, CHEST, V125, p1S, DOI 10.1378/chest.125.1_suppl.1S; Zeitlin P, 2004, NEW ENGL J MED, V351, P606, DOI 10.1056/NEJMcibr041584; Zeitlin PL, 2000, KIDNEY INT, V57, P832, DOI 10.1046/j.1523-1755.2000.00922.x; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	65	1111	1167	8	254	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2005	352	19					1992	2001		10.1056/NEJMra043184	http://dx.doi.org/10.1056/NEJMra043184			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924YL	15888700				2022-12-28	WOS:000229017100010
J	Conigliaro, RL				Conigliaro, RL			Satisfaction?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												conigliarorl@upmc.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2005	293	18					2193	2193		10.1001/jama.293.18.2193	http://dx.doi.org/10.1001/jama.293.18.2193			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	924LU	15886362				2022-12-28	WOS:000228981100001
J	Grant, AM; Anderson, FH; Avenell, A; Campbell, MK; Cooper, C; Donaldson, C; Francis, RM; Gillespie, WJ; Robinson, CM; Torgerson, DJ; Wallace, WA; McPherson, GC; MacLennan, GS; McDonald, AM; Grant, M; Avenell, A; Campbell, MK; McDonald, AM; MacLennan, GS; McPherson, GC; Anderson, FH; Cooper, C; Francis, RM; Donaldson, C; Gillespie, WJ; Robinson, CM; Torgerson, DJ; Wallace, WA				Grant, AM; Anderson, FH; Avenell, A; Campbell, MK; Cooper, C; Donaldson, C; Francis, RM; Gillespie, WJ; Robinson, CM; Torgerson, DJ; Wallace, WA; McPherson, GC; MacLennan, GS; McDonald, AM; Grant, M; Avenell, A; Campbell, MK; McDonald, AM; MacLennan, GS; McPherson, GC; Anderson, FH; Cooper, C; Francis, RM; Donaldson, C; Gillespie, WJ; Robinson, CM; Torgerson, DJ; Wallace, WA		RECORD Trial Grp	Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial	LANCET			English	Article							D SUPPLEMENTATION; HIP-FRACTURES; DOUBLE-BLIND; RISK; WOMEN; MEN	Background Elderly people who have a fracture are at high risk of another. Vitamin D and calcium supplements are often recommended for fracture prevention. We aimed to assess whether vitamin D3 and calcium, either alone or in combination, were effective in prevention of secondary fractures. Methods In a factorial-design trial, 5292 people aged 70 years or older (4481 [85%] of whom were women) who were mobile before developing a low-trauma fracture were randomly assigned 800 IU daily oral vitamin D3, 1000 mg calcium, oral vitamin D3 (800 IU per day) combined with calcium (1000 mg per day), or placebo. Participants who were recruited in 21 UK hospitals were followed up for between 24 months and 62 months. Analysis was by intention-to-treat and the primary outcome was new low-energy fractures. Findings 698 (13%) of 5292 participants had a new low-trauma fracture, 183 (26%) of which were of the hip. The incidence of new, low-trauma fractures did not differ significantly between participants allocated calcium and those who were not (331 [12.6%] of 2617 vs 367 [13.7%] of 2675; hazard ratio (HR) 0.94 [95% Cl 0.81-1.09]); between participants allocated vitamin D3 and those who were not (353 [13.3%] of 2649 vs 345 [13.1%] of 2643; 1.02 [0.88-1.19]); or between those allocated combination treatment and those assigned placebo (165 [12.6%] of 1306 vs 179 [13.4%] of 1332; HR for interaction term 1.01 [0.75-1.36]). The groups did not differ in the incidence of all new fractures, fractures confirmed by radiography, hip fractures, death, number of falls, or quality of life. By 24 months, 2886 (54.5%) of 5292 were still taking tablets, 451 (8.5%) had died, 58 (1.1%) had withdrawn, and 1897 (35.8%) had stopped taking tablets but were still providing data for at least the main outcomes. Compliance with tablets containing calcium was significantly lower (difference: 9.4% [95% CI 6.6-12.2]), partly because of gastrointestinal symptoms. However, potentially serious adverse events were rare and did not differ between groups. Interpretation The findings do not support routine oral supplementation with calcium and vitamin D3, either alone or in combination, for the prevention of further fractures in previously mobile elderly people.	Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; Univ Southampton, MRC, Epidemiol Resource Ctr, Southampton SO9 5NH, Hants, England; Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; Newcastle Univ, Ctr Hlth Serv Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Newcastle Univ, Business Sch Econ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Hull York Med Sch, Kingston Upon Hull, N Humberside, England; Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland; Dept Hlth Sci, York, N Yorkshire, England; Queens Med Ctr, Nottingham NG7 2UH, England	University of Aberdeen; University of Southampton; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Hull; University of York - UK; Royal Infirmary of Edinburgh; University of Edinburgh; University of York - UK; University of Nottingham	Grant, AM (corresponding author), Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland.	a.grant@abdn.ac.uk	Campbell, Marion/ABB-7063-2020; Golmohamad, Ramez/E-4848-2014; Torgerson, David/L-4566-2019; Robinson, Christopher/FKL-4907-2022	Golmohamad, Ramez/0000-0002-9958-7037; Torgerson, David/0000-0002-1667-4275; Cooper, Cyrus/0000-0003-3510-0709; Campbell, Marion/0000-0001-5386-4097				Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; CHAPUY MC, 1994, BRIT MED J, V308, P1081, DOI 10.1136/bmj.308.6936.1081; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Finch S., 1998, NATL DIET NUTR SURVE, V1; GILLESPIE WJ, 2001, COCHRANE DB SYST REV, V1; HINE TJ, 1994, ANN CLIN BIOCHEM, V31, P31, DOI 10.1177/000456329403100105; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Iglesias CP, 2002, QJM-INT J MED, V95, P305, DOI 10.1093/qjmed/95.5.305; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; MCDONALD A, 2004, APPL CLIN TRIALS, P58; Meyer HE, 2002, J BONE MINER RES, V17, P709, DOI 10.1359/jbmr.2002.17.4.709; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; NELSON M, 1988, Journal of Human Nutrition and Dietetics, V1, P115, DOI 10.1111/j.1365-277X.1988.tb00443.x; Sahota O, 2001, AGE AGEING, V30, P467, DOI 10.1093/ageing/30.6.467; Shea B, 2002, ENDOCR REV, V23, P552, DOI 10.1210/er.2001-7002; Smith H, 2004, OSTEOPOROSIS INT, V15, pS8; TORGERSON DJ, 2001, EFFECTIVE MANAGEMENT; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P624, DOI 10.1007/s001980200084; Vieth R, 2001, AM J CLIN NUTR, V73, P288; Ware Jnr JE, 2002, SCORE VERSION 2 SF 1; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	26	656	683	1	59	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2005	365	9471					1621	1628		10.1016/S0140-6736(05)63013-9	http://dx.doi.org/10.1016/S0140-6736(05)63013-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923UB	15885294				2022-12-28	WOS:000228933700026
J	Siotia, AK; Muthusamy, R				Siotia, AK; Muthusamy, R			Commentary: Easy yet so easily missed	BRITISH MEDICAL JOURNAL			English	Editorial Material									No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England; Rotherham Dist Gen Hosp, Rotherham S60 2UD, S Yorkshire, England	Northern General Hospital	Siotia, AK (corresponding author), No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England.	Anjan.Siotia@sth.nhs.uk						Behnia M, 2000, AM J MED SCI, V320, P368, DOI 10.1097/00000441-200012000-00003; BERCKET A, 1994, CLIN PEDIATR, V33, P749; KABADI UM, 1990, AM HEART J, V120, P1393, DOI 10.1016/0002-8703(90)90253-T; PUESCHEL SM, 1991, RES DEV DISABIL, V12, P287, DOI 10.1016/0891-4222(91)90013-I; Siotia AK, 2005, BRIT MED J, V330, P1068, DOI 10.1136/bmj.330.7499.1068	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 7	2005	330	7499					1070	1071		10.1136/bmj.330.7499.1070-a	http://dx.doi.org/10.1136/bmj.330.7499.1070-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925YY	15879396	Green Published			2022-12-28	WOS:000229090900026
J	Brauer, J				Brauer, J			Establishing indicators for biodiversity	SCIENCE			English	Letter									Augusta State Univ, Coll Business Adm, Augusta, GA 30904 USA; Economists Peace & Secur, Annandale on Hudson, NY 12405 USA	University System of Georgia; Augusta University	Brauer, J (corresponding author), Augusta State Univ, Coll Business Adm, Augusta, GA 30904 USA.	jbrauer@aug.edu	Mace, Georgina/I-3072-2016; Costanza, Robert/A-4912-2008	Mace, Georgina/0000-0001-8965-5211; Balmford, Andrew/0000-0002-0144-3589; Brauer, Jurgen/0000-0002-6316-9271; Costanza, Robert/0000-0001-6348-8734				2005, SCIENCE         0114, P212	1	3	3	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					791	791						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879191				2022-12-28	WOS:000228986500016
J	Nel, A				Nel, A			Air pollution-related illness: Effects of particles	SCIENCE			English	Editorial Material							DIESEL EXHAUST PARTICLES; OXIDATIVE STRESS; INFLAMMATION; MORTALITY; HEART		Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Nel, A (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.	anel@mednet.ucla.edu	Nel, Andre E/J-2808-2012					Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Donaldson K, 2002, INHAL TOXICOL, V14, P5, DOI 10.1080/089583701753338613; Ghio AJ, 2001, AM J RESP CRIT CARE, V164, P704, DOI 10.1164/ajrccm.164.4.2011089; Gilliland FD, 2004, LANCET, V363, P119, DOI 10.1016/S0140-6736(03)15262-2; Gurgueira SA, 2002, ENVIRON HEALTH PERSP, V110, P749, DOI 10.1289/ehp.02110749; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Lim HB, 1998, FREE RADICAL BIO MED, V25, P635, DOI 10.1016/S0891-5849(98)00073-2; MURANAKA M, 1986, J ALLERGY CLIN IMMUN, V77, P616, DOI 10.1016/0091-6749(86)90355-6; *NAT AC SCI NAT RE, 1998, RES PRIOR AIRB PART, V1; Nel AE, 1998, J ALLERGY CLIN IMMUN, V102, P539, DOI 10.1016/S0091-6749(98)70269-6; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; Oberdorster G, 2002, ENVIRON HEALTH PERSP, V110, pA440, DOI 10.1289/ehp.110-a440; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Silbajoris R, 2000, INHAL TOXICOL, V12, P453; Xiao GG, 2003, J BIOL CHEM, V278, P50781, DOI 10.1074/jbc.M306423200; 1994, ENVIRONMENT, V36, P4; 2002, HLTH EFFECTS I PERSP	19	1113	1181	9	363	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					804	806		10.1126/science.1108752	http://dx.doi.org/10.1126/science.1108752			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879201				2022-12-28	WOS:000228986500030
J	Nilsson, A; Wernet, P; Nordlund, D; Bergmann, U; Cavalleri, M; Odelius, M; Ogasawara, H; Naslund, LA; Hirsch, TK; Ojamae, L; Glatzel, P; Pettersson, LGM				Nilsson, A; Wernet, P; Nordlund, D; Bergmann, U; Cavalleri, M; Odelius, M; Ogasawara, H; Naslund, LA; Hirsch, TK; Ojamae, L; Glatzel, P; Pettersson, LGM			Comment on "Energetics of hydrogen bond network: Rearrangements in liquid water"	SCIENCE			English	Editorial Material							RAY RAMAN-SCATTERING; SPECTRA		Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA; Stockholm Univ, AlbaNova Univ Ctr, S-10691 Stockholm, Sweden; Berliner Elektronenspeicherring Gesell Synchrotro, D-12489 Berlin, Germany; AlbaNova Univ Ctr, Fysikum, Stockholm, Sweden; Linkoping Univ, Dept Chem, IFM, S-58183 Linkoping, Sweden; European Synchrotron Radiat Facil, Swiss Norwegian Beamlines, F-38043 Grenoble, France	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stockholm University; Linkoping University; European Synchrotron Radiation Facility (ESRF)	Nilsson, A (corresponding author), Stanford Synchrotron Radiat Lab, POB 20450, Stanford, CA 94309 USA.	nilsson@slac.stanford.edu	Odelius, Michael/A-7628-2014; Ogasawara, Hirohito/AAC-8754-2020; Pettersson, Lars G.M./F-8428-2011; Ogasawara, Hirohito/D-2105-2009; Ogasawara, Hirohito/AGU-4579-2022; Ojamäe, Lars/C-4974-2015; Wernet, Philippe/A-7085-2013; Cavalleri, Matteo/A-7689-2008; Nilsson, Anders/E-1943-2011; Nordlund, Dennis/A-8902-2008; Odelius, Michael/J-6142-2019; Pettersson, Lars GM/J-4925-2013; Glatzel, Pieter/E-9958-2010	Odelius, Michael/0000-0002-7023-2486; Ogasawara, Hirohito/0000-0001-5338-1079; Ogasawara, Hirohito/0000-0001-5338-1079; Ojamäe, Lars/0000-0002-5341-2637; Wernet, Philippe/0000-0001-7011-9072; Nilsson, Anders/0000-0003-1968-8696; Nordlund, Dennis/0000-0001-9524-6908; Pettersson, Lars GM/0000-0003-1133-9934; Glatzel, Pieter/0000-0001-6532-8144; SAYKALLY, RICHARD/0000-0001-8942-3656; Cappa, Christopher/0000-0002-3528-3368; Cavalleri, Matteo/0000-0002-7925-928X				Bergmann U, 2002, MICROCHEM J, V71, P221, DOI 10.1016/S0026-265X(02)00014-0; MIZUNO Y, 1967, J PHYS SOC JPN, V22, P445, DOI 10.1143/JPSJ.22.445; Nakajima R, 1999, PHYS REV B, V59, P6421, DOI 10.1103/PhysRevB.59.6421; Nilsson Goran E., 1995, Biochemistry and Molecular Biology of Fishes, V5, P19; Smith JD, 2004, SCIENCE, V306, P851, DOI 10.1126/science.1102560; Stohr J, 2013, SPRINGE SER SURF SCI; VONBARTH U, 1982, PHYS REV B, V25, P5150, DOI 10.1103/PhysRevB.25.5150; Walrafen GE, 2004, J CHEM PHYS, V120, P4868, DOI 10.1063/1.1640668; Wernet P, 2004, SCIENCE, V304, P995, DOI 10.1126/science.1096205	9	92	93	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					793A	793A		10.1126/science.1108864	http://dx.doi.org/10.1126/science.1108864			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879194				2022-12-28	WOS:000228986500021
J	Donohue, JF				Donohue, JF			Still looking for answers in COPD	LANCET			English	Editorial Material							SMOKING; TRIAL		Univ N Carolina, Sch Med, Div Pulm & Crit Care Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Donohue, JF (corresponding author), Univ N Carolina, Sch Med, Div Pulm & Crit Care Med, Chapel Hill, NC 27599 USA.	jdonohue@med.unc.edu						Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Black Peter N, 2004, BMC Pulm Med, V4, P13, DOI 10.1186/1471-2466-4-13; BOMAN G, 1983, EUR J RESPIR DIS, V64, P405; BOWLER RP, 2004, J COPD, V1, P255; Calverley P, 2004, EUR RESPIR J, V24, P206; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; DECRAMER M, 2004, J COPD, V1, P303; Dirksen A, 1999, AM J RESP CRIT CARE, V160, P1468, DOI 10.1164/ajrccm.160.5.9901055; GRASSI C, 1976, EUR J CLIN PHARMACOL, V9, P393, DOI 10.1007/BF00606554; Highland KB, 2003, ANN INTERN MED, V138, P969, DOI 10.7326/0003-4819-138-12-200306170-00008; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Rennard SI, 2004, LANCET, V364, P791, DOI 10.1016/S0140-6736(04)16941-9; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Vreim CE, 1998, AM J RESP CRIT CARE, V158, P49; Zamel N, 2002, AM J RESP CRIT CARE, V165, pA226	16	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1518	1520		10.1016/S0140-6736(05)66432-X	http://dx.doi.org/10.1016/S0140-6736(05)66432-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866290				2022-12-28	WOS:000228754800005
J	Haimowitz, MD; Hernandez, LA; Herron, RM				Haimowitz, MD; Hernandez, LA; Herron, RM			A blood donor with bacteraemia	LANCET			English	Editorial Material							STREPTOCOCCUS-BOVIS BACTEREMIA; ASSOCIATION		Amer Red Cross, Blood Serv, Pomona, CA 91768 USA	American Red Cross	Haimowitz, MD (corresponding author), Amer Red Cross, Blood Serv, So Calif Reg,100 Red Cross Circle, Pomona, CA 91768 USA.	haimowit@usa.redcross.org						Arendt A., 2005, Morbidity and Mortality Weekly Report, V54, P168; Gold JS, 2004, ARCH SURG-CHICAGO, V139, P760, DOI 10.1001/archsurg.139.7.760; Hillyer Christopher D, 2003, Hematology Am Soc Hematol Educ Program, P575; Jean SS, 2004, J FORMOS MED ASSOC, V103, P118; Lee RA, 2003, J MED MICROBIOL, V52, P903, DOI 10.1099/jmm.0.05199-0	5	18	20	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2005	365	9470					1596	1596		10.1016/S0140-6736(05)66462-8	http://dx.doi.org/10.1016/S0140-6736(05)66462-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866315				2022-12-28	WOS:000228754800033
J	Barabasi, AL				Barabasi, AL			Network theory - The emergence of the creative enterprise	SCIENCE			English	Editorial Material									Univ Notre Dame, Ctr Complex Network Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Barabasi, AL (corresponding author), Univ Notre Dame, Ctr Complex Network Res, Notre Dame, IN 46556 USA.	alb@nd.edu	Barabasi, Albert-Laszlo/S-6474-2017	Barabasi, Albert/0000-0002-4028-3522				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; ASIMOV I, 1991, FDN EMPIRE; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Ben-Naim E., 2004, COMPLEX NETWORKS; Bollobas B., 2001, RANDOM GRAPHS; Bornholdt S, 2003, HDB GRAPHS NETWORKS; Collins R., 1998, CHARLEMAGNE; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016131; PASTORSATORRAS A, 2004, EVOLUTION STRUCTURE; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725	14	93	97	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					639	641		10.1126/science.1112554	http://dx.doi.org/10.1126/science.1112554			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860613				2022-12-28	WOS:000228810900032
J	Tanaka, KD; Ueda, K				Tanaka, KD; Ueda, K			Horsfield's hawk-cuckoo nestlings simulate multiple gapes for begging	SCIENCE			English	Article							SIGNALS		Rikkyo Univ, Dept Life Sci, Tokyo 1718501, Japan	Rikkyo University	Tanaka, KD (corresponding author), Rikkyo Univ, Dept Life Sci, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	keita@zaf.att.ne.jp	Tanaka, Keita/A-5543-2008	Tanaka, Keita/0000-0001-9749-5094				Briskie JV, 1999, P ROY SOC B-BIOL SCI, V266, P2153, DOI 10.1098/rspb.1999.0902; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kilner RM, 2004, SCIENCE, V305, P877, DOI 10.1126/science.1098487; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; Tanaka K., UNPUB; TANAKA KD, IN PRESS J AVIAN BIO	7	56	58	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					653	653		10.1126/science.1109957	http://dx.doi.org/10.1126/science.1109957			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860618				2022-12-28	WOS:000228810900037
J	Kralovics, R; Passamonti, F; Buser, AS; Teo, S; Tiedt, R; Passweg, JR; Tichelli, A; Cazzola, M; Skoda, RC				Kralovics, R; Passamonti, F; Buser, AS; Teo, S; Tiedt, R; Passweg, JR; Tichelli, A; Cazzola, M; Skoda, RC			A gain-of-function mutation of JAK2 in myeloproliferative disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; ERYTHROID PROGENITORS; DIAGNOSTIC-CRITERIA; UNIPARENTAL DISOMY; IMATINIB MESYLATE; STEM-CELL; IN-VITRO; EXPRESSION; CLONALITY	BACKGROUND: Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are clonal myeloproliferative disorders arising from a multipotent progenitor. The loss of heterozygosity (LOH) on the short arm of chromosome 9 (9pLOH) in myeloproliferative disorders suggests that 9p harbors a mutation that contributes to the cause of clonal expansion of hematopoietic cells in these diseases. METHODS: We performed microsatellite mapping of the 9pLOH region and DNA sequencing in 244 patients with myeloproliferative disorders (128 with polycythemia vera, 93 with essential thrombocythemia, and 23 with idiopathic myelofibrosis). RESULTS: Microsatellite mapping identified a 9pLOH region that included the Janus kinase 2 (JAK2) gene. In patients with 9pLOH, JAK2 had a homozygous G(rightarrow)T transversion, causing phenylalanine to be substituted for valine at position 617 of JAK2 (V617F). All 51 patients with 9pLOH had the V617F mutation. Of 193 patients without 9pLOH, 66 were heterozygous for V617F and 127 did not have the mutation. The frequency of V617F was 65 percent among patients with polycythemia vera (83 of 128), 57 percent among patients with idiopathic myelofibrosis (13 of 23), and 23 percent among patients with essential thrombocythemia (21 of 93). V617F is a somatic mutation present in hematopoietic cells. Mitotic recombination probably causes both 9pLOH and the transition from heterozygosity to homozygosity for V617F. Genetic evidence and in vitro functional studies indicate that V617F gives hematopoietic precursors proliferative and survival advantages. Patients with the V617F mutation had a significantly longer duration of disease and a higher rate of complications (fibrosis, hemorrhage, and thrombosis) and treatment with cytoreductive therapy than patients with wild-type JAK2. CONCLUSIONS: A high proportion of patients with myeloproliferative disorders carry a dominant gain-of-function mutation of JAK2.	Univ Basel Hosp, Dept Res Expt Hematol, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Hematol, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Lab Med, CH-4031 Basel, Switzerland; Univ Pavia, Sch Med, Div Hematol, I-27100 Pavia, Italy; Policlin San Matteo, Ist Ric & Cura Carattere Sci, I-27100 Pavia, Italy	University of Basel; University of Basel; University of Basel; University of Pavia; IRCCS Fondazione San Matteo	Skoda, RC (corresponding author), Univ Basel Hosp, Dept Res, Hebelstr 20, CH-4031 Basel, Switzerland.	radek.skoda@unibas.ch	passweg, jakob/AAG-3911-2020; Passamonti, Francesco/AAB-2262-2022; Buser, Andreas/AAL-8676-2020; Cazzola, Mario/AAQ-8854-2021; Buser, Andreas S/A-2660-2008	Passamonti, Francesco/0000-0001-8068-5289; Buser, Andreas/0000-0002-7942-6746; Cazzola, Mario/0000-0001-6984-8817; Buser, Andreas S/0000-0002-7942-6746; Kralovics, Robert/0000-0002-6997-8539; Passweg, Jakob R/0000-0001-7092-3351				Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Axelrad AA, 2000, BLOOD, V96, P3310; Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; Brodmann S, 2000, ANN HEMATOL, V79, P312, DOI 10.1007/s002779900136; Chen Z, 1998, GENE CHROMOSOME CANC, V22, P321, DOI 10.1002/(SICI)1098-2264(199808)22:4<321::AID-GCC8>3.0.CO;2-X; CORREA PN, 1994, BLOOD, V83, P99; DAI CH, 1991, J CLIN INVEST, V87, P391, DOI 10.1172/JCI115009; DAI CH, 1992, BLOOD, V80, P891; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; DIEZMARTIN JL, 1991, MAYO CLIN PROC, V66, P287, DOI 10.1016/S0025-6196(12)61011-8; ElKassar N, 1997, BLOOD, V89, P128, DOI 10.1182/blood.V89.1.128.128_128_134; Ghilardi N, 1997, MOL ENDOCRINOL, V11, P393, DOI 10.1210/me.11.4.393; Hagstrom SA, 1999, P NATL ACAD SCI USA, V96, P2952, DOI 10.1073/pnas.96.6.2952; Harrison CN, 1999, BLOOD, V93, P417, DOI 10.1182/blood.V93.2.417.402a33_417_424; Horikawa Y, 1997, BLOOD, V90, P4031, DOI 10.1182/blood.V90.10.4031; Kralovics R, 2003, BLOOD, V102, P3793, DOI 10.1182/blood-2003-03-0885; Kralovics R, 2003, BLOOD, V102, P1869, DOI 10.1182/blood-2003-03-0744; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Liu E, 2003, BLOOD, V101, P3294, DOI 10.1182/blood-2002-07-2287; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; MERTENS F, 1991, LEUKEMIA, V5, P214; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; Murphy S, 1999, SEMIN HEMATOL, V36, P9; Najfeld V, 2002, BRIT J HAEMATOL, V119, P558, DOI 10.1046/j.1365-2141.2002.03763.x; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; PAL N, 1990, ONCOGENE, V5, P1665; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Passamonti F, 2004, BRIT J HAEMATOL, V126, P650, DOI 10.1111/j.1365-2141.2004.05098.x; Pearson TC, 2001, SEMIN HEMATOL, V38, P21, DOI 10.1053/shem.2001.23043; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Raghavan M, 2005, CANCER RES, V65, P375; REGECAMBRIN G, 1987, CANCER GENET CYTOGEN, V25, P233, DOI 10.1016/0165-4608(87)90183-X; Roder S, 2001, EXP HEMATOL, V29, P694, DOI 10.1016/S0301-472X(01)00637-3; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Silver RT, 2003, LEUKEMIA, V17, P1186, DOI 10.1038/sj.leu.2402938; Spivak JL, 2004, BLOOD, V103, P3241, DOI 10.1182/blood-2003-12-4248; Spivak JL, 2004, SEMIN HEMATOL, V41, P1, DOI 10.1053/j.seminhematol.2004.02.011; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Ugo V, 2004, EXP HEMATOL, V32, P179, DOI 10.1016/j.exphem.2003.11.003; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; WADEY RB, 1990, ONCOGENE, V5, P901; Weinberg RS, 1997, SEMIN HEMATOL, V34, P64; Westwood NB, 2000, BRIT J HAEMATOL, V110, P839, DOI 10.1046/j.1365-2141.2000.02242.x; Westwood NB, 2001, HAEMATOLOGICA, V86, P464	47	2689	2878	2	86	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2005	352	17					1779	1790		10.1056/NEJMoa051113	http://dx.doi.org/10.1056/NEJMoa051113			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	920KY	15858187	Bronze			2022-12-28	WOS:000228689000008
J	Malescio, G				Malescio, G			Predicting with unpredictability	NATURE			English	Editorial Material							RANDOMNESS		Univ Messina, Dept Phys, I-98166 Messina, Italy	University of Messina	Malescio, G (corresponding author), Univ Messina, Dept Phys, I-98166 Messina, Italy.							Calude CS, 1999, NATURE, V400, P319, DOI 10.1038/22435; CHAITIN GJ, 1975, SCI AM, V232, P47, DOI 10.1038/scientificamerican0575-47; Metropolis N., 1987, LOS ALAMOS SCI, V15, P125, DOI DOI 10.1128/JCM.05092-11	3	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2005	434	7037					1073	1073		10.1038/4341073a	http://dx.doi.org/10.1038/4341073a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858553	Bronze			2022-12-28	WOS:000228693300021
J	Bird, SM				Bird, SM			Random mandatory drugs testing of prisoners	LANCET			English	Editorial Material							ENGLAND; HARM		MRC, Biostat Unit, Cambridge CB2 2SR, England; Univ Strathclyde, Dept Stat & Modelling Sci, Glasgow, Lanark, Scotland	MRC Biostatistics Unit; University of Strathclyde	Bird, SM (corresponding author), MRC, Biostat Unit, Cambridge CB2 2SR, England.	sheila.bird@mrc-bsu.cam.ac.uk						Allwright S, 2000, BRIT MED J, V321, P78, DOI 10.1136/bmj.321.7253.78; Bird AG, 1997, BRIT MED J, V315, P21, DOI 10.1136/bmj.315.7099.21; Bird S M, 2002, J Cancer Epidemiol Prev, V7, P37, DOI 10.1080/14766650252962667; Bird SM, 2001, BRIT MED J, V323, P1212; Boys A, 2002, ADDICTION, V97, P1551, DOI 10.1046/j.1360-0443.2002.00229.x; EDGAR K, 1998, 189 HOM OFF RES STUD; Gore S M, 1999, Commun Dis Public Health, V2, P193; Gore S M, 1999, J Epidemiol Biostat, V4, P3; Gore SM, 1998, BRIT MED J, V316, P1256, DOI 10.1136/bmj.316.7140.1256; National Offender Management Service, 2005, STRAT MAN TREATM PRO; *SCOTT PRIS SERV, 2004, 7 PRIS SURV; Singleton Nicola, 2005, IMPACT MANDATORY DRU, V03; Weild A R, 2000, Commun Dis Public Health, V3, P121	13	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 23	2005	365	9469					1451	1452		10.1016/S0140-6736(05)66400-8	http://dx.doi.org/10.1016/S0140-6736(05)66400-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850619				2022-12-28	WOS:000228651600010
J	Wilkinson, L				Wilkinson, L			Historical keywords - Immunity	LANCET			English	Editorial Material												ucgalwi@ucl.ac.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2005	365	9469					1459	1459		10.1016/S0140-6736(05)66405-7	http://dx.doi.org/10.1016/S0140-6736(05)66405-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919XT	15850621				2022-12-28	WOS:000228651600013
J	Utada, AS; Lorenceau, E; Link, DR; Kaplan, PD; Stone, HA; Weitz, DA				Utada, AS; Lorenceau, E; Link, DR; Kaplan, PD; Stone, HA; Weitz, DA			Monodisperse double emulsions generated from a microcapillary device	SCIENCE			English	Article							MULTIPLE EMULSIONS; ACID) MICROSPHERES; STABILITY; DELIVERY; OIL; RELEASE; SYSTEMS; MICROPARTICLES; MICROCAPSULES; ENCAPSULATION	Double emulsions are highly structured fluids consisting of emulsion drops that contain smaller droplets inside. Although double emulsions are potentially of commercial value, traditional fabrication by means of two emulsification steps leads to very ill-controlled structuring. Using a microcapillary device, we fabricated double emulsions that contained a single internal droplet in a coreshell geometry. We show that the droplet size can be quantitatively predicted from the flow profiles of the fluids. The double emulsions were used to generate encapsulation structures by manipulating the properties of the fluid that makes up the shell. The high degree of control afforded by this method and the completely separate fluid streams make this a flexible and promising technique.	Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Unilever Skin Global Innovat Ctr, Trumbull, CT 06611 USA	Harvard University; Harvard University; Unilever	Utada, AS (corresponding author), Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA.		Kaplan, Peter/A-2972-2009; Stone, Howard A/B-6435-2008; Utada, Andrew S./U-6629-2019	Utada, Andrew S./0000-0003-4542-6315; Kaplan, Peter/0000-0002-2292-6862				ALEX R, 1990, J MICROENCAPSUL, V7, P347, DOI 10.3109/02652049009021845; Ambravaneswaran B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.034501; Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519; Benichou A, 2002, POLYM ADVAN TECHNOL, V13, P1019, DOI 10.1002/pat.270; Chiba M, 1997, BIOMATERIALS, V18, P893, DOI 10.1016/S0142-9612(97)00027-6; Chu LY, 2003, J COLLOID INTERF SCI, V265, P187, DOI 10.1016/S0021-9797(03)00350-3; Clanet C, 1999, J FLUID MECH, V383, P307, DOI 10.1017/S0022112098004066; Cohen I, 2001, SCIENCE, V292, P265, DOI 10.1126/science.1059175; COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384; Cortesi R, 2002, BIOMATERIALS, V23, P2283, DOI 10.1016/S0142-9612(01)00362-3; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Edris A, 2001, NAHRUNG, V45, P133, DOI 10.1002/1521-3803(20010401)45:2<133::AID-FOOD133>3.0.CO;2-C; Ficheux MF, 1998, LANGMUIR, V14, P2702, DOI 10.1021/la971271z; Gallarate M, 1999, INT J PHARM, V188, P233, DOI 10.1016/S0378-5173(99)00228-8; Gonzalez-Ochoa H, 2003, LANGMUIR, V19, P7837, DOI 10.1021/la0349323; Goubault C, 2001, LANGMUIR, V17, P5184, DOI 10.1021/la010407x; Jiao J, 2002, J COLLOID INTERF SCI, V250, P444, DOI 10.1006/jcis.2002.8365; Kim HK, 2004, J CONTROL RELEASE, V98, P115, DOI 10.1016/j.jconrel.2004.04.020; Lamprecht A, 2004, J CONTROL RELEASE, V98, P1, DOI 10.1016/j.jconrel.2004.02.001; Laugel C, 1998, INT J PHARM, V160, P109, DOI 10.1016/S0378-5173(97)00302-5; Laugel C, 2000, J CONTROL RELEASE, V63, P7, DOI 10.1016/S0168-3659(99)00169-8; Lee DH, 2002, J DISPER SCI TECHNOL, V23, P491, DOI 10.1081/DIS-120014017; Lee MH, 2001, J COLLOID INTERF SCI, V240, P83, DOI 10.1006/jcis.2001.7699; Lissant K., 1974, EMULSION EMULSION TE, V6; Loscertales IG, 2002, SCIENCE, V295, P1695, DOI 10.1126/science.1067595; Mezzenga R, 2004, LANGMUIR, V20, P3574, DOI 10.1021/la036396k; Muguet V, 2001, J CONTROL RELEASE, V70, P37, DOI 10.1016/S0168-3659(00)00314-X; NIHANT N, 1994, PHARMACEUT RES, V11, P1479, DOI 10.1023/A:1018912426983; Okushima S, 2004, LANGMUIR, V20, P9905, DOI 10.1021/la0480336; ORNI S, 2003, J APPL POLYM SCI, V57, P1013; Pays K, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.178304; Plateau J., 1849, ACAD SCI BRUXELLES M, V23, P5; Powers TR, 1998, PHYS FLUIDS, V10, P1052, DOI 10.1063/1.869650; RAGHURAMAN B, 1994, ENVIRON SCI TECHNOL, V28, P1090, DOI 10.1021/es00055a018; Rayleigh L., 1879, P R SOC LOND, V29, P71, DOI [10.1098/rspl.1879.0015, DOI 10.1098/RSPL.1879.0015]; Tomotika S., 1935, P ROY SOC LOND A MAT, V150, P322, DOI DOI 10.1098/RSPA.1935.0104; Vasishtha N., 2001, MICROENCAPSULATION F; Villa CH, 2003, LANGMUIR, V19, P244, DOI 10.1021/la026324d; WEN L, 2000, J COLLOID INTERF SCI, V235, P398; Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591; Yamaguchi Y, 2002, J CONTROL RELEASE, V81, P235, DOI 10.1016/S0168-3659(02)00060-3	41	1701	1810	45	1161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2005	308	5721					537	541		10.1126/science.1109164	http://dx.doi.org/10.1126/science.1109164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BK	15845850				2022-12-28	WOS:000228810500048
J	Walker, JJ; Spear, JR; Pace, NR				Walker, JJ; Spear, JR; Pace, NR			Geobiology of a microbial endolithic community in the Yellowstone geothermal environment	NATURE			English	Article							SEARCH; MARS; LIFE; MICROORGANISMS; BIOMARKERS; ECOSYSTEM; DESERT; RECORD; ALGAE; SOILS	The endolithic environment, the pore space of rocks, is a ubiquitous habitat for microorganisms on the Earth(1) and is an important target of the search for life elsewhere in the Solar System(2). Photosynthetic, endolithic microbial communities commonly inhabit the outer millimetres to centimetres of all rocks exposed to the Earth's surface. In the most extreme terrestrial climates, such as hot and cold deserts, endolithic microorganisms are often the main form of life(3-5). The endolithic microhabitat gives protection from intense solar radiation and desiccation, and it provides mineral nutrients, rock moisture and growth surfaces(4,5). Here we describe the discovery and identification of the constituents of an extremely acidic (pH 1) endolithic microbial community inhabiting the pore space of rocks in the geothermal environment of Yellowstone National Park, USA. Subjected to silica mineralization, such endolithic communities constitute biomarkers that can become fossilized and potentially preserved in the geological record. Remnants of these communities could serve as biosignatures and provide important clues about ancient life associated with geothermal environments on the Earth or elsewhere in the Solar System.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Univ Colorado, Ctr Astrobiol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Pace, NR (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	nrpace@colorado.edu	Spear, John R./ABI-5873-2020	Spear, John/0000-0002-4664-7438				Asada R, 2001, CAN MINERAL, V39, P1, DOI 10.2113/gscanmin.39.1.1; Ascaso C, 2003, GEOMICROBIOL J, V20, P439, DOI 10.1080/713851127; Banfield JF, 2001, ASTROBIOLOGY, V1, P447, DOI 10.1089/153110701753593856; BELL RA, 1993, J PHYCOL, V29, P133, DOI 10.1111/j.0022-3646.1993.00133.x; Blank CE, 2002, APPL ENVIRON MICROB, V68, P5123, DOI 10.1128/AEM.68.10.5123-5135.2002; Cady SL, 1996, CIBA F SYMP, V202, P150; Cady SL, 2003, ASTROBIOLOGY, V3, P351, DOI 10.1089/153110703769016442; Christensen PR, 2003, SCIENCE, V300, P2056, DOI 10.1126/science.1080885; Des Marais DJ, 1999, ANNU REV ECOL SYST, V30, P397; DOEMEL WN, 1971, NATURE, V229, P574, DOI 10.1038/229574a0; Farmer JD, 1999, J GEOPHYS RES-PLANET, V104, P26977, DOI 10.1029/1998JE000540; FRIEDMANN EI, 1982, SCIENCE, V215, P1045, DOI 10.1126/science.215.4536.1045; FRIEDMANN EI, 1976, SCIENCE, V193, P1247, DOI 10.1126/science.193.4259.1247; Frigaard NU, 1996, FEMS MICROBIOL ECOL, V20, P69; GOLUBIC S, 1981, J SEDIMENT PETROL, V51, P475; Gross W, 1998, EUR J PHYCOL, V33, P25, DOI 10.1080/09670269810001736503; Hall-Stoodley L, 1998, FEMS MICROBIOL LETT, V168, P77, DOI 10.1016/S0378-1097(98)00422-4; Hofmann BA, 2000, PLANET SPACE SCI, V48, P1077, DOI 10.1016/S0032-0633(00)00081-7; Iivanainen EK, 1997, FEMS MICROBIOL ECOL, V23, P325, DOI 10.1016/S0168-6496(97)00040-8; MOSSER JL, 1973, SCIENCE, V179, P1323, DOI 10.1126/science.179.4080.1323; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PAPINEAU D, IN PRESS APPL ENV MI; SCHOPF JW, 1965, SCIENCE, V149, P1365, DOI 10.1126/science.149.3690.1365; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; STAMAND AL, IN PRESS J CLIN MICR, V4; WALTER MR, 1972, ECON GEOL, V67, P965, DOI 10.2113/gsecongeo.67.7.965; White D. E., 1988, US GEOLOGICAL SURVEY; WIERZCHOS T, 1994, J MICROSC-OXFORD, V175, P54; ZIERENBERG RA, 1990, NATURE, V348, P155, DOI 10.1038/348155a0	30	165	172	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2005	434	7036					1011	1014		10.1038/nature03447	http://dx.doi.org/10.1038/nature03447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	918EH	15846344				2022-12-28	WOS:000228524600036
J	Oransky, I				Oransky, I			J Donald M Gass - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com						GASS JDM, PUBLICATION LIST	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 9	2005	365	9467					1302	1302		10.1016/S0140-6736(05)61016-1	http://dx.doi.org/10.1016/S0140-6736(05)61016-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914HY	15864835	Bronze			2022-12-28	WOS:000228219600014
J	Lester, HE; Tritter, JQ; Sorohan, H				Lester, HE; Tritter, JQ; Sorohan, H			Patients' and health professionals' views on primary care for people with serious mental illness: focus group study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTITIONERS; SCHIZOPHRENIA	Objective To explore the experience of providing and receiving primary care from the perspectives of primary care health professionals and patients with serious mental illness respectively. Design Qualitative study consisting of six patient groups, six health professional groups, and six combined focus groups. Setting Six primary care trusts in the West Midlands. Participants Forty five patients with serious mental illness, 39 general practitioners (GPs), and eight practice nurses. Results Most health professionals felt that the care of people with serious mental illness was too specialised for primary care. However, most patients viewed primary care as the cornerstone of their health care and prefer-red to consult their own GP, who listened and was willing to learn, rather than be referred to a different,GP with specific mental health knowledge. Swift access was important to patients, with barriers created by the effects of the illness and the noisy or crowded waiting area. Some patients described how they exaggerated symptoms ("acted up") to negotiate an urgent appointment, a strategy that was also employed by some GPs to facilitate admission to secondary care. Most participants felt that structured reviews of care had value. However, whereas health professionals perceived serious mental illness as a lifelong condition, patients emphasised the importance of optimism in treatment and hope for recovery. Conclusions Primary care is of central importance to people with serious mental illness. The challenge for health professionals and patients is to create a system in which patients can see a health professional when they want to without needing to exaggerate their symptoms. The importance that patients attach to optimism in treatment, continuity of care, and listening skills compared with specific mental health knowledge should encourage health professionals in primary care to play a greater role in the care of patients with serious mental illness.	Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Univ Warwick, Warwick Business Sch, Inst Governance & Publ Management, Coventry CV4 7AL, W Midlands, England	University of Birmingham; University of Warwick	Lester, HE (corresponding author), Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	H.E.Lester@bham.ac.uk	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213; Tritter, Jonathan Q/0000-0002-1651-2428				BAILEY D, 1997, J MENT HEALTH, V6, P101, DOI DOI 10.1080/09638239719085; Bindman J, 1997, BRIT J PSYCHIAT, V171, P169, DOI 10.1192/bjp.171.2.169; BRADLEY CP, 1992, FAM PRACT, V9, P98, DOI 10.1093/fampra/9.1.98; Brown S, 1997, BRIT J PSYCHIAT, V171, P502, DOI 10.1192/bjp.171.6.502; Burns T, 2000, PRIMARY CARE PSYCHIA, V6, P67, DOI 10.1185/135525700543253; Harrison G, 2001, BRIT J PSYCHIAT, V178, P506, DOI 10.1192/bjp.178.6.506; Jean YA, 2004, SOCIOL HEALTH ILL, V26, P385, DOI 10.1111/j.0141-9889.2004.00396.x; Kai J, 2001, BRIT J GEN PRACT, V51, P730; KENDRICK T, 1991, BRIT MED J, V302, P508, DOI 10.1136/bmj.302.6775.508; Lang FH, 1997, BRIT J PSYCHIAT, V171, P165, DOI 10.1192/bjp.171.2.165; NAZARETH I, 1993, BRIT MED J, V307, P910, DOI 10.1136/bmj.307.6909.910; ROGERS A, 2001, J MENTAL HLTH, V10, P317, DOI DOI 10.1080/09638230020023840; [No title captured]; [No title captured]; [No title captured]	15	190	191	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2005	330	7500					1122	1126B		10.1136/bmj.38440.418426.8F	http://dx.doi.org/10.1136/bmj.38440.418426.8F			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927BH	15843427	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000229166900020
J	Mitchell, DG; Brandt, PC; Roelof, EC; Dandouras, J; Krimigis, SM; Mauk, BH				Mitchell, DG; Brandt, PC; Roelof, EC; Dandouras, J; Krimigis, SM; Mauk, BH			Energetic neutral atom emissions from Titan interaction with Saturn's magnetosphere	SCIENCE			English	Article							UPPER-ATMOSPHERE; EXOSPHERE; MIMI	The Cassini Magnetospheric Imaging Instrument (MIMI) observed the interaction of Saturn's largest moon, Titan, with Saturn's magnetosphere during two close flybys of Titan on 26 October and 13 December 2004. The MIMI Ion and Neutral Camera (INCA) continuously imaged the energetic neutral atoms (ENAs) generated by charge exchange reactions between the energetic, singly ionized trapped magnetospheric ions and the outer atmosphere, or exosphere, of Titan. The images reveal a halo of variable ENA emission about Titan's nearly collisionless outer atmosphere that fades at larger distances as the exospheric density decays exponentially. The attitude of the emissions varies, and they are not symmetrical about the moon, reflecting the complexity of the interactions between Titan's upper atmosphere and Saturn's space environment.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 21042 USA; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Mitchell, DG (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 21042 USA.	don.mitchell@jhuapl.edu	Mitchell, Donald G/H-4601-2016; Krimigis, Stamatios/G-4591-2019; Roelof, Edmond/G-6654-2019; Mauk, Barry H/E-8420-2017; Dandouras, Iannis/V-2709-2017; Brandt, Pontus C/N-1218-2016	Mitchell, Donald G/0000-0003-1960-2119; Krimigis, Stamatios/0000-0003-2781-2386; Roelof, Edmond/0000-0002-2270-0652; Mauk, Barry H/0000-0001-9789-3797; Dandouras, Iannis/0000-0002-7121-1118; Brandt, Pontus C/0000-0002-4644-0306				Amsif A, 1997, J GEOPHYS RES-SPACE, V102, P22169, DOI 10.1029/97JA01597; Dandouras J, 1999, PLANET SPACE SCI, V47, P1355, DOI 10.1016/S0032-0633(99)00057-4; Krimigis SM, 2004, SPACE SCI REV, V114, P233, DOI 10.1007/s11214-004-1410-8; Krimigis SM, 2005, SCIENCE, V307, P1270, DOI 10.1126/science.1105978; Vervack RJ, 2004, ICARUS, V170, P91, DOI 10.1016/j.icarus.2004.03.005; YELLE RV, 1991, ASTROPHYS J, V383, P380, DOI 10.1086/170796	6	35	36	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2005	308	5724					989	992		10.1126/science.1109805	http://dx.doi.org/10.1126/science.1109805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927JR	15890874				2022-12-28	WOS:000229190700036
J	Acar, M; Becskei, A; van Oudenaarden, A				Acar, M; Becskei, A; van Oudenaarden, A			Enhancement of cellular memory by reducing stochastic transitions	NATURE			English	Article							EUKARYOTIC GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; POSITIVE-FEEDBACK; TOGGLE SWITCH; NETWORK; NOISE; MULTISTABILITY; METABOLISM; STABILITY	On induction of cell differentiation, distinct cell phenotypes are encoded by complex genetic networks(1-3). These networks can prevent the reversion of established phenotypes even in the presence of significant fluctuations. Here we explore the key parameters that determine the stability of cellular memory by using the yeast galactose-signalling network as a model system. This network contains multiple nested feedback loops. Of the two positive feedback loops, only the loop mediated by the cytoplasmic signal transducer Gal3p is able to generate two stable expression states with a persistent memory of previous galactose consumption states. The parallel loop mediated by the galactose transporter Gal2p only increases the expression difference between the two states. A negative feedback through the inhibitor Gal80p reduces the strength of the core positive feedback. Despite this, a constitutive increase in the Gal80p concentration tunes the system from having destabilized memory to having persistent memory. A model reveals that fluctuations are trapped more efficiently at higher Gal80p concentrations. Indeed, the rate at which single cells randomly switch back and forth between expression states was reduced. These observations provide a quantitative understanding of the stability and reversibility of cellular differentiation states.	MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	Acar, Murat/AIB-8244-2022; van Oudenaarden, Alexander/AAA-1705-2019	Becskei, Attila/0000-0002-9462-0934				Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BHAT PJ, 1991, GENETICS, V128, P233; Bialek W, 2001, ADV NEUR IN, V13, P103; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mizutani A, 2003, EMBO J, V22, P2178, DOI 10.1093/emboj/cdg220; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Peng G, 2002, P NATL ACAD SCI USA, V99, P8548, DOI 10.1073/pnas.142100099; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rohde JR, 2000, MOL CELL BIOL, V20, P3880, DOI 10.1128/MCB.20.11.3880-3886.2000; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sillje HHW, 1997, J BACTERIOL, V179, P6560, DOI 10.1128/jb.179.21.6560-6565.1997; SuzukiFujimoto T, 1996, MOL CELL BIOL, V16, P2504; Timson DJ, 2002, BIOCHEM J, V363, P515, DOI 10.1042/0264-6021:3630515; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	30	386	394	5	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					228	232		10.1038/nature03524	http://dx.doi.org/10.1038/nature03524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889097				2022-12-28	WOS:000229021100046
J	Blake, CH; Bloom, JS; Starr, DL; Falco, EE; Skrutskie, M; Fenimore, EE; Duchene, G; Szentgyorgyi, A; Hornstein, S; Prochaska, JX; McCabe, C; Ghez, A; Konopacky, Q; Stapelfeldt, K; Hurley, K; Campbell, R; Kassis, M; Chaffee, F; Gehrels, N; Barthelmy, S; Cummings, JR; Hullinger, D; Krimm, HA; Markwardt, CB; Palmer, D; Parsons, A; McLean, K; Tueller, J				Blake, CH; Bloom, JS; Starr, DL; Falco, EE; Skrutskie, M; Fenimore, EE; Duchene, G; Szentgyorgyi, A; Hornstein, S; Prochaska, JX; McCabe, C; Ghez, A; Konopacky, Q; Stapelfeldt, K; Hurley, K; Campbell, R; Kassis, M; Chaffee, F; Gehrels, N; Barthelmy, S; Cummings, JR; Hullinger, D; Krimm, HA; Markwardt, CB; Palmer, D; Parsons, A; McLean, K; Tueller, J			An infrared flash contemporaneous with the gamma-rays of GRB 041219a	NATURE			English	Article							EARLY OPTICAL-EMISSION; EARLY AFTERGLOW; BURST; RADIATION	The explosion that results in a cosmic gamma-ray burst (GRB) is thought to produce emission from two physical processes: the central engine gives rise to the high-energy emission of the burst through internal shocking(1), and the subsequent interaction of the flow with the external environment produces long-wavelength afterglows(2-4). Although observations of afterglows(5) continue to refine our understanding of GRB progenitors and relativistic shocks, gamma-ray observations alone have not yielded a clear picture of the origin of the prompt emission(6) nor details of the central engine. Only one concurrent visible-light transient has been found(7) and it was associated with emission from an external shock. Here we report the discovery of infrared emission contemporaneous with a GRB, beginning 7.2 minutes after the onset of GRB 041219a ( ref. 8). We acquired 21 images during the active phase of the burst, yielding early multi-colour observations. Our analysis of the initial infrared pulse suggests an origin consistent with internal shocks.	Harvard Univ, Coll Observ, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; Smithsonian Astrophys Observ, Cambridge, MA 02138 USA; Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; WM Keck Observ, Kamuela, HI 96743 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; Univ Calif Los Angeles, Los Angeles, CA 90095 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Observ Grenoble, Astrophys Lab, F-38041 Grenoble, France; Gemini Observ, Hilo, HI 96720 USA; Univ Maryland, College Pk, MD 20742 USA; Univ Space Res Assoc, Columbia, MD 21044 USA	Harvard University; University of California System; University of California Berkeley; Harvard University; Smithsonian Institution; University of California System; University of California Santa Cruz; University of California System; University of California Berkeley; United States Department of Energy (DOE); Los Alamos National Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Virginia; University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University System of Maryland; University of Maryland College Park; Universities Space Research Association (USRA)	Bloom, JS (corresponding author), Harvard Univ, Coll Observ, Cambridge, MA 02138 USA.	jbloom@astro.berkeley.edu	Tueller, Jack/D-5334-2012; Gehrels, Neil/D-2971-2012; Parsons, Ann/I-6604-2012; Stapelfeldt, Karl R/D-2721-2012; Barthelmy, Scott D/D-2943-2012	Blake, Cullen/0000-0002-6096-1749; Bloom, Joshua/0000-0002-7777-216X				Akerlof C, 1999, NATURE, V398, P400, DOI 10.1038/18837; Baring MG, 2004, ASTROPHYS J, V613, P460, DOI 10.1086/422867; Beloborodov AM, 2002, ASTROPHYS J, V565, P808, DOI 10.1086/324195; BLAKE C, 2004, 2870 GCN; CENKO SB, 2004, 2885 GCN; Fenimore EE, 1996, ASTROPHYS J, V473, P998, DOI 10.1086/178210; Fox DW, 2003, NATURE, V422, P284, DOI 10.1038/nature01504; Fox DW, 2003, ASTROPHYS J, V586, pL5, DOI 10.1086/374683; GOTZ D, 2004, 2866 GCN; HEARTY F, 2004, 2916 GCN; Klose S, 2003, ASTROPHYS J, V592, P1025, DOI 10.1086/375861; Kobayashi S, 2000, ASTROPHYS J, V545, P807, DOI 10.1086/317869; Li WD, 2003, ASTROPHYS J, V586, pL9, DOI 10.1086/374684; MATTHEWS K, 1994, ASTROPHYS SPACE SC L, V190, P239; Meszaros P, 1997, ASTROPHYS J, V476, P232, DOI 10.1086/303625; MOON DS, 2004, 2884 GCN; Nakar E, 2004, MON NOT R ASTRON SOC, V353, P647, DOI 10.1111/j.1365-2966.2004.08099.x; Ramirez-Ruiz E, 2000, ASTROPHYS J, V539, P712, DOI 10.1086/309260; Rykoff ES, 2004, ASTROPHYS J, V601, P1013, DOI 10.1086/380777; Sari R, 1999, ASTROPHYS J, V520, P641, DOI 10.1086/307508; Sari R, 1997, ASTROPHYS J, V489, pL37, DOI 10.1086/310957; Sari R, 1998, ASTROPHYS J, V497, pL17, DOI 10.1086/311269; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; van Paradijs J, 2000, ANNU REV ASTRON ASTR, V38, P379, DOI 10.1146/annurev.astro.38.1.379; VANDERHORST A, 2004, 2895 GCN; Vestrand WT, 2005, NATURE, V435, P178, DOI 10.1038/nature03515; Winkler C, 2003, ASTRON ASTROPHYS, V411, pL1, DOI 10.1051/0004-6361:20031288; Zerbi FM, 2003, P SOC PHOTO-OPT INS, V4841, P737, DOI 10.1117/12.459511; Zhang B, 2003, ASTROPHYS J, V595, P950, DOI 10.1086/377363	30	99	101	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2005	435	7039					181	184		10.1038/nature03520	http://dx.doi.org/10.1038/nature03520			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZO	15889085	Green Submitted			2022-12-28	WOS:000229021100033
J	Kassim, Z; Sellars, M; Greenough, A				Kassim, Z; Sellars, M; Greenough, A			Lesson of the week - Underwater birth and neonatal respiratory distress	BMJ-BRITISH MEDICAL JOURNAL			English	Review							WATER BIRTH		Kings Coll Hosp London, Guys Kings & St Thomas Sch Med, Dept Child Hlth, London SE5 9RS, England; Kings Coll Hosp London, Dept Radiol, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Greenough, A (corresponding author), Kings Coll Hosp London, Guys Kings & St Thomas Sch Med, Dept Child Hlth, Denmark Hill, London SE5 9RS, England.	anne.greenough@kcl.ac.uk		Greenough, Anne/0000-0002-8672-5349				BARRY CN, 1995, BRIT MED J, V310, P1602, DOI 10.1136/bmj.310.6994.1602b; Bowden K, 2003, PEDIATRICS, V112, P972; CLUETT ER, 2005, COCHRANE DB SYST REV; *HC HLTH SEL COMM, 1992, 2 HOUS COMM HLTH SEL; Johnson P, 1996, BRIT J OBSTET GYNAEC, V103, P202, DOI 10.1111/j.1471-0528.1996.tb09706.x; Kitzinger S, 2000, BIRTH-ISS PERINAT C, V27, P214; Nagai T, 2003, J CLIN MICROBIOL, V41, P2227, DOI 10.1128/JCM.41.5.2227-2229.2003; Nguyen S, 2002, PEDIATRICS, V110, P411, DOI 10.1542/peds.110.2.411; Pinette MG, 2004, AM J OBSTET GYNECOL, V190, P1211, DOI 10.1016/j.ajog.2003.12.007; RAWAL J, 1994, BRIT MED J, V309, P511, DOI 10.1136/bmj.309.6953.511; Rosser J, 1994, MIDIRS MIDWIFERY DIG, V4, P4; RUTH E, 1999, BRIT MED J, V319, P483; Schroeter K, 2004, PEDIATRICS, V114, P855, DOI 10.1542/peds.2004-0145	13	25	27	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2005	330	7499					1071	1072		10.1136/bmj.330.7499.1071	http://dx.doi.org/10.1136/bmj.330.7499.1071			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	925YY	15879398	Green Published			2022-12-28	WOS:000229090900027
J	Horton, JR; Liebert, K; Hattman, S; Jeltsch, A; Cheng, XD				Horton, JR; Liebert, K; Hattman, S; Jeltsch, A; Cheng, XD			Transition from nonspecific to specific DNA interactions along the substrate-recognition pathway of Dam methyltransferase	CELL			English	Article							ADENINE METHYLASE MUTANTS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TARGET BASE; YERSINIA-PSEUDOTUBERCULOSIS; HETEROLOGOUS SEROVARS; SEQUENCE SPECIFICITY; BACTERIOPHAGE-T4 DAM; IMMUNE-RESPONSES; GENE-EXPRESSION	DNA methyltransferases methylate target bases within specific nucleotide sequences. Three structures are described for bacteriophage T4 DNA-adenine methyltransferase (T4Dam) in ternary complexes with partially and fully specific DNA and a methyl-donor analog. We also report the effects of substitutions in the related Escherichia coli DNA methyltransferase (EcoDam), altering residues corresponding to those involved in specific interaction with the canonical GATC target sequence in T4Dam. We have identified two types of protein-DNA interactions: discriminatory contacts, which stabilize the transition state and accelerate methylation of the cognate site, and antidiscriminatory contacts, which do not significantly affect methylation of the cognate site but disfavor activity at noncognate sites. These structures illustrate the transition in enzyme-DNA interaction from nonspecific to specific interaction, suggesting that there is a temporal order for formation of specific contacts.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Int Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany; Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Emory University; University of Rochester	Jeltsch, A (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	a.jeltsch@iu-bremen.de; xcheng@emory.edu	Horton, John R/ABB-4770-2020; Hu, Ruogu/B-2203-2008; Jeltsch, Albert/O-7404-2014; Horton, John/F-2375-2010	Jeltsch, Albert/0000-0001-6113-9290; Horton, John/0000-0001-9749-8068	NIGMS NIH HHS [R01 GM049245, GM 49245, GM 29227, R01 GM049245-12] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049245] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan BW, 1999, BIOCHEMISTRY-US, V38, P5308, DOI 10.1021/bi9900020; Beck C, 2002, BIOCHEMISTRY-US, V41, P14103, DOI 10.1021/bi025979a; BROOKS JE, 1978, J MOL BIOL, V126, P381, DOI 10.1016/0022-2836(78)90047-5; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; Chen L, 2003, MICROBIOL-SGM, V149, P2283, DOI 10.1099/mic.0.26251-0; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; Dueger EL, 2003, INT J FOOD MICROBIOL, V80, P153, DOI 10.1016/S0168-1605(02)00152-6; Dueger EL, 2001, INFECT IMMUN, V69, P7950, DOI 10.1128/IAI.69.12.7950-7954.2001; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Garcia-Del Portillo F, 1999, P NATL ACAD SCI USA, V96, P11578, DOI 10.1073/pnas.96.20.11578; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hattman S, 2004, PROG NUCLEIC ACID RE, V77, P67, DOI 10.1016/S0079-6603(04)77003-8; HATTMAN S, 1970, VIROLOGY, V42, P359, DOI 10.1016/0042-6822(70)90279-5; HATTMAN S, 1978, J MOL BIOL, V126, P367, DOI 10.1016/0022-2836(78)90046-3; Hattman S, 1999, PHARMACOL THERAPEUT, V84, P367, DOI 10.1016/S0163-7258(99)00042-X; HATTMAN S, 1985, J BACTERIOL, V164, P932, DOI 10.1128/JB.164.2.932-937.1985; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Heithoff DM, 2001, INFECT IMMUN, V69, P6725, DOI 10.1128/IAI.69.11.6725-6730.2001; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; Horton NC, 2002, NAT STRUCT BIOL, V9, P42, DOI 10.1038/nsb741; Julio SM, 2002, INFECT IMMUN, V70, P1006, DOI 10.1128/IAI.70.2.1006-1009.2002; Julio SM, 2001, INFECT IMMUN, V69, P7610, DOI 10.1128/IAI.69.12.7610-7615.2001; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; KLIMASAUSKAS S, 1995, NUCLEIC ACIDS RES, V23, P1388, DOI 10.1093/nar/23.8.1388; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; KOSSYKH VG, 1995, J BIOL CHEM, V270, P14389, DOI 10.1074/jbc.270.24.14389; Krabbe M, 2000, BACTERIAL STRESS RESPONSES, P305; LACKS S, 1977, J MOL BIOL, V114, P153, DOI 10.1016/0022-2836(77)90289-3; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; LAUSTER R, 1987, FEBS LETT, V220, P167, DOI 10.1016/0014-5793(87)80897-9; Liebert K, 2004, J MOL BIOL, V341, P443, DOI 10.1016/j.jmb.2004.05.033; Lobner-Olesen A, 2003, P NATL ACAD SCI USA, V100, P4672, DOI 10.1073/pnas.0538053100; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Malygin EG, 1999, NUCLEIC ACIDS RES, V27, P1135, DOI 10.1093/nar/27.4.1135; MESSER W, 1988, CELL, V54, P735, DOI 10.1016/S0092-8674(88)90911-7; MINER Z, 1989, NUCLEIC ACIDS RES, V17, P8149, DOI 10.1093/nar/17.20.8149; MODRICH P, 1989, J BIOL CHEM, V264, P6597; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; Roth M, 2001, NUCLEIC ACIDS RES, V29, P3137, DOI 10.1093/nar/29.15.3137; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Serre L, 2002, EMBO J, V21, P2854, DOI 10.1093/emboj/cdf304; Tsutakawa SE, 1999, CELL, V99, P615, DOI 10.1016/S0092-8674(00)81550-0; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; Watson ME, 2004, MOL MICROBIOL, V53, P651, DOI 10.1111/j.1365-2958.2004.04140.x; Yang W, 2000, MUTAT RES-DNA REPAIR, V460, P245, DOI 10.1016/S0921-8777(00)00030-6; Yang Z, 2003, NAT STRUCT BIOL, V10, P849, DOI 10.1038/nsb973; Zinoviev VV, 2003, J BIOL CHEM, V278, P7829, DOI 10.1074/jbc.M210769200	53	73	74	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	2005	121	3					349	361		10.1016/j.cell.2005.02.021	http://dx.doi.org/10.1016/j.cell.2005.02.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	925DL	15882618	Green Accepted, Bronze			2022-12-28	WOS:000229031600006
J	Pinker, RT; Zhang, B; Dutton, EG				Pinker, RT; Zhang, B; Dutton, EG			Do satellites detect trends in surface solar radiation?	SCIENCE			English	Article							CLOUDS; IRRADIANCE; CLIMATE; ISCCP; AEROSOLS; PROJECT; BUDGET; SCALE	Long-term variations in solar radiation at Earth's surface (S) can affect our climate, the hydrological cycle, plant photosynthesis, and solar power. Sustained decreases in S have been widely reported from about the year 1960 to 1990. Here we present an estimate of global temporal variations in S by using the longest available satellite record. We observed an overall increase in S from 1983 to 2001 at a rate of 0.16 watts per square meter (0.10%) per year; this change is a combination of a decrease until about 1990, followed by a sustained increase. The global-scale findings are consistent with recent independent satellite observations but differ in sign and magnitude from previously reported ground observations. Unlike ground stations, satellites can uniformly sample the entire globe.	Univ Maryland, Dept Meteorol, College Pk, MD 20742 USA; NASA, Global Modeling & Assimilat Off, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; NOAA, Climate Monitoring & Diagnost Lab, Boulder, CO 80305 USA	University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Oceanic Atmospheric Admin (NOAA) - USA	Pinker, RT (corresponding author), Univ Maryland, Dept Meteorol, College Pk, MD 20742 USA.		Zhang, Banglin/GLN-6919-2022; Pinker, Rachel T/F-6565-2010	Zhang, Banglin/0000-0001-7836-8102; Pinker, Rachel/0000-0003-4249-4427				BARKSTROM BR, 1984, B AM METEOROL SOC, V65, P1170, DOI 10.1175/1520-0477(1984)065<1170:TERBE>2.0.CO;2; Brest CL, 1997, J ATMOS OCEAN TECH, V14, P1091, DOI 10.1175/1520-0426(1997)014<1091:UORCFI>2.0.CO;2; CHIACCHIO P, 2004, AM GEOPH UN 2004 SPR; DESORMEAUX Y, 1993, J ATMOS OCEAN TECH, V10, P304, DOI 10.1175/1520-0426(1993)010<0304:NACOGS>2.0.CO;2; Dutton EG, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003568; Hicks BB, 1996, B AM METEOROL SOC, V77, P2857, DOI 10.1175/1520-0477(1996)077<2857:TNISIS>2.0.CO;2; Liepert BG, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014910; Ohmura A, 1989, IRS 88 CURRENT PROBL; Palle E, 2004, SCIENCE, V304, P1299, DOI 10.1126/science.1094070; Philipona R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020937; Philipona R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018765; Pinker RT, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003301; PINKER RT, 1992, J APPL METEOROL, V31, P194, DOI 10.1175/1520-0450(1992)031<0194:MSSIFS>2.0.CO;2; Power HC, 2003, THEOR APPL CLIMATOL, V76, P47, DOI 10.1007/s00704-003-0005-8; Press W., 1992, NUMERICAL RECIPES FO; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Raveh E, 2003, J EXP BOT, V54, P365, DOI [10.1093/jxb/54.381.365, 10.1093/jxb/erg009]; Roderick ML, 2002, SCIENCE, V298, P1410; Roderick ML, 2001, OECOLOGIA, V129, P21, DOI 10.1007/s004420100760; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; ROSSOW WB, 1991, B AM METEOROL SOC, V72, P2, DOI 10.1175/1520-0477(1991)072<0002:ICDP>2.0.CO;2; ROSSOW WB, 2004, B AM METEOROL SOC, V85; Russak V., 1990, Tellus, Series B (Chemical and Physical Meteorology), V42B, P206, DOI 10.1034/j.1600-0889.1990.t01-1-00006.x; Smith TM, 2004, J CLIMATE, V17, P2466, DOI 10.1175/1520-0442(2004)017<2466:IEROS>2.0.CO;2; Stackhouse P.W., 2004, GEWEX NEWS, V14, P10; Stanhill G, 2001, AGR FOREST METEOROL, V107, P255, DOI 10.1016/S0168-1923(00)00241-0; Stone RS, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000286; Tateishi R, 2004, INT J REMOTE SENS, V25, P2287, DOI 10.1080/01431160310001618455; Tucker CJ, 2001, INT J BIOMETEOROL, V45, P184, DOI 10.1007/s00484-001-0109-8; Wang XJ, 2003, SCIENCE, V299, P1725, DOI 10.1126/science.1078065; WHITFIELD H, 1995, BRIT J UROL, V76, P1; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; Wielicki BA, 2002, SCIENCE, V295, P841, DOI 10.1126/science.1065837; Wild M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019188; WILD M, UNPUB	35	341	368	1	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2005	308	5723					850	854		10.1126/science.1103159	http://dx.doi.org/10.1126/science.1103159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879215				2022-12-28	WOS:000228986500047
J	Zimov, SA				Zimov, SA			Pleistocene park: Return of the mammoth's ecosystem	SCIENCE			English	Article									Russian Acad Sci, Pacific Inst Geog, NE Sci Stn, Far E Branch, Cherskii 678830, Republic Sakha, Russia	Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences	Zimov, SA (corresponding author), Russian Acad Sci, Pacific Inst Geog, NE Sci Stn, Far E Branch, POB 18, Cherskii 678830, Republic Sakha, Russia.		Zimov, Sergey/K-3009-2018	Zimov, Sergey/0000-0002-0053-6599					0	136	145	3	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2005	308	5723					796	798		10.1126/science.1113442	http://dx.doi.org/10.1126/science.1113442			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924NW	15879196				2022-12-28	WOS:000228986500025
J	Min, MS; Yang, SY; Bonett, RM; Vieites, DR; Brandon, RA; Wake, DB				Min, MS; Yang, SY; Bonett, RM; Vieites, DR; Brandon, RA; Wake, DB			Discovery of the first Asian plethodontid salamander	NATURE			English	Article							LIFE-HISTORY EVOLUTION; EASTERN NORTH-AMERICA	Nearly 70% of the 535 species of salamanders in the world are members of a single family, the Plethodontidae, or lungless salamanders(1). The centre of diversity for this clade is North and Middle America, where the vast majority (99%) of species salamander, from montane woodlands in southwestern Korea. The new species superficially resembles members of North American genera, in particular the morphologically conservative genus Plethodon. However, phylogenetic analysis of the nuclear encoded gene Rag-1 shows the new taxon to be widely divergent from Plethodon. The new salamander differs osteologically from putative relatives, especially with respect to the tongue ( attached protrusible) and the derived tarsus(2-6). We place the species in a new genus on the basis of the morphological and molecular data. The distribution of the new salamander adds to the enigma of Old World plethodontids, which are otherwise restricted to the western Mediterranean region(7,8), suggesting a more extensive past distribution of the family.	Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; Seoul Natl Univ, Sch Agr Biotechnol, Conservat Genome Resource Bank Korean Wildlife, Seoul 151742, South Korea; Seoul Natl Univ, Sch Agr Biotechnol, Brain Korea 21, Seoul 151742, South Korea; Inha Univ, Dept Biol, Inchon 402751, South Korea; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; So Illinois Univ, Dept Zool, Carbondale, IL 62901 USA	University of California System; University of California Berkeley; Seoul National University (SNU); Seoul National University (SNU); Inha University; University of California System; University of California Berkeley; Southern Illinois University System; Southern Illinois University	Wake, DB (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	wakelab@uclink.berkeley.edu	Vieites, David/B-4481-2009	Vieites, David/0000-0001-5551-7419				BRODIE E D JR, 1970, Herpetologica, V26, P468; Chippindale PT, 2004, EVOLUTION, V58, P2809; Jenkyns HC, 2004, NATURE, V432, P888, DOI 10.1038/nature03143; Larson Allan, 2003, P31; LOMBARD RE, 1977, J MORPHOL, V153, P39; Mueller RL, 2004, P NATL ACAD SCI USA, V101, P13820, DOI 10.1073/pnas.0405785101; Rasmuseen D.L, 2003, CENOZOIC SYSTEMS ROC, P479; Shubin Neil H., 2003, Amphibian Biology, V5, P1782; TIHEN JA, 1981, J HERPETOL, V15, P35, DOI 10.2307/1563644; Wake David B., 2000, P95, DOI 10.1016/B978-012632590-4/50005-8; WAKE DAVID B., 1966, MEM S CALIF ACAD SCI, V4, P1; WAKE DB, 1978, EVOLUTION, V32, P529, DOI 10.1111/j.1558-5646.1978.tb04595.x; WAKE DB, 1983, NATURAL HIST MUSEUM, V345, P1; Wallace SC, 2004, NATURE, V431, P556, DOI 10.1038/nature02819; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Xiang QY, 1998, MOL PHYLOGENET EVOL, V10, P178, DOI 10.1006/mpev.1998.0524; Xiang QYJ, 2004, EVOLUTION, V58, P2175, DOI 10.1111/j.0014-3820.2004.tb01596.x; 2005, AMPHIBIAWEB	18	81	90	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2005	435	7038					87	90		10.1038/nature03474	http://dx.doi.org/10.1038/nature03474			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922UL	15875021				2022-12-28	WOS:000228864600043
J	Decramer, M; Rutten-van Molken, M; Dekhuijzen, PNR; Troosters, T; van Herwaarden, C; Pellegrino, R; van Schayck, CPO; Olivieri, D; Del Donno, M; De Backer, W; Lankhorst, I; Ardia, A				Decramer, M; Rutten-van Molken, M; Dekhuijzen, PNR; Troosters, T; van Herwaarden, C; Pellegrino, R; van Schayck, CPO; Olivieri, D; Del Donno, M; De Backer, W; Lankhorst, I; Ardia, A			Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial	LANCET			English	Article							INHALED BUDESONIDE; LIPID-PEROXIDATION; OXIDATIVE STRESS; HEALTH-STATUS; DOUBLE-BLIND; COPD; EXACERBATIONS; DECLINE; 8-ISOPROSTANE; FLUTICASONE	Background Increased oxidative stress is important in the pathogenesis of chronic obstructive pulmonary disease (COPD). We postulated that treatment with the antioxidant N-acetylcysteine would reduce the rate of lung-function decline, reduce yearly exacerbation rate, and improve outcomes. Methods in a randomised placebo-controlled study in 50 centres, 523 patients with COPD were randomly assigned to 600 mg daily N-acetylcysteine or placebo. Patients were followed for 3 years. Primary outcomes were yearly reduction in forced expiratory volume in 1 s (FEV1) and the number of exacerbations per year. Analysis was by intention to treat. Findings The yearly rate of decline in FEV1 did not differ between patients assigned N-acetylcysteine and those assigned placebo (54 mL [SE 61 vs 47 mL [61; difference in slope between groups 8 mL [91; 95% CI -25 to 10). The number of exacerbations per year did not differ between groups (1.25 [SD 1.35] vs 1.29 [SD 1.46]; hazard ratio 0.99 [95% CI 0.89-1.10, p=0.85]). Subgroup analysis suggested that the exacerbation rate might be reduced with N-acetylcysteine in patients not treated with inhaled corticosteroids and secondary analysis was suggestive of an effect on hyperinflation. Interpretation N-acetylcysteine is ineffective at prevention of deterioration in lung function and prevention of exacerbations in patients with COPD.	Katholieke Univ Leuven, Univ Hosp, Div Resp, B-3000 Louvain, Belgium; Erasmus Med Ctr Rotterdam, Inst Med Technol, Rotterdam, Netherlands; Univ Med Ctr Nijmegen, Dept Pulm Dis, Nijmegen, Netherlands; Azienda Osped S Croce & Carle, Ctr Fysiopatol Resp & Studio Dispnea, Cuneo, Italy; Univ Parma, Dept Clin Sci, Univ Div Resp Dis, I-43100 Parma, Italy; Azienda Osped G Rummo, Unita Operat Pneumol, Benevento, Italy; Univ Hosp, Antwerp, Belgium; Zambon Grp, Bresso, Italy	KU Leuven; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; University of Parma; Zambon	Decramer, M (corresponding author), Katholieke Univ Leuven, Univ Hosp, Div Resp, Herestr 49, B-3000 Louvain, Belgium.	marc.decramer@uz.kuleuven.ac.be	De Backer, Wilfried/A-9001-2008; Pellegrino, Riccardo/AAA-1667-2022; Molken, Maureen Rutten-van/X-8712-2019; Dekhuijzen, P NR/H-8024-2014; Molken, Maureen PMH Rutten-van/G-8481-2014	Molken, Maureen Rutten-van/0000-0001-8706-3159; Dekhuijzen, P NR/0000-0003-1365-900X; Molken, Maureen PMH Rutten-van/0000-0001-8706-3159				Altose MD, 2000, NEW ENGL J MED, V343, P1902; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Biernacki WA, 2003, THORAX, V58, P294, DOI 10.1136/thorax.58.4.294; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brown H., 1999, APPL MIXED MODELS ME; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Decramer M, 2001, EUR RESPIR J, V17, P329, DOI 10.1183/09031936.01.17303290; Dekhuijzen PNR, 2004, EUR RESPIR J, V23, P629, DOI 10.1183/09031936.04.00016804; Dekhuijzen PNR, 1996, AM J RESP CRIT CARE, V154, P813, DOI 10.1164/ajrccm.154.3.8810624; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; DOOLAN P, 1997, MEDICARE, V35, P1095; Gerrits CMJM, 2003, EUR RESPIR J, V21, P795, DOI 10.1183/09031936.03.00063402; *GLOB INT CHRON OB, 2003, NHLBI WHO WORKSH REP; Grandjean EM, 2000, CLIN THER, V22, P209, DOI 10.1016/S0149-2918(00)88479-9; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Little R. J. A., 1987, STAT ANAL MISSING DA; MacNee W, 1999, AM J RESP CRIT CARE, V160, pS58, DOI 10.1164/ajrccm.160.supplement_1.15; Montuschi P, 2001, CHEST, V120, P496, DOI 10.1378/chest.120.2.496; Montuschi P, 2000, AM J RESP CRIT CARE, V162, P1175, DOI 10.1164/ajrccm.162.3.2001063; NIEDERMAN MS, 1983, AM REV RESPIR DIS, V127, P85, DOI 10.1164/arrd.1983.127.1.85; Paredi P, 2000, AM J RESP CRIT CARE, V162, P369, DOI 10.1164/ajrccm.162.2.9909025; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Pellegrino R, 1998, CHEST, V114, P1607, DOI 10.1378/chest.114.6.1607; Poole PJ, 2001, BMJ-BRIT MED J, V322, P1271, DOI 10.1136/bmj.322.7297.1271; Pratico D, 1998, AM J RESP CRIT CARE, V158, P1709, DOI 10.1164/ajrccm.158.6.9709066; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Repine JE, 1997, AM J RESP CRIT CARE, V156, P341, DOI 10.1164/ajrccm.156.2.9611013; RIISE GC, 1994, EUR RESPIR J, V7, P94, DOI 10.1183/09031936.94.07010094; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Spencer S, 2003, THORAX, V58, P589, DOI 10.1136/thorax.58.7.589; Stey C, 2000, EUR RESPIR J, V16, P253, DOI 10.1034/j.1399-3003.2000.16b12.x; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; THOMEER M, 2004, AM J RESP CRIT CARE, V169; Vestbo J, 1996, AM J RESP CRIT CARE, V153, P1530, DOI 10.1164/ajrccm.153.5.8630597; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702	40	450	476	0	24	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 30	2005	365	9470					1552	1560		10.1016/S0140-6736(05)66456-2	http://dx.doi.org/10.1016/S0140-6736(05)66456-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921HL	15866309				2022-12-28	WOS:000228754800027
J	Borak, A				Borak, A			Toward bridging the terahertz gap with silicon-based lasers	SCIENCE			English	Editorial Material							INTERSUBBAND ELECTROLUMINESCENCE; STIMULATED-EMISSION; CASCADE EMITTERS; CONTINUOUS-WAVE; DONORS		ICI Strateg Technol Grp, Wilton Ctr, Wilton TS10 4RF, Redcar, England		Borak, A (corresponding author), ICI Strateg Technol Grp, Wilton Ctr, Wilton TS10 4RF, Redcar, England.	alex_borak@ici.com						Arnone D, 2000, PHYS WORLD, V13, P35; Barbieri S, 2004, APPL PHYS LETT, V85, P1674, DOI 10.1063/1.1784874; Bates R, 2003, APPL PHYS LETT, V83, P4092, DOI 10.1063/1.1626003; Hubers HW, 2004, APPL PHYS LETT, V84, P3600, DOI 10.1063/1.1737800; Kohler R, 2002, NATURE, V417, P156, DOI 10.1038/417156a; LV P, 2005, MRS S P, V832; Lynch SA, 2002, APPL PHYS LETT, V81, P1543, DOI 10.1063/1.1501759; Mueller E., 2003, IND PHYS, P27; Murzyn P, 2002, APPL PHYS LETT, V80, P1456, DOI 10.1063/1.1452794; PAUL DR, 2000, POLYM BLENDS, V1, P1; Pavlov SG, 2002, APPL PHYS LETT, V80, P4717, DOI 10.1063/1.1489080; Pavlov SG, 2002, J APPL PHYS, V92, P5632, DOI 10.1063/1.1515377; Pavlov SG, 2000, PHYS REV LETT, V84, P5220, DOI 10.1103/PhysRevLett.84.5220; Rong HS, 2005, NATURE, V433, P725, DOI 10.1038/nature03346; Williams BS, 2003, APPL PHYS LETT, V83, P5142, DOI 10.1063/1.1635657	15	51	55	3	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2005	308	5722					638	639		10.1126/science.1109831	http://dx.doi.org/10.1126/science.1109831			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860612				2022-12-28	WOS:000228810900031
J	Fogassi, L; Ferrari, PF; Gesierich, B; Rozzi, S; Chersi, F; Rizzolatti, G				Fogassi, L; Ferrari, PF; Gesierich, B; Rozzi, S; Chersi, F; Rizzolatti, G			Parietal lobe: From action organization to intention understanding	SCIENCE			English	Article							CORTEX; NEURONS; MONKEY; REPRESENTATION; RECOGNITION; PROJECTIONS; MECHANISMS; AFFERENT; OBJECTS	Inferior parietal lobule (IPL) neurons were studied when monkeys performed motor acts embedded in different actions and when they observed similar acts done by an experimenter. Most motor IPL neurons coding a specific act (e.g., grasping) showed markedly different activations when this act was part of different actions (e.g., for eating or for placing). Many motor IPL neurons also discharged during the observation of acts done by others. Most responded differentially when the same observed act was embedded in a specific action. These neurons fired during the observation of an act, before the beginning of the subsequent acts specifying the action. Thus, these neurons not only code the observed motor act but also allow the observer to understand the agent's intentions.	Univ Parma, Dipartimento Psicol, I-43100 Parma, Italy; Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy	University of Parma; University of Parma	Fogassi, L (corresponding author), Univ Parma, Dipartimento Psicol, Borgo Carissimi 10, I-43100 Parma, Italy.	fogassi@unipr.it	Ferrari, Pier Francesco/G-5547-2017; Rozzi, Stefano/F-9915-2019; FOGASSI, Leonardo/K-3541-2018	Rozzi, Stefano/0000-0002-6147-1530; FOGASSI, Leonardo/0000-0003-3348-039X				Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; BAIZER JS, 1991, J NEUROSCI, V11, P168; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; COLBY CL, 1996, INFORMATION INTEGRAT, V14, P157; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; *EU, 2002, QLG3CT200200746 EU; FERRARI PF, 2003, SOC NEUR ABS, V919; FERRARI PF, UNPUB; FOGASSI L, 1998, SOC NEUR ABS, V257; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2002, ATTENTION PERFORM, V19, P334; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HYVARINEN J, 1982, PHYSIOL REV, V62, P1060, DOI 10.1152/physrev.1982.62.3.1060; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Jellema T., 2002, IMITATIVE MIND DEV E, P267; LUPPINO G, 2004, FENS ABSTR; Luria AR., 1973, WORKING BRAIN; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; PERRETT DI, 1989, J EXP BIOL, V146, P87; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Sakata Hideo, 1994, Current Opinion in Neurobiology, V4, P847, DOI 10.1016/0959-4388(94)90133-3; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; TANAKA M, 2004, SOC NEUR ABS, V82; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Yokochi H, 2003, SOMATOSENS MOT RES, V20, P115, DOI 10.1080/0899022031000105145	33	1302	1346	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					662	667		10.1126/science.1106138	http://dx.doi.org/10.1126/science.1106138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15860620				2022-12-28	WOS:000228810900040
J	Hurley, K; Boggs, SE; Smith, DM; Duncan, RC; Lin, R; Zoglauer, A; Krucker, S; Hurford, G; Hudson, H; Wigger, C; Hajdas, W; Thompson, C; Mitrofanov, I; Sanin, A; Boynton, W; Fellows, C; von Kienlin, A; Lichti, G; Rau, A; Cline, T				Hurley, K; Boggs, SE; Smith, DM; Duncan, RC; Lin, R; Zoglauer, A; Krucker, S; Hurford, G; Hudson, H; Wigger, C; Hajdas, W; Thompson, C; Mitrofanov, I; Sanin, A; Boynton, W; Fellows, C; von Kienlin, A; Lichti, G; Rau, A; Cline, T			An exceptionally bright flare from SGR 1806-20 and the origins of short-duration gamma-ray bursts	NATURE			English	Article							MAGNETIZED NEUTRON-STARS; 1998 AUGUST 27; 1979 MARCH 5; X-RAY; SGR 1900+14; RADIATIVE MECHANISM; GIANT FLARE; LBV 1806-20; REPEATERS; SPECTRUM	Soft-gamma-ray repeaters (SGRs) are galactic X-ray stars that emit numerous short-duration (about 0.1 s) bursts of hard X-rays during sporadic active periods. They are thought to be magnetars: strongly magnetized neutron stars with emissions powered by the dissipation of magnetic energy. Here we report the detection of a long (380 s) giant flare from SGR 1806-20, which was much more luminous than any previous transient event observed in our Galaxy. (In the first 0.2 s, the flare released as much energy as the Sun radiates in a quarter of a million years.) Its power can be explained by a catastrophic instability involving global crust failure and magnetic reconnection on a magnetar, with possible large-scale untwisting of magnetic field lines outside the star. From a great distance this event would appear to be a short-duration, hard-spectrum cosmic gamma-ray burst. At least a significant fraction of the mysterious short-duration gamma-ray bursts may therefore come from extragalactic magnetars.	Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; Univ Texas, Dept Astron, Austin, TX 78712 USA; Paul Scherrer Inst, CH-5232 Villigen, Switzerland; Canadian Inst Theoret Astrophys, Toronto, ON M5S 3H8, Canada; Space Res Inst, Moscow 117997, Russia; Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Texas System; University of Texas Austin; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; University of Arizona; Max Planck Society; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Hurley, K (corresponding author), Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA.	khurley@ssl.berkeley.edu	Boggs, Steven E/E-4170-2015; Sanin, Anton/T-9393-2017; Krucker, Säm/G-1021-2019; Smith, David M/A-1744-2011	Boggs, Steven E/0000-0001-9567-4224; Mitrofanov, Igor/0000-0001-7204-2101				BARAT C, 1983, ASTRON ASTROPHYS, V126, P400; BOGGS S, 2004, 2936 GCN; BOGGS S, UNPUB ASTROPHYS J; BORKOWSKI J, 2004, 2920 GCN; CLINE TL, 1980, ASTROPHYS J, V237, pL1, DOI 10.1086/183221; Connaughton V, 2002, ASTROPHYS J, V567, P1028, DOI 10.1086/338695; Corbel S, 2004, ASTRON ASTROPHYS, V419, P191, DOI 10.1051/0004-6361:20034054; Cross N, 2002, MON NOT R ASTRON SOC, V329, P579, DOI 10.1046/j.1365-8711.2002.05052.x; Dezalay JP, 1996, ASTROPHYS J, V471, pL27, DOI 10.1086/310321; Duncan RC, 2001, AIP CONF PROC, V586, P495; DUNCAN RC, 1992, ASTROPHYS J, V392, pL9, DOI 10.1086/186413; EICHLER D, 2002, MON NOT R ASTRON SOC, V576, P381; EVANS WD, 1980, ASTROPHYS J, V237, pL7, DOI 10.1086/183222; FENIMORE E, 2004, SWIFTS ABILITY DETEC; Feroci M, 2001, ASTROPHYS J, V549, P1021, DOI 10.1086/319441; Figer DF, 2004, ASTROPHYS J, V610, pL109, DOI 10.1086/423306; FISHMAN GJ, 1994, ASTROPHYS J SUPPL S, V92, P229, DOI 10.1086/191968; Gogus E, 2001, ASTROPHYS J, V558, P228, DOI 10.1086/322463; GOLENETSKII S, 2004, 2823 GCN; GOLENETSKII SV, 1984, NATURE, V307, P41, DOI 10.1038/307041a0; Hurley K, 1999, NATURE, V397, P41, DOI 10.1038/16199; HURLEY K, 1992, AIP CONF PROC, V265, P3; Hurley K, 2002, ASTROPHYS J, V567, P447, DOI 10.1086/338420; HURLEY K, 2004, 2921 GCN; Kouveliotou C, 1998, NATURE, V393, P235, DOI 10.1038/30410; Kouveliotou C, 1999, ASTROPHYS J, V510, pL115, DOI 10.1086/311813; KOUVELIOTOU C, 1993, ASTROPHYS J, V413, pL101, DOI 10.1086/186969; Kulkarni SR, 2003, ASTROPHYS J, V585, P948, DOI 10.1086/346110; Lazzati D, 2001, ASTRON ASTROPHYS, V379, pL39, DOI 10.1051/0004-6361:20011485; Lenters GT, 2003, ASTROPHYS J, V587, P761, DOI 10.1086/368343; LIN RP, 1995, SPACE SCI REV, V71, P125, DOI 10.1007/BF00751328; Luybarsky Y, 2002, ASTROPHYS J, V580, pL69, DOI 10.1086/345402; Lyutikov M, 2003, MON NOT R ASTRON SOC, V346, P540, DOI 10.1046/j.1365-2966.2003.07110.x; MAZETS E, 2004, 2922 GCN; MAZETS EP, 1979, NATURE, V282, P587, DOI 10.1038/282587a0; MAZETS EP, 1982, ASTROPHYS SPACE SCI, V84, P173, DOI 10.1007/BF00713635; NORRIS JP, 1984, NATURE, V308, P434, DOI 10.1038/308434a0; Paciesas WS, 1999, ASTROPHYS J SUPPL S, V122, P465, DOI 10.1086/313224; PACZYNSKI B, 1986, APJ, V308, P43; TERASAWA T, 2004, PREPRINT; THOMPSON C, 1993, ASTROPHYS J, V408, P194, DOI 10.1086/172580; Thompson C, 2001, ASTROPHYS J, V561, P980, DOI 10.1086/323256; Thompson C, 2002, ASTROPHYS J, V574, P332, DOI 10.1086/340586; Thompson C, 1996, ASTROPHYS J, V473, P322, DOI 10.1086/178147; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255, DOI 10.1093/mnras/275.2.255; Vrba FJ, 2000, ASTROPHYS J, V533, pL17, DOI 10.1086/312602; WOODS P, 2004, ASTRONOMERS TELEGRAM, P313; Woods PM, 2001, ASTROPHYS J, V552, P748, DOI 10.1086/320571; Woods PM, 2002, ASTROPHYS J, V576, P381, DOI 10.1086/341536	50	437	442	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2005	434	7037					1098	1103		10.1038/nature03519	http://dx.doi.org/10.1038/nature03519			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858565				2022-12-28	WOS:000228693300034
J	Terasawa, T; Tanaka, YT; Takei, Y; Kawai, N; Yoshida, A; Nomoto, K; Yoshikawa, I; Saito, Y; Kasaba, Y; Takashima, T; Mukai, T; Noda, H; Murakami, T; Watanabe, K; Muraki, Y; Yokoyama, T; Hoshino, M				Terasawa, T; Tanaka, YT; Takei, Y; Kawai, N; Yoshida, A; Nomoto, K; Yoshikawa, I; Saito, Y; Kasaba, Y; Takashima, T; Mukai, T; Noda, H; Murakami, T; Watanabe, K; Muraki, Y; Yokoyama, T; Hoshino, M			Repeated injections of energy in the first 600ms of the giant flare of SGR 1806-20	NATURE			English	Article							MAGNETIZED NEUTRON-STARS; SOFT GAMMA-REPEATERS; RADIATIVE MECHANISM; SGR 1900+14; AUGUST 27; SOLAR-A; X-RAY	The massive flare of 27 December 2004 from the soft gamma-ray repeater SGR 1806-20, a possible magnetar(1-3), saturated almost all gamma-ray detectors(4-7), meaning that the profile of the pulse was poorly characterized. An accurate profile is essential to determine physically what was happening at the source. Here we report the unsaturated gamma-ray profile for the first 600 ms of the flare, with a time resolution of 5.48 ms. The peak of the profile (of the order of 10(7) photons cm(-2) s(-1)) was reached similar to 50 ms after the onset of the flare, and was then followed by a gradual decrease with superposed oscillatory modulations possibly representing repeated energy injections with similar to 60-ms intervals. The implied total energy is comparable to the stored magnetic energy in a magnetar (similar to 10(47) erg) based on the dipole magnetic field intensity (similar to 10(15) G), suggesting either that the energy release mechanism was extremely efficient or that the interior magnetic field is much stronger than the external dipole field(2).	Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; Tokyo Inst Technol, Dept Phys, Tokyo 1528551, Japan; Aoyama Gakuin Univ, Dept Math & Phys, Sagamihara, Kanagawa 2298558, Japan; Univ Tokyo, Dept Astron, Tokyo 1130033, Japan; ISAS, JAXA, Sagamihara, Kanagawa 2298510, Japan; Natl Astron Observ, Mizusawa Astrogeodynam Observ, Mizusawa 0230861, Japan; Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; Nagoya Univ, Solar Terr Environm Res Lab, Aichi 4648601, Japan	University of Tokyo; Tokyo Institute of Technology; Aoyama Gakuin University; University of Tokyo; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Kanazawa University; Nagoya University	Terasawa, T (corresponding author), Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan.	terasawa@eps.s.u-tokyo.ac.jp	Yokoyama, Takaaki/B-9315-2008; Kasaba, Yasumasa/ABB-4167-2020; Hoshino, Masahiro/A-1837-2009	Yokoyama, Takaaki/0000-0001-5457-4999; Kasaba, Yasumasa/0000-0002-8160-3553; Hoshino, Masahiro/0000-0002-1818-9927; Terasawa, Toshio/0000-0003-2507-9803; Watanabe, Kyoko/0000-0003-0321-7881; Saito, Yoshifumi/0000-0002-1354-3544				BARAT C, 1983, ASTRON ASTROPHYS, V126, P400; HURLEY K, NATURE; KOSUGI T, 1991, SOL PHYS, V136, P17, DOI 10.1007/BF00151693; Matsumoto Y, 2005, PUBL ASTRON SOC JPN, V57, P211, DOI 10.1093/pasj/57.1.211; Mazets EP, 1999, ASTRON LETT+, V25, P635; MAZETS EP, 2005, KONUS WIND HELICON C; MEREGHETTI S, IN PRESS ASTROPHYS J; MUKAI T, 1994, J GEOMAGN GEOELECTR, V46, P669, DOI 10.5636/jgg.46.669; PALMER DM, NATURE; Thompson C, 2001, ASTROPHYS J, V561, P980, DOI 10.1086/323256; Thompson C, 1996, ASTROPHYS J, V473, P322, DOI 10.1086/178147; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255, DOI 10.1093/mnras/275.2.255; YOSHIMORI M, 1991, SOL PHYS, V136, P69, DOI 10.1007/BF00151695	13	118	120	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2005	434	7037					1110	1111		10.1038/nature03573	http://dx.doi.org/10.1038/nature03573			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920MD	15858568	Green Submitted			2022-12-28	WOS:000228693300037
J	Castilla, J; Saa, P; Hetz, C; Soto, C				Castilla, J; Saa, P; Hetz, C; Soto, C			In vitro generation of infectious scrapie prions	CELL			English	Article							CYCLIC AMPLIFICATION; ALPHA-HELICES; PROTEIN; CONVERSION; CONFORMATIONS; PROPAGATION; DISEASES	Prions are unconventional infectious agents responsible for transmissible spongiform encephalopathy (TSE) diseases. They are thought to be composed exclusively of the protease-resistant prion protein (PrPres) that replicates in the body by inducing the misfolding of the cellular prion protein (PrPc). Although compelling evidence supports this hypothesis, generation of infectious prion particles in vitro has not been convincingly demonstrated. Here we show that PrPc -> PrPres conversion can be mimicked in vitro by cyclic amplification of protein misfolding, resulting in indefinite amplification of PrPres. The in vitro-generated forms of PrPres share similar biochemical and structural properties with PrPres derived from sick brains. Inoculation of wild-type hamsters with in vitro-produced PrPres led to a scrapie disease identical to the illness produced by brain infectious material. These findings demonstrate that prions can be generated in vitro and provide strong evidence in support of the protein-only hypothesis of prion transmission.	Univ Texas, Med Branch, Dept Neurol, Galveston, TX 77555 USA; Univ Autonoma Madrid, Ctr Mol Biol, E-28049 Madrid, Spain; Univ Chile, Inst Ciencias Biomed, Santiago, Chile	University of Texas System; University of Texas Medical Branch Galveston; Autonomous University of Madrid; Universidad de Chile	Soto, C (corresponding author), Univ Texas, Med Branch, Dept Neurol, Galveston, TX 77555 USA.	clsoto@utmb.edu	Hetz, Claudio/ABD-7514-2021; Saa, Paula/AAB-6607-2019; Castilla, Joaquin/D-5261-2011; Hetz, Claudio/I-1900-2013; Castilla, Joaquín/J-8414-2019	Saa, Paula/0000-0001-6077-4532; Castilla, Joaquin/0000-0002-2216-1361; Hetz, Claudio/0000-0001-7724-1767; Castilla, Joaquín/0000-0002-2216-1361	NIA NIH HHS [R03 AG0224642] Funding Source: Medline; PHS HHS [R01 N549173] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baskakov IV, 2000, BIOCHEMISTRY-US, V39, P2792, DOI 10.1021/bi9923353; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Bieschke J, 2004, P NATL ACAD SCI USA, V101, P12207, DOI 10.1073/pnas.0404650101; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Castilla J, 2004, J NEUROSCI, V24, P5063, DOI 10.1523/JNEUROSCI.5400-03.2004; Castilla J, 2004, TECHNIQUES PRION RES, P198, DOI [10.1007/978-3-0348-7949-1_14, DOI 10.1007/978-3-0348-7949-1_14]; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chen YM, 2000, J LAW ECON ORGAN, V16, P209, DOI 10.1093/jleo/16.1.209; Chesebro B, 1998, SCIENCE, V279, P42, DOI 10.1126/science.279.5347.42; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; GABIZON R, 1988, P NATL ACAD SCI USA, V85, P6617, DOI 10.1073/pnas.85.18.6617; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lehmann S, 1996, P NATL ACAD SCI USA, V93, P5610, DOI 10.1073/pnas.93.11.5610; Lucassen R, 2003, BIOCHEMISTRY-US, V42, P4127, DOI 10.1021/bi027218d; May BCH, 2004, TRENDS BIOCHEM SCI, V29, P162, DOI 10.1016/j.tibs.2004.02.008; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Mestel R, 1996, SCIENCE, V273, P184, DOI 10.1126/science.273.5272.184; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Piening N, 2005, BIOCHEM BIOPH RES CO, V326, P339, DOI 10.1016/j.bbrc.2004.11.039; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa Paula, 2004, V299, P53; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; SIGURDSSON BJORN, 1954, BRIT VET JOUR, V110, P255; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2004, NAT MED, V10, pS63, DOI 10.1038/nm1069; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Wille H, 2000, J STRUCT BIOL, V130, P323, DOI 10.1006/jsbi.2000.4242; ZHANG H, 1995, J MOL BIOL, V250, P514, DOI 10.1006/jmbi.1995.0395	45	624	656	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 22	2005	121	2					195	206		10.1016/j.cell.2005.02.011	http://dx.doi.org/10.1016/j.cell.2005.02.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851027	Bronze			2022-12-28	WOS:000228705000008
J	Funabiki, H				Funabiki, H			Two birds with one stone - Dealing with nuclear transport and spindle assembly	CELL			English	Editorial Material							MITOTIC SPINDLE; EXPORT FACTOR; PORE COMPLEX; NUP98; RAE1; NUCLEOPORIN	Spindle assembly and nuclear transport both utilize the same simple device: Ran-GTP-sensitive interaction of importin beta and its cargo proteins. In this issue of Cell, Blower et al. (2005) report that one of these cargos required for spindle assembly turns out to be Rae1, previously known as an mRNA export protein. This study reveals the importance of RNAs in spindle structure.	Rockefeller Univ, Lab Chromosome & Cell Biol, New York, NY 10021 USA	Rockefeller University	Funabiki, H (corresponding author), Rockefeller Univ, Lab Chromosome & Cell Biol, New York, NY 10021 USA.			Funabiki, Hironori/0000-0003-4831-4087				Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Murphy R, 1996, MOL BIOL CELL, V7, P1921, DOI 10.1091/mbc.7.12.1921; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237	10	5	5	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 22	2005	121	2					157	158		10.1016/j.cell.2005.04.003	http://dx.doi.org/10.1016/j.cell.2005.04.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	920QK	15851021	Bronze			2022-12-28	WOS:000228705000002
J	Hansson, GK				Hansson, GK			Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							C-REACTIVE PROTEIN; LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE-CELLS; CHLAMYDIA-PNEUMONIAE; UNSTABLE ANGINA; HEART-DISEASE; T-CELLS; DECREASED ATHEROSCLEROSIS; REDUCED ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION		Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Dept Med, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Hansson, GK (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Dept Med, L8-03, SE-17176 Stockholm, Sweden.	goran.hansson@cmm.ki.se	Hansson, Goran K/B-7423-2012	Hansson, Goran/0000-0003-4148-5190				AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223; Arner P, 2003, TRENDS ENDOCRIN MET, V14, P137, DOI 10.1016/S1043-2760(03)00024-9; Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; BOBRYSHEV YV, 1995, ARCH HISTOL CYTOL, V58, P307, DOI 10.1679/aohc.58.307; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Caligiuri G, 2000, CIRCULATION, V102, P1114, DOI 10.1161/01.CIR.102.10.1114; Caligiuri G, 2003, MOL MED, V9, P10, DOI 10.1007/BF03402102; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Caligiuri G, 2001, CIRCULATION, V103, P2834; Cannon CP, 2005, NEW ENGL J MED, V352, P1646, DOI 10.1056/NEJMoa043528; Cercek B, 2003, LANCET, V361, P809, DOI 10.1016/S0140-6736(03)12706-7; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; Dai GH, 2004, P NATL ACAD SCI USA, V101, P14871, DOI 10.1073/pnas.0406073101; Damas JK, 2003, CIRCULATION, V107, P2670, DOI 10.1161/01.CIR.0000070542.18001.87; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; de Boer OJ, 2000, CARDIOVASC RES, V48, P402, DOI 10.1016/S0008-6363(00)00195-4; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Ehrenstein MR, 2005, NEW ENGL J MED, V352, P73, DOI 10.1056/NEJMe048326; Elhage R, 2003, CARDIOVASC RES, V59, P234, DOI 10.1016/S0008-6363(03)00343-2; Engstrom G, 2004, CIRCULATION, V110, P27, DOI 10.1161/01.CIR.0000133277.88655.00; Eriksson EE, 2001, J EXP MED, V194, P205, DOI 10.1084/jem.194.2.205; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P879, DOI 10.1161/01.ATV.0000067937.93716.DB; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Gallo R, 1999, CIRCULATION, V99, P2164, DOI 10.1161/01.CIR.99.16.2164; Grayston JT, 2005, NEW ENGL J MED, V352, P1637, DOI 10.1056/NEJMoa043526; Gredmark S, 2004, J VIROL, V78, P10378, DOI 10.1128/JVI.78.19.10378-10389.2004; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; HACKETT D, 1988, EUR HEART J, V9, P1317, DOI 10.1093/oxfordjournals.eurheartj.a062449; HANSSON GK, 1989, J EXP MED, V170, P1595, DOI 10.1084/jem.170.5.1595; HANSSON GK, 1989, AM J PATHOL, V135, P169; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Harats D, 2002, J AM COLL CARDIOL, V40, P1333, DOI 10.1016/S0735-1097(02)02135-6; Hsich E, 2001, ATHEROSCLEROSIS, V156, P23, DOI 10.1016/S0021-9150(00)00608-0; Hu H, 1999, J CLIN INVEST, V103, P747, DOI 10.1172/JCI4582; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; JONASSON L, 1988, P NATL ACAD SCI USA, V85, P2303, DOI 10.1073/pnas.85.7.2303; Jones CB, 2003, CARDIOVASC RES, V59, P812, DOI 10.1016/S0008-6363(03)00516-9; Kalayoglu MV, 2002, JAMA-J AM MED ASSOC, V288, P2724, DOI 10.1001/jama.288.21.2724; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Laurat E, 2001, CIRCULATION, V104, P197, DOI 10.1161/01.CIR.104.2.197; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Libby P, 2003, NAT MED, V9, P146, DOI 10.1038/nm0103-146b; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Liuzzo G, 1996, CIRCULATION, V94, P2373, DOI 10.1161/01.CIR.94.10.2373; Liuzzo G, 2000, CIRCULATION, V101, P2883, DOI 10.1161/01.CIR.101.25.2883; Ludewig B, 2000, P NATL ACAD SCI USA, V97, P12752, DOI 10.1073/pnas.220427097; Lutters BCH, 2004, CURR OPIN LIPIDOL, V15, P545, DOI 10.1097/00041433-200410000-00008; Mach F, 1997, CIRCULATION, V96, P396; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Mallat Z, 2001, CIRC RES, V89, pE41, DOI 10.1161/hh1901.098735; Maron R, 2002, CIRCULATION, V106, P1708, DOI 10.1161/01.CIR.0000029750.99462.30; Marx SO, 2001, CIRCULATION, V104, P852, DOI 10.1161/01.CIR.104.8.852; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Nilsson J, 2005, ARTERIOSCL THROM VAS, V25, P18, DOI 10.1161/01.ATV.0000149142.42590.a2; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Perschinka H, 2003, ARTERIOSCL THROM VAS, V23, P1060, DOI 10.1161/01.ATV.0000071701.62486.49; Pinderski LJ, 2002, CIRC RES, V90, P1064, DOI 10.1161/01.RES.0000018941.10726.FA; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Saren P, 1996, J IMMUNOL, V157, P4159; Shimizu K, 2004, J CLIN INVEST, V114, P739, DOI 10.1172/JCI200419855C1; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Soderberg-Naucler C, 2001, TRANSPLANTATION, V71, pSS24; Sposito AC, 2002, ARTERIOSCL THROM VAS, V22, P1524, DOI 10.1161/01.ATV.0000032033.39301.6A; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Streblow DN, 1999, CELL, V99, P511, DOI 10.1016/S0092-8674(00)81539-1; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; Uyemura K, 1996, J CLIN INVEST, V97, P2130, DOI 10.1172/JCI118650; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Whitman SC, 2002, J INTERF CYTOK RES, V22, P661, DOI 10.1089/10799900260100141; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804; Witztum JL, 2002, J CLIN INVEST, V109, P721, DOI 10.1172/JCI200215310; Xu QB, 2002, ARTERIOSCL THROM VAS, V22, P1547, DOI 10.1161/01.ATV.0000029720.59649.50; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Yudkin JS, 2004, METABOLISM, V53, P852, DOI 10.1016/j.metabol.2004.02.004; Zhou XH, 2001, ARTERIOSCL THROM VAS, V21, P108, DOI 10.1161/01.ATV.21.1.108; Zhu JH, 2000, AM J CARDIOL, V85, P140, DOI 10.1016/S0002-9149(99)00653-0	114	6403	6877	39	1267	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2005	352	16					1685	1695		10.1056/NEJMra043430	http://dx.doi.org/10.1056/NEJMra043430			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918CE	15843671				2022-12-28	WOS:000228515200010
J	Segev, DL; Gentry, SE; Warren, DS; Reel, B; Montgomery, RA				Segev, DL; Gentry, SE; Warren, DS; Reel, B; Montgomery, RA			Kidney paired donation and optimizing the use of live donor organs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RENAL-TRANSPLANTATION; CADAVERIC KIDNEYS; HLA ANTIGENS; PLASMAPHERESIS; RECIPIENTS; REJECTION; ALGORITHM; SURVIVAL; GLOBULIN; ANTIBODY	Context Blood type and crossmatch incompatibility will exclude at least one third of patients in need from receiving a live donor kidney transplant. Kidney paired donation (KPD) offers incompatible donor/recipient pairs the opportunity to match for compatible transplants. Despite its increasing popularity, very few transplants have resulted from KPD. Objective To determine the potential impact of improved matching schemes on the number and quality of transplants achievable with KPD. Design, Setting, and Population We developed a model that simulates pools of incompatible donor/recipient pairs. We designed a mathematically verifiable optimized matching algorithm and compared it with the scheme currently used in some centers and regions. Simulated patients from the general community with characteristics drawn from distributions describing end-stage renal disease patients eligible for renal transplantation and their willing and eligible live donors. Main Outcome Measures Number of kidneys matched, HLA mismatch of matched kidneys, and number of grafts surviving 5 years after transplantation. Results A national optimized matching algorithm would result in more transplants (47.7% vs 42.0%, P < .001), better HLA concordance (3.0 vs 4.5 mismatched antigens; P < .001), more grafts surviving at 5 years (34.9% vs 28.7%; P < .001), and a reduction in the number of pairs required to travel (2.9% vs 18.4%; P < .001) when compared with an extension of the currently used first-accept scheme to a national level. Furthermore, highly sensitized patients would benefit 6-fold from a national optimized scheme (2.3% vs 14.1% successfully matched; P < .001). Even if only 7% of patients awaiting kidney transplantation participated in an optimized national KPD program, the health care system could save as much as $750 million. Conclusions The combination of a national KPD program and a mathematically optimized matching algorithm yields more matches with lower HLA disparity. Optimized matching affords patients the flexibility of customizing their matching priorities and the security of knowing that the greatest number of high-quality matches will be found and distributed equitably.	Johns Hopkins Univ, Sch Med, Dept Surg, Div Transplantat, Baltimore, MD 21287 USA; MIT, Informat & Decis Syst Lab, Cambridge, MA 02139 USA	Johns Hopkins University; Massachusetts Institute of Technology (MIT)	Segev, DL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Div Transplantat, 720 Rutland Ave,Ross 765, Baltimore, MD 21287 USA.	dorry@jhmi.edu	Gentry, Sommer/H-7101-2019	Gentry, Sommer/0000-0003-4530-8917				Delmonico FL, 2004, AM J TRANSPLANT, V4, P1628, DOI 10.1111/j.1600-6143.2004.00572.x; Doxiadis IIN, 1996, LANCET, V348, P850, DOI 10.1016/S0140-6736(96)02296-9; Doxiadis IIN, 1996, TRANSPLANT P, V28, P224; Duquesnoy RJ, 2002, HUM IMMUNOL, V63, P339, DOI 10.1016/S0198-8859(02)00382-8; EDMONDS J, 1965, CANADIAN J MATH, V17, P449, DOI 10.4153/CJM-1965-045-4; GJERTSON DW, 1991, NEW ENGL J MED, V324, P1032, DOI 10.1056/NEJM199104113241505; Jordan Stanley C, 2003, Clin Transpl, P193; LEFFELL MS, 1994, TRANSPLANTATION, V58, P1119, DOI 10.1097/00007890-199411270-00011; LOVASZ L, 1986, MATCHING THEORY, P369; MARTIN S, 1993, TRANSPLANT P, V25, P265; Montgomery RA, 2004, AM J TRANSPLANT, V4, P1011, DOI 10.1111/j.1600-6143.2004.00496.x; Montgomery RA, 2000, TRANSPLANTATION, V70, P887, DOI 10.1097/00007890-200009270-00006; Montgomery Robert A, 2003, Clin Transpl, P199; Opelz G, 1997, TRANSPLANTATION, V64, P1473, DOI 10.1097/00007890-199711270-00017; Ross LF, 1997, NEW ENGL J MED, V336, P1752, DOI 10.1056/NEJM199706123362412; Ross LF, 2000, TRANSPLANTATION, V69, P1539; Roth AE, 2004, Q J ECON, V119, P457, DOI 10.1162/0033553041382157; Sonnenday CJ, 2004, AM J TRANSPLANT, V4, P1315, DOI 10.1111/j.1600-6143.2004.00507.x; Stegall MD, 2004, TRANSPLANTATION, V78, P635, DOI 10.1097/01.tp.0000136263.46262.0d; Takemoto SK, 2000, NEW ENGL J MED, V343, P1078, DOI 10.1056/NEJM200010123431504; Takemoto SK, 2004, AM J TRANSPLANT, V4, P1033, DOI 10.1111/j.1600-6143.2004.00500.x; Thompson JS, 2002, TRANSPLANTATION, V73, P1274, DOI 10.1097/00007890-200204270-00015; *UNOS, 2004, CONC PROP NAT LIV DO; *UNOS, UNOS ORG PROC TRANSP; *US REN DAT SYST, 2003, US REN DAT SYST ANN; Warren DS, 2004, AM J TRANSPLANT, V4, P561, DOI 10.1111/j.1600-6143.2004.00364.x; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Zachary AA, 2003, TRANSPLANTATION, V76, P1519, DOI 10.1097/01.TP.0000090868.88895.E0; Zenios SA, 2002, MANAGE SCI, V48, P328, DOI 10.1287/mnsc.48.3.328.7732; Zenios SA, 2001, TRANSPLANTATION, V72, P648, DOI 10.1097/00007890-200108270-00015	30	291	294	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2005	293	15					1883	1890		10.1001/jama.293.15.1883	http://dx.doi.org/10.1001/jama.293.15.1883			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	916QW	15840863	Bronze			2022-12-28	WOS:000228401700027
J	Beghi, E; Bendotti, C; Mennini, T				Beghi, E; Bendotti, C; Mennini, T			Merits of a new drug trial for ALS?	SCIENCE			English	Letter							AMYOTROPHIC-LATERAL-SCLEROSIS; CEFTRIAXONE		Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Beghi, E (corresponding author), Mario Negri Inst Pharmacol Res, Via Eritrea 62, I-20157 Milan, Italy.	beghi@marionegri.it	Bendotti, Caterina/AAB-2273-2020; Beghi, Ettore/AAA-7426-2020	Bendotti, Caterina/0000-0003-1055-1271; Beghi, Ettore/0000-0003-2542-0469; Cleveland, Don/0000-0002-1934-3682				Beghi E, 1996, EUR J NEUROL, V3, P295; CARELLI V, 1994, ITAL J NEUROL SCI, V15, P66; Carod Artal F J, 1994, Neurologia, V9, P29; COURATIER P, 1994, THERAPIE, V49, P146; Gil Llano J R, 1994, Neurologia, V9, P205; NORRIS FH, 1994, ARCH NEUROL-CHICAGO, V51, P447, DOI 10.1001/archneur.1994.00540170019006; ROBBERECHT W, 1992, LANCET, V340, P1096, DOI 10.1016/0140-6736(92)93115-4; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; SMITH LG, 1992, LANCET, V340, P379, DOI 10.1016/0140-6736(92)91463-I	9	11	11	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2005	308	5722					632	632						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	922BO	15864832				2022-12-28	WOS:000228810900018
